Citrus Sinensis ID: 025011
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S9M3 | 730 | Wall-associated receptor | yes | no | 0.915 | 0.324 | 0.483 | 6e-64 | |
| Q9S9M5 | 730 | Wall-associated receptor | yes | no | 0.938 | 0.332 | 0.5 | 1e-63 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.907 | 0.296 | 0.493 | 2e-63 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.915 | 0.316 | 0.495 | 4e-63 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.922 | 0.318 | 0.5 | 7e-63 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.934 | 0.314 | 0.473 | 2e-62 | |
| Q9LMN8 | 741 | Wall-associated receptor | no | no | 0.942 | 0.329 | 0.505 | 7e-62 | |
| Q9S9M1 | 731 | Wall-associated receptor | no | no | 0.930 | 0.329 | 0.483 | 7e-62 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.899 | 0.323 | 0.516 | 1e-61 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.934 | 0.307 | 0.502 | 8e-61 |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 244 bits (622), Expect = 6e-64, Method: Compositional matrix adjust.
Identities = 117/242 (48%), Positives = 175/242 (72%), Gaps = 5/242 (2%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+N+VK+LG CLET+VP+LVYE++PNG LF +HD+ + W+ L
Sbjct: 469 FINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRL 528
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A AL Y+HS+AS PI H D+K+TN+LLD+ Y+AK++DFG+S +++D QT +TT
Sbjct: 529 RIAVEIAGALSYMHSAASFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATD-QTHLTT 587
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF +DPEY ++ + T KSDVYSFGV+L EL+TG KP S + S EGI + YFL
Sbjct: 588 LVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPMS--RVRSEEGIGLATYFL 645
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N I++ ++ DES +++ VA LA +CL+ G +RP M++VS +L+R++ S
Sbjct: 646 EAMKENRAVDIIDIRIKDES--KQVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSSP 703
Query: 245 EN 246
++
Sbjct: 704 KD 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 243 bits (620), Expect = 1e-63, Method: Compositional matrix adjust.
Identities = 123/246 (50%), Positives = 178/246 (72%), Gaps = 3/246 (1%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+N+VK+LG CLET+VP+LVYE++PNG LF +HD+S W+ L
Sbjct: 470 FINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRL 529
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A AL Y+HS+AS PI H D+K+TN+LLD+ Y+AKV+DFG+S ++ D QT +TT
Sbjct: 530 RIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLD-QTHLTT 588
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF +DPEY ++ + T KSDVYSFGV+L EL+TG KP S + S EG + +FL
Sbjct: 589 LVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLS--RVRSEEGRGLATHFL 646
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ DES++E++ VA LA KCL+ G+ RP MK+VS EL+R++ S
Sbjct: 647 EAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSP 706
Query: 245 ENYEHR 250
E+ + R
Sbjct: 707 EDLDVR 712
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 242 bits (617), Expect = 2e-63, Method: Compositional matrix adjust.
Identities = 118/239 (49%), Positives = 171/239 (71%), Gaps = 4/239 (1%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWKTC 63
F +E+ ++SQINH+N+VK+LG CLETKVP+LVYEF+PNG LF+H+HD+ + ++ W
Sbjct: 488 FINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIR 547
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
LRIA + A AL YLHSSAS PI H DVKSTN++LD+ Y+AKV+DFG+S ++ D T +T
Sbjct: 548 LRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVD-HTHLT 606
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT +DPEY + + T+KSDVYSFGV+L EL+TG K S L S E ++ YF
Sbjct: 607 TVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSIS--FLRSQENRTLATYF 664
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242
+ +++ N L I++ ++ D + ++ A +A KCL+L GR+RP+M++VS ELD +++
Sbjct: 665 ILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRM 723
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 241 bits (615), Expect = 4e-63, Method: Compositional matrix adjust.
Identities = 119/240 (49%), Positives = 172/240 (71%), Gaps = 3/240 (1%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ V++QINH+N+VK+LG CLET+VP+LVYEFVPNG L +HD+S W+ L
Sbjct: 457 FINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRL 516
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
IA E A AL YLHS+AS PI H D+K+TN+LLD+ +AKV+DFG+S ++ D QT +TT
Sbjct: 517 HIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTID-QTHLTT 575
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+ GTF +DPEY + K TEKSDVYSFGV+L ELLTG KP S + N G++ +F+
Sbjct: 576 QVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAA--HFV 633
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ DE M+++ +VA LA +CL+ G++RP M++VS EL+ ++ SH
Sbjct: 634 EAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 240 bits (613), Expect = 7e-63, Method: Compositional matrix adjust.
Identities = 121/242 (50%), Positives = 170/242 (70%), Gaps = 3/242 (1%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ V+SQINH+N+VK++G CLET+VP+LVYE +PNG LF +H S W L
Sbjct: 462 FINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRL 521
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RI+ E A AL YLHS+AS P+ H DVK+TN+LLD+ Y+AKV+DFG+S I+ D QT +TT
Sbjct: 522 RISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVD-QTHLTT 580
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF LDPEY T + T+KSDVYSFGV+L EL+TG KP S M N G +V +F
Sbjct: 581 LVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRG--LVSHFN 638
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ + +E++ VA LA +CLSL G++RP M++VS EL+R++ S
Sbjct: 639 EAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSP 698
Query: 245 EN 246
E+
Sbjct: 699 ED 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 239 bits (609), Expect = 2e-62, Method: Compositional matrix adjust.
Identities = 118/249 (47%), Positives = 175/249 (70%), Gaps = 7/249 (2%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWKTC 63
F +E+ ++SQINH+N+VK+LG CLET VP+LVYEF+PNG LF+H+HD S + W+
Sbjct: 474 FINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVR 533
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
LRIA + A AL YLHS+AS PI H D+KSTN++LD+ ++AKV+DFG+S ++ D T +T
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVD-HTHLT 592
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT +DPEY + + T+KSDVYSFGV+LAEL+TG K S L S E ++ YF
Sbjct: 593 TVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVS--FLRSQEYRTLATYF 650
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
+++ N L I++ ++ D ++ ++ A +A KCL++ GR+RP+M+QVS EL++++
Sbjct: 651 TLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSY 710
Query: 244 HEN---YEH 249
E+ YE+
Sbjct: 711 SEDMQPYEY 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMN8|WAK3_ARATH Wall-associated receptor kinase 3 OS=Arabidopsis thaliana GN=WAK3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 127/251 (50%), Positives = 169/251 (67%), Gaps = 7/251 (2%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F HE+ V+SQINH+NVVKILG CLET+VPLLVYEF+ NGTLFDH+H W+ L
Sbjct: 456 FIHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRL 515
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A L YLHSSAS PIIH D+K+ N+LLD+N AKVADFG+S LI D + +TT
Sbjct: 516 RIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKE-QLTT 574
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGIS-MVQYF 183
GT LDPEY TG L EKSDVYSFGV+L ELL+G K + + +V YF
Sbjct: 575 MVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQK---ALCFERPQASKHLVSYF 631
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
+ + E N L +I++ QV +E ++EI+ A +A++C L G RP MK+V+ +L+ L++
Sbjct: 632 VSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRV- 690
Query: 244 HENYEHRRTEK 254
E +H+ +++
Sbjct: 691 -EKTKHKWSDQ 700
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M1|WAKLE_ARATH Wall-associated receptor kinase-like 5 OS=Arabidopsis thaliana GN=WAKL5 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 237 bits (604), Expect = 7e-62, Method: Compositional matrix adjust.
Identities = 118/244 (48%), Positives = 176/244 (72%), Gaps = 3/244 (1%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+N+VK++G CLET+VP+LVYE++PNG +F +HD+S W+ L
Sbjct: 473 FINEIILLSQINHRNIVKLIGCCLETEVPILVYEYIPNGDMFKRLHDESDDYAMTWEVRL 532
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A AL Y+HS+AS PI H D+K+TN+LLD+ Y AKV+DFG+S ++ D QT +TT
Sbjct: 533 RIAIEIAGALTYMHSAASFPIYHRDIKTTNILLDEKYGAKVSDFGTSRSVTID-QTHLTT 591
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF +DPEY ++ + T+KSDVYSFGV+L EL+TG KP S + S EG + +FL
Sbjct: 592 MVAGTFGYMDPEYFLSSQYTDKSDVYSFGVVLVELITGEKPLS--RIRSEEGRGLATHFL 649
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ +ES+++++ VA LA KCLS G +RP M++ S EL+R++ S
Sbjct: 650 EAMKENRVIDIIDIRIKEESKLDQLMAVAKLARKCLSRKGIKRPNMREASLELERIRSSP 709
Query: 245 ENYE 248
E+ E
Sbjct: 710 EDLE 713
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. May be involved in plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 236 bits (601), Expect = 1e-61, Method: Compositional matrix adjust.
Identities = 123/238 (51%), Positives = 168/238 (70%), Gaps = 5/238 (2%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+NVVKILG CLET+VP+LVYEF+PN LFDH+H+ S +W+ L
Sbjct: 431 FINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRL 490
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
IA E A AL YLHS+ S PI H DVKSTN+LLD+ ++AKV+DFG S ++ D+ T +TT
Sbjct: 491 CIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDD-THLTT 549
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV-QYF 183
GT +DPEY+ + T KSDVYSFGVLL ELLTG KP ++L + + M+ YF
Sbjct: 550 IVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKP---VSLLRRQEVRMLGAYF 606
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
L ++ N+ L +IL+ ++ +E + EE+ VA LA +CLSL+ RPTM+ V ELDR++
Sbjct: 607 LEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQ 664
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 233 bits (595), Expect = 8e-61, Method: Compositional matrix adjust.
Identities = 123/245 (50%), Positives = 171/245 (69%), Gaps = 3/245 (1%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWK 61
Q F +E+ ++SQINH++VVK+LG CLET+VP+LVYEF+ NG LF HIH++ + W
Sbjct: 483 QEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWG 542
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
LRIA + A AL YLHS+AS PI H D+KSTN+LLD+ Y+AKVADFG+S ++ D QT
Sbjct: 543 MRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTID-QTH 601
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
TT GT +DPEY + + TEKSDVYSFGV+LAEL+TG KP M + E I++ +
Sbjct: 602 WTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKP-VIMVQNTQEIIALAE 660
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+F +++ L I++ ++ D+S+ E++ VA LA KCLS GR RP M++V EL+R+
Sbjct: 661 HFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERIC 720
Query: 242 ISHEN 246
S E+
Sbjct: 721 TSPED 725
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | ||||||
| 224102957 | 615 | predicted protein [Populus trichocarpa] | 0.922 | 0.388 | 0.663 | 3e-85 | |
| 224102953 | 633 | predicted protein [Populus trichocarpa] | 0.922 | 0.377 | 0.659 | 6e-85 | |
| 255573259 | 771 | serine-threonine protein kinase, plant-t | 0.934 | 0.313 | 0.653 | 2e-82 | |
| 255573255 | 739 | kinase, putative [Ricinus communis] gi|2 | 0.930 | 0.326 | 0.642 | 1e-81 | |
| 224132160 | 667 | predicted protein [Populus trichocarpa] | 0.918 | 0.356 | 0.647 | 1e-81 | |
| 224132156 | 667 | predicted protein [Populus trichocarpa] | 0.918 | 0.356 | 0.647 | 2e-81 | |
| 224132144 | 646 | predicted protein [Populus trichocarpa] | 0.934 | 0.374 | 0.616 | 3e-80 | |
| 224132168 | 321 | predicted protein [Populus trichocarpa] | 0.938 | 0.757 | 0.604 | 7e-79 | |
| 255565901 | 457 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.915 | 0.518 | 0.630 | 3e-78 | |
| 224132184 | 291 | predicted protein [Populus trichocarpa] | 0.922 | 0.821 | 0.605 | 5e-78 |
| >gi|224102957|ref|XP_002312869.1| predicted protein [Populus trichocarpa] gi|222849277|gb|EEE86824.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 320 bits (820), Expect = 3e-85, Method: Compositional matrix adjust.
Identities = 160/241 (66%), Positives = 186/241 (77%), Gaps = 2/241 (0%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN+ FQHE+ VVSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTLF HIHDK SQVL +W
Sbjct: 325 MNEDFQHEICVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKRSQVLASW 384
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LRIA+E A ALDYLHS A PP+IHGDVKS N+LLDDNY AKVADFG+SVLIS
Sbjct: 385 SNRLRIASEAALALDYLHSLADPPVIHGDVKSVNILLDDNYTAKVADFGASVLISPGQTN 444
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GTF LDPEY++TG LTEKSDVYSFGV+L ELLTG KP S S + +
Sbjct: 445 ILATKIQGTFGYLDPEYLLTGNLTEKSDVYSFGVVLVELLTGEKPNSNA--KSGNKRNFI 502
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
QYF ++ENN L IL+FQ ADE+EM+EIE VA LA +CL+ G RP+MK+VSEEL +L
Sbjct: 503 QYFNSALENNDLFGILDFQAADEAEMDEIEAVAELAKRCLNSIGVNRPSMKEVSEELAKL 562
Query: 241 K 241
K
Sbjct: 563 K 563
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224102953|ref|XP_002312868.1| predicted protein [Populus trichocarpa] gi|222849276|gb|EEE86823.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 320 bits (819), Expect = 6e-85, Method: Compositional matrix adjust.
Identities = 159/241 (65%), Positives = 188/241 (78%), Gaps = 2/241 (0%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN+ FQHE+ VVSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTLF HIHDK SQVL +W
Sbjct: 395 MNEDFQHEICVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKRSQVLASW 454
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LRIA+E A ALDYLHS A PP+IHGDVKS N+LLDDNY AKVADFG+SVLIS
Sbjct: 455 SNRLRIASEAALALDYLHSLADPPVIHGDVKSVNILLDDNYTAKVADFGASVLISPGQTN 514
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GTF LDPEY++TG LTEKSDVYSFGV+L ELLTG KP S S + + +
Sbjct: 515 ILATKIQGTFGYLDPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNSNA--KSGKKRNFI 572
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
QYF ++ENN + IL+FQ ADE+EM+EIE VA LA +CL+ +G RP+MK+VSEEL +L
Sbjct: 573 QYFNSALENNDVFGILDFQAADEAEMDEIEAVAELAKRCLNSTGVNRPSMKEVSEELAKL 632
Query: 241 K 241
K
Sbjct: 633 K 633
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573259|ref|XP_002527558.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533050|gb|EEF34810.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 311 bits (796), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 160/245 (65%), Positives = 186/245 (75%), Gaps = 3/245 (1%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MNQ FQ E+ +VSQ+NH NVVK+LG CLET VPLLVYEFV NG L+ HIH K SQ+L W
Sbjct: 481 MNQEFQKEIGIVSQVNHINVVKVLGLCLETNVPLLVYEFVSNGNLYQHIHQKRSQLLTAW 540
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
K LRIAAETA ALDYLHS A+PPIIHGDVKS N+LLD+NY AKV+DFG+SVLISS NQT
Sbjct: 541 KNILRIAAETALALDYLHSLANPPIIHGDVKSANILLDENYTAKVSDFGASVLISS-NQT 599
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
M TK GTF LDPEY++TG LTEKSDVYSFGV+L ELLTG KP S S E +++
Sbjct: 600 DMATKIQGTFGYLDPEYLMTGNLTEKSDVYSFGVVLVELLTGEKPNSNP--KSGEKNNII 657
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
QYFL S+EN L QI F++ + EMEEIE A LA +CL SG +RPTM +V+ EL RL
Sbjct: 658 QYFLSSLENGDLNQIPCFEITSKEEMEEIEVFAELAKQCLRSSGIKRPTMNEVAHELVRL 717
Query: 241 KISHE 245
+ HE
Sbjct: 718 RKLHE 722
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573255|ref|XP_002527556.1| kinase, putative [Ricinus communis] gi|223533048|gb|EEF34808.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 308 bits (790), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 158/246 (64%), Positives = 189/246 (76%), Gaps = 5/246 (2%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ Q +QHE+ +VSQ+NHKNVVKILG CLETKVPLLVYEF+ NGTLF HIH K SQ+L NW
Sbjct: 451 IKQEYQHEIGIVSQVNHKNVVKILGLCLETKVPLLVYEFISNGTLFHHIHHKRSQILANW 510
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
K LRIAAETA A DYLHS A PPIIHGDVKS N+LLDD Y AKV+DFG+SVLISS ++
Sbjct: 511 KNRLRIAAETALAFDYLHSLADPPIIHGDVKSLNILLDDTYTAKVSDFGASVLISS-GES 569
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ K GTF LDPEY++TG LTEKSDVYSFGV+L ELLTG KP S ++ G ++
Sbjct: 570 DIGAKLQGTFGYLDPEYLMTGILTEKSDVYSFGVVLVELLTGEKPNS----SARSGEHII 625
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
QYFL S+E+++L QIL F V +E+EMEEI A LA +CL G +RPTMK+ +EEL RL
Sbjct: 626 QYFLSSLESHNLSQILCFNVTNENEMEEIVVFAELAKQCLRSCGVKRPTMKEAAEELGRL 685
Query: 241 KISHEN 246
K +EN
Sbjct: 686 KKLNEN 691
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132160|ref|XP_002328200.1| predicted protein [Populus trichocarpa] gi|222837715|gb|EEE76080.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 308 bits (790), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 156/241 (64%), Positives = 194/241 (80%), Gaps = 3/241 (1%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN+ FQ+E+ VVSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTLF HIHDK+SQ+L +W
Sbjct: 428 MNEEFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKTSQLLASW 487
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ LRIA+E A AL+YLHS A PPIIHGDVKS N+LLD+N AKVADFG+SVLISSD QT
Sbjct: 488 SSRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAKVADFGASVLISSD-QT 546
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GTF LDPEY++TG LT +SDV+SFGV+L ELLTG KP S + +S E +++
Sbjct: 547 IIATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEKPNS--SSSSGEKRNLI 604
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
Q+F+ ++E N+L +IL+FQ ADE EM+EIE VA LA CL+ G RPTMK+VS+EL +L
Sbjct: 605 QHFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMGLNRPTMKEVSDELAKL 664
Query: 241 K 241
K
Sbjct: 665 K 665
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132156|ref|XP_002328199.1| predicted protein [Populus trichocarpa] gi|222837714|gb|EEE76079.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 308 bits (788), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 156/241 (64%), Positives = 193/241 (80%), Gaps = 3/241 (1%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN+ FQ+E+ VVSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTLF HIHDK+SQ+L +W
Sbjct: 428 MNEEFQNEMGVVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLFKHIHDKTSQLLASW 487
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ LRIA+E A AL+YLHS A PPIIHGDVKS N+LLD+N AKVADFG+SVLISSD QT
Sbjct: 488 SSRLRIASEIALALNYLHSLADPPIIHGDVKSVNILLDNNNTAKVADFGASVLISSD-QT 546
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GTF LDPEY++TG LT +SDV+SFGV+L ELLTG KP S + S E +++
Sbjct: 547 IIATKIQGTFGYLDPEYLMTGILTARSDVFSFGVVLVELLTGEKPNS--SSTSGEKRNLI 604
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
Q+F+ ++E N+L +IL+FQ ADE EM+EIE VA LA CL+ G RPTMK+VS+EL +L
Sbjct: 605 QHFISALETNNLFRILDFQAADEGEMDEIEAVAELAKGCLNSMGLNRPTMKEVSDELAKL 664
Query: 241 K 241
K
Sbjct: 665 K 665
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132144|ref|XP_002328196.1| predicted protein [Populus trichocarpa] gi|222837711|gb|EEE76076.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 304 bits (778), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 151/245 (61%), Positives = 190/245 (77%), Gaps = 3/245 (1%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+N+ FQ E+ +VSQ+NH+NVVK+LG CLETKVPLLVYEF+ NGTL+ HIHDK SQ+L +W
Sbjct: 387 LNEEFQKEIGIVSQVNHRNVVKLLGLCLETKVPLLVYEFISNGTLYKHIHDKRSQILASW 446
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LRIA+E A ALDYLHS A PP+IHGDVKS N+LLD+NY AKVADFG+SVLISS Q+
Sbjct: 447 SNRLRIASEIALALDYLHSLADPPVIHGDVKSVNILLDNNYTAKVADFGASVLISS-GQS 505
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GTF LDPEY++TG LT KSDV+SFGV+L ELL G KP S S E +++
Sbjct: 506 FIATKIQGTFGYLDPEYLMTGNLTPKSDVFSFGVVLLELLIGQKPNS--HAKSGETRNII 563
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
+YF+ ++ENN+L IL+FQ ADE EM+EIE VA +A +C++ G RPTMK+VS+EL +
Sbjct: 564 EYFISALENNNLFGILDFQAADEGEMDEIEVVAEIAKRCVNSMGINRPTMKEVSDELAKQ 623
Query: 241 KISHE 245
K HE
Sbjct: 624 KALHE 628
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132168|ref|XP_002328202.1| predicted protein [Populus trichocarpa] gi|222837717|gb|EEE76082.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 299 bits (766), Expect = 7e-79, Method: Compositional matrix adjust.
Identities = 148/245 (60%), Positives = 183/245 (74%), Gaps = 2/245 (0%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN FQ E+ +VSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTL H+HDK S++L +W
Sbjct: 74 MNAEFQKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHVHDKGSRILASW 133
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LR+A+E A ALDYLHS A PP+IHGDVKS N+LLD NY AKVADFG+SVL+S
Sbjct: 134 TNRLRVASEAALALDYLHSLADPPVIHGDVKSVNILLDSNYTAKVADFGASVLMSPGKTD 193
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GT LDPEY++TG LT +SDVYSFGV+L ELLTG P S S E +++
Sbjct: 194 ILATKIQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNS--ISKSGEKRNVI 251
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
Q+F+ ++ENN L +IL+FQ ADE EM+EIE VA LA CL+ G RPTMK+VS+EL +L
Sbjct: 252 QHFISALENNHLFKILDFQTADEGEMDEIEAVAELAKGCLNSMGVNRPTMKEVSDELAKL 311
Query: 241 KISHE 245
K H+
Sbjct: 312 KALHQ 316
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255565901|ref|XP_002523939.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223536786|gb|EEF38426.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 297 bits (760), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 152/241 (63%), Positives = 184/241 (76%), Gaps = 4/241 (1%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+NQ FQ EL +VSQ+NH NVVKILG CLETKVPLLVYEF+ NG+L+ HIH K SQ+L +W
Sbjct: 166 INQEFQKELAIVSQVNHINVVKILGLCLETKVPLLVYEFISNGSLYQHIHQKRSQILTSW 225
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
K LRIA ETA A+DYLHS A+PPIIHGDVKS N+LLDDNY AKV+DFG+SVLIS T
Sbjct: 226 KNRLRIATETALAIDYLHSLANPPIIHGDVKSANILLDDNYTAKVSDFGASVLISP-GYT 284
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
M TK GTF LDPEY++TGKLTEKSDVYSFGV+L E+LTG KP S I +
Sbjct: 285 DMATKIQGTFGYLDPEYLMTGKLTEKSDVYSFGVVLVEILTGEKPNSNARSGVKSNI--I 342
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
QYFL S+E+ ++ L F V +E E+EEI+ + LA +CLS +G +RPTMK+V+EEL RL
Sbjct: 343 QYFLSSLESKNISGTLCFMV-NEDELEEIKVFSELAKRCLSSTGIKRPTMKEVAEELGRL 401
Query: 241 K 241
+
Sbjct: 402 R 402
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224132184|ref|XP_002328206.1| predicted protein [Populus trichocarpa] gi|222837721|gb|EEE76086.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 296 bits (759), Expect = 5e-78, Method: Compositional matrix adjust.
Identities = 146/241 (60%), Positives = 182/241 (75%), Gaps = 2/241 (0%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
MN+ FQ E+ +VSQ+NHKNVVK+LG CLETKVPLLVYEF+ NGTL HIHDK S+ L +W
Sbjct: 52 MNEEFQKEMSIVSQVNHKNVVKLLGLCLETKVPLLVYEFISNGTLSKHIHDKGSRTLASW 111
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LR+A+E A ALDYLHS A PP+IHGD+KS N+LLD+NY AKVADFG+SVL+S
Sbjct: 112 TNRLRVASEAALALDYLHSLADPPVIHGDIKSVNILLDNNYTAKVADFGASVLMSPGQTN 171
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ TK GT LDPEY++TG LT +SDVYSFGV+L ELLTG P S S E +++
Sbjct: 172 ILATKIQGTLGYLDPEYLMTGILTVQSDVYSFGVVLVELLTGEMPNS--ISKSGEKRNVI 229
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
Q+F+ ++ENN L +IL+FQ ADE E++EIE VA LA CL+ G RPTMK+VS+EL +L
Sbjct: 230 QHFISALENNHLFKILDFQTADEGEIDEIEAVAELAKGCLNSMGVNRPTMKEVSDELAKL 289
Query: 241 K 241
K
Sbjct: 290 K 290
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 259 | ||||||
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.945 | 0.335 | 0.502 | 8.8e-63 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.972 | 0.335 | 0.486 | 3.1e-60 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.915 | 0.316 | 0.495 | 8.1e-60 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.907 | 0.296 | 0.493 | 1.3e-59 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.969 | 0.326 | 0.459 | 3.5e-59 | |
| TAIR|locus:2014897 | 741 | WAK3 "wall associated kinase 3 | 0.942 | 0.329 | 0.505 | 5.7e-59 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.899 | 0.323 | 0.516 | 6.6e-58 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.934 | 0.307 | 0.502 | 1.1e-57 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.972 | 0.317 | 0.476 | 1.7e-57 | |
| TAIR|locus:2014962 | 733 | WAK5 "wall associated kinase 5 | 0.930 | 0.328 | 0.504 | 6.8e-56 |
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 641 (230.7 bits), Expect = 8.8e-63, P = 8.8e-63
Identities = 125/249 (50%), Positives = 180/249 (72%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+N+VK+LG CLET+VP+LVYE++PNG LF +HD+S W+ L
Sbjct: 470 FINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRL 529
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A AL Y+HS+AS PI H D+K+TN+LLD+ Y+AKV+DFG+S ++ D QT +TT
Sbjct: 530 RIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLD-QTHLTT 588
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF +DPEY ++ + T KSDVYSFGV+L EL+TG KP S + S EG + +FL
Sbjct: 589 LVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELITGEKPLS--RVRSEEGRGLATHFL 646
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ DES++E++ VA LA KCL+ G+ RP MK+VS EL+R++ S
Sbjct: 647 EAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSSP 706
Query: 245 ENYEHRRTE 253
E+ + R TE
Sbjct: 707 EDLDVR-TE 714
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 124/255 (48%), Positives = 175/255 (68%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ V+SQINH+N+VK++G CLET+VP+LVYE +PNG LF +H S W L
Sbjct: 462 FINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRL 521
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RI+ E A AL YLHS+AS P+ H DVK+TN+LLD+ Y+AKV+DFG+S I+ D QT +TT
Sbjct: 522 RISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVD-QTHLTT 580
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GTF LDPEY T + T+KSDVYSFGV+L EL+TG KP S M N G+ V +F
Sbjct: 581 LVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGL--VSHFN 638
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ + +E++ VA LA +CLSL G++RP M++VS EL+R++ S
Sbjct: 639 EAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSSP 698
Query: 245 ENYEHRRTEKRQSIC 259
E+ E E+ + C
Sbjct: 699 EDLELHIEEEDEEEC 713
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 119/240 (49%), Positives = 172/240 (71%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ V++QINH+N+VK+LG CLET+VP+LVYEFVPNG L +HD+S W+ L
Sbjct: 457 FINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRL 516
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
IA E A AL YLHS+AS PI H D+K+TN+LLD+ +AKV+DFG+S ++ D QT +TT
Sbjct: 517 HIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTID-QTHLTT 575
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+ GTF +DPEY + K TEKSDVYSFGV+L ELLTG KP S + N G++ +F+
Sbjct: 576 QVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAA--HFV 633
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N + I++ ++ DE M+++ +VA LA +CL+ G++RP M++VS EL+ ++ SH
Sbjct: 634 EAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 611 (220.1 bits), Expect = 1.3e-59, P = 1.3e-59
Identities = 118/239 (49%), Positives = 172/239 (71%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWKTC 63
F +E+ ++SQINH+N+VK+LG CLETKVP+LVYEF+PNG LF+H+HD+ + ++ W
Sbjct: 488 FINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIR 547
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
LRIA + A AL YLHSSAS PI H DVKSTN++LD+ Y+AKV+DFG+S ++ D+ T +T
Sbjct: 548 LRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDH-THLT 606
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT +DPEY + + T+KSDVYSFGV+L EL+TG K S L S E ++ YF
Sbjct: 607 TVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSIS--FLRSQENRTLATYF 664
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242
+ +++ N L I++ ++ D + ++ A +A KCL+L GR+RP+M++VS ELD +++
Sbjct: 665 ILAMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRM 723
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 607 (218.7 bits), Expect = 3.5e-59, P = 3.5e-59
Identities = 120/261 (45%), Positives = 182/261 (69%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWKTC 63
F +E+ ++SQINH+N+VK+LG CLET VP+LVYEF+PNG LF+H+HD S + W+
Sbjct: 474 FINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVR 533
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
LRIA + A AL YLHS+AS PI H D+KSTN++LD+ ++AKV+DFG+S ++ D+ T +T
Sbjct: 534 LRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDH-THLT 592
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT +DPEY + + T+KSDVYSFGV+LAEL+TG K S L S E ++ YF
Sbjct: 593 TVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVS--FLRSQEYRTLATYF 650
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
+++ N L I++ ++ D ++ ++ A +A KCL++ GR+RP+M+QVS EL++++
Sbjct: 651 TLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRSY 710
Query: 244 HEN---YEH---RRTEKRQSI 258
E+ YE+ EK++++
Sbjct: 711 SEDMQPYEYASENEEEKKETL 731
|
|
| TAIR|locus:2014897 WAK3 "wall associated kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 605 (218.0 bits), Expect = 5.7e-59, P = 5.7e-59
Identities = 127/251 (50%), Positives = 169/251 (67%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F HE+ V+SQINH+NVVKILG CLET+VPLLVYEF+ NGTLFDH+H W+ L
Sbjct: 456 FIHEVLVLSQINHRNVVKILGCCLETEVPLLVYEFITNGTLFDHLHGSIFDSSLTWEHRL 515
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A L YLHSSAS PIIH D+K+ N+LLD+N AKVADFG+S LI D + +TT
Sbjct: 516 RIAIEVAGTLAYLHSSASIPIIHRDIKTANILLDENLTAKVADFGASKLIPMDKEQ-LTT 574
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGIS-MVQYF 183
GT LDPEY TG L EKSDVYSFGV+L ELL+G K + + +V YF
Sbjct: 575 MVQGTLGYLDPEYYTTGLLNEKSDVYSFGVVLMELLSGQK---ALCFERPQASKHLVSYF 631
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
+ + E N L +I++ QV +E ++EI+ A +A++C L G RP MK+V+ +L+ L++
Sbjct: 632 VSATEENRLHEIIDDQVLNEDNLKEIQEAARIAAECTRLMGEERPRMKEVAAKLEALRV- 690
Query: 244 HENYEHRRTEK 254
E +H+ +++
Sbjct: 691 -EKTKHKWSDQ 700
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 595 (214.5 bits), Expect = 6.6e-58, P = 6.6e-58
Identities = 123/238 (51%), Positives = 168/238 (70%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ ++SQINH+NVVKILG CLET+VP+LVYEF+PN LFDH+H+ S +W+ L
Sbjct: 431 FINEIILLSQINHRNVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRL 490
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
IA E A AL YLHS+ S PI H DVKSTN+LLD+ ++AKV+DFG S ++ D+ T +TT
Sbjct: 491 CIACEVADALSYLHSAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDD-THLTT 549
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV-QYF 183
GT +DPEY+ + T KSDVYSFGVLL ELLTG KP ++L + + M+ YF
Sbjct: 550 IVQGTIGYVDPEYLQSNHFTGKSDVYSFGVLLIELLTGEKP---VSLLRRQEVRMLGAYF 606
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
L ++ N+ L +IL+ ++ +E + EE+ VA LA +CLSL+ RPTM+ V ELDR++
Sbjct: 607 LEAMRNDRLHEILDARIKEECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQ 664
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 593 (213.8 bits), Expect = 1.1e-57, P = 1.1e-57
Identities = 123/245 (50%), Positives = 171/245 (69%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWK 61
Q F +E+ ++SQINH++VVK+LG CLET+VP+LVYEF+ NG LF HIH++ + W
Sbjct: 483 QEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYTMIWG 542
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
LRIA + A AL YLHS+AS PI H D+KSTN+LLD+ Y+AKVADFG+S ++ D QT
Sbjct: 543 MRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTID-QTH 601
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
TT GT +DPEY + + TEKSDVYSFGV+LAEL+TG KP M + E I++ +
Sbjct: 602 WTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVI-MVQNTQEIIALAE 660
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+F +++ L I++ ++ D+S+ E++ VA LA KCLS GR RP M++V EL+R+
Sbjct: 661 HFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELERIC 720
Query: 242 ISHEN 246
S E+
Sbjct: 721 TSPED 725
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 591 (213.1 bits), Expect = 1.7e-57, P = 1.7e-57
Identities = 122/256 (47%), Positives = 177/256 (69%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWK 61
Q F +E+ ++SQINH++VVK+LG CLET+VP+LVYEF+ NG LF HIH++ S W
Sbjct: 492 QEFINEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHIHEEESDDYTMLWG 551
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
LRIA + A AL YLHSSAS PI H D+KSTN+LLD+ Y+AKVADFG+S ++ D QT
Sbjct: 552 MRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTID-QTH 610
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
TT GT +DPEY + + TEKSDVYSFGV+LAEL+TG KP M + E +++ +
Sbjct: 611 WTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVI-MVQNTQEIVALAE 669
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+F +++ L I++ ++ ++ + E++ VA +A KCLS G++RP M++V EL+R+
Sbjct: 670 HFRVAMKEKRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNMREVFTELERIC 729
Query: 242 ISHENYE-HRRTEKRQ 256
S E+ + H R ++ +
Sbjct: 730 TSPEDSQVHNRIDEEE 745
|
|
| TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 576 (207.8 bits), Expect = 6.8e-56, P = 6.8e-56
Identities = 123/244 (50%), Positives = 163/244 (66%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F +E+ V+SQINH+NVVK+LG CLET+VPLLVYEF+ +GTLFDH+H W+ L
Sbjct: 449 FINEVLVLSQINHRNVVKLLGCCLETEVPLLVYEFISSGTLFDHLHGSMFDSSLTWEHRL 508
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
RIA E A L YLHS AS PIIH DVK+ N+LLD+N AKVADFG+S LI D Q +TT
Sbjct: 509 RIAIEVAGTLAYLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMD-QEQLTT 567
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GT LDPEY TG L EKSDVYSFGV+L ELL+G K S++ +V YF+
Sbjct: 568 MVQGTLGYLDPEYYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSK--HLVSYFV 625
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+++ N L +I++ QV +E EI+ A +A +C + G RP+MK+V+ EL+ L++
Sbjct: 626 SAMKENRLHEIIDGQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALRVKT 685
Query: 245 ENYE 248
++
Sbjct: 686 TKHQ 689
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 259 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-39 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-38 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-35 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-32 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-25 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-24 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-23 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 8e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-19 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-19 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-19 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-18 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-18 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-17 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-16 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-14 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-14 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-13 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-13 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-13 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-13 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-12 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-12 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-12 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 7e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-12 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 9e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-12 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-11 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-11 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-11 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-11 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-10 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-10 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 4e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-08 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-08 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-08 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-07 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-07 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-07 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-07 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 3e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-05 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.001 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 0.002 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.003 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 0.003 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 8e-40
Identities = 58/160 (36%), Positives = 89/160 (55%), Gaps = 11/160 (6%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ E+ ++ ++NH N+VK+ G + LV E+ G+L D + + ++ +
Sbjct: 36 EELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKL--SEDE 93
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTA 121
LRI + L+YLHS+ IIH D+K N+LLD DN K K+ADFG S L++SD
Sbjct: 94 ILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL- 149
Query: 122 MTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAEL 159
+GT + PE V+ G +EKSD++S GV+L EL
Sbjct: 150 -LKTIVGTPAYMAPE-VLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 5e-39
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 12/169 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ +++H N+V++LG C + + +V E++P G L D + ++ L
Sbjct: 48 FLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDL--L 105
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
++A + A ++YL S +H D+ + N L+ +N K++DFG S I D+
Sbjct: 106 QMALQIAKGMEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG 162
Query: 125 KKIGTFVN---LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
G + + PE + GK T KSDV+SFGVLL E+ T G +P GM
Sbjct: 163 ---GGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 208
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 8e-39
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 25/234 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E R++ +++H NVVK+LG C E + +V E++ G L ++ ++ + L
Sbjct: 48 FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKL--SLSDLL 105
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A + A ++YL S IH D+ + N L+ +N K++DFG S + D+
Sbjct: 106 SFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG 162
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYF 183
K+ + PE + GK T KSDV+SFGVLL E+ T G +P GM+ E + ++
Sbjct: 163 GKLPIRW-MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE--EVLEYLK-- 217
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
L Q N E+ ++ +C + RPT ++ E L
Sbjct: 218 ----NGYRLPQPPN----CPPELYDL------MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-38
Identities = 69/234 (29%), Positives = 116/234 (49%), Gaps = 24/234 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E R++ +++H N+VK+LG C E + ++V E++P G L D++ + L + L
Sbjct: 48 FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKEL-SLSDLL 106
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A + A ++YL S IH D+ + N L+ +N K++DFG S + D+ +
Sbjct: 107 SFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKG 163
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYF 183
K+ + PE + GK T KSDV+SFGVLL E+ T G +P GM+ A E + ++
Sbjct: 164 GKLPIRW-MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNA--EVLEYLK-- 218
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ L + N E+ ++ +C + RPT ++ E L
Sbjct: 219 ----KGYRLPKPPN----CPPELYKL------MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 2e-37
Identities = 70/247 (28%), Positives = 106/247 (42%), Gaps = 40/247 (16%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
F E RV+ ++ H NVV++LG C E + LV E++ G L D++ K+
Sbjct: 43 FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL 102
Query: 64 -----LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
L A + A ++YL S +H D+ + N L+ ++ K++DFG S + D+
Sbjct: 103 SLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
Query: 119 QTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALA 172
T L PE + G T KSDV+SFGVLL E+ T G P G+
Sbjct: 160 YYRKKTGGK-----LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL--- 211
Query: 173 SNEGISMVQYFLYSIENNS-LRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231
SNE + L + L + E+ E+ C L RPT
Sbjct: 212 SNEEV------LEYLRKGYRLPKPEYCP----DELYEL------MLSCWQLDPEDRPTFS 255
Query: 232 QVSEELD 238
++ E L+
Sbjct: 256 ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 36/237 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E++++ ++ H N+V++ + LV E+ G LFD + + +
Sbjct: 44 ILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR---LSEDEAR 100
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ SAL+YLHS I+H D+K N+LLD++ K+ADFG + + T
Sbjct: 101 FYLRQILSALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE---KLT 154
Query: 125 KKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
+GT PEY V+ GK + D++S GV+L ELLTG P G ++ + +
Sbjct: 155 TFVGT-----PEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGD----DQLLEL 205
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQVSE 235
++I + +I L K L +R T ++ +
Sbjct: 206 ------------FKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-34
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 21/234 (8%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+Q + E+R++ +++H N+V+++ A + LV E+ G LFD++ L +
Sbjct: 41 KDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPL-SE 97
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+IA + L+YLHS+ IIH D+K N+LLD+N K+ADFG + + + +
Sbjct: 98 DEAKKIALQILRGLEYLHSNG---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSS 154
Query: 121 AMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
T +GT + PE ++ G K DV+S GV+L ELLTG P SG E I
Sbjct: 155 LTT--FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG------ENILD 206
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ I L L F S E L KCL+ +RPT +++
Sbjct: 207 QLQLIRRI----LGPPLEFDEPKWSSGS--EEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 4e-32
Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 14/166 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACL--ETKVPLLVYEFVPNGTLFDHIHDKSS---QVLRN 59
+ E+R++S + H N+V+ G+ E + E+V G+L + V+R
Sbjct: 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK 105
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + L YLHS+ I+H D+K N+L+D + K+ADFG + +
Sbjct: 106 Y------TRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
T GT + PE + + +D++S G + E+ TG P
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 6e-25
Identities = 51/193 (26%), Positives = 86/193 (44%), Gaps = 36/193 (18%)
Query: 1 MNQVFQHELRVVSQIN-HKNVVKILG-----ACLETKVPLLVYEFVPNGTLFDHIHDKSS 54
+ V E V++++N H ++K+ L V E+ PNG L +I S
Sbjct: 45 VKYVKI-EKEVLTRLNGHPGIIKLYYTFQDEENL-----YFVLEYAPNGELLQYIRKYGS 98
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
+ K AAE AL+YLHS IIH D+K N+LLD + K+ DFG++ ++
Sbjct: 99 ---LDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVL 152
Query: 115 SSDN--------------QTAMTTKKIGTFVN----LDPEYVITGKLTEKSDVYSFGVLL 156
++ Q ++ +FV + PE + + SD+++ G ++
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCII 212
Query: 157 AELLTGLKPGSGM 169
++LTG P G
Sbjct: 213 YQMLTGKPPFRGS 225
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-24
Identities = 51/162 (31%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR-- 65
E++++ + H N+VK G+ L+ +V EF G+L +L++ L
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL--------KDLLKSTNQTLTES 98
Query: 66 ----IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ E L+YLHS+ IIH D+K+ N+LL + + K+ DFG S + SD +
Sbjct: 99 QIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQL-SDTKAR 154
Query: 122 MTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTG 162
T +GT + PE VI GK K+D++S G+ EL G
Sbjct: 155 NTM--VGTPYWMAPE-VINGKPYDYKADIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-23
Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 32/241 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E V+ +I H N+V++LG C ++ EF+ G L D++ + + Q + N L
Sbjct: 49 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-NAVVLL 107
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+A + +SA++YL IH D+ + N L+ +N+ KVADFG S L++ D TA
Sbjct: 108 YMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYF 183
K PE + K + KSDV++FGVLL E+ T G+ P G+ L+
Sbjct: 165 AKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------- 213
Query: 184 LYSIENNSLRQILNFQVADESEMEEIE----TVAGLASKCLSLSGRRRPTMKQVSEELDR 239
+Y + R ME E V L C + RP+ ++ + +
Sbjct: 214 VYELLEKGYR------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261
Query: 240 L 240
+
Sbjct: 262 M 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-23
Identities = 59/160 (36%), Positives = 84/160 (52%), Gaps = 10/160 (6%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E ++S+INH +VK L +T+ L LV E+ P G LF H+ S + + +
Sbjct: 42 TERNILSRINHPFIVK-LHYAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF 97
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE AL+YLHS II+ D+K N+LLD + K+ DFG + +SS+ T
Sbjct: 98 YAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF- 153
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT L PE ++ + D +S GVLL E+LTG P
Sbjct: 154 -CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-23
Identities = 56/169 (33%), Positives = 87/169 (51%), Gaps = 12/169 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +++ ++ H +V++ C E + +V E++ G+L D + + LR +
Sbjct: 48 FLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-LPQLV 106
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+AA+ A + YL S IH D+ + N+L+ +N K+ADFG + LI D TA
Sbjct: 107 DMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163
Query: 125 KKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K T PE G+ T KSDV+SFG+LL E++T G P GM
Sbjct: 164 AKFPIKWT----APEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 96.3 bits (238), Expect = 5e-23
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 5 FQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E+++++ +NH N+VK+ + LV E+V G+L D + + +
Sbjct: 44 FLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEA 103
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQT-- 120
L I A+ SAL+YLHS IIH D+K N+LLD D K+ DFG + L+ T
Sbjct: 104 LFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160
Query: 121 --AMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175
A+ + +GT + PE ++ + SD++S G+ L ELLTGL P G +S
Sbjct: 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT 220
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232
I L ++ + + + L K L+ + R +
Sbjct: 221 SQ------TLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-22
Identities = 64/248 (25%), Positives = 109/248 (43%), Gaps = 42/248 (16%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
Q F E V++ + H N+V++LG L+ +V E++ G+L D++ + V+
Sbjct: 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVI-TL 101
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
L A + ++YL +H D+ + NVL+ ++ AKV+DFG ++ +
Sbjct: 102 AQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFG----LAKEASQ 154
Query: 121 AMTTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG 176
+ K+ T PE + K + KSDV+SFG+LL E+ + G P + L
Sbjct: 155 GQDSGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---- 206
Query: 177 ISMVQYFLYSIENNSLRQILNFQVADESEMEEIET----VAGLASKCLSLSGRRRPTMKQ 232
+V + +E ME E V + C L +RPT KQ
Sbjct: 207 -DVVPH----VEKG-------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQ 248
Query: 233 VSEELDRL 240
+ E+L +
Sbjct: 249 LREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 2e-22
Identities = 50/163 (30%), Positives = 75/163 (46%), Gaps = 10/163 (6%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHD-KSSQVLRNWKTCL 64
+E++++ ++NH N++K + E +V E+ G L I K + L
Sbjct: 47 LNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQIL 106
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMT 123
+ AL YLHS I+H D+K N+ L N K+ DFG S VL S+ +
Sbjct: 107 DWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST---VDLA 160
Query: 124 TKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+GT L PE + K KSD++S G +L EL T P
Sbjct: 161 KTVVGTPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 5e-22
Identities = 65/249 (26%), Positives = 118/249 (47%), Gaps = 35/249 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-----HD--KSSQ 55
Q F+ E ++S + H N+V +LG C + + +++E++ +G L + + H +
Sbjct: 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES 112
Query: 56 VLRNWKTCL------RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
K+ L IA + A+ ++YL +S +H D+ + N L+ + K++DFG
Sbjct: 113 GDETVKSSLDCSDFLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFG 169
Query: 110 SSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSG 168
S I S + + +K + + PE ++ GK T +SD++SFGV+L E+ + GL+P G
Sbjct: 170 LSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229
Query: 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228
++ E I M++ RQ+L + V L +C + RRP
Sbjct: 230 --FSNQEVIEMIRS----------RQLL------PCPEDCPARVYALMIECWNEIPARRP 271
Query: 229 TMKQVSEEL 237
K + L
Sbjct: 272 RFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 5e-22
Identities = 52/172 (30%), Positives = 89/172 (51%), Gaps = 18/172 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N+VK++G C++ + +V E VP G+L + K +++ K L
Sbjct: 39 FLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLL 96
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS------VLISSDN 118
+++ + A+ ++YL S IH D+ + N L+ +N K++DFG S + SD
Sbjct: 97 QMSLDAAAGMEYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153
Query: 119 QTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ K PE + G+ T +SDV+S+G+LL E + G P GM
Sbjct: 154 LKQIPIKWTA------PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-20
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 8/165 (4%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E++ +SQ NH NVVK + + LV ++ G+L D + + + +
Sbjct: 48 KEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATV 107
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
E L+YLHS+ IH D+K+ N+LL ++ K+ADFG S ++ +K
Sbjct: 108 LKEVLKGLEYLHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRK 164
Query: 127 --IGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAELLTGLKPGS 167
+GT + PE V+ K+D++SFG+ EL TG P S
Sbjct: 165 TFVGTPCWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 6e-20
Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 29/237 (12%)
Query: 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ EL+++S + NH+N+V +LGAC L++ E+ G L + + K L
Sbjct: 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
L + + A + +L AS IH D+ + NVLL K+ DFG + I +D+
Sbjct: 143 L-LSFSYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
Query: 122 MTTKKIGTFVNLD---PEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGI 177
+ K + + PE + T +SDV+S+G+LL E+ + G P GM + S
Sbjct: 199 V---KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--- 252
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
Y + R E + + C +RPT KQ+
Sbjct: 253 ------FYKLIKEGYRMAQPEHAPAE--------IYDIMKTCWDADPLKRPTFKQIV 295
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 8e-20
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 22/229 (9%)
Query: 14 QINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN--WKTCLRIAAETA 71
++ H N+VK++G C K L++E++ L S+VLRN W+ +IA A
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNL--------SEVLRNLSWERRRKIAIGIA 790
Query: 72 SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFV 131
AL +LH SP ++ G++ +++D + + +S TK +
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSA 843
Query: 132 NLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNS 191
+ PE T +TEKSD+Y FG++L ELLTG P + + S+V++ Y +
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSP-ADAEFGVHG--SIVEWARYCYSDCH 900
Query: 192 LRQILNFQVADESEMEEIETV--AGLASKCLSLSGRRRPTMKQVSEELD 238
L ++ + + + + E V LA C + RP V + L+
Sbjct: 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 8e-20
Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 10/161 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F+ E+ ++ ++H+N+VK G C + + L+ E++P+G+L D++ Q+ K
Sbjct: 53 FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL--KR 110
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L +++ +DYL S IH D+ + N+L++ K++DFG + ++ D
Sbjct: 111 LLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYY 167
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ F PE + T K + SDV+SFGV L EL T
Sbjct: 168 VKEPGESPIFW-YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-19
Identities = 53/178 (29%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLRNWKT 62
F+ E +++ H+N+VK G C E P++V+E++ +G L F H + L++ +
Sbjct: 55 FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114
Query: 63 ---------CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
L+IA + AS + YL AS +H D+ + N L+ + K+ DFG S
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRD 171
Query: 114 ISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
+ + + ++G L PE ++ K T +SDV+SFGV+L E+ T G +P
Sbjct: 172 VYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-19
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 7/168 (4%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E +V+ ++ H+ +V++ E + +V E++ G+L D + + + LR
Sbjct: 46 EAFLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLR-LPQ 103
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ +AA+ AS + Y+ +H D+++ N+L+ +N KVADFG + LI + TA
Sbjct: 104 LVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K PE + G+ T KSDV+SFG+LL EL T G P GM
Sbjct: 161 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-19
Identities = 61/224 (27%), Positives = 100/224 (44%), Gaps = 30/224 (13%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN---WKTCL 64
E RV+++++ +++ + L+ +V E+ NG L + + + L W
Sbjct: 49 EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW---- 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
R + L +LHS I+H D+KS N+ LD K+ D G + L+S + A T
Sbjct: 105 RFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+GT L PE EKSDV++ GV+L E TG P A+N+G
Sbjct: 162 --VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFD----ANNQGA------- 208
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228
+ +I+ S+M + +A L +CL+ R+RP
Sbjct: 209 ------LILKIIRGVFPPVSQMYS-QQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 5e-19
Identities = 52/158 (32%), Positives = 86/158 (54%), Gaps = 10/158 (6%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
Q F E V++Q+ H N+V++LG +E K L +V E++ G+L D++ + VL
Sbjct: 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGD 102
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
L+ + + A++YL ++ +H D+ + NVL+ ++ AKV+DFG + SS T
Sbjct: 103 CLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159
K PE + K + KSDV+SFG+LL E+
Sbjct: 160 KLPVKWTA-----PEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-19
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 25/172 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIH-DKSSQVLRNWK 61
F E++++S+++ N+ ++LG C ++ E++ NG L F H ++S + N K
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 62 -----TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLIS 115
T L +A + AS + YL S +H D+ + N L+ NY K+ADFG S L S
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 116 SDNQTAMTTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT 161
SD ++ L P E V+ GK T KSDV++FGV L E+LT
Sbjct: 183 SD------YYRVQGRAPL-PIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-19
Identities = 53/168 (31%), Positives = 88/168 (52%), Gaps = 7/168 (4%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E +++ ++ H +V++ E + +V E++ G+L D + D + L+
Sbjct: 46 ESFLEEAQIMKKLRHDKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALK-LPN 103
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ +AA+ A+ + Y+ IH D++S N+L+ D K+ADFG + LI + TA
Sbjct: 104 LVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K PE + G+ T KSDV+SFG+LL EL+T G P GM
Sbjct: 161 QGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-18
Identities = 45/161 (27%), Positives = 85/161 (52%), Gaps = 8/161 (4%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +V+ +++H N+V++ G C + + +V E++ NG L +++ ++ + L
Sbjct: 46 FIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLL 103
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ ++ A++YL S+ IH D+ + N L+ ++ KV+DFG + + D T+
Sbjct: 104 DMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160
Query: 125 KKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGLK 164
K V P V + + KSDV+SFGVL+ E+ + K
Sbjct: 161 TKFP--VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 49/166 (29%), Positives = 85/166 (51%), Gaps = 6/166 (3%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +++ ++ H ++++ C + +V E + G+L +++ + + L +
Sbjct: 48 FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL-KLPQLI 106
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+AA+ AS + YL + IH D+ + NVL+ +N KVADFG + +I D A
Sbjct: 107 DMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K PE + + + KSDV+SFG+LL E++T G P GM
Sbjct: 164 AKFPIKWTA-PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 2e-18
Identities = 52/168 (30%), Positives = 86/168 (51%), Gaps = 7/168 (4%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q FQ E++ + ++ HK+++ + C + ++ E + G+L + QVL +
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPV-AS 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ +A + A + YL IH D+ + N+L+ ++ KVADFG + LI D +
Sbjct: 106 LIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS- 161
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ KKI + PE G + KSDV+SFG+LL E+ T G P GM
Sbjct: 162 SDKKI-PYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGM 208
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 3e-18
Identities = 49/157 (31%), Positives = 84/157 (53%), Gaps = 6/157 (3%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +V+ +++H +V++ G C E LV+EF+ +G L D++ + + + +T L
Sbjct: 46 FIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQ--ETLL 103
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + YL SS +IH D+ + N L+ +N KV+DFG + + D T+ T
Sbjct: 104 GMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
K + PE K + KSDV+SFGVL+ E+ +
Sbjct: 161 TKFPVKWS-SPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 3e-18
Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 15/172 (8%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQVL 57
N+ E V++ ++H +VV++LG CL ++V L+ + +P G L D++ + SQ L
Sbjct: 53 NKEILDEAYVMASVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYL 111
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
NW C++IA + YL ++H D+ + NVL+ K+ DFG + L+ D
Sbjct: 112 LNW--CVQIA----KGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSG 168
+ + E ++ T KSDV+S+GV + EL+T G KP G
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 5e-18
Identities = 46/170 (27%), Positives = 78/170 (45%), Gaps = 17/170 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ---VLRNWKTCL 64
E++V+ + H N+VK G + + + E+ GTL + + V+R
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR------ 102
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ L YLHS I+H D+K N+ LD N K+ DFG +V + ++ T
Sbjct: 103 VYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159
Query: 125 KK--IGTFVNLDPEYVITGKLTEK---SDVYSFGVLLAELLTGLKPGSGM 169
+ GT + PE + GK +D++S G ++ E+ TG +P S +
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 5e-18
Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q F E V+++++HKN+V++LG L + +V E + G L + + + + L +
Sbjct: 44 QAFLEETAVMTKLHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRG-RALVSVIQ 101
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L+ + + A ++YL S ++H D+ + N+L+ ++ AKV+DFG ++ +
Sbjct: 102 LLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFG----LARVGSMGV 154
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQ 181
K+ PE + K + KSDV+S+GVLL E+ + G P M+L E
Sbjct: 155 DNSKLPVKWTA-PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--KE------ 205
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIE----TVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ V ME E V L + C ++RP+ ++ E+L
Sbjct: 206 --------------VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
Query: 238 DR 239
++
Sbjct: 252 EK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 7e-18
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 14/166 (8%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVLRN 59
+ E+ ++ + H N+VK +G +ET L ++ E+ NG+L I + L
Sbjct: 44 KSIMQEIDLLKNLKHPNIVKYIG-SIETSDSLYIILEYAENGSLRQIIKKFGPFPESL-- 100
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ L YLH +IH D+K+ N+L + K+ADFG + ++ ++
Sbjct: 101 ---VAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ +GT + PE + + SD++S G + ELLTG P
Sbjct: 155 DDASV--VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-17
Identities = 54/170 (31%), Positives = 88/170 (51%), Gaps = 7/170 (4%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
M + F E +++ ++ H +V + E + +V EF+ G+L D + + + L+
Sbjct: 44 MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPI-YIVTEFMGKGSLLDFLKEGDGKYLK-L 101
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ +AA+ A + Y+ IH D+++ N+L+ DN K+ADFG + LI + T
Sbjct: 102 PQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
A K PE + G+ T KSDV+SFG+LL EL+T G P GM
Sbjct: 159 ARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 7/166 (4%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E R++ Q +H N+VK++G C + + +V E VP G + K ++ K +
Sbjct: 39 FLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL--KTKQLV 96
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A + A+ + YL S IH D+ + N L+ +N K++DFG S ++
Sbjct: 97 KFALDAAAGMAYLESKNC---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL 153
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K+I PE + G+ + +SDV+S+G+LL E + G+ P GM
Sbjct: 154 KQI-PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 2e-17
Identities = 51/190 (26%), Positives = 92/190 (48%), Gaps = 23/190 (12%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQV 56
M FQ E ++++ +H N+VK+LG C K L++E++ G L + + +S +
Sbjct: 51 MQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSL 110
Query: 57 LRNWKTC---------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY 101
+ + L IA + A+ + YL + +H D+ + N L+ +N
Sbjct: 111 SHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENM 167
Query: 102 KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
K+ADFG S I S + + + PE + + T +SDV+++GV+L E+ +
Sbjct: 168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
Query: 162 -GLKPGSGMA 170
G++P GMA
Sbjct: 228 YGMQPYYGMA 237
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-17
Identities = 65/247 (26%), Positives = 113/247 (45%), Gaps = 38/247 (15%)
Query: 3 QVFQ----HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK----SS 54
Q FQ H L + S ++H +V++LG C + L V + P G+L DH+
Sbjct: 51 QTFQEITDHMLAMGS-LDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDP 108
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
Q L NW C++IA + YL ++H ++ + N+LL + ++ADFG + L+
Sbjct: 109 QRLLNW--CVQIA----KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS 173
D++ ++ + E ++ G+ T +SDV+S+GV + E+++ G +P +GM
Sbjct: 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
V L E + QI V + KC + RPT K++
Sbjct: 220 ------VPDLLEKGERLAQPQICTID------------VYMVMVKCWMIDENVRPTFKEL 261
Query: 234 SEELDRL 240
+ E R+
Sbjct: 262 ANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-17
Identities = 50/192 (26%), Positives = 99/192 (51%), Gaps = 20/192 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI--------------H 50
FQ E ++++++H N+V +LG + + +++E++ G L + +
Sbjct: 54 FQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113
Query: 51 DKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
D + + + L IA + A+ ++YL +S +H D+ + N+L+ + K++D G
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGL 170
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
S I S + + K + + PE ++ GK + SD++SFGV+L E+ + GL+P G
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG- 229
Query: 170 ALASNEGISMVQ 181
++ E I MV+
Sbjct: 230 -FSNQEVIEMVR 240
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-17
Identities = 48/169 (28%), Positives = 88/169 (52%), Gaps = 18/169 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL------------FDHIHDK 52
F E++++S++ + N++++LG C+ ++ E++ NG L F H ++
Sbjct: 64 FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123
Query: 53 SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112
S + N L +A + AS + YL AS +H D+ + N L+ ++Y K+ADFG S
Sbjct: 124 PSVSIAN---LLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 113 LISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ S + + + + + E ++ GK T SDV++FGV L E+ T
Sbjct: 178 NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-17
Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 17/182 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E V++Q++H +V+++G C + +LV E P G L ++ +
Sbjct: 43 FLREASVMAQLDHPCIVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRREI---PVSDLK 98
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAM 122
+A + A + YL S +H D+ + NVLL + ++AK++DFG S + + + A
Sbjct: 99 ELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155
Query: 123 TTKK--IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISM 179
T + + + PE + GK + KSDV+S+GV L E + G KP M E I+M
Sbjct: 156 TAGRWPLKWYA---PECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM--KGAEVIAM 210
Query: 180 VQ 181
++
Sbjct: 211 LE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 6e-17
Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 27/183 (14%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL--- 64
E+ ++ H N+V + L +V E++ G+L D ++ +
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD--------IITQNFVRMNEP 116
Query: 65 ---RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ E L+YLHS +IH D+KS N+LL + K+ADFG + ++ +
Sbjct: 117 QIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173
Query: 122 MTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTG------LKPGSGMALASN 174
+ +GT + PE VI K K D++S G++ E+ G P + L +
Sbjct: 174 NSV--VGTPYWMAPE-VIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT 230
Query: 175 EGI 177
+GI
Sbjct: 231 KGI 233
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 6e-17
Identities = 52/176 (29%), Positives = 91/176 (51%), Gaps = 16/176 (9%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLRNW 60
Q FQ E +++ + H+++V+ G C E + L+V+E++ +G L F H +++L
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 61 KTC----------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
+ L IA++ AS + YL AS +H D+ + N L+ K+ DFG
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGM 168
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
S I S + + + + + PE ++ K T +SD++SFGV+L E+ T G +P
Sbjct: 169 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-16
Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 43/255 (16%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH----------------- 50
E ++ Q+NH +V+K+ GAC + LL+ E+ G+L +
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 51 ----DKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVA 106
D + + A + + + YL A ++H D+ + NVL+ + K K++
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKIS 169
Query: 107 DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
DFG S + ++ +K + E + T +SDV+SFGVLL E++T G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 166 GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225
G+A + Y + EN S E + L C
Sbjct: 230 YPGIAPERLFNLLKTGYRMERPENCS------------------EEMYNLMLTCWKQEPD 271
Query: 226 RRPTMKQVSEELDRL 240
+RPT +S+EL+++
Sbjct: 272 KRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVL---RNWK 61
F E ++ ++H+N++++ G L + ++V E P G+L D + +
Sbjct: 43 FLKEAAIMHSLDHENLIRLYGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLISTLCD 101
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS--VLISSDNQ 119
++IA + YL S IH D+ + N+LL + K K+ DFG + + D+
Sbjct: 102 YAVQIAN----GMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K+ F PE + T + SDV+ FGV L E+ T G +P +G+
Sbjct: 155 VMEEHLKV-PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-16
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 6/156 (3%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E+ ++S + H N++ ++ L+ E+ GTL+D I + Q+ + L
Sbjct: 47 LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE-EMVLW 105
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
+ SA+ Y+H + I+H D+K+ N+ L K+ DFG S ++ S+ A T
Sbjct: 106 YLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV- 161
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+GT + PE K KSD+++ G +L ELLT
Sbjct: 162 -VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-16
Identities = 49/160 (30%), Positives = 87/160 (54%), Gaps = 8/160 (5%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q+E +V+ ++H N+++ LE K ++V E+ P GTL ++I + + +L T
Sbjct: 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDE-DT 102
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYK-AKVADFGSSVLISSDNQTA 121
L + AL ++H+ I+H D+K+ N+LLD + K+ DFG S ++SS ++ A
Sbjct: 103 ILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A 158
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
T +GT + PE +KSD+++ G +L EL +
Sbjct: 159 YTV--VGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-16
Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 17/175 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLRNWK- 61
FQ E +++ + H+++VK G C + ++V+E++ +G L F H + +L + +
Sbjct: 54 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113
Query: 62 ----------TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111
L IA++ AS + YL AS +H D+ + N L+ N K+ DFG S
Sbjct: 114 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
Query: 112 VLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
+ S + + + + PE ++ K T +SDV+SFGV+L E+ T G +P
Sbjct: 171 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-16
Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 8/157 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E+ ++ + H+N+VK G C E L+ EF+P+G+L +++ +++ N K L+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI--NLKQQLK 113
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
A + +DYL S +H D+ + NVL++ ++ K+ DFG + I +D +
Sbjct: 114 YAVQICKGMDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 170
Query: 126 KIGTFVN-LDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ + V PE +I K SDV+SFGV L ELLT
Sbjct: 171 DLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 4e-16
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 15/173 (8%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQVL 57
N F E +++ ++H ++V++LG CL + L V + +P+G L D++H+ SQ+L
Sbjct: 53 NVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLL 111
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
NW C++IA + YL ++H D+ + NVL+ K+ DFG + L+ D
Sbjct: 112 LNW--CVQIA----KGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ + E + K T +SDV+S+GV + EL+T G KP G+
Sbjct: 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 4e-16
Identities = 50/167 (29%), Positives = 84/167 (50%), Gaps = 9/167 (5%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E ++ Q+ H +V++ T+ P+ ++ E++ NG+L D + L
Sbjct: 48 FLAEANLMKQLQHPRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPEGIKL-TINKL 104
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ +AA+ A + ++ IH D+++ N+L+ + K+ADFG + LI + TA
Sbjct: 105 IDMAAQIAEGMAFIERKNY---IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTARE 161
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K PE + G T KSDV+SFG+LL E++T G P GM
Sbjct: 162 GAKF-PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-16
Identities = 63/253 (24%), Positives = 104/253 (41%), Gaps = 45/253 (17%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLR 58
F E + +H NV+K++G C E P+++ F+ +G L H S++
Sbjct: 48 FLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDL--HSFLLYSRLGG 105
Query: 59 N-----WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+T L+ + A ++YL ++ IH D+ + N +L ++ VADFG S
Sbjct: 106 LPEKLPLQTLLKFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 114 ISSDN---QT---AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGS 167
I S + Q M K I D Y T KSDV++FGV + E+ T
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVY------TSKSDVWAFGVTMWEIAT------ 210
Query: 168 GMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227
G+ + + Y N L+Q E ++E + L C + R
Sbjct: 211 -RGQTPYPGVENHEIYDYLRHGNRLKQ-------PEDCLDE---LYDLMYSCWRADPKDR 259
Query: 228 PTMKQVSEELDRL 240
PT ++ E L+ +
Sbjct: 260 PTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-16
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVL 57
+ QV +H E R++ I H +V + G+ + LV E+VP G LF H+ + S
Sbjct: 42 LKQV-EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRF 98
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
AA+ AL+YLHS I++ D+K N+LLD + K+ DFG + +
Sbjct: 99 PE-PVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
T GT PEY +I K K+ D ++ G+L+ E+L G P
Sbjct: 155 TYTL-----CGT-----PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 5e-16
Identities = 49/177 (27%), Positives = 80/177 (45%), Gaps = 15/177 (8%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK---SSQVLRNWKTCL 64
E R++ ++NH +V + + + + LV + + G L H+ K S + ++ W
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW---- 105
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
E AL+YLHS IIH D+K N+LLD+ + DF + ++ D +TT
Sbjct: 106 --ICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTT 157
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
GT + PE + + D +S GV E L G +P G + + I Q
Sbjct: 158 STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ 214
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-16
Identities = 49/173 (28%), Positives = 85/173 (49%), Gaps = 18/173 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNG---TLFDHIHDKSSQVL 57
M E+ ++ ++ H+N+V+ LG+ L+ + E+VP G L ++ ++
Sbjct: 49 MLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLV 108
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
RN+ + L+YLH+ IIH D+K N+L+D+ K++DFG S + +
Sbjct: 109 RNF------VRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEA- 158
Query: 118 NQTAMTTKKI-----GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
N + T G+ + PE V T K+D++S G L+ E+LTG P
Sbjct: 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-16
Identities = 59/187 (31%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 5 FQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR----- 58
F EL V+ ++ H N++ +LGAC L E+ P+G L D + + S+VL
Sbjct: 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAF 111
Query: 59 ----------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
+ + L AA+ A +DYL + IH D+ + N+L+ +NY AK+ADF
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 168
Query: 109 GSSVLISSDNQTAMTTKKIGTFVN--LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
G S Q K +G + E + T SDV+S+GVLL E+++ G P
Sbjct: 169 G-----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223
Query: 166 GSGMALA 172
GM A
Sbjct: 224 YCGMTCA 230
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 1e-15
Identities = 55/176 (31%), Positives = 81/176 (46%), Gaps = 22/176 (12%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNG---TLFDHIHDKSSQV 56
E ++SQ VVK+ + K L LV E++P G +L +++ V
Sbjct: 36 QVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDV 94
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
R AE AL+YLHS+ IIH D+K N+L+D N K+ DFG S +
Sbjct: 95 ARI------YIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145
Query: 117 DNQTAM------TTKKIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
Q + + +GT + PE VI G+ K+ D +S G +L E L G+ P
Sbjct: 146 RRQINLNDDEKEDKRIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-15
Identities = 56/240 (23%), Positives = 101/240 (42%), Gaps = 36/240 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E R++ Q +H N+V+++G C + + +V E V G + + ++ K +
Sbjct: 40 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRL--KVKELI 97
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS------VLISSDN 118
++ A+ ++YL S IH D+ + N L+ + K++DFG S V S+
Sbjct: 98 QMVENAAAGMEYLESKHC---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154
Query: 119 QTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGI 177
+ K PE + G+ + +SDV+SFG+LL E + G P + ++
Sbjct: 155 MKQIPVKWTA------PEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS------- 201
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
N R+ + V + V L +C +RP+ V +EL
Sbjct: 202 -----------NQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-15
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 8/170 (4%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH-DKSSQVLRNWK 61
Q F E ++ + H +V++ + + ++ E++ G+L D + D+ +VL
Sbjct: 46 QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVL--LP 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ +A+ A + Y+ IH D+++ NVL+ ++ K+ADFG + +I + TA
Sbjct: 104 KLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMA 170
K PE + G T KSDV+SFG+LL E++T G P GM+
Sbjct: 161 REGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-15
Identities = 46/165 (27%), Positives = 87/165 (52%), Gaps = 11/165 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--------FDHIHDKSSQV 56
F E++++S++ N++++L C+ + ++ E++ NG L +K+ V
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
++ T + +A + AS + YL +S +H D+ + N L+ NY K+ADFG S + S
Sbjct: 126 TISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ + + + + E ++ GK T SDV++FGV L E+LT
Sbjct: 183 GDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-15
Identities = 55/168 (32%), Positives = 86/168 (51%), Gaps = 24/168 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRN--WK 61
F E ++ +H NV+ +LG CL ++ PL+V ++ +G L + I ++ N K
Sbjct: 43 FLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSET----HNPTVK 98
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI------S 115
+ + A ++YL AS +H D+ + N +LD+++ KVADFG + I S
Sbjct: 99 DLIGFGLQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155
Query: 116 SDNQTA--MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
N T + K + E + T K T KSDV+SFGVLL EL+T
Sbjct: 156 VHNHTGAKLPVKWMAL------ESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-15
Identities = 50/173 (28%), Positives = 89/173 (51%), Gaps = 15/173 (8%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQVL 57
N+ E V++ +++ +V ++LG CL + V L + + +P G L D++ + SQ L
Sbjct: 53 NKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYL 111
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
NW C++IA ++YL ++H D+ + NVL+ K+ DFG + L+ +D
Sbjct: 112 LNW--CVQIA----KGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ + E ++ T +SDV+S+GV + EL+T G KP G+
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 3e-15
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 51/185 (27%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVL---------- 57
E+ ++ ++ H N+V+ +D I D+S+Q L
Sbjct: 49 EVNILRELKHPNIVR----------------------YYDRIIDRSNQTLYIVMEYCEGG 86
Query: 58 ---RNWKTC------------LRIAAETASALDYLH--SSASPPIIHGDVKSTNVLLDDN 100
+ + C RI + AL H S ++H D+K N+ LD N
Sbjct: 87 DLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDAN 146
Query: 101 YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
K+ DFG + ++ D+ A T +GT + PE + EKSD++S G L+ EL
Sbjct: 147 NNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELC 204
Query: 161 TGLKP 165
P
Sbjct: 205 ALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 67/248 (27%), Positives = 105/248 (42%), Gaps = 36/248 (14%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E+ ++ I HKN++ +LG C + +V E+ +G L D + + R
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 67 AAET-------------ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
ET A +++L AS IH D+ + NVL+ +++ K+ADFG +
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARD 181
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALA 172
I + TT + PE + T +SDV+SFGVLL E+ T G P
Sbjct: 182 IHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP------- 234
Query: 173 SNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232
GI + + F E + + N E + L C +RPT KQ
Sbjct: 235 -YPGIPVEELFKLLKEGYRMEKPQNCT--QE--------LYHLMRDCWHEVPSQRPTFKQ 283
Query: 233 VSEELDRL 240
+ E+LDR+
Sbjct: 284 LVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-15
Identities = 44/157 (28%), Positives = 82/157 (52%), Gaps = 6/157 (3%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +V+ +++H +V++ G C + K +V EF+ NG L +++ + ++ ++ L
Sbjct: 46 FIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLL 103
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + ++YL ++ IH D+ + N L+ KV+DFG + + D T+ +
Sbjct: 104 SMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
K + PE K + KSDV+SFGVL+ E+ T
Sbjct: 161 AKFPVKWS-PPEVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 63/245 (25%), Positives = 108/245 (44%), Gaps = 33/245 (13%)
Query: 17 HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH-------------DKSSQVLRNWKTC 63
HKN++ +LGAC + ++ E+ G L +++ + + ++K
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ A + A ++YL AS IH D+ + NVL+ ++ K+ADFG + I + T
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 199
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T + PE + T +SDV+SFGVLL E+ T + + G+ + + F
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT-------LGGSPYPGVPVEELF 252
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
E + + + N +E M + C +RPT KQ+ E+LDR+
Sbjct: 253 KLLKEGHRMDKPSN--CTNELYM--------MMRDCWHAVPSQRPTFKQLVEDLDRILAL 302
Query: 244 HENYE 248
N E
Sbjct: 303 TSNQE 307
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-15
Identities = 71/262 (27%), Positives = 110/262 (41%), Gaps = 47/262 (17%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR----- 58
F EL V+ ++ +H N++ +LGAC + E+ P G L D + + S+VL
Sbjct: 49 FAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFL--RKSRVLETDPAF 106
Query: 59 ----------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
+ L+ A++ A+ + YL + IH D+ + NVL+ +N +K+ADF
Sbjct: 107 AKEHGTASTLTSQQLLQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADF 163
Query: 109 GSSVLISSDNQTAMTTKKIGTFVN--LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
G S + K +G + E + T KSDV+SFGVLL E+++ G P
Sbjct: 164 G-----LSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
Query: 166 GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225
GM A LY R DE V L +C
Sbjct: 219 YCGMTCAE----------LYEKLPQGYRMEKPRNCDDE--------VYELMRQCWRDRPY 260
Query: 226 RRPTMKQVSEELDRLKISHENY 247
RP Q+S +L R+ + + Y
Sbjct: 261 ERPPFAQISVQLSRMLEARKAY 282
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-14
Identities = 45/172 (26%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL-----FDHIHDKSSQ---- 55
F E++++S++ N++++LG C++ ++ E++ NG L H+ DK
Sbjct: 66 FLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA 125
Query: 56 -------VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
++ + L +A + AS + YL +S +H D+ + N L+ +N K+ADF
Sbjct: 126 VPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADF 182
Query: 109 GSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
G S + + + + + + + E ++ GK T SDV++FGV L E+L
Sbjct: 183 GMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 47/159 (29%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI--HDKSSQVLRNWKT 62
F E +V+ +++H+ +V++ G C + + +V E++ NG L +++ H K Q + +
Sbjct: 46 FIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
C + + YL S IH D+ + N L+DD KV+DFG S + D T+
Sbjct: 106 C----KDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
K + PE ++ K + KSDV++FGVL+ E+ +
Sbjct: 159 VGSKFPVRWS-PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-14
Identities = 66/255 (25%), Positives = 114/255 (44%), Gaps = 34/255 (13%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-------SSQVLR- 58
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ + S + R
Sbjct: 70 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129
Query: 59 -----NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+K + + A ++YL AS IH D+ + NVL+ +N K+ADFG +
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARD 186
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
+++ + TT + PE + T +SDV+SFGVL+ E+ T + +
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT-------LGGSP 239
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
GI + + F E + + + N +E M + C RPT KQ+
Sbjct: 240 YPGIPVEELFKLLKEGHRMDKPAN--CTNELYM--------MMRDCWHAIPSHRPTFKQL 289
Query: 234 SEELDRLKISHENYE 248
E+LDR+ N E
Sbjct: 290 VEDLDRILTLTTNEE 304
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-14
Identities = 52/187 (27%), Positives = 93/187 (49%), Gaps = 16/187 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLR---- 58
F E +++ + H+++VK G C+E ++V+E++ +G L F H + ++
Sbjct: 54 FHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113
Query: 59 ----NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
L IA + A+ + YL AS +H D+ + N L+ +N K+ DFG S +
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV 170
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS 173
S + + + + PE ++ K T +SDV+S GV+L E+ T G +P L++
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP--WYQLSN 228
Query: 174 NEGISMV 180
NE I +
Sbjct: 229 NEVIECI 235
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 48/159 (30%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL ++ + N +V GA + E++ +G D I + + + +IA
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYM-DGGSLDKILKEVQGRI-PERILGKIA 106
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTKK 126
L YLH IIH DVK +N+L++ + K+ DFG S L+ N A T
Sbjct: 107 VAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NSLAKTF-- 159
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + KSD++S G+ L EL TG P
Sbjct: 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFP 198
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-14
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL+ + VVK GA + +V E++ G+L D + K ++ IA
Sbjct: 49 ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKI--PEPVLAYIA 105
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTKK 126
+ LDYLH+ IIH D+K +N+L++ + K+ADFG S VL +N
Sbjct: 106 RQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTF 160
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + +D++S G+ L E G P
Sbjct: 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 59/242 (24%), Positives = 110/242 (45%), Gaps = 34/242 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N++++ G +++ +++ E++ NG+L + + + +
Sbjct: 52 FLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLV 109
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ AS + YL +H D+ + N+L++ N KV+DFG S + T TT
Sbjct: 110 GMLRGIASGMKYLSEMNY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT-YTT 165
Query: 125 K--KIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGIS 178
K KI T PE + K T SDV+SFG+++ E+++ G +P M SN
Sbjct: 166 KGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SN---- 214
Query: 179 MVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238
Q + ++E+ +++ M+ + L C RPT Q+ LD
Sbjct: 215 --QDVIKAVED-------GYRL--PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
Query: 239 RL 240
++
Sbjct: 264 KM 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-14
Identities = 59/187 (31%), Positives = 90/187 (48%), Gaps = 29/187 (15%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR----- 58
F EL V+ ++ +H N++ +LGAC L E+ P+G L D + + S+VL
Sbjct: 42 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKSRVLETDPAF 99
Query: 59 ----------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
+ + L AA+ A +DYL + IH D+ + N+L+ +NY AK+ADF
Sbjct: 100 AIANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADF 156
Query: 109 GSSVLISSDNQTAMTTKKIGTFVN--LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
G S Q K +G + E + T SDV+S+GVLL E+++ G P
Sbjct: 157 G-----LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
Query: 166 GSGMALA 172
GM A
Sbjct: 212 YCGMTCA 218
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 3e-14
Identities = 59/250 (23%), Positives = 104/250 (41%), Gaps = 43/250 (17%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
F +E V+ + N +VV++LG + L+V E + G L ++ + +
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPE---AENNPG 112
Query: 64 ---------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
+++AAE A + YL + +H D+ + N ++ ++ K+ DFG + I
Sbjct: 113 LGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS 173
+ K + + PE + G T KSDV+SFGV+L E+ T +P G+ S
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---S 226
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIET----VAGLASKCLSLSGRRRPT 229
NE ++L F V D ++ E + L C + + RPT
Sbjct: 227 NE------------------EVLKF-VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPT 267
Query: 230 MKQVSEELDR 239
++ L
Sbjct: 268 FLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-14
Identities = 52/172 (30%), Positives = 77/172 (44%), Gaps = 20/172 (11%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+F E ++ + NH +VK+ + K ++ E+ G L+ + D+ L +
Sbjct: 38 EHIFS-EKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR---GLFDEY 93
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
T A A +YLH+ II+ D+K N+LLD N K+ DFG + + S +T
Sbjct: 94 TARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW 150
Query: 122 MTTKKIGTFVNLDPEYV----ITGK-LTEKSDVYSFGVLLAELLTGLKPGSG 168
GT PEYV I K D +S G+LL ELLTG P
Sbjct: 151 TF---CGT-----PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-14
Identities = 49/166 (29%), Positives = 89/166 (53%), Gaps = 13/166 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLRNWKT 62
F E ++ Q +H N++ + G ++K ++V E++ NG+L F HD V++
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ---- 107
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ + AS + YL + +H D+ + N+L++ N KV+DFG S ++ D + A
Sbjct: 108 LVGMLRGIASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164
Query: 123 TTK--KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
TT+ KI PE + K T SDV+S+G+++ E+++ G +P
Sbjct: 165 TTRGGKIPIRWT-APEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 16/172 (9%)
Query: 1 MNQVFQH----ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQV 56
M+Q + E+R+++ +NH N++ A L+ +V E+ P G L I +
Sbjct: 38 MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAI--SKRKK 95
Query: 57 LRNW---KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
R + RI + L LH I+H D+KS N+LL N K+ D G S +
Sbjct: 96 KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKV 152
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ + M +IGT + PE + KSD++S G LL E+ T P
Sbjct: 153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 66/239 (27%), Positives = 95/239 (39%), Gaps = 26/239 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLL--VYEFVPNGTLFDHIHDK-SSQVL 57
Q+ + EL + +VK GA L+ + E+ G+L D I+ K +
Sbjct: 43 QKQILR-ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGG 100
Query: 58 R-NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLIS 115
R K +IA L YLHS IIH D+K +N+LL + K+ DFG S L++
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157
Query: 116 SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175
S A T GT + PE + + SDV+S G+ L E+ P
Sbjct: 158 S---LAGTF--TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQ 232
I ++ Y I N N ++ DE E +CL RRPT
Sbjct: 213 PIELLSY----IVNMP-----NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 4e-14
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 17/168 (10%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
Q E++ +SQ + K G+ L+ ++ E+ G+ D + L
Sbjct: 47 QQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAF- 102
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
I E L+YLH IH D+K+ N+LL + K+ADFG S Q T
Sbjct: 103 ILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVS------GQLTSTMS 153
Query: 126 KIGTFVN----LDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
K TFV + PE + EK+D++S G+ EL G P S +
Sbjct: 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-14
Identities = 60/245 (24%), Positives = 109/245 (44%), Gaps = 33/245 (13%)
Query: 4 VFQHELRVVSQINHKNVVKILGACLETKVPL----LVYEFVPNGTLFDHIHDKSSQVLRN 59
+ ++E++ + +I+ N++KI G ++ L L+ E+ G L + + DK +
Sbjct: 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-DKEKDLS-- 120
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+KT L +A + L L+ + P + ++ S + L+ +NYK K+ G ++SS
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSP-- 176
Query: 120 TAMTTKKIGTFVNLDPEYV--ITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
K + V + + I + T K D+YS GV+L E+ TG P + + + I
Sbjct: 177 ---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEI 230
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
Y L +NNSL+ EI+ + C S +RP +K++ L
Sbjct: 231 ----YDLIINKNNSLK-------LPLDCPLEIKCI---VEACTSHDSIKRPNIKEILYNL 276
Query: 238 DRLKI 242
K
Sbjct: 277 SLYKF 281
|
Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 6e-14
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 10/167 (5%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q E+ + S + H+N+V+ LG+ E + E VP G+L + K + N +T
Sbjct: 50 QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQT 109
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--KVADFGSSVLISSDNQT 120
+ + L YLH + I+H D+K NVL+ + Y K++DFG+S ++ N
Sbjct: 110 IIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRLAGINPC 165
Query: 121 AMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAELLTGLKP 165
T GT + PE + G +D++S G + E+ TG P
Sbjct: 166 TETFT--GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-14
Identities = 50/157 (31%), Positives = 77/157 (49%), Gaps = 10/157 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E+ ++ + H+N+VK G C E K L+ E+VP G+L D++ N L
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL----NLAQLLL 111
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
A + + YLHS IH D+ + NVLLD++ K+ DFG + + ++ +
Sbjct: 112 FAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 168
Query: 126 KIGTFVN-LDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ V E + K + SDV+SFGV L ELLT
Sbjct: 169 DGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-14
Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVP--LLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F+ E+ ++ + H N+VK G C LV E++P G+L D++ ++ + +
Sbjct: 52 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL--DHRK 109
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L A++ ++YL S +H D+ + N+L++ + K+ DFG + ++ D +
Sbjct: 110 LLLYASQICKGMEYL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK 166
Query: 123 TTKK----IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ I + PE + K + SDV+SFGV+L EL T
Sbjct: 167 VREPGESPIFWYA---PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 64/196 (32%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E +++++NH +VK L +T+ L L+ +F+ G LF + S +V+ +
Sbjct: 48 ERDILAEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFY 103
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AE A ALD+LHS II+ D+K N+LLD+ K+ DFG S S +
Sbjct: 104 LAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSF 158
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG------MALASNEGISMV 180
GT + PE V T+ +D +SFGVL+ E+LTG P G M + + M
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP 218
Query: 181 QYFLYSIENNSLRQIL 196
Q+ S E SL + L
Sbjct: 219 QFL--SPEAQSLLRAL 232
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 9e-14
Identities = 66/247 (26%), Positives = 112/247 (45%), Gaps = 34/247 (13%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH-------DKSSQVLR- 58
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ D S +
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 59 -----NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+K + A + A ++YL AS IH D+ + NVL+ ++ K+ADFG +
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
+ + + TT + PE + T +SDV+SFGVLL E+ T G +
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT---LGG----SP 236
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
GI + + F E + + + N E M + +C +RPT KQ+
Sbjct: 237 YPGIPVEELFKLLKEGHRMDKPAN--CTHELYM--------IMRECWHAVPSQRPTFKQL 286
Query: 234 SEELDRL 240
E+LDR+
Sbjct: 287 VEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 8/169 (4%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-HDKSSQVLRNWKTCLRI 66
E+ ++ Q++H NV+K L + +E +V E G L I H K + L +T +
Sbjct: 52 EIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKY 111
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+ SAL+++HS I+H D+K NV + K+ D G SS +T
Sbjct: 112 FVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSL 166
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP--GSGMALAS 173
+GT + PE + KSD++S G LL E+ P G M L S
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-13
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 34/243 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLR---- 58
F+ EL + +++HKNVV++LG C E + ++ E+ G L F + L+
Sbjct: 55 FRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPL 114
Query: 59 NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
+ K + + + A +D+L ++ +H D+ + N L+ + KV S + +S D
Sbjct: 115 STKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKV----SLLSLSKDV 167
Query: 119 QTAMTTKKIGTFVN---LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASN 174
+ K + L PE V + KSDV+SFGVL+ E+ T G P G+ S+
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL---SD 224
Query: 175 EGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
E L ++ L V + + L ++C +++ + RP+ ++
Sbjct: 225 EE------VLNRLQAGKLE----LPVPEGCP----SRLYKLMTRCWAVNPKDRPSFSELV 270
Query: 235 EEL 237
L
Sbjct: 271 SAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 51/173 (29%), Positives = 84/173 (48%), Gaps = 15/173 (8%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK----SSQVL 57
N+ E V++ + V ++LG CL + V L V + +P G L D++ + SQ L
Sbjct: 53 NKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
NW C++IA + YL ++H D+ + NVL+ K+ DFG + L+ D
Sbjct: 112 LNW--CVQIA----KGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ E ++ + T +SDV+S+GV + EL+T G KP G+
Sbjct: 163 ETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 2e-13
Identities = 48/181 (26%), Positives = 89/181 (49%), Gaps = 14/181 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-------HDKSSQVL 57
F +E V+ + N +VV++LG + + L++ E + G L ++ + Q
Sbjct: 56 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP 115
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+ K +++A E A + YL+++ +H D+ + N ++ +++ K+ DFG + I
Sbjct: 116 PSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 172
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG 176
+ K + + PE + G T SDV+SFGV+L E+ T +P GM SNE
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM---SNEQ 229
Query: 177 I 177
+
Sbjct: 230 V 230
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-13
Identities = 50/161 (31%), Positives = 83/161 (51%), Gaps = 13/161 (8%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E RV+ +++H ++++ + + ++ E+VP G LF ++ ++S N T L
Sbjct: 49 HNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSN-STGLF 105
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
A+E AL+YLHS I++ D+K N+LLD K+ DFG + + T
Sbjct: 106 YASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---- 158
Query: 126 KIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT L PE VI K K+ D ++ G+L+ E+L G P
Sbjct: 159 -CGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 5e-13
Identities = 52/171 (30%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQV----LRNW 60
F E ++S NH N+VK+LG CL + ++ E + G L ++ D + L
Sbjct: 46 FLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL-----DDNYKAKVADFGSSVLIS 115
K L I + A YL IH D+ + N L+ D + K+ DFG + I
Sbjct: 106 KELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIY 162
Query: 116 SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
+ + + + PE ++ GK T +SDV+SFGVL+ E+LT G +P
Sbjct: 163 KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-13
Identities = 63/253 (24%), Positives = 111/253 (43%), Gaps = 47/253 (18%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTL-----FDHIHDKS 53
F E + + +H NV++++G CL+T P+++ F+ +G L + + D
Sbjct: 47 FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD-- 104
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ ++ + AS ++YL S + IH D+ + N +L++N VADFG S
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKK 161
Query: 114 ISSDNQ------TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPG 166
I + + M K I D Y T KSDV+SFGV + E+ T G P
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVY------TTKSDVWSFGVTMWEIATRGQTP- 214
Query: 167 SGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226
G+ + + Y + N L+Q + ++ + L S C L+ +
Sbjct: 215 -------YPGVENSEIYDYLRQGNRLKQ----------PPDCLDGLYSLMSSCWLLNPKD 257
Query: 227 RPTMKQVSEELDR 239
RP+ + + EL++
Sbjct: 258 RPSFETLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-13
Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 11/159 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL+++ + +V GA L + EF+ G+L D I+ K + + +IA
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPI--PVEILGKIA 109
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTKK 126
L YL++ I+H D+K +N+L++ + K+ DFG S LI+S T
Sbjct: 110 VAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF----- 162
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + GK T KSDV+S G+ + EL G P
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 8e-13
Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 25/160 (15%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD--HIHDKSSQVLRNWKTCLR 65
E+R + Q+ H N ++ G L LV E+ G+ D +H K Q +
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVE------- 116
Query: 66 IAAETASALD---YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
IAA AL YLHS IH D+K+ N+LL + K+ADFGS+ L+S N
Sbjct: 117 IAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF-- 171
Query: 123 TTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159
+GT + PE ++ G+ K DV+S G+ EL
Sbjct: 172 ----VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-13
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 20/176 (11%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ Q E+ ++ + H N+V+ LG CL+ + EFVP G++ S +L +
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSI--------SSILNRFGP 98
Query: 63 CL-----RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS-- 115
+ + + YLH++ ++H D+K NV+L N K+ DFG + ++
Sbjct: 99 LPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155
Query: 116 --SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
+ M GT + PE + KSD++S G + E+ TG P + M
Sbjct: 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM 211
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 51/164 (31%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
Q E+ V+SQ + V K G+ L+ ++ E++ G+ D + + T L+
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQ-IATMLK 108
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
E LDYLHS IH D+K+ NVLL + K+ADFG + + +D Q T
Sbjct: 109 ---EILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNT- 160
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
+GT + PE + K+D++S G+ EL G P S M
Sbjct: 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDM 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 1e-12
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 50/182 (27%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E++V+ Q+ H+N+V + A LV+E+V L ++L L
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL---------ELLEASPGGLPPD 100
Query: 68 A------ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
A + A+ Y HS IIH D+K N+L+ ++ K+ DFG + + + +
Sbjct: 101 AVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157
Query: 122 MTTKKIGTFVNLDPEYVIT---------------GKLTEKSDVYSFGVLLAELLTG--LK 164
+T +YV T GK DV++ G ++AELL G L
Sbjct: 158 LT------------DYVATRWYRAPELLVGDTNYGK---PVDVWAIGCIMAELLDGEPLF 202
Query: 165 PG 166
PG
Sbjct: 203 PG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 1e-12
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 21/165 (12%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL-- 64
+E+ V+ + H N+V L + L +V E++ G+L D + + TC+
Sbjct: 65 NEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDE 114
Query: 65 -RIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+IAA E AL++LHS+ +IH D+KS N+LL + K+ DFG I+ + Q+
Sbjct: 115 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 170
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+T +GT + PE V K D++S G++ E++ G P
Sbjct: 171 KRST-MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-12
Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 31/226 (13%)
Query: 14 QINHKNVVKILGACLETKVPLLVYEFV---PNGTLFDHIHDKSSQVL--RNWKTCLRIAA 68
Q+ H N+V+ LE +V + + P G F+ + +K + R W +++
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
AL YLH I+H D+ N++L ++ K + DFG L + T +G
Sbjct: 125 ----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFG---LAKQKQPESKLTSVVG 175
Query: 129 TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE 188
T + PE V EK+DV++FG +L ++ T L+P S +S+
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCT-LQP----PFYSTNMLSLAT------- 223
Query: 189 NNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
+I+ E E V + + CL+ RP + QVS
Sbjct: 224 -----KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-12
Identities = 45/169 (26%), Positives = 87/169 (51%), Gaps = 15/169 (8%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q F E ++ Q +H N++++ G + K +++ E++ NG L ++ D + +
Sbjct: 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF-----S 105
Query: 63 CLRIAAE---TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
++ A+ + YL + +H D+ + N+L++ N + KV+DFG S ++ D +
Sbjct: 106 SYQLVGMLRGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162
Query: 120 TAMTTK--KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
TT KI PE + K T SDV+SFG+++ E+++ G +P
Sbjct: 163 GTYTTSGGKIPIRWTA-PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 44/171 (25%), Positives = 81/171 (47%), Gaps = 21/171 (12%)
Query: 6 QHELRVVSQINH---KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q E+ ++SQ+ N+ K G+ L+ ++ E+ G++ + + +
Sbjct: 47 QREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYI 103
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ I E AL Y+H +IH D+K+ N+L+ + K+ DFG + L++
Sbjct: 104 SV-IIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ------ 153
Query: 123 TTKKIGTFVN----LDPEYVITGKLTE-KSDVYSFGVLLAELLTGLKPGSG 168
+ K TFV + PE + GK + K+D++S G+ + E+ TG P S
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-12
Identities = 53/175 (30%), Positives = 80/175 (45%), Gaps = 26/175 (14%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
Q E+ ++ + H N+V G+ L +V E+ G+L D I+ QV R + L+
Sbjct: 48 QQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD-IY----QVTRGPLSELQ 102
Query: 66 IA---AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
IA ET L YLH + IH D+K N+LL ++ K+ADFG S +++
Sbjct: 103 IAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTA------ 153
Query: 123 TTKK----IGTFVNLDPEYVI----TGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
T K IGT + PE V G K D+++ G+ EL P +
Sbjct: 154 TIAKRKSFIGTPYWMAPE-VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDL 207
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-12
Identities = 63/250 (25%), Positives = 118/250 (47%), Gaps = 39/250 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLR 58
F E + + +H NV+K++G L ++ +P+++ F+ +G L H S++
Sbjct: 48 FLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGE 105
Query: 59 N-----WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+T +R + AS ++YL +S IH D+ + N +L++N VADFG S
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 114 ISSDN--QTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMA 170
I S + + +K ++ L E + T SDV++FGV + E++T G P +
Sbjct: 163 IYSGDYYRQGCASKLPVKWLAL--ESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYA--- 217
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230
G+ + + Y I+ N L+Q + +E V L +C S + RP+
Sbjct: 218 -----GVENSEIYNYLIKGNRLKQPP----------DCLEDVYELMCQCWSPEPKCRPSF 262
Query: 231 KQVSEELDRL 240
+ + ++L+ +
Sbjct: 263 QHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 25/182 (13%)
Query: 5 FQHELRVVSQINHKNVVKIL--GACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F+ E + +++ H N+V +L G + V+E+VP TL +VL
Sbjct: 25 FRRETALCARLYHPNIVALLDSGEAPPGLL-FAVFEYVPGRTL--------REVLAA-DG 74
Query: 63 CLRIAAET----ASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLIS 115
L A ET LD L + + I+H D+K N+++ AKV DFG L+
Sbjct: 75 ALP-AGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 116 ----SDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
+D T TT+ +GT PE + +T SD+Y++G++ E LTG + G +
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGAS 193
Query: 171 LA 172
+A
Sbjct: 194 VA 195
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-12
Identities = 55/240 (22%), Positives = 102/240 (42%), Gaps = 33/240 (13%)
Query: 17 HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH-------------DKSSQVLRNWKTC 63
HKN++ +LG C + ++ E+ G L + + K + ++K
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ A + A ++YL S IH D+ + NVL+ ++ K+ADFG + + + T
Sbjct: 137 VSCAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
+ + PE + T +SDV+SFG+L+ E+ T + + GI + + F
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT-------LGGSPYPGIPVEELF 246
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243
E + + + N + L +C +RPT KQ+ E LD++ +
Sbjct: 247 KLLREGHRMDKPSNCT----------HELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 5e-12
Identities = 54/174 (31%), Positives = 82/174 (47%), Gaps = 20/174 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E+ ++S+ H N+V + A E K+ +L+ EF G L D I + + L T
Sbjct: 49 FMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGAL-DSIMLELERGL----TE 102
Query: 64 LRIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+I + AL++LHS +IH D+K+ N+LL + K+ADFG S S Q
Sbjct: 103 PQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTE-----KSDVYSFGVLLAELLTGLKPGSGM 169
T IGT + PE V + K+D++S G+ L EL P +
Sbjct: 160 RDTF--IGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-12
Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 13/167 (7%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVY-EFVPNGTLFDHIHDKSSQVLRNWK 61
+ E++++ + H+ +V+ G CL L ++ E++P G++ D + K+ L
Sbjct: 49 NALECEIQLLKNLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETV 105
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS--DNQ 119
T + + ++YLHS+ I+H D+K N+L D K+ DFG+S + + +
Sbjct: 106 T-RKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 120 TAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
T M + GT + PE VI+G+ K+DV+S G + E+LT P
Sbjct: 162 TGMKS-VTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-12
Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 8/169 (4%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-HDKSSQVLRNWKTCLRI 66
E+ ++ Q+NH NV+K + +E +V E G L I H K + L KT +
Sbjct: 52 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKY 111
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+ SAL+++HS ++H D+K NV + K+ D G SS A +
Sbjct: 112 FVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP--GSGMALAS 173
+GT + PE + KSD++S G LL E+ P G M L S
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 7e-12
Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 15/165 (9%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHD---KSSQVLRNWKT 62
Q E+ V+SQ + V K G+ L+ ++ E++ G+ D + +Q+ T
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI----AT 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
LR E LDYLHS IH D+K+ NVLL ++ + K+ADFG + + +D Q
Sbjct: 106 ILR---EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL-TDTQIK- 157
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGS 167
+GT + PE + K+D++S G+ EL G P S
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 7e-12
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 12/166 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQV--LRNWKT 62
F E++ ++NH NV++ LG C+E+ LLV EF P G L +++ V +
Sbjct: 42 FLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV 101
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV------LISS 116
R+A E AS L +LH + IH D+ N L + K+ D+G ++ +
Sbjct: 102 LQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158
Query: 117 DNQTAMTTKKIG-TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ A+ + + V + + ++ T+KS+++S GV + EL T
Sbjct: 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 7e-12
Identities = 45/133 (33%), Positives = 58/133 (43%), Gaps = 8/133 (6%)
Query: 36 VYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNV 95
V E++ G L HI AAE L +LH II+ D+K NV
Sbjct: 74 VMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICGLQFLHKKG---IIYRDLKLDNV 127
Query: 96 LLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155
LLD + K+ADFG + N + GT + PE + K E D +SFGVL
Sbjct: 128 LLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVL 185
Query: 156 LAELLTGLKPGSG 168
L E+L G P G
Sbjct: 186 LYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 7e-12
Identities = 40/180 (22%), Positives = 73/180 (40%), Gaps = 54/180 (30%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVP--LLVYEFVPN---------GTLFDHIHDKS--S 54
E++++ ++ H N+V++ +V+E++ + F K
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMK 107
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
Q+L L YLHS+ I+H D+K +N+L++++ K+ADFG +
Sbjct: 108 QLL--------------EGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPY 150
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVIT----------G--KLTEKSDVYSFGVLLAELLTG 162
+ N T + VIT G + + D++S G +LAEL G
Sbjct: 151 TKRNSADYTNR------------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 8e-12
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 11/165 (6%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW-KTCL 64
Q E+ V+SQ + + + G+ L+ ++ E++ G+ D + K + + T L
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATIL 107
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
R E LDYLHS IH D+K+ NVLL + K+ADFG + + +D Q T
Sbjct: 108 R---EILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNT 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
+GT + PE + K+D++S G+ EL G P S +
Sbjct: 161 -FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-12
Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E V+ Q+++ +V+++G C E + +LV E G L + +N +
Sbjct: 46 EANVMQQLDNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKN---ITELV 101
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTK 125
+ + + YL + +H D+ + NVLL + AK++DFG S + +D A T
Sbjct: 102 HQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
Query: 126 K--IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQ 181
K + + PE + K + KSDV+SFGVL+ E + G KP GM NE M++
Sbjct: 159 KWPVKWYA---PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM--KGNEVTQMIE 212
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-12
Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ F E V+ + H +VK+ + TK P+ ++ EF+ G+L D + K
Sbjct: 46 EAFLAEANVMKTLQHDKLVKL--HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPK 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ +A+ A + ++ IH D+++ N+L+ + K+ADFG + +I + TA
Sbjct: 104 L-IDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMA 170
K PE + G T KSDV+SFG+LL E++T G P GM+
Sbjct: 160 REGAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 1e-11
Identities = 46/171 (26%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHD----KSSQVLR 58
+ + E+R+++++NH +++++LGA E L E++ G++ + K + ++
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN 107
Query: 59 NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSD 117
+ LR L YLH + IIH DVK N+L+D + ++ADFG++ +++
Sbjct: 108 YTEQLLR-------GLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157
Query: 118 NQTA--MTTKKIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
A + +GT + PE V+ G+ +S DV+S G ++ E+ T P
Sbjct: 158 GTGAGEFQGQLLGTIAFMAPE-VLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 51/160 (31%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E RV++ + L +C +TK L V E+V G L HI S +
Sbjct: 45 EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ--RSGRFDEPRARF-Y 101
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AAE L +LH II+ D+K NVLLD K+ADFG T T+
Sbjct: 102 AAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTF 156
Query: 127 IGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT + PE +++ + + D ++ GVLL E+L G P
Sbjct: 157 CGTPDYIAPE-ILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-11
Identities = 49/169 (28%), Positives = 78/169 (46%), Gaps = 8/169 (4%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-HDKSSQVLRNWKTCLRI 66
E+ ++ Q+NH NV+K L + +E +V E G L I + K + L +T +
Sbjct: 52 EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+ SA++++HS ++H D+K NV + K+ D G SS A +
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP--GSGMALAS 173
+GT + PE + KSD++S G LL E+ P G M L S
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-11
Identities = 43/167 (25%), Positives = 85/167 (50%), Gaps = 13/167 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQVLRNWKT 62
F E ++ Q +H N++ + G +++ +++ EF+ NG L F +D V++
Sbjct: 52 FLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQ---- 107
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ + A+ + YL + +H D+ + N+L++ N KV+DFG S + D
Sbjct: 108 LVGMLRGIAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164
Query: 123 TTKKIGTFVNLD---PEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
T +G + + PE + K T SDV+S+G+++ E+++ G +P
Sbjct: 165 YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 40/182 (21%), Positives = 89/182 (48%), Gaps = 17/182 (9%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI----------- 49
+ + F+HE + S++ H N+V +LG + + +++ + + L + +
Sbjct: 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGS 110
Query: 50 --HDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVAD 107
DK+ + + I + A+ +++L +S ++H D+ + NVL+ D K++D
Sbjct: 111 TDDDKTVKSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISD 167
Query: 108 FGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPG 166
G + + + + + + PE ++ GK + SD++S+GV+L E+ + GL+P
Sbjct: 168 LGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 227
Query: 167 SG 168
G
Sbjct: 228 CG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 49/151 (32%), Positives = 65/151 (43%), Gaps = 20/151 (13%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
L AC +T+ + V E+ G L HIH V + AA L YLH +
Sbjct: 67 LFACFQTEDHVCFVMEYAAGGDLMMHIHTD---VFSEPRAVF-YAACVVLGLQYLHENK- 121
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK 142
I++ D+K N+LLD K+ADFG L T TF PE++
Sbjct: 122 --IVYRDLKLDNLLLDTEGFVKIADFG---LCKEGMGFGDRT---STFCG-TPEFLAPEV 172
Query: 143 LTEKS-----DVYSFGVLLAELLTGLKPGSG 168
LTE S D + GVL+ E+L G P G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 11/162 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E++++ ++NH N++K+L LV+EF+ + L+ + + L
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDLY-KLIKDRQRGLPESLIK-SYL 104
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+ L + HS I+H D+K N+L++ K+ADFG + S + T +
Sbjct: 105 YQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYV 159
Query: 128 GTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTG--LKPG 166
T PE ++ K + D++S G + AELL+ L PG
Sbjct: 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-11
Identities = 45/162 (27%), Positives = 79/162 (48%), Gaps = 7/162 (4%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ ++ Q + +VK G+ + +V E+ G++ D + K + + I
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAIL 105
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+T L+YLHS+ IH D+K+ N+LL++ +AK+ADFG S ++ T I
Sbjct: 106 YQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VI 160
Query: 128 GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
GT + PE + K+D++S G+ E+ G P S +
Sbjct: 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDI 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 2e-11
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 22/170 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-----SQVLRNWKT 62
E++ + H VVK+L +LV E++P L + + D+ +QV +
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L+ + Y+H++ I+H D+K N+L+ + K+ADFG + L S +
Sbjct: 108 LLK-------GVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157
Query: 123 TTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAELLTG--LKPGSG 168
+ ++ T PE ++ G K D+++ G + AELL G L PG
Sbjct: 158 -SHQVATRWYRAPE-LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-11
Identities = 54/240 (22%), Positives = 103/240 (42%), Gaps = 27/240 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-------HDKSSQVL 57
F +E V+ +VV++LG + + L+V E + +G L ++ + +
Sbjct: 56 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+ +++AAE A + YL++ +H D+ + N ++ ++ K+ DFG + I
Sbjct: 116 PTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET 172
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
+ K + + PE + G T SD++SFGV+L E+ + +A +G+
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI-------TSLAEQPYQGL 225
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
S Q + ++ L Q N E V L C + + RPT ++ L
Sbjct: 226 SNEQVLKFVMDGGYLDQPDNCP----------ERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 3e-11
Identities = 44/159 (27%), Positives = 78/159 (49%), Gaps = 9/159 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
+E+ ++ H+NVV++ + L + ++ EF+ G L D + SQ N + +
Sbjct: 67 NEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----SQTRLNEEQIATV 122
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AL YLHS +IH D+KS ++LL + + K++DFG IS D
Sbjct: 123 CESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSL 177
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + D++S G+++ E++ G P
Sbjct: 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.7 bits (149), Expect = 4e-11
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 15/162 (9%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK---SSQVLRNWKTC 63
+E+ V+ ++ + N+V L + L +V E++ G+L D + + +Q+ + C
Sbjct: 65 NEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCREC 124
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L+ AL++LH++ +IH D+KS NVLL + K+ DFG I+ + T
Sbjct: 125 LQ-------ALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST 174
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE V K D++S G++ E++ G P
Sbjct: 175 M--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-11
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD---HIHDKSSQVLRNWKTCL 64
E+ ++ H N+V++ + L +V EF+ G L D H Q+ L
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVL 125
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ AL +LH+ +IH D+KS ++LL + + K++DFG +S + +
Sbjct: 126 K-------ALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----VPR 171
Query: 125 KK--IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+K +GT + PE + + D++S G+++ E++ G P
Sbjct: 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 5e-11
Identities = 51/174 (29%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR----NW 60
F E ++S+ NH+N+V+++G E ++ E + G L + + + R
Sbjct: 56 FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLI-SS 116
K L A + A YL + IH D+ + N LL AK+ADFG + I +
Sbjct: 116 KDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 117 D----NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
AM K + PE + G T K+DV+SFGVLL E+ + G P
Sbjct: 173 SYYRKGGRAMLPIKW-----MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 61.3 bits (148), Expect = 5e-11
Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 45/237 (18%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL-- 64
+E+ V+ + + N+V L + L +V E++ G+L D + + TC+
Sbjct: 65 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDE 114
Query: 65 -RIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+IAA E ALD+LHS+ +IH D+KS N+LL + K+ DFG I+ +
Sbjct: 115 GQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
T +GT + PE V K D++S G++ E++ G P
Sbjct: 172 RSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP--------------- 214
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGL----ASKCLSLSGRRRPTMKQV 233
+ N LR + E++ E ++ + ++CL + RR + K++
Sbjct: 215 -----YLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-11
Identities = 50/136 (36%), Positives = 66/136 (48%), Gaps = 10/136 (7%)
Query: 34 LLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKST 93
V EF+ G L HI DK L ++ AAE L +LHS II+ D+K
Sbjct: 72 FFVMEFLNGGDLMFHIQDKGRFDL--YRATF-YAAEIVCGLQFLHSKG---IIYRDLKLD 125
Query: 94 NVLLDDNYKAKVADFG-SSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSF 152
NV+LD + K+ADFG + DN+ + GT + PE + K T D +SF
Sbjct: 126 NVMLDRDGHIKIADFGMCKENVFGDNRA---STFCGTPDYIAPEILQGLKYTFSVDWWSF 182
Query: 153 GVLLAELLTGLKPGSG 168
GVLL E+L G P G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-11
Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 24/172 (13%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVY-EFVPNGTLFDHIHDKSSQVLRNW-----K 61
E+ + ++H N+V+ LG T+ L ++ E+VP G++ LR + +
Sbjct: 58 EIETLKDLDHLNIVQYLG-FETTEEYLSIFLEYVPGGSI--------GSCLRTYGRFEEQ 108
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS--DNQ 119
+ L YLHS I+H D+K+ N+L+D + K++DFG S DN
Sbjct: 109 LVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDND 165
Query: 120 TAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAELLTGLKPGSGM 169
M+ + G+ + PE + + + K D++S G ++ E+ G +P S
Sbjct: 166 QNMSMQ--GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 54/172 (31%), Positives = 80/172 (46%), Gaps = 23/172 (13%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS---S 54
M QV QH E ++ +++H +V ++ + + + EFV G LF H+ +
Sbjct: 59 MKQV-QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPN 117
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
V + + AE A +YLHS II+ D+K N+LLD+ KV DFG + +
Sbjct: 118 DVAKFY------HAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKV 168
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
T GT L PE VI K K+ D ++ GVLL E + G P
Sbjct: 169 -----PDRTFTLCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 15/164 (9%)
Query: 8 ELRVVSQINHKNVVKILGACL----ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
E++++ + H +V+ G CL E K+ + V E++P G++ D + K+ L
Sbjct: 54 EIQLLKNLRHDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQL--KAYGALTE-NVT 108
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
R + + YLHS+ I+H D+K N+L D K+ DFG+S I + +
Sbjct: 109 RRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG 165
Query: 124 TKKI-GTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
K + GT + PE VI+G+ K+DV+S + E+LT P
Sbjct: 166 IKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 51/160 (31%), Positives = 85/160 (53%), Gaps = 18/160 (11%)
Query: 8 ELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E+ +++ NH +VK+LGA + K+ +++ EF P G + D I + + L + + I
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGAV-DAIMLELDRGLTEPQIQV-I 115
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+ AL YLHS IIH D+K+ NVLL + K+ADFG +S+ N + +
Sbjct: 116 CRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFG----VSAKNVKTLQRRD 168
Query: 127 --IGTFVNLDPEYVITGKLTE-----KSDVYSFGVLLAEL 159
IGT + PE V+ + + K+D++S G+ L E+
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-10
Identities = 51/169 (30%), Positives = 81/169 (47%), Gaps = 26/169 (15%)
Query: 1 MNQVFQ---HELRVVSQINHKNVVKILGACLETKVPLLVYEF-VPNGTLFDHIHDKSSQV 56
N+ +Q E++ + Q+ H N ++ G L+ LV E+ + + + +H K Q
Sbjct: 61 TNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQE 120
Query: 57 LRNWKTCLRIAAETASALD---YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ IAA T AL YLHS +IH D+K+ N+LL + + K+ADFGS+
Sbjct: 121 VE-------IAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASK 170
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159
S N +GT + PE ++ G+ K DV+S G+ EL
Sbjct: 171 SSPANSF------VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-10
Identities = 58/241 (24%), Positives = 104/241 (43%), Gaps = 36/241 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E ++ Q +H ++VK++G E V +V E P G L ++ QV +
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIGVITENPV-WIVMELAPLGELRSYL-----QVNKYSLD 105
Query: 63 CLRI---AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + + ++AL YL S +H D+ + NVL+ K+ DFG S + ++
Sbjct: 106 LASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY 162
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGIS 178
+ K+ + PE + + T SDV+ FGV + E+L G+KP G
Sbjct: 163 YKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG---------- 211
Query: 179 MVQYFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQVSEE 236
++NN + I + + M T+ L +KC + +RP ++ +
Sbjct: 212 --------VKNNDV--IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261
Query: 237 L 237
L
Sbjct: 262 L 262
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 2e-10
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK------SSQVLRNW- 60
E+ V+S + H N+V+ + E +V ++ G L+ I+ + Q+L +W
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQIL-DWF 107
Query: 61 -KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ CL AL ++H I+H D+KS N+ L + K+ DFG + +++S +
Sbjct: 108 VQICL--------ALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
A T IGT L PE KSD+++ G +L E+ T
Sbjct: 157 LARTC--IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 2e-10
Identities = 55/184 (29%), Positives = 78/184 (42%), Gaps = 32/184 (17%)
Query: 6 QHELRVVSQI-NHKNVVKILGACLETKVPL-------LVYEFVPNGTLFD---HIHDKSS 54
+ E ++ + NH N+ GA ++ K P LV E G++ D + K
Sbjct: 50 KEEYNILRKYSNHPNIATFYGAFIK-KNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK 108
Query: 55 QVLRNWKTCLRIA---AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111
++ W IA ET L YLH + +IH D+K N+LL N + K+ DFG S
Sbjct: 109 RLKEEW-----IAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS 160
Query: 112 VLISSDNQTAMTTKKIGTFVNLDPEYVITGKL------TEKSDVYSFGVLLAELLTGLKP 165
+ S T IGT + PE VI +SDV+S G+ EL G P
Sbjct: 161 AQLDSTLGRRNTF--IGTPYWMAPE-VIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
Query: 166 GSGM 169
M
Sbjct: 218 LCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-10
Identities = 51/150 (34%), Positives = 71/150 (47%), Gaps = 17/150 (11%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI--AAETASALDYLHSS 80
L +C +T L V E+V G L HI Q + +K + AAE A L +LHS
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI--GTFVNLDPEYV 138
II+ D+K NV+LD K+ADFG + +N T + GT + PE +
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFG----MCKENIFGGKTTRTFCGTPDYIAPEII 173
Query: 139 ITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+ D ++FGVLL E+L G P G
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 17/109 (15%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTA-- 121
++ AL YL +IH DVK +N+LLD + K+ DFG S L+ S +T
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175
Query: 122 -----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M ++I + +P+Y I ++DV+S G+ L EL TG P
Sbjct: 176 GCAAYMAPERI-DPPDPNPKYDI------RADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVY-EFVPNGTLFDHIHDKSS---QVLRNWKTC 63
E+ ++S++ H N+V+ LG E L ++ E VP G+L + S V+R +
Sbjct: 52 EIALLSKLQHPNIVQYLGTEREED-NLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY--- 107
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ L+YLH +H D+K N+L+D N K+ADFG + + A +
Sbjct: 108 ---TRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKS 160
Query: 124 TKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLTGLKPGS 167
K G+ + PE + G +D++S G + E+ TG P S
Sbjct: 161 FK--GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWS 203
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 29/173 (16%)
Query: 8 ELRVVSQINHKNVVKIL----GACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
E+ ++ + H N+V++ G L++ LV E+ D +S +L N T
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSI--FLVMEYCE--------QDLAS-LLDNMPTP 104
Query: 64 LRIAA------ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+ + L YLH + IIH D+K +N+LL D K+ADFG +
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GL 160
Query: 118 NQTAMTTKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLTG--LKPGS 167
MT K + T PE ++ T D+++ G +LAELL L PG
Sbjct: 161 PAKPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 48/161 (29%), Positives = 72/161 (44%), Gaps = 15/161 (9%)
Query: 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD--HIHDKSSQVLRNWK 61
V Q E+ ++ H N+V G+ L + EF G+L D H+ S+ +
Sbjct: 52 VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY- 110
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
++ ET L YLHS +H D+K N+LL DN K+ADFG S I++ A
Sbjct: 111 ----VSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITA--TIA 161
Query: 122 MTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159
IGT + PE G + D+++ G+ EL
Sbjct: 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 3e-10
Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 21/165 (12%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL-- 64
+E+ V+ + + N+V L + L +V E++ G+L D + + TC+
Sbjct: 66 NEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----------TCMDE 115
Query: 65 -RIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+IAA E AL++LHS+ +IH D+KS N+LL + K+ DFG I+ +
Sbjct: 116 GQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-- 170
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ + +GT + PE V K D++S G++ E++ G P
Sbjct: 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-10
Identities = 42/109 (38%), Positives = 58/109 (53%), Gaps = 17/109 (15%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTA-- 121
+IA AL+YLHS S +IH DVK +NVL++ N + K+ DFG S L+ S +T
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164
Query: 122 -----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M ++I +PE G KSDV+S G+ + EL TG P
Sbjct: 165 GCKPYMAPERI------NPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-10
Identities = 55/164 (33%), Positives = 76/164 (46%), Gaps = 13/164 (7%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLR-NWKTCLR 65
E RV++ + L +C +T L V E+V G L I QV R +
Sbjct: 50 EKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVF 105
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE A L +LHS II+ D+K NV+LD K+ADFG + + +TTK
Sbjct: 106 YAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKENMWDGVTTK 159
Query: 126 KI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
GT + PE + + D ++FGVLL E+L G P G
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 33/174 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFV-----------PNGTLFDHIHDKSSQV 56
E+R++ Q+ H+N+V ++ K LV+EFV PNG + Q+
Sbjct: 50 EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQI 109
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
LR +++ HS IIH D+K N+L+ + K+ DFG + +++
Sbjct: 110 LR--------------GIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG--LKPGS 167
+ + T + T PE ++ K D+++ G L+ E+LTG L PG
Sbjct: 153 PGE--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-10
Identities = 51/167 (30%), Positives = 76/167 (45%), Gaps = 27/167 (16%)
Query: 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD--HIHDKSSQVLRNWK 61
+ Q E+ +V + H N+V G+ L + + E+ G+L D H+ S+
Sbjct: 52 LIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE------ 105
Query: 62 TCLRIA---AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
L+IA ET L YLHS +H D+K N+LL DN K+ADFG + I
Sbjct: 106 --LQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI---- 156
Query: 119 QTAMTTKK---IGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159
TA K+ IGT + PE G + D+++ G+ EL
Sbjct: 157 -TATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-10
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +++ N VV++ A + + +V E++P G L + + + V W
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFY 147
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AE ALD +HS IH DVK N+LLD + K+ADFG+ + ++ + T
Sbjct: 148 --TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202
Query: 125 KKIGTFVNLDPEYVIT----GKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + G + D +S GV L E+L G P
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 4e-10
Identities = 42/133 (31%), Positives = 60/133 (45%), Gaps = 9/133 (6%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
L+ ++V G LF H++ + + + IA E ALD+LH II+ D+K N
Sbjct: 82 LILDYVNGGELFTHLY--QREHFTESEVRVYIA-EIVLALDHLHQLG---IIYRDIKLEN 135
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS--DVYSF 152
+LLD + DFG S ++ GT + PE + G D +S
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSL 194
Query: 153 GVLLAELLTGLKP 165
GVL ELLTG P
Sbjct: 195 GVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-10
Identities = 49/159 (30%), Positives = 77/159 (48%), Gaps = 23/159 (14%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEF-VPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E++ + +I H N ++ G L LV E+ + + + +H K Q + I
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------I 127
Query: 67 AAETASALD---YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
AA T AL YLHS +IH D+K+ N+LL + + K+ADFGS+ + S N
Sbjct: 128 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF--- 181
Query: 124 TKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159
+GT + PE ++ G+ K DV+S G+ EL
Sbjct: 182 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 33/184 (17%)
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
LR +++ A +D+L AS IH DV + NVLL D AK+ DFG + I +D+ +
Sbjct: 215 LRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS------NEG 176
+ PE + T +SDV+S+G+LL E+ + G P G+ + S G
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG 331
Query: 177 ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236
M + E S+ ++ C +L RPT Q+S+
Sbjct: 332 YQMSRPDFAPPEIYSIMKM-----------------------CWNLEPTERPTFSQISQL 368
Query: 237 LDRL 240
+ R
Sbjct: 369 IQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 5e-10
Identities = 48/165 (29%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +++ N + +V++ A + K +V E++P G L + + + + W
Sbjct: 90 FWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFY 147
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AE ALD +HS IH DVK N+LLD + K+ADFG+ + + ++ T
Sbjct: 148 --TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT 202
Query: 125 KKIGTFVNLDPEYVIT----GKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + G + D +S GV L E+L G P
Sbjct: 203 -AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 6e-10
Identities = 51/167 (30%), Positives = 80/167 (47%), Gaps = 16/167 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +++ N VV++ A + K +V E++P G L + + + V W
Sbjct: 90 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFY 147
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT- 123
AE ALD +HS +IH DVK N+LLD + K+ADFG+ + + ++T M
Sbjct: 148 --TAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM---DETGMVR 199
Query: 124 -TKKIGTFVNLDPEYVIT----GKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + G + D +S GV L E+L G P
Sbjct: 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 7e-10
Identities = 47/162 (29%), Positives = 71/162 (43%), Gaps = 19/162 (11%)
Query: 16 NHKNVVKILGACLETKVP------LLVYEFVPNGTLFDHIHDKSSQVLRN-WKTCLRIAA 68
+H+N+ GA ++ P LV EF G++ D I + L+ W I
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICR 118
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
E L +LH +IH D+K NVLL +N + K+ DFG S + D IG
Sbjct: 119 EILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 173
Query: 129 TFVNLDPEYVITGKLTE-----KSDVYSFGVLLAELLTGLKP 165
T + PE + + + KSD++S G+ E+ G P
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 39/108 (36%), Positives = 53/108 (49%), Gaps = 18/108 (16%)
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTA--- 121
IA T AL+YL IIH DVK +N+LLD N K+ DFG S L+ S +T
Sbjct: 112 IAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAG 169
Query: 122 ----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M ++I + Y + +SDV+S G+ L E+ TG P
Sbjct: 170 CRPYMAPERIDP--SARDGYDV------RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 8e-10
Identities = 51/165 (30%), Positives = 77/165 (46%), Gaps = 15/165 (9%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK--TCL 64
E RV++ + + L +C +T L V E+V G L HI Q + +K +
Sbjct: 50 EKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAV 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AAE + L +LH II+ D+K NV+LD K+ADFG + +TT
Sbjct: 105 FYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFG---MCKEHMVDGVTT 158
Query: 125 KKI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+ GT + PE + + D +++GVLL E+L G P G
Sbjct: 159 RTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-10
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 7/167 (4%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+ E+ +++++ H N+V + E +V E+ G L I ++ VL + L
Sbjct: 47 KKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILS 105
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYK-AKVADFGSSVLISSDNQTAMTT 124
+ + L ++H I+H D+KS N+ L N AK+ DFG + ++ + A T
Sbjct: 106 WFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTC 162
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMAL 171
+GT L PE K+D++S G +L EL T P G L
Sbjct: 163 --VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-10
Identities = 54/172 (31%), Positives = 76/172 (44%), Gaps = 29/172 (16%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E RV+S + L +TK L V E++ G L HI ++C +
Sbjct: 45 EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHI-----------QSCHKF 93
Query: 67 --------AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
AAE L +LHS I++ D+K N+LLD + K+ADFG + +N
Sbjct: 94 DLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFG----MCKEN 146
Query: 119 Q--TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
A T GT + PE ++ K D +SFGVLL E+L G P G
Sbjct: 147 MLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 9e-10
Identities = 55/164 (33%), Positives = 73/164 (44%), Gaps = 19/164 (11%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E R++S + + L C +T L V EFV G L HI + S+ +
Sbjct: 45 EKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARF-Y 101
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AAE SAL +LH II+ D+K NVLLD K+ADFG + TT
Sbjct: 102 AAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFG---MCKEGIFNGKTT-- 153
Query: 127 IGTFVNLDPEYVITGKLTEK-----SDVYSFGVLLAELLTGLKP 165
TF P+Y+ L E D ++ GVLL E+L G P
Sbjct: 154 -STFCG-TPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-09
Identities = 46/163 (28%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 8 ELRVVSQINHKNVVKILGACLE---TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E++++ + H+ +V+ G CL K + E++P G++ D + K+ L T
Sbjct: 54 EIQLLKNLQHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVT-R 109
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + YLHS+ I+H D+K N+L D K+ DFG+S + + +
Sbjct: 110 KYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGI 166
Query: 125 KKI-GTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ + GT + PE VI+G+ K+DV+S G + E+LT P
Sbjct: 167 RSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 10/165 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E ++ Q+++ +V+++G C E + +LV E G L + K ++ + +
Sbjct: 45 EAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEI--TVSNVVELM 101
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTK 125
+ + + YL +H D+ + NVLL + + AK++DFG S + +D+ A +
Sbjct: 102 HQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K PE + K + +SDV+S+G+ + E + G KP M
Sbjct: 159 K-WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-09
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 6/158 (3%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E +++++ H N+V + +V E+ G L I + ++ T L+
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE-DTILQWF 106
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+ + ++H ++H D+KS N+ L N K K+ DFGS+ L++S A T +
Sbjct: 107 VQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--V 161
Query: 128 GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE KSD++S G +L EL T P
Sbjct: 162 GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 2e-09
Identities = 36/134 (26%), Positives = 55/134 (41%), Gaps = 18/134 (13%)
Query: 35 LVYEFVPNG---TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVK 91
LV E++ G +L + + + AE ++ LH IIH D+K
Sbjct: 74 LVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQRG---IIHRDIK 124
Query: 92 STNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151
N+L+D K+ DFG S K +GT L PE ++ + SD +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLS------RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 152 FGVLLAELLTGLKP 165
G ++ E L G P
Sbjct: 179 LGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD---HIHDKSSQVLRNWKTC 63
+E+ ++ +H+NVV + + L +V EF+ G L D H Q+ C
Sbjct: 68 NEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA---TVC 124
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L + AL YLH+ +IH D+KS ++LL + + K++DFG +S +
Sbjct: 125 LSVL----RALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS--KEVPKR 175
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + D++S G+++ E++ G P
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 9/160 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E +++ ++N + VV L ETK L LV + G L HI+ +
Sbjct: 49 NEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF- 106
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE L+ LH I++ D+K N+LLDD+ +++D G +V + QT
Sbjct: 107 YAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QT--IKG 160
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
++GT + PE V + T D ++ G LL E++ G P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-09
Identities = 39/159 (24%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
+E+ ++ H+NVV++ + L +V EF+ G L D + + N + +
Sbjct: 66 NEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV----THTRMNEEQIAAV 121
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AL LH+ +IH D+KS ++LL + + K++DFG +S + +
Sbjct: 122 CLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-- 176
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + D++S G+++ E++ G P
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 23/160 (14%)
Query: 15 INHKNVVKILGACLE-TKVPLLVYEFVPNGTL--F----DHIHDKSSQVLRNWKTCLRIA 67
++H+N++ IL C+E + P ++Y ++ G L F + Q L + + +A
Sbjct: 65 LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL-VHMA 123
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTKK 126
+ A + YLH +IH D+ + N ++D+ + K+ D S L D
Sbjct: 124 IQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC------ 174
Query: 127 IGTFVN-----LDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+G N + E ++ + + SDV+SFGVLL EL+T
Sbjct: 175 LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 58/226 (25%), Positives = 89/226 (39%), Gaps = 65/226 (28%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPLLV-YEFVPNGTLFDHIHDK------------- 52
EL+++ I NH NVV +LGAC + PL+V EF G L + + K
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPK 119
Query: 53 ---------------------SSQVLRN-------------------WKTCLRI------ 66
+ VL + WK+ L +
Sbjct: 120 QRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICY 179
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+ + A +++L AS IH D+ + N+LL +N K+ DFG + I D
Sbjct: 180 SFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMAL 171
+ PE + T +SDV+SFGVLL E+ + G P G+ +
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-09
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEF-VPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E+R + ++ H N ++ G L LV E+ + + + +H K Q + I
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE-------I 117
Query: 67 AAETASALD---YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
AA T AL YLHS +IH DVK+ N+LL + K+ DFGS+ +++ N
Sbjct: 118 AAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF--- 171
Query: 124 TKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159
+GT + PE ++ G+ K DV+S G+ EL
Sbjct: 172 ---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 40/242 (16%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F ++SQ++HK++VK+ G C+ + ++V E+V G L +H + + V +WK L
Sbjct: 48 FFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHWK--L 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS--SDNQTAM 122
+A + ASAL YL ++HG+V N+L+ A+ V SD +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPI 156
Query: 123 TTKKIGTFVN----LDPEYVITG--KLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNE 175
T V + PE + G LT +D +SFG L E+ + G +P S ++ +
Sbjct: 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS--- 213
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235
+ +Q M + +A L ++C + +RP+ + +
Sbjct: 214 -----------------EKERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256
Query: 236 EL 237
+L
Sbjct: 257 DL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-09
Identities = 60/234 (25%), Positives = 97/234 (41%), Gaps = 40/234 (17%)
Query: 14 QINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASA 73
Q++HK++V + G C+ ++V EFV G L +H KS + WK ++A + ASA
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWK--FKVAKQLASA 117
Query: 74 LDYLHSSASPPIIHGDVKSTNVLL-----DDNYKA--KVADFGSSVLISSDNQTAMTTKK 126
L YL ++HG+V + N+LL D K++D G + + S +
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPW 174
Query: 127 IGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAEL-LTGLKPGSGMALASNEGISMVQYFL 184
I PE V K L+ +D +SFG L E+ G P LA E Q L
Sbjct: 175 IA------PECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCML 228
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238
+ L A L + C++ +RP + + +++
Sbjct: 229 VTPSCKEL--------------------ADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-09
Identities = 49/158 (31%), Positives = 73/158 (46%), Gaps = 8/158 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E V++Q+N +V + + + LV F+ G LF H+ + L +
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARF---YT 99
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE AL+ LH +I+ D+K N+LLD + DFG L D+ T
Sbjct: 100 AELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFC 154
Query: 128 GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT L PE ++ T+ D ++ GVLL E+LTGL P
Sbjct: 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 9e-09
Identities = 46/198 (23%), Positives = 78/198 (39%), Gaps = 63/198 (31%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT----AMTTKKIG 128
AL Y+HS +IH D+K +N+LL+ + + K+ADFG + +S + +T
Sbjct: 119 ALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT----- 170
Query: 129 TFVNLDPEYVIT------------GKLTEKSDVYSFGVLLAELLTG--LKPGS------- 167
+YV T + T+ D++S G +L E+L G L PG+
Sbjct: 171 -------DYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 168 ------GM-------ALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG 214
G ++ S +M+ L S L ++L D +
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDS-LPSRPRKPLDELLPKASDDALD--------- 273
Query: 215 LASKCLSLSGRRRPTMKQ 232
L K L + +R T ++
Sbjct: 274 LLKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-09
Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 7/157 (4%)
Query: 6 QHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E +++SQ+ H N+V + E + +V F G L+ + ++ ++L +
Sbjct: 47 EQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPE-NQVV 105
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A AL YLH I+H D+K+ NV L KV D G + ++ +NQ M +
Sbjct: 106 EWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMAS 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
IGT + PE KSDV++ G + E+ T
Sbjct: 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 44/168 (26%), Positives = 81/168 (48%), Gaps = 17/168 (10%)
Query: 8 ELRVVSQINHKNVVKIL-----GACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
E++++ + H+N++ IL + +V E + L+ I +Q L N
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI---KTQHLSNDHI 108
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTA 121
+ + L Y+HS+ ++H D+K +N+LL+ N K+ DFG + + + T
Sbjct: 109 QYFLY-QILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTG--LKPG 166
T+ + T PE ++ K K+ D++S G +LAE+L+ L PG
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 16 NHKNVVKILGACLETKVP------LLVYEFVPNGTLFDHIHDKSSQVLR-NWKTCLRIAA 68
+H+N+ GA ++ P LV EF G++ D + + L+ +W I
Sbjct: 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICR 128
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
E L +LH+ +IH D+K NVLL +N + K+ DFG S + D IG
Sbjct: 129 EILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNTFIG 183
Query: 129 TFVNLDPEYVITGKLTE-----KSDVYSFGVLLAELLTGLKP 165
T + PE + + + +SD++S G+ E+ G P
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-08
Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 11/162 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E++++ + H+ +V+ G + + + E +P G++ D + KS L +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTE-NVTRK 110
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
+ + YLHS+ I+H D+K N+L D K+ DFG+S + + + K
Sbjct: 111 YTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167
Query: 126 KI-GTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ GT + PE VI+G+ K+D++S G + E+LT P
Sbjct: 168 SVTGTPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-08
Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 14/163 (8%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E +V+ I + L +T L L+ +++ G LF H+ SQ R + ++I
Sbjct: 54 ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFKEQEVQI 109
Query: 67 -AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTT 124
+ E AL++LH II+ D+K N+LLD N + DFG S + + A +
Sbjct: 110 YSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSF 166
Query: 125 KKIGTFVNLDPEYVITGKLTEKS--DVYSFGVLLAELLTGLKP 165
GT + P+ V G D +S GVL+ ELLTG P
Sbjct: 167 --CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 21/165 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ ++ +NH NVVK ++ EF+ G+L + H Q L + +A
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTHIADEQFLAD------VA 174
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM--TTK 125
+ S + YLH I+H D+K +N+L++ K+ADFG S ++ QT M
Sbjct: 175 RQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRIL---AQT-MDPCNS 227
Query: 126 KIGTFVNLDPEYVIT----GKLTEKS-DVYSFGVLLAELLTGLKP 165
+GT + PE + T G + D++S GV + E G P
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-08
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 39/170 (22%)
Query: 9 LRVVSQINHKNVVKILGACL------ETKVPLLVYEFV------------PNGTLFDHIH 50
L+ + +H N+V+++ C ETKV L V+E V P G + I
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTL-VFEHVDQDLRTYLDKVPPPGLPAETIK 111
Query: 51 DKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
D Q LR LD+LH++ I+H D+K N+L+ + K+ADFG
Sbjct: 112 DLMRQFLR--------------GLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
+ + S Q A+T + T PE ++ D++S G + AE+
Sbjct: 155 ARIYSC--QMALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-08
Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E RV+ H + L +TK L V E+V G LF H+ +V +T
Sbjct: 45 ESRVLKNTRHPFLTS-LKYSFQTKDRLCFVMEYVNGGELFFHL--SRERVFSEDRTRF-Y 100
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AE SALDYLHS I++ D+K N++LD + K+ DFG L A T K
Sbjct: 101 GAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFG---LCKEGITDAATMKT 154
Query: 127 I-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT L PE + D + GV++ E++ G P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-08
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 9/160 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E +++ ++N + VV L ETK L LV + G L HI++ + + +
Sbjct: 49 NEKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE-ERAVF 106
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE L+ LH I++ D+K N+LLDD +++D G +V I + +T
Sbjct: 107 YAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGET--IRG 160
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
++GT + PE V + T D + G L+ E++ G P
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 16/159 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ +++ +H N+VK+L A ++ EF G + D + + + L + + +
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV-DAVMLELERPLTEPQIRV-VC 109
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK- 126
+T AL+YLH + IIH D+K+ N+L + K+ADFG +S+ N + +
Sbjct: 110 KQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFG----VSAKNTRTIQRRDS 162
Query: 127 -IGTFVNLDPEYVITGKLTE-----KSDVYSFGVLLAEL 159
IGT + PE V+ + K+DV+S G+ L E+
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMT 123
+I+ L YL I+H DVK +N+L++ + K+ DFG S LI S M
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-----MA 155
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + T +SD++S G+ L E+ G P
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 9/160 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E +++ ++N + VV L ETK L LV + G L HI++ + + L
Sbjct: 49 NEKQILEKVNSQFVVN-LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERA-LF 106
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE L+ LH ++ D+K N+LLDD +++D G +V I
Sbjct: 107 YAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRG 160
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
++GT + PE + + T D + G L+ E++ G P
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 3e-08
Identities = 35/111 (31%), Positives = 51/111 (45%), Gaps = 31/111 (27%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG--SSVLISSDNQTAMTTKKIGTF 130
L YLHS+ +IH D+K +N+L++ N K+ DFG V D + +T
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------- 164
Query: 131 VNLDPEYVIT------------GKLTEKSDVYSFGVLLAELLTG--LKPGS 167
EYV+T + T+ D++S G + AELLT L PG
Sbjct: 165 -----EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-08
Identities = 45/131 (34%), Positives = 60/131 (45%), Gaps = 8/131 (6%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
V +FV G LF H+ + S + AAE ASAL YLHS I++ D+K N
Sbjct: 73 FVLDFVNGGELFFHLQRERSFPEPRARF---YAAEIASALGYLHSIN---IVYRDLKPEN 126
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154
+LLD + DFG + Q+ TT GT L PE + D + G
Sbjct: 127 ILLDSQGHVVLTDFG--LCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGA 184
Query: 155 LLAELLTGLKP 165
+L E+L GL P
Sbjct: 185 VLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 33/92 (35%), Positives = 49/92 (53%)
Query: 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPE 136
+H S +IH D+KS N+LL N K+ DFG S + ++ + GT + PE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 137 YVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
++K+D++S GVLL ELLT +P G
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 48/134 (35%), Positives = 67/134 (50%), Gaps = 16/134 (11%)
Query: 36 VYEFVPNGTLFDHIH-DKSSQVLRNWKTCLRI-AAETASALDYLHSSASPPIIHGDVKST 93
V ++V G LF H+ ++S R R AAE ASAL YLHS II+ D+K
Sbjct: 74 VLDYVNGGELFFHLQRERSFPEPRA-----RFYAAEIASALGYLHSLN---IIYRDLKPE 125
Query: 94 NVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI-GTFVNLDPEYVITGKLTEKS-DVYS 151
N+LLD + DFG L + + TT GT L PE V+ + +++ D +
Sbjct: 126 NILLDSQGHVVLTDFG---LCKEGIEHSKTTSTFCGTPEYLAPE-VLRKQPYDRTVDWWC 181
Query: 152 FGVLLAELLTGLKP 165
G +L E+L GL P
Sbjct: 182 LGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 43/159 (27%), Positives = 65/159 (40%), Gaps = 10/159 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E RV+ H + + + V E+ G LF H+ +V +
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARF-YG 101
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE SAL YLHS +++ D+K N++LD + K+ DFG L T K
Sbjct: 102 AEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFG---LCKEGISDGATMKTF 155
Query: 128 -GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT L PE + D + GV++ E++ G P
Sbjct: 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-08
Identities = 40/159 (25%), Positives = 73/159 (45%), Gaps = 9/159 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E +++ +++ + +V L ETK L LV + G L HI++ + +
Sbjct: 43 EKKILEKVSSRFIVS-LAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARA-IFY 100
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AA+ L++LH I++ D+K NVLLDD+ +++D G +V + + +
Sbjct: 101 AAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGR 154
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE + D ++ G L E++ G P
Sbjct: 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 36/174 (20%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL----------LVYEFVPN---GTL------FDH 48
E++++ Q+NH+N+V + + + L LV+E++ + G L F
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 49 IHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
H KS + L+Y H +H D+K +N+LL++ + K+ADF
Sbjct: 116 DHIKS------------FMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADF 160
Query: 109 GSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLT 161
G + L +S+ T K I T PE ++ + DV+S G +L EL T
Sbjct: 161 GLARLYNSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 4e-08
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 12/165 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHD--KSSQVLRNWKT 62
F E + + H N+++ LG C E LLV EF P G L ++ K+ + + T
Sbjct: 42 FLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT 101
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
R+A E A L +LH + IH D+ N LL + K+ D+G S ++
Sbjct: 102 LQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 123 TTKKIGTFVNLDPEYV--ITGKL-----TEKSDVYSFGVLLAELL 160
+ + PE V + G L T++S+V+S GV + EL
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-08
Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 20/161 (12%)
Query: 11 VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAET 70
++SQ++HK++V G C+ ++V E+V G+L ++ + + +WK L +A +
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQL 109
Query: 71 ASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKA----KVADFGSSVLISSDNQTAM 122
A AL +L + HG+V + NVLL D K++D G S+ + +
Sbjct: 110 AWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---I 163
Query: 123 TTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTG 162
++I + PE + + L+ +D +SFG L E+ +G
Sbjct: 164 LLERIPW---VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-08
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 9/160 (5%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+E R++ ++N + VV L ETK L LV + G L HI++ + +
Sbjct: 49 NEKRILEKVNSRFVVS-LAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF- 106
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
AAE L+ L I++ D+K N+LLDD +++D G +V I + +T
Sbjct: 107 YAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGET--VRG 160
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
++GT + PE + K T D + G L+ E++ G P
Sbjct: 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 5e-08
Identities = 44/152 (28%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75
++ N +K+ + K +L+ +++ +G LFD + K L +I + AL+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSE-AEVKKIIRQLVEALN 123
Query: 76 YLHSSASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLD 134
LH IIH D+K NVL D + + D+G L + GT
Sbjct: 124 DLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYG---LCKIIGTPSCYD---GTLDYFS 174
Query: 135 PEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
PE I G + S D ++ GVL ELLTG P
Sbjct: 175 PEK-IKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-08
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 19/158 (12%)
Query: 15 INHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-----HDKSSQVLRNWKTCLRIAAE 69
+ H N+++ LG C+E LLV+E+ G L ++ H ++SQ+L R+A E
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACE 107
Query: 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGT 129
A+ + ++H +H D+ N L + KV D+G ++ K
Sbjct: 108 IAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVP 164
Query: 130 FVNLDPEYV-------ITGKLTEKSDVYSFGVLLAELL 160
L PE V IT + T+ S+V++ GV L EL
Sbjct: 165 LRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-08
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 16/166 (9%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL-RI 66
EL ++ + +V GA + E++ G+L D ++ + L RI
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRI 107
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTK 125
L +L + IIH DVK TNVL++ N + K+ DFG S L++S +T
Sbjct: 108 TYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKT----- 160
Query: 126 KIGTFVNLDPEYVITGKLTE------KSDVYSFGVLLAELLTGLKP 165
IG + PE + +G + +SDV+S G+ + E+ G P
Sbjct: 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 7e-08
Identities = 49/187 (26%), Positives = 87/187 (46%), Gaps = 17/187 (9%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
++ VF E ++++ INH V + G+ + LV EFV G F + + ++ N
Sbjct: 75 VDHVFS-ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL--RRNKRFPND 131
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
C AA+ +YL S I++ D+K N+LLD + K+ DFG + ++ + T
Sbjct: 132 VGCF-YAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT 187
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
GT + PE ++ + +D ++ G+ + E+L G P +NE + +
Sbjct: 188 L-----CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP-----FYANEPLLIY 237
Query: 181 QYFLYSI 187
Q L I
Sbjct: 238 QKILEGI 244
|
Length = 340 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (124), Expect = 1e-07
Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 9/156 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ ++ ++ H N+VK+L + LV+E+ L ++ + + N I
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPN--LIKSIM 104
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+ L Y HS I+H D+K N+L++ + K+ADFG + +T T ++
Sbjct: 105 YQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEV 159
Query: 128 GTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTG 162
T PE ++ K + D++S G + AE++TG
Sbjct: 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE A+D +H +H D+K NVLLD N ++ADFGS + + +D T + +
Sbjct: 109 AEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQSNVAV 164
Query: 128 GTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE + G+ + D +S GV + E+L G P
Sbjct: 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
NQ+ + EL+V+ + N +V GA + E + G+L D + K+ ++ +
Sbjct: 48 NQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPE--Q 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQT 120
+++ L YL I+H DVK +N+L++ + K+ DFG S LI S
Sbjct: 104 ILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M +GT + PE + + +SD++S G+ L E+ G P
Sbjct: 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 1e-07
Identities = 45/181 (24%), Positives = 72/181 (39%), Gaps = 31/181 (17%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
Q E+ Q+ H N++ + + + +V + G+ +L+
Sbjct: 47 QQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS--------CEDLLKT--HFPE 96
Query: 66 IAAETA---------SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV-LIS 115
E A +ALDY+HS IH VK++++LL + K ++ SV +I
Sbjct: 97 GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIK 153
Query: 116 SDN-QTAMTTKKIGTFVNLD---PEYVITGKL---TEKSDVYSFGVLLAELLTGLKPGSG 168
Q + + NL PE V+ L EKSD+YS G+ EL G P
Sbjct: 154 HGKRQRVVHDFPKSSVKNLPWLSPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212
Query: 169 M 169
M
Sbjct: 213 M 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-07
Identities = 39/155 (25%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGT--LFDHIHDKSSQVLRNWKTCLR 65
E+ ++ I+H+ ++ ++ A +V +P LF ++ L + +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPL---EQAIT 189
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
I AL YLH IIH DVK+ N+ LD+ A + DFG++ + + T
Sbjct: 190 IQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
GT PE + K+D++S G++L E+
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 40/161 (24%), Positives = 79/161 (49%), Gaps = 11/161 (6%)
Query: 5 FQHELRVVSQINHKNVVKI---LGACLETKVPLLVYEFVPNGTLFDHIHD-KSSQVLRNW 60
++E+ + ++NH+N++KI L + T + Y+F ++D D K +L
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL--K 267
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+T I + A++Y+H +IH D+K N+ L+ + K + DFG + + +
Sbjct: 268 QT-RAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFG-TAMPFEKERE 322
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
A +GT PE + E +D++S G++L ++L+
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 38/134 (28%), Positives = 68/134 (50%), Gaps = 8/134 (5%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
L+ E++ G LF H+ ++ + + C ++ E + AL++LH II+ D+K N
Sbjct: 77 LILEYLSGGELFMHL-EREGIFMED-TACFYLS-EISLALEHLHQQG---IIYRDLKPEN 130
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154
+LLD K+ DFG + S ++ +T GT + PE ++ + D +S G
Sbjct: 131 ILLDAQGHVKLTDFG--LCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGA 188
Query: 155 LLAELLTGLKPGSG 168
L+ ++LTG P +
Sbjct: 189 LMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 37/117 (31%), Positives = 56/117 (47%), Gaps = 9/117 (7%)
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE A+ +H +H D+K NVLLD N ++ADFGS + ++ D T ++ +
Sbjct: 109 AEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQSSVAV 164
Query: 128 GTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
GT + PE + GK + D +S GV + E+L G P +L G M
Sbjct: 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 18/160 (11%)
Query: 8 ELRVVSQINHKNVVKILGAC-LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
EL ++ + + ++ GA +E ++ + EF+ G+L D VL RI
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICT-EFMDGGSL-DVYRKIPEHVLG------RI 100
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMTTK 125
A L YL S I+H DVK +N+L++ + K+ DFG S+ L++S +
Sbjct: 101 AVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-----IAKT 152
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + SDV+S G+ EL G P
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 11/96 (11%)
Query: 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNL 133
L Y+HS+ ++H D+K +N+L+++N K+ DFG + + Q T + T
Sbjct: 121 LKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172
Query: 134 DPEYVIT-GKLTEKSDVYSFGVLLAELLTG--LKPG 166
PE ++T K + D++S G + AE+L G L PG
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-07
Identities = 45/165 (27%), Positives = 78/165 (47%), Gaps = 12/165 (7%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
NQ+ + EL+V+ + N +V GA + E + G+L D + ++ ++ +
Sbjct: 48 NQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPE--E 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQT 120
+++ L YL I+H DVK +N+L++ + K+ DFG S LI S
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---- 157
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M +GT + PE + + +SD++S G+ L EL G P
Sbjct: 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-07
Identities = 43/132 (32%), Positives = 64/132 (48%), Gaps = 9/132 (6%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
LV +++ G LF H+ + K + AE AL++LH I++ D+K N
Sbjct: 73 LVTDYMSGGELFWHLQKEGRFSEDRAKFYI---AELVLALEHLHKY---DIVYRDLKPEN 126
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFG 153
+LLD + DFG S +DN+T T GT L PE ++ K T+ D +S G
Sbjct: 127 ILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLG 184
Query: 154 VLLAELLTGLKP 165
VL+ E+ G P
Sbjct: 185 VLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 51/178 (28%), Positives = 79/178 (44%), Gaps = 44/178 (24%)
Query: 8 ELRVVSQINHKNVVKI----LGACLET-KVPLLVYEFVPNGTLFD---HIHDKSSQVLRN 59
E++++ ++H+NV+ I E +VYE L D H +SSQ L +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE------LMDTDLHQIIRSSQTLSD 107
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
C + L Y+HS+ ++H D+K +N+LL+ N K+ DFG + +S+
Sbjct: 108 -DHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA-RTTSEKG 162
Query: 120 TAMTTKKIGTFVNLDPEYVIT------------GKLTEKSDVYSFGVLLAELLTGLKP 165
MT EYV+T + T DV+S G + AELL G KP
Sbjct: 163 DFMT------------EYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKP 207
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 43/143 (30%), Positives = 64/143 (44%), Gaps = 18/143 (12%)
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE A+D +H +H D+K N+L+D N ++ADFGS + + D T ++ +
Sbjct: 109 AEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAV 164
Query: 128 GTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQY 182
GT + PE + GK + D +S GV + E+L G P +L G
Sbjct: 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------ 218
Query: 183 FLYSIENNSLRQILNFQVADESE 205
I N+ R QV D SE
Sbjct: 219 ---KIMNHKERFQFPAQVTDVSE 238
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-07
Identities = 42/167 (25%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD---HIHDKSSQVLRNWKTCL 64
E+R++ Q+ H N+V ++ + LV+E+ + L + + +++
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------ 103
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+I +T A+++ H IH DVK N+L+ + K+ DFG + +++ T
Sbjct: 104 KIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTG--PGDDYT 158
Query: 125 KKIGTFVNLDPEYVITGKLTEKS--DVYSFGVLLAELLTG--LKPGS 167
+ T PE ++ G DV++ G + AELLTG L PG
Sbjct: 159 DYVATRWYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 52/179 (29%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-----LVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
EL+++ H N++ I L +V + + + L IH S Q L
Sbjct: 54 ELKILRHFKHDNIIAIR-DILRPPGADFKDVYVVMDLMES-DLHHIIH--SDQPLTEEHI 109
Query: 63 C------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
LR L Y+HS+ +IH D+K +N+L++++ + ++ DFG + +SS
Sbjct: 110 RYFLYQLLR-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159
Query: 117 ---DNQTAMTTKKIGTFVNLDPEYVIT------------GKLTEKSDVYSFGVLLAELL 160
+++ MT EYV T + T D++S G + AE+L
Sbjct: 160 SPTEHKYFMT------------EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 4e-07
Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDK---SSQVLRNWKTC 63
E V+ + + L +T+ L L+ ++V G +F H++ + S +R +
Sbjct: 54 ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY--- 110
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ E AL++LH I++ D+K N+LLD + DFG S S+ + T
Sbjct: 111 ---SGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RT 163
Query: 124 TKKIGTFVNLDPEYVITGKLTEKS--DVYSFGVLLAELLTGLKP 165
GT + PE +I GK D +S G+L+ ELLTG P
Sbjct: 164 YSFCGTIEYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 44/156 (28%), Positives = 68/156 (43%), Gaps = 26/156 (16%)
Query: 27 CLETKVPL-LVYEFVPNG---TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
ETK L +V E+V G TL +I + R + AET AL+YLH+
Sbjct: 69 SFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY------FAETVLALEYLHNYG- 121
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL-------------ISSDNQTAMTTKKIGT 129
I+H D+K N+L+ K+ DFG S + I D + + + GT
Sbjct: 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 130 FVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ PE ++ + D ++ G++L E L G P
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 6e-07
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR--NWKTCLR 65
E++++ ++ H N++ +L LV+EF+ L I DKS VL + K+
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSI-VLTPADIKS--- 106
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
T L+YLHS+ I+H D+K N+L+ + K+ADFG + S N MT +
Sbjct: 107 YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-RKMTHQ 162
Query: 126 KIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTG--LKPGSG 168
+ T PE + + D++S G + AELL PG
Sbjct: 163 VV-TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 6e-07
Identities = 41/156 (26%), Positives = 73/156 (46%), Gaps = 13/156 (8%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHD--KSSQVLRNWKTCLR 65
E +++S+++H +VK + LE ++ E+ L + + + + L + C
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVC-E 110
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI--SSDNQTAMT 123
+ + Y+H I+H D+K+ N+ L +N K+ DFG S L+ S D T T
Sbjct: 111 WFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT 166
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159
GT + PE + KSD++S G +L E+
Sbjct: 167 ----GTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 47/182 (25%)
Query: 9 LRVVSQINHKNVVKILGACL------ETKVPLLVYEFV------------PNGTLFDHIH 50
L+ + H N+V++L C E K+ LV+E V G + I
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKL-TLVFEHVDQDLATYLSKCPKPGLPPETIK 110
Query: 51 DKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
D Q+LR +D+LHS I+H D+K N+L+ + + K+ADFG
Sbjct: 111 DLMRQLLR--------------GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGL 153
Query: 111 SVLISSDNQTAMTTKKIGTFVNL---DPEYVITGKLTEKSDVYSFGVLLAEL--LTGLKP 165
+ + + A+T+ V L PE ++ D++S G + AEL L
Sbjct: 154 ARIY--SFEMALTS----VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207
Query: 166 GS 167
G+
Sbjct: 208 GT 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 3/96 (3%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVN 132
ALD +HS ++H D+KS N+ L K+ DFG S S + + GT
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYY 237
Query: 133 LDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
L PE + ++K+D++S GV+L ELLT +P G
Sbjct: 238 LAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 7/131 (5%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
V E+ G LF H+ S + + + AE SALDYLHS + +++ D+K N
Sbjct: 72 FVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLEN 126
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154
++LD + K+ DFG D T T GT L PE + D + GV
Sbjct: 127 LMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLGV 184
Query: 155 LLAELLTGLKP 165
++ E++ G P
Sbjct: 185 VMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 42/160 (26%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 9 LRVVSQINHKNVVKILGACL------ETKVPLLVYEFVPNG--TLFDHIHDKSSQVLRNW 60
LR + H NVV++ C ETK+ L V+E V T D + +
Sbjct: 55 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTL-VFEHVDQDLTTYLDKVPEPGVPT---- 109
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+T + + LD+LHS ++H D+K N+L+ + + K+ADFG + + S
Sbjct: 110 ETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--- 163
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
T + T PE ++ D++S G + AE+
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 1e-06
Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 8/99 (8%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT-TKKIGTFV 131
AL Y+H++ + H D+K N+L + + K K+ DFG + + +D TA+ T + T
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 132 NLDPEYV--ITGKLTEKSDVYSFGVLLAELLTG--LKPG 166
PE K T D++S G + AE+LTG L PG
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 40/131 (30%), Positives = 60/131 (45%), Gaps = 8/131 (6%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
V E+ G LF H+ S + + + AE SAL+YLHS +++ D+K N
Sbjct: 72 FVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLEN 125
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154
++LD + K+ DFG SD T T GT L PE + D + GV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLGV 183
Query: 155 LLAELLTGLKP 165
++ E++ G P
Sbjct: 184 VMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 44/138 (31%), Positives = 58/138 (42%), Gaps = 22/138 (15%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR------IAAETASALDYLHSSASPPIIHG 88
V ++V G LF H+ + C AAE ASA+ YLHS II+
Sbjct: 73 FVLDYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLHSLN---IIYR 120
Query: 89 DVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI-GTFVNLDPEYVITGKLTEKS 147
D+K N+LLD + DFG L + TT GT L PE +
Sbjct: 121 DLKPENILLDSQGHVVLTDFG---LCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 148 DVYSFGVLLAELLTGLKP 165
D + G +L E+L GL P
Sbjct: 178 DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-06
Identities = 47/150 (31%), Positives = 64/150 (42%), Gaps = 23/150 (15%)
Query: 24 LGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTCLR--IAAETASALDYLHSS 80
L C +TK L V E+V G L I Q R + AAE AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQI-----QRSRKFDEPRSRFYAAEVTLALMFLHRH 115
Query: 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140
+I+ D+K N+LLD K+ADFG + TT GT P+Y+
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFG--MCKEGILNGVTTTTFCGT-----PDYIAP 165
Query: 141 GKLTEKS-----DVYSFGVLLAELLTGLKP 165
L E D ++ GVL+ E++ G P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 16/159 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP--NGTLFDHIHDKSSQVLRNWKTC-- 63
E ++ INH +++++ G K L+ +P L+ ++ K RN C
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-----RNIAICDI 184
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L I A+ YLH + IIH D+K+ N+ ++ + DFG++ N
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162
GT PE + D++S G++L E+ T
Sbjct: 242 GWA-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-06
Identities = 45/147 (30%), Positives = 63/147 (42%), Gaps = 17/147 (11%)
Query: 19 NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL-RIAAETASALDYL 77
N+V + + LV + G L+ HI S+ L + C+ R AAE ALD L
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI----SKFLNIPEECVKRWAAEMVVALDAL 101
Query: 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFG--SSVLISSDNQTAMTTKKIGTFVNLDP 135
H I+ D+ N+LLDD ++ F S V S D + + P
Sbjct: 102 HREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN-------MYCAP 151
Query: 136 EYVITGKLTEKSDVYSFGVLLAELLTG 162
E + TE D +S G +L ELLTG
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-06
Identities = 60/275 (21%), Positives = 100/275 (36%), Gaps = 93/275 (33%)
Query: 8 ELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-----SSQVLRNWK 61
E++ + ++N H N+VK+ E V+E++ G L+ + D+ S V+R+
Sbjct: 47 EVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRS-- 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHG----DVKSTNVLLDDNYKAKVADFGSSVLISSD 117
I + L ++H HG D+K N+L+ K+ADFG +
Sbjct: 104 ----IIYQILQGLAHIHK-------HGFFHRDLKPENLLVSGPEVVKIADFGLA------ 146
Query: 118 NQTAMTTKKIGTFVNLDP--EYVIT------------GKLTEKSDVYSFGVLLAELLTG- 162
++I + P +YV T + D+++ G ++AEL T
Sbjct: 147 -------REI---RSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 163 -LKPGS-----------------------GMALASNEGISMVQYFLYSIENNSLRQILNF 198
L PGS G LAS G Q+ SL Q++
Sbjct: 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF-----APTSLHQLIP- 250
Query: 199 QVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ E+ L L ++RPT Q
Sbjct: 251 NASPEA--------IDLIKDMLRWDPKKRPTASQA 277
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 46/178 (25%), Positives = 80/178 (44%), Gaps = 40/178 (22%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD--------HIHDKS------ 53
ELR++ ++H+NV+ +L F P +L D H+
Sbjct: 64 ELRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNNIVK 111
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
Q L + + + L Y+HS+ IIH D+K +N+ ++++ + K+ DFG +
Sbjct: 112 CQKLSDDHIQF-LVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH 167
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKL--TEKSDVYSFGVLLAELLTG--LKPGS 167
+ MT + T PE ++ + + D++S G ++AELLTG L PGS
Sbjct: 168 TDDE----MTG-YVATRWYRAPE-IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 53/201 (26%), Positives = 84/201 (41%), Gaps = 29/201 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F+ E ++S N + ++ A + LV E+ P G L ++ Q +
Sbjct: 48 FEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFY 107
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AE A+ +H +H D+K NVL+D K+ADFGS+ +++ N+ +
Sbjct: 108 --LAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA-NKMVNSK 161
Query: 125 KKIGTFVNLDPEYVITGKLTEKS------DVYSFGVLLAELLTGLKPGSGMALASNEGIS 178
+GT + PE + T K D +S GV+ E++ G P EG S
Sbjct: 162 LPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH-------EGTS 214
Query: 179 MVQYFLYSIENNSLRQILNFQ 199
Y NN I+NFQ
Sbjct: 215 AKTY------NN----IMNFQ 225
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 42/131 (32%), Positives = 59/131 (45%), Gaps = 8/131 (6%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
V +++ G LF H+ + + + AAE ASAL YLHS I++ D+K N
Sbjct: 73 FVLDYINGGELFYHLQRERCFLEPRARF---YAAEIASALGYLHSLN---IVYRDLKPEN 126
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154
+LLD + DFG N T T+ GT L PE + D + G
Sbjct: 127 ILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 184
Query: 155 LLAELLTGLKP 165
+L E+L GL P
Sbjct: 185 VLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 42/179 (23%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIH------DKS-SQVLR 58
EL ++ +NHKN++ +L F P +L F ++ D + QV++
Sbjct: 65 ELVLMKLVNHKNIIGLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQ 112
Query: 59 NWKTCLRIAAETASALDY--------LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
+ + E S L Y LHS+ IIH D+K +N+++ + K+ DFG
Sbjct: 113 -----MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG- 163
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG--LKPGS 167
L + + M T + T PE ++ E D++S G ++ E++ G L PG+
Sbjct: 164 --LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 2e-06
Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 13/191 (6%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
Q E V Q ++ + L +C +T+ L V E+V G L H+ + + +
Sbjct: 43 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-- 100
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG--SSVLISSDNQTAM 122
+AE + AL+YLH II+ D+K NVLLD K+ D+G L D
Sbjct: 101 -YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---- 152
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQY 182
T+ GT + PE + D ++ GVL+ E++ G P + + N + Y
Sbjct: 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212
Query: 183 FLYSIENNSLR 193
I +R
Sbjct: 213 LFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+ A +++L AS IH D+ + N+LL +N K+ DFG + I D
Sbjct: 187 QVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 129 TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMAL 171
+ PE + T +SDV+SFGVLL E+ + G P G+ +
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 287
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 33/158 (20%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
LV E++P G L + + K V +T AE ALD +H IH D+K N
Sbjct: 78 LVMEYMPGGDLMNLLIRK--DVFPE-ETARFYIAELVLALDSVHKLG---FIHRDIKPDN 131
Query: 95 VLLDDNYKAKVADFGSS-----------------VLISSDNQTAMTTKKIGTFVNLD--- 134
+L+D + K+ADFG L+ DN V +
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTV 191
Query: 135 --PEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
P+Y V+ G + D +S GV+L E+L G P
Sbjct: 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 11/164 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E + Q +H N+V++ G ++V E++ NG L + Q++ +
Sbjct: 53 FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAG--QLM 110
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ AS + YL + +H + + VL++ + K++ F + D A+ T
Sbjct: 111 GMLPGLASGMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRR---LQEDKSEAIYT 164
Query: 125 KKIGTFVNL--DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
G L PE + + SDV+SFG+++ E+++ G +P
Sbjct: 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-06
Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 21/177 (11%)
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L + + A + +L AS IH D+ + N+LL K+ DFG + I +D+ +
Sbjct: 217 LSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQY 182
+ PE + T +SDV+S+G+LL E+ + G P GM + S
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-------- 325
Query: 183 FLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239
Y + R +L+ + A SEM +I C +RPT KQ+ + +++
Sbjct: 326 -FYKMIKEGYR-MLSPECA-PSEMYDI------MKSCWDADPLKRPTFKQIVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-06
Identities = 57/233 (24%), Positives = 104/233 (44%), Gaps = 34/233 (14%)
Query: 11 VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAET 70
++SQ++H ++ + G C+ ++V EFV +G L + + +V WK + +A +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWK--ITVAQQL 126
Query: 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT----KK 126
ASAL YL ++HG+V + N+LL + +A+ S + SD + T ++
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLA---RLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 127 IGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAEL-LTGLKPGSGMALASNEGISMVQYFL 184
+ + PE V G L+ +D +SFG L E+ G P + E ++ L
Sbjct: 181 VERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRL 240
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
E +E+ A L S+CL+ +RP+ + + +L
Sbjct: 241 -----------------PEPSCKEL---ATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-06
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 9/161 (5%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
Q E V Q + + L +C +T L LV E+V G L H+ + + +
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARF-- 100
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AAE AL++LH II+ D+K NVLLD + K+ D+G T T+
Sbjct: 101 -YAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TS 154
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE + + D ++ GVL+ E++ G P
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-06
Identities = 45/161 (27%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIH--DKSSQVLRNWKTCL 64
E R++++++ + +V L +TK L LV + G L HI+ D+ + + C
Sbjct: 43 EKRILAKVHSRFIVS-LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A+ S L++LH II+ D+K NVLLD++ +++D G +V + D Q+ T
Sbjct: 102 -YTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVEL-KDGQSK-TK 155
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE + + D ++ GV L E++ P
Sbjct: 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 35/118 (29%), Positives = 54/118 (45%), Gaps = 21/118 (17%)
Query: 47 DHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVA 106
DH+ Q+LR L YLHS+ I+H D+K N+L++ N K+
Sbjct: 103 DHVKVFLYQILR--------------GLKYLHSAG---ILHRDIKPGNLLVNSNCVLKIC 145
Query: 107 DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAELLTG 162
DFG + + D MT + + + PE ++ G T D++S G + AELL
Sbjct: 146 DFGLARVEEPDESKHMTQEVVTQYYR-APE-ILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 4/102 (3%)
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+ A +++L AS IH D+ + N+LL +N K+ DFG + I D
Sbjct: 181 QVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 129 TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ PE + T +SDV+SFGVLL E+ + G P G+
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 5e-06
Identities = 47/181 (25%), Positives = 77/181 (42%), Gaps = 27/181 (14%)
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L + A +++L AS +H D+ + NVLL K+ DFG + I D+
Sbjct: 240 LSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN---Y 293
Query: 124 TKKIGTFVN---LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISM 179
K TF+ + PE + T SDV+S+G+LL E+ + G P GM +
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM---------I 344
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239
V Y N ++ D + E V + KC + +RP+ +S+ ++
Sbjct: 345 VDSTFY----NKIKSGYRMAKPDHATQE----VYDIMVKCWNSEPEKRPSFLHLSDIVES 396
Query: 240 L 240
L
Sbjct: 397 L 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 5e-06
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 9/143 (6%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
L +C +T+ L V EFV G L H+ + + + +AE + AL++LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARF---YSAEISLALNFLHERG- 116
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK 142
II+ D+K NVLLD K+ D+G T T+ GT + PE +
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--TSTFCGTPNYIAPEILRGED 172
Query: 143 LTEKSDVYSFGVLLAELLTGLKP 165
D ++ GVL+ E++ G P
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-06
Identities = 42/159 (26%), Positives = 77/159 (48%), Gaps = 9/159 (5%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E ++ ++N +V L E+K L LV + G L HI++ + L + +
Sbjct: 43 EKEILEKVNSPFIVN-LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGL-EMERVIHY 100
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
+A+ + +LHS I++ D+K NVLLDD +++D G +V + D +T T++
Sbjct: 101 SAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVEL-KDGKT--ITQR 154
Query: 127 IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
GT + PE + + D ++ G + E++ G P
Sbjct: 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 7e-06
Identities = 48/174 (27%), Positives = 76/174 (43%), Gaps = 21/174 (12%)
Query: 1 MNQVFQ--HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNG---TLFDHIHDKSSQ 55
+N+V E +++ + +VK+L A + + L E+VP G TL + +
Sbjct: 42 LNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLN-----NLG 96
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLI 114
VL +A E A+D LH IH D+K N L+D + K+ DFG S ++
Sbjct: 97 VLSEDHARFYMA-EMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+ N +G+ + PE + D +S G +L E L G P SG
Sbjct: 153 TYANSV------VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 22/174 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL+++++I H+N++ ++ +E LV + + L + K K L
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL-- 126
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG---------SSVLISSDN 118
+ + L+ LH +H D+ N+ ++ K+ADFG S +S D
Sbjct: 127 -QILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 119 QTAMT---TKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLTG--LKPG 166
T K+ T PE ++ K D++S G + AELLTG L PG
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 1e-05
Identities = 42/163 (25%), Positives = 72/163 (44%), Gaps = 22/163 (13%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL ++ +NHKN++ +L K + EF + + + QV+ + +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIH-----MELD 121
Query: 68 AETASALDY--------LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
E S L Y LHS+ IIH D+K +N+++ + K+ DFG L +
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTACT 175
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162
M T + T PE ++ E D++S G ++ EL+ G
Sbjct: 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-05
Identities = 42/172 (24%), Positives = 76/172 (44%), Gaps = 31/172 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFV-----------PNGTLFDHIHDKSSQV 56
EL+++ + +N+V++ A LV+E+V PNG + + Q+
Sbjct: 50 ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQL 109
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
++ A+ + H + I+H D+K N+L+ N K+ DFG + +S
Sbjct: 110 IK--------------AIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG--LKPG 166
+ A T+ + T PE ++ + D++S G +L EL G L PG
Sbjct: 153 GSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 7/96 (7%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD--NQTAMTTKKIGTF 130
L Y+HS+ ++H D+K N+L++ + + K+ DFG + S + T+ + T
Sbjct: 117 GLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 131 VNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
PE +++ + K+ DV+S G +LAELL G KP
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKP 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 37/189 (19%), Positives = 79/189 (41%), Gaps = 43/189 (22%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN-W--- 60
F E ++ + + H +V + C + ++ TL +L++ W
Sbjct: 49 FLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL--------KSLLKSVWQKE 100
Query: 61 ------------KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
L I + + ++Y+HS ++H D+K N+LL + + D+
Sbjct: 101 SLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDW 157
Query: 109 GSSVLISSDNQ--------------TAMTT--KKIGTFVNLDPEYVITGKLTEKSDVYSF 152
G+++ + + ++MT K +GT + PE ++ +E +D+Y+
Sbjct: 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYAL 217
Query: 153 GVLLAELLT 161
GV+L ++LT
Sbjct: 218 GVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 38/158 (24%), Positives = 74/158 (46%), Gaps = 19/158 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP--NGTLFDHIHDKSSQVLRNWKTCLR 65
E ++ +NH +V+++ + + +V +P + L+ ++ +S + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPL--PIDQALI 161
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS---VLISSDNQTAM 122
I + L YLH+ IIH DVK+ N+ ++D + + D G++ V+ + A
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA- 217
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
GT PE + K K+D++S G++L E+L
Sbjct: 218 -----GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+ A+ +++L AS +H D+ + NVL+ + K+ DFG + I D+ K
Sbjct: 247 QVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY---ISKGS 300
Query: 129 TFVNLD---PEYVITGKLTEKSDVYSFGVLLAELLT 161
TF+ L PE + T SDV+SFG+LL E+ T
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 47/179 (26%), Positives = 73/179 (40%), Gaps = 39/179 (21%)
Query: 20 VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79
VVK+ + + + L+ EF+P G + + K + L T IA ET A+D +H
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT--LSEEATQFYIA-ETVLAIDAIHQ 119
Query: 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT------------------- 120
IH D+K N+LLD K++DFG + ++T
Sbjct: 120 LG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 121 -----AMTTKK---------IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
A T KK +GT + PE + + D +S GV++ E+L G P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 41/165 (24%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL ++ +NHKN++ +L K + EF + + + QV++ R++
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMS 129
Query: 68 A---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + +LHS+ IIH D+K +N+++ + K+ DFG L + + M T
Sbjct: 130 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 183
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG--LKPGS 167
+ T PE ++ E D++S G ++ E++ G L PG+
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 3e-05
Identities = 43/170 (25%), Positives = 83/170 (48%), Gaps = 21/170 (12%)
Query: 8 ELRVVSQINHKNVVKI----LGACLETKVPLLVYEFVPNG--TLFDHIHDKSSQVLRNWK 61
E+ ++ ++ H N+V + +G+ L+ K+ +V E+V + +L + + Q K
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLD-KI-YMVMEYVEHDLKSLMETMKQPFLQSEV--K 109
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ + S + +LH + I+H D+K++N+LL++ K+ DFG + S
Sbjct: 110 CLML---QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS-PLKP 162
Query: 122 MTTKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLTG--LKPGSG 168
T+ + T PE ++ + + D++S G + AELLT L PG
Sbjct: 163 Y-TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 41/173 (23%), Positives = 75/173 (43%), Gaps = 32/173 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ ++ ++NH N+VK+L LV+EF+ Q L+ + ++
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-------------HQDLKKFMDASPLS 95
Query: 68 A-----------ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
+ L + HS ++H D+K N+L++ K+ADFG +
Sbjct: 96 GIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 152
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT--GLKPG 166
+T T ++ T PE ++ K + D++S G + AE++T L PG
Sbjct: 153 PVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 9/95 (9%)
Query: 72 SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFV 131
+LD++H + I H D+K N+L+ D+ K+ADFGS T+ I T
Sbjct: 111 KSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGS---CRGIYSKPPYTEYISTRW 163
Query: 132 NLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGLKP 165
PE ++T G K D+++ G + E+L+ L P
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFP 197
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 26/171 (15%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
ELR++ + H+NV+ +L + P E + L H+ L N C ++
Sbjct: 66 ELRLLKHMKHENVIGLL----DVFTPARSLEEFNDVYLVTHLMGAD---LNNIVKCQKLT 118
Query: 68 AETAS--------ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ L Y+HS+ IIH D+K +N+ ++++ + K+ DFG ++
Sbjct: 119 DDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG----LARHTD 171
Query: 120 TAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG--LKPGS 167
M T + T PE ++ + D++S G ++AELLTG L PG+
Sbjct: 172 DEM-TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 39/164 (23%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
L+ EF+P G + + K + L +T IA ET A+D +H IH D+K N
Sbjct: 78 LIMEFLPGGDMMTLLMKKDT--LTEEETQFYIA-ETVLAIDSIHQLG---FIHRDIKPDN 131
Query: 95 VLLDDNYKAKVADFGSSVLISSDNQTA-----------------MTTKK----------- 126
+LLD K++DFG + ++T M +K+
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191
Query: 127 -----IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + D +S GV++ E+L G P
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 4e-05
Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 26/166 (15%)
Query: 16 NHKNVVKILGACLETKVP-----LLVYEFVPNGTLFDHIH------DKSSQVLRNWKTCL 64
+H NVVK G + V LV E G++ D + ++ + + +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY---- 128
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
I E L +LH + + IH DVK N+LL K+ DFG S ++S T+
Sbjct: 129 -ILHEALMGLQHLHVNKT---IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 184
Query: 125 KKIGTFVNLDPEYV-----ITGKLTEKSDVYSFGVLLAELLTGLKP 165
+GT + PE + + + DV+S G+ EL G P
Sbjct: 185 --VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP 228
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 29/112 (25%), Positives = 54/112 (48%), Gaps = 18/112 (16%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVP--------LLVYEFVPN--GTLFDHIHDKSSQVL 57
E++++ + H+NVV ++ C P LV+EF + L + + K + L
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFT--L 118
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
K ++ + L Y+H + I+H D+K+ N+L+ + K+ADFG
Sbjct: 119 SEIKKVMK---MLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 4e-05
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 8/100 (8%)
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AAE L+++H+ +++ D+K N+LLD++ +++D G + S A
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----S 155
Query: 127 IGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+GT + PE + G + S D +S G +L +LL G P
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 37/156 (23%), Positives = 73/156 (46%), Gaps = 12/156 (7%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
EL ++ +NHKN++ +L K + EF + + + QV++ R++
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMS 122
Query: 68 A---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + +LHS+ IIH D+K +N+++ + K+ DFG L + + M T
Sbjct: 123 YLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 176
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160
+ T PE ++ E D++S G ++ E++
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-05
Identities = 27/100 (27%), Positives = 50/100 (50%), Gaps = 8/100 (8%)
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
A E L+++H+ +++ D+K N+LLD++ +++D G ++ D
Sbjct: 103 ATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLG----LACDFSKKKPHAS 155
Query: 127 IGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+GT + PE + G + S D +S G +L +LL G P
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 38/154 (24%), Positives = 70/154 (45%), Gaps = 10/154 (6%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVP--NGTLFDHIHDKSSQVLRNWKTCL 64
HE R++ +++H V+ +L + + LV +P L+ ++ + + T
Sbjct: 209 HEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTA- 264
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+A + SA+DY+H IIH D+K+ NVL++ + DFG++ T
Sbjct: 265 -VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158
GT PE + T D++S G+++ E
Sbjct: 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 8e-05
Identities = 42/182 (23%), Positives = 76/182 (41%), Gaps = 33/182 (18%)
Query: 6 QHELRVVSQINHKNVVKILGACLE-----TKVPLLVYEFVP------NGTLFD-HIHDKS 53
E++++ ++ H NVV ++ +E + VY P +G L + +
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTE 114
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
SQ+ L ++YLH + I+H D+K+ N+L+D+ K+ADFG +
Sbjct: 115 SQIKCYMLQLL-------EGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP 164
Query: 114 ISSDNQTAMTTKKIGT--FVNL-------DPEYVITGK-LTEKSDVYSFGVLLAELLTGL 163
GT + NL PE ++ + T D++ G + AE+ T
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR- 223
Query: 164 KP 165
+P
Sbjct: 224 RP 225
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 32/98 (32%), Positives = 47/98 (47%), Gaps = 10/98 (10%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVN 132
L +LH++ IIH DVK N+LL K+ DFG S ++S T+ +GT
Sbjct: 140 GLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFW 194
Query: 133 LDPEYVITGKLTEKS-----DVYSFGVLLAELLTGLKP 165
+ PE + + + S DV+S G+ EL G P
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP 232
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 2e-04
Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 36/176 (20%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL--FDHIHDKSSQV---LRNWKT 62
ELR++ + H+NV+ +L F P ++ F+ ++ ++ + L N
Sbjct: 64 ELRLLKHMKHENVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNNIVK 111
Query: 63 CLRIAAETAS--------ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
C +++ E L Y+HS+ IIH D+K +NV ++++ + ++ DFG +
Sbjct: 112 CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG--LAR 166
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG--LKPGS 167
+D++ T + T PE ++ + D++S G ++AELL G L PG+
Sbjct: 167 QADDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 5e-04
Identities = 37/169 (21%), Positives = 79/169 (46%), Gaps = 17/169 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPN---GTLFDHIHDKSSQVLRNWKT 62
E+ ++ ++ H+NVV ++ LE K L++++ + + H K + +
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPS--M 109
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDN 118
+ + + + YLHS+ ++H D+K N+L+ + K+ D G + L ++
Sbjct: 110 VKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166
Query: 119 QTAMTTKK-IGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ + T PE ++ + T+ D+++ G + AELLT L+P
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 7e-04
Identities = 26/90 (28%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNL 133
L Y+H++ IIH D+K N+ ++++ + K+ DFG + S+ + T+
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRA---- 183
Query: 134 DPEYVITG-KLTEKSDVYSFGVLLAELLTG 162
PE ++ T+ D++S G ++AE+LTG
Sbjct: 184 -PEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 8e-04
Identities = 24/86 (27%), Positives = 39/86 (45%), Gaps = 8/86 (9%)
Query: 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
Q EL+++S + H N+V +LGAC + ++ E+ G L D++H RN
Sbjct: 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLH-------RNKH 137
Query: 62 TCLRIAAETASALDYLHSSASPPIIH 87
T L+ + L S S P+
Sbjct: 138 TFLQYYLDKNRDDGSLISGGSTPLSQ 163
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 8e-04
Identities = 20/44 (45%), Positives = 26/44 (59%), Gaps = 3/44 (6%)
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111
+E A ALDYLH IIH D+K N+L+ + K+ DFG S
Sbjct: 111 SEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.001
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 31/185 (16%)
Query: 8 ELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK--TC 63
E+ V+ ++ HKN+V+ + L + ++ EF G L +I K ++ +
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAI 120
Query: 64 LRIAAETASALDYLHSSASPP----IIHGDVKSTNVLLDDNYK----------------- 102
+ I + AL Y H+ P ++H D+K N+ L +
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 103 AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI--TGKLTEKSDVYSFGVLLAELL 160
AK+ DFG S I + +M +GT PE ++ T +KSD+++ G ++ EL
Sbjct: 181 AKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237
Query: 161 TGLKP 165
+G P
Sbjct: 238 SGKTP 242
|
Length = 1021 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 47/249 (18%), Positives = 103/249 (41%), Gaps = 37/249 (14%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQV---LRNWKTCL 64
E++++ +++H N+VK+ + L E V + T + ++ + L N
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDL--TEDVGSLTELNSVYIVQEYMETDLANVLEQG 109
Query: 65 RIAAETAS--------ALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLIS 115
++ E A L Y+HS+ ++H D+K NV ++ ++ K+ DFG + ++
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 116 SD-NQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
+ ++ + T P +++ T+ D+++ G + AE+LTG A
Sbjct: 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-----KPLFAG 221
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ +Q L S+ V E + E+ V + S + G R ++ +
Sbjct: 222 AHELEQMQLILESV-----------PVVREEDRNELLNV--IPSFVRNDGGEPRRPLRDL 268
Query: 234 SEELDRLKI 242
++ +
Sbjct: 269 LPGVNPEAL 277
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.001
Identities = 24/96 (25%), Positives = 46/96 (47%), Gaps = 5/96 (5%)
Query: 15 INHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR-IAAETASA 73
I+H + K G C K + Y F+ L ++ + ++ K ++ I + +
Sbjct: 80 IDHLGIPKYYG-CGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTT 138
Query: 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
L+Y+H I HGD+K N+++D N + + D+G
Sbjct: 139 LEYIHEHG---ISHGDIKPENIMVDGNNRGYIIDYG 171
|
Length = 294 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+ L Y+HS+ IIH D+K N+ ++++ + K+ DFG + +D A T +
Sbjct: 125 QMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFG--LARHAD---AEMTGYVV 176
Query: 129 TFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG 162
T PE ++ + D++S G ++AE+LTG
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 61/258 (23%), Positives = 104/258 (40%), Gaps = 69/258 (26%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFV-----------PNGTLFDHIHDKSSQ 55
E ++ + H N+V +L + TK L LV+E+V P G +++ Q
Sbjct: 53 EASLLKGLKHANIV-LLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
+LR L Y+H I+H D+K N+L+ D + K+ADFG + S
Sbjct: 112 LLR--------------GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154
Query: 116 SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS---DVYSFGVLLAELLTGLKPGSGMALA 172
+ T + ++ T P+ ++ TE S D++ G + E++ G+ GM
Sbjct: 155 VPSHT--YSNEVVTLWYRPPDVLLGS--TEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210
Query: 173 SNE-----------------GISMVQYF------LYSIENNSLRQILNFQVADESEMEEI 209
++ G+ + +F LYS +N LRQ N ++ +
Sbjct: 211 QDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKN--LRQAWN-------KLSYV 261
Query: 210 ETVAGLASKCLSLSGRRR 227
LASK L + R
Sbjct: 262 NHAEDLASKLLQCFPKNR 279
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.003
Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+ ++ ++ H N+V++ K LV+E++ + L H+ D S +N +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHM-DSSPDFAKNPRLIKTYL 108
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA-KVADFGSSVLISSDNQTAMTTKK 126
+ + Y HS ++H D+K N+L+D A K+ADFG + +T T +
Sbjct: 109 YQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHE 163
Query: 127 IGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTG--LKPG 166
+ T PE ++ + + D++S G + AE++ L PG
Sbjct: 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206
|
Length = 294 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.6 bits (88), Expect = 0.004
Identities = 44/194 (22%), Positives = 70/194 (36%), Gaps = 49/194 (25%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW--KTCLR 65
E +++ ++H + + + LV ++ P G LF L CL
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFR---------LLQRQPGKCLS 101
Query: 66 I------AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL------ 113
AAE AL+YLH I++ D+K N+LL ++ ++DF S
Sbjct: 102 EEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
Query: 114 ----ISSDNQTAMTTKKI-----------------GTFVNLDPEYVITGK-LTEKSDVYS 151
+ I GT + PE VI+G D ++
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWT 217
Query: 152 FGVLLAELLTGLKP 165
G+LL E+L G P
Sbjct: 218 LGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.89 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.82 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.71 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.71 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.69 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.52 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.44 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.43 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.25 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.22 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.11 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.04 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.97 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.68 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.1 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.99 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.96 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.95 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.81 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.57 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.53 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.45 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.39 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.3 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.21 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.97 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.85 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 96.45 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 96.31 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.97 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.77 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.65 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.57 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.51 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 95.49 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.33 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.09 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.0 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.81 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.11 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 93.83 | |
| PLN02236 | 344 | choline kinase | 93.82 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 93.64 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.49 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 93.49 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.47 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.0 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 92.99 | |
| KOG4720 | 391 | consensus Ethanolamine kinase [Lipid transport and | 92.96 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 92.88 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.86 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=298.55 Aligned_cols=212 Identities=24% Similarity=0.337 Sum_probs=176.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCc-ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKV-PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS- 79 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~- 79 (259)
++++.+|+++++..+|||||++|+.|..++. +.|+||||++|||.+.+...+. .++....+++.++++||.|||+
T Consensus 121 ~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~---i~E~~L~~ia~~VL~GL~YLh~~ 197 (364)
T KOG0581|consen 121 QKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR---IPEPVLGKIARAVLRGLSYLHEE 197 (364)
T ss_pred HHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhc
Confidence 5788999999999999999999999999995 9999999999999999987643 5788999999999999999996
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
.+ |+||||||+|++++..|.+||+|||.+...... ....++||..|||||.+.+..|+.++||||||++++|+
T Consensus 198 ~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 198 RK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred cC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 77 999999999999999999999999999876543 56678899999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|+.||..... ......+.... +.+...+.......++++.+++..||++||.+|||++++++
T Consensus 271 a~GrfP~~~~~~---~~~~~~~Ll~~---------Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 271 AIGRFPYPPPNP---PYLDIFELLCA---------IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred hhCCCCCCCcCC---CCCCHHHHHHH---------HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999987411 11111111111 11111111111135588999999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-48 Score=287.97 Aligned_cols=217 Identities=25% Similarity=0.344 Sum_probs=174.7
Q ss_pred hhHHHHHHHHHhcCCCccccccce-eEEeCCc-ceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHh
Q 025011 2 NQVFQHELRVVSQINHKNVVKILG-ACLETKV-PLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+|+...|+.+|++|+|||||++++ .|.+++. ++||||||.+|+|..+++.... ....++..+|+++.|++.||..+|
T Consensus 62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH 141 (375)
T KOG0591|consen 62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH 141 (375)
T ss_pred HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh
Confidence 577899999999999999999999 5555555 8999999999999999977533 346789999999999999999999
Q ss_pred hCC-CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSA-SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~-~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
..- ...|+||||||.|||++.+|.+||+|||+++.+.. ........+||+.||+||.+.+..|+.++||||+||++|
T Consensus 142 ~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGClly 219 (375)
T KOG0591|consen 142 SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLY 219 (375)
T ss_pred ccccccceeeccCcchheEEcCCCceeeccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHH
Confidence 832 12399999999999999999999999999998765 344556678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
||+.-++||.+... .+... ....+...+ -..-.++..+..+|..|+..||..||+.-.++..+
T Consensus 220 EMcaL~~PF~g~n~--------~~L~~-KI~qgd~~~--------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 220 EMCALQSPFYGDNL--------LSLCK-KIEQGDYPP--------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHhcCCCcccccH--------HHHHH-HHHcCCCCC--------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence 99999999998311 11111 111111111 11234668899999999999999999854444433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=309.73 Aligned_cols=207 Identities=21% Similarity=0.327 Sum_probs=175.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++.++|+|||||+++++|++.+++|||+|+|..++|..++++.. .+++.++..++.||+.||.|||+++
T Consensus 62 reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~ 138 (592)
T KOG0575|consen 62 REKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG 138 (592)
T ss_pred HHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC
Confidence 5778999999999999999999999999999999999999999999998543 3788999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+|||||..|+|++++.++||+|||+|......... .....||+.|.|||++.....+..+||||+||++|.|+.
T Consensus 139 ---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er--k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~ 213 (592)
T KOG0575|consen 139 ---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER--KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV 213 (592)
T ss_pred ---ceecccchhheeecCcCcEEecccceeeeecCcccc--cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh
Confidence 999999999999999999999999999887643222 234579999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++||+....- ..+..+......-+ ...+....+||.+||+.||.+|||+++|+.
T Consensus 214 G~PPFetk~vk-----------------ety~~Ik~~~Y~~P--~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 214 GRPPFETKTVK-----------------ETYNKIKLNEYSMP--SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CCCCcccchHH-----------------HHHHHHHhcCcccc--cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 99999973211 11111111111111 134467899999999999999999999974
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=299.43 Aligned_cols=205 Identities=25% Similarity=0.343 Sum_probs=168.8
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
.++|+++|++|+|||||+++++|+.....|+||||++||+|.+.+-.... +.+.....++.|++.|+.|||++|
T Consensus 223 v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~---l~ed~~K~~f~Qll~avkYLH~~G--- 296 (475)
T KOG0615|consen 223 VQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY---LREDLGKLLFKQLLTAVKYLHSQG--- 296 (475)
T ss_pred hHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc---cccchhHHHHHHHHHHHHHHHHcC---
Confidence 47999999999999999999999999999999999999999999987755 456777889999999999999999
Q ss_pred eEeCCCCCCCeEeCCC---CceEEeecCCcccccCCccccccccccCcccccCcchhccCCc---ccccchhhHHHHHHH
Q 025011 85 IIHGDVKSTNVLLDDN---YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL---TEKSDVYSFGVLLAE 158 (259)
Q Consensus 85 i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il~~ 158 (259)
|+||||||+||+++.+ ..+|++|||+++..+. ........||+.|.|||++..... ..++|+||+||++|.
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfv 373 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFV 373 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEE
Confidence 9999999999999766 6799999999988763 334556789999999999987653 347899999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+++|.+||.+...... -..++........ .....+++..+||.+||..||++|||+.|++
T Consensus 374 cLsG~pPFS~~~~~~s----------------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 374 CLSGYPPFSEEYTDPS----------------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred EeccCCCcccccCCcc----------------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 9999999987332210 1112222222221 2234568899999999999999999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=297.56 Aligned_cols=222 Identities=32% Similarity=0.463 Sum_probs=182.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++|.+|+.+|.+++|||||+++|++.... ..++||||+++|+|.+++... ....+++..+..|+.+|+.|+.|||+++
T Consensus 84 ~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 84 KAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 58999999999999999999999999877 789999999999999999875 2334788999999999999999999998
Q ss_pred CCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhc--cCCcccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI--TGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~~ 158 (259)
. |+|+|||++||+++.++ .+||+|||+++...... .......||+.|||||++. ...++.++||||||+++||
T Consensus 163 ~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWE 238 (362)
T KOG0192|consen 163 P--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWE 238 (362)
T ss_pred C--eeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHH
Confidence 5 89999999999999997 99999999998765432 2223357999999999999 5589999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|+||..||.+.... ..... +.........+...++.+..++..||+.||..||++.+++..++
T Consensus 239 l~t~~~Pf~~~~~~--------~~~~~---------v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 239 LLTGEIPFEDLAPV--------QVASA---------VVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred HHHCCCCCCCCCHH--------HHHHH---------HHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 99999999984321 00111 11111111111124578999999999999999999999999999
Q ss_pred hccccccc
Q 025011 239 RLKISHEN 246 (259)
Q Consensus 239 ~~~~~~~~ 246 (259)
.+......
T Consensus 302 ~~~~~~~~ 309 (362)
T KOG0192|consen 302 SIMSHISS 309 (362)
T ss_pred HHHHhhcc
Confidence 88775544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=299.79 Aligned_cols=219 Identities=31% Similarity=0.482 Sum_probs=187.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
++|.+|+++|++|+|++||+++++|..++.++|||||++.|+|.++|+.... ..++....+.++.|||.|++||++++
T Consensus 246 ~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~-~~l~~~~Ll~~a~qIaeGM~YLes~~- 323 (468)
T KOG0197|consen 246 EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREG-GLLNLPQLLDFAAQIAEGMAYLESKN- 323 (468)
T ss_pred hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCC-CccchHHHHHHHHHHHHHHHHHHhCC-
Confidence 6799999999999999999999999999999999999999999999998332 33677899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
+|||||.+.|||++++..+||+|||+++...++ .+.......-+..|.|||.+....++.+|||||||+++||++|
T Consensus 324 --~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 324 --YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTY 400 (468)
T ss_pred --ccchhhhhhheeeccCceEEEcccccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhcc
Confidence 999999999999999999999999999954443 3333333445668899999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|+.||.+++ ....-+.++.+..-+.+..+++.+.+++..||+.+|++|||++.+...++++.
T Consensus 401 G~~py~~ms------------------n~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 401 GRVPYPGMS------------------NEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CCCCCCCCC------------------HHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 899998843 23344444455455555567889999999999999999999999999999876
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 463 ~~~ 465 (468)
T KOG0197|consen 463 TST 465 (468)
T ss_pred hcc
Confidence 543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=287.46 Aligned_cols=236 Identities=43% Similarity=0.711 Sum_probs=200.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++|.+|+.++.+++|||+++++|||.+++ ..+||+||+++|+|.+++...... .++|..+++|+.+++.||+|||...
T Consensus 116 ~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 116 REFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCC
Confidence 35999999999999999999999999988 499999999999999999876554 5799999999999999999999998
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccc-cCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK-IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
.++|+|||||+.||++|++...||+|||+++..+.. ....... .||..|++||+......+.++||||||+++.|++
T Consensus 195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 888999999999999999999999999999655431 1111111 6999999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccC-CchhH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVA-DESEM-EEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
+|+.+..... .........|.........+..+++..+. ..... .....+..+...|++.+|.+||++.+|.+.|+
T Consensus 273 tgr~~~d~~~--~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~ 350 (361)
T KOG1187|consen 273 TGRKAVDQSR--PRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELE 350 (361)
T ss_pred hCCcccCCCC--CcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHH
Confidence 9998766533 12233477787888888899999999876 33332 46677999999999999999999999999997
Q ss_pred hcccc
Q 025011 239 RLKIS 243 (259)
Q Consensus 239 ~~~~~ 243 (259)
.+...
T Consensus 351 ~~~~~ 355 (361)
T KOG1187|consen 351 GILSL 355 (361)
T ss_pred hhccc
Confidence 66543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-44 Score=278.15 Aligned_cols=158 Identities=28% Similarity=0.486 Sum_probs=144.6
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++-+..|+.+|+.++|||||++++++..++.+|+|||||.||+|.+++...+. +++..+..++.||+.|+.+||+++
T Consensus 53 ~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~t~r~Fm~QLA~alq~L~~~~ 129 (429)
T KOG0595|consen 53 VELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---LPEATARHFMQQLASALQFLHENN 129 (429)
T ss_pred HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35578899999999999999999999999999999999999999999988764 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCC------CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDN------YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|+||||||+||+++.+ -.+||+|||+++.... ........|++.|||||++....|+.|+|+||+|++
T Consensus 130 ---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~I 203 (429)
T KOG0595|consen 130 ---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTI 203 (429)
T ss_pred ---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHH
Confidence 9999999999999865 4589999999998763 234455679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCC
Q 025011 156 LAELLTGLKPGSG 168 (259)
Q Consensus 156 l~~l~~g~~p~~~ 168 (259)
+|++++|..||..
T Consensus 204 lyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 204 LYQCLTGKPPFDA 216 (429)
T ss_pred HHHHHhCCCCccc
Confidence 9999999999986
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=271.53 Aligned_cols=227 Identities=20% Similarity=0.278 Sum_probs=173.0
Q ss_pred ChhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 1 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
|++--.+|+++|++|+|||+|.++++|...+..++|||||+. ++.+.++..+.+ .+...+.+++.|++.|+.|+|++
T Consensus 44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~ 120 (396)
T KOG0593|consen 44 VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKN 120 (396)
T ss_pred HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhc
Confidence 355678999999999999999999999999999999999977 666667766554 36689999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l 159 (259)
+ ++||||||+||+++.+|.+||||||+|+.....+ ...+..+.|.+|+|||.+.+. +|..++|||++||++.||
T Consensus 121 n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl 195 (396)
T KOG0593|consen 121 N---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAEL 195 (396)
T ss_pred C---eecccCChhheEEecCCcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHH
Confidence 9 9999999999999999999999999999877432 233455799999999999984 599999999999999999
Q ss_pred HhCCCCCCCCccccccchhHH---HHH----HHhhccch-----hhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 160 LTGLKPGSGMALASNEGISMV---QYF----LYSIENNS-----LRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~---~~~----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
++|.+.|++.+....-..... ... .....+.. +.+...........+..+.-+.+++.+||+.||++|
T Consensus 196 ~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R 275 (396)
T KOG0593|consen 196 LTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDR 275 (396)
T ss_pred hcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccc
Confidence 999999998543321110000 000 00000000 001111111111222344678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
++.+++++
T Consensus 276 ~sc~qll~ 283 (396)
T KOG0593|consen 276 LSCEQLLH 283 (396)
T ss_pred ccHHHHhc
Confidence 99999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=276.14 Aligned_cols=220 Identities=25% Similarity=0.387 Sum_probs=175.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+..++.++||||++++..|..+..+|+||+|+.+||+.+.+...-... +++..|..++.+++.||.|||++|
T Consensus 69 d~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-l~E~~Ia~iLre~LkaL~YLH~~G- 146 (516)
T KOG0582|consen 69 DALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-LEEASIATILREVLKALDYLHQNG- 146 (516)
T ss_pred HHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-ccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 468999999999999999999999999999999999999999999998764444 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc-ccccc-ccccCcccccCcchhccC--CcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN-QTAMT-TKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-~~~~~-~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~ 158 (259)
.+|||+|+.||+++.+|.++|+|||.+...-.++ +.... ....|++.|+|||++... .|+.|+||||||++..|
T Consensus 147 --~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~E 224 (516)
T KOG0582|consen 147 --HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACE 224 (516)
T ss_pred --ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHH
Confidence 9999999999999999999999999865444332 22222 556899999999996543 48999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|+.||..... .+.+.....+...... ......+.....+..+.+++..||..||.+|||++++++
T Consensus 225 LA~G~aPf~k~pP--------mkvLl~tLqn~pp~~~-t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 225 LAHGHAPFSKYPP--------MKVLLLTLQNDPPTLL-TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HhcCCCCcccCCh--------HHHHHHHhcCCCCCcc-cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 9999999987321 1111111111111110 122222333344568999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=283.92 Aligned_cols=213 Identities=25% Similarity=0.360 Sum_probs=173.4
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.+.+|+.+++.+. ||||+++++++......++||||+.||+|++++...+. +.+..+..++.|+++|+.|+|++
T Consensus 63 ~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---l~E~~ar~~F~Qlisav~y~H~~ 139 (370)
T KOG0583|consen 63 DELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---LKEDEARKYFRQLISAVAYCHSR 139 (370)
T ss_pred chhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---CChHHHHHHHHHHHHHHHHHHhC
Confidence 355778999999998 99999999999999999999999999999999988433 56799999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cc-cccchhhHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LT-EKSDVYSFGVLLA 157 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~ 157 (259)
+ |+||||||+|++++.+ +++||+|||++.... ..........|++.|+|||++.+.. |+ .++||||+|+++|
T Consensus 140 g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy 214 (370)
T KOG0583|consen 140 G---IVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILY 214 (370)
T ss_pred C---EeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHH
Confidence 9 9999999999999999 999999999998763 1223445567999999999999877 75 7899999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
.|++|..||..... .. ....+.......+.... ++.+.+++.+||..||.+|+|+.+|+ .-
T Consensus 215 ~ml~G~~PF~d~~~--------~~---------l~~ki~~~~~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~-~h 275 (370)
T KOG0583|consen 215 VLLCGRLPFDDSNV--------PN---------LYRKIRKGEFKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL-EH 275 (370)
T ss_pred HHHhCCCCCCCccH--------HH---------HHHHHhcCCccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh-hC
Confidence 99999999987210 00 01111111111111111 47799999999999999999999998 43
Q ss_pred Hhcc
Q 025011 238 DRLK 241 (259)
Q Consensus 238 ~~~~ 241 (259)
.-+.
T Consensus 276 ~w~~ 279 (370)
T KOG0583|consen 276 PWFQ 279 (370)
T ss_pred hhhc
Confidence 3333
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=283.82 Aligned_cols=209 Identities=25% Similarity=0.395 Sum_probs=176.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.+|+..+|+|||.+++.|..++.+|+||||++||+|.|.+.... +++.++..++.+++.||+|||.++
T Consensus 314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g 389 (550)
T KOG0578|consen 314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG 389 (550)
T ss_pred hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc
Confidence 4678999999999999999999999999999999999999999999997654 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+|+|||.+||+++.+|.+||+|||++..+..... .....+||+.|||||+.....|.+++||||||++.+||+.
T Consensus 390 ---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve 464 (550)
T KOG0578|consen 390 ---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE 464 (550)
T ss_pred ---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc
Confidence 99999999999999999999999999887765432 4556689999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|.+||-... ..+..+ ....+...++.. +...++.+.+++.+||..|+.+|+||.++|+
T Consensus 465 GEPPYlnE~--------PlrAly-LIa~ng~P~lk~-------~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 465 GEPPYLNEN--------PLRALY-LIATNGTPKLKN-------PEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCCCccCCC--------hHHHHH-HHhhcCCCCcCC-------ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 999987511 111111 111222222211 2234478999999999999999999999985
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=276.19 Aligned_cols=216 Identities=28% Similarity=0.409 Sum_probs=170.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+.+|++++|||||+++|...... ..+++|||+++|+|.+++...+. .+++..+..+..|++.||.|||++
T Consensus 59 ~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~ 136 (313)
T KOG0198|consen 59 ESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSK 136 (313)
T ss_pred HHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45899999999999999999999755444 68999999999999999998765 278899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccC-CccccccccccCcccccCcchhccC-CcccccchhhHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISS-DNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLA 157 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~ 157 (259)
+ ++|+||||+||+++. ++.+||+|||.+..... ...........||+.|+|||+.... ....++||||+||++.
T Consensus 137 g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVv 213 (313)
T KOG0198|consen 137 G---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVV 213 (313)
T ss_pred C---EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEE
Confidence 9 999999999999999 79999999999876653 1122234456799999999999853 3445999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
+|+||..||... .....+........... ..+...++...+++.+|+..||.+||||.++++--
T Consensus 214 EM~Tg~~PW~~~-------~~~~~~~~~ig~~~~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 214 EMLTGKPPWSEF-------FEEAEALLLIGREDSLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred eccCCCCcchhh-------cchHHHHHHHhccCCCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 999999999863 01111111111111111 11222447799999999999999999999998754
Q ss_pred Hh
Q 025011 238 DR 239 (259)
Q Consensus 238 ~~ 239 (259)
--
T Consensus 278 f~ 279 (313)
T KOG0198|consen 278 FL 279 (313)
T ss_pred hh
Confidence 33
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=288.32 Aligned_cols=203 Identities=27% Similarity=0.353 Sum_probs=173.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|+.+|+.+.|||++++|+++++..++|+|.||+++|-|++++-..+. +.+.++.+++.||+.|+.|+|..+
T Consensus 57 ~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---l~e~eaa~ff~QIi~gv~yCH~~~- 132 (786)
T KOG0588|consen 57 AGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---LPEREAAHFFRQILDGVSYCHAFN- 132 (786)
T ss_pred cchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHhhhc-
Confidence 3478999999999999999999999999999999999999999999987765 677999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
|+|+|+||+|++++..+++||+|||+|..-. ........+|+++|.+||+..+.+| ..++||||+|+|+|.|++
T Consensus 133 --icHRDLKpENlLLd~~~nIKIADFGMAsLe~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 133 --ICHRDLKPENLLLDVKNNIKIADFGMASLEV---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred --ceeccCCchhhhhhcccCEeeeccceeeccc---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 9999999999999999999999999986533 2334556689999999999999987 568999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhcccc--CCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQV--ADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+ .++..++.+-. ....+-+.+.+..+||++||..||.+|.|.++|++
T Consensus 208 G~LPFdD---------------------dNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 208 GKLPFDD---------------------DNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred CCCCCCC---------------------ccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 9999986 22222221111 12233455688999999999999999999999965
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=269.95 Aligned_cols=199 Identities=28% Similarity=0.329 Sum_probs=166.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
..++|..+|..++||.||+++-.|++.+.+|+|+||+.||.|+..|++... +++..+.-+++.|+.||.|||+++
T Consensus 71 ~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---F~E~~arfYlaEi~lAL~~LH~~g-- 145 (357)
T KOG0598|consen 71 HTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---FSEDRARFYLAEIVLALGYLHSKG-- 145 (357)
T ss_pred HHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---cchhHHHHHHHHHHHHHHHHHhCC--
Confidence 467899999999999999999999999999999999999999999987654 678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|+|||+||+||+++..|.++|+|||+++..-.. ...+....||+.|+|||++.+..++.++|.||||+++|+|++|.
T Consensus 146 -IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~ 222 (357)
T KOG0598|consen 146 -IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGK 222 (357)
T ss_pred -eeeccCCHHHeeecCCCcEEEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCC
Confidence 999999999999999999999999999854432 23345578999999999999999999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
+||.+.+.. .....+....... .+...+....+++.++|..||.+|.
T Consensus 223 pPF~~~~~~-----------------~~~~~I~~~k~~~-~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 223 PPFYAEDVK-----------------KMYDKILKGKLPL-PPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCcCccHH-----------------HHHHHHhcCcCCC-CCccCCHHHHHHHHHHhccCHHHhc
Confidence 999873211 1111111111111 1111236799999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=277.32 Aligned_cols=207 Identities=29% Similarity=0.392 Sum_probs=172.8
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|-.+|.+| .||+|++++-.|.++..+|+|+||+++|+|.+++.+.+. +++..+..++.+|+.||.|||++|
T Consensus 119 YV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---fde~caR~YAAeIldAleylH~~G- 194 (604)
T KOG0592|consen 119 YVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---FDETCARFYAAEILDALEYLHSNG- 194 (604)
T ss_pred hhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---chHHHHHHHHHHHHHHHHHHHhcC-
Confidence 456788899999 899999999999999999999999999999999998865 788899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc---------c--ccccccCcccccCcchhccCCcccccchhh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT---------A--MTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
|+||||||+|||++++++++|.|||.++.++..... . ....++||..|.+||++.....+.++|||+
T Consensus 195 --IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWA 272 (604)
T KOG0592|consen 195 --IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWA 272 (604)
T ss_pred --ceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHH
Confidence 999999999999999999999999999887653222 1 114578999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||||+|+|+.|.+||.+..... ...++..-.. ..+...++...+||.++|..||.+|+|++
T Consensus 273 lGCilyQmlaG~PPFra~Neyl-----------------iFqkI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 273 LGCILYQMLAGQPPFRAANEYL-----------------IFQKIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred HHHHHHHHhcCCCCCccccHHH-----------------HHHHHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 9999999999999998732211 1111111111 11122337799999999999999999998
Q ss_pred HHHH
Q 025011 232 QVSE 235 (259)
Q Consensus 232 ~il~ 235 (259)
+|.+
T Consensus 334 qIk~ 337 (604)
T KOG0592|consen 334 QIKA 337 (604)
T ss_pred HHhh
Confidence 8854
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=292.24 Aligned_cols=226 Identities=27% Similarity=0.458 Sum_probs=191.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-----------cccCCHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-----------QVLRNWKTCLRIAAET 70 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i 70 (259)
+++|++|++++..|+|||||+++|+|.+++..|+|+||+..|+|.++|..... ...++..+.+.|+.||
T Consensus 533 ~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QI 612 (774)
T KOG1026|consen 533 RQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQI 612 (774)
T ss_pred HHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHH
Confidence 68899999999999999999999999999999999999999999999965311 3347788999999999
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchh
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVY 150 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 150 (259)
+.|+.||-++. ++||||...|+++.++-.|||+|||+++..-+..-++......-...|||||.+....++.+||||
T Consensus 613 AaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVW 689 (774)
T KOG1026|consen 613 AAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVW 689 (774)
T ss_pred HHHHHHHHhCc---ccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhh
Confidence 99999999999 999999999999999999999999999987766555555566778899999999999999999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 151 SFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 151 slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|+|+++||+++ |..||.+.+.. ..-+.+..+..-.-+-+++..+.+|+..||+.+|++|||
T Consensus 690 s~GVvLWEIFsyG~QPy~glSn~------------------EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 690 SFGVVLWEIFSYGKQPYYGLSNQ------------------EVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred hhhhhhhhhhccccCcccccchH------------------HHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCC
Confidence 99999999999 99999884321 111111111112233356688999999999999999999
Q ss_pred HHHHHHHHHhccccccchh
Q 025011 230 MKQVSEELDRLKISHENYE 248 (259)
Q Consensus 230 ~~~il~~l~~~~~~~~~~~ 248 (259)
+++|-..|++.....+.+.
T Consensus 752 F~eI~~~L~~~~~~s~~~~ 770 (774)
T KOG1026|consen 752 FKEIHSRLQAWAQASPKYS 770 (774)
T ss_pred HHHHHHHHHHHHhcCcccc
Confidence 9999999998877665544
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=276.89 Aligned_cols=220 Identities=26% Similarity=0.414 Sum_probs=171.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC-CcceEEEEecCCCChhhhhhccCC--------------------------
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSS-------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------------------- 54 (259)
+.+.+|+.+++.+ +||||+++++++... +..+++|||+++|+|.+++.....
T Consensus 55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 134 (338)
T cd05102 55 KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD 134 (338)
T ss_pred HHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence 4588999999999 899999999988764 457899999999999999875321
Q ss_pred ---------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCC
Q 025011 55 ---------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY 101 (259)
Q Consensus 55 ---------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~ 101 (259)
...+++..+..++.|++.||.|||+++ ++|+||||+||+++.++
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~ 211 (338)
T cd05102 135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENN 211 (338)
T ss_pred cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCC
Confidence 123567788899999999999999999 99999999999999999
Q ss_pred ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHH
Q 025011 102 KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMV 180 (259)
Q Consensus 102 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~ 180 (259)
.++|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+..... .
T Consensus 212 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~-- 285 (338)
T cd05102 212 VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----E-- 285 (338)
T ss_pred cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----H--
Confidence 999999999876543222222223345678999999988889999999999999999997 999998633211 0
Q ss_pred HHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 025011 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
.......+.. ...+...++.+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 286 --~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 286 --FCQRLKDGTR---------MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0001111110 00111234679999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=252.83 Aligned_cols=207 Identities=24% Similarity=0.345 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
|.+.+|+++-+.|+||||+++.+.+...+..|+|+|++.|++|..-+-+. ...++..+...+.||+.||.|+|.++
T Consensus 55 e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~- 130 (355)
T KOG0033|consen 55 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG- 130 (355)
T ss_pred HHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC-
Confidence 57899999999999999999999999999999999999999997666443 33678889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC---CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|||+||.|+++. .+.-+||+|||++...+ .......+.|++.|+|||++...+++..+|||+.|+++|-|
T Consensus 131 --IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 131 --IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 205 (355)
T ss_pred --ceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence 99999999999994 34469999999998876 33445667899999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccc--cCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQ--VADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.|.+||.+.+... + ..++.... ...+.-...++...+|+++||..||++|+|+.|.++
T Consensus 206 L~G~~PF~~~~~~r---------l--------ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 206 LVGYPPFWDEDQHR---------L--------YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HhCCCCCCCccHHH---------H--------HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 99999998833211 0 11111111 111112234578999999999999999999999854
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=270.06 Aligned_cols=212 Identities=23% Similarity=0.347 Sum_probs=170.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.|.+|+.++++++||||+++++++.+ ....+++|||+++|+|.+++..... +++.....++.+++.|+.+||
T Consensus 63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lH 139 (283)
T PHA02988 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLY 139 (283)
T ss_pred HHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCC---CChhHHHHHHHHHHHHHHHHH
Confidence 567899999999999999999999876 3467999999999999999976532 577889999999999999999
Q ss_pred hC-CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc--CCcccccchhhHHHH
Q 025011 79 SS-ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~-~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~i 155 (259)
+. + ++|+||+|+||+++.++.++++|||++...... .....++..|+|||++.+ ..++.++||||||++
T Consensus 140 ~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvi 211 (283)
T PHA02988 140 KYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211 (283)
T ss_pred hcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHH
Confidence 85 7 889999999999999999999999998754332 123457889999999976 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+|++|..||.+.... .......... .....+...++.+.+++.+||+.||.+|||++++++
T Consensus 212 l~el~~g~~Pf~~~~~~--------~~~~~i~~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 212 LWEIFTGKIPFENLTTK--------EIYDLIINKN---------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHCCCCCCCCCHH--------HHHHHHHhcC---------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999863211 1111110000 011111134577999999999999999999999999
Q ss_pred HHHhccc
Q 025011 236 ELDRLKI 242 (259)
Q Consensus 236 ~l~~~~~ 242 (259)
.|+.+..
T Consensus 275 ~l~~~~~ 281 (283)
T PHA02988 275 NLSLYKF 281 (283)
T ss_pred HHHHHHh
Confidence 9998753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=273.64 Aligned_cols=220 Identities=21% Similarity=0.316 Sum_probs=172.3
Q ss_pred HHHHHHHhcCC-CccccccceeEEeCC-cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 6 QHELRVVSQIN-HKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 6 ~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+|++-|++|+ ||||+++.+++.+.+ .+++||||+ ..+|++++++. ..++++..+..|+.||++||+|+|++|
T Consensus 56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G-- 130 (538)
T KOG0661|consen 56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG-- 130 (538)
T ss_pred HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC--
Confidence 47999999998 999999999998877 899999999 55999999887 445899999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g 162 (259)
+.|||+||+||++.++..+||+|||+++...+.. ..+..+.|.+|+|||++... .|+.+.|+|++|||++|+.+-
T Consensus 131 -fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL 206 (538)
T KOG0661|consen 131 -FFHRDLKPENILISGNDVIKIADFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL 206 (538)
T ss_pred -cccccCChhheEecccceeEecccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999876543 23455789999999998765 489999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhcc-----chhhhhhccccCC-------chhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIEN-----NSLRQILNFQVAD-------ESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
++.|+|.+..+. ....++.+...... ..+....+...+. ..-.+.++++.++|..|+.+||.+||||
T Consensus 207 rPLFPG~sE~Dq-i~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA 285 (538)
T KOG0661|consen 207 RPLFPGASEIDQ-IYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTA 285 (538)
T ss_pred cccCCCCcHHHH-HHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccH
Confidence 999998543221 11122221111111 1111111111111 1112356889999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 286 ~~al~ 290 (538)
T KOG0661|consen 286 SQALQ 290 (538)
T ss_pred HHHhc
Confidence 99976
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=270.11 Aligned_cols=220 Identities=22% Similarity=0.305 Sum_probs=171.7
Q ss_pred HHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
-.+|+.+|++|.||||+++.+..... +.+|+||||++. +|.-++.... ..+++.++..++.||+.||.|+|.++
T Consensus 163 ~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g- 238 (560)
T KOG0600|consen 163 AIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG- 238 (560)
T ss_pred HHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC-
Confidence 36899999999999999999998876 789999999976 8888886543 23688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
|+|||||..|||+|.+|.+||+|||+++.+..... ...+..+-|.+|+|||++.+.. |+.++|+||+|||+.||+.
T Consensus 239 --vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 239 --VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred --eeeccccccceEEcCCCCEEeccccceeeccCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 99999999999999999999999999998776533 3356678999999999999875 9999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh--ccchhh-------hhhccccCCc-----hhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI--ENNSLR-------QILNFQVADE-----SEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|++.|++..... .+...+.... .+..+. ..+.....-. .....++...+|+..||..||.+|
T Consensus 316 gkPI~~G~tEve----Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 316 GKPILQGRTEVE----QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred CCCCcCCccHHH----HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 999999843322 2222211111 111111 0011110100 111234678899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
.||.+++.
T Consensus 392 ~tA~~aL~ 399 (560)
T KOG0600|consen 392 GTASSALQ 399 (560)
T ss_pred ccHHHHhc
Confidence 99999864
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=275.18 Aligned_cols=211 Identities=22% Similarity=0.320 Sum_probs=179.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCc-ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKV-PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.-.+|+.++++++|||||.+.+.|..++. .+|||+||+||++.+.+.+.. ...+++..+.+|+.|++.|+.|||++
T Consensus 47 r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~ 125 (426)
T KOG0589|consen 47 RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHEN 125 (426)
T ss_pred hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhh
Confidence 3456789999999999999999999999887 999999999999999998876 45689999999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
. |+|||||+.|||+++++.++|+|||+++..+... .......||+.|++||.+.+.+|..++|||||||++|+|+
T Consensus 126 ~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 126 R---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred h---hhcccchhhhhhccccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 9 9999999999999999999999999999877543 2344457999999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+-+.+|.+.+.. .-..++.. ....+.+..++..+..+|..||..+|..||++.+++..
T Consensus 201 ~lk~aF~a~~m~-----------------~Li~ki~~-~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 201 TLKPAFKASNMS-----------------ELILKINR-GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred hcccccCccchH-----------------HHHHHHhh-ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 999999873211 01111111 11333445566889999999999999999999999876
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=267.50 Aligned_cols=217 Identities=27% Similarity=0.465 Sum_probs=175.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc-------------ccCCHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ-------------VLRNWKTCLRIAAE 69 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~i~~~ 69 (259)
+.|.+|+++++.++||||+++++++...+..+++|||+++++|.+++...... ..+++..++.++.|
T Consensus 53 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 132 (283)
T cd05048 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132 (283)
T ss_pred HHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHH
Confidence 56889999999999999999999999999999999999999999999764221 33677889999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccch
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDV 149 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 149 (259)
++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+
T Consensus 133 l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 209 (283)
T cd05048 133 IAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDI 209 (283)
T ss_pred HHHHHHHHHhCC---eeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhH
Confidence 999999999999 99999999999999999999999999876543322233344456788999999988889999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 150 YSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 150 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
||||+++|+|++ |..||.+.... +... .+........+...+..+.+++.+||+.||.+||
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~~--------~~~~----------~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp 271 (283)
T cd05048 210 WSFGVVLWEIFSYGLQPYYGFSNQ--------EVIE----------MIRSRQLLPCPEDCPARVYALMIECWNEIPARRP 271 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCHH--------HHHH----------HHHcCCcCCCcccCCHHHHHHHHHHccCChhhCc
Confidence 999999999998 99998763211 0000 0101111111223457899999999999999999
Q ss_pred CHHHHHHHHHhc
Q 025011 229 TMKQVSEELDRL 240 (259)
Q Consensus 229 t~~~il~~l~~~ 240 (259)
|+.+|++.|+++
T Consensus 272 ~~~~i~~~l~~~ 283 (283)
T cd05048 272 RFKDIHTRLRSW 283 (283)
T ss_pred CHHHHHHHHhcC
Confidence 999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=267.75 Aligned_cols=224 Identities=25% Similarity=0.401 Sum_probs=179.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAAE 69 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ 69 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... ...+++..++.++.|
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 131 (291)
T cd05094 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131 (291)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHH
Confidence 5688999999999999999999999999999999999999999999975432 123678899999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccch
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDV 149 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 149 (259)
++.|+.|||+++ ++|+||+|.||+++.++.++|+|||++................++..|+|||.+.+..++.++||
T Consensus 132 i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 208 (291)
T cd05094 132 IASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 208 (291)
T ss_pred HHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhH
Confidence 999999999999 99999999999999999999999999876544322222333456788999999988889999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 150 YSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 150 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
||+|+++|+|++ |..||...... ..... ....... ......+..+.+++.+||+.+|++||
T Consensus 209 ~slG~il~el~t~g~~p~~~~~~~-----~~~~~----~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp 270 (291)
T cd05094 209 WSFGVILWEIFTYGKQPWFQLSNT-----EVIEC----ITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRL 270 (291)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHH-----HHHHH----HhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCc
Confidence 999999999999 99998653211 01110 1111110 01112346799999999999999999
Q ss_pred CHHHHHHHHHhccccccch
Q 025011 229 TMKQVSEELDRLKISHENY 247 (259)
Q Consensus 229 t~~~il~~l~~~~~~~~~~ 247 (259)
|+.++++.|+++....+++
T Consensus 271 t~~~v~~~l~~~~~~~~~~ 289 (291)
T cd05094 271 NIKEIYKILHALGKATPIY 289 (291)
T ss_pred CHHHHHHHHHHHHhhcCcc
Confidence 9999999999997765554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=248.22 Aligned_cols=220 Identities=23% Similarity=0.296 Sum_probs=172.8
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
...+|++.|+.++|+||+.++++|.....+.||+||++. +|+..++.... .++...+..++.++++|++|||.+.
T Consensus 47 talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~-- 121 (318)
T KOG0659|consen 47 TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW-- 121 (318)
T ss_pred HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh--
Confidence 357899999999999999999999999999999999955 99999987654 3677999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||.|++++.+|.+|++|||+++.++..... ....+-|.+|+|||.+.|.. |...+|+||+||++.||+-|
T Consensus 122 -IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 122 -ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred -hhcccCCccceEEcCCCcEEeecccchhccCCCCcc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 999999999999999999999999999998865433 23337889999999998875 89999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhh--------------ccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQIL--------------NFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
.+.|+|.+... .+...+. ........+|. ............+....+|+.+||..||.+|+
T Consensus 199 ~P~fpG~sDid----QL~~If~-~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri 273 (318)
T KOG0659|consen 199 VPFFPGDSDID----QLSKIFR-ALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI 273 (318)
T ss_pred CCCCCCCchHH----HHHHHHH-HcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc
Confidence 88888843221 1111111 11111111111 10001111223456789999999999999999
Q ss_pred CHHHHHHH
Q 025011 229 TMKQVSEE 236 (259)
Q Consensus 229 t~~~il~~ 236 (259)
|++|+++.
T Consensus 274 ta~qaL~~ 281 (318)
T KOG0659|consen 274 TASQALKH 281 (318)
T ss_pred cHHHHhcc
Confidence 99999763
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=254.74 Aligned_cols=219 Identities=25% Similarity=0.392 Sum_probs=176.9
Q ss_pred ChhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 1 MNQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 1 ~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
|+++-..|+.+|+++ .||+|+++.++++.+...++|+|.++.|.|+|++...-. +++....+++.|+..|+.|||.
T Consensus 65 ~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt---lSEK~tR~iMrqlfegVeylHa 141 (411)
T KOG0599|consen 65 MREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT---LSEKETRRIMRQLFEGVEYLHA 141 (411)
T ss_pred HHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee---ecHHHHHHHHHHHHHHHHHHHH
Confidence 467788999999999 699999999999999999999999999999999976543 7889999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc------CCcccccchhhHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------GKLTEKSDVYSFG 153 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG 153 (259)
++ |+|+|+||+||+++++.+++++|||+++....+. ......||++|+|||.+.. ..|+..+|+|++|
T Consensus 142 ~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~G 215 (411)
T KOG0599|consen 142 RN---IVHRDLKPENILLDDNMNIKISDFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACG 215 (411)
T ss_pred hh---hhhcccChhheeeccccceEEeccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHH
Confidence 99 9999999999999999999999999998876543 3345679999999998753 2377889999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|-|+.|.+||.+... ..+...+... . -....+...+.+....+||.+||+.||.+|.|++|+
T Consensus 216 VImyTLLaGcpPFwHRkQ-----mlMLR~ImeG----k------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~ 280 (411)
T KOG0599|consen 216 VIMYTLLAGCPPFWHRKQ-----MLMLRMIMEG----K------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEA 280 (411)
T ss_pred HHHHHHHcCCCchhHHHH-----HHHHHHHHhc----c------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHH
Confidence 999999999999887321 1111111111 0 011112223456789999999999999999999999
Q ss_pred HH--HHHhcccc
Q 025011 234 SE--ELDRLKIS 243 (259)
Q Consensus 234 l~--~l~~~~~~ 243 (259)
+. .+..+...
T Consensus 281 LaHpff~q~~~~ 292 (411)
T KOG0599|consen 281 LAHPFFIQIAQQ 292 (411)
T ss_pred hcChHHHHHHHh
Confidence 85 34444333
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=248.68 Aligned_cols=223 Identities=22% Similarity=0.295 Sum_probs=176.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcc-cCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQV-LRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~ 76 (259)
+...+|++..++++|||+++++++...+ ...||+++|...|+|.+.++...... ..++.++++|+.++++||.+
T Consensus 63 e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~ 142 (302)
T KOG2345|consen 63 EEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEA 142 (302)
T ss_pred HHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHH
Confidence 4578899999999999999999977543 34899999999999999997654333 67999999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-------ccccccCcccccCcchhccC---Ccccc
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-------MTTKKIGTFVNLDPEYVITG---KLTEK 146 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~---~~~~~ 146 (259)
||+.. ++++|+||||.||++++++.+++.|||.++...-.-... .......|..|+|||.+.-. ..+.+
T Consensus 143 lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 143 LHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred HhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccc
Confidence 99987 579999999999999999999999999987665321111 11233588999999998643 46889
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 147 SDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 147 ~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+|||||||++|.|+.|..||+..-. ..+.-...+.......+....+++.+.++|.+||++||.+
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~---------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~q 286 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQ---------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQ 286 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhh---------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCccc
Confidence 9999999999999999999975211 1112222223333333333336789999999999999999
Q ss_pred CCCHHHHHHHHHhcc
Q 025011 227 RPTMKQVSEELDRLK 241 (259)
Q Consensus 227 Rpt~~~il~~l~~~~ 241 (259)
||++.+++..++++.
T Consensus 287 RP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 287 RPTIPELLSKLDDLI 301 (302)
T ss_pred CCCHHHHHHHHHhhc
Confidence 999999999998763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=275.22 Aligned_cols=203 Identities=26% Similarity=0.365 Sum_probs=173.0
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+++|+++++.++||||+.++++|++..+.|+|+||+.| +|+.+++.... +++..+..++.+++.||.|||+++
T Consensus 48 l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---lpEe~v~~~a~~LVsaL~yLhs~r--- 120 (808)
T KOG0597|consen 48 LRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---LPEEQVRAIAYDLVSALYYLHSNR--- 120 (808)
T ss_pred HHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHhcC---
Confidence 78999999999999999999999999999999999966 99999987655 678999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
|.|+|+||+||++++++.+|++|||+++..+. ...+....-||+.|||||+..+..|+..+|.||+||++||+++|++
T Consensus 121 ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 121 ILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred cccccCCcceeeecCCCceeechhhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999987765 3444555679999999999999999999999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
||...+. .........+ .. ..+...+..+..++..+|.+||.+|.|..+++.
T Consensus 199 PF~a~si--------~~Lv~~I~~d---------~v--~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 199 PFYARSI--------TQLVKSILKD---------PV--KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CchHHHH--------HHHHHHHhcC---------CC--CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 9986221 1111111111 11 112245578999999999999999999999864
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=282.68 Aligned_cols=212 Identities=25% Similarity=0.279 Sum_probs=170.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+++|+.+++.++||||+++++++..++..++||||+++|+|.+++... .....+++..+..++.|++.||.|||+++
T Consensus 110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ 189 (478)
T PTZ00267 110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK 189 (478)
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35788999999999999999999999999999999999999999988643 22334678899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++...............|++.|+|||++.+..++.++||||+||++|+|++
T Consensus 190 ---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~t 266 (478)
T PTZ00267 190 ---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266 (478)
T ss_pred ---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHh
Confidence 99999999999999999999999999987654332223344568999999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+.... ........ +.. ...+...+..+.++|.+||..||++|||+.+++.
T Consensus 267 g~~Pf~~~~~~--------~~~~~~~~-~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 267 LHRPFKGPSQR--------EIMQQVLY-GKY---------DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCCCCHH--------HHHHHHHh-CCC---------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 99999763210 11111000 000 0011123467999999999999999999999864
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=264.47 Aligned_cols=223 Identities=24% Similarity=0.374 Sum_probs=177.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC----------cccCCHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS----------QVLRNWKTCLRIAAETAS 72 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~i~~~i~~ 72 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++..... ...+++..++.++.|++.
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~ 131 (288)
T cd05093 52 KDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131 (288)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999865431 123688899999999999
Q ss_pred HHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhH
Q 025011 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSF 152 (259)
Q Consensus 73 ~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 152 (259)
||.|||+++ ++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++|+|||
T Consensus 132 aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwsl 208 (288)
T cd05093 132 GMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL 208 (288)
T ss_pred HHHHHHhCC---eeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHH
Confidence 999999999 99999999999999999999999999876543322222333345778999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 153 GVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 153 G~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
|+++|+|++ |..||...... ........ +.... .+...+..+.+++.+||+.||.+|||+.
T Consensus 209 G~il~~l~t~g~~p~~~~~~~--------~~~~~i~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 270 (288)
T cd05093 209 GVVLWEIFTYGKQPWYQLSNN--------EVIECITQ-GRVLQ---------RPRTCPKEVYDLMLGCWQREPHMRLNIK 270 (288)
T ss_pred HHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc-CCcCC---------CCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 999999998 89998763211 00111111 11000 0111236799999999999999999999
Q ss_pred HHHHHHHhccccccc
Q 025011 232 QVSEELDRLKISHEN 246 (259)
Q Consensus 232 ~il~~l~~~~~~~~~ 246 (259)
++.+.|+++...-..
T Consensus 271 ~v~~~l~~~~~~~~~ 285 (288)
T cd05093 271 EIHSLLQNLAKASPV 285 (288)
T ss_pred HHHHHHHHHHHhccc
Confidence 999999998865443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=273.95 Aligned_cols=218 Identities=28% Similarity=0.452 Sum_probs=171.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
+.+.+|+++++.+ +|+||+++++++..++..+++|||+++|+|.+++.....
T Consensus 86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (374)
T cd05106 86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165 (374)
T ss_pred HHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcc
Confidence 4588999999999 899999999999999999999999999999999854211
Q ss_pred ----------------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCC
Q 025011 55 ----------------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94 (259)
Q Consensus 55 ----------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~n 94 (259)
...+++..++.++.|++.||.|||+++ ++|+||||+|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~N 242 (374)
T cd05106 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARN 242 (374)
T ss_pred cccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchhe
Confidence 123567888999999999999999999 9999999999
Q ss_pred eEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCCCcccc
Q 025011 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS 173 (259)
Q Consensus 95 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~ 173 (259)
|+++.++.++|+|||+++...............++..|+|||++.+..++.++||||+|+++|+|++ |..||.......
T Consensus 243 il~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~ 322 (374)
T cd05106 243 VLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS 322 (374)
T ss_pred EEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH
Confidence 9999999999999999876543322222222335567999999988889999999999999999997 999997632110
Q ss_pred ccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
...... ... .....+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 323 ----~~~~~~----~~~---------~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 323 ----KFYKMV----KRG---------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ----HHHHHH----Hcc---------cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 000000 000 00000111236799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=261.82 Aligned_cols=204 Identities=26% Similarity=0.408 Sum_probs=172.8
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+++|+++++.|+||||+.+|++|++...+.|||||..+|.|+|++...+. +++.++..++.||++|+.|+|+++
T Consensus 100 IRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsErEaRhfFRQIvSAVhYCHknr--- 173 (668)
T KOG0611|consen 100 IRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---LSEREARHFFRQIVSAVHYCHKNR--- 173 (668)
T ss_pred HHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHHHHHHHHHHHHHHHHHHhhcc---
Confidence 78999999999999999999999999999999999999999999987765 788999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHhCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~ 163 (259)
++|+|+|.+||++|.|++++++|||++-.+.. ......+.|++.|.+||...+.+| .+.+|.||||+++|-|+.|.
T Consensus 174 VvHRDLKLENILLD~N~NiKIADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGt 250 (668)
T KOG0611|consen 174 VVHRDLKLENILLDQNNNIKIADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGT 250 (668)
T ss_pred ceecccchhheeecCCCCeeeeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcc
Confidence 99999999999999999999999999876653 335567789999999999999887 57799999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
.||.+.++.. ...++.......+. .+.....||+|||..||.+|.|+.+|..-.
T Consensus 251 MPFDG~Dhk~-----------------lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 251 MPFDGRDHKR-----------------LVRQISRGAYREPE---TPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred cccCCchHHH-----------------HHHHhhcccccCCC---CCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 9999854211 11111111111111 124577799999999999999999987654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=284.21 Aligned_cols=224 Identities=25% Similarity=0.303 Sum_probs=186.7
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEE-e------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACL-E------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~-~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
+..++|++++++|+ |+|||.+++... . ...+.|+||||.||+|-|++.+..... +++.++++|+.+++.|+
T Consensus 79 ~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AV 157 (738)
T KOG1989|consen 79 NAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAV 157 (738)
T ss_pred HHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHH
Confidence 46889999999996 999999999332 1 135689999999999999998765545 78999999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-------cccccCcccccCcchh---ccCCcc
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-------TTKKIGTFVNLDPEYV---ITGKLT 144 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-------~~~~~~~~~y~aPE~~---~~~~~~ 144 (259)
++||... ++++|||||.+|||++.+|..||||||.+........... .-...-|+.|+|||.+ .+..++
T Consensus 158 a~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~ 236 (738)
T KOG1989|consen 158 AAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG 236 (738)
T ss_pred HHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence 9999987 7899999999999999999999999999875443221110 1123578999999986 456789
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCC
Q 025011 145 EKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 145 ~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 224 (259)
.|+|||+|||++|-|+....||++ .....+++.....+....++..+.+||+.||+.||
T Consensus 237 eKsDIWALGclLYkLCy~t~PFe~---------------------sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP 295 (738)
T KOG1989|consen 237 EKSDIWALGCLLYKLCYFTTPFEE---------------------SGKLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNP 295 (738)
T ss_pred chhHHHHHHHHHHHHHHhCCCcCc---------------------CcceeEEeccccCCCCccHHHHHHHHHHHHhccCc
Confidence 999999999999999999999987 44455666666776667888999999999999999
Q ss_pred CCCCCHHHHHHHHHhccccccchhh
Q 025011 225 RRRPTMKQVSEELDRLKISHENYEH 249 (259)
Q Consensus 225 ~~Rpt~~~il~~l~~~~~~~~~~~~ 249 (259)
.+||++.++++.+-.+.........
T Consensus 296 ~~RPnI~Qv~~~~~~l~~~~~~~~~ 320 (738)
T KOG1989|consen 296 DERPNIYQVLEEIFELANKPCPIPD 320 (738)
T ss_pred ccCCCHHHHHHHHHHHhcCCCCccc
Confidence 9999999999999998877655443
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=261.96 Aligned_cols=216 Identities=25% Similarity=0.428 Sum_probs=172.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-----------cccCCHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-----------QVLRNWKTCLRIAAETA 71 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i~ 71 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++...+. ...+++..+..++.|++
T Consensus 53 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~ 132 (280)
T cd05049 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132 (280)
T ss_pred HHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHH
Confidence 5789999999999999999999999999999999999999999999975432 22357788999999999
Q ss_pred HHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhh
Q 025011 72 SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 72 ~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
.|+.+||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||++.+..++.++||||
T Consensus 133 ~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 209 (280)
T cd05049 133 SGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 209 (280)
T ss_pred HHHHHHhhCC---eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHH
Confidence 9999999999 9999999999999999999999999987543322212223334567899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 152 FGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 152 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
||+++|+|++ |..||.+.... ....... .+. ....+...+..+.+++.+||+.||.+|||+
T Consensus 210 lG~il~e~~~~g~~p~~~~~~~-----~~~~~~~----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 271 (280)
T cd05049 210 FGVVLWEIFTYGKQPWYGLSNE-----EVIECIT----QGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINI 271 (280)
T ss_pred HHHHHHHHHhcCCCCCCCCCHH-----HHHHHHH----cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 9999999998 99998763211 1111100 010 111111234679999999999999999999
Q ss_pred HHHHHHHHh
Q 025011 231 KQVSEELDR 239 (259)
Q Consensus 231 ~~il~~l~~ 239 (259)
.++++.|++
T Consensus 272 ~eil~~l~~ 280 (280)
T cd05049 272 KDIHERLQK 280 (280)
T ss_pred HHHHHHhhC
Confidence 999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=273.21 Aligned_cols=217 Identities=26% Similarity=0.418 Sum_probs=170.8
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
+.+.+|+++++.+ +||||+++++++..++..+++|||+++|+|.+++.....
T Consensus 83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (375)
T cd05104 83 EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC 162 (375)
T ss_pred HHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence 4688999999999 899999999999999999999999999999999864321
Q ss_pred ---------------------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCC
Q 025011 55 ---------------------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGD 89 (259)
Q Consensus 55 ---------------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~d 89 (259)
...+++..+..++.|++.||.|||+++ ++|+|
T Consensus 163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 239 (375)
T cd05104 163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRD 239 (375)
T ss_pred hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 113567888999999999999999999 99999
Q ss_pred CCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCC
Q 025011 90 VKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSG 168 (259)
Q Consensus 90 i~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~ 168 (259)
|||+||+++.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 240 lkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 240 LAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred CchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999876654322222222345567999999988889999999999999999998 8888876
Q ss_pred CccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
..... ...... ..+. ....+...+..+.+++.+||+.||++|||+.+|++.|++
T Consensus 320 ~~~~~----~~~~~~----~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 320 MPVDS----KFYKMI----KEGY---------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred CCchH----HHHHHH----HhCc---------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 32111 111111 0000 000011123679999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=262.33 Aligned_cols=223 Identities=22% Similarity=0.367 Sum_probs=169.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC----------------CcccCCHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----------------SQVLRNWKTCLRI 66 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~i 66 (259)
+.|.+|++++.+++||||+++++++...+..+++|||+++++|.+++.... ....+++..++.+
T Consensus 64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 143 (304)
T cd05096 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV 143 (304)
T ss_pred HHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence 468899999999999999999999999999999999999999999986532 1123567788999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
+.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.+
T Consensus 144 ~~~i~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 220 (304)
T cd05096 144 ALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220 (304)
T ss_pred HHHHHHHHHHHHHCC---ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCch
Confidence 999999999999999 99999999999999999999999999876543322222333445778999999988889999
Q ss_pred cchhhHHHHHHHHHh--CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCC
Q 025011 147 SDVYSFGVLLAELLT--GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 147 ~DiwslG~il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 224 (259)
+||||||+++|+|++ +..||.+.... ................. ....+...++.+.+++.+||+.||
T Consensus 221 ~Dv~slG~~l~el~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p 289 (304)
T cd05096 221 SDVWAFGVTLWEILMLCKEQPYGELTDE-----QVIENAGEFFRDQGRQV------YLFRPPPCPQGLYELMLQCWSRDC 289 (304)
T ss_pred hhhHHHHHHHHHHHHccCCCCCCcCCHH-----HHHHHHHHHhhhccccc------cccCCCCCCHHHHHHHHHHccCCc
Confidence 999999999999987 55677653211 00110000000000000 000111234679999999999999
Q ss_pred CCCCCHHHHHHHHHh
Q 025011 225 RRRPTMKQVSEELDR 239 (259)
Q Consensus 225 ~~Rpt~~~il~~l~~ 239 (259)
.+|||+.+|.+.|++
T Consensus 290 ~~RPs~~~i~~~l~~ 304 (304)
T cd05096 290 RERPSFSDIHAFLTE 304 (304)
T ss_pred hhCcCHHHHHHHHhC
Confidence 999999999888763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=258.20 Aligned_cols=215 Identities=29% Similarity=0.441 Sum_probs=171.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++...... .+++..++.++.|++.||++||+++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~- 124 (263)
T cd05052 47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN- 124 (263)
T ss_pred HHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35889999999999999999999999999999999999999999999765432 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... .........+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 125 --i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~ 201 (263)
T cd05052 125 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 201 (263)
T ss_pred --EeecccCcceEEEcCCCcEEeCCCccccccccce-eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999987654321 111122234567999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... +....... ......+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus 202 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 202 GMSPYPGIDLS--------QVYELLEK----------GYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHH--------HHHHHHHC----------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 88998763211 01111100 001111122346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=254.75 Aligned_cols=226 Identities=21% Similarity=0.296 Sum_probs=173.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
++-.+|+++|+.++|+||+.+.+++.. -+.+|+|+|++ +.+|...++.+.. ++...+.-++.|++.||+|+
T Consensus 66 kRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~---L~d~H~q~f~YQiLrgLKyi 141 (359)
T KOG0660|consen 66 KRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD---LTDDHAQYFLYQILRGLKYI 141 (359)
T ss_pred HHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcc---ccHHHHHHHHHHHHHhcchh
Confidence 456789999999999999999998875 35689999999 6699999987654 67789999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il 156 (259)
|+.+ |+|||+||.|++++.+..+|++|||+++...........+..+.|.+|+|||++... .|+.+.||||+|||+
T Consensus 142 HSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~ 218 (359)
T KOG0660|consen 142 HSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL 218 (359)
T ss_pred hccc---ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence 9999 999999999999999999999999999988654333344566799999999998654 599999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHH------HHHHHhhccchhhhhhccc-cCC-----chhHHHHHHHHHHHHHhcccCC
Q 025011 157 AELLTGLKPGSGMALASNEGISMV------QYFLYSIENNSLRQILNFQ-VAD-----ESEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~li~~~l~~~p 224 (259)
.||++|++.|.|.+.......... ...............+... ... ...++..+...+|+.+||..||
T Consensus 219 AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP 298 (359)
T KOG0660|consen 219 AEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDP 298 (359)
T ss_pred HHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCc
Confidence 999999999999655433221110 0001111111111111110 000 0111334779999999999999
Q ss_pred CCCCCHHHHHH
Q 025011 225 RRRPTMKQVSE 235 (259)
Q Consensus 225 ~~Rpt~~~il~ 235 (259)
.+|+|+++++.
T Consensus 299 ~kRita~eAL~ 309 (359)
T KOG0660|consen 299 KKRITAEEALA 309 (359)
T ss_pred cccCCHHHHhc
Confidence 99999999975
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=257.97 Aligned_cols=214 Identities=20% Similarity=0.307 Sum_probs=170.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.++++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.|++|||+++
T Consensus 51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~- 127 (266)
T cd05064 51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG- 127 (266)
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976532 3578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||.+....... ........++..|+|||.+.+..++.++||||+|+++|++++
T Consensus 128 --iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 204 (266)
T cd05064 128 --YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred --EeeccccHhhEEEcCCCcEEECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999875432211 111112235578999999988889999999999999999775
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ...... ... .....+...+..+.+++.+||+.+|.+|||+.+|.+.|+++
T Consensus 205 g~~p~~~~~~~-----~~~~~~----~~~---------~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 205 GERPYWDMSGQ-----DVIKAV----EDG---------FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCcCcCCHH-----HHHHHH----HCC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 99999763211 011110 000 00111223446799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=263.08 Aligned_cols=212 Identities=24% Similarity=0.313 Sum_probs=171.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+..++|+.+|+++.|||||+++++..+ ...+|||+|||..|.+...-.... .+++.++++++.+++.||.|||.+
T Consensus 153 ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~---els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 153 EKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP---ELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred HHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcc---cccHHHHHHHHHHHHHHHHHHHhc
Confidence 578999999999999999999999986 458999999999887643332222 278899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc---cccccccccCcccccCcchhccCC----cccccchhhHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN---QTAMTTKKIGTFVNLDPEYVITGK----LTEKSDVYSFG 153 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG 153 (259)
+ |+||||||+|++++++|.+||+|||.+..+..+. .......-+||+.|+|||...+.. .+.+.||||+|
T Consensus 230 g---iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 230 G---IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred C---eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 9 9999999999999999999999999988663321 122233457999999999987733 35689999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|.|+.|+.||-+.. .-....++++..+..+...+..+.+.+||.+||.+||.+|.++.+|
T Consensus 307 VTLYCllfG~~PF~~~~-----------------~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~i 369 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDF-----------------ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDI 369 (576)
T ss_pred hhHHHhhhccCCcccch-----------------HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhh
Confidence 99999999999998721 1123345555555555555667889999999999999999999998
Q ss_pred HHHH
Q 025011 234 SEEL 237 (259)
Q Consensus 234 l~~l 237 (259)
..-.
T Consensus 370 k~Hp 373 (576)
T KOG0585|consen 370 KLHP 373 (576)
T ss_pred eecc
Confidence 6543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=246.50 Aligned_cols=193 Identities=30% Similarity=0.362 Sum_probs=166.3
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
..+|-.+|+.+.||.++++++.|.+..++++||||++||.|++++.+.+. +++..+.-++.||+.|+.|||+++
T Consensus 91 ~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---F~e~~arFYAAeivlAleylH~~~--- 164 (355)
T KOG0616|consen 91 THNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---FSEPHARFYAAEIVLALEYLHSLD--- 164 (355)
T ss_pred HhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---CCchhHHHHHHHHHHHHHHHHhcC---
Confidence 56899999999999999999999999999999999999999999987655 678999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
|++||+||+||++|.+|.++++|||.++.... .+....||+.|+|||++....++.++|.|+||+++|||+.|.+
T Consensus 165 iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~p 239 (355)
T KOG0616|consen 165 IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYP 239 (355)
T ss_pred eeeccCChHHeeeccCCcEEEEeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999987543 2455679999999999999999999999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
||.+... .....+++......+ ...++.+.+|+.++|+.|-++|
T Consensus 240 PF~~~~~-----------------~~iY~KI~~~~v~fP--~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 240 PFYDDNP-----------------IQIYEKILEGKVKFP--SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcCCCh-----------------HHHHHHHHhCcccCC--cccCHHHHHHHHHHHhhhhHhh
Confidence 9987332 122223333322222 2233779999999999999999
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=259.70 Aligned_cols=216 Identities=24% Similarity=0.397 Sum_probs=169.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------cccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------QVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... ....++..+..++.|++.|+.
T Consensus 54 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 54 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 3578999999999999999999999999999999999999999999865322 123467788999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+.+ ++|+||||+||++++++.++++|||++................++..|+|||.+.+..++.++|+||||++
T Consensus 134 ~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCC---cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 999999 99999999999999999999999999875543222222223345678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... ....... ...... .+...++.+.+++.+||+.||.+|||+.+++
T Consensus 211 l~el~~~~~~p~~~~~~~--------~~~~~~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 272 (277)
T cd05062 211 LWEIATLAEQPYQGMSNE--------QVLRFVM-EGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272 (277)
T ss_pred HHHHHcCCCCCCCCCCHH--------HHHHHHH-cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 999999 68888763210 1111000 010000 0112236799999999999999999999999
Q ss_pred HHHHh
Q 025011 235 EELDR 239 (259)
Q Consensus 235 ~~l~~ 239 (259)
+.+++
T Consensus 273 ~~l~~ 277 (277)
T cd05062 273 SSIKE 277 (277)
T ss_pred HHhhC
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=255.23 Aligned_cols=213 Identities=24% Similarity=0.386 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~- 114 (252)
T cd05084 38 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH- 114 (252)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999865432 3578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++.................+..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 115 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~ 192 (252)
T cd05084 115 --CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSL 192 (252)
T ss_pred --ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875432211111111223457999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|..||...... .. .. ..........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 193 ~~~p~~~~~~~-----~~---~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 193 GAVPYANLSNQ-----QT---RE----------AIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCCCccccCHH-----HH---HH----------HHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 88888652210 00 00 00000001111123467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=261.55 Aligned_cols=218 Identities=29% Similarity=0.423 Sum_probs=172.5
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-------------CcccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------------SQVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~ 68 (259)
..+.+|+++++.+ +||||+++++++..++..+++|||+++++|.+++.... ....+++..++.++.
T Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 139 (293)
T cd05053 60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139 (293)
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 3578899999999 89999999999999999999999999999999996531 223467889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|
T Consensus 140 qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 216 (293)
T cd05053 140 QVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSD 216 (293)
T ss_pred HHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccc
Confidence 9999999999999 9999999999999999999999999987654432222222233556799999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|++++ |..||.+.... +....... ......+...+..+.+++.+||..||++|
T Consensus 217 i~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 278 (293)
T cd05053 217 VWSFGVLLWEIFTLGGSPYPGIPVE--------ELFKLLKE----------GYRMEKPQNCTQELYHLMRDCWHEVPSQR 278 (293)
T ss_pred eeehhhHHHHHhcCCCCCCCCCCHH--------HHHHHHHc----------CCcCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999999999998 88998763211 00110000 00001111234679999999999999999
Q ss_pred CCHHHHHHHHHhcc
Q 025011 228 PTMKQVSEELDRLK 241 (259)
Q Consensus 228 pt~~~il~~l~~~~ 241 (259)
||+.++++.|+++.
T Consensus 279 ps~~eil~~l~~~~ 292 (293)
T cd05053 279 PTFKQLVEDLDRML 292 (293)
T ss_pred cCHHHHHHHHHHhh
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=260.33 Aligned_cols=219 Identities=26% Similarity=0.413 Sum_probs=173.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC---------------------CcccCCHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS---------------------SQVLRNWK 61 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------~~~~~~~~ 61 (259)
+.+.+|+.+++.++||||+++++.+..++..++++||+.+++|.+++.... ....+++.
T Consensus 48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 127 (290)
T cd05045 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127 (290)
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence 358899999999999999999999999999999999999999999986431 11236778
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC
Q 025011 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG 141 (259)
Q Consensus 62 ~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 141 (259)
.++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...............++..|+|||.+.+.
T Consensus 128 ~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred HHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 89999999999999999999 999999999999999999999999998765433222222233456789999999888
Q ss_pred CcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhc
Q 025011 142 KLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 142 ~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
.++.++||||||+++++|++ |..||.+... ..... ..........+...+..+.+++.+||
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~cl 266 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP--------ERLFN----------LLKTGYRMERPENCSEEMYNLMLTCW 266 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH----------HHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence 89999999999999999998 9999876321 01111 11111111111223467999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhccc
Q 025011 221 SLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
+.+|.+|||+.++++.|+++-.
T Consensus 267 ~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 267 KQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred cCCcccCCCHHHHHHHHHHHHh
Confidence 9999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=266.76 Aligned_cols=205 Identities=23% Similarity=0.267 Sum_probs=166.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~-- 115 (323)
T cd05571 41 HTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALGYLHSCD-- 115 (323)
T ss_pred HHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467899999999999999999999999999999999999999999876542 678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||+++...... .......|+..|+|||++.+..++.++||||+||++|+|++|.
T Consensus 116 -ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 192 (323)
T cd05571 116 -VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred -eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCC
Confidence 9999999999999999999999999986533221 1223346899999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
.||.+.+.. .. ...... . .. ..+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 193 ~Pf~~~~~~-----~~---~~~~~~-~--------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 193 LPFYNQDHE-----KL---FELILM-E--------EI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCCCHH-----HH---HHHHHc-C--------CC--CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999763211 00 000000 0 00 01112346799999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=260.22 Aligned_cols=213 Identities=33% Similarity=0.512 Sum_probs=164.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++.+++++||||+++++++...+..++|+||+++|+|.+++...... .+++..++.|+.|++.|+.|||+++
T Consensus 46 ~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~-~~~~~~~~~i~~~i~~~l~~Lh~~~- 123 (259)
T PF07714_consen 46 EEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKE-PLSEQQRLSIAIQIAEALSYLHSNN- 123 (259)
T ss_dssp HHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTT-TSBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred eeeeecccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccc-
Confidence 57899999999999999999999999888899999999999999999887222 2578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|++|++.||++++++.+||+|||+.....................|+|||.+.+..++.++||||||+++|++++
T Consensus 124 --iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~ 201 (259)
T PF07714_consen 124 --IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTL 201 (259)
T ss_dssp --EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTT
T ss_pred --cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999887633222233334457789999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|..||...... ........... ...+...+..+.+++..||+.||.+|||+.++++.|
T Consensus 202 ~~~p~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 202 GKFPFSDYDNE--------EIIEKLKQGQR----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SSGTTTTSCHH--------HHHHHHHTTEE----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccccccc--------ccccccccccc----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 67888763211 01111111111 111112336799999999999999999999998875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=256.60 Aligned_cols=215 Identities=23% Similarity=0.395 Sum_probs=171.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+||+++++.+..++..+++|||+++++|.+++...... ..++..+..++.|++.|+.|||+.+
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~l~~~l~~LH~~~- 123 (261)
T cd05072 46 QAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGG-KVLLPKLIDFSAQIAEGMAYIERKN- 123 (261)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999999999999999999999999999999999999764322 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 124 --i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 124 --YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred --eeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 999999999999999999999999999765432211 1222335678999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ...... . .. .........+..+.+++.+||+.+|.+|||++++++.|+++
T Consensus 201 g~~p~~~~~~~-----~~~~~~---~-~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 201 GKIPYPGMSNS-----DVMSAL---Q-RG---------YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCHH-----HHHHHH---H-cC---------CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 89998752210 000000 0 00 00011112346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=256.19 Aligned_cols=215 Identities=23% Similarity=0.370 Sum_probs=172.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... .+++..++.++.|++.|+.|||+++
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~- 126 (266)
T cd05033 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN- 126 (266)
T ss_pred HHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688899999999999999999999999999999999999999999976543 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|.||++++++.++++|||++................++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 127 --i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~ 204 (266)
T cd05033 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred --cccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHcc
Confidence 99999999999999999999999999987652222222222335578999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||...... .. ..... .. .....+...++.+.+++.+||+.+|++||++.+|++.|+++
T Consensus 205 g~~p~~~~~~~-----~~---~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 205 GERPYWDMSNQ-----DV---IKAVE-DG---------YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCCCCCHH-----HH---HHHHH-cC---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99998653211 00 00000 00 00011122346799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=255.00 Aligned_cols=215 Identities=24% Similarity=0.370 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..+++|||+.+++|.+++..... ..+++..+..++.|++.|+.+||+++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~- 123 (261)
T cd05068 46 KDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAG-RALKLPQLIDMAAQVASGMAYLEAQN- 123 (261)
T ss_pred HHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999976542 23688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... .........+..|+|||.+.+..++.++|+||||+++++|++
T Consensus 124 --i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~ 200 (261)
T cd05068 124 --YIHRDLAARNVLVGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred --eeeccCCcceEEEcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987765321 111111223457999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|+.||.+.... ........ ..........++.+.+++.+||+.+|.+||++.++++.|+++
T Consensus 201 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 201 GRMPYPGMTNA--------EVLQQVDQ----------GYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCCCCHH--------HHHHHHHc----------CCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 99998763210 00000000 000011122346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=266.66 Aligned_cols=225 Identities=19% Similarity=0.222 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..+...++++|++ +++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 128 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~ylH~~~- 202 (391)
T PHA03212 128 GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRN---IAICDILAIERSVLRAIQYLHENR- 202 (391)
T ss_pred hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45789999999999999999999999999999999999 4688888865432 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+|+||||+||+++.++.++|+|||++...... .........||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 203 --IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 279 (391)
T PHA03212 203 --IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279 (391)
T ss_pred --cccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999998643321 11122334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccc---hhHHHHHHHhh---------ccchhhhhh----c-------cccCCchhHHHHHHHHHHHHHh
Q 025011 163 LKPGSGMALASNEG---ISMVQYFLYSI---------ENNSLRQIL----N-------FQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 163 ~~p~~~~~~~~~~~---~~~~~~~~~~~---------~~~~~~~~~----~-------~~~~~~~~~~~~~~~~~li~~~ 219 (259)
..||.+........ ........... ......... . ...........+..+.++|.+|
T Consensus 280 ~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~m 359 (391)
T PHA03212 280 HDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKM 359 (391)
T ss_pred CCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHH
Confidence 98765432111100 00000000000 000000000 0 0000011123456799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||++++++
T Consensus 360 L~~dP~~Rpta~elL~ 375 (391)
T PHA03212 360 LAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhCCCHHHHhc
Confidence 9999999999999974
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=264.46 Aligned_cols=209 Identities=26% Similarity=0.275 Sum_probs=166.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.++++++||||+++++++..++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 39 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~-- 113 (312)
T cd05585 39 HTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR---FDLSRARFYTAELLCALENLHKFN-- 113 (312)
T ss_pred HHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467899999999999999999999999999999999999999999976533 678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||+|+++|+|++|.
T Consensus 114 -i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred -eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 9999999999999999999999999987533221 1223446899999999999888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
.||.+.... ....... ..... .+...++.+.+++.+||+.||.+||++..+.+.++.
T Consensus 191 ~pf~~~~~~--------~~~~~~~---------~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 191 PPFYDENVN--------EMYRKIL---------QEPLR--FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CCcCCCCHH--------HHHHHHH---------cCCCC--CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 999763210 1111111 10000 111234678999999999999999865444444444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=265.76 Aligned_cols=207 Identities=24% Similarity=0.363 Sum_probs=174.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
++++.|+.+|.+++++||.++|+.+..+..++++||||.||++.+.++..+. +++..+.-++.+++.|+.|+|.++
T Consensus 56 ediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~---~~E~~i~~ilre~l~~l~ylH~~~- 131 (467)
T KOG0201|consen 56 EDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI---LDEFEIAVILREVLKGLDYLHSEK- 131 (467)
T ss_pred HHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC---CccceeeeehHHHHHHhhhhhhcc-
Confidence 4688999999999999999999999999999999999999999999987654 366788889999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
.+|+|||+.||++..+|.++|+|||.+...... ......++||+.|||||++.+..|+.++||||||++.++|++|
T Consensus 132 --kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G 207 (467)
T KOG0201|consen 132 --KIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG 207 (467)
T ss_pred --eecccccccceeEeccCcEEEEecceeeeeech--hhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC
Confidence 999999999999999999999999998776653 2233667899999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.+|+...... ...-.+....+.......++.+.+++..||+.||+.||||.++++
T Consensus 208 ePP~s~~hPm------------------rvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 208 EPPHSKLHPM------------------RVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCcccCcc------------------eEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 9998763321 111111111122222245578999999999999999999999985
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=258.51 Aligned_cols=216 Identities=25% Similarity=0.433 Sum_probs=170.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.++||||+++++++..+...+++|||+++++|.+++..... ...+++..+..++.
T Consensus 52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 131 (283)
T cd05090 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999853321 12357788899999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+++ ++|+||+|+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|
T Consensus 132 ~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05090 132 QIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD 208 (283)
T ss_pred HHHHHHHHHHhcC---eehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhh
Confidence 9999999999999 9999999999999999999999999987654432222223334567899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
+||||+++|+|++ |..||.+.... ........ .. ....+...++.+.+++.+||+.||.+|
T Consensus 209 v~slG~il~el~~~g~~p~~~~~~~--------~~~~~~~~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05090 209 IWSFGVVLWEIFSFGLQPYYGFSNQ--------EVIEMVRK-RQ---------LLPCSEDCPPRMYSLMTECWQEGPSRR 270 (283)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHc-CC---------cCCCCCCCCHHHHHHHHHHcccCcccC
Confidence 9999999999998 88898763210 00010000 00 001111234679999999999999999
Q ss_pred CCHHHHHHHHHh
Q 025011 228 PTMKQVSEELDR 239 (259)
Q Consensus 228 pt~~~il~~l~~ 239 (259)
|++.+|++.++.
T Consensus 271 p~~~~i~~~l~~ 282 (283)
T cd05090 271 PRFKDIHTRLRS 282 (283)
T ss_pred cCHHHHHHHhhc
Confidence 999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=255.06 Aligned_cols=214 Identities=26% Similarity=0.453 Sum_probs=172.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++...... .+++..++.++.|++.|+.|||+++
T Consensus 47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~- 124 (261)
T cd05148 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-VLPVASLIDMACQVAEGMAYLEEQN- 124 (261)
T ss_pred HHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999999999999999999999999999999999999765432 3678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 125 --i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~ 200 (261)
T cd05148 125 --SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTY 200 (261)
T ss_pred --eeccccCcceEEEcCCceEEEccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543211 1223345678999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|+.||.+.... +....... ......+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 201 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 201 GQVPYPGMNNH--------EVYDQITA----------GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCcCCHH--------HHHHHHHh----------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 89998763210 00111110 001111123346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=257.88 Aligned_cols=225 Identities=20% Similarity=0.198 Sum_probs=166.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||++++++..+..... .+++..+..++.|++.||.|||+.+
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~- 120 (287)
T cd07848 45 ETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN---GVPPEKVRSYIYQLIKAIHWCHKND- 120 (287)
T ss_pred hhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 467899999999999999999999999999999999998876655543322 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ .......++..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 121 --i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 197 (287)
T cd07848 121 --IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197 (287)
T ss_pred --eecCCCCHHHEEEcCCCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhC
Confidence 99999999999999999999999999876543211 122234588999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHH--------HHHhhccchhhhhhccccCC------chhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 163 LKPGSGMALASNEGISMVQY--------FLYSIENNSLRQILNFQVAD------ESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
+.||.+.+..... ...... .................... ......+..+.+++.+||+.||++||
T Consensus 198 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~ 276 (287)
T cd07848 198 QPLFPGESEIDQL-FTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY 276 (287)
T ss_pred CCCCCCCCHHHHH-HHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC
Confidence 9999874321100 000000 00000000000000000000 00112346799999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|++++++
T Consensus 277 s~~~~l~ 283 (287)
T cd07848 277 LTEQCLN 283 (287)
T ss_pred CHHHHhc
Confidence 9999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=257.53 Aligned_cols=216 Identities=25% Similarity=0.391 Sum_probs=170.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC------------cccCCHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS------------QVLRNWKTCLRIAAET 70 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~i 70 (259)
+.+.+|+++++.++|+||+++++++..+...+++|||+++++|.+++..... ...+++..++.++.|+
T Consensus 52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 131 (280)
T cd05092 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131 (280)
T ss_pred HHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHH
Confidence 5689999999999999999999999999999999999999999999875432 1235778999999999
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchh
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVY 150 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 150 (259)
+.|+.|||+.+ ++|+||+|+||++++++.++|+|||++................++..|+|||.+.+..++.++|||
T Consensus 132 ~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 208 (280)
T cd05092 132 ASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208 (280)
T ss_pred HHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHH
Confidence 99999999999 999999999999999999999999998755432222222233456789999999888899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 151 SFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 151 slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|||+++|+|++ |..||....... . ........ ....+...++.+.+++.+||+.||.+||+
T Consensus 209 slG~il~el~~~g~~p~~~~~~~~-----~---~~~~~~~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~ 270 (280)
T cd05092 209 SFGVVLWEIFTYGKQPWYQLSNTE-----A---IECITQGR----------ELERPRTCPPEVYAIMQGCWQREPQQRMV 270 (280)
T ss_pred HHHHHHHHHHcCCCCCCccCCHHH-----H---HHHHHcCc----------cCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 99999999998 899986532110 0 00000000 00111123467899999999999999999
Q ss_pred HHHHHHHHHh
Q 025011 230 MKQVSEELDR 239 (259)
Q Consensus 230 ~~~il~~l~~ 239 (259)
+.+|++.|+.
T Consensus 271 ~~~l~~~l~~ 280 (280)
T cd05092 271 IKDIHSRLQA 280 (280)
T ss_pred HHHHHHHHhC
Confidence 9999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=261.53 Aligned_cols=203 Identities=26% Similarity=0.348 Sum_probs=165.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 121 (291)
T cd05612 46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYLHSKE- 121 (291)
T ss_pred HHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999976543 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++...... .....|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 122 --i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g 194 (291)
T cd05612 122 --IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194 (291)
T ss_pred --eeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765332 1234588999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
..||.+.... ..... +...... .+...++.+.++|.+||+.||.+||+ +.++++
T Consensus 195 ~~pf~~~~~~--------~~~~~---------i~~~~~~--~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 195 YPPFFDDNPF--------GIYEK---------ILAGKLE--FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CCCCCCCCHH--------HHHHH---------HHhCCcC--CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 9999763211 00000 0000000 01112367899999999999999995 777754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=259.53 Aligned_cols=217 Identities=26% Similarity=0.425 Sum_probs=172.7
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++++ +||||+++++++...+..+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+++
T Consensus 83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~ 161 (302)
T cd05055 83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN 161 (302)
T ss_pred HHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4688999999999 799999999999999999999999999999999975433 22688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++................++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 162 ---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t 238 (302)
T cd05055 162 ---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238 (302)
T ss_pred ---eehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999876554322212222345678999999988889999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+..... .... ..... .....+...++.+.+++.+||+.+|.+|||+.++++.|++.
T Consensus 239 ~g~~p~~~~~~~~----~~~~----~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 239 LGSNPYPGMPVDS----KFYK----LIKEG---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CCCCCcCCCCchH----HHHH----HHHcC---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 899987632110 0000 00000 00001112236799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=261.90 Aligned_cols=219 Identities=22% Similarity=0.295 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC-C
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS-A 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~ 81 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+. +
T Consensus 48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~ 124 (331)
T cd06649 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQ 124 (331)
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 5688999999999999999999999999999999999999999999976543 57788999999999999999985 6
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++||||+||++|+|++
T Consensus 125 ---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~t 197 (331)
T cd06649 125 ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAI 197 (331)
T ss_pred ---EEcCCCChhhEEEcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999999999999999998755332 2233468899999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh-c--c---------------------------c---h-hhhhhccccCCchhHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI-E--N---------------------------N---S-LRQILNFQVADESEME 207 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~-~--~---------------------------~---~-~~~~~~~~~~~~~~~~ 207 (259)
|+.||....... ......... . . . . ...+............
T Consensus 198 g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (331)
T cd06649 198 GRYPIPPPDAKE-----LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGV 272 (331)
T ss_pred CCCCCCCCCHHH-----HHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCcc
Confidence 999997532110 000000000 0 0 0 0 0000000001111112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 208 EIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 208 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
.++.+.++|.+||..||++|||+.++++.
T Consensus 273 ~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 273 FTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 45679999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=253.58 Aligned_cols=216 Identities=30% Similarity=0.454 Sum_probs=175.7
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC------cccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS------QVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+.+|+++++.++|+|++++++++..+...+++|||+++++|.+++..... ...+++..++.++.|++.|+.
T Consensus 40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~ 119 (262)
T cd00192 40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119 (262)
T ss_pred HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 35788999999999999999999999999999999999999999999987621 234688999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
+||+++ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+....++.++||||+|++
T Consensus 120 ~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 196 (262)
T cd00192 120 YLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVL 196 (262)
T ss_pred HHHcCC---cccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHH
Confidence 999999 99999999999999999999999999987765433233444567889999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||...... ........ ......+...++.+.+++.+||+.+|.+|||+.+++
T Consensus 197 l~~l~~~g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~ 258 (262)
T cd00192 197 LWEIFTLGATPYPGLSNE--------EVLEYLRK----------GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELV 258 (262)
T ss_pred HHHHHhcCCCCCCCCCHH--------HHHHHHHc----------CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHH
Confidence 999999 68998874210 01111110 001111122357799999999999999999999999
Q ss_pred HHHH
Q 025011 235 EELD 238 (259)
Q Consensus 235 ~~l~ 238 (259)
+.|+
T Consensus 259 ~~l~ 262 (262)
T cd00192 259 ERLE 262 (262)
T ss_pred HhhC
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=259.70 Aligned_cols=223 Identities=27% Similarity=0.419 Sum_probs=176.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+.+++.+ +||||+++++++...+..+++|||+.+++|.+++..... ...+++..+..++.
T Consensus 65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (304)
T cd05101 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY 144 (304)
T ss_pred HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence 4588999999999 899999999999999999999999999999999976421 12356778899999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|
T Consensus 145 qi~~al~~LH~~g---ivH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 145 QVARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred HHHHHHHHHHHCC---eeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence 9999999999999 9999999999999999999999999987665432222222334567899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|++++ |..||.+... ............ ...+...+..+.+++.+||+.+|.+|
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~R 283 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPV--------EELFKLLKEGHR----------MDKPANCTNELYMMMRDCWHAIPSHR 283 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcccChhhC
Confidence 9999999999998 7888865321 111111111100 00111234679999999999999999
Q ss_pred CCHHHHHHHHHhccccccc
Q 025011 228 PTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~ 246 (259)
||+.++++.|+++.....|
T Consensus 284 ps~~e~l~~l~~~~~~~~~ 302 (304)
T cd05101 284 PTFKQLVEDLDRILTLTTN 302 (304)
T ss_pred CCHHHHHHHHHHHHHhhhc
Confidence 9999999999998766554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=257.17 Aligned_cols=216 Identities=24% Similarity=0.384 Sum_probs=171.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------cccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------QVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~ 75 (259)
..+.+|+.+++.++||||+++++++..+...+++|||+++++|.+++..... ....++..++.++.|++.|+.
T Consensus 54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 133 (277)
T cd05032 54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133 (277)
T ss_pred HHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999999865422 123567889999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+.+ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||++
T Consensus 134 ~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 210 (277)
T cd05032 134 YLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVV 210 (277)
T ss_pred HHHhCC---ccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHH
Confidence 999999 99999999999999999999999999876544322223334456788999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|++++ |..||.+.+.. .. ..... ...... .+...+..+.+++.+||+.+|++|||+.+++
T Consensus 211 l~el~t~g~~p~~~~~~~-----~~---~~~~~-~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 272 (277)
T cd05032 211 LWEMATLAEQPYQGLSNE-----EV---LKFVI-DGGHLD---------LPENCPDKLLELMRMCWQYNPKMRPTFLEIV 272 (277)
T ss_pred HHHhhccCCCCCccCCHH-----HH---HHHHh-cCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 999998 88998763211 11 11111 111000 0111246799999999999999999999999
Q ss_pred HHHHh
Q 025011 235 EELDR 239 (259)
Q Consensus 235 ~~l~~ 239 (259)
+.|++
T Consensus 273 ~~l~~ 277 (277)
T cd05032 273 SSLKD 277 (277)
T ss_pred HHhcC
Confidence 98763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=261.03 Aligned_cols=220 Identities=22% Similarity=0.380 Sum_probs=173.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..+ ..+++++|+++|+|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 54 ~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~- 129 (316)
T cd05108 54 KEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR- 129 (316)
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence 5688999999999999999999998764 56899999999999999976543 2567888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++................+..|+|||.+.+..++.++||||||+++|+|++
T Consensus 130 --iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~ 207 (316)
T cd05108 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 207 (316)
T ss_pred --eeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcC
Confidence 99999999999999999999999999987654322222222234568999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... .... ..... .....+...+..+.+++.+||..+|.+|||+.+++..+..+.
T Consensus 208 g~~p~~~~~~~-----~~~~----~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 208 GSKPYDGIPAS-----EISS----ILEKG---------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CCCCCCCCCHH-----HHHH----HHhCC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 99998763211 0000 00000 000011112356889999999999999999999999999887
Q ss_pred ccccc
Q 025011 242 ISHEN 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.....
T Consensus 270 ~~~~~ 274 (316)
T cd05108 270 RDPQR 274 (316)
T ss_pred cCCch
Confidence 66543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=256.90 Aligned_cols=217 Identities=22% Similarity=0.363 Sum_probs=171.4
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-------------CcccCCHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------------SQVLRNWKTCLRIAA 68 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~ 68 (259)
++.+.+|+.++..++||||+++++++......++++||+.+++|.+++.... ....+++..+..++.
T Consensus 52 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (283)
T cd05091 52 REEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131 (283)
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence 3568899999999999999999999999999999999999999999985321 122357788899999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|+|+++ ++|+||||+||++++++.++|+|||+++...............++..|+|||.+.+..++.++|
T Consensus 132 ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05091 132 QIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSD 208 (283)
T ss_pred HHHHHHHHHHHcC---ccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchh
Confidence 9999999999999 9999999999999999999999999987654332222233345677899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||+|+++|+|++ |..||.+... ......... .. ....+...+..+.+++.+||+.+|.+|
T Consensus 209 v~slG~~l~el~~~g~~p~~~~~~--------~~~~~~i~~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~R 270 (283)
T cd05091 209 IWSYGVVLWEVFSYGLQPYCGYSN--------QDVIEMIRN-RQ---------VLPCPDDCPAWVYTLMLECWNEFPSRR 270 (283)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHc-CC---------cCCCCCCCCHHHHHHHHHHhCCCcccC
Confidence 9999999999998 8888876221 011111111 00 011112344678999999999999999
Q ss_pred CCHHHHHHHHHh
Q 025011 228 PTMKQVSEELDR 239 (259)
Q Consensus 228 pt~~~il~~l~~ 239 (259)
|++++|+..|+.
T Consensus 271 P~~~~i~~~l~~ 282 (283)
T cd05091 271 PRFKDIHSRLRT 282 (283)
T ss_pred CCHHHHHHHhhC
Confidence 999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=266.74 Aligned_cols=219 Identities=25% Similarity=0.409 Sum_probs=172.5
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
+.+.+|+++++.+. ||||+++++++...+..++||||+++|+|.+++.....
T Consensus 85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (400)
T cd05105 85 QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTR 164 (400)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccccccc
Confidence 56889999999996 99999999999999999999999999999998854310
Q ss_pred ------------------------------------------------------------------cccCCHHHHHHHHH
Q 025011 55 ------------------------------------------------------------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 55 ------------------------------------------------------------------~~~~~~~~~~~i~~ 68 (259)
...+++..+..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~ 244 (400)
T cd05105 165 SYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTY 244 (400)
T ss_pred chhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHH
Confidence 11256677889999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+.+ ++|+||||.||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|
T Consensus 245 qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 321 (400)
T cd05105 245 QVARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSD 321 (400)
T ss_pred HHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhh
Confidence 9999999999999 9999999999999999999999999987654332222223334677899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+...... ........ .....+...+..+.+++.+||+.||++|
T Consensus 322 iwSlGvil~ellt~g~~P~~~~~~~~~--------~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~R 384 (400)
T cd05105 322 VWSYGILLWEIFSLGGTPYPGMIVDST--------FYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKR 384 (400)
T ss_pred HHHHHHHHHHHHHCCCCCCcccchhHH--------HHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHC
Confidence 9999999999997 8899876321110 00000000 0001112234679999999999999999
Q ss_pred CCHHHHHHHHHhcc
Q 025011 228 PTMKQVSEELDRLK 241 (259)
Q Consensus 228 pt~~~il~~l~~~~ 241 (259)
||+.+|.+.|+++-
T Consensus 385 Pt~~~l~~~l~~l~ 398 (400)
T cd05105 385 PSFLHLSDIVESLL 398 (400)
T ss_pred cCHHHHHHHHHHHc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=261.47 Aligned_cols=202 Identities=24% Similarity=0.289 Sum_probs=164.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+.+++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 63 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 138 (329)
T PTZ00263 63 QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPNDVAKFYHAELVLAFEYLHSKD- 138 (329)
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578999999999999999999999999999999999999999999976543 567888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 139 --ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 211 (329)
T PTZ00263 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211 (329)
T ss_pred --eeecCCCHHHEEECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcC
Confidence 999999999999999999999999998765432 1224588999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il 234 (259)
..||.+.... ....... ...... +...+..+.+++.+||+.||.+||+ +++++
T Consensus 212 ~~pf~~~~~~--------~~~~~i~---------~~~~~~--p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 212 YPPFFDDTPF--------RIYEKIL---------AGRLKF--PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred CCCCCCCCHH--------HHHHHHh---------cCCcCC--CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 9999763211 0001000 000000 0112366899999999999999997 56665
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=252.21 Aligned_cols=211 Identities=24% Similarity=0.350 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++|+|.+++..... .+++..+..++.|++.|+.|||+++
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 120 (256)
T cd05114 44 EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS- 120 (256)
T ss_pred HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999875432 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||.++...... ........++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 121 --i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~ 197 (256)
T cd05114 121 --FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTE 197 (256)
T ss_pred --ccccccCcceEEEcCCCeEEECCCCCccccCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcC
Confidence 9999999999999999999999999887543321 111122235568999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|+.||.+.... +.......... . ..+...+..+.+++.+||+.+|.+|||+.+++..|
T Consensus 198 g~~p~~~~~~~--------~~~~~i~~~~~---~-------~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 198 GKMPFEKKSNY--------EVVEMISRGFR---L-------YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCCCCHH--------HHHHHHHCCCC---C-------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 89998763211 01111111000 0 00011235689999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=255.11 Aligned_cols=215 Identities=25% Similarity=0.376 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC----cccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS----QVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
..|.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++..... ...+++..+..++.|++.|+.|||
T Consensus 54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH 133 (277)
T cd05036 54 SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133 (277)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3588899999999999999999999998899999999999999999876532 124688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
+++ ++|+||+|+||+++.++ .++|+|||+++................+..|+|||++.+..++.++|||||||+
T Consensus 134 ~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 210 (277)
T cd05036 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVL 210 (277)
T ss_pred HCC---EeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHH
Confidence 999 99999999999998654 589999999876532211111222234568999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... ........... ...+...+..+.+++.+||+.+|++|||+.+|+
T Consensus 211 l~el~~~g~~pf~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl 272 (277)
T cd05036 211 LWEIFSLGYMPYPGRTNQ--------EVMEFVTGGGR----------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATIL 272 (277)
T ss_pred HHHHHcCCCCCCCCCCHH--------HHHHHHHcCCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 999997 99998763211 01111111100 011122346789999999999999999999999
Q ss_pred HHHH
Q 025011 235 EELD 238 (259)
Q Consensus 235 ~~l~ 238 (259)
+.|+
T Consensus 273 ~~l~ 276 (277)
T cd05036 273 ERIQ 276 (277)
T ss_pred HHhh
Confidence 8875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=252.12 Aligned_cols=212 Identities=24% Similarity=0.380 Sum_probs=168.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++......+++|||+.+++|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 120 (256)
T cd05113 44 DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ- 120 (256)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999988899999999999999999976433 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|.||+++.++.++++|||.++...... ........++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 121 --i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~ 197 (256)
T cd05113 121 --FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSL 197 (256)
T ss_pred --eeccccCcceEEEcCCCCEEECCCccceecCCCc-eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999987554321 111112235678999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|..||...... ........... ...+...++.+.+++.+||+.+|.+|||+.++++.++
T Consensus 198 g~~p~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 198 GKMPYERFNNS--------ETVEKVSQGLR----------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCcCcCCHH--------HHHHHHhcCCC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 99998753210 00000111000 0001112367999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=255.73 Aligned_cols=210 Identities=22% Similarity=0.254 Sum_probs=166.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++|+||+++++++.+++..+++|||+++|+|.+++...... .+++..+..++.|++.|+.|||+.+
T Consensus 46 ~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~-- 122 (285)
T cd05631 46 MALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFDEQRAIFYAAELCCGLEDLQRER-- 122 (285)
T ss_pred HHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4678999999999999999999999999999999999999999888654322 3678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..++.++||||+||++|+|++|+
T Consensus 123 -iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred -EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 9999999999999999999999999987654321 122346899999999999888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
.||.+...... ........ . .. ........++.+.+|+.+||+.||.+||| ++++++
T Consensus 199 ~pf~~~~~~~~----~~~~~~~~-~--------~~--~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 199 SPFRKRKERVK----REEVDRRV-K--------ED--QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCCCCCCcchh----HHHHHHHh-h--------cc--cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 99986332110 00000000 0 00 00111123467899999999999999997 677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=251.69 Aligned_cols=213 Identities=25% Similarity=0.334 Sum_probs=168.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++. +...+++|||+++++|.+++.... .+++..+..++.|++.|+.+||+++
T Consensus 41 ~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~- 115 (257)
T cd05116 41 DELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN- 115 (257)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999999999999875 456799999999999999997543 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|.||+++.++.++|+|||++.......... ......++..|+|||.+....++.++|+||||+++|+|++
T Consensus 116 --i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t 193 (257)
T cd05116 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFS 193 (257)
T ss_pred --EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987665432211 1112234578999999987788999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ........ .. ....+...++.+.++|.+||+.||.+|||+.+|.+.|++.
T Consensus 194 ~g~~p~~~~~~~--------~~~~~i~~-~~---------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 194 YGQKPYKGMKGN--------EVTQMIES-GE---------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCCCHH--------HHHHHHHC-CC---------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 99999763211 01111111 10 1111122447799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=262.91 Aligned_cols=212 Identities=24% Similarity=0.312 Sum_probs=169.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~- 121 (333)
T cd05600 46 RHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---LSEDHARFYMAEMFEAVDALHELG- 121 (333)
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3577899999999999999999999999999999999999999999976543 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++..... ......|+..|+|||++.+..++.++||||+||++|+|++|
T Consensus 122 --ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g 194 (333)
T cd05600 122 --YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194 (333)
T ss_pred --ccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhC
Confidence 99999999999999999999999999875433 22345689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||.+..... ....... .................++.+.+++.+||..+|.+|||+.++++.
T Consensus 195 ~~pf~~~~~~~-----~~~~i~~------~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 195 FPPFSGSTPNE-----TWENLKY------WKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCCCCCCHHH-----HHHHHHh------ccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 99998632110 0000000 000001011110112234779999999999999999999999853
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=262.11 Aligned_cols=206 Identities=24% Similarity=0.269 Sum_probs=165.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.||+.||.|||+++
T Consensus 40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~- 115 (328)
T cd05593 40 AHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERV---FSEDRTRFYGAEIVSALDYLHSGK- 115 (328)
T ss_pred HHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3577899999999999999999999999999999999999999998866532 678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++||||+||++|+|++|
T Consensus 116 --ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 191 (328)
T cd05593 116 --IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 191 (328)
T ss_pred --eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhC
Confidence 999999999999999999999999998653221 1112234689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+.+.. ......... .. ..+...++.+.+++.+||..||.+|| ++.++++
T Consensus 192 ~~Pf~~~~~~--------~~~~~~~~~---------~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 192 RLPFYNQDHE--------KLFELILME---------DI--KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCCCCCCHH--------HHHHHhccC---------Cc--cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 9999763211 001100000 00 00112346789999999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=252.60 Aligned_cols=216 Identities=27% Similarity=0.419 Sum_probs=170.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC----CcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
..+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++.... ....+++..+..++.|++.|+.|||
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH 123 (269)
T cd05044 44 KEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE 123 (269)
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999999999899999999999999999996532 1233578899999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC-----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY-----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~-----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
+.+ ++|+||+|+||+++.++ .++++|||++................++..|+|||.+.+..++.++||||||
T Consensus 124 ~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 200 (269)
T cd05044 124 QMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200 (269)
T ss_pred hCC---cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence 999 99999999999999877 8999999998765432222222233456789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||...... . ........ .........++.+.++|.+||..+|.+|||+++
T Consensus 201 ~il~ellt~g~~p~~~~~~~-----~---~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 262 (269)
T cd05044 201 VLMWEILTLGQQPYPALNNQ-----E---VLQHVTAG----------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDR 262 (269)
T ss_pred HHHHHHHHcCCCCCcccCHH-----H---HHHHHhcC----------CccCCcccchHHHHHHHHHHcCCCcccCCCHHH
Confidence 99999998 99998752210 0 01110000 001111234577899999999999999999999
Q ss_pred HHHHHHh
Q 025011 233 VSEELDR 239 (259)
Q Consensus 233 il~~l~~ 239 (259)
+++.|++
T Consensus 263 i~~~l~~ 269 (269)
T cd05044 263 IQEILQN 269 (269)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=255.97 Aligned_cols=214 Identities=19% Similarity=0.222 Sum_probs=167.4
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+..|++++++++||||+++++++..+...+++|||+++++|.+++....... .++..+..++.|++.|+.|||+.+
T Consensus 39 ~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH~~~-- 115 (277)
T cd05607 39 MALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG-LEMERVIHYSAQITCGILHLHSMD-- 115 (277)
T ss_pred HHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccC-CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 35569999999999999999999999999999999999999998886544322 577888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++|+||+|+++|+|++|.
T Consensus 116 -ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~ 191 (277)
T cd05607 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR 191 (277)
T ss_pred -EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987654321 122345888999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
.||.+...... .......... ..... .....++.+.+++.+||+.||.+|||+.++++.+.
T Consensus 192 ~p~~~~~~~~~----~~~~~~~~~~---------~~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 192 TPFKDHKEKVA----KEELKRRTLE---------DEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CCCCCCcchhh----HHHHHHHhhc---------ccccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 99976321110 0011111000 00000 01123467899999999999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=258.17 Aligned_cols=219 Identities=26% Similarity=0.416 Sum_probs=172.2
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAAE 69 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~~ 69 (259)
.+.+|+++++++ +||||+++++++..++..+++|||+++++|.+++..... ...+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (314)
T cd05099 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ 142 (314)
T ss_pred HHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence 578899999999 699999999999998999999999999999999976421 123678889999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccch
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDV 149 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 149 (259)
++.||.|||+++ ++|+||+|+||+++.++.++|+|||.++...............++..|+|||.+.+..++.++||
T Consensus 143 i~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 143 VARGMEYLESRR---CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred HHHHHHHHHHCC---eeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 999999999999 99999999999999999999999999876543221111222234467999999988889999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 150 YSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 150 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
||||+++|++++ |..||.+.... ........ .. ....+...+..+.+++.+||+.+|++||
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~--------~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVE--------ELFKLLRE-GH---------RMDKPSNCTHELYMLMRECWHAVPTQRP 281 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc-CC---------CCCCCCCCCHHHHHHHHHHcCCCcccCc
Confidence 999999999999 88898763210 01111110 00 0011112346788999999999999999
Q ss_pred CHHHHHHHHHhcccc
Q 025011 229 TMKQVSEELDRLKIS 243 (259)
Q Consensus 229 t~~~il~~l~~~~~~ 243 (259)
|+.++++.|+++...
T Consensus 282 s~~~ll~~l~~~~~~ 296 (314)
T cd05099 282 TFKQLVEALDKVLAA 296 (314)
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=258.05 Aligned_cols=222 Identities=29% Similarity=0.424 Sum_probs=173.9
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|++++.++ +||||+++++++..++..+++|||+++++|.+++..... ...+++..++.++.
T Consensus 52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 131 (303)
T cd05088 52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131 (303)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHH
Confidence 4578899999999 899999999999999999999999999999999965421 12467889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+++ ++|+||+|+||+++.++.++|+|||++...... ........+..|+|||.+.+..++.++|
T Consensus 132 qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~D 205 (303)
T cd05088 132 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSD 205 (303)
T ss_pred HHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCccccc
Confidence 9999999999999 999999999999999999999999998532211 1111223456799999998888899999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||+|+++|+|++ |..||.+.... +........ .....+...++.+.+++.+||+.+|.+|
T Consensus 206 i~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R 267 (303)
T cd05088 206 VWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQG----------YRLEKPLNCDDEVYDLMRQCWREKPYER 267 (303)
T ss_pred chhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhcC----------CcCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999998 99998763211 011111000 0000111234678999999999999999
Q ss_pred CCHHHHHHHHHhccccccchh
Q 025011 228 PTMKQVSEELDRLKISHENYE 248 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~~~ 248 (259)
||+.+++..++++......+.
T Consensus 268 p~~~~il~~l~~~~~~~~~~~ 288 (303)
T cd05088 268 PSFAQILVSLNRMLEERKTYV 288 (303)
T ss_pred cCHHHHHHHHHHHHHhhhhhh
Confidence 999999999998766655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=256.58 Aligned_cols=221 Identities=29% Similarity=0.407 Sum_probs=172.9
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-------------CcccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------------SQVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~ 68 (259)
+.+.+|+.++.++ +||||+++++++...+..++++||+++++|.+++.... ....+++..++.++.
T Consensus 47 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 126 (297)
T cd05089 47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126 (297)
T ss_pred HHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHH
Confidence 4688899999999 79999999999999999999999999999999996532 112367889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+++ ++|+||||+||+++.++.++|+|||++....... .......+..|+|||+..+..++.++|
T Consensus 127 qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred HHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhh
Confidence 9999999999999 9999999999999999999999999975322110 111112345799999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+.... ........ ......+...+..+.+++.+||+.+|.+|
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 262 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ----------GYRMEKPRNCDDEVYELMRQCWRDRPYER 262 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHH--------HHHHHHhc----------CCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999997 99999763211 01111100 00001111234678999999999999999
Q ss_pred CCHHHHHHHHHhccccccch
Q 025011 228 PTMKQVSEELDRLKISHENY 247 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~~ 247 (259)
||+.+++..++++.......
T Consensus 263 p~~~~i~~~l~~~~~~~~~~ 282 (297)
T cd05089 263 PPFAQISVQLSRMLEARKAY 282 (297)
T ss_pred cCHHHHHHHHHHHHHhhccc
Confidence 99999999999888766443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=250.83 Aligned_cols=214 Identities=21% Similarity=0.357 Sum_probs=168.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.. ...++||||+++++|.+++..... .+++..++.++.|++.|+.|||+++
T Consensus 40 ~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 115 (257)
T cd05115 40 DEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN- 115 (257)
T ss_pred HHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC-
Confidence 568899999999999999999998854 567999999999999999875432 3578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+....++.++|+||||+++|++++
T Consensus 116 --i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 193 (257)
T cd05115 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193 (257)
T ss_pred --eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhc
Confidence 99999999999999999999999999875543321111 111223568999999988888999999999999999996
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... .... .+........+...++.+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 194 ~g~~p~~~~~~~--------~~~~----------~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 194 YGQKPYKKMKGP--------EVMS----------FIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCcCcCCHH--------HHHH----------HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 99998763210 0010 0001011111122347799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=262.96 Aligned_cols=203 Identities=24% Similarity=0.293 Sum_probs=165.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 76 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 151 (340)
T PTZ00426 76 DHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---FPNDVGCFYAAQIVLIFEYLQSLN- 151 (340)
T ss_pred HHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3577899999999999999999999999999999999999999999976543 677889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++||||||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++.++|+||+||++|+|++|
T Consensus 152 --ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G 224 (340)
T PTZ00426 152 --IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224 (340)
T ss_pred --eEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC
Confidence 999999999999999999999999998764321 1234688999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+..... . .. .+...... .+...++.+.++|.+||+.||.+|+ |++++++
T Consensus 225 ~~Pf~~~~~~~-----~---~~---------~i~~~~~~--~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 225 CPPFYANEPLL-----I---YQ---------KILEGIIY--FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCCCCCCHHH-----H---HH---------HHhcCCCC--CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 99998632110 0 00 00010000 0111236688999999999999995 7888764
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=258.45 Aligned_cols=223 Identities=28% Similarity=0.413 Sum_probs=174.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+.+++.+ +||||+++++++..++..+++|||+++++|.+++..... ...+++..+..++.
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 147 (307)
T cd05098 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147 (307)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 3577899999999 799999999999999999999999999999999976432 12367788999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..++.++|
T Consensus 148 qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 148 QVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred HHHHHHHHHHHCC---cccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence 9999999999999 9999999999999999999999999987654321111122223456899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
+||+|+++|+|++ |..||.+... ......... . .....+...+..+.+++.+||..+|.+|
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~--------~~~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~R 286 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPV--------EELFKLLKE-G---------HRMDKPSNCTNELYMMMRDCWHAVPSQR 286 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHHc-C---------CCCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 9999999999998 8888865221 011111110 0 0001111234678999999999999999
Q ss_pred CCHHHHHHHHHhccccccc
Q 025011 228 PTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~ 246 (259)
||+.++++.|+++-....+
T Consensus 287 ps~~evl~~l~~~~~~~~~ 305 (307)
T cd05098 287 PTFKQLVEDLDRILALTSN 305 (307)
T ss_pred cCHHHHHHHHHHHHHHhhc
Confidence 9999999999998765433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=251.46 Aligned_cols=211 Identities=24% Similarity=0.376 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++...+..+++|||+++++|.+++..... .+++..+..++.|++.|+.|||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 120 (256)
T cd05059 44 DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG- 120 (256)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688899999999999999999999999999999999999999999976443 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||+++..... .........++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 121 --i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 121 --FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD-QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred --cccccccHhhEEECCCCcEEECCcccceecccc-cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 999999999999999999999999998765432 1111112224457999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|..||...+.. ........ ......+...++.+.+++.+||..+|.+|||+.++++.|
T Consensus 198 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 198 GKMPYERFSNS--------EVVESVSA----------GYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCCHH--------HHHHHHHc----------CCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 78998753211 00000000 000011112347799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=261.69 Aligned_cols=205 Identities=24% Similarity=0.263 Sum_probs=164.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~-- 115 (323)
T cd05595 41 HTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD-- 115 (323)
T ss_pred HHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 466899999999999999999999999999999999999999998876542 678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||+||++|+|++|.
T Consensus 116 -ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~ 192 (323)
T cd05595 116 -VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (323)
T ss_pred -eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC
Confidence 9999999999999999999999999876432211 1122345889999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
.||.+.+... ....... ... ..+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 193 ~Pf~~~~~~~--------~~~~~~~---------~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 193 LPFYNQDHER--------LFELILM---------EEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCCCHHH--------HHHHHhc---------CCC--CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 9997632110 0000000 000 00112346789999999999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=252.44 Aligned_cols=217 Identities=25% Similarity=0.396 Sum_probs=169.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc------ceEEEEecCCCChhhhhhccC---CcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV------PLLVYEFVPNGTLFDHIHDKS---SQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~ 73 (259)
+.+.+|++.++.++||||+++++++..... .++++||+++++|.+++.... ....+++..+..++.|++.|
T Consensus 46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~a 125 (273)
T cd05035 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125 (273)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHH
Confidence 358899999999999999999998865443 799999999999999985432 22346788899999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
|.|||+++ ++|+||+|+||++++++.++|+|||+++...............++..|+|||.+.+..++.++||||+|
T Consensus 126 L~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG 202 (273)
T cd05035 126 MEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202 (273)
T ss_pred HHHHHhCC---eeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHH
Confidence 99999999 999999999999999999999999998766543222222223356789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||.+.... . ......... ....+...+..+.+++.+||+.||.+|||+.+
T Consensus 203 ~il~el~~~g~~p~~~~~~~-----~---~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e 264 (273)
T cd05035 203 VTMWEIATRGQTPYPGVENH-----E---IYDYLRHGN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTK 264 (273)
T ss_pred HHHHHHHhCCCCCCCCCCHH-----H---HHHHHHcCC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999 88898763210 1 111111100 00111223467999999999999999999999
Q ss_pred HHHHHHhc
Q 025011 233 VSEELDRL 240 (259)
Q Consensus 233 il~~l~~~ 240 (259)
+++.|+++
T Consensus 265 ~~~~l~~~ 272 (273)
T cd05035 265 LREVLENI 272 (273)
T ss_pred HHHHHHhh
Confidence 99999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=247.84 Aligned_cols=220 Identities=20% Similarity=0.213 Sum_probs=169.0
Q ss_pred HHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 6 QHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+|+.+|.+.+|||||.+.++.... +.+|+|||||+. +|.+++...+. .+...++.-++.|++.|++|||.+.
T Consensus 123 LREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w-- 197 (419)
T KOG0663|consen 123 LREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW-- 197 (419)
T ss_pred HHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce--
Confidence 5899999999999999999988743 479999999966 99999988763 2567889999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g 162 (259)
|+|||+||+|++++..|.+|++|||+|+.++.. ....+..+-|.+|+|||.+.+.. |+.+.|+||+|||+.+++++
T Consensus 198 -ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~ 274 (419)
T KOG0663|consen 198 -ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQ 274 (419)
T ss_pred -eEecccchhheeeccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhc
Confidence 999999999999999999999999999998874 33345567899999999999876 99999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhc------cccCCchh---------HHHHHHHHHHHHHhcccCCCCC
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILN------FQVADESE---------MEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~---------~~~~~~~~~li~~~l~~~p~~R 227 (259)
.+.|+|.+.......... ....+.+..+..+.. ........ ...++.-.+|+..+|..||.+|
T Consensus 275 kPlf~G~sE~dQl~~If~--llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR 352 (419)
T KOG0663|consen 275 KPLFPGKSEIDQLDKIFK--LLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKR 352 (419)
T ss_pred CCCCCCCchHHHHHHHHH--HhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccc
Confidence 999998543322111000 000011111110000 00000000 0133677899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
.||.+.++
T Consensus 353 ~tA~~~L~ 360 (419)
T KOG0663|consen 353 ITAEDGLK 360 (419)
T ss_pred ccHHHhhc
Confidence 99999864
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=252.26 Aligned_cols=214 Identities=29% Similarity=0.433 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++..... ...+++..+..++.
T Consensus 40 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 119 (270)
T cd05047 40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119 (270)
T ss_pred HHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHH
Confidence 4678899999999 799999999999999999999999999999999865421 12357889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.|+.|||+.+ ++|+||+|+||++++++.++++|||++...... ........+..|+|||++....++.++|
T Consensus 120 ~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~D 193 (270)
T cd05047 120 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSD 193 (270)
T ss_pred HHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhh
Confidence 9999999999999 999999999999999999999999997532211 1111122355799999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
+||||+++++|++ |..||.+.... .......... ....+...+..+.+++.+||..||.+|
T Consensus 194 i~slG~il~el~~~g~~pf~~~~~~--------~~~~~~~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R 255 (270)
T cd05047 194 VWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQGY----------RLEKPLNCDDEVYDLMRQCWREKPYER 255 (270)
T ss_pred HHHHHHHHHHHHcCCCCCccccCHH--------HHHHHHhCCC----------CCCCCCcCCHHHHHHHHHHcccChhhC
Confidence 9999999999997 99998763211 0011111000 000111233568999999999999999
Q ss_pred CCHHHHHHHHHhc
Q 025011 228 PTMKQVSEELDRL 240 (259)
Q Consensus 228 pt~~~il~~l~~~ 240 (259)
||+.+++..|+++
T Consensus 256 ps~~~il~~l~~~ 268 (270)
T cd05047 256 PSFAQILVSLNRM 268 (270)
T ss_pred CCHHHHHHHHHHh
Confidence 9999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=250.04 Aligned_cols=210 Identities=24% Similarity=0.317 Sum_probs=177.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+.+.|-+||+.++||.++.+|..|+.++..|++||||+||+|..++++++... +++..+.-++..++-||.|||-.|
T Consensus 123 Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~-fse~~aRFYaAEvl~ALEYLHmlG-- 199 (459)
T KOG0610|consen 123 RAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKR-FSESAARFYAAEVLLALEYLHMLG-- 199 (459)
T ss_pred HHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCc-cchhhHHHHHHHHHHHHHHHHhhc--
Confidence 46779999999999999999999999999999999999999999999887655 788999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCC--------------------------------c-c-----------
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD--------------------------------N-Q----------- 119 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~--------------------------------~-~----------- 119 (259)
|++|||||+||++-++|++-|+||.++...... . .
T Consensus 200 -ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~ 278 (459)
T KOG0610|consen 200 -IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASR 278 (459)
T ss_pred -eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccc
Confidence 999999999999999999999999987432110 0 0
Q ss_pred ----------ccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc
Q 025011 120 ----------TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN 189 (259)
Q Consensus 120 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 189 (259)
......++||..|+|||++.+...+.++|.|+||+++|||+.|..||.|.. ..
T Consensus 279 ~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~-----------------~~ 341 (459)
T KOG0610|consen 279 SLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN-----------------NK 341 (459)
T ss_pred cchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC-----------------ch
Confidence 011224479999999999999999999999999999999999999998832 23
Q ss_pred chhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC----HHHHH
Q 025011 190 NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT----MKQVS 234 (259)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il 234 (259)
..+..++......+.....+..+.+||+++|.+||.+|.. |.||.
T Consensus 342 ~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 342 ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 4455566655555555567788999999999999999998 66653
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=253.98 Aligned_cols=229 Identities=26% Similarity=0.339 Sum_probs=171.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++... ...+++|||+++++|.+++.... +++..++.++.|++.|+.|||++
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~----l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 51 SGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcC----CCHHHHHHHHHHHHHHHHHHHHC
Confidence 4678999999999999999999988653 35789999999999999997542 57899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++++|
T Consensus 127 ~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred C---eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 9 99999999999999999999999999876654322111 1222355679999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||.......... ..............+..........+...+..+.+++.+||+.+|++|||++++++.|++
T Consensus 204 ~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~ 280 (283)
T cd05080 204 LTHCDSKQSPPKKFEEM---IGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE 280 (283)
T ss_pred HhCCCCCCCCcchhhhh---hcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence 99999986532111000 000000000001111111111111112234679999999999999999999999999988
Q ss_pred cc
Q 025011 240 LK 241 (259)
Q Consensus 240 ~~ 241 (259)
+.
T Consensus 281 ~~ 282 (283)
T cd05080 281 MH 282 (283)
T ss_pred hh
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=283.11 Aligned_cols=224 Identities=25% Similarity=0.410 Sum_probs=185.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC----CcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----SQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
.+|.+|+.+++.++||||++++|++...+..+|++||+++|+|..+|++.. ....++....+.++.+|++|+.||+
T Consensus 740 ~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe 819 (1025)
T KOG1095|consen 740 SDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE 819 (1025)
T ss_pred HHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH
Confidence 579999999999999999999999999999999999999999999998761 1234678899999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
+++ ++||||...|++++....+|++|||+++.+-...-+.......-...|||||.+....++.++||||||+++||
T Consensus 820 ~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWE 896 (1025)
T KOG1095|consen 820 SKH---FVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWE 896 (1025)
T ss_pred hCC---CcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHH
Confidence 999 99999999999999999999999999995544433434444456679999999999999999999999999999
Q ss_pred HHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 159 LLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 159 l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
+++ |..||.+.+... ........+ .-+.+..+++.+.+++..||+.+|++||++..|++.+
T Consensus 897 ifslG~~PY~~~~n~~--------v~~~~~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~ 958 (1025)
T KOG1095|consen 897 IFSLGATPYPSRSNFE--------VLLDVLEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQD 958 (1025)
T ss_pred HHhCCCCCCCCcchHH--------HHHHHHhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhh
Confidence 999 899999843211 111111111 2233445678899999999999999999999999988
Q ss_pred Hhccccccch
Q 025011 238 DRLKISHENY 247 (259)
Q Consensus 238 ~~~~~~~~~~ 247 (259)
.++.......
T Consensus 959 ~~i~~~~~~~ 968 (1025)
T KOG1095|consen 959 PAISNAALGT 968 (1025)
T ss_pred hhhhhhhccC
Confidence 8887665443
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=257.93 Aligned_cols=205 Identities=22% Similarity=0.265 Sum_probs=165.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... +.+..+..++.|++.||.|||+++
T Consensus 46 ~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~-- 120 (323)
T cd05584 46 HTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---FMEDTACFYLSEISLALEHLHQQG-- 120 (323)
T ss_pred HHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467899999999999999999999999999999999999999999976543 566788889999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 121 -ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 197 (323)
T cd05584 121 -IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197 (323)
T ss_pred -eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCC
Confidence 9999999999999999999999999986543221 1223346899999999998888899999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
.||.+.... ....... ..... .+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 198 ~pf~~~~~~--------~~~~~~~---------~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 198 PPFTAENRK--------KTIDKIL---------KGKLN--LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHH--------HHHHHHH---------cCCCC--CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 999763211 0011110 00000 0111236789999999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=252.35 Aligned_cols=217 Identities=24% Similarity=0.416 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+..|+.+++.+.||||+++++++. +...++++||+++|+|.+++..... .+++..+..++.|++.|+.|||+++
T Consensus 54 ~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 129 (279)
T cd05111 54 QEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR- 129 (279)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 35677888899999999999999875 4567899999999999999976432 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++
T Consensus 130 --iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~ 207 (279)
T cd05111 130 --MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207 (279)
T ss_pred --EeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543322222233346678999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... ...... ..+... ..+...+..+.+++.+||..||.+|||+.++++.|..+.
T Consensus 208 g~~p~~~~~~~-----~~~~~~----~~~~~~---------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 208 GAEPYAGMRPH-----EVPDLL----EKGERL---------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCCCCCCCHH-----HHHHHH----HCCCcC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 99998763211 000110 100000 000012256788999999999999999999999998876
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 270 ~~ 271 (279)
T cd05111 270 RD 271 (279)
T ss_pred hC
Confidence 53
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=248.95 Aligned_cols=215 Identities=26% Similarity=0.411 Sum_probs=168.8
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++++.++|||++++++++. .+..+++|||+.+++|.+++..... ...++..+..++.|++.||.|||+.+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~ 122 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN 122 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357889999999999999999999875 4567999999999999999976432 23578889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||++++++.++|+|||++....... ........++..|+|||...+..++.++|+||+|+++|+|++
T Consensus 123 ---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t 198 (260)
T cd05069 123 ---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVT 198 (260)
T ss_pred ---EeecccCcceEEEcCCCeEEECCCccceEccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654321 111122345678999999988889999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ..... .... .....+...+..+.+++.+||..||.+|||++++++.|+++
T Consensus 199 ~g~~p~~~~~~~-----~~~~~---~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 199 KGRVPYPGMVNR-----EVLEQ---VERG----------YRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred CCCCCCCCCCHH-----HHHHH---HHcC----------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 88998763210 00000 0000 00011112346799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=252.80 Aligned_cols=219 Identities=21% Similarity=0.374 Sum_probs=172.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCc-----ccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQ-----VLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++.. +...+++++|+++++|.+++...... ..+++..++.++.|++.||.|
T Consensus 53 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 132 (280)
T cd05043 53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSY 132 (280)
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999999999998766 46789999999999999998764322 346788999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||+|+||++++++.++++|||+++.+.............++..|+|||++.+..++.++||||+|+++
T Consensus 133 LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l 209 (280)
T cd05043 133 LHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLL 209 (280)
T ss_pred HHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHH
Confidence 99999 999999999999999999999999998765432211112223456789999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++++ |..||..... ........ ... ........++.+.+++.+||..||++|||+.++++
T Consensus 210 ~el~~~g~~p~~~~~~-----~~~~~~~~---~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 210 WELMTLGQTPYVEIDP-----FEMAAYLK---DGY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHhcCCCCCcCcCCH-----HHHHHHHH---cCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999 9999876221 11111111 100 00111123467999999999999999999999999
Q ss_pred HHHhccc
Q 025011 236 ELDRLKI 242 (259)
Q Consensus 236 ~l~~~~~ 242 (259)
.|+++..
T Consensus 272 ~l~~~~~ 278 (280)
T cd05043 272 CLTDFHA 278 (280)
T ss_pred HHHHHHh
Confidence 9998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=254.28 Aligned_cols=216 Identities=27% Similarity=0.439 Sum_probs=169.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------------cccCCHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------------QVLRNWKTC 63 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~~~~~~ 63 (259)
+.+.+|+.+++.++||||+++++++..+...+++|||+++++|.+++..... ...+++..+
T Consensus 53 ~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 132 (288)
T cd05050 53 ADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132 (288)
T ss_pred HHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHH
Confidence 5688999999999999999999999999999999999999999999974321 123567788
Q ss_pred HHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc
Q 025011 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL 143 (259)
Q Consensus 64 ~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 143 (259)
+.++.|++.||.+||+++ ++|+||+|.||+++.++.++++|||++.................+..|+|||.+.+..+
T Consensus 133 ~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 209 (288)
T cd05050 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY 209 (288)
T ss_pred HHHHHHHHHHHHHHHhCC---eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC
Confidence 999999999999999999 99999999999999999999999999875443211111222234567999999988889
Q ss_pred ccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhccc
Q 025011 144 TEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 144 ~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 222 (259)
+.++|+||||+++|+|++ |..||.+.... +...... ..... ..+...+..+.+++.+||+.
T Consensus 210 ~~~~Dv~slG~il~el~~~~~~p~~~~~~~--------~~~~~~~-~~~~~---------~~~~~~~~~l~~li~~~l~~ 271 (288)
T cd05050 210 TTESDVWAYGVVLWEIFSYGMQPYYGMAHE--------EVIYYVR-DGNVL---------SCPDNCPLELYNLMRLCWSK 271 (288)
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHh-cCCCC---------CCCCCCCHHHHHHHHHHccc
Confidence 999999999999999998 88888653211 1111111 11110 00112346799999999999
Q ss_pred CCCCCCCHHHHHHHHHh
Q 025011 223 SGRRRPTMKQVSEELDR 239 (259)
Q Consensus 223 ~p~~Rpt~~~il~~l~~ 239 (259)
+|.+|||+.++++.|++
T Consensus 272 ~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 272 LPSDRPSFASINRILQR 288 (288)
T ss_pred CcccCCCHHHHHHHhhC
Confidence 99999999999998874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=249.23 Aligned_cols=214 Identities=26% Similarity=0.396 Sum_probs=169.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++. .+..+++|||+++++|.+++.... .+++..+..++.|++.|+.+||..+
T Consensus 41 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~- 115 (257)
T cd05060 41 KEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH- 115 (257)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC-
Confidence 56889999999999999999999876 456799999999999999997665 3578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++||||||+++|++++
T Consensus 116 --i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 116 --FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred --eeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 99999999999999999999999999876654322111 111223467999999988889999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||..... ........ . .. ....+...+..+.++|.+||+.+|.+|||+.++++.|+++
T Consensus 194 ~g~~p~~~~~~-----~~~~~~~~---~-~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 194 YGAKPYGEMKG-----AEVIAMLE---S-GE---------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCcccCCH-----HHHHHHHH---c-CC---------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 9999875321 11111111 0 00 0011112346789999999999999999999999999886
Q ss_pred c
Q 025011 241 K 241 (259)
Q Consensus 241 ~ 241 (259)
.
T Consensus 256 ~ 256 (257)
T cd05060 256 P 256 (257)
T ss_pred c
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=251.25 Aligned_cols=217 Identities=25% Similarity=0.414 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhcc---CCcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDK---SSQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~ 73 (259)
+.+.+|+++++.++||||+++++++... ...+++|||+.+++|.+++... .....+++..+..++.|++.|
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 124 (272)
T cd05075 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124 (272)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999977432 2468999999999999887432 122336788999999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
+.|||+++ ++|+||||+||+++.++.++++|||+++...............++..|++||.+.+..++.++|+||+|
T Consensus 125 l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG 201 (272)
T cd05075 125 MEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201 (272)
T ss_pred HHHHHHCC---eeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHH
Confidence 99999999 999999999999999999999999998866443221112223456789999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||.+.... .... ... ..... ......+..+.+++.+||+.||.+|||+.+
T Consensus 202 ~il~el~~~g~~p~~~~~~~-----~~~~---~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 263 (272)
T cd05075 202 VTMWEIATRGQTPYPGVENS-----EIYD---YLR-QGNRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFET 263 (272)
T ss_pred HHHHHHHcCCCCCCCCCCHH-----HHHH---HHH-cCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 99999999 78998763211 1111 111 11100 011123366899999999999999999999
Q ss_pred HHHHHHhc
Q 025011 233 VSEELDRL 240 (259)
Q Consensus 233 il~~l~~~ 240 (259)
+++.|+++
T Consensus 264 l~~~l~~~ 271 (272)
T cd05075 264 LRCELEKA 271 (272)
T ss_pred HHHHHHhh
Confidence 99999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=252.74 Aligned_cols=223 Identities=24% Similarity=0.404 Sum_probs=170.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc--------ccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ--------VLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+.+++.++|+||+++++++..++..+++|||+++++|.+++...... ..+++..+..++.|++.|+
T Consensus 64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05095 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM 143 (296)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence 56889999999999999999999999999999999999999999998764321 2356678999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.|||+.+ ++|+||||+||+++.++.++|+|||++.................+..|++||...+..++.++|+||||+
T Consensus 144 ~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~ 220 (296)
T cd05095 144 KYLSSLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220 (296)
T ss_pred HHHHHCC---eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHH
Confidence 9999999 9999999999999999999999999987654332222222233467899999988888999999999999
Q ss_pred HHHHHHh--CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLT--GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|+|++ |..||....... ........ ....... .....+...++.+.+++.+||+.||.+|||+.+
T Consensus 221 ~l~el~~~~~~~p~~~~~~~~----~~~~~~~~-~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 289 (296)
T cd05095 221 TLWEILTLCKEQPYSQLSDEQ----VIENTGEF-FRDQGRQ------VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQE 289 (296)
T ss_pred HHHHHHHhCCCCCccccChHH----HHHHHHHH-Hhhcccc------ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHH
Confidence 9999998 678876532110 00000000 0000000 000111123467999999999999999999999
Q ss_pred HHHHHHh
Q 025011 233 VSEELDR 239 (259)
Q Consensus 233 il~~l~~ 239 (259)
|++.|++
T Consensus 290 i~~~l~~ 296 (296)
T cd05095 290 IHATLLE 296 (296)
T ss_pred HHHHHhC
Confidence 9998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=248.32 Aligned_cols=209 Identities=26% Similarity=0.357 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++++..++..+++|||+++++|.+++..... ..+++..++.++.|++.|+.|||+.+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~~l~~al~~lH~~~- 121 (256)
T cd08529 44 EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRG-RPLPEDQVWRFFIQILLGLAHLHSKK- 121 (256)
T ss_pred HHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976532 23677899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++++|++|
T Consensus 122 --i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 197 (256)
T cd08529 122 --ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197 (256)
T ss_pred --cccCCCCcceEEEeCCCCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC
Confidence 99999999999999999999999999876554321 12233578899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... . ... ........ ......+..+.+++.+||+.+|++||++.++++
T Consensus 198 ~~p~~~~~~~-----~---~~~---------~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 198 KHPFDANNQG-----A---LIL---------KIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCCCCCCCHH-----H---HHH---------HHHcCCCC-CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 9999763210 0 000 00000000 111133467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=262.75 Aligned_cols=202 Identities=26% Similarity=0.289 Sum_probs=163.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|++++++++||||+++++++..++..|+||||+++++|.+++.+.. .+++..+..++.|++.||.|||+++
T Consensus 44 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~-- 118 (318)
T cd05582 44 RTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG-- 118 (318)
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46789999999999999999999999999999999999999999986543 2678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||||+++|+|++|+
T Consensus 119 -i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 195 (318)
T cd05582 119 -IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGS 195 (318)
T ss_pred -EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCC
Confidence 9999999999999999999999999987543321 1223346889999999998888899999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
.||.+.... ....... ..... .+...++.+.+++.+||+.||.+|||+.+
T Consensus 196 ~p~~~~~~~--------~~~~~i~---------~~~~~--~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 196 LPFQGKDRK--------ETMTMIL---------KAKLG--MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCHH--------HHHHHHH---------cCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 999763211 0000000 00000 01123467899999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.82 Aligned_cols=213 Identities=26% Similarity=0.415 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+|++++++++. .+..+++|||+++++|.+++...... .+++..+..++.|++.|+.|||+++
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~al~~lH~~~- 122 (260)
T cd05070 46 ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGR-ALKLPNLVDMAAQVAAGMAYIERMN- 122 (260)
T ss_pred HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56899999999999999999999875 45679999999999999999764332 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 123 --i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~ 199 (260)
T cd05070 123 --YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTK 199 (260)
T ss_pred --cccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhc
Confidence 999999999999999999999999998765432111 1122235567999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
|..||.+.... .. ...... . .....+...+..+.+++.+||..+|.+|||+.++.+.|++
T Consensus 200 g~~p~~~~~~~-----~~---~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 200 GRVPYPGMNNR-----EV---LEQVER-G---------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCCHH-----HH---HHHHHc-C---------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 88998763211 01 111100 0 0011112234679999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=263.13 Aligned_cols=222 Identities=26% Similarity=0.462 Sum_probs=178.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
|+|++|+.++++-+|.||+-+.|+|..... .||+.+|+|.+|+.++..... .++....++|+.|++.|+.|||.++
T Consensus 433 qaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~- 508 (678)
T KOG0193|consen 433 QAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN- 508 (678)
T ss_pred HHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh-
Confidence 789999999999999999999999998877 999999999999999976543 2678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l 159 (259)
|+|+|||..|||+.+++.|+|+|||++.....-.........-+...|+|||++... +|++.+||||||+++|||
T Consensus 509 --IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YEL 586 (678)
T KOG0193|consen 509 --IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYEL 586 (678)
T ss_pred --hhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHH
Confidence 999999999999999999999999998766544334444455688999999998743 489999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||..-..+. .+.....+....+. .....+++..+.+|+..||..++++||++.+|+..|+.
T Consensus 587 ltg~lPysi~~~dq--------IifmVGrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~ 652 (678)
T KOG0193|consen 587 LTGELPYSIQNRDQ--------IIFMVGRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEE 652 (678)
T ss_pred HhCcCCcCCCChhh--------eEEEecccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHH
Confidence 99999987411000 00000111000111 11222445789999999999999999999999999988
Q ss_pred ccccc
Q 025011 240 LKISH 244 (259)
Q Consensus 240 ~~~~~ 244 (259)
+..+.
T Consensus 653 l~~~~ 657 (678)
T KOG0193|consen 653 LLPSL 657 (678)
T ss_pred hhhcc
Confidence 87764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=256.87 Aligned_cols=156 Identities=24% Similarity=0.357 Sum_probs=138.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC-C
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS-A 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~ 81 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+. +
T Consensus 48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~~ 124 (333)
T cd06650 48 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK 124 (333)
T ss_pred HHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 4688999999999999999999999999999999999999999999976533 57788899999999999999974 6
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||+||++|+|++
T Consensus 125 ---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 197 (333)
T cd06650 125 ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAI 197 (333)
T ss_pred ---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999998654322 1223458899999999988889999999999999999999
Q ss_pred CCCCCCC
Q 025011 162 GLKPGSG 168 (259)
Q Consensus 162 g~~p~~~ 168 (259)
|..||..
T Consensus 198 g~~p~~~ 204 (333)
T cd06650 198 GRYPIPP 204 (333)
T ss_pred CCCCCCC
Confidence 9999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=252.61 Aligned_cols=224 Identities=18% Similarity=0.237 Sum_probs=164.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+.+ +|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~- 123 (288)
T cd07871 48 CTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK- 123 (288)
T ss_pred hhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3577899999999999999999999999999999999965 89888865432 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++||||+|+++|+|++
T Consensus 124 --ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 124 --ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred --cccCCCCHHHEEECCCCCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987543321 11233457889999999865 458899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHH--------HHhhccchhhhhhccccCCch----hHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYF--------LYSIENNSLRQILNFQVADES----EMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|+.||.+........ ...... ..................... ....++.+.++|.+||+.||.+|||
T Consensus 200 g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t 278 (288)
T cd07871 200 GRPMFPGSTVKEELH-LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS 278 (288)
T ss_pred CCCCCCCCCHHHHHH-HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC
Confidence 999998633211000 000000 000000000000000000000 0112356889999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
++++++
T Consensus 279 ~~~~l~ 284 (288)
T cd07871 279 AEAALR 284 (288)
T ss_pred HHHHhc
Confidence 999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=247.34 Aligned_cols=213 Identities=27% Similarity=0.425 Sum_probs=168.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++...+..+++|||+.+++|.+++..... ..++..+..++.+++.++.|||+++
T Consensus 37 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~- 113 (251)
T cd05041 37 RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN- 113 (251)
T ss_pred HHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5689999999999999999999999999999999999999999999866433 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||.+.................+..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 114 --i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~ 191 (251)
T cd05041 114 --CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSL 191 (251)
T ss_pred --EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhc
Confidence 99999999999999999999999999876542211111122234567999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|..||...... ....... . ......+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus 192 ~~~p~~~~~~~-----~~~~~~~---~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 192 GDTPYPGMSNQ-----QTRERIE---S----------GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCCCccCCHH-----HHHHHHh---c----------CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 78888763211 0000000 0 0000011123467999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=258.09 Aligned_cols=221 Identities=27% Similarity=0.413 Sum_probs=174.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++++ +||||+++++++..++..++++||+++++|.+++..... ...+++..+..++.
T Consensus 62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 141 (334)
T cd05100 62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY 141 (334)
T ss_pred HHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 4688999999999 799999999999999999999999999999999975321 12356788899999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|
T Consensus 142 qi~~al~~LH~~g---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 142 QVARGMEYLASQK---CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred HHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhh
Confidence 9999999999999 9999999999999999999999999987654322221222223456799999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+... ......... . .....+...+..+.+++.+||+.+|.+|
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~--------~~~~~~~~~-~---------~~~~~~~~~~~~l~~li~~cl~~~p~~R 280 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPV--------EELFKLLKE-G---------HRMDKPANCTHELYMIMRECWHAVPSQR 280 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-C---------CCCCCCCCCCHHHHHHHHHHcccChhhC
Confidence 9999999999998 8888876321 111111110 0 0001111233678999999999999999
Q ss_pred CCHHHHHHHHHhccccc
Q 025011 228 PTMKQVSEELDRLKISH 244 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~ 244 (259)
||+.++++.|+++....
T Consensus 281 ps~~ell~~l~~~~~~~ 297 (334)
T cd05100 281 PTFKQLVEDLDRVLTVT 297 (334)
T ss_pred cCHHHHHHHHHHHhhhc
Confidence 99999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=257.37 Aligned_cols=219 Identities=25% Similarity=0.399 Sum_probs=170.4
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
.+.+|+.+++++ +|+||+++++++.. +...++++||+++++|.+++.....
T Consensus 56 ~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (337)
T cd05054 56 ALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDS 135 (337)
T ss_pred HHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccccccccccc
Confidence 467899999999 79999999998865 4578899999999999999854321
Q ss_pred -------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCce
Q 025011 55 -------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA 103 (259)
Q Consensus 55 -------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~ 103 (259)
...+++..+..++.|++.||.|||+++ |+|+||||.||+++.++.+
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~v 212 (337)
T cd05054 136 VSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVV 212 (337)
T ss_pred CCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcE
Confidence 114678889999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHH
Q 025011 104 KVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQY 182 (259)
Q Consensus 104 ~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 182 (259)
+|+|||++................++..|+|||++.+..++.++||||+||++|+|++ |..||.+..... .
T Consensus 213 kL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~---- 284 (337)
T cd05054 213 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----E---- 284 (337)
T ss_pred EEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----H----
Confidence 9999999987644322222233346678999999999899999999999999999998 999987632110 0
Q ss_pred HHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 025011 183 FLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
.......... ...+...++.+.+++.+||+.+|.+|||+.++++.|+++-.
T Consensus 285 ~~~~~~~~~~---------~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 285 FCRRLKEGTR---------MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHhccCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1011111100 00011233678999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=237.34 Aligned_cols=208 Identities=26% Similarity=0.385 Sum_probs=175.7
Q ss_pred ChhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 1 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+++++|+++.+.|+||||.++|++|-++..+|+++||..+|.++..++...... +++...+.++.|++.|+.|+|.+
T Consensus 65 v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~-f~e~~~a~Yi~q~A~Al~y~h~k 143 (281)
T KOG0580|consen 65 VEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKR-FDEQRAATYIKQLANALLYCHLK 143 (281)
T ss_pred chhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccc-ccccchhHHHHHHHHHHHHhccC
Confidence 35789999999999999999999999999999999999999999999998654433 67889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ |+||||||+|++++..+.++++|||-+...++.. .....||..|.+||...+...+..+|+|++|++.|+++
T Consensus 144 ~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~k----R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yefl 216 (281)
T KOG0580|consen 144 R---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNK----RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFL 216 (281)
T ss_pred C---cccCCCCHHHhccCCCCCeeccCCCceeecCCCC----ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999987765332 23456999999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.|.+||.+... .....++....... +...+....++|..|+..+|.+|.+..++++
T Consensus 217 vg~ppFes~~~-----------------~etYkrI~k~~~~~--p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 217 VGLPPFESQSH-----------------SETYKRIRKVDLKF--PSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred hcCCchhhhhh-----------------HHHHHHHHHccccC--CcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 99999987331 12222222221111 1334577999999999999999999999865
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=252.95 Aligned_cols=217 Identities=23% Similarity=0.374 Sum_probs=170.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------cccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------QVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~ 75 (259)
..+.+|+.+++.++||||+++++++...+..+++|||+++|+|.+++..... ....+...+..++.|++.|+.
T Consensus 54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (288)
T cd05061 54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133 (288)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence 3578899999999999999999999999999999999999999999975321 223456788899999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ ++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||+|++
T Consensus 134 ~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~ 210 (288)
T cd05061 134 YLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVV 210 (288)
T ss_pred HHHhCC---CcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHH
Confidence 999999 99999999999999999999999999875543222222222345678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... +.......... .. .+...++.+.+++.+||+.||.+|||+.+++
T Consensus 211 l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~-~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll 272 (288)
T cd05061 211 LWEITSLAEQPYQGLSNE--------QVLKFVMDGGY-LD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIV 272 (288)
T ss_pred HHHHHhCCCCCCCCCCHH--------HHHHHHHcCCC-CC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 999998 78888763211 11111111100 00 0112236799999999999999999999999
Q ss_pred HHHHhc
Q 025011 235 EELDRL 240 (259)
Q Consensus 235 ~~l~~~ 240 (259)
+.+++.
T Consensus 273 ~~l~~~ 278 (288)
T cd05061 273 NLLKDD 278 (288)
T ss_pred HHHHhh
Confidence 998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=249.84 Aligned_cols=219 Identities=24% Similarity=0.313 Sum_probs=173.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++++++...+..++++||+++++|.+++..... ....++..+..++.|++.|+.|||+++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 126 (267)
T cd08228 47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR 126 (267)
T ss_pred HHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 4688999999999999999999999999999999999999999998864321 223577889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 127 ---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~ 201 (267)
T cd08228 127 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred ---eeCCCCCHHHEEEcCCCCEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhc
Confidence 9999999999999999999999999987654321 11223457889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|+.||...... .......... ...........+..+.+++.+||..+|.+|||+.++++.+++++
T Consensus 202 g~~p~~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 202 LQSPFYGDKMN------LFSLCQKIEQ---------CDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCCcccccc------HHHHHHHHhc---------CCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 99998652211 0111111000 00111111234467999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=248.38 Aligned_cols=211 Identities=27% Similarity=0.423 Sum_probs=167.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE-eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++|+|++++++++. .++..++++||+++++|.+++...... ..++..++.++.|++.||.|||+++
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (256)
T cd05082 44 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN 122 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46889999999999999999999764 456789999999999999998765432 3578899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++....... .....+..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 123 ---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 194 (256)
T cd05082 123 ---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 194 (256)
T ss_pred ---EeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999986543221 12234567999999988889999999999999999997
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||..... .......... .........++.+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 195 ~g~~p~~~~~~--------~~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 195 FGRVPYPRIPL--------KDVVPRVEKG----------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCCH--------HHHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 9999875221 0111110000 00011112346799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=247.46 Aligned_cols=214 Identities=27% Similarity=0.410 Sum_probs=168.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++.+.. ...+++|||+++++|.+++..... ..+++..+..++.|++.||.++|+.+
T Consensus 46 ~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~- 122 (262)
T cd05071 46 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN- 122 (262)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899999999999999999998754 567999999999999999976432 23578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||.+........ .......++..|+|||...+..++.++|+||||+++|++++
T Consensus 123 --i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~ 199 (262)
T cd05071 123 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 199 (262)
T ss_pred --ccccccCcccEEEcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543221 11122345678999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ........ ..........++.+.+++.+||+.+|.+|||+.++++.|+..
T Consensus 200 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 200 GRVPYPGMVNR--------EVLDQVER----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCCCCChH--------HHHHHHhc----------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 88888763210 00000000 000111223457799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=260.97 Aligned_cols=205 Identities=23% Similarity=0.262 Sum_probs=164.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~ 82 (259)
.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+ .+
T Consensus 41 ~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~~- 116 (325)
T cd05594 41 HTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKN- 116 (325)
T ss_pred HHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhcCC-
Confidence 467899999999999999999999999999999999999999998876542 6788999999999999999997 78
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||+|+++|+|++|
T Consensus 117 --ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG 192 (325)
T cd05594 117 --VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 192 (325)
T ss_pred --EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccC
Confidence 99999999999999999999999999865332211 12234589999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+.... .......... ... +...++.+.+++.+||+.||.+|+ ++.++++
T Consensus 193 ~~Pf~~~~~~--------~~~~~i~~~~-------~~~----p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 193 RLPFYNQDHE--------KLFELILMEE-------IRF----PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCCCCCHH--------HHHHHHhcCC-------CCC----CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 9999763211 0000000000 000 111336789999999999999997 8888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=255.93 Aligned_cols=221 Identities=19% Similarity=0.276 Sum_probs=162.4
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++..+...++||||+. ++|.+++..... .++...+..++.|++.||.|||+++
T Consensus 49 ~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~-- 123 (303)
T cd07869 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY-- 123 (303)
T ss_pred hHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46789999999999999999999999999999999995 688888765432 2567889999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++||||+||++|+|++|
T Consensus 124 -ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 200 (303)
T cd07869 124 -ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200 (303)
T ss_pred -eecCCCCHHHEEECCCCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999999999999999986543221 122334578999999998664 478899999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHh--hccchhh------hhhccccC--Cchh-------HHHHHHHHHHHHHhcccCCC
Q 025011 163 LKPGSGMALASNEGISMVQYFLYS--IENNSLR------QILNFQVA--DESE-------MEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~--~~~~-------~~~~~~~~~li~~~l~~~p~ 225 (259)
..||.+...... ......... .....+. ........ .... ...+..+.+++.+||+.||+
T Consensus 201 ~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~ 277 (303)
T cd07869 201 VAAFPGMKDIQD---QLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPK 277 (303)
T ss_pred CCCCCCCccHHH---HHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCch
Confidence 999987422110 000000000 0000000 00000000 0000 01125688999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.++++
T Consensus 278 ~R~s~~~~l~ 287 (303)
T cd07869 278 NRLSAQAALS 287 (303)
T ss_pred hccCHHHHhc
Confidence 9999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=247.19 Aligned_cols=219 Identities=24% Similarity=0.324 Sum_probs=174.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|++++++++|+|++++++++..++..+++|||+++++|.+++.... ....+++..+..++.+++.|+.+||+.+
T Consensus 47 ~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 126 (267)
T cd08224 47 QDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR 126 (267)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 568899999999999999999999999999999999999999999986532 2234678899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 127 ---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~ 201 (267)
T cd08224 127 ---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred ---EecCCcChhhEEECCCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHH
Confidence 9999999999999999999999999987554321 11223457888999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||...... ......... .. ..........+..+.++|.+||..+|.+|||+.+|++.++++.
T Consensus 202 g~~p~~~~~~~------~~~~~~~~~-~~--------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 202 LQSPFYGDKMN------LYSLCKKIE-KC--------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCcccCCcc------HHHHHhhhh-cC--------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 99998652210 000000000 00 0011111134467999999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=264.60 Aligned_cols=219 Identities=31% Similarity=0.412 Sum_probs=180.7
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+++|.+|++++++++|||||++||+......+++|||+|.||+|.+++++.+.. .+..+...++.+.+.||.|||+++
T Consensus 205 ~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~--v~~~ek~~~~~~AA~Gl~YLh~k~ 282 (474)
T KOG0194|consen 205 IKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKS--LPTLEKLRFCYDAARGLEYLHSKN 282 (474)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCC--CCHHHHHHHHHHHHhHHHHHHHCC
Confidence 356899999999999999999999999999999999999999999999988752 577999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccc-cccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT-KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++||||.+.|++++.++.+|++|||+++... ...... ..--+..|+|||.+....++.++||||+|+++||++
T Consensus 283 ---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 283 ---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred ---CcchhHhHHHheecCCCeEEeCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 9999999999999999999999999987543 111111 123557899999999989999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhh-ccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQIL-NFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
+ |..||.+.... .....+ .....-..+...+..+..++.+||..+|+.|||+.++.+.++
T Consensus 357 ~~g~~Py~g~~~~------------------~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~ 418 (474)
T KOG0194|consen 357 ENGAEPYPGMKNY------------------EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLE 418 (474)
T ss_pred ccCCCCCCCCCHH------------------HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHH
Confidence 9 78899984322 111111 111111222234477889999999999999999999999999
Q ss_pred hccccccc
Q 025011 239 RLKISHEN 246 (259)
Q Consensus 239 ~~~~~~~~ 246 (259)
.+.....+
T Consensus 419 ~~~~~~~~ 426 (474)
T KOG0194|consen 419 ALEKKKEA 426 (474)
T ss_pred HHHhcccc
Confidence 99888775
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=248.92 Aligned_cols=215 Identities=25% Similarity=0.382 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... .+++..++.++.|++.|+.+||+.+
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~- 126 (267)
T cd05066 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG- 126 (267)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976543 3578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++........... .....++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 127 --i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~ 204 (267)
T cd05066 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204 (267)
T ss_pred --EeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhc
Confidence 99999999999999999999999999876654322111 112223567999999988889999999999999999886
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... .. ....... ...+.....++.+.+++.+||+.+|.+|||+.++++.|+++
T Consensus 205 ~g~~p~~~~~~~-----~~---~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 205 YGERPYWEMSNQ-----DV---IKAIEEG----------YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCCCCcccCCHH-----HH---HHHHhCC----------CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 99998763211 00 0000000 00111122346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=246.29 Aligned_cols=212 Identities=26% Similarity=0.415 Sum_probs=168.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|+++++.++||||+++++++...+..+++|||+++++|.+++..... .+++..+..++.|++.++.|+|+++
T Consensus 37 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 113 (250)
T cd05085 37 IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN- 113 (250)
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999875432 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++|+||+|+++|++++
T Consensus 114 --~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~ 190 (250)
T cd05085 114 --CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSL 190 (250)
T ss_pred --eeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999986543221 111112234567999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|..||.+..... ..... .. .. ....+...+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus 191 g~~p~~~~~~~~-----~~~~~---~~-~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 191 GVCPYPGMTNQQ-----AREQV---EK-GY---------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCCCCCHHH-----HHHHH---Hc-CC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 899987632110 00000 00 00 00001123467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=251.11 Aligned_cols=213 Identities=21% Similarity=0.204 Sum_probs=167.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|+++++.++||||+++.+++..++..+++|||+++|+|.+++... .....+++..+..++.|++.||.|||+++
T Consensus 38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 117 (280)
T cd05608 38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR 117 (280)
T ss_pred HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34678999999999999999999999999999999999999998887442 22234688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 118 ---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~ 192 (280)
T cd05608 118 ---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA 192 (280)
T ss_pred ---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543221 1223468899999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
|+.||......... ..... ....... ..+...++.+.+++.+||+.||.+|| |++++++
T Consensus 193 g~~pf~~~~~~~~~----~~~~~---------~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 193 ARGPFRARGEKVEN----KELKQ---------RILNDSV--TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCCCCCCCcchhH----HHHHH---------hhcccCC--CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 99999763221100 00000 0000000 11122446799999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=247.53 Aligned_cols=214 Identities=25% Similarity=0.385 Sum_probs=171.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.. ...++++||+++++|.+++..... ..+++..++.++.|++.||.|||+++
T Consensus 41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~- 117 (257)
T cd05040 41 DDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR- 117 (257)
T ss_pred HHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC-
Confidence 578899999999999999999999988 889999999999999999977543 34688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++++|++
T Consensus 118 --i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t 195 (257)
T cd05040 118 --FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195 (257)
T ss_pred --ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHh
Confidence 999999999999999999999999998876543221 12223446788999999988889999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
|..||....... . ......... . ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus 196 ~g~~p~~~~~~~~-----~---~~~~~~~~~-------~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 196 YGEEPWAGLSGSQ-----I---LKKIDKEGE-------R--LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCCCCCCHHH-----H---HHHHHhcCC-------c--CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 999986532110 0 000000000 0 0001123467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=247.42 Aligned_cols=211 Identities=28% Similarity=0.440 Sum_probs=170.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+||+++++++......+++|||+++++|.+++...... ..++..+..++.|++.|+.|||+++
T Consensus 45 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~- 122 (256)
T cd05039 45 QAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRA-VITLAQQLGFALDVCEGMEYLEEKN- 122 (256)
T ss_pred HHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56889999999999999999999999888999999999999999999765432 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||.+........ ....+..|+|||.+....++.++|+||+|++++++++
T Consensus 123 --i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~ 195 (256)
T cd05039 123 --FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSF 195 (256)
T ss_pred --ccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999999999876532211 2234567999999988888999999999999999997
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||...... .. .. .... ......+...++.+.+++.+||..+|.+|||+.+++++|+++
T Consensus 196 g~~p~~~~~~~-----~~---~~-~~~~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 196 GRVPYPRIPLK-----DV---VP-HVEK---------GYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCCCCCCCHH-----HH---HH-HHhc---------CCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 99998753211 00 00 0000 000011112347799999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=249.86 Aligned_cols=218 Identities=23% Similarity=0.376 Sum_probs=171.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.. ...+++++|+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~- 129 (279)
T cd05109 54 KEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR- 129 (279)
T ss_pred HHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899999999999999999999875 456899999999999999976432 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...............++..|+|||...+..++.++||||||+++|+|++
T Consensus 130 --iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~ 207 (279)
T cd05109 130 --LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTF 207 (279)
T ss_pred --eeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999887654322212222235678999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||...... ..... +........+...+..+.+++.+||+.||.+|||+.++++.++++.
T Consensus 208 g~~p~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 208 GAKPYDGIPAR-----EIPDL-------------LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCCCCCCCCHH-----HHHHH-------------HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 88998752210 00010 0010011111123467899999999999999999999999998876
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 270 ~~~ 272 (279)
T cd05109 270 RDP 272 (279)
T ss_pred cCC
Confidence 554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=248.58 Aligned_cols=210 Identities=19% Similarity=0.346 Sum_probs=167.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..++++||+++++|.+++..... +++..+..++.|++.|+.+||+.+
T Consensus 49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lH~~~- 124 (263)
T cd06625 49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYLHSNM- 124 (263)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999876543 567888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++||||+|+++|++++
T Consensus 125 --i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 202 (263)
T cd06625 125 --IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202 (263)
T ss_pred --eecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999875543211111 123457789999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||...... ..... ...... ....+...+..+.+++.+||..+|.+|||+.++++
T Consensus 203 g~~p~~~~~~~-------~~~~~-~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 203 EKPPWAEFEAM-------AAIFK-IATQPT---------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCccccchH-------HHHHH-HhccCC---------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 99998753211 00000 000000 01111123467899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=255.56 Aligned_cols=209 Identities=23% Similarity=0.263 Sum_probs=162.4
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+ +||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~lH~~~- 116 (329)
T cd05588 41 WVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRK---LPEEHARFYSAEISLALNFLHERG- 116 (329)
T ss_pred HHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 477899999998 799999999999999999999999999999998865533 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 117 --ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g 192 (329)
T cd05588 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred --eEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHC
Confidence 9999999999999999999999999986422211 122334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
..||...............+...... ..... .+...+..+.+++.+||+.||.+|||+
T Consensus 193 ~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 193 RSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQIR--IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCcccccccccccccchHHHHHHHH--------cCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 99997532221111111111111111 11100 011233678999999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=249.21 Aligned_cols=223 Identities=24% Similarity=0.363 Sum_probs=169.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------cccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS---------QVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~ 73 (259)
+.|.+|+++++.++|||++++++++..++..+++|||+.+++|.+++..... ....++..++.++.|++.|
T Consensus 62 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a 141 (295)
T cd05097 62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG 141 (295)
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999865321 1235678889999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
+.|||+++ ++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+||||
T Consensus 142 l~~lH~~~---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG 218 (295)
T cd05097 142 MKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218 (295)
T ss_pred HHHHHhcC---eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHH
Confidence 99999999 999999999999999999999999998765433222223333456789999999888899999999999
Q ss_pred HHHHHHHh--CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 154 VLLAELLT--GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 154 ~il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
+++++|++ +..||....... .............. . .....+...++.+.+++.+||+.||.+|||+.
T Consensus 219 ~~l~el~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~-~------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~ 287 (295)
T cd05097 219 VTLWEMFTLCKEQPYSLLSDEQ----VIENTGEFFRNQGR-Q------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN 287 (295)
T ss_pred HHHHHHHHcCCCCCCcccChHH----HHHHHHHhhhhccc-c------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 99999998 567776522110 00000000000000 0 00000111336799999999999999999999
Q ss_pred HHHHHHHh
Q 025011 232 QVSEELDR 239 (259)
Q Consensus 232 ~il~~l~~ 239 (259)
+|++.|++
T Consensus 288 ~i~~~l~~ 295 (295)
T cd05097 288 KIHHFLRE 295 (295)
T ss_pred HHHHHHhC
Confidence 99998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=249.62 Aligned_cols=220 Identities=24% Similarity=0.372 Sum_probs=173.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.. ...+++|||+++|+|.+++...... +++..+..++.|++.|+.|||+.+
T Consensus 54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~--~~~~~~~~~~~qi~~~l~~LH~~~- 129 (279)
T cd05057 54 KEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR- 129 (279)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCC--CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999887 7889999999999999999765332 578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+....++.++|+||+|++++++++
T Consensus 130 --i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~ 207 (279)
T cd05057 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTF 207 (279)
T ss_pred --EEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999876553322211122224567999999987888999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... +....... . .....+...+..+.+++.+||..+|.+|||+.++++.++++.
T Consensus 208 g~~p~~~~~~~--------~~~~~~~~-~---------~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 208 GAKPYEGIPAV--------EIPDLLEK-G---------ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CCCCCCCCCHH--------HHHHHHhC-C---------CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 99998763211 00111110 0 000111112356889999999999999999999999999986
Q ss_pred ccccc
Q 025011 242 ISHEN 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.....
T Consensus 270 ~~~~~ 274 (279)
T cd05057 270 RDPQR 274 (279)
T ss_pred hCCcc
Confidence 65443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=249.76 Aligned_cols=223 Identities=26% Similarity=0.386 Sum_probs=171.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--------cccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------QVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|++++++++||||+++++++..++..+++||++.+++|.+++..... ...+++..++.++.|++.||
T Consensus 64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05051 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM 143 (296)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence 4688999999999999999999999999999999999999999999976541 12468889999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.|||+++ ++|+||+|+||+++.++.++++|||++................++..|+|||.+.+..++.++||||||+
T Consensus 144 ~~LH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 144 RYLESLN---FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220 (296)
T ss_pred HHHHHcC---ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH
Confidence 9999999 9999999999999999999999999987654332222233344677899999998888999999999999
Q ss_pred HHHHHHh--CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLT--GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|+|++ +..||...... ............... ......+...+..+.+++.+||+.||.+|||+.+
T Consensus 221 ~l~el~~~~~~~p~~~~~~~-----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~e 289 (296)
T cd05051 221 TLWEILTLCREQPYEHLTDQ-----QVIENAGHFFRDDGR------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFRE 289 (296)
T ss_pred HHHHHHhcCCCCCCCCcChH-----HHHHHHHhccccccc------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHH
Confidence 9999998 66777652210 000101000000000 0001111223467999999999999999999999
Q ss_pred HHHHHHh
Q 025011 233 VSEELDR 239 (259)
Q Consensus 233 il~~l~~ 239 (259)
|++.|++
T Consensus 290 l~~~L~~ 296 (296)
T cd05051 290 IHLFLQR 296 (296)
T ss_pred HHHHhcC
Confidence 9988763
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=256.73 Aligned_cols=224 Identities=21% Similarity=0.291 Sum_probs=162.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
.+.+|+++++.++||||+++++++... ...+++|||+ +++|.+++..... +++..+..++.|++.||.|||
T Consensus 45 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 45 RILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD---LTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred HHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhccc---CCHHHHHHHHHHHHHHHHHHH
Confidence 478899999999999999999988643 2479999999 5689998876543 678999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhcc--CCcccccchhhHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~i 155 (259)
+++ ++|+||||+||+++.++.++|+|||+++....... ........++..|+|||++.+ ..++.++||||+||+
T Consensus 121 ~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 TAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HCC---eecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 999 99999999999999999999999999875433211 112234468999999999865 568899999999999
Q ss_pred HHHHHhCCCCCCCCccccccch-------hHHHHHHHhhccchhhhhh---ccccCCch---hHHHHHHHHHHHHHhccc
Q 025011 156 LAELLTGLKPGSGMALASNEGI-------SMVQYFLYSIENNSLRQIL---NFQVADES---EMEEIETVAGLASKCLSL 222 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~~---~~~~~~~~~~li~~~l~~ 222 (259)
+|+|++|+.||.+......... ........ .......... ........ ....++.+.+++.+||+.
T Consensus 198 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR-VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH-hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCc
Confidence 9999999999976432110000 00000000 0000000000 00000000 011235688999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||+.++++
T Consensus 277 ~P~~Rpt~~e~l~ 289 (338)
T cd07859 277 DPKDRPTAEEALA 289 (338)
T ss_pred CcccCCCHHHHhc
Confidence 9999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=247.19 Aligned_cols=219 Identities=24% Similarity=0.317 Sum_probs=173.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.|+.|||+++
T Consensus 47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 126 (267)
T cd08229 47 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR 126 (267)
T ss_pred HHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 468899999999999999999999999999999999999999999987532 2234678899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 127 ---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 201 (267)
T cd08229 127 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201 (267)
T ss_pred ---eecCCCCHHHEEEcCCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999887654321 11223457889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ...... ..............++.+.+++.+||..||.+|||+.+|++.++++.
T Consensus 202 g~~p~~~~~~~~------~~~~~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 202 LQSPFYGDKMNL------YSLCKK---------IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCcccccchH------HHHhhh---------hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 999987522110 000000 00000011111234567999999999999999999999999988763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=247.92 Aligned_cols=215 Identities=25% Similarity=0.387 Sum_probs=170.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++.+++...+..+++|||+++++|.+++..... .+++..+..++.|++.|+.|||+.+
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~- 127 (268)
T cd05063 51 QDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN- 127 (268)
T ss_pred HHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976432 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++........... ......+..|+|||++....++.++|+||+|+++|++++
T Consensus 128 --i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~ 205 (268)
T cd05063 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205 (268)
T ss_pred --eeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543221111 111223457999999988888999999999999999997
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||...... ......... ...+.....+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 206 ~g~~p~~~~~~~--------~~~~~i~~~----------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 206 FGERPYWDMSNH--------EVMKAINDG----------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCCCCCcCCHH--------HHHHHHhcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99998653210 111111100 01111112346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=247.65 Aligned_cols=215 Identities=27% Similarity=0.421 Sum_probs=171.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..+...+++|||+++++|.+++...... .+++..+..++.+++.|+.|||+++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~-~~~~~~~~~~~~~i~~al~~lh~~~- 123 (261)
T cd05034 46 EAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGK-KLRLPQLVDMAAQIAEGMAYLESRN- 123 (261)
T ss_pred HHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999999999999889999999999999999999765432 2678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||.+...... ..........+..|+|||.+.+..++.++|+||+|++++++++
T Consensus 124 --i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 124 --YIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred --cccCCcchheEEEcCCCCEEECccccceeccch-hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765432 1111112234568999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|+.||.+.... .. ....... .....+...++.+.+++.+||+.+|.+|||++++++.|+++
T Consensus 201 g~~p~~~~~~~-----~~---~~~~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 201 GRVPYPGMTNR-----EV---LEQVERG----------YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCCCHH-----HH---HHHHHcC----------CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 99998763210 00 0100000 00011111246799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=248.50 Aligned_cols=217 Identities=24% Similarity=0.356 Sum_probs=171.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+ ...+++|||+++++|.+++..... .+++..++.++.|++.|+.|||+.+
T Consensus 52 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~- 127 (270)
T cd05056 52 EKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR- 127 (270)
T ss_pred HHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 568899999999999999999998875 557899999999999999976543 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||++........ .......++..|+|||.+....++.++||||||++++++++
T Consensus 128 --~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 204 (270)
T cd05056 128 --FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILML 204 (270)
T ss_pred --eeccccChheEEEecCCCeEEccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHc
Confidence 99999999999999999999999999876544321 11222234568999999888889999999999999999996
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ........... ..+...+..+.+++.+|+..+|.+|||+.++++.|+++.
T Consensus 205 g~~pf~~~~~~~--------~~~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 205 GVKPFQGVKNND--------VIGRIENGERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred CCCCCCCCCHHH--------HHHHHHcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999997632110 00000000000 011123467999999999999999999999999999987
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 267 ~~~ 269 (270)
T cd05056 267 QEE 269 (270)
T ss_pred hcc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=256.41 Aligned_cols=200 Identities=26% Similarity=0.254 Sum_probs=160.9
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+ +||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~---l~~~~~~~~~~ql~~~L~~lH~~~- 116 (320)
T cd05590 41 CTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEITSALMFLHDKG- 116 (320)
T ss_pred HHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 456788888876 699999999999999999999999999999998876543 678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 117 --ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (320)
T cd05590 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG 192 (320)
T ss_pred --eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC
Confidence 9999999999999999999999999986533221 122334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
+.||.+.... ........ .... .+...+..+.+++.+||+.||.+||++
T Consensus 193 ~~Pf~~~~~~--------~~~~~i~~---------~~~~--~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 193 HAPFEAENED--------DLFEAILN---------DEVV--YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCCHH--------HHHHHHhc---------CCCC--CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 9999863211 11111110 0000 011133678999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=262.05 Aligned_cols=211 Identities=22% Similarity=0.286 Sum_probs=168.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++..++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g- 121 (350)
T cd05573 46 AHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG- 121 (350)
T ss_pred HHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 357889999999999999999999999999999999999999999997763 2678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc---------------------------cccccccccCcccccCc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN---------------------------QTAMTTKKIGTFVNLDP 135 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~---------------------------~~~~~~~~~~~~~y~aP 135 (259)
++|+||||+||+++.++.++|+|||++....... .........|+..|+||
T Consensus 122 --iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 122 --FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred --eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence 9999999999999999999999999987655432 01122344689999999
Q ss_pred chhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHH
Q 025011 136 EYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGL 215 (259)
Q Consensus 136 E~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 215 (259)
|.+.+..++.++|||||||++|+|++|+.||.+..... ....... +. .....+.....++.+.++
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~--------~~~~i~~------~~-~~~~~p~~~~~~~~~~~l 264 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE--------TYNKIIN------WK-ESLRFPPDPPVSPEAIDL 264 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH--------HHHHHhc------cC-CcccCCCCCCCCHHHHHH
Confidence 99999889999999999999999999999998632110 0000000 00 000000111134779999
Q ss_pred HHHhcccCCCCCCC-HHHHHH
Q 025011 216 ASKCLSLSGRRRPT-MKQVSE 235 (259)
Q Consensus 216 i~~~l~~~p~~Rpt-~~~il~ 235 (259)
|.+||. ||.+||+ +.++++
T Consensus 265 i~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 265 ICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred HHHHcc-ChhhcCCCHHHHhc
Confidence 999997 9999999 999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=246.49 Aligned_cols=214 Identities=24% Similarity=0.385 Sum_probs=168.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.+|+.+++.++|+|++++++++. ++..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~al~~LH~~~- 122 (260)
T cd05067 46 EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGI-KLTINKLIDMAAQIAEGMAFIERKN- 122 (260)
T ss_pred HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 46889999999999999999999874 45789999999999999998765432 3677899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||++....... ........++..|+|||.+....++.++||||+|+++|++++
T Consensus 123 --i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~ 199 (260)
T cd05067 123 --YIHRDLRAANILVSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTY 199 (260)
T ss_pred --eecccccHHhEEEcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654221 111122335678999999988888999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... .... .... ......+...+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 200 g~~p~~~~~~~-----~~~~---~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 200 GRIPYPGMTNP-----EVIQ---NLER----------GYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCChH-----HHHH---HHHc----------CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 99999763210 0000 0000 000001112336799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=246.11 Aligned_cols=214 Identities=23% Similarity=0.401 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++.. ...+++|||+++++|.+++..... ...++..+..++.|++.|+.+||+.+
T Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~- 122 (260)
T cd05073 46 EAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN- 122 (260)
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999877 778999999999999999976533 23577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||.+....... ........++..|+|||++....++.++|+||||+++|++++
T Consensus 123 --i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 123 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred --ccccccCcceEEEcCCCcEEECCCcceeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 9999999999999999999999999987654321 111222345677999999988888999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.+.. ....... . . .........+..+.+++.+||+.+|.+||++.++.+.|+++
T Consensus 200 g~~p~~~~~~~-----~~~~~~~---~-~---------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 200 GRIPYPGMSNP-----EVIRALE---R-G---------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCCCCCCCHH-----HHHHHHh---C-C---------CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 89998763211 0011000 0 0 00011112346799999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=256.02 Aligned_cols=209 Identities=24% Similarity=0.263 Sum_probs=161.8
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.+|..++.++ +||||+++++++..++..++||||+++++|..++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~~l~~lH~~~- 116 (329)
T cd05618 41 WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116 (329)
T ss_pred HHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 467888888877 899999999999999999999999999999988866533 678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||+++...... .......|+..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 117 --ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 192 (329)
T cd05618 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192 (329)
T ss_pred --eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhC
Confidence 9999999999999999999999999986532211 122334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
..||...............+...... ..... .+...+..+.+++.+||+.||.+|||+
T Consensus 193 ~~Pf~~~~~~~~~~~~~~~~~~~~i~--------~~~~~--~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 193 RSPFDIVGSSDNPDQNTEDYLFQVIL--------EKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCccCCCcCCcccccHHHHHHHHh--------cCCCC--CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 99996422211111111111111110 00000 111233668899999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=247.74 Aligned_cols=215 Identities=22% Similarity=0.383 Sum_probs=169.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... .+++..++.++.|++.|+.|||+++
T Consensus 50 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g- 126 (269)
T cd05065 50 RDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN- 126 (269)
T ss_pred HHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976533 3578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccc-cc--cCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT-KK--IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~-~~--~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++++|||++............. .. ..+..|+|||.+.+..++.++||||+|+++|++
T Consensus 127 --~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~ 204 (269)
T cd05065 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204 (269)
T ss_pred --EeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence 9999999999999999999999999987554322111111 11 123579999999888899999999999999998
Q ss_pred Hh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++ |..||...... ...... ... .....+...+..+.+++.+||..+|.+||++.+++..|+
T Consensus 205 l~~g~~p~~~~~~~-----~~~~~i---~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 266 (269)
T cd05065 205 MSYGERPYWDMSNQ-----DVINAI---EQD----------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266 (269)
T ss_pred hcCCCCCCCCCCHH-----HHHHHH---HcC----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 86 99998763211 111111 000 000111223467899999999999999999999999988
Q ss_pred hc
Q 025011 239 RL 240 (259)
Q Consensus 239 ~~ 240 (259)
++
T Consensus 267 ~~ 268 (269)
T cd05065 267 KM 268 (269)
T ss_pred hh
Confidence 65
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=246.82 Aligned_cols=210 Identities=23% Similarity=0.309 Sum_probs=168.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++.+..++..+++|||+++++|.+++...... .+++..+..++.|++.|+.+||+++
T Consensus 43 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~i~~al~~lH~~~- 120 (255)
T cd08219 43 EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGK-LFPEDTILQWFVQMCLGVQHIHEKR- 120 (255)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 46788999999999999999999999999999999999999999988654332 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||.+........ ......++..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 121 --i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g 196 (255)
T cd08219 121 --VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL 196 (255)
T ss_pred --cccCCCCcceEEECCCCcEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc
Confidence 99999999999999999999999999876543211 12234588889999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||...... ....... ..... ..+...+..+.+++.+||+.||.+|||+.+++..
T Consensus 197 ~~p~~~~~~~--------~~~~~~~-~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 197 KHPFQANSWK--------NLILKVC-QGSYK---------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCCCCCCCHH--------HHHHHHh-cCCCC---------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 9999762210 0011100 01110 0111234568999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=261.11 Aligned_cols=225 Identities=21% Similarity=0.271 Sum_probs=168.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
...+|++++++++||||+++++++...+..+++||++. ++|.+++.... .+++..++.++.|++.||.|||+++
T Consensus 132 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~ql~~aL~~LH~~g-- 205 (392)
T PHA03207 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG---PLPLEQAITIQRRLLEALAYLHGRG-- 205 (392)
T ss_pred cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 45789999999999999999999999999999999994 68888885432 3678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|+|+||||+||+++.++.++|+|||++................|+..|+|||++.+..++.++||||+||++|+|++|+
T Consensus 206 -ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 284 (392)
T PHA03207 206 -IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284 (392)
T ss_pred -ccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999999999999999999987665443333334456999999999999888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhc------cc---hh----hhhh---ccccCCc---hhHHHHHHHHHHHHHhcccCC
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIE------NN---SL----RQIL---NFQVADE---SEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~------~~---~~----~~~~---~~~~~~~---~~~~~~~~~~~li~~~l~~~p 224 (259)
.||.+...... ...+......... .. .. .... ......+ .....+..+.++|.+||..||
T Consensus 285 ~pf~~~~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp 363 (392)
T PHA03207 285 VTLFGKQVKSS-SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ 363 (392)
T ss_pred CCCCCCCCCCc-HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence 99977433211 1111111110000 00 00 0000 0000000 001123568899999999999
Q ss_pred CCCCCHHHHHHH
Q 025011 225 RRRPTMKQVSEE 236 (259)
Q Consensus 225 ~~Rpt~~~il~~ 236 (259)
.+|||+.+++..
T Consensus 364 ~~Rpsa~e~l~~ 375 (392)
T PHA03207 364 EFRPSAQDILSL 375 (392)
T ss_pred hhCCCHHHHhhC
Confidence 999999999753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=242.09 Aligned_cols=226 Identities=19% Similarity=0.242 Sum_probs=171.1
Q ss_pred HHHHHHHHhcCCCcc-ccccceeEEeCC------cceEEEEecCCCChhhhhhccCCc-ccCCHHHHHHHHHHHHHHHHH
Q 025011 5 FQHELRVVSQINHKN-VVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQ-VLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~-iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~ 76 (259)
..+|+.+|+.|+|+| |+++++++...+ ..++||||+ ..+|..++...+.. ...+...+..++.||+.||+|
T Consensus 57 aiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~ 135 (323)
T KOG0594|consen 57 AIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAF 135 (323)
T ss_pred hhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHH
Confidence 468999999999999 999999998877 789999999 45999999876632 224557899999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
||+++ |+||||||+||+++++|.+||+|||+++.+....+ .....+.|.+|+|||++.+. .|+...||||+||+
T Consensus 136 ~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI 210 (323)
T KOG0594|consen 136 LHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI 210 (323)
T ss_pred HHhCC---eecccCCcceEEECCCCcEeeeccchHHHhcCCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence 99999 99999999999999999999999999996654322 24556799999999999988 59999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhc--cchhhhhh---ccc-----c--CCchhHH---HHHHHHHHHHHhc
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQIL---NFQ-----V--ADESEME---EIETVAGLASKCL 220 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~---~~~-----~--~~~~~~~---~~~~~~~li~~~l 220 (259)
+.+|++++..|++.+. .......+..... +..+.... +.. . ....... ..+...+++.+||
T Consensus 211 faEm~~~~~LFpG~se----~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L 286 (323)
T KOG0594|consen 211 FAEMFTRRPLFPGDSE----IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLL 286 (323)
T ss_pred HHHHHhCCCCCCCCcH----HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHh
Confidence 9999999999998433 1111111111111 11111110 000 0 0000011 1146889999999
Q ss_pred ccCCCCCCCHHHHHHH--HHhc
Q 025011 221 SLSGRRRPTMKQVSEE--LDRL 240 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~~--l~~~ 240 (259)
+.+|.+|.|++.++.. +..+
T Consensus 287 ~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 287 QYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred ccCcccCcCHHHHhcChhhccc
Confidence 9999999999999875 4444
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=255.84 Aligned_cols=211 Identities=23% Similarity=0.256 Sum_probs=164.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.+ +||||+++++++..++..+++|||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ 125 (332)
T cd05614 49 EHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILALEHLHKLG 125 (332)
T ss_pred HHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3577899999999 589999999999999999999999999999999875433 577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~ 160 (259)
++||||||+||+++.++.++|+|||++........ .......|+..|+|||++.+.. ++.++||||||+++|+|+
T Consensus 126 ---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 201 (332)
T cd05614 126 ---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201 (332)
T ss_pred ---cEecCCCHHHeEECCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhh
Confidence 99999999999999999999999999876543211 1223346899999999987654 788999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
+|..||.......... ..... +.... ...+...++.+.+++.+||+.||++|| +++++++
T Consensus 202 tg~~pf~~~~~~~~~~----~~~~~---------~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 202 TGASPFTLEGERNTQS----EVSRR---------ILKCD--PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred cCCCCCCCCCCCCCHH----HHHHH---------HhcCC--CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 9999997532211100 00000 00000 001112346789999999999999999 6667653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.89 Aligned_cols=226 Identities=19% Similarity=0.258 Sum_probs=164.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|++++++++|+||+++++++..++..+++|+++ .++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 206 ~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g-- 280 (461)
T PHA03211 206 SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG-- 280 (461)
T ss_pred CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4678999999999999999999999999999999999 4688888865432 3688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|+|+||||+||+++.++.++|+|||+++...............|+..|+|||++.+..++.++|||||||++|+|++|.
T Consensus 281 -IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 281 -IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred -EEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999987654322222222346899999999999888999999999999999999987
Q ss_pred CCCCCCccccccc---hhHHHHHHHhhc-cchhh---------hhhc-------cccCC---chhHHHHHHHHHHHHHhc
Q 025011 164 KPGSGMALASNEG---ISMVQYFLYSIE-NNSLR---------QILN-------FQVAD---ESEMEEIETVAGLASKCL 220 (259)
Q Consensus 164 ~p~~~~~~~~~~~---~~~~~~~~~~~~-~~~~~---------~~~~-------~~~~~---~~~~~~~~~~~~li~~~l 220 (259)
.++.......... ............ ..... .... ..... .........+.+||.+||
T Consensus 360 ~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 439 (461)
T PHA03211 360 ASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRAL 439 (461)
T ss_pred CCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHc
Confidence 6543321111100 111111110000 00000 0000 00000 000012346889999999
Q ss_pred ccCCCCCCCHHHHHH
Q 025011 221 SLSGRRRPTMKQVSE 235 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~ 235 (259)
+.||.+|||+.|+++
T Consensus 440 ~~DP~~RPsa~elL~ 454 (461)
T PHA03211 440 TFDGARRPSAAELLR 454 (461)
T ss_pred ccChhhCcCHHHHhh
Confidence 999999999999976
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=247.29 Aligned_cols=209 Identities=24% Similarity=0.425 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++...+..++++||+++++|.+++..... +++..+..++.|++.|+.+||+++
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~l~~~l~~lH~~~- 126 (267)
T cd06628 51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA---FEETLVRNFVRQILKGLNYLHNRG- 126 (267)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC---ccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 4688999999999999999999999999999999999999999999976532 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc----ccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||+|+||+++.++.++|+|||.++......... ......++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 127 --ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 204 (267)
T cd06628 127 --IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204 (267)
T ss_pred --cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence 9999999999999999999999999987665321111 1122347789999999988888999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+.... .... .... ......+...+..+.++|.+||+.||.+|||+.++++
T Consensus 205 l~~g~~p~~~~~~~-------~~~~----------~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 205 MLTGKHPFPDCTQL-------QAIF----------KIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HhhCCCCCCCccHH-------HHHH----------HHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99999999863211 0000 0000 0000111223467899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=255.81 Aligned_cols=205 Identities=21% Similarity=0.231 Sum_probs=163.7
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|.+++..+ +||||+++++++..++..|+||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 116 (321)
T cd05591 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---FDEPRSRFYAAEVTLALMFLHRHG- 116 (321)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 466788888876 799999999999999999999999999999998876543 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||+|+++|+|++|
T Consensus 117 --ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg 192 (321)
T cd05591 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAG 192 (321)
T ss_pred --eeccCCCHHHeEECCCCCEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcC
Confidence 9999999999999999999999999987543221 122334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-------TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------t~~~il~ 235 (259)
..||.+.... ........ .... .+...++.+.+++.+||+.||.+|| ++.++++
T Consensus 193 ~~Pf~~~~~~--------~~~~~i~~---------~~~~--~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 193 QPPFEADNED--------DLFESILH---------DDVL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCCCHH--------HHHHHHHc---------CCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 9999863211 11111111 0000 0111236789999999999999999 7777753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=259.16 Aligned_cols=218 Identities=24% Similarity=0.399 Sum_probs=170.7
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
+.+.+|++++..+. ||||+++++++...+..++||||+++|+|.+++.....
T Consensus 85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (401)
T cd05107 85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR 164 (401)
T ss_pred HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence 46889999999997 99999999999999999999999999999999865321
Q ss_pred --------------------------------------------------------------------cccCCHHHHHHH
Q 025011 55 --------------------------------------------------------------------QVLRNWKTCLRI 66 (259)
Q Consensus 55 --------------------------------------------------------------------~~~~~~~~~~~i 66 (259)
...+++..+..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 244 (401)
T cd05107 165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF 244 (401)
T ss_pred ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence 123466778889
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
+.|++.||.|||+.+ ++|+||||.||+++.++.++|+|||+++...............++..|+|||.+.+..++.+
T Consensus 245 ~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 321 (401)
T cd05107 245 SYQVANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL 321 (401)
T ss_pred HHHHHHHHHHHhcCC---cCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH
Confidence 999999999999999 99999999999999999999999999876543222112223346788999999988889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 147 SDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 147 ~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+|+||+|+++|+|++ |..||....... ........+ .....+...+..+.+++.+||..+|.
T Consensus 322 ~DvwslGvil~e~l~~g~~P~~~~~~~~--------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~ 384 (401)
T cd05107 322 SDVWSFGILLWEIFTLGGTPYPELPMNE--------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFE 384 (401)
T ss_pred hHHHHHHHHHHHHHHcCCCCCCCCCchH--------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChh
Confidence 999999999999998 888987532110 000000000 00011112346799999999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 025011 226 RRPTMKQVSEELDRL 240 (259)
Q Consensus 226 ~Rpt~~~il~~l~~~ 240 (259)
+||++++|++.|+++
T Consensus 385 ~RPs~~ell~~L~~~ 399 (401)
T cd05107 385 IRPDFSQLVHLVGDL 399 (401)
T ss_pred HCcCHHHHHHHHHHH
Confidence 999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=254.62 Aligned_cols=205 Identities=25% Similarity=0.270 Sum_probs=164.3
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|.++++.+ +||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~~l~~LH~~~- 116 (318)
T cd05570 41 CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR---FDEPRARFYAAEIVLGLQFLHERG- 116 (318)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 466788899888 699999999999999999999999999999998876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||+||++|+|++|
T Consensus 117 --ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G 192 (318)
T cd05570 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192 (318)
T ss_pred --eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence 9999999999999999999999999986432211 112234588999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM-----KQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-----~~il~ 235 (259)
..||.+.... ........ .... .+...++.+.++|.+||..||.+|||+ .++++
T Consensus 193 ~~pf~~~~~~--------~~~~~i~~---------~~~~--~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 193 QSPFEGDDED--------ELFQSILE---------DEVR--YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCCCCCCHH--------HHHHHHHc---------CCCC--CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 9999763211 00111100 0000 011234678999999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=245.22 Aligned_cols=216 Identities=26% Similarity=0.400 Sum_probs=165.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE-eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++||||+++++++. .++..++++||+.+++|.+++...... .++..+..++.|++.|+.|||+.+
T Consensus 41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~ 118 (262)
T cd05058 41 EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQVAKGMEYLASKK 118 (262)
T ss_pred HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCC--CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46788999999999999999999775 455689999999999999999764332 356778889999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc--ccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|+|
T Consensus 119 ---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 195 (262)
T cd05058 119 ---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 195 (262)
T ss_pred ---ccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHH
Confidence 99999999999999999999999999875432211 1111122356789999999888899999999999999999
Q ss_pred HhC-CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LTG-LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++| .+||..... ...... ..... ....+...++.+.+++.+||..+|++|||+.++++.++
T Consensus 196 ~~~~~~~~~~~~~-----~~~~~~---~~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~ 257 (262)
T cd05058 196 MTRGAPPYPDVDS-----FDITVY---LLQGR----------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIE 257 (262)
T ss_pred HcCCCCCCCCCCH-----HHHHHH---HhcCC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHH
Confidence 995 566654211 011111 10000 00001112367999999999999999999999999998
Q ss_pred hcc
Q 025011 239 RLK 241 (259)
Q Consensus 239 ~~~ 241 (259)
++.
T Consensus 258 ~~~ 260 (262)
T cd05058 258 QIF 260 (262)
T ss_pred HHh
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=257.76 Aligned_cols=207 Identities=22% Similarity=0.303 Sum_probs=159.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++++.++|+||+++++++..++..++||||+++++|.+.. ..++..+..++.|++.||.|||+++
T Consensus 116 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~ 188 (353)
T PLN00034 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH 188 (353)
T ss_pred HHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356889999999999999999999999999999999999999986532 1355778899999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLL 156 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il 156 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.. ...+.++|||||||++
T Consensus 189 ---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil 263 (353)
T PLN00034 189 ---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSI 263 (353)
T ss_pred ---EeecCCCHHHEEEcCCCCEEEcccccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHH
Confidence 9999999999999999999999999987654321 11233468999999998743 2345689999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+|++|+.||...... ........... ..........+..+.++|.+||+.||.+|||+.++++
T Consensus 264 ~el~~g~~pf~~~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 264 LEFYLGRFPFGVGRQG-----DWASLMCAICM----------SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred HHHHhCCCCCCCCCCc-----cHHHHHHHHhc----------cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999742111 00000000000 0001111223467999999999999999999999975
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=245.28 Aligned_cols=219 Identities=26% Similarity=0.382 Sum_probs=162.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc--ccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ--VLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
..+.+|+.+++.++||||+++++.+......+++|||+++|+|.+++...... ...++..+..++.|++.|+.|||++
T Consensus 40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 119 (269)
T cd05042 40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119 (269)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence 35788999999999999999999999999999999999999999999765321 2235677889999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-------CCcccccchhhHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-------GKLTEKSDVYSFG 153 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG 153 (259)
+ ++|+||||+||+++.++.++++|||++................++..|+|||++.. ..++.++||||+|
T Consensus 120 ~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG 196 (269)
T cd05042 120 D---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLG 196 (269)
T ss_pred C---EecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHH
Confidence 9 99999999999999999999999999865432211111222345667999998743 3467899999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||...... ........... ..+.... .....++.+.+++..|+ .||.+|||+++
T Consensus 197 ~~l~el~~~~~~p~~~~~~~--------~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~ 262 (269)
T cd05042 197 VTMWELFTAADQPYPDLSDE--------QVLKQVVREQD-IKLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEE 262 (269)
T ss_pred HHHHHHHhCCCCCCCcCCHH--------HHHHHHhhccC-ccCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHH
Confidence 99999999 77888753210 00111111100 0011111 11123366788899998 59999999999
Q ss_pred HHHHHH
Q 025011 233 VSEELD 238 (259)
Q Consensus 233 il~~l~ 238 (259)
|++.+.
T Consensus 263 v~~~l~ 268 (269)
T cd05042 263 VHELLT 268 (269)
T ss_pred HHHHhc
Confidence 998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=252.47 Aligned_cols=208 Identities=23% Similarity=0.238 Sum_probs=162.4
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.+|+.++.++ +||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.|+.|||+++
T Consensus 41 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qi~~al~~lH~~~- 116 (327)
T cd05617 41 WVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LPEEHARFYAAEICIALNFLHERG- 116 (327)
T ss_pred HHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 477899999888 699999999999999999999999999999998875533 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 117 --ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g 192 (327)
T cd05617 117 --IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 192 (327)
T ss_pred --eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhC
Confidence 9999999999999999999999999986432211 122334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
..||......... ........... ..... .+...+..+.+++.+||+.||.+|+++.
T Consensus 193 ~~pf~~~~~~~~~--~~~~~~~~~~~--------~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 193 RSPFDIITDNPDM--NTEDYLFQVIL--------EKPIR--IPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCccCCCccc--ccHHHHHHHHH--------hCCCC--CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 9999753221111 01111111110 00000 1112336688999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=255.60 Aligned_cols=200 Identities=27% Similarity=0.291 Sum_probs=158.6
Q ss_pred HHHHHH-HHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELR-VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+..|.. +++.++||||+++++++...+..++||||+++++|.+++..... +++..+..++.||+.||.|||+++
T Consensus 42 ~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~g-- 116 (323)
T cd05575 42 IMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSLN-- 116 (323)
T ss_pred HHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 334443 56788999999999999999999999999999999999876543 577889999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++||||||+++|+|++|.
T Consensus 117 -ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~ 193 (323)
T cd05575 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGL 193 (323)
T ss_pred -eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCC
Confidence 999999999999999999999999998653221 11223446899999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
.||.+.+.. +... .+...... .....++.+.+++.+||+.||.+||++.
T Consensus 194 ~pf~~~~~~--------~~~~---------~i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 194 PPFYSRDTA--------EMYD---------NILNKPLR--LKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHH--------HHHH---------HHHcCCCC--CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 999763211 0000 01111000 0112246799999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=248.27 Aligned_cols=220 Identities=21% Similarity=0.266 Sum_probs=162.3
Q ss_pred HHHHHHHHHhcC---CCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI---NHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|+.+++.+ +||||+++++++.. ....+++|||+. ++|.+++....... +++..+..++.|++.||.
T Consensus 47 ~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~ 124 (290)
T cd07862 47 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLD 124 (290)
T ss_pred HHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCC-CCHHHHHHHHHHHHHHHH
Confidence 466788887776 69999999998853 346899999995 58999987654332 578899999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ ++|+||||+||+++.++.++|+|||++...... .......++..|+|||.+.+..++.++||||+|++
T Consensus 125 ~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 198 (290)
T cd07862 125 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198 (290)
T ss_pred HHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHH
Confidence 999999 999999999999999999999999998765432 12234458899999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchhh-------hhhccccCCc---hhHHHHHHHHHHHHHhcccC
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSLR-------QILNFQVADE---SEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-------~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~ 223 (259)
+|+|++|.+||.+..... .......... ....+. ..+....... .....++.+.+++.+||+.|
T Consensus 199 l~el~~g~~~f~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 274 (290)
T cd07862 199 FAEMFRRKPLFRGSSDVD----QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 274 (290)
T ss_pred HHHHHcCCCCcCCCCHHH----HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccC
Confidence 999999999998743211 1111110000 000000 0000000000 00123466889999999999
Q ss_pred CCCCCCHHHHHH
Q 025011 224 GRRRPTMKQVSE 235 (259)
Q Consensus 224 p~~Rpt~~~il~ 235 (259)
|++|||+.++++
T Consensus 275 P~~R~s~~~~l~ 286 (290)
T cd07862 275 PAKRISAYSALS 286 (290)
T ss_pred chhcCCHHHHhc
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=258.01 Aligned_cols=216 Identities=24% Similarity=0.381 Sum_probs=176.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.=..+++=|++|+||||+.+.|+|...--+|||||||..|.|.+.|+..... .......|..+|+.|+.|||.+.
T Consensus 156 ~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~i---tp~llv~Wsk~IA~GM~YLH~hK 232 (904)
T KOG4721|consen 156 RELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPI---TPSLLVDWSKGIAGGMNYLHLHK 232 (904)
T ss_pred hhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCcc---CHHHHHHHHHHhhhhhHHHHHhh
Confidence 455566889999999999999999999988899999999999999999887653 44778899999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+|||||.-||+|+.+..+||+|||-++..... ...-.+.||..|||||++...+.+.|+||||||+++|+|+|
T Consensus 233 ---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 233 ---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred ---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 999999999999999999999999998776543 22234579999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.+...- .+..+. ..+.-..+..+++.+.-|++.||+-.|.+||++++|+.-++=..
T Consensus 307 ~EiPYkdVdssAI-----------IwGVGs------NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 307 GEIPYKDVDSSAI-----------IWGVGS------NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cCCCccccchhee-----------EEeccC------CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 9999987432110 011010 01111122345578999999999999999999999988876544
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 370 pe 371 (904)
T KOG4721|consen 370 PE 371 (904)
T ss_pred HH
Confidence 43
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=258.39 Aligned_cols=209 Identities=25% Similarity=0.342 Sum_probs=164.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.... +++..+..++.|++.||.|||+++
T Consensus 89 ~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----l~~~~~~~~~~qi~~aL~~LH~~~-- 162 (370)
T cd05596 89 FFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD----IPEKWARFYTAEVVLALDAIHSMG-- 162 (370)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46789999999999999999999999999999999999999999986542 467888899999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC----CcccccchhhHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG----KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||++........ .......|++.|+|||++.+. .++.++|+|||||++|+|
T Consensus 163 -ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 163 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred -eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 99999999999999999999999999876543211 122345689999999998653 378899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~ 235 (259)
++|..||.+.... ........... ....+.....+..+.++|.+||+.+|.+ |+|+.++++
T Consensus 241 ltG~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 241 LVGDTPFYADSLV--------GTYSKIMDHKN-------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred HhCCCCcCCCCHH--------HHHHHHHcCCC-------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 9999999863211 00011100000 0111111223477999999999999988 999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=248.82 Aligned_cols=232 Identities=21% Similarity=0.347 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++.. ....++++||+++++|.+++..... .+++..++.++.|++.||.|||++
T Consensus 50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~ 127 (284)
T cd05081 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSK 127 (284)
T ss_pred HHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 468899999999999999999998753 3467999999999999999975432 257889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-cccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 128 ~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 204 (284)
T cd05081 128 R---YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204 (284)
T ss_pred C---ceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999886654322111 1122244569999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..++............. ...........................+..+.+++.+||+.+|++|||+.+|++.|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05081 205 FTYSDKSCSPPAEFMRMMGN--DKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA 282 (284)
T ss_pred hhcCCcCCCcchhhhhhccc--ccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence 99877654321110000000 0000000000001111111111112234679999999999999999999999999987
Q ss_pred cc
Q 025011 240 LK 241 (259)
Q Consensus 240 ~~ 241 (259)
++
T Consensus 283 ~~ 284 (284)
T cd05081 283 IR 284 (284)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=253.79 Aligned_cols=235 Identities=20% Similarity=0.226 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+++++.++||||+++++++..++..++||||+++++|.+++....... +++..+..++.|++.||.|||+++
T Consensus 44 ~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~- 121 (327)
T cd08227 44 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MSELAIAYILQGVLKALDYIHHMG- 121 (327)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCC-CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457889999999999999999999999999999999999999999997643322 578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-----ccccccCcccccCcchhcc--CCcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~i 155 (259)
++|+||||+||+++.++.+++.||+............ ......++..|+|||++.+ ..++.++||||+||+
T Consensus 122 --iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~i 199 (327)
T cd08227 122 --YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 199 (327)
T ss_pred --EecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHH
Confidence 9999999999999999999999997654332211111 1112346678999999876 358899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHh--------------hc----cchhhhh---------hccccCCchhHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYS--------------IE----NNSLRQI---------LNFQVADESEMEE 208 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------------~~----~~~~~~~---------~~~~~~~~~~~~~ 208 (259)
+|+|++|..||.................... .. ....... .............
T Consensus 200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (327)
T cd08227 200 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTF 279 (327)
T ss_pred HHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccccccccc
Confidence 9999999999975321110000000000000 00 0000000 0000000111123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 025011 209 IETVAGLASKCLSLSGRRRPTMKQVSE--ELDRLK 241 (259)
Q Consensus 209 ~~~~~~li~~~l~~~p~~Rpt~~~il~--~l~~~~ 241 (259)
++.+.+++.+||+.||.+|||++++++ .+++++
T Consensus 280 ~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 280 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred CHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 467999999999999999999999986 354443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=252.79 Aligned_cols=206 Identities=28% Similarity=0.372 Sum_probs=174.0
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+|++++ ||||+.++++|++....++|||++.||.|++.+... . +++..+..++.|++.++.|||+.|
T Consensus 80 ~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~-~sE~da~~~~~~il~av~~lH~~g 155 (382)
T KOG0032|consen 80 EDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---H-YSERDAAGIIRQILEAVKYLHSLG 155 (382)
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---c-CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 57899999999998 999999999999999999999999999999999877 1 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCC----CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDN----YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
++|+|+||+|+++... +.++++|||++..... ........||+.|+|||++....++..+|+||+|+++|
T Consensus 156 ---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~y 229 (382)
T KOG0032|consen 156 ---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILY 229 (382)
T ss_pred ---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHH
Confidence 9999999999999643 4799999999987665 23345567999999999999899999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhcc--ccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNF--QVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.|++|.+||.+...... ...+... ..........++.+.++|+.||..||.+|+|+.++++
T Consensus 230 iLL~G~~PF~~~~~~~~-----------------~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 230 ILLSGVPPFWGETEFEI-----------------FLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHhhCCCCCcCCChhHH-----------------HHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 99999999988432110 0011111 1222333345688999999999999999999999977
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=249.11 Aligned_cols=210 Identities=22% Similarity=0.257 Sum_probs=166.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++.+..++..+++|||+.+++|.+++..... ..+++..+..++.|++.|+.|||+.+
T Consensus 46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-- 122 (285)
T cd05605 46 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER-- 122 (285)
T ss_pred HHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 467899999999999999999999999999999999999999988865432 23678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||++++++.++|+|||++........ .....++..|+|||++.+..++.++||||+|+++|++++|.
T Consensus 123 -ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred -cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 99999999999999999999999999876543211 12346889999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
.||.+..... ....... .. ... ....+...+..+.+++.+||..||.+|| ++.++++
T Consensus 199 ~pf~~~~~~~----~~~~~~~-~~---------~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 199 SPFRQRKEKV----KREEVER-RV---------KED-QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CCCCCCchhh----HHHHHHH-Hh---------hhc-ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 9998632110 0000000 00 000 0011122446789999999999999999 7888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=265.60 Aligned_cols=212 Identities=23% Similarity=0.275 Sum_probs=167.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC--------cceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--------VPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~ 73 (259)
..+.+|+.++..++|+|++++++.+.... ..++||||+++|+|.+++.... ....+++..+..++.|++.|
T Consensus 76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~a 155 (496)
T PTZ00283 76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA 155 (496)
T ss_pred HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence 35788999999999999999988775432 3689999999999999986532 22346888999999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
|.|||+.+ ++|+||||+||+++.++.++|+|||+++...............|++.|+|||++.+..++.++||||||
T Consensus 156 L~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlG 232 (496)
T PTZ00283 156 VHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG 232 (496)
T ss_pred HHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHH
Confidence 99999999 999999999999999999999999998765533222223345689999999999988899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|+|++|..||.+... ......... .. ....+...++.+.+++.+||+.||.+|||+.++
T Consensus 233 vilyeLltG~~Pf~~~~~--------~~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~el 294 (496)
T PTZ00283 233 VLLYELLTLKRPFDGENM--------EEVMHKTLA-GR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKL 294 (496)
T ss_pred HHHHHHHHCCCCCCCCCH--------HHHHHHHhc-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHH
Confidence 999999999999976321 111111110 00 001112334779999999999999999999998
Q ss_pred HH
Q 025011 234 SE 235 (259)
Q Consensus 234 l~ 235 (259)
++
T Consensus 295 l~ 296 (496)
T PTZ00283 295 LN 296 (496)
T ss_pred Hh
Confidence 75
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=252.46 Aligned_cols=204 Identities=25% Similarity=0.297 Sum_probs=161.1
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+ +||||+++++++..++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~LH~~~- 116 (316)
T cd05592 41 CTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLHKKG- 116 (316)
T ss_pred HHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 345566777654 899999999999999999999999999999999876543 677889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++||||+||++|+|++|
T Consensus 117 --ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G 192 (316)
T cd05592 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG 192 (316)
T ss_pred --EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC
Confidence 9999999999999999999999999987543221 223344689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK-QVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il 234 (259)
..||.+.... ......... . ...+...+..+.+++.+||+.||.+||++. +++
T Consensus 193 ~~Pf~~~~~~--------~~~~~i~~~---------~--~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 193 QSPFHGEDED--------ELFDSILND---------R--PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCCCHH--------HHHHHHHcC---------C--CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 9999863211 011111000 0 001112336688999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=253.60 Aligned_cols=204 Identities=25% Similarity=0.281 Sum_probs=160.1
Q ss_pred HHHHHHHHH---hcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 4 VFQHELRVV---SQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 4 ~~~~E~~~l---~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.+|.+++ +.++||||+++++++..++..|+||||+++++|..++... .+++..+..++.|++.|+.|||++
T Consensus 45 ~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05589 45 SLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHEN 120 (324)
T ss_pred HHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 466666655 4567999999999999999999999999999998888643 267899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+..++.++||||||+++|+|+
T Consensus 121 ~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 195 (324)
T cd05589 121 K---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195 (324)
T ss_pred C---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHH
Confidence 9 9999999999999999999999999976433211 1223346899999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
+|..||.+.... ....... ..... .+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 196 ~G~~pf~~~~~~--------~~~~~i~---------~~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 196 VGESPFPGDDEE--------EVFDSIV---------NDEVR--YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred hCCCCCCCCCHH--------HHHHHHH---------hCCCC--CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 999999863211 0111000 00000 1112346789999999999999999 4666644
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=253.73 Aligned_cols=203 Identities=22% Similarity=0.353 Sum_probs=164.2
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
++.|-.+|....+|+||+++-.|.+...+||||||++||++.++|...+. +++..+..++.+++.|+..+|+.|
T Consensus 188 V~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---L~e~~arfYiaE~vlAI~~iH~~g--- 261 (550)
T KOG0605|consen 188 VRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---LTEDWARFYIAETVLAIESIHQLG--- 261 (550)
T ss_pred HHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---CchHHHHHHHHHHHHHHHHHHHcC---
Confidence 56788999999999999999999999999999999999999999988765 788999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc----------------------c-----cc---------------
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ----------------------T-----AM--------------- 122 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----------------------~-----~~--------------- 122 (259)
++|+||||+|+++|..|++||+|||++........ . ..
T Consensus 262 yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 262 YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 99999999999999999999999999854322000 0 00
Q ss_pred ---cccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccc
Q 025011 123 ---TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQ 199 (259)
Q Consensus 123 ---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (259)
....+||+.|+|||++.+..|+..+|.||||||+|||+.|.+||.+.... ..+..+....
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~-----------------~T~rkI~nwr 404 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQ-----------------ETYRKIVNWR 404 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----------------HHHHHHHHHh
Confidence 01226999999999999999999999999999999999999999873211 1111111111
Q ss_pred --cCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 200 --VADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 200 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
+..+.....+++..+||.+||. ||.+|.-..
T Consensus 405 ~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 405 ETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred hhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 2222233344789999999999 999997633
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=252.66 Aligned_cols=204 Identities=26% Similarity=0.279 Sum_probs=161.2
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++... +||||+++++++.+++..++||||+.+++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 116 (316)
T cd05620 41 CTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG- 116 (316)
T ss_pred HHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 456677787754 899999999999999999999999999999999876533 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||+++...... .......|+..|+|||++.+..++.++||||+|+++|+|++|
T Consensus 117 --ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g 192 (316)
T cd05620 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred --eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC
Confidence 9999999999999999999999999986432211 122334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK-QVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il 234 (259)
..||.+.+.. .. ........ ... +...+..+.+++.+||+.||.+||++. +++
T Consensus 193 ~~Pf~~~~~~-----~~---~~~~~~~~-------~~~----~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 193 QSPFHGDDED-----EL---FESIRVDT-------PHY----PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCCHH-----HH---HHHHHhCC-------CCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 9999763210 11 11000000 000 011236789999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=255.67 Aligned_cols=199 Identities=26% Similarity=0.280 Sum_probs=158.3
Q ss_pred HHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeC
Q 025011 9 LRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHG 88 (259)
Q Consensus 9 ~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~ 88 (259)
..+++.++||||+++++++..++..+++|||+++++|.+++..... +.+..+..++.|++.||.|||+++ ++|+
T Consensus 47 ~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~g---iiHr 120 (325)
T cd05602 47 NVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLN---IVYR 120 (325)
T ss_pred HHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---eEec
Confidence 3456788999999999999999999999999999999999976543 466788889999999999999999 9999
Q ss_pred CCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCC
Q 025011 89 DVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 89 di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~ 168 (259)
||||+||+++.++.++|+|||+++...... .......|+..|+|||++.+..++.++||||+||++|+|++|..||.+
T Consensus 121 Dlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 121 DLKPENILLDSQGHIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred CCCHHHeEECCCCCEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 999999999999999999999986533211 122344689999999999988899999999999999999999999976
Q ss_pred CccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
.... ..... +...... .....+..+.+++.+||+.||.+||++.+..
T Consensus 199 ~~~~-----~~~~~------------i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 199 RNTA-----EMYDN------------ILNKPLQ--LKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCHH-----HHHHH------------HHhCCcC--CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 3211 00000 0000000 1112346789999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=256.24 Aligned_cols=210 Identities=21% Similarity=0.316 Sum_probs=164.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 47 ~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~~-- 121 (364)
T cd05599 47 HVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTEEETRFYIAETILAIDSIHKLG-- 121 (364)
T ss_pred HHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 477899999999999999999999999999999999999999999976543 678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc------------------------------------cccccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA------------------------------------MTTKKI 127 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------------------------------~~~~~~ 127 (259)
++|+||||+||+++.++.++|+|||++.......... ......
T Consensus 122 -ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 122 -YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV 200 (364)
T ss_pred -eEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence 9999999999999999999999999986543211000 011235
Q ss_pred CcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHH
Q 025011 128 GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEME 207 (259)
Q Consensus 128 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (259)
||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ........... .........
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~ 265 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQ--------ETYRKIINWKE-------TLQFPDEVP 265 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHH--------HHHHHHHcCCC-------ccCCCCCCC
Confidence 899999999998888999999999999999999999999863211 00000000000 000011112
Q ss_pred HHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 025011 208 EIETVAGLASKCLSLSGRRRPT---MKQVSE 235 (259)
Q Consensus 208 ~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 235 (259)
.++.+.++|.+|+. +|.+|++ +.+++.
T Consensus 266 ~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 266 LSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 34678999999996 9999998 877765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=251.79 Aligned_cols=205 Identities=21% Similarity=0.327 Sum_probs=171.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+..|++.++.++|||||++|++...+..+|+|+|.=.+|+|++++-+...+ +.+..+.++++||+.|+.|+|+..
T Consensus 63 hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH-- 138 (864)
T KOG4717|consen 63 HLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH-- 138 (864)
T ss_pred HHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh--
Confidence 4778999999999999999999999999999999999999999999877654 578999999999999999999999
Q ss_pred CeEeCCCCCCCeEe-CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcc-cccchhhHHHHHHHHHh
Q 025011 84 PIIHGDVKSTNVLL-DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLT-EKSDVYSFGVLLAELLT 161 (259)
Q Consensus 84 ~i~h~di~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~ 161 (259)
++|+|+||+|+++ .+-|-+||.|||++-.+..+ .......|+..|.|||++.+..|+ +++||||||+|+|.|++
T Consensus 139 -VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 139 -VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred -hhcccCCcceeEEeeecCceEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 9999999999977 46789999999998665543 345567899999999999999876 67999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++||+.... ...+.-+.+=.. .-+...+.++.+||..||..||++|.|.++|..
T Consensus 215 Gq~PFqeAND-----------------SETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 215 GQPPFQEAND-----------------SETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred CCCccccccc-----------------hhhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 9999986221 111222222111 123345688999999999999999999999864
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=242.89 Aligned_cols=209 Identities=27% Similarity=0.428 Sum_probs=166.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++..+ ..+++|||+.+++|.+++...... ..++..++.++.|++.|+.|||+.+
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~~- 120 (254)
T cd05083 44 QAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRA-LVSVIQLLQFSLDVAEGMEYLESKK- 120 (254)
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999998664 479999999999999999765432 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||.+...... ......+..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 121 --~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~ 193 (254)
T cd05083 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193 (254)
T ss_pred --eeccccCcceEEEcCCCcEEECCCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998654321 111234567999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
|+.||.+.... ........ ..........++.+.+++.+||+.+|.+|||++++++.|++
T Consensus 194 g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 194 GRAPYPKMSLK--------EVKECVEK----------GYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCccCCHH--------HHHHHHhC----------CCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 99998763211 11111110 00011112234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=243.48 Aligned_cols=218 Identities=25% Similarity=0.341 Sum_probs=163.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+|+.+++.++||||+++++++.+....++||||+++++|.+++..... ....++..+..++.|++.|+.|||+.+
T Consensus 41 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (269)
T cd05087 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120 (269)
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 578899999999999999999999998899999999999999999965321 123456778889999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-------CcccccchhhHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-------KLTEKSDVYSFGV 154 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~ 154 (259)
++|+||||+||+++.++.++|+|||.+................++..|+|||++.+. .++.++|+||+|+
T Consensus 121 ---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 197 (269)
T cd05087 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197 (269)
T ss_pred ---EeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHH
Confidence 999999999999999999999999998654432222222234567789999988542 3578999999999
Q ss_pred HHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 155 LLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 155 il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
++|+|++ |..||....... . ...... ............ ...++.+.+++..|+ .+|.+|||+++|
T Consensus 198 ~l~el~~~g~~p~~~~~~~~-----~---~~~~~~-~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l 263 (269)
T cd05087 198 TIWELFELGSQPYRHLSDEQ-----V---LTYTVR-EQQLKLPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEV 263 (269)
T ss_pred HHHHHHhCCCCCCCCCChHH-----H---HHHHhh-cccCCCCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHH
Confidence 9999996 999997532110 0 000000 000111111111 112356888999999 689999999999
Q ss_pred HHHHH
Q 025011 234 SEELD 238 (259)
Q Consensus 234 l~~l~ 238 (259)
...|+
T Consensus 264 ~~~l~ 268 (269)
T cd05087 264 HLLLS 268 (269)
T ss_pred HHHhc
Confidence 98764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=242.57 Aligned_cols=210 Identities=24% Similarity=0.355 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++..... ..+++..+..++.|++.++.|||+.+
T Consensus 44 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~- 121 (256)
T cd08221 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG-QLFEEEMVLWYLFQIVSAVSYIHKAG- 121 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4588999999999999999999999999999999999999999999976532 23678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++........ ......++..|.|||.+.+..++.++|+||+|+++++|++|
T Consensus 122 --i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08221 122 --ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTL 197 (256)
T ss_pred --ccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHC
Confidence 99999999999999999999999999876544321 23344688999999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||...... +....... +... ......+..+.+++.+||..+|.+|||+.++++.
T Consensus 198 ~~~~~~~~~~--------~~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 198 KRTFDATNPL--------NLVVKIVQ-GNYT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCCCCCCCHH--------HHHHHHHc-CCCC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 9998752210 01111110 1110 0112234679999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=254.67 Aligned_cols=211 Identities=21% Similarity=0.263 Sum_probs=166.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~- 122 (330)
T cd05601 46 SFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG- 122 (330)
T ss_pred HHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999976532 2678889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc------cCCcccccchhhHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI------TGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il 156 (259)
++|+||||+||+++.++.++|+|||++......... ......++..|+|||++. ...++.++||||+|+++
T Consensus 123 --i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il 199 (330)
T cd05601 123 --YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199 (330)
T ss_pred --eEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeeccccee
Confidence 999999999999999999999999998765433221 223346899999999986 34577899999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+|++|..||.+.... ........... ....+.....++.+.+++.+||. +|.+|||+.+++.
T Consensus 200 ~el~~g~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 200 YEMIYGRSPFHEGTSA--------KTYNNIMNFQR-------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred eeeccCCCCCCCCCHH--------HHHHHHHcCCC-------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 9999999999763211 00111110000 00111111234678999999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=256.51 Aligned_cols=212 Identities=19% Similarity=0.275 Sum_probs=162.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+++++.++||||+++++++.+++..|+||||+++|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~g- 121 (377)
T cd05629 46 AHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT---FSEDVTRFYMAECVLAIEAVHKLG- 121 (377)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999976532 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc------------------------------------------
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT------------------------------------------ 120 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------------------------------------ 120 (259)
++|+||||+||+++.++.++|+|||+++.+......
T Consensus 122 --ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (377)
T cd05629 122 --FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKK 199 (377)
T ss_pred --eeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 999999999999999999999999998643211000
Q ss_pred ---cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhc
Q 025011 121 ---AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILN 197 (259)
Q Consensus 121 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (259)
.......|+..|+|||++.+..++.++||||+||++|+|++|..||.+..... ..........
T Consensus 200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~------ 265 (377)
T cd05629 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHE--------TYRKIINWRE------ 265 (377)
T ss_pred cccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHH--------HHHHHHccCC------
Confidence 00012358999999999988889999999999999999999999997632110 0000000000
Q ss_pred cccCCchhHHHHHHHHHHHHHhcccCCCCC---CCHHHHHHH
Q 025011 198 FQVADESEMEEIETVAGLASKCLSLSGRRR---PTMKQVSEE 236 (259)
Q Consensus 198 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---pt~~~il~~ 236 (259)
....+.....+..+.++|.+||. +|.+| +|+.+++..
T Consensus 266 -~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 266 -TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred -ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 00001111234678999999997 77765 588888653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=251.02 Aligned_cols=204 Identities=27% Similarity=0.299 Sum_probs=161.3
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+ +||||+++++++.+.+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~LH~~~- 116 (316)
T cd05619 41 CTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG- 116 (316)
T ss_pred HHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 355677788764 899999999999999999999999999999999976432 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+||++|+|++|
T Consensus 117 --ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G 192 (316)
T cd05619 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIG 192 (316)
T ss_pred --eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhC
Confidence 9999999999999999999999999986432211 122334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK-QVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il 234 (259)
..||.+.... .. ........ .. .+...+..+.+++.+||+.||.+||++. +++
T Consensus 193 ~~pf~~~~~~-----~~---~~~i~~~~-------~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 193 QSPFHGHDEE-----EL---FQSIRMDN-------PC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCCCCCCCHH-----HH---HHHHHhCC-------CC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 9999763211 00 10000000 00 0111236688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=242.49 Aligned_cols=205 Identities=26% Similarity=0.398 Sum_probs=160.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..+...+++|||+++++|..++..... .+++..++.++.|++.|+.|||+++
T Consensus 49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 125 (262)
T cd05077 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD- 125 (262)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 4688899999999999999999999998899999999999999888865432 2578889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCc-------eEEeecCCcccccCCccccccccccCcccccCcchhc-cCCcccccchhhHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYK-------AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGV 154 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~-------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~ 154 (259)
++|+||+|+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++||||||+
T Consensus 126 --ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 197 (262)
T cd05077 126 --LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGT 197 (262)
T ss_pred --eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHH
Confidence 999999999999986654 899999987654321 2234778899999886 456889999999999
Q ss_pred HHHHHH-hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 155 LLAELL-TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 155 il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
++|+|+ .|..||....... ... ... ... .... ...+.+.+++.+||+.||.+||++.+|
T Consensus 198 ~l~el~~~~~~p~~~~~~~~--------~~~-~~~-~~~------~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~i 257 (262)
T cd05077 198 TLWEICYNGEIPLKDKTLAE--------KER-FYE-GQC------MLVT----PSCKELADLMTHCMNYDPNQRPFFRAI 257 (262)
T ss_pred HHHHHHhCCCCCCCCcchhH--------HHH-HHh-cCc------cCCC----CChHHHHHHHHHHcCCChhhCcCHHHH
Confidence 999998 4788876522110 000 000 000 0001 112568899999999999999999999
Q ss_pred HHHHH
Q 025011 234 SEELD 238 (259)
Q Consensus 234 l~~l~ 238 (259)
++.++
T Consensus 258 l~~~~ 262 (262)
T cd05077 258 MRDIN 262 (262)
T ss_pred HHhcC
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=247.26 Aligned_cols=228 Identities=27% Similarity=0.373 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+++.+|+++++.++|||++++.+++... ...+++|||+++++|.+++..... ..++..+..++.|++.||.|||++
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~ 128 (284)
T cd05079 51 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSR 128 (284)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4688999999999999999999998775 568999999999999999966532 257889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 129 g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el 205 (284)
T cd05079 129 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205 (284)
T ss_pred C---eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhh
Confidence 9 999999999999999999999999998766543221 112233466789999999888899999999999999999
Q ss_pred HhCCCCCCCCcccc-ccc-hhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 160 LTGLKPGSGMALAS-NEG-ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 160 ~~g~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
++++.|+....... ... ........ ...................+..+.+++.+||+.+|.+|||+.++++.+
T Consensus 206 lt~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 280 (284)
T cd05079 206 LTYCDSESSPMTLFLKMIGPTHGQMTV-----TRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGF 280 (284)
T ss_pred hcCCCCCccccchhhhhcccccccccH-----HHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 99876643211000 000 00000000 000000000001111112446799999999999999999999999999
Q ss_pred Hhc
Q 025011 238 DRL 240 (259)
Q Consensus 238 ~~~ 240 (259)
+++
T Consensus 281 ~~~ 283 (284)
T cd05079 281 EAI 283 (284)
T ss_pred Hhh
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=248.12 Aligned_cols=227 Identities=17% Similarity=0.171 Sum_probs=166.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..++||||++ ++|.+++........+++..+..++.|++.||.|||+.+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~- 121 (285)
T cd07861 44 STAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR- 121 (285)
T ss_pred HHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 467899999999999999999999999999999999996 589888876554445788999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+. .++.++|+||+|+++++|++
T Consensus 122 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 122 --VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred --eeecCCCHHHEEEcCCCcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999987554321 112233567889999988654 47889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHH---HHhhc----cchhhhhhcc---ccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 162 GLKPGSGMALASNEGISMVQYF---LYSIE----NNSLRQILNF---QVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
|+.||.+............... ...+. .......... ..........++.+.++|.+||+.||.+|||+.
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ 277 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 9999986322110000000000 00000 0000000000 000000111346788999999999999999999
Q ss_pred HHHH
Q 025011 232 QVSE 235 (259)
Q Consensus 232 ~il~ 235 (259)
++++
T Consensus 278 ~ll~ 281 (285)
T cd07861 278 KALN 281 (285)
T ss_pred HHhc
Confidence 9864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=257.44 Aligned_cols=212 Identities=19% Similarity=0.249 Sum_probs=162.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~~LH~~g- 121 (381)
T cd05626 46 AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV---FPEVLARFYIAELTLAIESVHKMG- 121 (381)
T ss_pred HHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999976543 577888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc------------------------------------------
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT------------------------------------------ 120 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------------------------------------ 120 (259)
|+||||||+||+++.++.++|+|||++.........
T Consensus 122 --ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (381)
T cd05626 122 --FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQ 199 (381)
T ss_pred --eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccc
Confidence 999999999999999999999999987543110000
Q ss_pred ---cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhc
Q 025011 121 ---AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILN 197 (259)
Q Consensus 121 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (259)
.......||..|+|||++.+..++.++||||+||++|+|++|..||....... ..........
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--------~~~~i~~~~~------ 265 (381)
T cd05626 200 HQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE--------TQLKVINWEN------ 265 (381)
T ss_pred ccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHH--------HHHHHHcccc------
Confidence 00112468999999999988889999999999999999999999997632110 0000000000
Q ss_pred cccCCchhHHHHHHHHHHHHHhc--ccCCCCCCCHHHHHH
Q 025011 198 FQVADESEMEEIETVAGLASKCL--SLSGRRRPTMKQVSE 235 (259)
Q Consensus 198 ~~~~~~~~~~~~~~~~~li~~~l--~~~p~~Rpt~~~il~ 235 (259)
....+.....++.+.++|.+|+ ..+|..||++.+++.
T Consensus 266 -~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 266 -TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred -ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 0001111123467889999855 556666999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=255.90 Aligned_cols=213 Identities=21% Similarity=0.289 Sum_probs=162.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+.++..++||||+++++.+.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~lH~~g- 121 (363)
T cd05628 46 GHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSIHQLG- 121 (363)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc---------------------------------cccccccCc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT---------------------------------AMTTKKIGT 129 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------------~~~~~~~~~ 129 (259)
|+||||||+||+++.++.++|+|||+++........ .......||
T Consensus 122 --ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 199 (363)
T cd05628 122 --FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT 199 (363)
T ss_pred --eEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence 999999999999999999999999998754321100 001234689
Q ss_pred ccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHH
Q 025011 130 FVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEI 209 (259)
Q Consensus 130 ~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (259)
..|+|||++.+..++.++||||+||++|+|++|..||.+..... ......... .....+.....+
T Consensus 200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~p~~~~~s 264 (363)
T cd05628 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE--------TYKKVMNWK-------ETLIFPPEVPIS 264 (363)
T ss_pred ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCc-------CcccCCCcCCCC
Confidence 99999999988889999999999999999999999997632110 000000000 000001111234
Q ss_pred HHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 025011 210 ETVAGLASKCLS--LSGRRRPTMKQVSEE 236 (259)
Q Consensus 210 ~~~~~li~~~l~--~~p~~Rpt~~~il~~ 236 (259)
+.+.++|.+|+. .++..||++.+|++.
T Consensus 265 ~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 265 EKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred HHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 678888888765 233456899999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=241.84 Aligned_cols=219 Identities=23% Similarity=0.305 Sum_probs=162.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++||||+++++.+......+++|||+++++|.+++..... ....+...+..++.|++.||.|||+.+
T Consensus 40 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 119 (268)
T cd05086 40 NEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN 119 (268)
T ss_pred HHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence 4688999999999999999999999999999999999999999999976432 223456778899999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-------CCcccccchhhHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-------GKLTEKSDVYSFGV 154 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~ 154 (259)
++|+||||+||+++.++.++|+|||++................++..|+|||++.. ..++.++||||+|+
T Consensus 120 ---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 196 (268)
T cd05086 120 ---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGV 196 (268)
T ss_pred ---eeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHH
Confidence 99999999999999999999999998754322211112233457789999998743 23577899999999
Q ss_pred HHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 155 LLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 155 il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
++|+|++ |..||..... .+........ ............ ..++.+.+++..|| .+|.+|||+++|
T Consensus 197 ~l~el~~~~~~p~~~~~~--------~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 197 TLWELFENAAQPYSHLSD--------REVLNHVIKD-QQVKLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred HHHHHHhCCCCCCCCCCH--------HHHHHHHHhh-cccccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 9999997 5678765221 0111111111 111111111111 13367888999999 689999999999
Q ss_pred HHHHH
Q 025011 234 SEELD 238 (259)
Q Consensus 234 l~~l~ 238 (259)
++.|-
T Consensus 263 ~~~l~ 267 (268)
T cd05086 263 HRLLT 267 (268)
T ss_pred HHHhc
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=245.53 Aligned_cols=215 Identities=24% Similarity=0.369 Sum_probs=168.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc------ccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ------VLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|++++++++||||+++++++.+....+++|||+++++|.+++...... ..+++..+..++.|++.||.|
T Consensus 53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~ 132 (275)
T cd05046 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132 (275)
T ss_pred HHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 56899999999999999999999999989999999999999999999765422 136889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||+|+||+++.++.++++|||++...... .........++..|+|||.+.+..++.++||||+|+++
T Consensus 133 LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 208 (275)
T cd05046 133 LSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208 (275)
T ss_pred hhhcC---cccCcCccceEEEeCCCcEEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHH
Confidence 99999 999999999999999999999999987643221 11112223456779999998888889999999999999
Q ss_pred HHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++++ |..||...... .... ....... ........+..+.+++.+||+.+|.+|||+.++++
T Consensus 209 ~~l~~~~~~p~~~~~~~--------~~~~-~~~~~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~ 271 (275)
T cd05046 209 WEVFTQGELPFYGLSDE--------EVLN-RLQAGKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVS 271 (275)
T ss_pred HHHHhCCCCCccccchH--------HHHH-HHHcCCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999 77888652210 0000 0000000 00011123367999999999999999999999998
Q ss_pred HHH
Q 025011 236 ELD 238 (259)
Q Consensus 236 ~l~ 238 (259)
.|.
T Consensus 272 ~l~ 274 (275)
T cd05046 272 ALG 274 (275)
T ss_pred Hhc
Confidence 875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=247.11 Aligned_cols=226 Identities=24% Similarity=0.276 Sum_probs=165.0
Q ss_pred HHHHHHhcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 7 HELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+|+++|+.++|||||++.-+|.... ...+||||++. +|...++.. ......+...+.-+..||++|++|||+.
T Consensus 66 rEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~ 144 (364)
T KOG0658|consen 66 RELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH 144 (364)
T ss_pred HHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence 6999999999999999988887432 34699999976 899988753 1111245567888999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAE 158 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~ 158 (259)
+ ||||||||+|+++|.+ |.+||+|||.|+....+. .......+..|+|||.+.+.. |+.+.||||.||++.|
T Consensus 145 ~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aE 218 (364)
T KOG0658|consen 145 G---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAE 218 (364)
T ss_pred C---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHH
Confidence 9 9999999999999976 899999999998765432 223445788999999998875 9999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhh--c------------cchhhhhhccccCCchhHHHHHHHHHHHHHhcccCC
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSI--E------------NNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 224 (259)
|+-|++.|.|.+... .......... . +....++.............++...+++.++|..+|
T Consensus 219 Ll~g~plFpG~s~~d----QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P 294 (364)
T KOG0658|consen 219 LLKGQPLFPGDSSVD----QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSP 294 (364)
T ss_pred HhcCCcccCCCCHHH----HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccCh
Confidence 999999999843221 1111111110 0 011111111111111222344789999999999999
Q ss_pred CCCCCHHHHHH--HHHhcccc
Q 025011 225 RRRPTMKQVSE--ELDRLKIS 243 (259)
Q Consensus 225 ~~Rpt~~~il~--~l~~~~~~ 243 (259)
.+|.++.+++. .++.+...
T Consensus 295 ~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 295 SKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCCHHHHhcchhhHHhhCc
Confidence 99999999874 34444433
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=248.68 Aligned_cols=217 Identities=25% Similarity=0.414 Sum_probs=169.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++... ..+++++|+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~-- 129 (303)
T cd05110 55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR-- 129 (303)
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC--
Confidence 578999999999999999999998654 46799999999999999876532 2577889999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-C
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-G 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g 162 (259)
++|+||+|+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|++++ |
T Consensus 130 -ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 130 -LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred -eeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986654322222223345678999999988889999999999999999997 8
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
..||.+... ....... .... ....+...+..+.+++.+||..+|.+||++.++++.++.+..
T Consensus 209 ~~p~~~~~~-----~~~~~~~----~~~~---------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 209 GKPYDGIPT-----REIPDLL----EKGE---------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred CCCCCCCCH-----HHHHHHH----HCCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 899876321 0111111 0000 000011123568899999999999999999999999998754
Q ss_pred cc
Q 025011 243 SH 244 (259)
Q Consensus 243 ~~ 244 (259)
..
T Consensus 271 ~~ 272 (303)
T cd05110 271 DP 272 (303)
T ss_pred ch
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=241.50 Aligned_cols=212 Identities=24% Similarity=0.346 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++..... .+++..+..++.|++.|+.|||+++
T Consensus 45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~- 121 (262)
T cd06613 45 EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETG- 121 (262)
T ss_pred HHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5688999999999999999999999999999999999999999999876522 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 122 --i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 122 --KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred --ceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 99999999999999999999999999876543211 12234578889999998776 788899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+...... ... ... ... .. .........+..+.+++.+||..+|.+|||+.+|+.
T Consensus 198 ~tg~~p~~~~~~~~~-------~~~-~~~-~~~----~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 198 AELQPPMFDLHPMRA-------LFL-ISK-SNF----PP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HhCCCCCCCCCHHHH-------HHH-HHh-ccC----CC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 999999876321100 000 000 000 00 000112234567999999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=250.15 Aligned_cols=163 Identities=22% Similarity=0.338 Sum_probs=133.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC------CcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS------SQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l 74 (259)
..+.+|+.+++.++||||+++++++.. +...+++|||+. ++|.+++.... ....+++..+..++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 121 (317)
T cd07868 43 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence 457889999999999999999998864 456899999994 58888875321 122367888999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEe----CCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccC-Ccccccc
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITG-KLTEKSD 148 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 148 (259)
.|||+++ ++|+||||+||++ +.++.++|+|||+++........ .......++..|+|||++.+. .++.++|
T Consensus 122 ~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (317)
T cd07868 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 198 (317)
T ss_pred HHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhh
Confidence 9999999 9999999999999 45678999999999766543211 122345688999999998774 4889999
Q ss_pred hhhHHHHHHHHHhCCCCCCCC
Q 025011 149 VYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~ 169 (259)
|||+||++|+|++|..||...
T Consensus 199 iwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 199 IWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HHHHHHHHHHHHhCCCCccCC
Confidence 999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=257.39 Aligned_cols=211 Identities=18% Similarity=0.245 Sum_probs=162.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++.+.+++..++||||+++|+|.+++.+... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~al~~lH~~~- 121 (382)
T cd05625 46 AHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FPEDLARFYIAELTCAVESVHKMG- 121 (382)
T ss_pred HHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999976532 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-------------------------------------------
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ------------------------------------------- 119 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------------------------------------------- 119 (259)
|+|+||||+||+++.++.++|+|||++..+.....
T Consensus 122 --ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (382)
T cd05625 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQ 199 (382)
T ss_pred --eecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccc
Confidence 99999999999999999999999999753211000
Q ss_pred --ccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhc
Q 025011 120 --TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILN 197 (259)
Q Consensus 120 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (259)
........|++.|+|||++.+..++.++||||+||++|+|++|..||.+..... ........ .
T Consensus 200 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~-------~ 264 (382)
T cd05625 200 HQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLE--------TQMKVINW-------Q 264 (382)
T ss_pred cccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHH--------HHHHHHcc-------C
Confidence 000112358899999999988889999999999999999999999998632110 00000000 0
Q ss_pred cccCCchhHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 025011 198 FQVADESEMEEIETVAGLASKCLSLSGRRRPT---MKQVSE 235 (259)
Q Consensus 198 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 235 (259)
.....+.....++.+.++|.+|+ .+|.+|++ +.+++.
T Consensus 265 ~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 265 TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 00011111123467888898876 59999997 777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=246.83 Aligned_cols=219 Identities=22% Similarity=0.317 Sum_probs=167.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+ .+
T Consensus 44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~ 120 (308)
T cd06615 44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPENILGKISIAVLRGLTYLREKHK 120 (308)
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 4588999999999999999999999999999999999999999999976532 5778899999999999999997 57
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++...... ......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 121 ---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~ 193 (308)
T cd06615 121 ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAI 193 (308)
T ss_pred ---EEECCCChHHEEEecCCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHh
Confidence 999999999999999999999999987654322 1233468889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccch------------------------hhhhhccccCCchhHHHHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNS------------------------LRQILNFQVADESEMEEIETVAGLAS 217 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~~~~~~~li~ 217 (259)
|..||...+... ............. .................+..+.+++.
T Consensus 194 g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 268 (308)
T cd06615 194 GRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD 268 (308)
T ss_pred CCCCCCCcchhh-----HHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHH
Confidence 999986532110 0000000000000 00000000000000113467999999
Q ss_pred HhcccCCCCCCCHHHHHHH
Q 025011 218 KCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 218 ~~l~~~p~~Rpt~~~il~~ 236 (259)
+||..+|++|||+.+++..
T Consensus 269 ~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 269 KCLKKNPKERADLKELTKH 287 (308)
T ss_pred HHccCChhhCcCHHHHhcC
Confidence 9999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=240.08 Aligned_cols=205 Identities=25% Similarity=0.396 Sum_probs=161.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++..+...++||||+++|+|.+++..... .+++..+..++.|++.|+.|||+++
T Consensus 44 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 120 (258)
T cd05078 44 ESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG- 120 (258)
T ss_pred HHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688899999999999999999999998999999999999999999976543 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCc--------eEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYK--------AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFG 153 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG 153 (259)
++|+||||+||+++.++. ++++|||.+..... .....++..|+|||++.+. .++.++|+||+|
T Consensus 121 --iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG 192 (258)
T cd05078 121 --LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFG 192 (258)
T ss_pred --eecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHH
Confidence 999999999999987665 68999998764432 1223477889999998764 478999999999
Q ss_pred HHHHHHHhCC-CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLTGL-KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++|. .||....... ......... .. +...+..+.+++.+||+.||.+|||+++
T Consensus 193 ~~l~~l~~g~~~~~~~~~~~~--------~~~~~~~~~--------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ 252 (258)
T cd05078 193 TTLWEIFSGGDKPLSALDSQK--------KLQFYEDRH--------QL----PAPKWTELANLINQCMDYEPDFRPSFRA 252 (258)
T ss_pred HHHHHHHcCCCCChhhccHHH--------HHHHHHccc--------cC----CCCCcHHHHHHHHHHhccChhhCCCHHH
Confidence 9999999984 5655421110 000000000 00 1112356899999999999999999999
Q ss_pred HHHHHH
Q 025011 233 VSEELD 238 (259)
Q Consensus 233 il~~l~ 238 (259)
+++.|+
T Consensus 253 il~~l~ 258 (258)
T cd05078 253 IIRDLN 258 (258)
T ss_pred HHHhcC
Confidence 998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=255.04 Aligned_cols=207 Identities=25% Similarity=0.398 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc--ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV--PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
|+|..|+.+|+.|+||||+++|+++.+... +.+|+|.+..|+|..|+++... .+...+..|+.||+.||.|||++
T Consensus 86 eR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~ 162 (632)
T KOG0584|consen 86 ERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQ 162 (632)
T ss_pred HHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcC
Confidence 789999999999999999999998886554 7899999999999999988765 46689999999999999999998
Q ss_pred CCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
. |+|+|||||-+|||++++ |.+||+|+|+|+...... ...-.||+.|||||.+- ..|+..+||||||+.++||
T Consensus 163 ~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEM 236 (632)
T KOG0584|consen 163 D-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEM 236 (632)
T ss_pred C-CCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHH
Confidence 6 899999999999999865 899999999998765332 12247999999999874 7899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+..||.....- ....+..........+.++.+ +.++++|.+||.. .+.|||+.|+|+
T Consensus 237 vT~eYPYsEC~n~----AQIYKKV~SGiKP~sl~kV~d------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 237 VTSEYPYSECTNP----AQIYKKVTSGIKPAALSKVKD------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HhccCChhhhCCH----HHHHHHHHcCCCHHHhhccCC------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 9999998864321 111122222222222222222 7799999999999 999999999975
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=242.36 Aligned_cols=207 Identities=26% Similarity=0.367 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.+.||||+++++++..++..++||||+++++|.+++.... +++..+..++.|++.|+.++|+.+
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~----l~~~~~~~~~~~l~~~l~~lh~~~- 121 (277)
T cd06640 47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP----FDEFQIATMLKEILKGLDYLHSEK- 121 (277)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999999999999987532 567888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 122 --ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06640 122 --KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred --ccCcCCChhhEEEcCCCCEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC
Confidence 9999999999999999999999999987654322 112233577889999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||....... .... .............+..+.+++.+||+.+|.+|||+.+++..
T Consensus 198 ~~p~~~~~~~~--------~~~~----------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 198 EPPNSDMHPMR--------VLFL----------IPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCCcChHh--------Hhhh----------hhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 99987532110 0000 00001111222345779999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=246.30 Aligned_cols=208 Identities=23% Similarity=0.369 Sum_probs=166.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.+.|||++++++.+..+...++||||+++++|.+++.... +++..+..++.|++.|+.|||+.+
T Consensus 62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~i~~ql~~aL~~LH~~g- 136 (296)
T cd06654 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ- 136 (296)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 467899999999999999999999999999999999999999999986532 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 137 --i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g 212 (296)
T cd06654 137 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212 (296)
T ss_pred --cccCCCCHHHEEEcCCCCEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987544321 112234588899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||....... . ......... .....+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 213 ~~pf~~~~~~~-------~-~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 213 EPPYLNENPLR-------A-LYLIATNGT--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCCCCCCCHHH-------h-HHHHhcCCC--------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 99997532110 0 000000000 000011223466899999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=252.34 Aligned_cols=200 Identities=27% Similarity=0.287 Sum_probs=157.5
Q ss_pred HHHHH-HHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHEL-RVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~-~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+..|. .+++.++||||+++++++.+.+..++||||+++++|...+..... +++..+..++.|++.||.|||+++
T Consensus 42 ~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~-- 116 (321)
T cd05603 42 IMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERC---FLEPRARFYAAEVASAIGYLHSLN-- 116 (321)
T ss_pred HHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 34444 467889999999999999999999999999999999988865432 567888899999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||+++..... ........++..|+|||.+.+..++.++||||+||++|+|++|.
T Consensus 117 -ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (321)
T cd05603 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGL 193 (321)
T ss_pred -eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCC
Confidence 999999999999999999999999998643221 11223446899999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
.||.+.+.. ..... +...... .+...+..+.+++.+||+.||.+||++.
T Consensus 194 ~pf~~~~~~--------~~~~~---------i~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 194 PPFYSRDVS--------QMYDN---------ILHKPLQ--LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHH--------HHHHH---------HhcCCCC--CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 999763210 00000 0111000 1112236689999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=241.58 Aligned_cols=212 Identities=30% Similarity=0.467 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+||+++++++.+.+..+++|||+++++|.+++....... +++..+..++.|++.|+.+||+.+
T Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~ql~~~l~~lh~~~- 123 (258)
T smart00219 46 EEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKE-LSLSDLLSFALQIARGMEYLESKN- 123 (258)
T ss_pred HHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhcc-CCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 468899999999999999999999999999999999999999999997654322 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||++......... ......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus 124 --~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 124 --FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred --eeecccccceEEEccCCeEEEcccCCceeccccccc-ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998766543211 1112236788999999977789999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|..||..... ...... ... .. ........+..+.+++.+||+.||.+|||+.++++.|
T Consensus 201 g~~p~~~~~~-----~~~~~~---~~~-~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 201 GESPYPGMSN-----EEVLEY---LKK-GY---------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCCCH-----HHHHHH---Hhc-CC---------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 7888875211 000000 000 00 0011112447799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=245.99 Aligned_cols=231 Identities=25% Similarity=0.378 Sum_probs=173.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.|.+|+++++.++||||+++++++.. ....+++|||+++++|.+++..... .+++..+..++.|++.||.+||++
T Consensus 51 ~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 51 SDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhC
Confidence 578999999999999999999999887 5578999999999999999976543 367889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|+||+++.++.++++|||.+.......... ......++..|+|||.+.+..++.++|+||+|+++++|
T Consensus 129 ~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 R---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred C---eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 9 9999999999999999999999999988765332211 11122345679999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..|+............. ......................+...+..+.+++.+||+.+|.+|||+.+|+++|++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~ 282 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGI---AQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282 (284)
T ss_pred eccCCCcccccchhcccccc---ccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence 99999876522111000000 000000000111111111111112234679999999999999999999999999988
Q ss_pred cc
Q 025011 240 LK 241 (259)
Q Consensus 240 ~~ 241 (259)
+.
T Consensus 283 i~ 284 (284)
T cd05038 283 LR 284 (284)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=243.83 Aligned_cols=207 Identities=25% Similarity=0.358 Sum_probs=168.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++.+++.++...++++||+++++|.+++... .+++..++.++.|++.|+.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~- 118 (274)
T cd06609 44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG- 118 (274)
T ss_pred HHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35789999999999999999999999999999999999999999999764 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||+++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 119 --i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg 194 (274)
T cd06609 119 --KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194 (274)
T ss_pred --cccCCCCHHHEEECCCCCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987765432 122334578889999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ....... .... ........++.+.+++.+||..+|.+|||++++++
T Consensus 195 ~~p~~~~~~~--------~~~~~~~-~~~~--------~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 195 EPPLSDLHPM--------RVLFLIP-KNNP--------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcccCchH--------HHHHHhh-hcCC--------CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9999753211 0000000 0000 00000113467999999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=241.39 Aligned_cols=211 Identities=26% Similarity=0.392 Sum_probs=166.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++|||++++++++......+++|||+++++|.+++..... .+++..++.++.|++.++.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~- 120 (256)
T cd05112 44 EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN- 120 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4689999999999999999999999999999999999999999999876432 2567889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 121 --i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~ 197 (256)
T cd05112 121 --VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred --ccccccccceEEEcCCCeEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcC
Confidence 99999999999999999999999999876543211 11112234568999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|..||...... . ......... ...... ..+..+.+++.+||+.+|++|||+.++++.|
T Consensus 198 g~~p~~~~~~~-----~---~~~~~~~~~---~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 198 GKTPYENRSNS-----E---VVETINAGF---RLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCcCCHH-----H---HHHHHhCCC---CCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 89998752211 1 111111000 000000 1236799999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=254.84 Aligned_cols=210 Identities=25% Similarity=0.343 Sum_probs=163.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++.+++..++||||+++|+|.+++.... +++..+..++.|++.||.|||+++
T Consensus 89 ~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~----~~~~~~~~~~~qil~aL~~LH~~~-- 162 (370)
T cd05621 89 FFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLALDAIHSMG-- 162 (370)
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 47789999999999999999999999999999999999999999996542 467888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC----cccccchhhHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l 159 (259)
|+||||||+||+++.++.++|+|||++....... ........|++.|+|||++.+.. ++.++|+||+||++|+|
T Consensus 163 -IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 163 -LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred -eEecCCCHHHEEECCCCCEEEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 9999999999999999999999999987654321 11223456999999999987543 77899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSEE 236 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~~ 236 (259)
++|..||.+.... ........... ....+.....+..+.+++..||..++.+ |+|+.++++.
T Consensus 241 l~G~~Pf~~~~~~--------~~~~~i~~~~~-------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 241 LVGDTPFYADSLV--------GTYSKIMDHKN-------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HhCCCCCCCCCHH--------HHHHHHHhCCc-------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 9999999863211 00111100000 0111111233467889999999855543 8899998664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=240.91 Aligned_cols=209 Identities=24% Similarity=0.348 Sum_probs=166.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++|+|++++.+.+.. ++..+++|||+++++|.+++...... .+++..+..++.+++.++.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~-~l~~~~~~~~~~~l~~~l~~lH~~~ 122 (257)
T cd08223 44 KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK-LLPENQVVEWFVQIAMALQYLHEKH 122 (257)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 457889999999999999999998764 44679999999999999999764332 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+..++.++|+||+|++++++++
T Consensus 123 ---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08223 123 ---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197 (257)
T ss_pred ---eeccCCCchhEEEecCCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHc
Confidence 9999999999999999999999999987654321 12233457889999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+.+.. ........ ... ...+...++.+.+++.+||+.||.+|||+.++++
T Consensus 198 g~~~~~~~~~~--------~~~~~~~~-~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 198 LKHAFNAKDMN--------SLVYRIIE-GKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCCCCCCCHH--------HHHHHHHh-cCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 99998753210 11111110 000 0111234477999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=255.45 Aligned_cols=212 Identities=20% Similarity=0.266 Sum_probs=163.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++.+.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~~- 121 (376)
T cd05598 46 AHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI---FEEDLARFYIAELTCAIESVHKMG- 121 (376)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3578899999999999999999999999999999999999999999976542 577888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-----------------------------------------cc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-----------------------------------------TA 121 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-----------------------------------------~~ 121 (259)
|+||||||+||+++.++.++|+|||++..+..... ..
T Consensus 122 --ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred --eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 99999999999999999999999999753210000 00
Q ss_pred ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccC
Q 025011 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVA 201 (259)
Q Consensus 122 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (259)
......|++.|+|||++.+..++.++||||+||++|+|++|..||.+..... .......... ...
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~-------~~~ 264 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAE--------TQLKVINWET-------TLH 264 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHH--------HHHHHhccCc-------ccc
Confidence 0112368999999999998889999999999999999999999998632110 0000000000 000
Q ss_pred CchhHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 025011 202 DESEMEEIETVAGLASKCLSLSGRRRP---TMKQVSEE 236 (259)
Q Consensus 202 ~~~~~~~~~~~~~li~~~l~~~p~~Rp---t~~~il~~ 236 (259)
.......++.+.++|.+|+ .+|.+|+ |+.++++.
T Consensus 265 ~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 265 IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 0111123466888999977 5999999 88888643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=243.72 Aligned_cols=206 Identities=27% Similarity=0.391 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++|+||+++++|.+++... .+++..+..++.|++.|+.|||+++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~- 121 (277)
T cd06642 47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER- 121 (277)
T ss_pred HHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 46899999999999999999999999999999999999999999988643 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus 122 --ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg 197 (277)
T cd06642 122 --KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKG 197 (277)
T ss_pred --eeccCCChheEEEeCCCCEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654321 112233578899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||....... .... ..... ........+..+.+++.+||+.+|.+|||+.+++.
T Consensus 198 ~~p~~~~~~~~--------~~~~-~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 198 EPPNSDLHPMR--------VLFL-IPKNS---------PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred CCCCcccchhh--------HHhh-hhcCC---------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99987522110 0000 00000 00111123466899999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=239.86 Aligned_cols=210 Identities=25% Similarity=0.347 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..+...++++||+++++|.+++..... .+++..+..++.|++.|+.|||+.+
T Consensus 43 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~- 119 (256)
T cd06612 43 QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK- 119 (256)
T ss_pred HHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5789999999999999999999999999999999999999999999865432 3578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||+|+++++|++|
T Consensus 120 --i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 120 --KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred --cccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876554321 22234478899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.||........ .. ...... ......+...+..+.+++.+||+.||.+|||+.++++
T Consensus 196 ~~p~~~~~~~~~--------~~-~~~~~~-------~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 196 KPPYSDIHPMRA--------IF-MIPNKP-------PPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCCCCCcchhhh--------hh-hhccCC-------CCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 999876321100 00 000000 0000112223467999999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=240.28 Aligned_cols=204 Identities=25% Similarity=0.458 Sum_probs=162.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.. ...+++|||+++++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~- 121 (259)
T cd05037 46 LAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK- 121 (259)
T ss_pred HHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 568899999999999999999999988 778999999999999999987543 3577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC-------ceEEeecCCcccccCCccccccccccCcccccCcchhccC--CcccccchhhHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY-------KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFG 153 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG 153 (259)
++|+||||+||+++.++ .++++|||++..... .....++..|+|||++.+. .++.++|+||+|
T Consensus 122 --i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 193 (259)
T cd05037 122 --LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFG 193 (259)
T ss_pred --eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHH
Confidence 99999999999999887 799999999876443 1223466789999998876 688999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||...+... ..... .. .. ..... ....+.+++.+||..+|.+|||+.+
T Consensus 194 ~~~~~l~~~~~~p~~~~~~~~-----~~~~~---~~-~~-------~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 194 TTLLEICSNGEEPLSTLSSSE-----KERFY---QD-QH-------RLPMP----DCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred HHHHHHHhCCCCCcccCCchh-----HHHHH---hc-CC-------CCCCC----CchHHHHHHHHHhccChhhCCCHHH
Confidence 99999999 577776532110 00000 00 00 00000 0156899999999999999999999
Q ss_pred HHHHHH
Q 025011 233 VSEELD 238 (259)
Q Consensus 233 il~~l~ 238 (259)
+++.|+
T Consensus 254 il~~l~ 259 (259)
T cd05037 254 ILRDLN 259 (259)
T ss_pred HHHhcC
Confidence 988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=242.17 Aligned_cols=205 Identities=24% Similarity=0.391 Sum_probs=160.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..+...++||||+++++|..++..... .+++..+..++.|++.||.|||+++
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 137 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN- 137 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 4688899999999999999999999999999999999999999999865432 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC-------ceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY-------KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGV 154 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~-------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~ 154 (259)
++|+||||+||+++..+ .++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+
T Consensus 138 --iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~ 209 (274)
T cd05076 138 --LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGT 209 (274)
T ss_pred --ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHH
Confidence 99999999999997643 3799999987543221 12346778999998865 45789999999999
Q ss_pred HHHHHH-hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 155 LLAELL-TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 155 il~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
++|+++ +|..||.+..... ...... . ....... ..+.+.++|.+||+.+|.+|||+.++
T Consensus 210 ~l~el~~~g~~p~~~~~~~~-----~~~~~~---~--------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~i 269 (274)
T cd05076 210 TLLEICFDGEVPLKERTPSE-----KERFYE---K--------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTI 269 (274)
T ss_pred HHHHHHhCCCCCccccChHH-----HHHHHH---h--------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHH
Confidence 999985 6889987632110 000000 0 0001111 12468999999999999999999999
Q ss_pred HHHHH
Q 025011 234 SEELD 238 (259)
Q Consensus 234 l~~l~ 238 (259)
++.|.
T Consensus 270 l~~L~ 274 (274)
T cd05076 270 LRDLT 274 (274)
T ss_pred HHhhC
Confidence 88763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=243.42 Aligned_cols=211 Identities=25% Similarity=0.351 Sum_probs=163.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+++|+.++++++||||+++++++..++..+++|||+++++|.+++.... .+++..+..++.|++.|+.|||+.+
T Consensus 52 ~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-- 126 (267)
T cd06646 52 LIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG-- 126 (267)
T ss_pred HHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 47789999999999999999999999999999999999999999986543 2578899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+|++|+||+++.++.++++|||++....... .......++..|+|||.+. ...++.++|+||+|+++|+|+
T Consensus 127 -i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~ 203 (267)
T cd06646 127 -KMHRDIKGANILLTDNGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred -ccccCCCHHHEEECCCCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 1122345788999999874 334678999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+|..||......... . ........ .... ......+..+.+++.+||+.+|.+|||++++++.
T Consensus 204 ~g~~p~~~~~~~~~~-------~--~~~~~~~~---~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 204 ELQPPMFDLHPMRAL-------F--LMSKSNFQ---PPKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred hCCCCccccchhhhh-------e--eeecCCCC---CCCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 999998652211000 0 00000000 0000 0111234679999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=269.09 Aligned_cols=225 Identities=18% Similarity=0.282 Sum_probs=172.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--------cccCCHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------QVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~i~~~i~~~ 73 (259)
+++|.+|+++++.++||||+++++++.+++..+++|||++|++|.+++..... ....++..++.++.|++.|
T Consensus 46 ~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~A 125 (932)
T PRK13184 46 KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125 (932)
T ss_pred HHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHH
Confidence 35689999999999999999999999999999999999999999999864211 1223556788999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc----------------ccccccccCcccccCcch
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ----------------TAMTTKKIGTFVNLDPEY 137 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~----------------~~~~~~~~~~~~y~aPE~ 137 (259)
|.|||+++ ++||||||+||+++.++.++++|||++........ ........|++.|+|||.
T Consensus 126 L~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~ 202 (932)
T PRK13184 126 IEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPER 202 (932)
T ss_pred HHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHH
Confidence 99999999 99999999999999999999999999976521100 001123468999999999
Q ss_pred hccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHH
Q 025011 138 VITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLAS 217 (259)
Q Consensus 138 ~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 217 (259)
+.+..++.++||||+||++|+|++|..||........ .... ..............++.+.+++.
T Consensus 203 l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki------~~~~----------~i~~P~~~~p~~~iP~~L~~LI~ 266 (932)
T PRK13184 203 LLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI------SYRD----------VILSPIEVAPYREIPPFLSQIAM 266 (932)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh------hhhh----------hccChhhccccccCCHHHHHHHH
Confidence 9988899999999999999999999999976221100 0000 00000000011133467899999
Q ss_pred HhcccCCCCCC-CHHHHHHHHHhcccccc
Q 025011 218 KCLSLSGRRRP-TMKQVSEELDRLKISHE 245 (259)
Q Consensus 218 ~~l~~~p~~Rp-t~~~il~~l~~~~~~~~ 245 (259)
+||+.||++|| +++++++.++.......
T Consensus 267 rcL~~DP~kR~ss~eeLl~~Le~~lq~~p 295 (932)
T PRK13184 267 KALAVDPAERYSSVQELKQDLEPHLQGSP 295 (932)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHHhcCc
Confidence 99999999996 67778888877755433
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=253.24 Aligned_cols=203 Identities=28% Similarity=0.291 Sum_probs=159.7
Q ss_pred HHHHHH-HHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELR-VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+..|.. +++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.||+.||.|||+++
T Consensus 42 ~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~g-- 116 (325)
T cd05604 42 IMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERS---FPEPRARFYAAEIASALGYLHSIN-- 116 (325)
T ss_pred HHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 444544 56778999999999999999999999999999999988875433 578899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++...... ........|+..|+|||++.+..++.++||||+||++|+|++|.
T Consensus 117 -ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~ 193 (325)
T cd05604 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGL 193 (325)
T ss_pred -eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCC
Confidence 999999999999999999999999998643221 11223346899999999999888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
.||.+.+.. ..... +....... ....+..+.+++.+||+.+|.+||++.+.+
T Consensus 194 ~pf~~~~~~--------~~~~~---------~~~~~~~~--~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 194 PPFYCRDVA--------EMYDN---------ILHKPLVL--RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred CCCCCCCHH--------HHHHH---------HHcCCccC--CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 999763211 00010 01100000 112336688999999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=242.97 Aligned_cols=210 Identities=21% Similarity=0.287 Sum_probs=163.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++++|..+. ..++..+..++.|++.|+.|||+.+
T Consensus 44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~- 115 (279)
T cd06619 44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK- 115 (279)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 46889999999999999999999999999999999999999886542 1466788899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 116 --i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g 189 (279)
T cd06619 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALG 189 (279)
T ss_pred --EeeCCCCHHHEEECCCCCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhC
Confidence 999999999999999999999999998755432 12234688899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||.......... .......... ............++.+.+++.+||+.+|.+||+++++++.
T Consensus 190 ~~pf~~~~~~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 190 RFPYPQIQKNQGSL-MPLQLLQCIV---------DEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCchhhccccccc-chHHHHHHHh---------ccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 99997632211110 0000000000 0000000011133678999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=242.08 Aligned_cols=210 Identities=26% Similarity=0.362 Sum_probs=164.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+.+
T Consensus 52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~-- 126 (267)
T cd06645 52 VVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKG-- 126 (267)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 477899999999999999999999999999999999999999999876543 678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++|+|||++...... ........++..|+|||.+. ...++.++|+||+|+++|+|+
T Consensus 127 -i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 127 -KMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred -eecCCCCHHHEEECCCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 999999999999999999999999998655432 11223346889999999874 345788999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||....... . .......... ..... .....+..+.+++.+||..+|.+|||++++++
T Consensus 204 ~~~~p~~~~~~~~-------~-~~~~~~~~~~----~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 204 ELQPPMFDLHPMR-------A-LFLMTKSNFQ----PPKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cCCCCcccccchh-------h-HHhhhccCCC----CCccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 9999986522110 0 0000000000 00000 01112356889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=245.31 Aligned_cols=210 Identities=22% Similarity=0.268 Sum_probs=166.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++|++++.+++.+..++..+++|||+++++|.+++...... .+++..+..++.|++.|+.|||+.+
T Consensus 46 ~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~-- 122 (285)
T cd05630 46 MALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-GFEEGRAVFYAAEICCGLEDLHQER-- 122 (285)
T ss_pred HHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4678999999999999999999999999999999999999999988654332 2677899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++++|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 123 -iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 123 -IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred -EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 99999999999999999999999999865443211 12346889999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
.||......... ......... .. . ......++.+.+++.+||+.||.+||| +.++++
T Consensus 199 ~Pf~~~~~~~~~-~~~~~~~~~------~~----~----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 199 SPFQQRKKKIKR-EEVERLVKE------VQ----E----EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CCCCCCCccchH-HHHHhhhhh------hh----h----hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 999863211000 000000000 00 0 001123366899999999999999999 788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=249.51 Aligned_cols=201 Identities=26% Similarity=0.281 Sum_probs=159.4
Q ss_pred hHHHHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|.+++..++| ++|+++++++...+..|+||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~ 121 (324)
T cd05587 45 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPHAVFYAAEIAIGLFFLHSKG 121 (324)
T ss_pred HHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346789999999976 5688999999999999999999999999999876543 577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+||++|+|++
T Consensus 122 ---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt 196 (324)
T cd05587 122 ---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 196 (324)
T ss_pred ---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh
Confidence 9999999999999999999999999986432211 11223458999999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|+.||.+.... .. ...... ... ..+...++.+.+++.+||..||.+|++.
T Consensus 197 G~~pf~~~~~~-----~~---~~~i~~---------~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 197 GQPPFDGEDED-----EL---FQSIME---------HNV--SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHH-----HH---HHHHHc---------CCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 99999763211 00 000000 000 0011233678999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=240.56 Aligned_cols=211 Identities=30% Similarity=0.441 Sum_probs=165.4
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
..+|+.++++++||||+++++++..+...+++||++.+++|.+++.... .+++..+..++.|++.||.+||+++
T Consensus 45 ~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~--- 118 (260)
T PF00069_consen 45 NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG--- 118 (260)
T ss_dssp HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhhhhccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccc---
Confidence 3459999999999999999999999999999999999999999998332 2578999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-cCCcccccchhhHHHHHHHHHhCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-TGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++|+|||.+..... .........++..|+|||++. +..++.++|+||+|+++++|++|.
T Consensus 119 i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~ 196 (260)
T PF00069_consen 119 IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGK 196 (260)
T ss_dssp EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSS
T ss_pred cccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999875421 222334556889999999998 777899999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.||...... .................... .....+.+.+++.+||+.||++|||+.++++
T Consensus 197 ~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 197 LPFEESNSD-----DQLEIIEKILKRPLPSSSQQ-------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSSTTSSHH-----HHHHHHHHHHHTHHHHHTTS-------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccccccch-----hhhhhhhhcccccccccccc-------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999874110 11111111110000000000 0000167999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=241.90 Aligned_cols=210 Identities=24% Similarity=0.302 Sum_probs=163.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++++..++..++++||+++++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH~~~- 123 (282)
T cd06643 47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK- 123 (282)
T ss_pred HHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999888765322 3678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||++. +..++.++|+||+|+++|
T Consensus 124 --i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 124 --IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred --eeecCCCcccEEEccCCCEEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 9999999999999999999999999986543321 1123345888999999874 344778999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||...... ........... . .. ..+...+..+.++|.+||+.||.+|||+.++++
T Consensus 200 el~~g~~p~~~~~~~--------~~~~~~~~~~~-~-----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 200 EMAQIEPPHHELNPM--------RVLLKIAKSEP-P-----TL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred HHccCCCCccccCHH--------HHHHHHhhcCC-C-----CC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999998763210 00000000000 0 00 011123467999999999999999999999854
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=241.69 Aligned_cols=211 Identities=23% Similarity=0.374 Sum_probs=167.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++..++..++++||+++++|.+++.+... +++..+..++.|++.|+.|||+.+
T Consensus 47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 122 (265)
T cd06631 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---LPEPVFCKYTKQILDGVAYLHNNC- 122 (265)
T ss_pred HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4588999999999999999999999999999999999999999999976532 567888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc----cccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN----QTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||+|+||+++.++.++|+|||++....... .........++..|+|||.+.+..++.++|+||+|+++++
T Consensus 123 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~ 200 (265)
T cd06631 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFE 200 (265)
T ss_pred --cccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHH
Confidence 9999999999999999999999999987543211 1111223457889999999988888999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||...+... ........... ....+...+..+.++|.+||+.+|.+|||+.+++.
T Consensus 201 l~~g~~p~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 201 MATGKPPLASMDRLA-------AMFYIGAHRGL---------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred HHhCCCccccCChHH-------HHHHhhhccCC---------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999997632111 00000000000 00011123467899999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=244.52 Aligned_cols=208 Identities=23% Similarity=0.377 Sum_probs=166.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++..++..++++||+++++|.+++.... +++..+..++.|++.|+.+||+.+
T Consensus 61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~~- 135 (296)
T cd06655 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHANQ- 135 (296)
T ss_pred HHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 567899999999999999999999999999999999999999999886532 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus 136 --i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg 211 (296)
T cd06655 136 --VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (296)
T ss_pred --cccCCCCHHHEEECCCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999998775443211 12234578899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+.+... ......... ... ...+...++.+.++|.+||..||.+|||+.++++
T Consensus 212 ~~pf~~~~~~~--------~~~~~~~~~-~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 212 EPPYLNENPLR--------ALYLIATNG-TPE-------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCCCCCCCHHH--------HHHHHHhcC-Ccc-------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 99997632210 000000000 000 0011123467889999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=250.17 Aligned_cols=222 Identities=19% Similarity=0.235 Sum_probs=163.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++++.++||||+++++++...+ ..++|+||+. ++|.+.+.... .+++..+..++.|++.||.||
T Consensus 44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~L 119 (372)
T cd07853 44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYL 119 (372)
T ss_pred HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHH
Confidence 45788999999999999999999998766 7899999995 57888775543 367889999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il 156 (259)
|+.+ ++|+||||+||+++.++.++|+|||+++...... ........++..|+|||.+.+.. ++.++||||+||++
T Consensus 120 H~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 195 (372)
T cd07853 120 HSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIF 195 (372)
T ss_pred HhCC---eeCCCCChHHEEECCCCCEEeccccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHH
Confidence 9999 9999999999999999999999999987654321 11223345788999999987754 78999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHH--------HHHHHhhccchhhhhh-ccccCCc-------hhHHHHHHHHHHHHHhc
Q 025011 157 AELLTGLKPGSGMALASNEGISMV--------QYFLYSIENNSLRQIL-NFQVADE-------SEMEEIETVAGLASKCL 220 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~-~~~~~~~-------~~~~~~~~~~~li~~~l 220 (259)
|+|++|+.||.+........ ... ....... ......+ ....... .....++.+.++|.+||
T Consensus 196 ~el~~g~~pf~~~~~~~~~~-~i~~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 272 (372)
T cd07853 196 AELLGRRILFQAQSPIQQLD-LITDLLGTPSLEAMRSAC--EGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRML 272 (372)
T ss_pred HHHHcCCCCCCCCCHHHHHH-HHHHHcCCCCHHHHHHhh--HHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhC
Confidence 99999999998743211000 000 0000000 0000000 0000000 00112467899999999
Q ss_pred ccCCCCCCCHHHHHH
Q 025011 221 SLSGRRRPTMKQVSE 235 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~ 235 (259)
+.||.+|||+.++++
T Consensus 273 ~~dP~~R~t~~e~l~ 287 (372)
T cd07853 273 VFDPDKRISAADALA 287 (372)
T ss_pred CCChhhCcCHHHHhc
Confidence 999999999999976
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=239.77 Aligned_cols=209 Identities=23% Similarity=0.320 Sum_probs=167.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++.+++...+..++++||+.+++|.+++...... ..++..+..++.|++.|+.+||+++
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~- 121 (256)
T cd08218 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHDRK- 121 (256)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999999999999999999999999999999998764332 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|++++++++|
T Consensus 122 --i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g 197 (256)
T cd08218 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTL 197 (256)
T ss_pred --EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcC
Confidence 99999999999999999999999999876543221 12233578889999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ........ ... ...+...+..+.++|.+||+.+|.+||++.++++
T Consensus 198 ~~~~~~~~~~--------~~~~~~~~---------~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 198 KHAFEAGNMK--------NLVLKIIR---------GSY-PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCCccCCCHH--------HHHHHHhc---------CCC-CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 9998652110 00100000 000 0011123467999999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=246.28 Aligned_cols=212 Identities=21% Similarity=0.288 Sum_probs=167.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++.+..++..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~- 123 (316)
T cd05574 46 KRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGK-CLSEEVARFYAAEVLLALEYLHLLG- 123 (316)
T ss_pred HHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCC-ccCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 35788999999999999999999999999999999999999999998765332 3678889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc---------------------------cccccccCcccccCc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT---------------------------AMTTKKIGTFVNLDP 135 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------~~~~~~~~~~~y~aP 135 (259)
++|+||||+||+++.++.++|+|||++......... .......|+..|+||
T Consensus 124 --i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aP 201 (316)
T cd05574 124 --IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAP 201 (316)
T ss_pred --eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCH
Confidence 999999999999999999999999987654322110 011123578889999
Q ss_pred chhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHH
Q 025011 136 EYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGL 215 (259)
Q Consensus 136 E~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 215 (259)
|++.+..++.++||||||+++|+|++|..||.+.+... . .................++.+.++
T Consensus 202 E~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~----~-------------~~~~~~~~~~~~~~~~~~~~~~~l 264 (316)
T cd05574 202 EVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE----T-------------FSNILKKEVTFPGSPPVSSSARDL 264 (316)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH----H-------------HHHHhcCCccCCCccccCHHHHHH
Confidence 99988889999999999999999999999997633210 0 001111111111111145789999
Q ss_pred HHHhcccCCCCCCC----HHHHHH
Q 025011 216 ASKCLSLSGRRRPT----MKQVSE 235 (259)
Q Consensus 216 i~~~l~~~p~~Rpt----~~~il~ 235 (259)
+.+||..||.+||| +.+++.
T Consensus 265 i~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 265 IRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHccCCHhHCCCchhhHHHHHc
Confidence 99999999999999 666655
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=241.07 Aligned_cols=213 Identities=22% Similarity=0.392 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+++++.++|+||+++++++.+.+..++++||+++++|.+++.... .+++..+..++.|++.|+.+||+++
T Consensus 48 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~- 123 (268)
T cd06630 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ- 123 (268)
T ss_pred HHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999999999999997654 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccc--cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|.||+++.++ .++|+|||.+......... .......++..|+|||.+.+..++.++|+||+|++++++
T Consensus 124 --i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 201 (268)
T cd06630 124 --IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201 (268)
T ss_pred --eecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHH
Confidence 99999999999998775 5999999998766543111 112233578899999999888889999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||........ .... ............+...++.+.+++.+||..+|.+|||+.++++
T Consensus 202 ~~g~~p~~~~~~~~~-----~~~~---------~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 202 ATAKPPWNAEKHSNH-----LALI---------FKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhCCCCCCCCCCcch-----HHHH---------HHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 999999865221100 0000 0000011111122234577999999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=249.07 Aligned_cols=211 Identities=24% Similarity=0.325 Sum_probs=162.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++|+|.+++.... +++..+..++.|++.||.|||+++
T Consensus 88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~----~~~~~~~~~~~qi~~aL~~LH~~~- 162 (371)
T cd05622 88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG- 162 (371)
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 347789999999999999999999999999999999999999999986543 467888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC----cccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~ 158 (259)
|+|+||||+||+++.++.++|+|||++....... ........|++.|+|||++.+.. ++.++||||+||++|+
T Consensus 163 --ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilye 239 (371)
T cd05622 163 --FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYE 239 (371)
T ss_pred --EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHH
Confidence 9999999999999999999999999987654321 11223456999999999987543 7889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSEE 236 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~~ 236 (259)
|++|..||.+.... ............ ...+.....++.+.++|.+||..++.+ |+++.++++.
T Consensus 240 ll~G~~Pf~~~~~~--------~~~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 240 MLVGDTPFYADSLV--------GTYSKIMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred HHhCCCCCCCCCHH--------HHHHHHHcCCCc-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 99999999863211 001111110000 001111234467899999999844433 6788888663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.43 Aligned_cols=218 Identities=29% Similarity=0.426 Sum_probs=182.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
++|..|+.+++.++|||+|+++++|...-.+|||+||+..|+|.++|...+... .+....+.++.||.+|+.||..++
T Consensus 308 eEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~e-v~avvLlyMAtQIsSaMeYLEkkn- 385 (1157)
T KOG4278|consen 308 EEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSE-VPAVVLLYMATQISSAMEYLEKKN- 385 (1157)
T ss_pred HHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhh-cchhHHHHHHHHHHHHHHHHHHhh-
Confidence 579999999999999999999999999999999999999999999998876644 455677889999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++||||.+.|+++.++..+|++|||+++.+..+.... ....-...-|.|||.+....++.++|||+||+++|++.|
T Consensus 386 --FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY 462 (1157)
T KOG4278|consen 386 --FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY 462 (1157)
T ss_pred --hhhhhhhhhhccccccceEEeeccchhhhhcCCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhc
Confidence 9999999999999999999999999999876532111 111124457899999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||++.+. .....++.....-..+-.+++.+.+|++.||+++|.+||++.++-..++.+-
T Consensus 463 GMsPYPGidl------------------SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 463 GMSPYPGIDL------------------SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred CCCCCCCccH------------------HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 8899998432 2223333444444445567789999999999999999999999999988875
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
.+
T Consensus 525 ~~ 526 (1157)
T KOG4278|consen 525 SS 526 (1157)
T ss_pred cc
Confidence 43
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=240.21 Aligned_cols=218 Identities=27% Similarity=0.456 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccC---CcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKS---SQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~ 73 (259)
+++.+|+++++.++||||+++++++.... ..+++++|+.+++|.+++.... ....++...+..++.|++.|
T Consensus 46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~ 125 (273)
T cd05074 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125 (273)
T ss_pred HHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHH
Confidence 35788999999999999999999886532 2478999999999988874321 11235778899999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
+.|||+++ ++|+||+|+||+++.++.++++|||.++...............++..|++||.+.+..++.++||||||
T Consensus 126 l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG 202 (273)
T cd05074 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202 (273)
T ss_pred HHHHHhCC---EeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHH
Confidence 99999999 999999999999999999999999998865443222222233456789999999888889999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||.+.... ...... ...... ......+..+.+++.+||+.+|.+|||+.+
T Consensus 203 ~il~el~~~g~~p~~~~~~~-----~~~~~~---~~~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~ 264 (273)
T cd05074 203 VTMWEIMTRGQTPYAGVENS-----EIYNYL---IKGNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQH 264 (273)
T ss_pred HHHHHHhhCCCCCCCCCCHH-----HHHHHH---HcCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 99999999 88888763210 100110 000000 001123367999999999999999999999
Q ss_pred HHHHHHhcc
Q 025011 233 VSEELDRLK 241 (259)
Q Consensus 233 il~~l~~~~ 241 (259)
++..|+++.
T Consensus 265 ~~~~l~~~~ 273 (273)
T cd05074 265 LRDQLELIW 273 (273)
T ss_pred HHHHHHhhC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=239.24 Aligned_cols=212 Identities=25% Similarity=0.333 Sum_probs=168.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
+.+.+|+++++.++||||+++++++..++..++++||+.+++|.+++.... ..+++..+..++.|++.|+.+||+ .+
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ 121 (265)
T cd06605 44 KQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK 121 (265)
T ss_pred HHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC
Confidence 568899999999999999999999999999999999999999999997653 236778999999999999999999 88
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||.+........ ....++..|+|||.+.+..++.++|+||+|++++++++
T Consensus 122 ---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (265)
T cd06605 122 ---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELAT 194 (265)
T ss_pred ---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999999999999999865533211 11567889999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||......... ......... ............++.+.++|.+||..||.+|||+.+++.
T Consensus 195 g~~p~~~~~~~~~~---~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 195 GRFPYPPENDPPDG---IFELLQYIV---------NEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCCCCcccccccc---HHHHHHHHh---------cCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 99998764221110 011111111 110011111114567999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=245.55 Aligned_cols=223 Identities=17% Similarity=0.263 Sum_probs=163.8
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++..++..+++|||+++ +|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 50 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~-- 124 (309)
T cd07872 50 TAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK-- 124 (309)
T ss_pred hHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 577899999999999999999999999999999999965 88888765433 2577888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g 162 (259)
++||||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||+|+++|+|++|
T Consensus 125 -ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg 201 (309)
T cd07872 125 -VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG 201 (309)
T ss_pred -eecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875433211 12234578899999988654 578999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHH-------HHhh-ccchhhhhhccccCC----chhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYF-------LYSI-ENNSLRQILNFQVAD----ESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~-------~~~~-~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
+.||.+........ ...... +... ............... ......++.+.++|.+||+.||.+|||+
T Consensus 202 ~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 280 (309)
T cd07872 202 RPLFPGSTVEDELH-LIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280 (309)
T ss_pred CCCCCCCChHHHHH-HHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCH
Confidence 99998743211100 000000 0000 000000000000000 0011234678899999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 281 ~e~l~ 285 (309)
T cd07872 281 EEAMK 285 (309)
T ss_pred HHHhc
Confidence 99976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=257.28 Aligned_cols=220 Identities=21% Similarity=0.263 Sum_probs=157.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC--------CcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET--------KVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l 74 (259)
...+|+.+++.++||||+++++++... ..++++|||+++ ++.+++... .....+++..+..++.|++.||
T Consensus 105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL 183 (440)
T PTZ00036 105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRAL 183 (440)
T ss_pred hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 356799999999999999999887432 246799999965 777776542 1223367889999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSF 152 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl 152 (259)
.|||+.+ |+||||||+||+++.++ .++|+|||+++....... .....++..|+|||++.+. .++.++||||+
T Consensus 184 ~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 257 (440)
T PTZ00036 184 AYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSL 257 (440)
T ss_pred HHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHH
Confidence 9999999 99999999999998665 699999999986543221 2234578899999998764 58999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc---------cchhhhh-----hccccCCchhHHHHHHHHHHHHH
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE---------NNSLRQI-----LNFQVADESEMEEIETVAGLASK 218 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~ 218 (259)
||++|+|++|.+||.+..... ........... ......+ .........+...++.+.+||.+
T Consensus 258 Gvil~elltG~~pf~~~~~~~----~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~ 333 (440)
T PTZ00036 258 GCIIAEMILGYPIFSGQSSVD----QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQ 333 (440)
T ss_pred HHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHH
Confidence 999999999999998743211 01110000000 0000000 00000000011134678999999
Q ss_pred hcccCCCCCCCHHHHH
Q 025011 219 CLSLSGRRRPTMKQVS 234 (259)
Q Consensus 219 ~l~~~p~~Rpt~~~il 234 (259)
||..||.+|||+.+++
T Consensus 334 ~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 334 FLKYEPLKRLNPIEAL 349 (440)
T ss_pred HCCCChhHCcCHHHHh
Confidence 9999999999999987
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.61 Aligned_cols=222 Identities=21% Similarity=0.285 Sum_probs=160.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++...+ ..+++|||+.+ ++.+.+... ++...+..++.|++.||.|
T Consensus 65 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHME-----LDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred HHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhcc-----CCHHHHHHHHHHHHHHHHH
Confidence 45778999999999999999999986543 46999999965 666666432 4678888999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .......++..|+|||.+.+..++.++||||+|+++
T Consensus 139 LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 212 (359)
T cd07876 139 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212 (359)
T ss_pred HHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHH
Confidence 99999 999999999999999999999999998754322 122334688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCccccccchh----------HHHHHHH----hh-ccch-----hhhhhccc-c--CCchhHHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGIS----------MVQYFLY----SI-ENNS-----LRQILNFQ-V--ADESEMEEIETVA 213 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~----------~~~~~~~----~~-~~~~-----~~~~~~~~-~--~~~~~~~~~~~~~ 213 (259)
|+|++|+.||.+.+........ ....... .. .... ........ . ........++.+.
T Consensus 213 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (359)
T cd07876 213 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQAR 292 (359)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHH
Confidence 9999999999874321100000 0000000 00 0000 00000000 0 0000011235689
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
++|.+||..||.+|||+.++++.
T Consensus 293 ~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 293 DLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHhccCcccCCCHHHHhcC
Confidence 99999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=245.94 Aligned_cols=163 Identities=21% Similarity=0.336 Sum_probs=132.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhcc------CCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDK------SSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~i~~~i~~~l 74 (259)
..+.+|+++++.++||||+++++++.. +...+++|||+. ++|.+++... .....+++..+..++.|++.||
T Consensus 43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL 121 (317)
T cd07867 43 MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121 (317)
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence 357899999999999999999998854 557899999995 4787777432 1122367788999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEe----CCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccC-Ccccccc
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITG-KLTEKSD 148 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 148 (259)
.|||+.+ ++|+||||+||++ +.++.++|+|||+++........ .......++..|+|||++.+. .++.++|
T Consensus 122 ~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D 198 (317)
T cd07867 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 198 (317)
T ss_pred HHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHH
Confidence 9999999 9999999999999 55678999999999866543221 122334678899999998764 4789999
Q ss_pred hhhHHHHHHHHHhCCCCCCCC
Q 025011 149 VYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~ 169 (259)
|||+|+++|+|++|..||...
T Consensus 199 iwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 199 IWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred HHhHHHHHHHHHhCCCCcccc
Confidence 999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=247.77 Aligned_cols=200 Identities=26% Similarity=0.278 Sum_probs=159.7
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+ .|++|+++++++...+..++||||+++|+|.+.+..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 121 (323)
T cd05616 46 CTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FKEPHAVFYAAEIAIGLFFLHSKG- 121 (323)
T ss_pred HHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 356678888777 589999999999999999999999999999999876543 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|++.|+|||++.+..++.++|+||+||++|+|++|
T Consensus 122 --ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg 197 (323)
T cd05616 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (323)
T ss_pred --EEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhC
Confidence 9999999999999999999999999987543211 122334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
..||.+.... .. ..... ..... .+...++.+.+++.+||+.||.+|++.
T Consensus 198 ~~Pf~~~~~~-----~~---~~~i~---------~~~~~--~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 198 QAPFEGEDED-----EL---FQSIM---------EHNVA--YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCCCHH-----HH---HHHHH---------hCCCC--CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 9999863211 00 00000 00000 111234678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=244.17 Aligned_cols=225 Identities=20% Similarity=0.286 Sum_probs=167.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++....... +++..+..++.|++.||.|||+++
T Consensus 44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~l~~~L~~LH~~~- 121 (314)
T cd08216 44 KLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIAFILKDVLNALDYIHSKG- 121 (314)
T ss_pred HHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468999999999999999999999999999999999999999999997643322 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccC--CcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~i 155 (259)
++|+||+|+||+++.++.++++||+.+......... .......++..|+|||.+... .++.++|+||+|++
T Consensus 122 --ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~i 199 (314)
T cd08216 122 --FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199 (314)
T ss_pred --eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHH
Confidence 999999999999999999999999988655432111 011223466789999998663 47889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh----ccch-------h--------hhhhccccCCchhHHHHHHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI----ENNS-------L--------RQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~-------~--------~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
+++|++|..||........ ..+...... .... . ................+..+.+++
T Consensus 200 l~el~~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 275 (314)
T cd08216 200 ACELANGHVPFKDMPATQM----LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFV 275 (314)
T ss_pred HHHHHhCCCCCCCCCHHHH----HHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHH
Confidence 9999999999986322110 000000000 0000 0 000000111112223456789999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 025011 217 SKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il~ 235 (259)
.+||+.||++|||+.++++
T Consensus 276 ~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 276 ELCLQRDPESRPSASQLLN 294 (314)
T ss_pred HHHhhcCCCcCcCHHHHhc
Confidence 9999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=237.87 Aligned_cols=208 Identities=26% Similarity=0.398 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++.+..++..++||||+++++|.+++...... .+++..+..++.+++.++.+||+++
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~- 121 (256)
T cd08220 44 LAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL- 121 (256)
T ss_pred HHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999999999999999999999999999999999765332 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++ .++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus 122 --i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred --eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999998554 57999999987665332 1223457889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... . ....... ..... .+...++.+.+++.+||+.+|.+|||+.+++.
T Consensus 197 ~~~~~~~~~~~-----~---~~~~~~~-~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 197 LKRAFEAANLP-----A---LVLKIMS-GTFAP---------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCcccCchH-----H---HHHHHHh-cCCCC---------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 99998763210 0 0000000 00000 01123467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=246.90 Aligned_cols=219 Identities=26% Similarity=0.399 Sum_probs=167.0
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeC-CcceEEEEecCCCChhhhhhccCC---------------------------
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSS--------------------------- 54 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--------------------------- 54 (259)
.+.+|+.++..+ +||||+++++++... +..+++|||+++|+|.+++.....
T Consensus 56 ~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (343)
T cd05103 56 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLK 135 (343)
T ss_pred HHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhh
Confidence 577899999999 689999999988654 467899999999999999864321
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEe
Q 025011 55 -------------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97 (259)
Q Consensus 55 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 97 (259)
...+++..+..++.|++.||.|||+++ ++|+||||.||++
T Consensus 136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~ 212 (343)
T cd05103 136 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 212 (343)
T ss_pred hhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEE
Confidence 112467778899999999999999999 9999999999999
Q ss_pred CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCCCccccccc
Q 025011 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG 176 (259)
Q Consensus 98 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~ 176 (259)
+.++.++++|||++................++..|+|||.+.+..++.++||||+|+++|++++ |..||.+.....
T Consensus 213 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--- 289 (343)
T cd05103 213 SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--- 289 (343)
T ss_pred cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH---
Confidence 9999999999999876543222222222335677999999988889999999999999999997 889987632110
Q ss_pred hhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 025011 177 ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
. ............ .+...++.+.+++..||+.||.+|||+.+|++.|+.+-.
T Consensus 290 -~----~~~~~~~~~~~~---------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 290 -E----FCRRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred -H----HHHHHhccCCCC---------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0 000000010000 001123568999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=240.14 Aligned_cols=216 Identities=23% Similarity=0.332 Sum_probs=169.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-C
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-S 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 80 (259)
++.+.+|+++++.++||||+++++++...+..+++|||+++++|.+++...+. +++..+..++.+++.++.|||+ .
T Consensus 47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 47 RKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred HHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHhc
Confidence 35688999999999999999999999999999999999999999998876432 5788999999999999999997 5
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||+|+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++|+||+|+++|+++
T Consensus 124 ~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~ 196 (284)
T cd06620 124 R---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELA 196 (284)
T ss_pred C---eeccCCCHHHEEECCCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHH
Confidence 7 999999999999999999999999987654321 122346889999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccc---hhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 161 TGLKPGSGMALASNEG---ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+|..||.......... ........... ............+..+.+++.+||+.||.+|||+.++++.
T Consensus 197 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 197 LGKFPFAFSNIDDDGQDDPMGILDLLQQIV---------QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred hCCCCCcccchhhhhhhhhhHHHHHHHHHh---------hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 9999998633211100 00011111111 1000111111244679999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=240.63 Aligned_cols=211 Identities=25% Similarity=0.340 Sum_probs=165.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
+.+.+|+.++++++||||+++++.+..++..+++|||+++++|.+++........+++..+..++.|++.|+.|||+ .+
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~ 123 (286)
T cd06622 44 NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123 (286)
T ss_pred HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 46888999999999999999999999999999999999999999988764333346889999999999999999996 47
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC------cccccchhhHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK------LTEKSDVYSFGVL 155 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~i 155 (259)
++|+||+|+||+++.++.++++|||.+...... ......++..|+|||.+.+.. ++.++|+||+|++
T Consensus 124 ---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 196 (286)
T cd06622 124 ---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLS 196 (286)
T ss_pred ---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHH
Confidence 999999999999999999999999998655322 122235778899999985443 4789999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+|++|..||...... ...... ..+.... ....+...++.+.++|.+||+.+|.+||++.+++.
T Consensus 197 l~~l~~g~~pf~~~~~~-----~~~~~~---------~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 197 ILEMALGRYPYPPETYA-----NIFAQL---------SAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHHHHhCCCCCCCcchh-----hHHHHH---------HHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 99999999999752110 000000 0010100 01111224577999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=240.00 Aligned_cols=210 Identities=26% Similarity=0.375 Sum_probs=162.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
..+.+|+.+++.+ +|||++++++++... ...+++|||+.+++|.+++...... .+++..+..++.|++.|+.
T Consensus 47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~-~l~~~~~~~~~~qi~~~l~ 125 (272)
T cd06637 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLS 125 (272)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHH
Confidence 4588999999998 699999999998753 3578999999999999998764332 3678889999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diw 150 (259)
|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++|+|
T Consensus 126 ~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 200 (272)
T cd06637 126 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 200 (272)
T ss_pred HHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHH
Confidence 999999 9999999999999999999999999987543221 12233458889999999862 3478899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|+|+++|+|++|..||....... .... ... ... ........+..+.+++.+||..+|.+|||+
T Consensus 201 slGv~l~el~~g~~p~~~~~~~~-------~~~~-~~~-~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 263 (272)
T cd06637 201 SLGITAIEMAEGAPPLCDMHPMR-------ALFL-IPR-NPA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPTT 263 (272)
T ss_pred HHHHHHHHHHhCCCCccccCHHH-------HHHH-Hhc-CCC--------CCCCCCCcCHHHHHHHHHHcCCChhhCCCH
Confidence 99999999999999986532110 0000 000 000 000111233678999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 264 ~~il~ 268 (272)
T cd06637 264 EQLMK 268 (272)
T ss_pred HHHhh
Confidence 99864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=251.35 Aligned_cols=220 Identities=23% Similarity=0.378 Sum_probs=183.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+|.|..|+.++++++||||++++|+|.+ ...|||||.++.|.|..+++..... ++......++.||+.|++|||+..
T Consensus 435 tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~~Qi~talaYLeSkr 511 (974)
T KOG4257|consen 435 TEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYCYQICTALAYLESKR 511 (974)
T ss_pred HHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhcccc--chHHHHHHHHHHHHHHHHHHHhhc
Confidence 4679999999999999999999999976 5679999999999999999887654 466888899999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++||||...||++.....+||+|||+++......-+ ..+.-.-..-|+|||.+....++.++|||.||+.+||++.
T Consensus 512 ---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY-kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~ 587 (974)
T KOG4257|consen 512 ---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY-KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILS 587 (974)
T ss_pred ---hhhhhhhhhheeecCcceeeecccchhhhccccchh-hccccccceeecCccccchhcccchhhHHHHHHHHHHHHH
Confidence 999999999999999999999999999987665333 2333335568999999999999999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|-.||++... .+.--.++.+-.-+.+.++++.+..|+.+||..+|.+||++.++...|.++
T Consensus 588 lGvkPfqgvkN------------------sDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 588 LGVKPFQGVKN------------------SDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred hcCCccccccc------------------cceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 8999998322 222112222333344556789999999999999999999999999999998
Q ss_pred cccccc
Q 025011 241 KISHEN 246 (259)
Q Consensus 241 ~~~~~~ 246 (259)
-..+..
T Consensus 650 ~qeek~ 655 (974)
T KOG4257|consen 650 LQEEKI 655 (974)
T ss_pred HHHhhh
Confidence 775443
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=241.37 Aligned_cols=232 Identities=22% Similarity=0.318 Sum_probs=176.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.+.|||++++++++..++..++++||+++++|.+++... .+++..++.++.|++.|+.+||+++
T Consensus 63 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~- 137 (297)
T cd06659 63 ELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG- 137 (297)
T ss_pred HHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 46889999999999999999999999999999999999999999887543 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++|+||+|+++++|++|
T Consensus 138 --ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 213 (297)
T cd06659 138 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213 (297)
T ss_pred --eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999865443211 12234588899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE--LDRL 240 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~--l~~~ 240 (259)
..||....... .. .... ...... .......+..+.+++.+||+.+|.+|||+.++++. +.+.
T Consensus 214 ~~p~~~~~~~~----~~-~~~~----~~~~~~-------~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 214 EPPYFSDSPVQ----AM-KRLR----DSPPPK-------LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCCCCCCCHHH----HH-HHHh----ccCCCC-------ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 99987532110 00 0000 000000 00011223668999999999999999999999873 2211
Q ss_pred -cccccchhhhhhhhhcccC
Q 025011 241 -KISHENYEHRRTEKRQSIC 259 (259)
Q Consensus 241 -~~~~~~~~~~~~~~~~~~~ 259 (259)
..++.-...++..||-+-|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~ 297 (297)
T cd06659 278 GLPECLVPLIQQYRKRTSTC 297 (297)
T ss_pred CCcccccchHHHHhhhccCC
Confidence 2233334555555555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=257.49 Aligned_cols=226 Identities=18% Similarity=0.233 Sum_probs=161.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--cccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--QVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+.++++++||||+++++++...+..+++++++ ++++.+++..... ........+..++.|++.||.|||++
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 45789999999999999999999999999999999999 4577777654321 11123466788999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ |+|+||||+||+++.++.++|+|||++..+..... .......|+..|+|||++.+..++.++|||||||++|+|+
T Consensus 287 g---IiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 287 K---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred C---eecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999976654321 1223356899999999999888999999999999999999
Q ss_pred hCCCC-CCCCccccccchhHHHHHHHhh------cc--chhhhhhccccC-----C----chhHHHHHHHHHHHHHhccc
Q 025011 161 TGLKP-GSGMALASNEGISMVQYFLYSI------EN--NSLRQILNFQVA-----D----ESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 161 ~g~~p-~~~~~~~~~~~~~~~~~~~~~~------~~--~~~~~~~~~~~~-----~----~~~~~~~~~~~~li~~~l~~ 222 (259)
+|..+ |.+.... ............. .. .....++..... . ......+..+.++|.+||+.
T Consensus 363 ~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~ 440 (501)
T PHA03210 363 SHDFCPIGDGGGK--PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTF 440 (501)
T ss_pred HCCCCCccCCCCC--HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhcc
Confidence 98754 4331111 0111111110000 00 000011000000 0 00011235678889999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||+.|++.
T Consensus 441 DP~~Rpsa~elL~ 453 (501)
T PHA03210 441 DWHLRPGAAELLA 453 (501)
T ss_pred CcccCcCHHHHhh
Confidence 9999999999975
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=251.22 Aligned_cols=204 Identities=23% Similarity=0.251 Sum_probs=156.9
Q ss_pred HHHHHHHhcC---CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 6 QHELRVVSQI---NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 6 ~~E~~~l~~l---~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..|..++... .||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 41 ~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~qil~al~~LH~~~- 116 (330)
T cd05586 41 IGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKYD- 116 (330)
T ss_pred HHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3455666554 699999999999999999999999999999999876543 578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+.. ++.++||||+|+++|+|++
T Consensus 117 --ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt 192 (330)
T cd05586 117 --IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192 (330)
T ss_pred --eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc
Confidence 9999999999999999999999999986543221 1223346899999999987654 7899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT----MKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~ 235 (259)
|..||.+.... ........ ... ... ....++.+.+++.+||+.||.+||+ +.++++
T Consensus 193 G~~Pf~~~~~~--------~~~~~i~~-~~~------~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 193 GWSPFYAEDTQ--------QMYRNIAF-GKV------RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCCCCCCCCHH--------HHHHHHHc-CCC------CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 99999763211 00000000 000 000 0112367889999999999999985 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=243.35 Aligned_cols=209 Identities=22% Similarity=0.355 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++.+..++..+++|||+++++|.+++.... +++..+..++.|++.|+.|||+++
T Consensus 64 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~~~~~~qi~~~l~~LH~~~- 138 (292)
T cd06658 64 ELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIATVCLSVLRALSYLHNQG- 138 (292)
T ss_pred HHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899999999999999999999999999999999999999999885432 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus 139 --ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g 214 (292)
T cd06658 139 --VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214 (292)
T ss_pred --EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999986544321 112234578899999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||...+... ..... ......... .....+..+.+++.+||..||.+|||+.++++.
T Consensus 215 ~~p~~~~~~~~-----~~~~~---------~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 215 EPPYFNEPPLQ-----AMRRI---------RDNLPPRVK--DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred CCCCCCCCHHH-----HHHHH---------HhcCCCccc--cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 99987532110 00000 000000000 111233668899999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=253.82 Aligned_cols=199 Identities=27% Similarity=0.314 Sum_probs=163.5
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
....|-+++... +||.++.++..|.+..++|+||||+.||++..+..... +++..+.-+++.++.||.|||+++
T Consensus 414 ~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~~----F~e~rarfyaAev~l~L~fLH~~~- 488 (694)
T KOG0694|consen 414 SLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTDV----FSEPRARFYAAEVVLGLQFLHENG- 488 (694)
T ss_pred HHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEeccc----ccHHHHHHHHHHHHHHHHHHHhcC-
Confidence 467788888888 59999999999999999999999999999544443222 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+|||||.+||++|..|.+||+|||+.+.--. ....++.+.||+.|+|||++.+..|+.++|.||||+++|+|+.|
T Consensus 489 --IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~G 564 (694)
T KOG0694|consen 489 --IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVG 564 (694)
T ss_pred --ceeeecchhheEEcccCcEEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcC
Confidence 99999999999999999999999999976443 23356778999999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
..||++-+.. .....++.... .++...+.+..++++++|.+||++|.-+
T Consensus 565 q~PF~gddEe-----------------e~FdsI~~d~~--~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 565 ESPFPGDDEE-----------------EVFDSIVNDEV--RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCCCHH-----------------HHHHHHhcCCC--CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 9999982211 11111111111 1233345778999999999999999755
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=250.78 Aligned_cols=217 Identities=20% Similarity=0.271 Sum_probs=161.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++... ...++||||+.+ +|.+.+... +++..+..++.|++.||.|
T Consensus 68 ~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred HHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHhc-----CCHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999987643 357999999955 777777532 5678889999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .......++..|+|||++.+..++.++|||||||++
T Consensus 142 LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il 215 (364)
T cd07875 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 215 (364)
T ss_pred HhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHH
Confidence 99999 999999999999999999999999998765432 122334688999999999988899999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhh-------------------ccc-----hhhhhhcccc---CCchhHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSI-------------------ENN-----SLRQILNFQV---ADESEMEEI 209 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------------~~~-----~~~~~~~~~~---~~~~~~~~~ 209 (259)
|+|++|+.||.+.+.... ......... ... .......... .........
T Consensus 216 ~ell~g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (364)
T cd07875 216 GEMIKGGVLFPGTDHIDQ----WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 291 (364)
T ss_pred HHHHhCCCCCCCCCHHHH----HHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCcccccccccccccccc
Confidence 999999999987432111 000000000 000 0000000000 000011123
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 210 ETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 210 ~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..+.++|.+||+.||.+|||+.++++
T Consensus 292 ~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 292 SQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 56889999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=229.69 Aligned_cols=213 Identities=25% Similarity=0.286 Sum_probs=169.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.-++|+++-=.. .|||||.++++|++. .-+.+|||.++||.|+..++..+.+. +++.++..|+.||+.|+.||
T Consensus 99 ~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~a-fTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 99 PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQA-FTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccccc-chHHHHHHHHHHHHHHHHHH
Confidence 4467788776555 699999999999864 24579999999999999999887765 68899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
|+.+ |.|||+||+|++++. |..+||+|||+++.....+ .......|+.|.|||++....|+...|+||+|+
T Consensus 178 H~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgV 251 (400)
T KOG0604|consen 178 HSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_pred Hhcc---hhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhH
Confidence 9999 999999999999964 4569999999998755322 233456889999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccc--cCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQ--VADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|-|++|.+||...... . ...+...++.... .+.+.....++...++|+.+|..+|++|.|+.+
T Consensus 252 imYIlLCGyPPFYS~hg~-a------------ispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 252 IMYILLCGYPPFYSNHGL-A------------ISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred HHHHhhcCCCcccccCCc-c------------CChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHH
Confidence 999999999999763211 0 1111112222111 222333456788999999999999999999999
Q ss_pred HHH
Q 025011 233 VSE 235 (259)
Q Consensus 233 il~ 235 (259)
+++
T Consensus 319 ~m~ 321 (400)
T KOG0604|consen 319 VMD 321 (400)
T ss_pred hhc
Confidence 853
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=238.58 Aligned_cols=214 Identities=21% Similarity=0.351 Sum_probs=167.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++...+..++||||+++++|.+++.... .+++..+..++.|++.|+.+||+++
T Consensus 53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~- 128 (272)
T cd06629 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG- 128 (272)
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 467889999999999999999999999999999999999999999997763 3677889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++++|||++................++..|+|||.+.... ++.++|+||+|+++++++
T Consensus 129 --i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~ 206 (272)
T cd06629 129 --ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMF 206 (272)
T ss_pred --eeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHH
Confidence 9999999999999999999999999987654322222223345788999999987654 788999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||...... ...... .. .... ...........+..+.+++.+||..+|.+|||+.+++.
T Consensus 207 ~g~~p~~~~~~~-------~~~~~~-~~-~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 207 AGRRPWSDEEAI-------AAMFKL-GN-KRSA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hCCCCCcCcchH-------HHHHHh-hc-cccC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 999998642211 000000 00 0000 00111111234577999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=242.93 Aligned_cols=218 Identities=22% Similarity=0.241 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++.+..++..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+.+
T Consensus 46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~- 121 (305)
T cd05609 46 QQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA---LPVDMARMYFAETVLALEYLHNYG- 121 (305)
T ss_pred HHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3577899999999999999999999999999999999999999999976542 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-------------cccccccCcccccCcchhccCCcccccch
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-------------AMTTKKIGTFVNLDPEYVITGKLTEKSDV 149 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 149 (259)
++|+||+|.||+++.++.++++|||+++........ .......++..|+|||.+.+..++.++|+
T Consensus 122 --i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 122 --IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred --ccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999999999999999987632111000 01112346778999999988889999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
||||+++|++++|..||.+.... +......... . .... .....+..+.+++.+||+.||.+|||
T Consensus 200 ~slG~vl~el~~g~~pf~~~~~~--------~~~~~~~~~~-~------~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~ 263 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDTPE--------ELFGQVISDD-I------EWPE-GDEALPADAQDLISRLLRQNPLERLG 263 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHH--------HHHHHHHhcc-c------CCCC-ccccCCHHHHHHHHHHhccChhhccC
Confidence 99999999999999998752210 0011000000 0 0000 01123467899999999999999999
Q ss_pred HHHHHHHHHhccc
Q 025011 230 MKQVSEELDRLKI 242 (259)
Q Consensus 230 ~~~il~~l~~~~~ 242 (259)
+.++.+.++.-..
T Consensus 264 ~~~~~~ll~~~~~ 276 (305)
T cd05609 264 TGGAFEVKQHRFF 276 (305)
T ss_pred ccCHHHHHhCccc
Confidence 8777777777544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=251.34 Aligned_cols=155 Identities=30% Similarity=0.414 Sum_probs=137.9
Q ss_pred HHHHHHHHhcCC-C-----ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 5 FQHELRVVSQIN-H-----KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 5 ~~~E~~~l~~l~-h-----~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
-..|+.+|..|+ | -|+|+++++|...++.|||+|.+ ..+|.++++.+.... ++...+..++.||+.||..||
T Consensus 229 ~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~G-lsl~~ir~~~~Qil~~L~~L~ 306 (586)
T KOG0667|consen 229 AQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRG-LSLPLVRKFAQQILTALLFLH 306 (586)
T ss_pred HHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHH
Confidence 457999999995 3 38999999999999999999999 559999999887766 788999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCC--CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDN--YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
+.+ |+|+||||+||++... ..+||+|||.++.... .......+..|+|||++.+.+|+.+.||||||||+
T Consensus 307 ~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIl 378 (586)
T KOG0667|consen 307 ELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCIL 378 (586)
T ss_pred hCC---eeeccCChhheeeccCCcCceeEEecccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhH
Confidence 999 9999999999999643 3699999999987543 22255688899999999999999999999999999
Q ss_pred HHHHhCCCCCCCC
Q 025011 157 AELLTGLKPGSGM 169 (259)
Q Consensus 157 ~~l~~g~~p~~~~ 169 (259)
.||++|.+.|+|.
T Consensus 379 AEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 379 AELFTGEPLFPGD 391 (586)
T ss_pred HhHhcCccccCCC
Confidence 9999999999884
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=237.52 Aligned_cols=209 Identities=22% Similarity=0.363 Sum_probs=161.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+.+++.++||||+++++++.. ++..++++||+++++|.+++..... +++..++.++.|++.|+.+||+.
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA---LTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 358889999999999999999998875 3577899999999999999976543 57788899999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 126 ~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred C---eeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 9 99999999999999999999999999875432111 1111223478899999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||...... ..... ..........+....+.+.+++ .||..+|++|||++++++
T Consensus 203 ~~g~~pf~~~~~~-------~~~~~----------~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 203 LTEKPPWAEYEAM-------AAIFK----------IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHCCCCccccchH-------HHHHH----------HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 9999999763211 00000 0000001111222346677888 688899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=252.65 Aligned_cols=215 Identities=22% Similarity=0.292 Sum_probs=163.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+.++..++||||+++++.+.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~~L~~lH~~g- 121 (360)
T cd05627 46 AHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSEEATQFYIAETVLAIDAIHQLG- 121 (360)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999976543 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc---------------------------------cccccccCc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT---------------------------------AMTTKKIGT 129 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---------------------------------~~~~~~~~~ 129 (259)
++|+||||+||+++.++.++|+|||++......... .......|+
T Consensus 122 --ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 199 (360)
T cd05627 122 --FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGT 199 (360)
T ss_pred --eEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCC
Confidence 999999999999999999999999998644321100 001134689
Q ss_pred ccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHH
Q 025011 130 FVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEI 209 (259)
Q Consensus 130 ~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 209 (259)
..|+|||++.+..++.++|+||+||++|+|++|..||.+..... ......... .....+.....+
T Consensus 200 ~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~p~~~~~s 264 (360)
T cd05627 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE--------TYRKVMNWK-------ETLVFPPEVPIS 264 (360)
T ss_pred ccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHH--------HHHHHHcCC-------CceecCCCCCCC
Confidence 99999999998889999999999999999999999997632110 000000000 000001111234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 210 ETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 210 ~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+.+.++|.+|+ .||.+|++...+.+.++.
T Consensus 265 ~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 265 EKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 67889999987 499999964433333443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=237.89 Aligned_cols=216 Identities=25% Similarity=0.368 Sum_probs=170.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+|++++++.+..++..++++|++++++|.+++........+++..+..++.|++.|+.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~- 122 (267)
T cd06610 44 DELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG- 122 (267)
T ss_pred HHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999976543334688899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccC-CcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||++++++.++|+|||++.......... ......++..|+|||.+... .++.++|+||+|+++++|
T Consensus 123 --i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l 200 (267)
T cd06610 123 --QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIEL 200 (267)
T ss_pred --eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHH
Confidence 9999999999999999999999999987665433221 22334578899999998776 688999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc-hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE-SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||....... ...+.. .. . ....... .....++.+.+++.+||..||.+|||+.++++
T Consensus 201 ~~g~~p~~~~~~~~----~~~~~~----~~-~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 201 ATGAAPYSKYPPMK----VLMLTL----QN-D-----PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HhCCCCccccChhh----hHHHHh----cC-C-----CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 99999987532110 000000 00 0 0000000 01234477899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=237.43 Aligned_cols=212 Identities=24% Similarity=0.365 Sum_probs=163.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+||+++++++..++..++++||+++++|.+++.........+...+..++.|++.|+.|||+++
T Consensus 50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~- 128 (268)
T cd06624 50 QPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ- 128 (268)
T ss_pred HHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976432211266788899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l 159 (259)
++|+||+|.||+++. ++.++|+|||.+........ ......++..|+|||++.... ++.++|+||+|+++|+|
T Consensus 129 --i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l 204 (268)
T cd06624 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204 (268)
T ss_pred --EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHH
Confidence 999999999999976 67899999999875543211 122335788999999986543 78899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||........ ..+..... ......+...++.+.+++.+||+.+|.+|||+.+++.
T Consensus 205 ~~g~~p~~~~~~~~~-----~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 205 ATGKPPFIELGEPQA-----AMFKVGMF-----------KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred HhCCCCCccccChhh-----hHhhhhhh-----------ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 999999865221100 00000000 0000111123467899999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=241.95 Aligned_cols=208 Identities=24% Similarity=0.351 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... +++..+..++.|++.|+.+||+.+
T Consensus 61 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~l~~~L~~LH~~~- 135 (297)
T cd06656 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQ- 135 (297)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457889999999999999999999999999999999999999999986532 467889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus 136 --i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg 211 (297)
T cd06656 136 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (297)
T ss_pred --cccCCCCHHHEEECCCCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875443221 12234578899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+....... ..... . .......+...+..+.+++.+||..+|.+|||+.++++
T Consensus 212 ~~pf~~~~~~~~~--------~~~~~-~-------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 212 EPPYLNENPLRAL--------YLIAT-N-------GTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCCCCCCCcchhe--------eeecc-C-------CCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999763211100 00000 0 00000011223466889999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=242.09 Aligned_cols=220 Identities=20% Similarity=0.273 Sum_probs=160.9
Q ss_pred HHHHHHHHHhcC---CCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI---NHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|+.+++.+ +||||+++++++.. ....+++|||+. ++|.+++...... .+++..+..++.|++.||.
T Consensus 45 ~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 45 STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPP-GLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred HHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHH
Confidence 466788888776 69999999998864 245799999996 4898888765432 2678999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+.+ ++|+||||+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++||||+||+
T Consensus 123 ~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred HHHhCC---eecCCCCHHHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 999999 9999999999999999999999999987654321 1223457889999999988889999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchhhh-------hhccccC---CchhHHHHHHHHHHHHHhcccC
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSLRQ-------ILNFQVA---DESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~---~~~~~~~~~~~~~li~~~l~~~ 223 (259)
+|+|++|.+||.+..... .......... ....+.. ....... .......++.+.+++.+||+.|
T Consensus 197 l~~l~~g~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 272 (288)
T cd07863 197 FAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFN 272 (288)
T ss_pred HHHHHhCCcCcCCCCHHH----HHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccC
Confidence 999999999987632111 1111110000 0000000 0000000 0001123467889999999999
Q ss_pred CCCCCCHHHHHH
Q 025011 224 GRRRPTMKQVSE 235 (259)
Q Consensus 224 p~~Rpt~~~il~ 235 (259)
|.+|||+.+++.
T Consensus 273 P~~R~t~~~~l~ 284 (288)
T cd07863 273 PHKRISAFRALQ 284 (288)
T ss_pred cccCCCHHHHhc
Confidence 999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=248.20 Aligned_cols=156 Identities=22% Similarity=0.336 Sum_probs=132.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
....|+.+++.++||||+++++++..++..++|+|++ .++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 103 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~-- 177 (357)
T PHA03209 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR-- 177 (357)
T ss_pred ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 3467999999999999999999999999999999999 4588888865433 3678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|+||||||+||+++.++.++|+|||+++..... .......|+..|+|||++.+..++.++||||+||++|+|+++.
T Consensus 178 -ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~ 253 (357)
T PHA03209 178 -IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYP 253 (357)
T ss_pred -eecCCCCHHHEEECCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcC
Confidence 999999999999999999999999998643321 1122345889999999998888999999999999999999865
Q ss_pred C-CCCC
Q 025011 164 K-PGSG 168 (259)
Q Consensus 164 ~-p~~~ 168 (259)
. +|..
T Consensus 254 ~~~f~~ 259 (357)
T PHA03209 254 STIFED 259 (357)
T ss_pred CccccC
Confidence 4 4443
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=237.34 Aligned_cols=209 Identities=25% Similarity=0.287 Sum_probs=167.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++.+... ++...+..++.|++.|+.|||+++
T Consensus 38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~~i~~~l~~lH~~~- 113 (262)
T cd05572 38 EHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEYTARFYIACVVLAFEYLHNRG- 113 (262)
T ss_pred HHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 5688999999999999999999999999999999999999999999976533 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|
T Consensus 114 --~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g 188 (262)
T cd05572 114 --IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG 188 (262)
T ss_pred --cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC
Confidence 9999999999999999999999999987665432 12234578899999998888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
..||...... . ..... .+.........+...++.+.+++.+||+.+|.+||| +.++++
T Consensus 189 ~~p~~~~~~~---~---~~~~~---------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 189 RPPFGEDDED---P---MEIYN---------DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CCCcCCCCCC---H---HHHHH---------HHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 9999763310 0 00000 011000001111112467999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=242.69 Aligned_cols=223 Identities=19% Similarity=0.267 Sum_probs=164.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|+.+++.++||||+++++++..++..+++|||+. ++|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 49 ~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~- 124 (301)
T cd07873 49 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK- 124 (301)
T ss_pred hHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 357789999999999999999999999999999999996 589888865433 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+. .++.++||||+|+++|+|++
T Consensus 125 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 125 --VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred --eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999875433211 12233568899999998664 47889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhc---------cccCC----chhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILN---------FQVAD----ESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|.+||.+.+..... ........ ......+..+.. ..... ......++.+.++|.+||+.||.+||
T Consensus 201 g~~~f~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~ 278 (301)
T cd07873 201 GRPLFPGSTVEEQL-HFIFRILG-TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278 (301)
T ss_pred CCCCCCCCCHHHHH-HHHHHHcC-CCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc
Confidence 99999864321100 00000000 000000000000 00000 00112346789999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|++++++
T Consensus 279 t~~eil~ 285 (301)
T cd07873 279 SAEEAMK 285 (301)
T ss_pred CHHHHhc
Confidence 9999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=241.91 Aligned_cols=222 Identities=18% Similarity=0.212 Sum_probs=162.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+.+..++++||+. ++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 44 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~- 119 (284)
T cd07839 44 SSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN- 119 (284)
T ss_pred cchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457789999999999999999999999999999999996 578887765322 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus 120 --i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t 195 (284)
T cd07839 120 --VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 195 (284)
T ss_pred --EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543211 122345778999999987654 7899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchh---hhhhcc----ccC-----CchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSL---RQILNF----QVA-----DESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~---~~~~~~----~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..|+....... ............ ...+ ....+. ... .......++.+.+++.+||+.||.+|
T Consensus 196 g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07839 196 AGRPLFPGNDVD---DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQR 272 (284)
T ss_pred cCCCCcCCCCHH---HHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhc
Confidence 988854321110 000000000000 0000 000000 000 00011234678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 273 ~t~~~il~ 280 (284)
T cd07839 273 ISAEEALQ 280 (284)
T ss_pred CCHHHHhc
Confidence 99999965
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=239.38 Aligned_cols=210 Identities=25% Similarity=0.289 Sum_probs=163.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++.+..++..+++|||+++++|..++.+... .+++..+..++.|++.++.+||+.+
T Consensus 54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~- 130 (292)
T cd06644 54 EDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK- 130 (292)
T ss_pred HHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 4678899999999999999999999999999999999999999888765432 2578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||++.+ ..++.++|+||||+++|
T Consensus 131 --i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~ 206 (292)
T cd06644 131 --IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 206 (292)
T ss_pred --eeecCCCcceEEEcCCCCEEEccCccceeccccc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHH
Confidence 9999999999999999999999999876543221 11223457789999998853 34678999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||...... ......... ... ....+...+..+.+++.+||+.||.+||++.++++
T Consensus 207 el~~g~~p~~~~~~~--------~~~~~~~~~-~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 207 EMAQIEPPHHELNPM--------RVLLKIAKS-EPP-------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHhcCCCCCccccHH--------HHHHHHhcC-CCc-------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 999999998752210 000000000 000 00011123356899999999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=245.62 Aligned_cols=209 Identities=20% Similarity=0.293 Sum_probs=165.0
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+-|.+|+.+|.+|+ |.+|+++++|-..++.+|+||||= ..+|..+|++.....+ . ..+..++.|++.|+.++|++|
T Consensus 404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~-~-~~lk~ywkqML~aV~~IH~~g 480 (677)
T KOG0596|consen 404 DGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDP-D-WFLKFYWKQMLLAVKTIHQHG 480 (677)
T ss_pred HHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCc-h-HHHHHHHHHHHHHHHHHHHhc
Confidence 35899999999995 899999999999999999999987 5599999988765442 2 378889999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-----------cccccchh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-----------LTEKSDVY 150 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~Diw 150 (259)
|||.||||.|+++-+ |.+||+|||.+..+..+...-.....+||+.||+||.+.... .+.++|||
T Consensus 481 ---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvW 556 (677)
T KOG0596|consen 481 ---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVW 556 (677)
T ss_pred ---eeecCCCcccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchh
Confidence 999999999999875 599999999998877654444555678999999999986433 45689999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhcccc--CCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQV--ADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|||||+|+|+.|+.||..... .-..+..+.+... ..+.- .....+.++++.||.+||++||
T Consensus 557 SLGCILYqMvYgktPf~~~~n----------------~~aKl~aI~~P~~~Iefp~~-~~~~~li~~mK~CL~rdPkkR~ 619 (677)
T KOG0596|consen 557 SLGCILYQMVYGKTPFGQIIN----------------QIAKLHAITDPNHEIEFPDI-PENDELIDVMKCCLARDPKKRW 619 (677)
T ss_pred hhhhHHHHHHhcCCchHHHHH----------------HHHHHHhhcCCCccccccCC-CCchHHHHHHHHHHhcCcccCC
Confidence 999999999999999886211 0011222222211 11000 0112399999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|+.+++.
T Consensus 620 si~eLLq 626 (677)
T KOG0596|consen 620 SIPELLQ 626 (677)
T ss_pred CcHHHhc
Confidence 9999975
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=239.12 Aligned_cols=210 Identities=21% Similarity=0.261 Sum_probs=165.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++|+|++.+.+.+..++..+++|||+.+++|.+++...... .+++..+..++.|++.||.|||+.+
T Consensus 46 ~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~-- 122 (285)
T cd05632 46 MALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-GFEEERALFYAAEILCGLEDLHREN-- 122 (285)
T ss_pred HHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4678999999999999999999999999999999999999999888654332 3688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 123 -iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred -eeecCCCHHHEEECCCCCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 9999999999999999999999999986544321 112346889999999998888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
.||.+...... ...... ...... .......++.+.+++.+||+.||.+||| +.++++
T Consensus 199 ~P~~~~~~~~~----~~~~~~-~~~~~~----------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 199 SPFRGRKEKVK----REEVDR-RVLETE----------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CCCCCCCHHHH----HHHHHH-hhhccc----------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 99986321100 000000 000000 0011123356889999999999999999 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=239.28 Aligned_cols=211 Identities=24% Similarity=0.319 Sum_probs=165.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++..... .+++..+..++.|++.|+.|||+++
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~- 123 (280)
T cd06611 47 EDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK- 123 (280)
T ss_pred HHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999876432 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++++|||.+........ ......++..|+|||.+.. ..++.++|+||+|+++|
T Consensus 124 --i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred --cccCCCChhhEEECCCCCEEEccCccchhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 99999999999999999999999998765433211 1223457889999998752 34678999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+|++|..||.+.+... ..... .. .... .. ..+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 200 ~l~~g~~p~~~~~~~~----~~~~~----~~-~~~~-----~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 200 ELAQMEPPHHELNPMR----VLLKI----LK-SEPP-----TL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhCCCCcccCCHHH----HHHHH----hc-CCCC-----Cc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 9999999987632110 00000 00 0000 00 0111233678999999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=249.40 Aligned_cols=222 Identities=19% Similarity=0.267 Sum_probs=161.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++... ...+++|||+++ ++.+.+... +++..+..++.|++.||.|
T Consensus 61 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----l~~~~~~~~~~qi~~aL~~ 134 (355)
T cd07874 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKH 134 (355)
T ss_pred HHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhhc-----CCHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999988643 346999999965 677766432 5678889999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .......++..|+|||++.+..++.++||||+||++
T Consensus 135 LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il 208 (355)
T cd07874 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_pred HHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHH
Confidence 99999 999999999999999999999999998765432 122334688999999999888899999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHH-------HH-------HHhh-ccchh-----hhhhccccC---CchhHHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQ-------YF-------LYSI-ENNSL-----RQILNFQVA---DESEMEEIETVA 213 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~-------~~-------~~~~-~~~~~-----~~~~~~~~~---~~~~~~~~~~~~ 213 (259)
|+|++|..||.+.+........... .. .... ..... ......... .......+..+.
T Consensus 209 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (355)
T cd07874 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288 (355)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHH
Confidence 9999999999874321110000000 00 0000 00000 000000000 000111235688
Q ss_pred HHHHHhcccCCCCCCCHHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
++|.+||..||.+|||+.++++.
T Consensus 289 ~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 289 DLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHHHhcCCchhcCCHHHHhcC
Confidence 99999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.91 Aligned_cols=218 Identities=23% Similarity=0.319 Sum_probs=164.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.|..|+.++++|+||||++++++|.. ...+||||||+++++|.+++.... ....+++..++.|+.||+.||.|||+
T Consensus 57 ~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs 136 (1021)
T PTZ00266 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHN 136 (1021)
T ss_pred HHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 468899999999999999999998864 356899999999999999997532 22346889999999999999999998
Q ss_pred CCC----CCeEeCCCCCCCeEeCC-----------------CCceEEeecCCcccccCCccccccccccCcccccCcchh
Q 025011 80 SAS----PPIIHGDVKSTNVLLDD-----------------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYV 138 (259)
Q Consensus 80 ~~~----~~i~h~di~p~nil~~~-----------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 138 (259)
.+. .+|+|+||||+||+++. .+.++|+|||++....... ......+++.|+|||++
T Consensus 137 ~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELL 213 (1021)
T ss_pred cccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHH
Confidence 431 23999999999999964 2348999999987654321 22334689999999998
Q ss_pred cc--CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHH
Q 025011 139 IT--GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 139 ~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
.+ ..++.++|||||||++|+|++|..||...... ........... .......+..+.+||
T Consensus 214 ~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~-------~qli~~lk~~p-----------~lpi~~~S~eL~dLI 275 (1021)
T PTZ00266 214 LHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF-------SQLISELKRGP-----------DLPIKGKSKELNILI 275 (1021)
T ss_pred hccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH-------HHHHHHHhcCC-----------CCCcCCCCHHHHHHH
Confidence 64 34789999999999999999999999752211 01111100000 000011246799999
Q ss_pred HHhcccCCCCCCCHHHHH--HHHHhcc
Q 025011 217 SKCLSLSGRRRPTMKQVS--EELDRLK 241 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il--~~l~~~~ 241 (259)
..||..+|.+|||+.+++ ..+..+.
T Consensus 276 ~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 276 KNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred HHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999999999999999998 4454443
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=237.20 Aligned_cols=210 Identities=21% Similarity=0.354 Sum_probs=166.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHh-
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLH- 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh- 78 (259)
+++.+|+++++.++||||+++++++.. +...+++|||+++++|.+++.... ....+++..++.++.|++.|+.+||
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 123 (265)
T cd08217 44 QQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123 (265)
T ss_pred HHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 467889999999999999999998754 456799999999999999997541 2234688899999999999999999
Q ss_pred ----hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 79 ----SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 79 ----~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
+.+ ++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||||+
T Consensus 124 ~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 124 RSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred CccccCc---ceecCCCHHHEEEecCCCEEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 777 99999999999999999999999999887654321 122345888999999998888899999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++++|++|..||..... ..... ..... .....+...+..+.+++.+||+.+|.+|||+.+|+
T Consensus 199 il~~l~~g~~p~~~~~~-----~~~~~----~~~~~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 199 LIYELCALSPPFTARNQ-----LQLAS----KIKEG---------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred HHHHHHHCCCcccCcCH-----HHHHH----HHhcC---------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 99999999999886321 01111 01111 11111223447799999999999999999999997
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 261 ~ 261 (265)
T cd08217 261 Q 261 (265)
T ss_pred h
Confidence 5
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=244.97 Aligned_cols=214 Identities=22% Similarity=0.301 Sum_probs=162.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|..+++.++|+||+++++++.+++..++||||+++++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 122 (331)
T cd05597 46 ACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG- 122 (331)
T ss_pred HHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3578899999999999999999999999999999999999999999976432 2577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~ 157 (259)
++|+||||+||+++.++.++|+|||++......... ......|+..|+|||++.. ..++.++||||+||++|
T Consensus 123 --ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~ 199 (331)
T cd05597 123 --YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199 (331)
T ss_pred --eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHH
Confidence 999999999999999999999999998665432211 1222458999999999863 34678999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~ 235 (259)
+|++|+.||.+.... +.............+ .......++.+.+++.+||..++++ ||++.++++
T Consensus 200 el~~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 200 EMLYGETPFYAESLV--------ETYGKIMNHKEHFQF------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred HHhhCCCCCCCCCHH--------HHHHHHHcCCCcccC------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 999999999763211 001111100000000 0001123467899999988654433 788888865
Q ss_pred H
Q 025011 236 E 236 (259)
Q Consensus 236 ~ 236 (259)
-
T Consensus 266 h 266 (331)
T cd05597 266 H 266 (331)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=239.01 Aligned_cols=224 Identities=20% Similarity=0.272 Sum_probs=165.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++|||++++++++..+...+++|||+++++|..+...... +++..+..++.|++.+|.|||+.+
T Consensus 45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~ql~~~l~~LH~~~- 120 (286)
T cd07847 45 KIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKHN- 120 (286)
T ss_pred HHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5678999999999999999999999999999999999999888777654332 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++
T Consensus 121 --i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~ 196 (286)
T cd07847 121 --CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT 196 (286)
T ss_pred --ceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence 99999999999999999999999999876654321 1223357788999999866 457889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHH-------hhccchh-hhhhccccCCc-----hhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLY-------SIENNSL-RQILNFQVADE-----SEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|..||.+...... .......... ....... ........... .....+..+.+++.+||+.+|++||
T Consensus 197 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 275 (286)
T cd07847 197 GQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL 275 (286)
T ss_pred CCCCCCCCChHHH-HHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC
Confidence 9999986432110 0000000000 0000000 00000000000 0012346789999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|+.+++.
T Consensus 276 ~~~eil~ 282 (286)
T cd07847 276 SCEELLE 282 (286)
T ss_pred CHHHHhc
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=244.20 Aligned_cols=201 Identities=24% Similarity=0.279 Sum_probs=159.7
Q ss_pred HHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|..++..+. |++|+++++++...+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~- 121 (323)
T cd05615 46 CTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FKEPQAVFYAAEISVGLFFLHRRG- 121 (323)
T ss_pred HHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4677888888885 57888999999999999999999999999999876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... .......|+..|+|||++.+..++.++|+||+|+++|+|++|
T Consensus 122 --ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (323)
T cd05615 122 --IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG 197 (323)
T ss_pred --eeccCCCHHHeEECCCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC
Confidence 9999999999999999999999999987543221 112234589999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
..||.+.... .. ..... .... ..+...+..+.+++.+||+.+|.+|++..
T Consensus 198 ~~pf~~~~~~-----~~---~~~i~---------~~~~--~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 198 QPPFDGEDED-----EL---FQSIM---------EHNV--SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCCCCHH-----HH---HHHHH---------hCCC--CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 9999863211 00 00000 0000 01112336789999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=237.03 Aligned_cols=212 Identities=23% Similarity=0.348 Sum_probs=166.9
Q ss_pred HHHHHHHHHhc-CCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhh-C
Q 025011 4 VFQHELRVVSQ-INHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHS-S 80 (259)
Q Consensus 4 ~~~~E~~~l~~-l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 80 (259)
.+.+|+.++.+ ++||||+++++++..++..+++|||+++++|.+++... .....+++..++.++.|++.++.+||+ .
T Consensus 54 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~ 133 (269)
T cd08528 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK 133 (269)
T ss_pred HHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC
Confidence 46678888875 69999999999999999999999999999999988542 122336788999999999999999996 6
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||+|.||+++.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|+|+
T Consensus 134 ~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~ 207 (269)
T cd08528 134 R---IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMC 207 (269)
T ss_pred c---eeecCCCHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHH
Confidence 7 9999999999999999999999999987654332 223445888999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
+|..||...... ....... ...... ......++.+.+++.+||+.||.+|||+.++.+.++
T Consensus 208 ~g~~p~~~~~~~--------~~~~~~~-~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 208 TLQPPFYSTNML--------SLATKIV-EAVYEP--------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hCCCcccccCHH--------HHHHHHh-hccCCc--------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 999998652110 0000000 010000 001122367999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=243.51 Aligned_cols=225 Identities=17% Similarity=0.226 Sum_probs=165.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+++|+.+++.++||||++++++|..++..++++||+.++++.+++....... +++..+..++.|++.||.|||+++
T Consensus 44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~qi~~aL~~lH~~~- 121 (328)
T cd08226 44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLHQNG- 121 (328)
T ss_pred HHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccC-CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 568899999999999999999999999999999999999999999987654322 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc-----cccccCcccccCcchhccC--CcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM-----TTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~i 155 (259)
++|+||||+||+++.++.+++.||+.+........... .....++..|+|||++.+. .++.++||||+||+
T Consensus 122 --ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~ 199 (328)
T cd08226 122 --YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGIT 199 (328)
T ss_pred --eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHH
Confidence 99999999999999999999999975433222111100 1112345679999998764 37889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHH----------------h----------------hccchhhhhhccccCCc
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLY----------------S----------------IENNSLRQILNFQVADE 203 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------------~----------------~~~~~~~~~~~~~~~~~ 203 (259)
+|+|++|..||.+...... ....... . .................
T Consensus 200 l~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd08226 200 ACELATGRVPFQDMLRTQM----LLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP 275 (328)
T ss_pred HHHHHhCCCCCCCcChHHH----HHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccch
Confidence 9999999999976432110 0000000 0 00000000111111122
Q ss_pred hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 204 SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 204 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.....++.+.+++++||+.||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 276 SSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 23345678999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=238.50 Aligned_cols=208 Identities=21% Similarity=0.312 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++..++..++++||+++++|.+++... .+++..+..++.|++.|+.+||+++
T Consensus 61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~- 135 (285)
T cd06648 61 ELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG- 135 (285)
T ss_pred HHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45788999999999999999999999999999999999999999998762 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus 136 --i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g 211 (285)
T cd06648 136 --VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211 (285)
T ss_pred --eecCCCChhhEEEcCCCcEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999876544321 112234588899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ......... .. .... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 212 ~~p~~~~~~~--------~~~~~~~~~-~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 212 EPPYFNEPPL--------QAMKRIRDN-LP-----PKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCCCcCCCHH--------HHHHHHHhc-CC-----CCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 9998652211 000000000 00 0000 01113467999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=237.48 Aligned_cols=212 Identities=26% Similarity=0.356 Sum_probs=163.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCC------cceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+.+++.+ +|+||+++++++.... ..+++|||+++++|.+++.... ....+++..+..++.|++.|+
T Consensus 47 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al 126 (275)
T cd06608 47 EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126 (275)
T ss_pred HHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHH
Confidence 5688999999999 7999999999997644 4899999999999999986532 123367889999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-----Ccccccch
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-----KLTEKSDV 149 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Di 149 (259)
.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .......++..|+|||.+... .++.++||
T Consensus 127 ~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999 9999999999999999999999999987654321 122334588899999987542 36778999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
||+|++++++++|..||...... .. ...... .... ........++.+.+++.+||..||.+|||
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~----~~----~~~~~~-~~~~-------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt 265 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPM----RA----LFKIPR-NPPP-------TLKSPENWSKKFNDFISECLIKNYEQRPF 265 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchH----HH----HHHhhc-cCCC-------CCCchhhcCHHHHHHHHHHhhcChhhCcC
Confidence 99999999999999998752111 00 000000 0000 00111224467999999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
+.++++
T Consensus 266 ~~~ll~ 271 (275)
T cd06608 266 MEELLE 271 (275)
T ss_pred HHHHhc
Confidence 999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=236.63 Aligned_cols=202 Identities=26% Similarity=0.353 Sum_probs=164.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++..... ++...+..++.|++.||.+||+.+
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~qil~~l~~lH~~~- 121 (290)
T cd05580 46 EHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR---FPEPVARFYAAQVVLALEYLHSLD- 121 (290)
T ss_pred HHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999976632 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++|+|||++...... .....++..|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 122 --i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 194 (290)
T cd05580 122 --IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194 (290)
T ss_pred --EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999999999999999999999999998765432 2234578899999999888888999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il 234 (259)
..||...... ....... .. ... .+...++.+.+++.+||..||.+|+ ++++++
T Consensus 195 ~~p~~~~~~~--------~~~~~~~-~~--------~~~--~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 195 YPPFFDDNPI--------QIYEKIL-EG--------KVR--FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CCCCCCCCHH--------HHHHHHh-cC--------Ccc--CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 9998763310 0000000 00 000 0111246789999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=235.68 Aligned_cols=209 Identities=24% Similarity=0.362 Sum_probs=166.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++.+..++..++++||+++++|.+++...... .+++..+..++.|++.|+.|||+.+
T Consensus 44 ~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~- 121 (257)
T cd08225 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV-LFSEDQILSWFVQISLGLKHIHDRK- 121 (257)
T ss_pred HHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 46789999999999999999999999999999999999999999999765432 3578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCc-eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYK-AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|.||++++++. ++++|||.+........ ......++..|+|||++.+..++.++|+||+|++++++++
T Consensus 122 --i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~ 197 (257)
T cd08225 122 --ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197 (257)
T ss_pred --cccccCCHHHEEEcCCCCeEEecccccchhccCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999998864 69999999876543221 1223357889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||..... .+....... .... ......+..+.+++.+||..+|++|||+.++++
T Consensus 198 g~~p~~~~~~--------~~~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 198 LKHPFEGNNL--------HQLVLKICQ-GYFA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCccH--------HHHHHHHhc-ccCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 9999875221 111111111 0000 011123367999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=239.39 Aligned_cols=210 Identities=24% Similarity=0.353 Sum_probs=161.6
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEe------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLE------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
..+..|+.+++.+ +||||+++++++.. ....+++|||+.+++|.+++....... .++..+..++.|++.|+.
T Consensus 57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~qi~~al~ 135 (282)
T cd06636 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA-LKEDWIAYICREILRGLA 135 (282)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCC-CCHHHHHHHHHHHHHHHH
Confidence 3578899999998 69999999999853 457899999999999999997654332 567888999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diw 150 (259)
|||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+. ...++.++|+|
T Consensus 136 ~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw 210 (282)
T cd06636 136 HLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW 210 (282)
T ss_pred HHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence 999999 99999999999999999999999999875432211 122345888999999875 34577899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|||+++|+|++|..||....... .... ..............+..+.++|.+||+.||.+|||+
T Consensus 211 slG~~l~el~~g~~p~~~~~~~~-------~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 273 (282)
T cd06636 211 SLGITAIEMAEGAPPLCDMHPMR-------ALFL----------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPST 273 (282)
T ss_pred HHHHHHHHHHhCCCCccccCHHh-------hhhh----------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCH
Confidence 99999999999999987532110 0000 000000111111234679999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 274 ~ell~ 278 (282)
T cd06636 274 EQLLK 278 (282)
T ss_pred HHHhc
Confidence 99964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=234.62 Aligned_cols=207 Identities=24% Similarity=0.328 Sum_probs=166.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++..+...++++||+++++|.+++..... +++..+..++.|++.|+.+||+.+
T Consensus 47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~- 122 (258)
T cd06632 47 KQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDRN- 122 (258)
T ss_pred HHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4588999999999999999999999999999999999999999999976542 577888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|++||.+.... ++.++|+||+|+++|+|++
T Consensus 123 --i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~ 197 (258)
T cd06632 123 --TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT 197 (258)
T ss_pred --cccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence 9999999999999999999999999987654332 223345788899999987766 8899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||...... ............. ..+...++.+.+++.+||+.+|.+|||+.+++.
T Consensus 198 g~~pf~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 198 GKPPWSQLEGV--------AAVFKIGRSKELP---------PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CCCCcccCcHH--------HHHHHHHhcccCC---------CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 99998763210 0000000000000 011123467899999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=229.26 Aligned_cols=230 Identities=20% Similarity=0.258 Sum_probs=168.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhcc--CCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDK--SSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.--+|+.+++.++|||++.+..+|.. +..+++++||.+. +|...+... ......+......+++||+.|+.|||+
T Consensus 72 ~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~ 150 (438)
T KOG0666|consen 72 MSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS 150 (438)
T ss_pred HHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh
Confidence 345689999999999999999999987 8899999999966 898888543 122345667888999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCC----CceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCC-cccccchhhHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDN----YKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFG 153 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG 153 (259)
+. |+|||+||.||++..+ |.+|++|||+++.+...-... ....-+-|.+|+|||.+.+.. |+++.|+|++|
T Consensus 151 NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiG 227 (438)
T KOG0666|consen 151 NW---VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIG 227 (438)
T ss_pred hh---eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHH
Confidence 99 9999999999999887 899999999999887654333 233445788999999999876 89999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccc-h----hHHHHHHHh--hccchhhhhh------------ccccCCchhH--------
Q 025011 154 VLLAELLTGLKPGSGMALASNEG-I----SMVQYFLYS--IENNSLRQIL------------NFQVADESEM-------- 206 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~-~----~~~~~~~~~--~~~~~~~~~~------------~~~~~~~~~~-------- 206 (259)
||+.||++-.+.|.+........ . .+...+.-. +....+..+. ..........
T Consensus 228 CIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k 307 (438)
T KOG0666|consen 228 CIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHK 307 (438)
T ss_pred HHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhc
Confidence 99999999999998754332222 1 111111000 0011111000 0000000000
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 207 EEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 207 ~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..++...+|+.+||+.||.+|.|+.++++-
T Consensus 308 ~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 308 VKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred CCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 012447899999999999999999999653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=236.36 Aligned_cols=210 Identities=21% Similarity=0.235 Sum_probs=165.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++...+..|++|||+++++|.+++...... .+++..+..++.|++.|+.|||+.+
T Consensus 39 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~~-- 115 (277)
T cd05577 39 MALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEP-GFPEARAIFYAAQIICGLEHLHQRR-- 115 (277)
T ss_pred HHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4678999999999999999999999999999999999999999998765432 3678899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++++|++|+
T Consensus 116 -i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~ 191 (277)
T cd05577 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191 (277)
T ss_pred -cccCCCCHHHEEECCCCCEEEccCcchhhhccC---CccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC
Confidence 999999999999999999999999988755431 1122345778999999998888899999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
.||.......... . .... .... ....+...++.+.++|.+||+.||.+|| ++.+++.
T Consensus 192 ~p~~~~~~~~~~~----~-~~~~--------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 192 SPFRQRKEKVEKE----E-LKRR--------TLEM--AVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCCCCCcccccHH----H-HHhc--------cccc--cccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 9997643211000 0 0000 0000 0001112247799999999999999999 6666753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=246.10 Aligned_cols=224 Identities=23% Similarity=0.367 Sum_probs=182.7
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+|.+|+++|.+|+||||++++++|..++.+|+++||++.|+|..++.+..... .+......++.||++|++||.+.+
T Consensus 579 r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n 657 (807)
T KOG1094|consen 579 RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN 657 (807)
T ss_pred HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc
Confidence 5689999999999999999999999999999999999999999999998773322 344666779999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|||+.+.|++++++.++|++|||+++..-.+..+...+..+-...|+|||.+...+++.++|+|++|+++||+++
T Consensus 658 ---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~ 734 (807)
T KOG1094|consen 658 ---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFM 734 (807)
T ss_pred ---hhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHH
Confidence 99999999999999999999999999997766656666777788899999999999999999999999999999876
Q ss_pred --CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 162 --GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 162 --g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
...||...... ...+-............. ...+.-++..+.+++..||..+..+|||++++-..|.+
T Consensus 735 ~C~e~Py~~lt~e-----~vven~~~~~~~~~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 735 LCREQPYSQLTDE-----QVVENAGEFFRDQGRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred HHhhCchhhhhHH-----HHHHhhhhhcCCCCccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 66888763211 111111122222222222 22333455779999999999999999999999888876
Q ss_pred c
Q 025011 240 L 240 (259)
Q Consensus 240 ~ 240 (259)
.
T Consensus 804 ~ 804 (807)
T KOG1094|consen 804 D 804 (807)
T ss_pred h
Confidence 4
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=235.78 Aligned_cols=219 Identities=24% Similarity=0.288 Sum_probs=165.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+++++.++||||+++++++.. .+..+++|||+++++|.+++.... ....++...+..++.|++.||.|||+
T Consensus 44 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~ 123 (287)
T cd06621 44 KQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS 123 (287)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 468899999999999999999998865 346899999999999998875421 22335778899999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
.+ ++|+||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 124 ~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 124 RK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred CC---cccCCCCHHHEEEecCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 99 9999999999999999999999999976543221 1223467889999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||......... ..+....... ...... ..... .....++.+.+++.+||..+|.+|||+.++++
T Consensus 197 ~~g~~p~~~~~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 197 AQNRFPFPPEGEPPLG---PIELLSYIVN-MPNPEL-KDEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HhCCCCCCcccCCCCC---hHHHHHHHhc-CCchhh-ccCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 9999999864221001 1111111111 000000 00000 00123467899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.81 Aligned_cols=209 Identities=19% Similarity=0.324 Sum_probs=162.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++.+. ...+++|||+++++|.+++..... +++..+..++.|++.||.+||++
T Consensus 49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA---LTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 3578899999999999999999988763 467899999999999999875532 56788899999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|.||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 126 ~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred C---EecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 9 999999999999999999999999998754321111 111223578899999999888889999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|+.||...... ..... ..........+...+..+.+++.+|+ .+|++|||+++++.
T Consensus 203 ~~g~~p~~~~~~~-------~~~~~----------~~~~~~~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 203 LTEKPPWAEFEAM-------AAIFK----------IATQPTNPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred hhCCCCCCccchH-------HHHHH----------HhcCCCCCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 9999998752110 00000 00000011112234467889999999 49999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=236.68 Aligned_cols=210 Identities=23% Similarity=0.368 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+|++++++.+..++..++++||+++++|.+++.... ..+++..+..++.|++.|+.+||+.+
T Consensus 60 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g- 136 (286)
T cd06614 60 ELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN- 136 (286)
T ss_pred HHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 568899999999999999999999999999999999999999999998764 23678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 137 --i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g 212 (286)
T cd06614 137 --VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212 (286)
T ss_pred --eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC
Confidence 99999999999999999999999998765443211 11223477889999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||....... . ..... ..... ........+..+.++|.+||+.+|.+|||+.++++
T Consensus 213 ~~p~~~~~~~~----~----~~~~~-~~~~~-------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 213 EPPYLREPPLR----A----LFLIT-TKGIP-------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCCCCCHHH----H----HHHHH-hcCCC-------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 99987522110 0 00000 00000 00111123467999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=235.52 Aligned_cols=222 Identities=19% Similarity=0.234 Sum_probs=166.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..++|+||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+
T Consensus 44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~- 119 (286)
T cd07832 44 NQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG- 119 (286)
T ss_pred HHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 46889999999999999999999999999999999999 999999987654 23688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||.+........ .......++..|+|||.+.+.. ++.++||||+|+++++|++
T Consensus 120 --i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t 196 (286)
T cd07832 120 --IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196 (286)
T ss_pred --eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence 99999999999999999999999999876654321 1222346888999999886544 6889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhcc--------c---hhhhhhccccCC----chhHHHHHHHHHHHHHhcccCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIEN--------N---SLRQILNFQVAD----ESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
|.++|.+..... ............ . ............ ....+.+..+.+++.+||+.+|.+
T Consensus 197 g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 272 (286)
T cd07832 197 GSPLFPGENDIE----QLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSK 272 (286)
T ss_pred CCcCcCCCCHHH----HHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhh
Confidence 988886532110 000000000000 0 000000000000 000123477899999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
|||+++++.
T Consensus 273 R~~~~~~l~ 281 (286)
T cd07832 273 RLSAAEALR 281 (286)
T ss_pred CCCHHHHhh
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.03 Aligned_cols=216 Identities=20% Similarity=0.296 Sum_probs=159.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++... ...+++++++ +++|.+++... .+++..+..++.|++.||.|
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~ 133 (343)
T cd07878 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKY 133 (343)
T ss_pred HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence 3577899999999999999999988643 3468999998 77998887643 25789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+++ ++|+||||+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++||||+||+
T Consensus 134 LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 205 (343)
T cd07878 134 IHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred HHHCC---eecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHH
Confidence 99999 999999999999999999999999998765432 223468899999999876 458899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHh----------hccchhhhhhccc--cCCch----hHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYS----------IENNSLRQILNFQ--VADES----EMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~li~~~ 219 (259)
+|+|++|..||.+..... ......... ............. ..... .....+.+.+++.+|
T Consensus 206 l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 281 (343)
T cd07878 206 MAELLKGKALFPGNDYID----QLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHH
Confidence 999999999997632110 000000000 0000000000000 00000 001224578999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 282 L~~dp~~R~s~~ell~ 297 (343)
T cd07878 282 LVLDSDKRISASEALA 297 (343)
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999985
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=238.23 Aligned_cols=222 Identities=20% Similarity=0.232 Sum_probs=164.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..+++|||+. ++|.+++...... .+++..+..++.|++.|+.|||+.+
T Consensus 44 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lh~~~- 120 (284)
T cd07860 44 STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLS-GIPLPLIKSYLFQLLQGLAFCHSHR- 120 (284)
T ss_pred hHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899999999999999999999999999999999995 5898888664433 3678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||++........ ......++..|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus 121 --i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 196 (284)
T cd07860 121 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 196 (284)
T ss_pred --eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999875543211 122334678899999887654 6889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhcc-ch----------hhhhhccccCC---chhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIEN-NS----------LRQILNFQVAD---ESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||.+..... ...+........ .. ....+...... ......++.+.++|.+||+.||.+|
T Consensus 197 g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 272 (284)
T cd07860 197 RRALFPGDSEID----QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKR 272 (284)
T ss_pred CCCCCCCCCHHH----HHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccC
Confidence 999997632111 111111000000 00 00000000000 0011233668899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 273 pt~~~~l~ 280 (284)
T cd07860 273 ISAKAALA 280 (284)
T ss_pred CCHHHHhc
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=243.49 Aligned_cols=213 Identities=22% Similarity=0.283 Sum_probs=162.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|..++..++|++|+++++++.+.+..++||||+++|+|.+++..... .+++..+..++.|++.|+.|||+.+
T Consensus 47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~-- 122 (332)
T cd05623 47 CFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH-- 122 (332)
T ss_pred HHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 478899999999999999999999999999999999999999999976432 2577888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ 158 (259)
++||||||+||+++.++.++|+|||++....... ........|+..|+|||++.. ..++.++||||+|+++|+
T Consensus 123 -iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 123 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred -eEecCCCHHHEEECCCCCEEEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 9999999999999999999999999986543321 112223468999999999862 357889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSEE 236 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~~ 236 (259)
|++|+.||.+.+... ............. ........++.+.+++.+||..++.+ |+++.++++.
T Consensus 201 ll~g~~Pf~~~~~~~--------~~~~i~~~~~~~~------~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 201 MLYGETPFYAESLVE--------TYGKIMNHKERFQ------FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred HhcCCCCCCCCCHHH--------HHHHHhCCCcccc------CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 999999997632111 1111111000000 00011123477999999999765444 6888888654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=259.82 Aligned_cols=222 Identities=24% Similarity=0.395 Sum_probs=187.6
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+|..|+.|+-+++||||+++.|+....+.+.||+||+++|+|..+|.....+ ++..+...+++.|+.|++||.+.+
T Consensus 674 rrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGq--ftviQLVgMLrGIAsGMkYLsdm~ 751 (996)
T KOG0196|consen 674 RRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQ--FTVIQLVGMLRGIASGMKYLSDMN 751 (996)
T ss_pred HhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCc--eEeehHHHHHHHHHHHhHHHhhcC
Confidence 457999999999999999999999999999999999999999999999988755 577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++||||.+.|||++.+..+|++|||+++....+.... .+..---...|.|||.+...+++.++||||+|+++||.+
T Consensus 752 ---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVm 828 (996)
T KOG0196|consen 752 ---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 828 (996)
T ss_pred ---chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEec
Confidence 9999999999999999999999999999765543111 111111235899999999999999999999999999988
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |..||.+++ +.+.-+-++....-+.+++++..+..|+..||++|..+||.+.+|+..|.+
T Consensus 829 SyGERPYWdmS------------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk 890 (996)
T KOG0196|consen 829 SYGERPYWDMS------------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK 890 (996)
T ss_pred ccCCCcccccc------------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence 8 889988743 222333334455556678888999999999999999999999999999998
Q ss_pred ccccccc
Q 025011 240 LKISHEN 246 (259)
Q Consensus 240 ~~~~~~~ 246 (259)
+...-++
T Consensus 891 lIrnP~S 897 (996)
T KOG0196|consen 891 LIRNPNS 897 (996)
T ss_pred HhcCchh
Confidence 8654433
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=235.57 Aligned_cols=207 Identities=23% Similarity=0.377 Sum_probs=164.9
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+.+++.++ |||++++++++..+...+++|||+++++|.+++... .+++..++.++.|++.++.+||+
T Consensus 44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~ 119 (277)
T cd06917 44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHK 119 (277)
T ss_pred HHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHh
Confidence 45788999999996 999999999999999999999999999999998654 36789999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ 158 (259)
.+ ++|+||+|+||+++.++.++++|||++....... .......++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus 120 ~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ 194 (277)
T cd06917 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYE 194 (277)
T ss_pred CC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHH
Confidence 99 9999999999999999999999999987665432 122334688899999988654 47889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+..... ... ........ ..... ..+..+.+++.+||+.||.+|||+.+++.
T Consensus 195 ll~g~~p~~~~~~~~--------~~~-~~~~~~~~-----~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 195 MATGNPPYSDVDAFR--------AMM-LIPKSKPP-----RLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred HHhCCCCCCCCChhh--------hhh-ccccCCCC-----CCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 999999997632110 000 00000000 00000 13367999999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=235.23 Aligned_cols=226 Identities=20% Similarity=0.238 Sum_probs=166.0
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++++.++|+||+++++++..++..+++|||++++.+..+...... +++..++.++.|++.|+.|||+++
T Consensus 44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~ 120 (288)
T cd07833 44 KKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSHN 120 (288)
T ss_pred hhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688999999999999999999999999999999999988666655544322 577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~ 160 (259)
++|+|++|+||++++++.++|+|||++........ .......++..|+|||++.+. .++.++|+||+|+++|+|+
T Consensus 121 ---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~ 196 (288)
T cd07833 121 ---IIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196 (288)
T ss_pred ---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999876654322 122334578889999999887 7889999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHH--------HHhhccchhh--hhhccccCC----chhHHHHHHHHHHHHHhcccCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYF--------LYSIENNSLR--QILNFQVAD----ESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+|..||.+...... ........ .......... ......... ..+...++.+.++|.+||..+|.+
T Consensus 197 ~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 275 (288)
T cd07833 197 DGEPLFPGDSDIDQ-LYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKE 275 (288)
T ss_pred hCCCCCCCCCHHHH-HHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchh
Confidence 99999976321100 00000000 0000000000 000000000 001112577999999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
|||++++++
T Consensus 276 Rps~~~il~ 284 (288)
T cd07833 276 RLTCDELLQ 284 (288)
T ss_pred cccHHHHhc
Confidence 999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=247.58 Aligned_cols=204 Identities=27% Similarity=0.394 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+-+.+|++++..|+|||||+++.+......+|+||||+.+|.+++++.+.+.. .+..+..++.|+++|+.|||+++
T Consensus 100 ~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~---~e~~ar~~F~q~vsaveYcH~k~- 175 (596)
T KOG0586|consen 100 QKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRM---KEKEARAKFRQIVSAVEYCHSKN- 175 (596)
T ss_pred HHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccc---hhhhhhhhhHHHHHHHHHHhhcc-
Confidence 44889999999999999999999999999999999999999999999988764 34888999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
|+|+|||++|++++.+-.++|+|||++..+..+ .+.....|++.|.|||++.+..+ .+.+|+||+|+++|.|++
T Consensus 176 --ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~ 250 (596)
T KOG0586|consen 176 --IVHRDLKAENILLDENMNIKIADFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE 250 (596)
T ss_pred --eeccccchhhcccccccceeeeccccceeeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee
Confidence 999999999999999999999999999887643 34566789999999999998875 578999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCch--hHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADES--EMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
|.+||.+-. +...-...+.... +...+..+.++|+++|-.+|.+|++.+++.+.
T Consensus 251 GsLPFDG~~---------------------lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 251 GSLPFDGQN---------------------LKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cccccCCcc---------------------cccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 999999721 1111111111111 11123568999999999999999999998653
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=238.49 Aligned_cols=221 Identities=25% Similarity=0.293 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++.+.+..++||||+ +++|.+++.... ..+++..+..++.|++.||.|||+++
T Consensus 47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~- 122 (298)
T cd07841 47 FTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW- 122 (298)
T ss_pred HHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 45678999999999999999999999999999999999 889999997654 23688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++++|++
T Consensus 123 --i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 123 --ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred --eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 99999999999999999999999999876654321 1222346778999998865 347889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cc------hhhhhhccccCCc-----hhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NN------SLRQILNFQVADE-----SEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~------~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|.++|.+..... ........... .. ............. .....+..+.++|.+||+.||++||
T Consensus 199 g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 274 (298)
T cd07841 199 RVPFLPGDSDID----QLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI 274 (298)
T ss_pred CCccccCCccHH----HHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc
Confidence 988877633211 00011000000 00 0000000000000 0112346789999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|+.++++
T Consensus 275 s~~e~l~ 281 (298)
T cd07841 275 TARQALE 281 (298)
T ss_pred CHHHHhh
Confidence 9999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=235.56 Aligned_cols=216 Identities=27% Similarity=0.332 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++.+..++..++++||+++++|.+++.... .+++..+..++.|++.||.+||+.+
T Consensus 38 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~- 113 (265)
T cd05579 38 DQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG- 113 (265)
T ss_pred HHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 468889999999999999999999999999999999999999999997654 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc------ccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ------TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.......+.++|+||||+++
T Consensus 114 --i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred --eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 99999999999999999999999999875443211 1122334577889999999888889999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+++++|..||...... ........ ...........+..+.+++.+||+.+|.+|||+..+.+.
T Consensus 192 ~~l~~g~~p~~~~~~~--------~~~~~~~~---------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~ 254 (265)
T cd05579 192 YEFLVGIPPFHGETPE--------EIFQNILN---------GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEI 254 (265)
T ss_pred HHHHhCCCCCCCCCHH--------HHHHHHhc---------CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHH
Confidence 9999999998753210 00100000 000011111124779999999999999999999776666
Q ss_pred HHhcc
Q 025011 237 LDRLK 241 (259)
Q Consensus 237 l~~~~ 241 (259)
++.-.
T Consensus 255 l~~~~ 259 (265)
T cd05579 255 KNHPF 259 (265)
T ss_pred hcCcc
Confidence 66443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=252.74 Aligned_cols=212 Identities=25% Similarity=0.359 Sum_probs=173.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
|-+..|+.+-++|+|.|||++.|.+.+++++-|.||-++||||.+++...=.....++.++--+-.||+.||.|||++.
T Consensus 617 QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~- 695 (1226)
T KOG4279|consen 617 QPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK- 695 (1226)
T ss_pred ccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc-
Confidence 5578999999999999999999999999999999999999999999976533333477888889999999999999999
Q ss_pred CCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l 159 (259)
|+|||||.+|++++ -.|.+|++|||-++.... -..++..+.||..|||||++..++ |..++|||||||++.||
T Consensus 696 --IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEM 771 (1226)
T KOG4279|consen 696 --IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEM 771 (1226)
T ss_pred --eeeccccCCcEEEeeccceEEecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEee
Confidence 99999999999995 578999999998876543 344566788999999999997664 88999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.||++||..... . .......+..+. ..+.+.+.+.....+|.+|+.+||..||+|++++.
T Consensus 772 ATGrPPF~Elgs---p-------qAAMFkVGmyKv------HP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 772 ATGRPPFVELGS---P-------QAAMFKVGMYKV------HPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ccCCCCeeecCC---h-------hHhhhhhcceec------CCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 999999976321 0 111111122111 12234456678999999999999999999999964
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=234.29 Aligned_cols=207 Identities=26% Similarity=0.387 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.++.+||+.+
T Consensus 47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~- 121 (277)
T cd06641 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK- 121 (277)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC-
Confidence 46889999999999999999999999999999999999999999998653 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++++|||++....... .......++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus 122 --i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (277)
T cd06641 122 --KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG 197 (277)
T ss_pred --eecCCCCHHhEEECCCCCEEEeecccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999986554321 112234578889999999887889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||...... ...... .... ........+..+.+++.+||+.+|.+||++.+++..
T Consensus 198 ~~p~~~~~~~--------~~~~~~-~~~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 198 EPPHSELHPM--------KVLFLI-PKNN---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCCccchH--------HHHHHH-hcCC---------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9998652110 000000 0000 000111234678999999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=233.45 Aligned_cols=211 Identities=23% Similarity=0.327 Sum_probs=170.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-C
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-S 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 80 (259)
.+.+.+|++.++.++|+|++++++++..++..++++||+++++|.+++.... .+++..++.++.|++.|+.+||+ .
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lh~~~ 119 (264)
T cd06623 43 RKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPVLAYIARQILKGLDYLHTKR 119 (264)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhccC
Confidence 3578999999999999999999999999999999999999999999997652 36789999999999999999999 9
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+....++.++|+||||+++|+|+
T Consensus 120 ~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 194 (264)
T cd06623 120 H---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECA 194 (264)
T ss_pred C---CccCCCCHHHEEECCCCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHH
Confidence 9 99999999999999999999999999876643221 122345788999999998888899999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEME-EIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||...... . ..+...... ... ....... .++.+.++|.+||+.+|++|||+.++++
T Consensus 195 tg~~p~~~~~~~--~---~~~~~~~~~---------~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 195 LGKFPFLPPGQP--S---FFELMQAIC---------DGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred hCCCCCcccccc--C---HHHHHHHHh---------cCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 999998764320 0 001011000 000 0111112 4477999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=235.16 Aligned_cols=207 Identities=25% Similarity=0.282 Sum_probs=166.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++.+..++..++++||+.+++|.+++.... .+++..+..++.|++.|+.|||+++
T Consensus 45 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~- 120 (258)
T cd05578 45 RNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKG- 120 (258)
T ss_pred HHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999999999999997652 3577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||++++++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 121 --i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g 195 (258)
T cd05578 121 --IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRG 195 (258)
T ss_pred --eeccCCCHHHeEEcCCCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhC
Confidence 9999999999999999999999999987654332 22334578899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM--KQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~--~~il 234 (259)
..||...+... ...... .... .....+...+..+.++|.+||+.||.+||++ ++++
T Consensus 196 ~~p~~~~~~~~-----~~~~~~-~~~~----------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 196 KRPYRGHSRTI-----RDQIRA-KQET----------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred CCCCCCCCccH-----HHHHHH-Hhcc----------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 99998643210 001110 0000 0011111234779999999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=248.99 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=166.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.+|++.|++++|||++.+.++|..+...|+||||| -||-.|++.-... ++.+.+|..|..+.+.||+|||+.+
T Consensus 71 qDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~- 146 (948)
T KOG0577|consen 71 QDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN- 146 (948)
T ss_pred HHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh-
Confidence 57889999999999999999999999999999999999 5688898876543 3577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc---CCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l 159 (259)
.+|+|||+.||++++.|.|||+|||.+.... ..+.++||+.|||||++.. +.|+.++||||||++..+|
T Consensus 147 --~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 147 --RIHRDIKAGNILLSEPGLVKLADFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred --HHhhhccccceEecCCCeeeeccccchhhcC------chhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence 9999999999999999999999999986543 2356789999999999863 4699999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
...++|+.++... ..+.-... +. . ++-....-+..+..++..||+.-|.+|||..+++.
T Consensus 219 AERkPPlFnMNAM--------SALYHIAQ-Ne-----s---PtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 219 AERKPPLFNMNAM--------SALYHIAQ-NE-----S---PTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hhcCCCccCchHH--------HHHHHHHh-cC-----C---CCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 9999997763221 11111111 11 1 11112233467999999999999999999998864
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=234.58 Aligned_cols=213 Identities=24% Similarity=0.332 Sum_probs=161.8
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEE-----eCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACL-----ETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.+.+|+.+++.+ +||||+++++++. .++..+++|||+++++|.+++... .....+++..+..++.|++.|+.
T Consensus 59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~ 138 (286)
T cd06638 59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138 (286)
T ss_pred HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence 4578899999999 6999999999874 345789999999999999987642 12223577889999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~Diw 150 (259)
|||+.+ ++|+||+|+||+++.++.++|+|||+++...... .......++..|+|||++.. ..++.++|+|
T Consensus 139 ~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~ 213 (286)
T cd06638 139 HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVW 213 (286)
T ss_pred HHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhh
Confidence 999999 9999999999999999999999999987654321 11223458899999998753 3478899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|+|+++|+|++|..||....... .... .......... .+...+..+.+++.+||+.||.+|||+
T Consensus 214 slGvi~~el~~g~~p~~~~~~~~-------~~~~--~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~ 277 (286)
T cd06638 214 SLGITAIELGDGDPPLADLHPMR-------ALFK--IPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTV 277 (286)
T ss_pred hHHHHHHHHhcCCCCCCCCchhH-------HHhh--ccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCH
Confidence 99999999999999987632110 0000 0000000000 001123569999999999999999999
Q ss_pred HHHHHH
Q 025011 231 KQVSEE 236 (259)
Q Consensus 231 ~~il~~ 236 (259)
.++++.
T Consensus 278 ~ell~~ 283 (286)
T cd06638 278 SDLLQH 283 (286)
T ss_pred HHHhhc
Confidence 999763
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=237.95 Aligned_cols=225 Identities=23% Similarity=0.325 Sum_probs=165.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+++++.++||||+++++++..++..++++||+++++|.++...... +++..+..++.|++.|+.|||+.+
T Consensus 44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~LH~~~ 120 (286)
T cd07846 44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSHN 120 (286)
T ss_pred hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688999999999999999999999999999999999999888877654322 578999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||++++++.++|+|||++....... .......++..|+|||.+.+. .++.++||||+|+++++|+
T Consensus 121 ---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 195 (286)
T cd07846 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195 (286)
T ss_pred ---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHH
Confidence 9999999999999999999999999987654322 122234578899999998653 4678999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhc-------cch-hhhhhccccCC-----chhHHHHHHHHHHHHHhcccCCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIE-------NNS-LRQILNFQVAD-----ESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~-~~~~~~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
+|.+||.+..... .............. ... ........... ......+..+.+++.+||+.+|.+|
T Consensus 196 ~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 274 (286)
T cd07846 196 TGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDR 274 (286)
T ss_pred cCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccc
Confidence 9999987532110 00000000000000 000 00000000000 0011234679999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 275 p~~~~il~ 282 (286)
T cd07846 275 PSSSQLLH 282 (286)
T ss_pred hhHHHHhc
Confidence 99999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=232.25 Aligned_cols=208 Identities=25% Similarity=0.326 Sum_probs=168.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++|+||+++.+++..+...++++||+++++|.+++..... ...+++..++.++.|++.|+.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~ 123 (256)
T cd08530 44 EDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK 123 (256)
T ss_pred HHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 3577899999999999999999999999999999999999999999866321 233678889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|.||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus 124 ---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 124 ---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred ---cccCCCCcceEEEecCCcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999998766543 2223457889999999988888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||...+.. ..... .. ...........+..+.+++.+||+.+|.+|||+.+++.
T Consensus 197 g~~p~~~~~~~--------~~~~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 197 FAPPFEARSMQ--------DLRYK-VQ---------RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCCCCCCCHH--------HHHHH-Hh---------cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 99999763211 00000 00 01111112244577999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=229.71 Aligned_cols=209 Identities=26% Similarity=0.400 Sum_probs=168.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+|++++.+++..++..++++||+++++|.+++.... ..+++..+..++.|++.++.+||+.+
T Consensus 42 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~- 118 (253)
T cd05122 42 EKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG- 118 (253)
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC-
Confidence 568899999999999999999999999999999999999999999987753 23678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus 119 --i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g 193 (253)
T cd05122 119 --IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193 (253)
T ss_pred --EecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876654321 2344588899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...+... ....... ...... ......+..+.++|..||+.||++|||+.++++
T Consensus 194 ~~p~~~~~~~~--------~~~~~~~-~~~~~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 194 KPPYSELPPMK--------ALFKIAT-NGPPGL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCCCCCCchHH--------HHHHHHh-cCCCCc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99987632110 0000000 000000 011112467999999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=270.16 Aligned_cols=209 Identities=25% Similarity=0.375 Sum_probs=170.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.++..++|||+|+++++=.+....+|.||||++|+|.++++.+.. .++.....+-.|++.|++|||++|
T Consensus 1280 ~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---~dE~vt~vyt~qll~gla~LH~~g-- 1354 (1509)
T KOG4645|consen 1280 LIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---EDEMVTRVYTKQLLEGLAYLHEHG-- 1354 (1509)
T ss_pred chHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---hhhhHHHHHHHHHHHHHHHHHhcC--
Confidence 478999999999999999999999999999999999999999999987643 455667778999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc--ccccccccCcccccCcchhccCC---cccccchhhHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTKKIGTFVNLDPEYVITGK---LTEKSDVYSFGVLLAE 158 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~ 158 (259)
||||||||.||+++.+|.+|++|||.+..+..... ........||+-|||||++.+.. ...++|||||||++.|
T Consensus 1355 -IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlE 1433 (1509)
T KOG4645|consen 1355 -IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLE 1433 (1509)
T ss_pred -ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEE
Confidence 99999999999999999999999999988765421 11233557999999999998754 4578999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+||+.||...+.. ..+.+....+...++ +-..+..-.++|..||..||++|.++.|+++
T Consensus 1434 M~tGkrPW~~~dne--------~aIMy~V~~gh~Pq~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1434 MATGKRPWAELDNE--------WAIMYHVAAGHKPQI---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred eecCCCchhhccch--------hHHHhHHhccCCCCC---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 99999999874321 112222322332222 2225577889999999999999999988765
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=235.14 Aligned_cols=209 Identities=23% Similarity=0.362 Sum_probs=166.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|||++++++++..++..++|+||+++++|.+++.+.. +++..+..++.|++.|+.|||+++
T Consensus 61 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~~~i~~~l~~al~~LH~~g- 135 (293)
T cd06647 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ- 135 (293)
T ss_pred HHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999999999999986542 467889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|++||.+....++.++|+||+|+++|++++|
T Consensus 136 --i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g 211 (293)
T cd06647 136 --VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211 (293)
T ss_pred --EeeccCCHHHEEEcCCCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765443221 22234578889999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||......... ....... ..........+..+.+++.+||..+|.+||++.+++..
T Consensus 212 ~~pf~~~~~~~~~--------~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 212 EPPYLNENPLRAL--------YLIATNG--------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCCCCCChhhhe--------eehhcCC--------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 9999763221100 0000000 00011111234668899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=230.44 Aligned_cols=211 Identities=23% Similarity=0.345 Sum_probs=170.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|++++++++||||+++++.+... +..++++||+++++|.+++.... .+++..++.++.|++.++.|||+.
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 44 EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5688999999999999999999999988 88999999999999999998765 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+|++|+||+++.++.++|+|||.+................++..|+|||.+.+...+.++|+||+|+++++|+
T Consensus 121 ~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 121 G---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred C---ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9 9999999999999999999999999987766543211233456888999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||...... ......... .......+...+..+.+++.+||..+|.+|||+.+++.
T Consensus 198 ~g~~p~~~~~~~-------~~~~~~~~~---------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 198 TGKPPWSELGNP-------MAALYKIGS---------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred hCCCCCCCCCch-------HHHHHhccc---------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 999999864300 000000000 00011111122477999999999999999999999974
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=234.46 Aligned_cols=223 Identities=17% Similarity=0.249 Sum_probs=161.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++..++..++||||+.+ +|.+++..... .+++..+..++.|++.||.|||+.+
T Consensus 49 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~-- 123 (291)
T cd07844 49 TAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR-- 123 (291)
T ss_pred hHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 467899999999999999999999999999999999964 89998876543 3578899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|
T Consensus 124 -i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g 200 (291)
T cd07844 124 -VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200 (291)
T ss_pred -eecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999865432211 1122346788999998865 4478899999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhh------cc--ccCCch-------hHHHHHHHHHHHHHhcccCCCCC
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQIL------NF--QVADES-------EMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~--~~~~~~-------~~~~~~~~~~li~~~l~~~p~~R 227 (259)
..||.+................ ........... .. ...... .......+.+++.+||+.+|.+|
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 279 (291)
T cd07844 201 RPLFPGSTDVEDQLHKIFRVLG-TPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279 (291)
T ss_pred CCCCCCCccHHHHHHHHHHhcC-CCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccc
Confidence 9999763311000000000000 00000000000 00 000000 01112567899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.+++.
T Consensus 280 ps~~e~l~ 287 (291)
T cd07844 280 ISAAEAMK 287 (291)
T ss_pred cCHHHHhc
Confidence 99999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=233.85 Aligned_cols=222 Identities=20% Similarity=0.252 Sum_probs=169.5
Q ss_pred hhHHHHHHHHHhcCC-C-c----cccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQIN-H-K----NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h-~----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+++-+-|+++|+++. + | -++.+.+||+-.++.|||+|.+ |.|+++++..++..+ ++...+..++.|++.+++
T Consensus 129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~-fpi~~ir~m~~QL~~sv~ 206 (415)
T KOG0671|consen 129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIP-FPIDHIRHMGYQLLESVA 206 (415)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccc-cchHHHHHHHHHHHHHHH
Confidence 466788999999993 2 2 3788899999999999999999 889999999887755 788999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCC--------------------CCceEEeecCCcccccCCccccccccccCcccccCc
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDD--------------------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDP 135 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~--------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aP 135 (259)
+||+.+ ++|.||||+||++.+ +..++++|||.++.-... ....+.|..|+||
T Consensus 207 fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAP 278 (415)
T KOG0671|consen 207 FLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAP 278 (415)
T ss_pred HHHhcc---eeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCc
Confidence 999999 999999999999942 345899999998753322 2445789999999
Q ss_pred chhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhh-----hccc--------cCC
Q 025011 136 EYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQI-----LNFQ--------VAD 202 (259)
Q Consensus 136 E~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--------~~~ 202 (259)
|++.+..|+.++||||+|||+.|+.+|...|+..+ +.+...+.+......+.....+. +... ...
T Consensus 279 EViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe--n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~ 356 (415)
T KOG0671|consen 279 EVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE--NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKG 356 (415)
T ss_pred hheeccCcCCccCceeeeeEEEEeeccceecccCC--cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccc
Confidence 99999999999999999999999999999999744 23333333332221111111111 0000 000
Q ss_pred --------c--------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 203 --------E--------SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 203 --------~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
. ........+.+|+++||..||++|+|+.|++.
T Consensus 357 ~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 357 KSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred cchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence 0 00123366999999999999999999999974
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=241.15 Aligned_cols=212 Identities=22% Similarity=0.291 Sum_probs=161.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|..++..++|+||+++++++..++..|+||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 47 ~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~-- 122 (331)
T cd05624 47 CFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH-- 122 (331)
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 478899999999999999999999999999999999999999999976432 2577888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~ 158 (259)
++|+||||+||+++.++.++|+|||++........ .......|+..|+|||++.+ ..++.++|+||+|+++|+
T Consensus 123 -iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 123 -YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred -eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 99999999999999999999999999876543221 12223468999999999865 457889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~ 235 (259)
|++|+.||.+.... ..............+ . ......++.+.+++.+||..++.+ |++++++++
T Consensus 201 ll~g~~Pf~~~~~~--------~~~~~i~~~~~~~~~-p-----~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 201 MLYGETPFYAESLV--------ETYGKIMNHEERFQF-P-----SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred hhhCCCCccCCCHH--------HHHHHHHcCCCcccC-C-----CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 99999999763211 001111100000000 0 001123467999999999866544 467777754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=235.70 Aligned_cols=220 Identities=19% Similarity=0.218 Sum_probs=164.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+|+.++++++||||+++++++... +..++++||+. ++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 50 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ 126 (293)
T cd07843 50 TSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW 126 (293)
T ss_pred hHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 467899999999999999999998877 88999999996 489888876543 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+.. ++.++|+||+|+++++|+
T Consensus 127 ---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 201 (293)
T cd07843 127 ---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELL 201 (293)
T ss_pred ---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHH
Confidence 9999999999999999999999999987665432 1122345778899999987654 688999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhc--c--------------chhhhhhccccCCchhHH-HHHHHHHHHHHhcccC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIE--N--------------NSLRQILNFQVADESEME-EIETVAGLASKCLSLS 223 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~ 223 (259)
+|..||.+...... .......... . ...............+.. .++.+.++|.+||+.+
T Consensus 202 ~g~~~f~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 277 (293)
T cd07843 202 TKKPLFPGKSEIDQ----LNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYD 277 (293)
T ss_pred hCCCCCCCCChHHH----HHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccC
Confidence 99999986432111 0000000000 0 000000000000000001 2467899999999999
Q ss_pred CCCCCCHHHHHH
Q 025011 224 GRRRPTMKQVSE 235 (259)
Q Consensus 224 p~~Rpt~~~il~ 235 (259)
|++|||+.++++
T Consensus 278 p~~R~t~~ell~ 289 (293)
T cd07843 278 PAKRISAEDALK 289 (293)
T ss_pred ccccCCHHHHhc
Confidence 999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=230.40 Aligned_cols=212 Identities=24% Similarity=0.391 Sum_probs=166.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++...+..++++||+++++|.+++..... .++..+..++.+++.|+.|||+.+
T Consensus 44 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~- 119 (264)
T cd06626 44 KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---LDEHVIRVYTLQLLEGLAYLHSHG- 119 (264)
T ss_pred HHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCC---CChHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976532 567889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc--cccccCcccccCcchhccCC---cccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM--TTKKIGTFVNLDPEYVITGK---LTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||++........... .....++..|+|||.+.+.. ++.++|+||+|++++
T Consensus 120 --i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 120 --IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred --cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 99999999999999999999999999877654322111 11245778999999987766 788999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++++|..||...+... .... ...... ....+.....++.+.+++.+||+.+|.+|||+.+++.
T Consensus 198 ~l~~g~~pf~~~~~~~-------~~~~-~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 198 EMATGKRPWSELDNEF-------QIMF-HVGAGH-------KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHhCCCCccCCcchH-------HHHH-HHhcCC-------CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 9999999997632100 0000 000000 0000111122467889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=233.40 Aligned_cols=223 Identities=16% Similarity=0.240 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..+++|||+++ +|.+++........+++..+..++.|++.|+.|||+.+
T Consensus 43 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~- 120 (284)
T cd07836 43 STAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR- 120 (284)
T ss_pred HHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3567899999999999999999999999999999999975 88888876554445788999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||++++++.++++|||++........ ......++..|++||.+.+. .++.++|+||+|+++|++++
T Consensus 121 --i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 121 --VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred --eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999865443211 12233567889999988664 46889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHh--hccchhh------hhhccccC------CchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYS--IENNSLR------QILNFQVA------DESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~------~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||.+...... ........ .....+. .+...... .......+..+.+++.+||+.||.+|
T Consensus 197 g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 272 (284)
T cd07836 197 GRPLFPGTNNEDQ----LLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELR 272 (284)
T ss_pred CCCCCCCCCcHHH----HHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccC
Confidence 9999986432110 00000000 0000000 00000000 00111234678899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 273 ~~~~~~l~ 280 (284)
T cd07836 273 ISAHDALQ 280 (284)
T ss_pred CCHHHHhc
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=230.15 Aligned_cols=210 Identities=27% Similarity=0.355 Sum_probs=169.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++|||++++.+.+..++..++++|++++++|.+++.... ....+++..+..++.+++.|+.+||+++
T Consensus 44 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 123 (258)
T cd08215 44 EDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123 (258)
T ss_pred HHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 468899999999999999999999999999999999999999999997642 1234688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+..++.++|+||+|+++++|++
T Consensus 124 ---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 124 ---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred ---EecccCChHHeEEcCCCcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 9999999999999999999999999987665432 12233467889999999888888999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||...... ........ .... ..+...+..+.+++.+||..+|.+|||+.++++
T Consensus 199 g~~p~~~~~~~--------~~~~~~~~-~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 199 LKHPFEGENLL--------ELALKILK-GQYP---------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCcHH--------HHHHHHhc-CCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 99998763210 11111110 0000 011123467999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=233.60 Aligned_cols=212 Identities=24% Similarity=0.314 Sum_probs=161.5
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.+.+|+.+++.+ +|||++++++++... +..+++|||+++++|.+++.... ....+++..++.++.|++.|+.
T Consensus 63 ~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 142 (291)
T cd06639 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQ 142 (291)
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 4577899999999 899999999998753 35799999999999999886431 1223678899999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-----cccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-----LTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~Diw 150 (259)
+||+.+ ++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.... ++.++|+|
T Consensus 143 ~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 143 HLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999 99999999999999999999999999876543211 112335788999999875432 67899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|+|+++|+|++|+.||....... . ..... ....... . .+......+.++|.+||+.+|.+|||+
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~----~----~~~~~-~~~~~~~-----~--~~~~~~~~l~~li~~~l~~~p~~Rps~ 281 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVK----T----LFKIP-RNPPPTL-----L--HPEKWCRSFNHFISQCLIKDFEARPSV 281 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHH----H----HHHHh-cCCCCCC-----C--cccccCHHHHHHHHHHhhcChhhCcCH
Confidence 99999999999999987632110 0 00000 0000000 0 011223568999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.+++.
T Consensus 282 ~~il~ 286 (291)
T cd06639 282 THLLE 286 (291)
T ss_pred HHHhc
Confidence 99975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=245.32 Aligned_cols=198 Identities=25% Similarity=0.301 Sum_probs=160.4
Q ss_pred HHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
.+|+.++... +||||+++.+.+.++.+.|+|||.+.|+-+.+.+..... .. ..+..|+++|+.|+.|||++|
T Consensus 363 ~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~---~~-~e~~~w~~~lv~Av~~LH~~g--- 435 (612)
T KOG0603|consen 363 QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE---FC-SEASQWAAELVSAVDYLHEQG--- 435 (612)
T ss_pred ccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch---hH-HHHHHHHHHHHHHHHHHHhcC---
Confidence 4455555444 799999999999999999999999999988888866543 22 677889999999999999999
Q ss_pred eEeCCCCCCCeEe-CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 85 IIHGDVKSTNVLL-DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 85 i~h~di~p~nil~-~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|||+||+||++ +..++++|+|||.++..... .....-|..|.|||++....+++++|+||||+++|+|++|+
T Consensus 436 vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~ 510 (612)
T KOG0603|consen 436 VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR 510 (612)
T ss_pred eeecCCChhheeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC
Confidence 9999999999999 68899999999998765543 33345778999999999888999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.||...... .++.............++..++|+.+||++||.+||++.++..
T Consensus 511 tp~~~~P~~--------------------~ei~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 511 TLFAAHPAG--------------------IEIHTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CccccCCch--------------------HHHHHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 999863221 1111111111122455688999999999999999999999964
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=233.60 Aligned_cols=208 Identities=21% Similarity=0.330 Sum_probs=165.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.+++... .+++..+..++.|++.++.|||+.+
T Consensus 62 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g- 136 (292)
T cd06657 62 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG- 136 (292)
T ss_pred HHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 45888999999999999999999999999999999999999999887543 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++++|||++........ ......++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 137 --ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg 212 (292)
T cd06657 137 --VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212 (292)
T ss_pred --eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999998765543211 12234578889999998887889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+.... ........ . ....... ....+..+.+++.+||+.+|.+||++.+++.
T Consensus 213 ~~p~~~~~~~-----~~~~~~~~-----~----~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 213 EPPYFNEPPL-----KAMKMIRD-----N----LPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred CCCCCCCCHH-----HHHHHHHh-----h----CCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9998763211 00000000 0 0000000 0112356889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=234.04 Aligned_cols=222 Identities=19% Similarity=0.237 Sum_probs=164.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++++.+++..+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+++
T Consensus 43 ~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~- 119 (283)
T cd07835 43 STAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR- 119 (283)
T ss_pred hHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457889999999999999999999999999999999995 689999876543 23688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++|+||+|+++|+|++
T Consensus 120 --~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 195 (283)
T cd07835 120 --VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195 (283)
T ss_pred --eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999875543211 11223467889999987664 46889999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh-ccc----------hhhhhhccccC---CchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI-ENN----------SLRQILNFQVA---DESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~----------~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||.+..... .......... ... .....+..... .......+..+.++|.+||+.||.+|
T Consensus 196 g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 271 (283)
T cd07835 196 RRPLFPGDSEID----QLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKR 271 (283)
T ss_pred CCCCCCCCCHHH----HHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhC
Confidence 999997633211 0111100000 000 00000000000 00011233678899999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||++++++
T Consensus 272 pt~~~il~ 279 (283)
T cd07835 272 ISAKAALQ 279 (283)
T ss_pred cCHHHHhc
Confidence 99999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=234.09 Aligned_cols=205 Identities=27% Similarity=0.369 Sum_probs=161.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++.+++..++..++|+||+. |++.+.+..... .+++..+..++.|++.|+.|||+.+
T Consensus 60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~- 135 (307)
T cd06607 60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE- 135 (307)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 458899999999999999999999999999999999996 577777754322 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|.||+++.++.++|+|||++...... ....++..|+|||++. ...++.++||||+|+++|+|
T Consensus 136 --i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 136 --RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred --ceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 999999999999999999999999988654321 2235778899999874 34578899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
++|..||.+..... ...... .. ..........+..+.+++.+||+.+|.+|||+.+++..
T Consensus 208 ~tg~~p~~~~~~~~--------~~~~~~-~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 208 AERKPPLFNMNAMS--------ALYHIA-QN--------DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HcCCCCCCCccHHH--------HHHHHh-cC--------CCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 99999987632110 000000 00 00111111244679999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=235.32 Aligned_cols=229 Identities=21% Similarity=0.247 Sum_probs=164.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCC--cccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSS--QVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.+++.++||||+++++++... +..++||||+++ ++.+++..... ...+++..++.++.|++.|+.|||
T Consensus 47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH 125 (316)
T cd07842 47 QSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH 125 (316)
T ss_pred HHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH
Confidence 4678899999999999999999999987 789999999964 77777654321 224678899999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCC----CCceEEeecCCcccccCCccc-cccccccCcccccCcchhccC-CcccccchhhH
Q 025011 79 SSASPPIIHGDVKSTNVLLDD----NYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSF 152 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~----~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl 152 (259)
+.+ ++|+||+|+||+++. ++.++++|||++......... .......++..|+|||.+.+. .++.++|+||+
T Consensus 126 ~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~sl 202 (316)
T cd07842 126 SNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAI 202 (316)
T ss_pred hCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHH
Confidence 999 999999999999999 899999999998765443221 122233577889999988764 47899999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccc-----hhHHHHHHHhhc-----------cchhhh----hhccccCCch-----hH-
Q 025011 153 GVLLAELLTGLKPGSGMALASNEG-----ISMVQYFLYSIE-----------NNSLRQ----ILNFQVADES-----EM- 206 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~~-----------~~~~~~----~~~~~~~~~~-----~~- 206 (259)
|+++++|++|..||.+........ ............ ...... .......... ..
T Consensus 203 G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (316)
T cd07842 203 GCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKH 282 (316)
T ss_pred HHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhc
Confidence 999999999999998744322100 011111100000 000000 0000000000 00
Q ss_pred -HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 207 -EEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 207 -~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..+..+.+++.+||+.||++|||+.++++
T Consensus 283 ~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 283 KKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred cCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 22356899999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=227.63 Aligned_cols=207 Identities=23% Similarity=0.350 Sum_probs=167.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++|||++++++++..++..++++||+++++|.+++.... .+++..+..++.|++.++.+||+.+
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~- 119 (254)
T cd06627 44 KSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG- 119 (254)
T ss_pred HHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 468899999999999999999999999999999999999999999997653 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++|+|||.+......... .....++..|+|||...+..++.++|+|++|+++++|++|
T Consensus 120 --i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g 195 (254)
T cd06627 120 --VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTG 195 (254)
T ss_pred --cccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhC
Confidence 999999999999999999999999998766543221 2334578899999998877788999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ..... .. .... ...+...++.+.+++.+||..+|++|||+.+++.
T Consensus 196 ~~p~~~~~~~-------~~~~~-~~-~~~~---------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 196 NPPYYDLNPM-------AALFR-IV-QDDH---------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCccHH-------HHHHH-Hh-ccCC---------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 9998753210 00000 00 0000 0011123467899999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=231.24 Aligned_cols=205 Identities=20% Similarity=0.209 Sum_probs=158.4
Q ss_pred HHHHHHHHhc---CCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 5 FQHELRVVSQ---INHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 5 ~~~E~~~l~~---l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+|..+++. ..||||+.+++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---l~~~~~~~i~~qi~~al~~lH~~~ 117 (279)
T cd05633 41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---FSEKEMRFYATEIILGLEHMHNRF 117 (279)
T ss_pred HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3455544444 3799999999999999999999999999999998875543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++++|||++...... ......++..|+|||.+.. ..++.++|+||+|+++|+|+
T Consensus 118 ---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 190 (279)
T cd05633 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190 (279)
T ss_pred ---cCCCCCCHHHEEECCCCCEEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHH
Confidence 999999999999999999999999998654332 1223458899999998864 55889999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
+|..||......... . ...... ......+...+..+.++|.+||+.||.+|| |++++++
T Consensus 191 ~g~~pf~~~~~~~~~-----~-~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 191 RGHSPFRQHKTKDKH-----E-IDRMTL----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred hCCCCcCCCCCcCHH-----H-HHHHhh----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 999999763211100 0 000000 000111122346799999999999999999 5988876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=242.73 Aligned_cols=210 Identities=23% Similarity=0.330 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
++|.-|+++|...+||+|+++++.|..++.+||+.|||.||.....+-.-+. .+.+.++.-++.|++.||.|||+++
T Consensus 74 EDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~- 150 (1187)
T KOG0579|consen 74 EDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN- 150 (1187)
T ss_pred hhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc-
Confidence 4577899999999999999999999999999999999999988877765543 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ 157 (259)
|+|+|||+.||+++-+|.++|+|||.+..... .......+.||+.|||||+.. ..+|+.++||||||+++.
T Consensus 151 --iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLI 226 (1187)
T KOG0579|consen 151 --IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLI 226 (1187)
T ss_pred --hhhhhccccceEEEecCcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHH
Confidence 99999999999999999999999999765433 223455678999999999864 456899999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..+.+|-... ..++..+.....+.. .++. +..-+..+.+++..||..||..||++.++++
T Consensus 227 EMAqiEPPHhel-------npMRVllKiaKSePP--TLlq-------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 227 EMAQIEPPHHEL-------NPMRVLLKIAKSEPP--TLLQ-------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhccCCCcccc-------chHHHHHHHhhcCCC--cccC-------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 999999985431 112222221111111 1111 1112356999999999999999999999964
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=232.73 Aligned_cols=212 Identities=25% Similarity=0.351 Sum_probs=164.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++++..++..+++|||+.+ ++.+.+..... .+++..+..++.|++.|+.|||+++
T Consensus 70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~- 145 (317)
T cd06635 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN- 145 (317)
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3588899999999999999999999999999999999964 77777754322 2678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++|+|||++..... .....++..|+|||.+. ...++.++|+||+|+++|+|
T Consensus 146 --i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el 217 (317)
T cd06635 146 --MIHRDIKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217 (317)
T ss_pred --cccCCCCcccEEECCCCCEEEecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHH
Confidence 99999999999999999999999998764332 12345788899999874 34578899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||....... ... .+.............++.+.+++.+||+.+|.+|||+.++++..-.
T Consensus 218 ~~g~~p~~~~~~~~--------~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 218 AERKPPLFNMNAMS--------ALY---------HIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred HhCCCCCCCccHHH--------HHH---------HHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 99999987521110 000 0000001111111234678999999999999999999999876544
Q ss_pred cccc
Q 025011 240 LKIS 243 (259)
Q Consensus 240 ~~~~ 243 (259)
+...
T Consensus 281 ~~~~ 284 (317)
T cd06635 281 LRER 284 (317)
T ss_pred hccC
Confidence 4333
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=231.33 Aligned_cols=221 Identities=16% Similarity=0.197 Sum_probs=160.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++|+||+++++++..++..++++||+. +++.+++..... .+.+..+..++.|++.||.|||+.+
T Consensus 49 ~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~-- 123 (291)
T cd07870 49 TAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH-- 123 (291)
T ss_pred HHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 57889999999999999999999999999999999995 677777654332 2466788889999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||+++....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|
T Consensus 124 -i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g 200 (291)
T cd07870 124 -ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200 (291)
T ss_pred -cccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999999999999999999875433211 12233578899999998654 478899999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHh--hcc---------ch-hhhhhccccCCc-----hhHHHHHHHHHHHHHhcccCCC
Q 025011 163 LKPGSGMALASNEGISMVQYFLYS--IEN---------NS-LRQILNFQVADE-----SEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~---------~~-~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~ 225 (259)
..||.+..... ....+..... ... .. ............ .....+..+.+++.+|+..||+
T Consensus 201 ~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~ 277 (291)
T cd07870 201 QPAFPGVSDVF---EQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPK 277 (291)
T ss_pred CCCCCCchhHH---HHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcc
Confidence 99998643210 0000000000 000 00 000000000000 0001135788999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.+++.
T Consensus 278 ~R~t~~~~l~ 287 (291)
T cd07870 278 DRISAQDALL 287 (291)
T ss_pred cCcCHHHHhc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=239.29 Aligned_cols=222 Identities=20% Similarity=0.291 Sum_probs=162.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++... ...++||||+. ++|.+.+... ++...+..++.|++.||.|
T Consensus 60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred HHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHH
Confidence 3567899999999999999999988643 35699999995 5888887543 5778889999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.++||||+|+++
T Consensus 134 LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 207 (353)
T cd07850 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (353)
T ss_pred HHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHH
Confidence 99999 9999999999999999999999999987654321 12234578899999999988899999999999999
Q ss_pred HHHHhCCCCCCCCccccccch----------hHHHHHH----Hhhcc------chhhhhhcccc----CCchhHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGI----------SMVQYFL----YSIEN------NSLRQILNFQV----ADESEMEEIETV 212 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~----------~~~~~~~----~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~ 212 (259)
|+|++|..||.+.+....... ....... ..... ........... ........++.+
T Consensus 208 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (353)
T cd07850 208 GEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQA 287 (353)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHH
Confidence 999999999976432110000 0000000 00000 00000000000 000011234678
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHH
Q 025011 213 AGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 213 ~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
.++|.+||+.||.+|||+.+++..
T Consensus 288 ~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 288 RDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHHcCCChhhCcCHHHHhcC
Confidence 999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=229.55 Aligned_cols=207 Identities=22% Similarity=0.217 Sum_probs=160.0
Q ss_pred HHHHHHH-hcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVV-SQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l-~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
..|..++ ...+|+|++++++++..++..++++||+++++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 44 ~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~--- 117 (260)
T cd05611 44 KAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LPEDWAKQYIAEVVLGVEDLHQRG--- 117 (260)
T ss_pred HHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 3444443 445899999999999999999999999999999999976543 577899999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
++|+||+|.||+++.++.++|+|||++..... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 118 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~ 191 (260)
T cd05611 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYP 191 (260)
T ss_pred eecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCC
Confidence 99999999999999999999999998865432 223357788999999988778999999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
||...... ...... ..... ..........++.+.+++.+||+.+|.+|||+.++.+.+..
T Consensus 192 p~~~~~~~--------~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 192 PFHAETPD--------AVFDNI-LSRRI------NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred CCCCCCHH--------HHHHHH-Hhccc------CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 99753211 000000 00000 00001111234779999999999999999988766665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=244.83 Aligned_cols=225 Identities=18% Similarity=0.200 Sum_probs=158.7
Q ss_pred HHHHHHHHHhcCCC------ccccccceeEEeC-CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINH------KNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 4 ~~~~E~~~l~~l~h------~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
.+..|+++++.++| .+++++++++..+ ++.|+||+++ +++|.+++.+... +++..+..++.|++.||.|
T Consensus 171 ~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~y 246 (467)
T PTZ00284 171 DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP---FSHRHLAQIIFQTGVALDY 246 (467)
T ss_pred HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHH
Confidence 45678888887754 4588888888764 5789999998 7789988876532 6788999999999999999
Q ss_pred Hhh-CCCCCeEeCCCCCCCeEeCCCC----------------ceEEeecCCcccccCCccccccccccCcccccCcchhc
Q 025011 77 LHS-SASPPIIHGDVKSTNVLLDDNY----------------KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI 139 (259)
Q Consensus 77 lh~-~~~~~i~h~di~p~nil~~~~~----------------~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 139 (259)
||+ .+ |+||||||+||+++.++ .++|+|||.+..... ......|+..|+|||++.
T Consensus 247 LH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~ 318 (467)
T PTZ00284 247 FHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVL 318 (467)
T ss_pred HHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhh
Confidence 997 58 99999999999998765 499999998754221 223456899999999999
Q ss_pred cCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHH--------HHHHh---------hccchhhhhhccc---
Q 025011 140 TGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ--------YFLYS---------IENNSLRQILNFQ--- 199 (259)
Q Consensus 140 ~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------~~~~~---------~~~~~~~~~~~~~--- 199 (259)
+..++.++|||||||++|+|++|+.||.+........ .... +.... .............
T Consensus 319 ~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (467)
T PTZ00284 319 GLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLA 397 (467)
T ss_pred cCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHH
Confidence 9899999999999999999999999998643211000 0000 00000 0000000000000
Q ss_pred ----cCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcc
Q 025011 200 ----VADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE--ELDRLK 241 (259)
Q Consensus 200 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~--~l~~~~ 241 (259)
..........+.+.+||.+||..||.+|||++++++ .+.+..
T Consensus 398 ~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 398 RIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 000001112356889999999999999999999986 455443
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=230.99 Aligned_cols=208 Identities=24% Similarity=0.315 Sum_probs=157.9
Q ss_pred HHHHHHH-HhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhC-C
Q 025011 5 FQHELRV-VSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSS-A 81 (259)
Q Consensus 5 ~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~ 81 (259)
+..|+.. ++.++||||+++++++..++..+++|||++ ++|.+++... .....+++..++.++.|++.|+.|||++ +
T Consensus 46 ~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~ 124 (283)
T cd06617 46 LLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124 (283)
T ss_pred HHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 4455554 566789999999999999999999999995 5888877653 2223478899999999999999999997 8
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc----CCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT----GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus 125 ---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 125 ---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred ---eecCCCCHHHEEECCCCCEEEeeccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHH
Confidence 9999999999999999999999999987654321 1122457889999998865 34688999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|+.||....... +... ...............++.+.++|.+||..+|.+|||+.++++
T Consensus 199 ~l~~g~~p~~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 199 ELATGRFPYDSWKTPF-------QQLK---------QVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHhCCCCCCccccCH-------HHHH---------HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999986522110 0000 000000000011123467999999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=230.38 Aligned_cols=221 Identities=21% Similarity=0.245 Sum_probs=166.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+||+++++++..++..++++||+++ ++.+.+..... .+++..+..++.|++.|+.+||+.+
T Consensus 43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~- 118 (283)
T cd05118 43 KTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQR--GLPESLIKSYLYQLLQGLAFCHSHG- 118 (283)
T ss_pred HHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcc--cCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678899999999999999999999999999999999965 88888876432 3578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++++|||.+....... .......++..|+|||.+.+. .++.++|+||+|+++|+|++
T Consensus 119 --i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t 194 (283)
T cd05118 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194 (283)
T ss_pred --eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987665432 112234577889999998776 68899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchhhh-----------hhccccC--CchhHHHHHHHHHHHHHhcccCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQ-----------ILNFQVA--DESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
|+.||.+.+.... .......... ...+.. ....... .......+..+.++|.+||+.||.+
T Consensus 195 g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 270 (283)
T cd05118 195 RRPLFPGKSEIDQ----LFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHK 270 (283)
T ss_pred CCCCCCCCCHHHH----HHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCccc
Confidence 9999976432110 0000000000 000000 0000000 0111234578999999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
||++.+++.
T Consensus 271 Rp~~~~ll~ 279 (283)
T cd05118 271 RITAEQALA 279 (283)
T ss_pred CcCHHHHhh
Confidence 999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=227.07 Aligned_cols=209 Identities=22% Similarity=0.327 Sum_probs=162.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+++|++++++++||||+++++++... +..++++||+++++|.+++..... +++..+..++.|++.|+.+||++
T Consensus 49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~---l~~~~~~~~~~~i~~al~~LH~~ 125 (264)
T cd06653 49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA---LTENVTRRYTRQILQGVSYLHSN 125 (264)
T ss_pred HHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 3688999999999999999999998764 467899999999999999875433 56788899999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++|+||+|++++++
T Consensus 126 ~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 202 (264)
T cd06653 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEM 202 (264)
T ss_pred C---EecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHH
Confidence 9 99999999999999999999999999876532111 1111234578899999999888889999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|+.||...... .... +..........+...++.+.+++.+||. +|..|||+.+++.
T Consensus 203 ~~g~~p~~~~~~~-------~~~~----------~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 203 LTEKPPWAEYEAM-------AAIF----------KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HhCCCCCCccCHH-------HHHH----------HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 9999998752110 0001 0000001111122344779999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=263.05 Aligned_cols=224 Identities=26% Similarity=0.435 Sum_probs=171.9
Q ss_pred HHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 025011 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPI 85 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i 85 (259)
..|++.+++++||||+++++++.+++..++||||+++|+|.+++.. +++..+..++.|++.|+.|||....+++
T Consensus 731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~i 804 (968)
T PLN00113 731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAV 804 (968)
T ss_pred HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCe
Confidence 4679999999999999999999999999999999999999999963 5778999999999999999995433339
Q ss_pred EeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCC
Q 025011 86 IHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165 (259)
Q Consensus 86 ~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 165 (259)
+|||+||+||+++.++..++. ++....... .....++..|+|||++.+..++.++||||+|+++|||++|+.|
T Consensus 805 iH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p 877 (968)
T PLN00113 805 VVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877 (968)
T ss_pred ecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCC
Confidence 999999999999988887765 554332211 1123578899999999888899999999999999999999999
Q ss_pred CCCCccccccchhHHHHHHHhhccchhhhhhccccCC--chhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 025011 166 GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD--ESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~ 243 (259)
|..... ......+|............+.+..... .........+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 878 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 878 ADAEFG---VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred CCcccC---CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 854211 1223333443333333333333333221 12234456788999999999999999999999999988664
Q ss_pred cc
Q 025011 244 HE 245 (259)
Q Consensus 244 ~~ 245 (259)
..
T Consensus 955 ~~ 956 (968)
T PLN00113 955 SS 956 (968)
T ss_pred cc
Confidence 43
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=244.84 Aligned_cols=212 Identities=23% Similarity=0.397 Sum_probs=178.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+|.+|+.++.+|+|||++++||++.+ ....+|||.++.|||.+.|.+.... .+-......++.||+.|+.||..++
T Consensus 156 ddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~-~llv~~Lcdya~QiA~aM~YLeskr- 232 (1039)
T KOG0199|consen 156 DDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKA-ILLVSRLCDYAMQIAKAMQYLESKR- 232 (1039)
T ss_pred HHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhcccc-ceeHHHHHHHHHHHHHHHHHHhhhh-
Confidence 579999999999999999999999887 6778999999999999999884433 3566888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|||+...|+++.....+||+|||+.+..+...+ +.+....--...|+|||.+....++.++|+|++|++||||++
T Consensus 233 --lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt 310 (1039)
T KOG0199|consen 233 --LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT 310 (1039)
T ss_pred --hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc
Confidence 99999999999999999999999999998875433 334445556678999999999999999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|..||.+.. ...+.+.++.+-.-..+..+++.+.+++..||..+|.+|||+..|.+.+
T Consensus 311 yGEePW~G~~------------------g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 311 YGEEPWVGCR------------------GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCCCC------------------HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 789999832 2223333333333444556779999999999999999999999997443
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.66 Aligned_cols=204 Identities=26% Similarity=0.371 Sum_probs=159.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|||++++++++..+...+++|||+. +++.+++..... .+++..+..++.|++.++.|||+++
T Consensus 66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g- 141 (313)
T cd06633 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN- 141 (313)
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 357889999999999999999999999999999999995 578777765432 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++|+|||++..... .....++..|+|||++. ...++.++|+||+|+++|+|
T Consensus 142 --i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el 213 (313)
T cd06633 142 --MIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213 (313)
T ss_pred --eecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999999999998754321 22345788899999974 34578899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+..... ....... ... ........+..+.+++.+||+.+|.+|||+.+++.
T Consensus 214 ~~g~~p~~~~~~~~--------~~~~~~~-~~~--------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 214 AERKPPLFNMNAMS--------ALYHIAQ-NDS--------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred HhCCCCCCCCChHH--------HHHHHHh-cCC--------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999987632110 0000000 000 00011112356899999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=229.98 Aligned_cols=222 Identities=20% Similarity=0.257 Sum_probs=161.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..++||||++ +++.+.+...... ..++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~- 122 (294)
T PLN00009 46 STAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDF-AKNPRLIKTYLYQILRGIAYCHSHR- 122 (294)
T ss_pred HHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCC-CcCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 457899999999999999999999999999999999995 5788887654432 2467888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++. ++.++++|||++....... .......++..|+|||.+.+. .++.++|+||+|+++|+|+
T Consensus 123 --i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 123 --VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred --eeCCCCCcceEEEECCCCEEEEcccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999985 5679999999987554321 111233567899999988664 4788999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhc--cc---------hhhhhhccccCC---chhHHHHHHHHHHHHHhcccCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIE--NN---------SLRQILNFQVAD---ESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~---------~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+|..||.+..... ........... .. ............ ......++.+.+++.+||+.+|.+
T Consensus 199 tg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~ 274 (294)
T PLN00009 199 NQKPLFPGDSEID----ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSK 274 (294)
T ss_pred hCCCCCCCCCHHH----HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhh
Confidence 9999997632210 00000000000 00 000000000000 001123466899999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
||++.++++
T Consensus 275 Rps~~~~l~ 283 (294)
T PLN00009 275 RITARAALE 283 (294)
T ss_pred CcCHHHHhc
Confidence 999999975
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=226.35 Aligned_cols=193 Identities=22% Similarity=0.294 Sum_probs=154.4
Q ss_pred CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCe
Q 025011 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNV 95 (259)
Q Consensus 16 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~ni 95 (259)
+|||++++++++..++..++||||+++++|.+++.... .+++..+..++.|++.|+.+||+.+ ++|+||+|+||
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~ni 140 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENV 140 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHE
Confidence 69999999999999999999999999999999997654 3688999999999999999999999 99999999999
Q ss_pred EeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccc
Q 025011 96 LLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASN 174 (259)
Q Consensus 96 l~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~ 174 (259)
+++.++ .++++|||++...... ....++..|+|||++.+..++.++|+||+|+++|+|++|..||.......
T Consensus 141 l~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~- 213 (267)
T PHA03390 141 LYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE- 213 (267)
T ss_pred EEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-
Confidence 999988 9999999998755432 12347889999999988889999999999999999999999997532111
Q ss_pred cchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 025011 175 EGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-MKQVSE 235 (259)
Q Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~il~ 235 (259)
.....+.... .... ......++.+.++|.+||+.+|.+||+ ++++++
T Consensus 214 --~~~~~~~~~~----------~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 --LDLESLLKRQ----------QKKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --hhHHHHHHhh----------cccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0001111100 0000 011134477999999999999999996 588863
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=231.05 Aligned_cols=211 Identities=25% Similarity=0.339 Sum_probs=163.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++|+|++++.+++..++..++||||+. +++.+.+..... .+++..+..++.|++.|+.|||+.+
T Consensus 60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~l~~~~~~~~~~~l~~~l~~LH~~~- 135 (308)
T cd06634 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN- 135 (308)
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 357789999999999999999999999999999999996 588777754332 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc---CCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|.||+++.++.++++|||++...... ....++..|+|||.+.+ ..++.++||||+|+++|+|
T Consensus 136 --i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 207 (308)
T cd06634 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (308)
T ss_pred --cccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHH
Confidence 999999999999999999999999998654321 22357789999999752 4578899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||....... ... ...............+..+.++|.+||..+|.+||++.++++.-.-
T Consensus 208 ~~g~~p~~~~~~~~--------~~~---------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~ 270 (308)
T cd06634 208 AERKPPLFNMNAMS--------ALY---------HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (308)
T ss_pred HcCCCCCccccHHH--------HHH---------HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence 99999986532110 000 0000001111112334678999999999999999999999876544
Q ss_pred ccc
Q 025011 240 LKI 242 (259)
Q Consensus 240 ~~~ 242 (259)
...
T Consensus 271 ~~~ 273 (308)
T cd06634 271 LRE 273 (308)
T ss_pred ccc
Confidence 443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=230.72 Aligned_cols=214 Identities=25% Similarity=0.305 Sum_probs=160.4
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhcc--CCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK--SSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
..+.+|+.++.++. ||||+++++++..++..+++|||+. +++.++.... .....+++..+..++.|++.|+.|||+
T Consensus 47 ~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~ 125 (288)
T cd06616 47 KRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125 (288)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 45788999999996 9999999999999889999999985 4665543221 111236788999999999999999997
Q ss_pred C-CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHH
Q 025011 80 S-ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVL 155 (259)
Q Consensus 80 ~-~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~i 155 (259)
. + ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+. .++.++||||+|++
T Consensus 126 ~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 126 ELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred cCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 5 7 9999999999999999999999999987554321 11223578889999998766 58899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+|++|..||..... .......... ... ...........+..+.+++.+||+.+|.+|||+.+|++
T Consensus 200 l~el~~g~~p~~~~~~-------~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 200 LYEVATGKFPYPKWNS-------VFDQLTQVVK-GDP-----PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred HHHHHhCCCCchhcch-------HHHHHhhhcC-CCC-----CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999999876320 0000100000 000 00111111234567999999999999999999999976
Q ss_pred H
Q 025011 236 E 236 (259)
Q Consensus 236 ~ 236 (259)
.
T Consensus 267 ~ 267 (288)
T cd06616 267 H 267 (288)
T ss_pred C
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=228.83 Aligned_cols=221 Identities=22% Similarity=0.217 Sum_probs=170.7
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.+ +||||+++++.+..++..++||||+.+++|.+++.... .+++..+..++.|++.+|.+||+.+
T Consensus 49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~ 125 (288)
T cd05583 49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG 125 (288)
T ss_pred HHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4577899999999 59999999999999999999999999999999986543 2577889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l 159 (259)
++|+||+|.||+++.++.++++|||++....... ........++..|+|||.+.+.. .+.++|+||+|+++++|
T Consensus 126 ---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el 201 (288)
T cd05583 126 ---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFEL 201 (288)
T ss_pred ---eeccCCCHHHeEECCCCCEEEEECcccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHH
Confidence 9999999999999999999999999987654321 11122335788999999987655 68899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||........ ......... ... ...+...+..+.+++.+||+.||++|||+.++.+.++.
T Consensus 202 ~tg~~p~~~~~~~~~----~~~~~~~~~---------~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 202 LTGASPFTVDGEQNS----QSEISRRIL---------KSK--PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HhCCCCcccCcccch----HHHHHHHHH---------ccC--CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 999999864211110 000000000 000 00111233668999999999999999999999888887
Q ss_pred cccccc
Q 025011 240 LKISHE 245 (259)
Q Consensus 240 ~~~~~~ 245 (259)
.....-
T Consensus 267 ~~~~~~ 272 (288)
T cd05583 267 PFFQGI 272 (288)
T ss_pred cccccC
Confidence 765443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=229.74 Aligned_cols=221 Identities=19% Similarity=0.281 Sum_probs=158.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCC--------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETK--------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|++++++++||||+++++++...+ ..+++|||+. ++|.+++..... .+++..++.++.|++.|+.
T Consensus 57 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 57 TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred HHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHH
Confidence 4568999999999999999999987654 3499999995 588888765432 3578999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhccCC-cccccchhhH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSF 152 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diwsl 152 (259)
|||+++ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+.. ++.++|+||+
T Consensus 134 ~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred HHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 999999 999999999999999999999999998766432211 1122345778899999886654 6889999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc---cchhh-----hhhc-cccCCch---------hHHHHHHHHH
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE---NNSLR-----QILN-FQVADES---------EMEEIETVAG 214 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~-~~~~~~~---------~~~~~~~~~~ 214 (259)
|+++|+|++|..||.+..... .......... ..... ...+ ....... .......+.+
T Consensus 211 G~~l~el~t~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~d 285 (310)
T cd07865 211 GCIMAEMWTRSPIMQGNTEQH-----QLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALD 285 (310)
T ss_pred HHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHH
Confidence 999999999999987632110 0000000000 00000 0000 0000000 0001255789
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 025011 215 LASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 215 li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|.+||..||.+|||++++++
T Consensus 286 li~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 286 LIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HHHHHhcCChhhccCHHHHhc
Confidence 999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=231.77 Aligned_cols=220 Identities=21% Similarity=0.218 Sum_probs=160.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+|+.++++++|+|++++++++... +..++||||+. ++|.+++.... ..+++..+..++.|++.|+.|||+.+
T Consensus 52 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ 128 (309)
T cd07845 52 SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF 128 (309)
T ss_pred hhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356899999999999999999998754 46899999996 48888887543 23688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 129 ---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~ 203 (309)
T cd07845 129 ---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203 (309)
T ss_pred ---eecCCCCHHHEEECCCCCEEECccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHH
Confidence 99999999999999999999999999876654221 1222345778999999865 44789999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhh--ccchhh-----------hhhccccCC--chhHHHHHHHHHHHHHhcccCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSI--ENNSLR-----------QILNFQVAD--ESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~-----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+|..||.+.+... .......... ....+. ......... ......++.+.++|.+||+.||.
T Consensus 204 ~g~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~ 279 (309)
T cd07845 204 AHKPLLPGKSEIE----QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPK 279 (309)
T ss_pred hCCCCCCCCCHHH----HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChh
Confidence 9999997632211 0000000000 000000 000000000 00011246788999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.+++.
T Consensus 280 ~R~t~~~il~ 289 (309)
T cd07845 280 KRATAEEALE 289 (309)
T ss_pred hCcCHHHHhc
Confidence 9999999964
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=226.14 Aligned_cols=208 Identities=20% Similarity=0.278 Sum_probs=163.6
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+..|+.+++.++||||+++++++.+....++++||+++++|.+++... .....+++..++.++.|++.|+.|||+.+
T Consensus 48 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~- 126 (260)
T cd08222 48 QANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR- 126 (260)
T ss_pred HHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 3567899999999999999999999989999999999999999988652 22234688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++. +.++++|||++........ ......++..|+|||.+.+..++.++|+||+|+++++|++|
T Consensus 127 --i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~ 201 (260)
T cd08222 127 --ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCL 201 (260)
T ss_pred --ccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999975 5799999999876543211 22234578889999998887888999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+.... ........ . .....+...+..+.++|.+||+.+|.+||++.++++
T Consensus 202 ~~~~~~~~~~--------~~~~~~~~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 202 AHAFEGQNFL--------SVVLRIVE-G---------PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCccHH--------HHHHHHHc-C---------CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 9998652210 00110000 0 000112234567999999999999999999999974
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=227.96 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++++. ||||+++++++..++..+++||++++++|.+++.+.. .+++..++.++.|++.|+.+||+.+
T Consensus 46 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~ 122 (280)
T cd05581 46 KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG 122 (280)
T ss_pred HHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45788999999998 9999999999999999999999999999999998764 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc------------------cccccccCcccccCcchhccCCc
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT------------------AMTTKKIGTFVNLDPEYVITGKL 143 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~------------------~~~~~~~~~~~y~aPE~~~~~~~ 143 (259)
++|+||+|+||+++.++.++++|||++......... .......++..|+|||......+
T Consensus 123 ---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~ 199 (280)
T cd05581 123 ---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA 199 (280)
T ss_pred ---eeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC
Confidence 999999999999999999999999998766543211 12223357789999999888888
Q ss_pred ccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccC
Q 025011 144 TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 144 ~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 223 (259)
+.++|+||+|++++++++|..||....... ...... .. ....+...++.+.+++.+||+.+
T Consensus 200 ~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~---------~~--~~~~~~~~~~~~~~li~~~l~~~ 260 (280)
T cd05581 200 GKSSDLWALGCIIYQMLTGKPPFRGSNEYL--------TFQKIL---------KL--EYSFPPNFPPDAKDLIEKLLVLD 260 (280)
T ss_pred ChhhhHHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHH---------hc--CCCCCCccCHHHHHHHHHHhcCC
Confidence 999999999999999999999998643110 000000 00 00011122467999999999999
Q ss_pred CCCCCCH----HHHHH
Q 025011 224 GRRRPTM----KQVSE 235 (259)
Q Consensus 224 p~~Rpt~----~~il~ 235 (259)
|.+|||+ .+++.
T Consensus 261 p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 261 PQDRLGVNEGYDELKA 276 (280)
T ss_pred HhhCCCcccCHHHHhc
Confidence 9999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=234.89 Aligned_cols=225 Identities=20% Similarity=0.279 Sum_probs=163.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.+++.++||||+++++++.. ....++||||+. ++|.+++..... +++..+..++.|++.||.|||
T Consensus 49 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 49 KRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP---LTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred HHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 457789999999999999999998863 346799999995 689888865433 688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
+++ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|++
T Consensus 125 ~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 125 SAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HCC---eecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 999 999999999999999999999999998765432211 11223468889999999865 347899999999999
Q ss_pred HHHHHhCCCCCCCCccccccch-------hHHHHHHHhhccchhhhhh---ccccCCc---hhHHHHHHHHHHHHHhccc
Q 025011 156 LAELLTGLKPGSGMALASNEGI-------SMVQYFLYSIENNSLRQIL---NFQVADE---SEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~li~~~l~~ 222 (259)
+|+|++|+.||.+.+....... ....... ........... ....... .....++.+.++|.+||+.
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 280 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN-RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQF 280 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh-hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccC
Confidence 9999999999976432110000 0000000 00000000000 0000000 0112357799999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
+|.+|||+.+++.
T Consensus 281 ~P~~Rpt~~~~l~ 293 (334)
T cd07855 281 DPEERITVEQALQ 293 (334)
T ss_pred ChhhCcCHHHHHh
Confidence 9999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=224.37 Aligned_cols=203 Identities=30% Similarity=0.324 Sum_probs=164.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++|||++++++.+..++..+++|||+++++|.+++..... +++..+..++.|++.|+.++|+.+
T Consensus 38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~~l~~lh~~~- 113 (250)
T cd05123 38 EHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR---FSEERARFYAAEIVLALEYLHSLG- 113 (250)
T ss_pred HHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3688999999999999999999999999999999999999999999976642 578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++++|||++....... .......++..|+|||...+..++.++|+||||+++|++++|
T Consensus 114 --~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g 189 (250)
T cd05123 114 --IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG 189 (250)
T ss_pred --ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999987654322 123344578899999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
..||...+. . ........ ... ..+...+..+.+++.+||..||.+|||+.+
T Consensus 190 ~~p~~~~~~-----~---~~~~~~~~---------~~~--~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 190 KPPFYAEDR-----K---EIYEKILK---------DPL--RFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCCCCCH-----H---HHHHHHhc---------CCC--CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999976321 0 00000000 000 001111367899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=234.51 Aligned_cols=231 Identities=24% Similarity=0.335 Sum_probs=165.6
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.+|+.+++++ +||||+++++++... ...++||||+. ++|..++... .+++..+..++.|++.||.|||+.
T Consensus 52 ~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~ 126 (337)
T cd07852 52 RTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSG 126 (337)
T ss_pred hhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 467899999999 999999999998653 36799999996 5898888664 357788889999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc---cccccccCcccccCcchhccC-CcccccchhhHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT---AMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLL 156 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il 156 (259)
+ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+. .++.++|+||+|+++
T Consensus 127 ~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l 203 (337)
T cd07852 127 N---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203 (337)
T ss_pred C---eecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHH
Confidence 9 999999999999999999999999998766543221 122234578899999987653 478899999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHH-------HHhhccchhhhhhc----cccC--CchhHHHHHHHHHHHHHhcccC
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYF-------LYSIENNSLRQILN----FQVA--DESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~li~~~l~~~ 223 (259)
|+|++|+.||.+........ ...... .............. .... .......+..+.++|.+||+.|
T Consensus 204 ~el~tg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 282 (337)
T cd07852 204 GEMLLGKPLFPGTSTLNQLE-KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN 282 (337)
T ss_pred HHHHhCCCCCCCCChHHHHH-HHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence 99999999997643211000 000000 00000000000000 0000 0001113467899999999999
Q ss_pred CCCCCCHHHHHHH--HHhcccc
Q 025011 224 GRRRPTMKQVSEE--LDRLKIS 243 (259)
Q Consensus 224 p~~Rpt~~~il~~--l~~~~~~ 243 (259)
|.+|||+.++++. ++++...
T Consensus 283 P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 283 PNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred cccccCHHHHhhChhhhhhccC
Confidence 9999999999865 5555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=224.88 Aligned_cols=209 Identities=24% Similarity=0.329 Sum_probs=171.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
|.+.+|+.++++.+.|++|++|+.+-....+|||||||..|++.+.+..... .+++.++..++...+.||.|||...
T Consensus 73 QEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~- 149 (502)
T KOG0574|consen 73 QEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK- 149 (502)
T ss_pred HHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH-
Confidence 5688999999999999999999999888899999999999999999976543 4788999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
-+|||||+.||+++-+|..+|+|||.+-...... ...+...||+.|+|||++..-.|+.++||||||++..+|..|
T Consensus 150 --KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG 225 (502)
T KOG0574|consen 150 --KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG 225 (502)
T ss_pred --HHHhhcccccEEEcccchhhhhhccccchhhhhH--HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence 8999999999999999999999999987655422 233455799999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCC-chhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD-ESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++||.+....... +... ....++ ..+-.-+..+.+++++||-.+|++|-|+.++++
T Consensus 226 ~PPYsDIHPMRAI-------FMIP----------T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 226 RPPYSDIHPMRAI-------FMIP----------TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCCccccccccee-------Eecc----------CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 9999863211100 0000 000111 112223467999999999999999999999875
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=227.77 Aligned_cols=223 Identities=18% Similarity=0.199 Sum_probs=161.3
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCc-----ceEEEEecCCCChhhhhhccCC--cccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKV-----PLLVYEFVPNGTLFDHIHDKSS--QVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+.+++.+. ||||+++++++..... .+++|||+++ +|.+++..... ...+++..++.++.|++.||
T Consensus 45 ~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L 123 (295)
T cd07837 45 PTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123 (295)
T ss_pred hHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHH
Confidence 45788999999995 6999999999887665 7999999975 88888765432 23468899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSF 152 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diwsl 152 (259)
.|||+++ ++|+||+|+||+++. ++.++|+|||++........ ......+++.|+|||.+.+. .++.++|+||+
T Consensus 124 ~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~sl 198 (295)
T cd07837 124 AHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSV 198 (295)
T ss_pred HHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHH
Confidence 9999999 999999999999998 88999999999875543211 11223467889999988653 47899999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--chh------hhhhcccc-C----CchhHHHHHHHHHHHHHh
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--NSL------RQILNFQV-A----DESEMEEIETVAGLASKC 219 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~------~~~~~~~~-~----~~~~~~~~~~~~~li~~~ 219 (259)
|+++|+|++|..||.+..... ............ ... ........ . .......++.+.++|.+|
T Consensus 199 G~~l~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 274 (295)
T cd07837 199 GCIFAEMSRKQPLFPGDSELQ----QLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKM 274 (295)
T ss_pred HHHHHHHHcCCCCCCCCCHHH----HHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHH
Confidence 999999999999997632211 011110000000 000 00000000 0 000112346799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|..||.+|||+.+++.
T Consensus 275 l~~~P~~R~~~~eil~ 290 (295)
T cd07837 275 LRYDPAKRISAKAALT 290 (295)
T ss_pred ccCChhhcCCHHHHhc
Confidence 9999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=226.58 Aligned_cols=199 Identities=21% Similarity=0.239 Sum_probs=155.8
Q ss_pred HHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCC
Q 025011 11 VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDV 90 (259)
Q Consensus 11 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di 90 (259)
+++...||+|+++.+++...+..++||||+.+++|.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||
T Consensus 50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di 123 (278)
T cd05606 50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDL 123 (278)
T ss_pred HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCC
Confidence 3444579999999999999999999999999999999886543 3688999999999999999999999 999999
Q ss_pred CCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHhCCCCCCCC
Q 025011 91 KSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 91 ~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~ 169 (259)
+|+||+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++||||+|+++|+|++|..||.+.
T Consensus 124 ~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 124 KPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CHHHEEECCCCCEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999998754332 12234688999999998754 5889999999999999999999999763
Q ss_pred ccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 170 ALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
...... . ........ .. ..+...+..+.+++.+||..+|.+|| ++.++++
T Consensus 200 ~~~~~~-----~-~~~~~~~~------~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 200 KTKDKH-----E-IDRMTLTM------AV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CccchH-----H-HHHHhhcc------CC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 211100 0 00000000 00 01111246799999999999999999 9999974
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=226.36 Aligned_cols=220 Identities=22% Similarity=0.245 Sum_probs=158.8
Q ss_pred HHHHHHHHhcCC-CccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 5 FQHELRVVSQIN-HKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 5 ~~~E~~~l~~l~-h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..+|+.+++++. |+|++++++++.++ +..+++|||++ +++.+.+.... ..+++..++.++.|++.||.|||+.+
T Consensus 44 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ 120 (282)
T cd07831 44 NLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG 120 (282)
T ss_pred HHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 346888898885 99999999999987 88999999996 58888876543 23688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++. +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||+|+++|+|+
T Consensus 121 ---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~ 193 (282)
T cd07831 121 ---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193 (282)
T ss_pred ---ceecccCHHHEEEcC-CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHH
Confidence 999999999999999 9999999999876543211 122357889999997654 44788999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHH-------HHhhccchhhhhhccccC----CchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYF-------LYSIENNSLRQILNFQVA----DESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
+|..||.+...... ........ .................. .......+..+.++|.+||+.+|.+|||
T Consensus 194 ~~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~ 272 (282)
T cd07831 194 SLFPLFPGTNELDQ-IAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272 (282)
T ss_pred cCCcCCCCCCHHHH-HHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC
Confidence 99999976332110 00000000 000000000000000000 0001134578999999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
+.+++.
T Consensus 273 ~~~~l~ 278 (282)
T cd07831 273 AKQALR 278 (282)
T ss_pred HHHHhh
Confidence 999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=228.73 Aligned_cols=205 Identities=21% Similarity=0.258 Sum_probs=168.4
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
-.+|-.+|++++.+.||.+--.|++.+.+|+|+..+.||+|.-+|-..+... +++..+.-++.+|+-||.+||+..
T Consensus 232 aLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~g-F~e~ra~FYAAEi~cGLehlH~~~--- 307 (591)
T KOG0986|consen 232 ALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPG-FDEQRARFYAAEIICGLEHLHRRR--- 307 (591)
T ss_pred hhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCC-CchHHHHHHHHHHHhhHHHHHhcc---
Confidence 4679999999999999999999999999999999999999999998776544 788999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
||+||+||+||++|+.|+++|+|+|++..++.+.. ...++||.+|||||++.+..|+...|.||+||++|+|+.|+.
T Consensus 308 iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~s 384 (591)
T KOG0986|consen 308 IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHS 384 (591)
T ss_pred eeeccCChhheeeccCCCeEeeccceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccC
Confidence 99999999999999999999999999998876432 234479999999999999999999999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||.....- .....+.+.... .....+-..++...++.+.+|..||.+|.-.+
T Consensus 385 PFr~~KeK--------------vk~eEvdrr~~~-~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 385 PFRQRKEK--------------VKREEVDRRTLE-DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred chhhhhhh--------------hhHHHHHHHHhc-chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 99762211 011111111100 01112233457899999999999999996443
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=224.89 Aligned_cols=212 Identities=16% Similarity=0.205 Sum_probs=154.1
Q ss_pred HHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 8 ELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 8 E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+...+..+.|+|++++++.+.... ..+++++++ ..++.+.+..... .++..+..++.|++.|+.|||+.+
T Consensus 73 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~-- 146 (294)
T PHA02882 73 LWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKC---KNKKLIKNIMKDMLTTLEYIHEHG-- 146 (294)
T ss_pred HHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhcc---CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 334455678999999998766543 346788877 4467666654322 356788899999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++||||||+||+++.++.++|+|||+++.+...... .......||+.|+|||.+.+..++.++||||+||++++
T Consensus 147 -iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 147 -ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225 (294)
T ss_pred -eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999999999999999876432111 11123358999999999998889999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
|++|..||.+................ ..+....... ...++.+.+++..|++.+|.+||++.++++.+
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFI--------KRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHH--------HHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99999999874321111000000000 1111110000 11236799999999999999999999998876
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=225.52 Aligned_cols=221 Identities=22% Similarity=0.265 Sum_probs=163.6
Q ss_pred hHHHHHHHHHhcC---CCccccccceeEEeCCc-----ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI---NHKNVVKILGACLETKV-----PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l---~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
..+.+|+.+++++ +|||++++++++..... .+++|||+.+ +|.+++...... .+++..++.++.|++.||
T Consensus 43 ~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~-~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 43 LSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKP-GLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCC-CCCHHHHHHHHHHHHHHH
Confidence 3466788887766 59999999999987776 8999999964 898888765432 368899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.+||+.+ ++|+||+|+||+++.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+
T Consensus 121 ~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~ 194 (287)
T cd07838 121 DFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGC 194 (287)
T ss_pred HHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHH
Confidence 9999999 99999999999999999999999999877643321 12234678899999998888999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchh---------hhhhccccC---CchhHHHHHHHHHHHHHhccc
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSL---------RQILNFQVA---DESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~ 222 (259)
++|+|++|.+||.+.... ................ ......... .......++.+.+++.+||+.
T Consensus 195 ~l~~l~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 270 (287)
T cd07838 195 IFAELFRRRPLFRGTSEA----DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTF 270 (287)
T ss_pred HHHHHHhCCCcccCCChH----HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhcc
Confidence 999999999998763221 1111111100000000 000000000 111123457788999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+||++.+++.
T Consensus 271 dp~~Rp~~~~il~ 283 (287)
T cd07838 271 NPHKRISAFEALQ 283 (287)
T ss_pred CCccCCCHHHHhc
Confidence 9999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=225.60 Aligned_cols=222 Identities=21% Similarity=0.294 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++|||++++++++... +..++++||+++ +|.+++.... ..+++..++.++.|++.|+.+||+.
T Consensus 43 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 43 ITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred HHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4578899999999999999999999987 889999999965 8888886653 2367899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||+|.||++++++.++++|||++........ .......++..|+|||.+.+. .++.++||||||+++++|
T Consensus 120 ~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el 195 (287)
T cd07840 120 G---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAEL 195 (287)
T ss_pred C---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHH
Confidence 9 99999999999999999999999999876654321 112233567889999987654 478999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHh--hccchhhhh--------hccccCCc-----hhHH-HHHHHHHHHHHhcccC
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYS--IENNSLRQI--------LNFQVADE-----SEME-EIETVAGLASKCLSLS 223 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~--------~~~~~~~~-----~~~~-~~~~~~~li~~~l~~~ 223 (259)
++|..||....... ......... .....+... ........ .... .++.+.+++.+||+.+
T Consensus 196 ~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 271 (287)
T cd07840 196 FLGKPIFQGSTELE----QLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLD 271 (287)
T ss_pred HhCCCCCCCCChHH----HHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCC
Confidence 99999997633210 000000000 000000000 00000000 0001 2567899999999999
Q ss_pred CCCCCCHHHHHH
Q 025011 224 GRRRPTMKQVSE 235 (259)
Q Consensus 224 p~~Rpt~~~il~ 235 (259)
|.+|||+.++++
T Consensus 272 P~~Rp~~~~~l~ 283 (287)
T cd07840 272 PKKRISADQALQ 283 (287)
T ss_pred hhhCcCHHHHhh
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=231.22 Aligned_cols=228 Identities=23% Similarity=0.308 Sum_probs=165.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
.+.+|+.+++.++|+||+++++++... ...++++||+. ++|.+++..... +++..+..++.|++.|+.|||
T Consensus 50 ~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH 125 (337)
T cd07858 50 RTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIH 125 (337)
T ss_pred HHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 467899999999999999999988654 35799999995 689888876532 678999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~ 157 (259)
+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.. ..++.++|+||+|+++|
T Consensus 126 ~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 126 SAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred hCC---EecCCCCHHHEEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 999 9999999999999999999999999987654321 12223457889999998865 45889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHH-------HHhhccchhhhhhcc---ccCC---chhHHHHHHHHHHHHHhcccCC
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYF-------LYSIENNSLRQILNF---QVAD---ESEMEEIETVAGLASKCLSLSG 224 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~li~~~l~~~p 224 (259)
+|++|+.||.+....... ....... ............... .... ......++.+.++|.+||+.+|
T Consensus 201 ~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 279 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQL-KLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDP 279 (337)
T ss_pred HHHcCCCCCCCCChHHHH-HHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCCh
Confidence 999999999764221100 0000000 000000011100000 0000 0011245678999999999999
Q ss_pred CCCCCHHHHHHH--HHhcc
Q 025011 225 RRRPTMKQVSEE--LDRLK 241 (259)
Q Consensus 225 ~~Rpt~~~il~~--l~~~~ 241 (259)
.+|||+.++++. ++.+.
T Consensus 280 ~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 280 SKRITVEEALAHPYLASLH 298 (337)
T ss_pred hhccCHHHHHcCcchhhhc
Confidence 999999999876 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=222.13 Aligned_cols=192 Identities=22% Similarity=0.215 Sum_probs=152.6
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+.+|...+....||||+++++++...+..+++|||+++++|.+++..... +++..+..++.|++.|+.|||+.+
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~ql~~~l~~lH~~~--- 105 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALHREG--- 105 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 44566666666799999999999999999999999999999999876543 678899999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
++|+||+|+||+++.++.++++|||.+...... .....++..|+|||...+..++.++|+||+|+++|++++|..
T Consensus 106 i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~ 180 (237)
T cd05576 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKT 180 (237)
T ss_pred eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcc
Confidence 999999999999999999999999987554332 112235667999999887788999999999999999999998
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|+....... ... ... ..+...++.+.++|.+||+.||.+|||+
T Consensus 181 ~~~~~~~~~--------------~~~-----~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 181 LVECHPSGI--------------NTH-----TTL----NIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred hhhcCchhc--------------ccc-----ccc----CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 865311000 000 000 0111234678999999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=236.27 Aligned_cols=233 Identities=23% Similarity=0.295 Sum_probs=171.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+++.-+|+++|++|+|||||+++++=++.. ...++||||.+|||...+++-....-+++.+.+.++..++.|+.
T Consensus 55 ~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~ 134 (732)
T KOG4250|consen 55 RERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALR 134 (732)
T ss_pred HHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHH
Confidence 467889999999999999999999866543 46899999999999999987655555789999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCC----CceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDN----YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diw 150 (259)
|||+++ |+||||||+||++..+ ...||+|||+|+....+. .....+||..|.+||++.. ..|+..+|.|
T Consensus 135 ~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLW 208 (732)
T KOG4250|consen 135 HLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLW 208 (732)
T ss_pred HHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehh
Confidence 999999 9999999999999432 347999999999877542 5667789999999999984 7789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc---------cchhhhh-hccccCCchhHHHHHHHHHHHHHhc
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE---------NNSLRQI-LNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
|+||++|+++||..||.....-......+......... .++.-.+ ..-.............+-.++..+|
T Consensus 209 S~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L 288 (732)
T KOG4250|consen 209 SFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASML 288 (732)
T ss_pred hhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHH
Confidence 99999999999999997643221100000000000000 0000000 0000111122233456778899999
Q ss_pred ccCCCCCC--CHHHHHHHHHhc
Q 025011 221 SLSGRRRP--TMKQVSEELDRL 240 (259)
Q Consensus 221 ~~~p~~Rp--t~~~il~~l~~~ 240 (259)
..+|.+|- ...+....+.+|
T Consensus 289 ~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 289 EWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred hhhHHHhCCCCcchHHHHHHHH
Confidence 99999998 666666665554
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=229.41 Aligned_cols=229 Identities=21% Similarity=0.294 Sum_probs=170.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.+++.++||||+++.+++.... ..+++|+|+. ++|.+++.... .+++..++.++.|++.|+.+|
T Consensus 44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~L 119 (330)
T cd07834 44 KRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYL 119 (330)
T ss_pred hhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHH
Confidence 56889999999999999999999988765 7899999996 58888886654 367899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
|+.+ ++|+||+|+||+++.++.++|+|||.+......... .......++..|+|||.+.+. .++.++|+||+|++
T Consensus 120 H~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~i 196 (330)
T cd07834 120 HSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCI 196 (330)
T ss_pred HhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHH
Confidence 9999 999999999999999999999999998876543211 122334578889999999887 68999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh-----------ccchhhhhhcc-ccCCc-----hhHHHHHHHHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI-----------ENNSLRQILNF-QVADE-----SEMEEIETVAGLASK 218 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~li~~ 218 (259)
+++|++|..||.+..... ......... ........... ..... .....++.+.+++..
T Consensus 197 l~~l~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 271 (330)
T cd07834 197 FAELLTRKPLFPGRDYID-----QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEK 271 (330)
T ss_pred HHHHHcCCCCcCCCCHHH-----HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHH
Confidence 999999999998743211 000000000 00000000000 00000 011134678999999
Q ss_pred hcccCCCCCCCHHHHHHH--HHhcccc
Q 025011 219 CLSLSGRRRPTMKQVSEE--LDRLKIS 243 (259)
Q Consensus 219 ~l~~~p~~Rpt~~~il~~--l~~~~~~ 243 (259)
||+.+|.+|||+.+++.. ++++...
T Consensus 272 ~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 272 MLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred HccCChhhCCCHHHHHhCccHHhhccc
Confidence 999999999999999873 5555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=231.90 Aligned_cols=227 Identities=20% Similarity=0.302 Sum_probs=163.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.+++.++||||+++++++... ...++++||+. +++.+++... .+++..+..++.|++.||.+|
T Consensus 48 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~L 122 (336)
T cd07849 48 QRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYI 122 (336)
T ss_pred HHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHH
Confidence 3577899999999999999999987654 35799999995 4888777543 257789999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
|+.+ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+ ..++.++||||+|++
T Consensus 123 H~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvi 199 (336)
T cd07849 123 HSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCI 199 (336)
T ss_pred HhCC---eeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHH
Confidence 9999 9999999999999999999999999987654322111 1123457889999998755 458899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHh--hccchhhh--------hhc---cccCCc---hhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYS--IENNSLRQ--------ILN---FQVADE---SEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--------~~~---~~~~~~---~~~~~~~~~~~li~~~ 219 (259)
+|+|++|+.||.+..... ......... ........ ... ...... .....++.+.+++.+|
T Consensus 200 l~el~~G~~~f~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 275 (336)
T cd07849 200 LAEMLSNRPLFPGKDYLH----QLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKM 275 (336)
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHH
Confidence 999999999997632111 000000000 00000000 000 000000 0012346789999999
Q ss_pred cccCCCCCCCHHHHHHH--HHhcc
Q 025011 220 LSLSGRRRPTMKQVSEE--LDRLK 241 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~--l~~~~ 241 (259)
|+.+|.+|||+.++++. ++...
T Consensus 276 l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 276 LTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred cCCChhhCcCHHHHhcCccccccC
Confidence 99999999999999875 55443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=223.26 Aligned_cols=221 Identities=21% Similarity=0.261 Sum_probs=165.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++|+|++++++++...+..++++||+. ++|.+++..... .+++..+..++.|++.|+.+||+++
T Consensus 43 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~- 118 (282)
T cd07829 43 STALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPG--PLSPNLIKSIMYQLLRGLAYCHSHR- 118 (282)
T ss_pred HHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 457789999999999999999999999999999999996 589999987532 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+. .++.++|+||+|++++++++
T Consensus 119 --i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 194 (282)
T cd07829 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT 194 (282)
T ss_pred --cccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh
Confidence 99999999999999999999999999876543221 12223456789999998766 68899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh--ccchh---------hhhhccccCC---chhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI--ENNSL---------RQILNFQVAD---ESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||.+..... .......... ....+ .......... ......+..+.++|.+||..||.+|
T Consensus 195 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R 270 (282)
T cd07829 195 GKPLFPGDSEID----QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKR 270 (282)
T ss_pred CCCCCCCccHHH----HHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccC
Confidence 999987632110 0000000000 00000 0000000000 0011124679999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
|++.+++.
T Consensus 271 p~~~~~l~ 278 (282)
T cd07829 271 ISAKEALK 278 (282)
T ss_pred CCHHHHhh
Confidence 99999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=229.41 Aligned_cols=221 Identities=20% Similarity=0.238 Sum_probs=162.8
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++..++..+++|||+. ++|.+++..... +++..+..++.|++.||.+||+.+
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---~~~~~~~~~~~ql~~aL~~LH~~~-- 139 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIR---LTESQVKCILLQILNGLNVLHKWY-- 139 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 47789999999999999999999999999999999996 589998865432 577899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc------------cccccccccCcccccCcchhccCC-cccccchh
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN------------QTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVY 150 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~------------~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diw 150 (259)
++|+||+|+||+++.++.++++|||.+....... .........++..|+|||.+.+.. ++.++|+|
T Consensus 140 -i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~ 218 (335)
T PTZ00024 140 -FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW 218 (335)
T ss_pred -eecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence 9999999999999999999999999987655211 011112234677899999987644 68899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc--cchhhhhh--------ccccCC---chhHHHHHHHHHHHH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQIL--------NFQVAD---ESEMEEIETVAGLAS 217 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--------~~~~~~---~~~~~~~~~~~~li~ 217 (259)
|+|+++|+|++|..||.+..... ........... ...+.... ...... ......+..+.+++.
T Consensus 219 slG~~l~el~tg~~p~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 294 (335)
T PTZ00024 219 SVGCIFAELLTGKPLFPGENEID----QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQ 294 (335)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHH
Confidence 99999999999999998643211 11111000000 00000000 000000 000112467889999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 025011 218 KCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 218 ~~l~~~p~~Rpt~~~il~ 235 (259)
+||+.+|.+|||+.+++.
T Consensus 295 ~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 295 SLLKLNPLERISAKEALK 312 (335)
T ss_pred HHcCCCchhccCHHHHhc
Confidence 999999999999999975
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=215.93 Aligned_cols=221 Identities=26% Similarity=0.347 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
|.++.+|++++.+. .|+||++++++|+++...|+|||.+.||+|...+++... +++.++..+..+|+.||.+||.+
T Consensus 119 R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~---F~E~EAs~vvkdia~aLdFlH~k 195 (463)
T KOG0607|consen 119 RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH---FNEREASRVVKDIASALDFLHTK 195 (463)
T ss_pred HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh---ccHHHHHHHHHHHHHHHHHHhhc
Confidence 56788999999999 599999999999999999999999999999999987644 78899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCcc-----ccccccccCcccccCcchhc---c--CCccccc
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQ-----TAMTTKKIGTFVNLDPEYVI---T--GKLTEKS 147 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~---~--~~~~~~~ 147 (259)
| |.|||+||+||+....+. +||+||.+..-...... .......+|+..|||||+.. + ..|+.+.
T Consensus 196 g---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrC 272 (463)
T KOG0607|consen 196 G---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRC 272 (463)
T ss_pred C---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccc
Confidence 9 999999999999987655 79999988654332211 11223457888999999853 2 2478899
Q ss_pred chhhHHHHHHHHHhCCCCCCCCcc-----ccccchhHHHHHHHhhccchhhhhhccc--cCCchhHHHHHHHHHHHHHhc
Q 025011 148 DVYSFGVLLAELLTGLKPGSGMAL-----ASNEGISMVQYFLYSIENNSLRQILNFQ--VADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 148 DiwslG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l 220 (259)
|.||||+|+|-|++|.+||.+.=. ...+.-..++... ...+.+.. .+......++....+++..+|
T Consensus 273 DlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L-------FesIQEGkYeFPdkdWahIS~eakdlisnLl 345 (463)
T KOG0607|consen 273 DLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL-------FESIQEGKYEFPDKDWAHISSEAKDLISNLL 345 (463)
T ss_pred cHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH-------HHHHhccCCcCChhhhHHhhHHHHHHHHHHH
Confidence 999999999999999999987311 1111111111110 11111111 122233456788999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 025011 221 SLSGRRRPTMKQVSE 235 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~ 235 (259)
..|+.+|.++.+++.
T Consensus 346 vrda~~rlsa~~vln 360 (463)
T KOG0607|consen 346 VRDAKQRLSAAQVLN 360 (463)
T ss_pred hccHHhhhhhhhccC
Confidence 999999999999876
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=216.67 Aligned_cols=210 Identities=23% Similarity=0.324 Sum_probs=161.2
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+++.+.++++..- .+|+||+.+|+|-.+..+++.||.+ ...+..++...... .++..+-++...+++||.||-++.
T Consensus 135 kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~p--iPE~ilGk~tva~v~AL~YLKeKH 211 (391)
T KOG0983|consen 135 KRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGP--IPERILGKMTVAIVKALYYLKEKH 211 (391)
T ss_pred HHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCC--chHHhhhhhHHHHHHHHHHHHHhc
Confidence 3566677776665 4899999999999999999999998 44677777654332 466777789999999999998765
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~ 158 (259)
+ |+|||+||+||++|+.|++|++|||.+-....+ ...+...|.+.|||||.+... .|+.++||||||+++++
T Consensus 212 ~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlve 286 (391)
T KOG0983|consen 212 G--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVE 286 (391)
T ss_pred c--eeecccCccceEEccCCCEEeecccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhh
Confidence 4 999999999999999999999999998655433 233445699999999998643 48889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|.||+.||.+...+..-. ..... ... ..+. .....++.+.+++..||.+|+.+||...++++
T Consensus 287 LaTg~yPy~~c~tdFe~l-------tkvln-~eP-P~L~------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 287 LATGQYPYKGCKTDFEVL-------TKVLN-EEP-PLLP------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred hhcccCCCCCCCccHHHH-------HHHHh-cCC-CCCC------cccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 999999999855443211 11111 000 1111 11124578999999999999999999999875
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=224.26 Aligned_cols=211 Identities=23% Similarity=0.285 Sum_probs=162.2
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.+ +|+||+++++.+..++..++++||+++++|.+++..... +++..+..++.|++.||.+||+.+
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~ 125 (290)
T cd05613 49 EHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLALEHLHKLG 125 (290)
T ss_pred HHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578899999999 589999999999999999999999999999999976532 567888899999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC--CcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+... .++.++|+||+|+++|+|
T Consensus 126 ---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~l 201 (290)
T cd05613 126 ---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYEL 201 (290)
T ss_pred ---eeccCCCHHHeEECCCCCEEEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 1122234578899999998653 367899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVS 234 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il 234 (259)
++|..||....... ............. . ..+...++.+.+++.+||+.||.+|| ++.+++
T Consensus 202 l~g~~p~~~~~~~~----~~~~~~~~~~~~~---------~--~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~ 266 (290)
T cd05613 202 LTGASPFTVDGEKN----SQAEISRRILKSE---------P--PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK 266 (290)
T ss_pred hcCCCCCCcCCccc----cHHHHHHHhhccC---------C--CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence 99999986421110 0011111100000 0 01112346789999999999999997 667775
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 267 ~ 267 (290)
T cd05613 267 K 267 (290)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=226.19 Aligned_cols=209 Identities=22% Similarity=0.299 Sum_probs=157.1
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
.+..|+.++... .||||+++++++..+...+++|||+ ++++.+++..... .+++..+..++.|++.|+.|||+ .+
T Consensus 59 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~ 135 (296)
T cd06618 59 RILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG 135 (296)
T ss_pred HHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC
Confidence 355677666666 5999999999999999999999998 4578777765433 36788899999999999999997 58
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC----cccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||++........ .....++..|+|||.+.+.. ++.++|+||+|+++|
T Consensus 136 ---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 209 (296)
T cd06618 136 ---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209 (296)
T ss_pred ---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHH
Confidence 99999999999999999999999999865543211 12234778899999987553 788999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
+|++|..||....... +......... ... .......++.+.+++.+||+.||.+|||+.+++..
T Consensus 210 el~~g~~p~~~~~~~~-------~~~~~~~~~~-~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 210 ELATGQFPYKNCKTEF-------EVLTKILQEE-PPS-------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHhCCCCCCcchhHH-------HHHHHHhcCC-CCC-------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 9999999987521110 0011111000 000 00001234679999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=225.43 Aligned_cols=221 Identities=20% Similarity=0.281 Sum_probs=160.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC----------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK----------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETAS 72 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~ 72 (259)
..+.+|+++++.++|||++++++++.... ..++++||+++ ++.+.+..... .+++..+..++.|++.
T Consensus 51 ~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~ 127 (302)
T cd07864 51 ITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLV--HFSEDHIKSFMKQLLE 127 (302)
T ss_pred HHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCC--CCCHHHHHHHHHHHHH
Confidence 45778999999999999999999887654 78999999976 77777765422 3678999999999999
Q ss_pred HHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-Ccccccchhh
Q 025011 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYS 151 (259)
Q Consensus 73 ~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws 151 (259)
||.|||+.+ ++|+||+|.||+++.++.++|+|||++........ .......++..|+|||.+.+. .++.++||||
T Consensus 128 aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~s 203 (302)
T cd07864 128 GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWS 203 (302)
T ss_pred HHHHHHhCC---eecCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHH
Confidence 999999999 99999999999999999999999999876543321 111223456789999988654 4688999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc---chhhhhhccc---------c----CCchhHHHHHHHHHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN---NSLRQILNFQ---------V----ADESEMEEIETVAGL 215 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~---------~----~~~~~~~~~~~~~~l 215 (259)
+|+++++|++|+.||..... ............. ..+..+.... . ........+..+.++
T Consensus 204 lG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 278 (302)
T cd07864 204 CGCILGELFTKKPIFQANQE-----LAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDL 278 (302)
T ss_pred HHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHH
Confidence 99999999999999875221 1111111111000 0000000000 0 000000124679999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 025011 216 ASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 216 i~~~l~~~p~~Rpt~~~il~ 235 (259)
+..||+.||.+|||+.++++
T Consensus 279 i~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 279 LDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHHccCChhhCCCHHHHhc
Confidence 99999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=244.16 Aligned_cols=219 Identities=27% Similarity=0.405 Sum_probs=177.2
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-------Cc------ccCCHHHHHHHH
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------SQ------VLRNWKTCLRIA 67 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~------~~~~~~~~~~i~ 67 (259)
++++..|+++++.+ +|+||+.+.+++..++..++++||+..|+|.+++.... .. ..+.....+.++
T Consensus 345 ~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa 424 (609)
T KOG0200|consen 345 KKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFA 424 (609)
T ss_pred HHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHH
Confidence 46799999999999 69999999999999999999999999999999997765 00 125678899999
Q ss_pred HHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccccc-ccccCcccccCcchhccCCcccc
Q 025011 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT-TKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 68 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
.||+.|+.||++.. ++|||+.+.||+++++..+|++|||+++........... ....-...|+|||.+....++.+
T Consensus 425 ~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 425 YQIANGMEYLASVP---CVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred HHHHHHHHHHhhCC---ccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCccccc
Confidence 99999999999999 999999999999999999999999999865544333222 11113446999999999889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 147 SDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 147 ~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+||||+|+++||+++ |..||.+.... ..+-+.+..+..-..+..+++++.++++.||+.+|+
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~-----------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPT-----------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcH-----------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcc
Confidence 999999999999999 88999872210 111112222222233334457899999999999999
Q ss_pred CCCCHHHHHHHHHhc
Q 025011 226 RRPTMKQVSEELDRL 240 (259)
Q Consensus 226 ~Rpt~~~il~~l~~~ 240 (259)
+||++.++.+.+...
T Consensus 565 ~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 565 DRPTFSECVEFFEKH 579 (609)
T ss_pred cCCCHHHHHHHHHHH
Confidence 999999999999995
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=224.00 Aligned_cols=222 Identities=20% Similarity=0.239 Sum_probs=162.8
Q ss_pred HHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
..+|+..++.++ |||++++++++..++..+++|||+ +++|.+++..... ..+++..+..++.|++.++.|||+++
T Consensus 44 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~-- 119 (283)
T cd07830 44 NLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG-- 119 (283)
T ss_pred HHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 456899999998 999999999999999999999999 7899988876542 23578999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHhC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|
T Consensus 120 -i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 120 -FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred -cccCCCChhhEEEcCCCCEEEeecccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 9999999999999999999999999987654321 1223457888999998754 3478999999999999999999
Q ss_pred CCCCCCCccccccchhHHH---------HHHHhhccchhhhhhccccCC---chhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQ---------YFLYSIENNSLRQILNFQVAD---ESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
..||.......... .... +.................... ......+..+.++|.+||+.+|.+|||+
T Consensus 196 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~ 274 (283)
T cd07830 196 RPLFPGSSEIDQLY-KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTA 274 (283)
T ss_pred CCccCCCChHHHHH-HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCH
Confidence 99997643211100 0000 000000000000000000000 0000113679999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.+++.
T Consensus 275 ~ei~~ 279 (283)
T cd07830 275 SQALQ 279 (283)
T ss_pred HHHhh
Confidence 99864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=211.86 Aligned_cols=223 Identities=20% Similarity=0.324 Sum_probs=163.2
Q ss_pred HHHHHHHHhcCCCccccccceeEEe--------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 5 FQHELRVVSQINHKNVVKILGACLE--------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
-.+|+++|+.|+|+|++.+++.|.. ...+|+||++|+. +|.-++..... .++..++.+++.+++.||.|
T Consensus 63 alreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~ 139 (376)
T KOG0669|consen 63 ALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYY 139 (376)
T ss_pred HHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHH
Confidence 3579999999999999999998863 2357999999966 89888866533 25779999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccCC-cccccchhhHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFG 153 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG 153 (259)
+|.+. |+|||+||.|++++++|.++|+|||+++.+....... ..+.++-|.+|++||.+.+.. +.++.|||..|
T Consensus 140 iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 140 IHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred HHHhh---HHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 99999 9999999999999999999999999998765432221 234556799999999998765 89999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccc---------cCCchhH---H------HHHHHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQ---------VADESEM---E------EIETVAGL 215 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~---~------~~~~~~~l 215 (259)
|++.+|+++.+.+++...- ......+..........+..+.+-. +...... + -.+...+|
T Consensus 217 CimaeMwtrspimqgnteq--qql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dL 294 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQ--QQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDL 294 (376)
T ss_pred HHHHHHHccCccccCChHH--HHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHH
Confidence 9999999999998873211 1111111111111111111110000 0000000 0 01467899
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 025011 216 ASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 216 i~~~l~~~p~~Rpt~~~il~ 235 (259)
+.++|..||.+|++++++++
T Consensus 295 le~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 295 LEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred HHHHhccCcccCcchHhhhc
Confidence 99999999999999998864
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=224.38 Aligned_cols=222 Identities=20% Similarity=0.220 Sum_probs=157.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCC--------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETK--------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|+++++.++||||+++++++.... ..+++++|+.+ ++...+..... .+++..+..++.|++.||.
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~--~~~~~~~~~i~~~l~~al~ 129 (311)
T cd07866 53 TALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSV--KLTESQIKCYMLQLLEGIN 129 (311)
T ss_pred hHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhcccc--CCCHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999875433 46999999954 77777654322 3688999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc---------cccccCcccccCcchhccC-Cccc
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM---------TTKKIGTFVNLDPEYVITG-KLTE 145 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~-~~~~ 145 (259)
|||+.+ ++|+||+|+||+++.++.++++|||++........... .....++..|+|||.+.+. .++.
T Consensus 130 ~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 130 YLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred HHHhCC---eecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCc
Confidence 999999 99999999999999999999999999876543221111 1122457789999987654 4788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchh------hh----hhccccCCch---hHHHHH
Q 025011 146 KSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSL------RQ----ILNFQVADES---EMEEIE 210 (259)
Q Consensus 146 ~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~------~~----~~~~~~~~~~---~~~~~~ 210 (259)
++||||+|+++|+|++|..||.+....... ........ ..... .. .......... .....+
T Consensus 207 ~~Dv~slG~il~el~~g~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRPILQGKSDIDQL----HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGP 282 (311)
T ss_pred hhHhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCCh
Confidence 999999999999999999999763321100 00000000 00000 00 0000000000 001225
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.+.+++.+||+.||.+|||+.+++.
T Consensus 283 ~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 283 EGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hHHHHHHHHcccCcccCcCHHHHhc
Confidence 6889999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=225.17 Aligned_cols=220 Identities=19% Similarity=0.289 Sum_probs=159.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++.+++.. ++..++++||+ +++|.+++.... ++...+..++.|++.|+.|||+.+
T Consensus 54 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----~~~~~~~~~~~ql~~aL~~LH~~~ 128 (328)
T cd07856 54 KRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSRP----LEKQFIQYFLYQILRGLKYVHSAG 128 (328)
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567889999999999999999999865 55789999999 668988886432 466778889999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|.||+++.++.++++|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 129 ---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 129 ---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred ---cccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999998754321 122346778999998765 45889999999999999999
Q ss_pred hCCCCCCCCccccccchhH--------HHHHHHhhccchhhhhhccccCCchh-----HHHHHHHHHHHHHhcccCCCCC
Q 025011 161 TGLKPGSGMALASNEGISM--------VQYFLYSIENNSLRQILNFQVADESE-----MEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R 227 (259)
+|..||.+...... .... .++...........-+.........+ ...++.+.++|.+||+.+|.+|
T Consensus 201 tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 279 (328)
T cd07856 201 EGKPLFPGKDHVNQ-FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKR 279 (328)
T ss_pred hCCCCCCCCCHHHH-HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhC
Confidence 99999976332100 0000 00000000000000000000000000 1124679999999999999999
Q ss_pred CCHHHHHHH
Q 025011 228 PTMKQVSEE 236 (259)
Q Consensus 228 pt~~~il~~ 236 (259)
||+.+++..
T Consensus 280 ~t~~ell~~ 288 (328)
T cd07856 280 ISAAEALAH 288 (328)
T ss_pred CCHHHHhcC
Confidence 999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=215.80 Aligned_cols=208 Identities=27% Similarity=0.380 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++.+++++|+|++++++++..+...++++|++.+++|.+++..... .+...++.++.+++.++.+||+.+
T Consensus 32 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~l~~~l~~lh~~~- 107 (244)
T smart00220 32 ERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEARFYARQILSALEYLHSNG- 107 (244)
T ss_pred HHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 5789999999999999999999999999999999999999999999976543 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|.||+++.++.++++|||.+....... ......++..|++||.+.+..++.++|+|++|++++++++|
T Consensus 108 --i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~ 182 (244)
T smart00220 108 --IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTG 182 (244)
T ss_pred --eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999988765432 22344578889999999888889999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEME-EIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ....+... ........... .+..+.+++.+||..+|++||++.++++
T Consensus 183 ~~p~~~~~~~----~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 183 KPPFPGDDQL----LELFKKIG------------KPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CCCCCCCCcH----HHHHHHHh------------ccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 9998652110 00000000 00000000000 3367999999999999999999999975
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=225.88 Aligned_cols=225 Identities=20% Similarity=0.216 Sum_probs=159.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.+++.+ +||||+++++.+... ...+++++++. ++|.+++.... .+++..+..++.|++.||.||
T Consensus 46 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~L 121 (332)
T cd07857 46 KRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYI 121 (332)
T ss_pred HHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHH
Confidence 4578899999999 599999999875432 45789999985 68988886543 267899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhcc-CCcccccchhhHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGV 154 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~ 154 (259)
|+++ ++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+ ..++.++|+||+|+
T Consensus 122 H~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv 198 (332)
T cd07857 122 HSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGC 198 (332)
T ss_pred HhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHH
Confidence 9999 999999999999999999999999998765432211 11223468889999998765 45889999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchh-------HHHHHHHhhccchhhhh---hccccCC---chhHHHHHHHHHHHHHhcc
Q 025011 155 LLAELLTGLKPGSGMALASNEGIS-------MVQYFLYSIENNSLRQI---LNFQVAD---ESEMEEIETVAGLASKCLS 221 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~---~~~~~~~---~~~~~~~~~~~~li~~~l~ 221 (259)
++|++++|..||.+.+........ ........ ........ ....... ......+..+.+++.+||+
T Consensus 199 ~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 277 (332)
T cd07857 199 ILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI-GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLA 277 (332)
T ss_pred HHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh-hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHcc
Confidence 999999999999764321000000 00000000 00000000 0000000 0000123678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025011 222 LSGRRRPTMKQVSE 235 (259)
Q Consensus 222 ~~p~~Rpt~~~il~ 235 (259)
.||.+|||+.+++.
T Consensus 278 ~~P~~R~t~~~ll~ 291 (332)
T cd07857 278 FDPTKRISVEEALE 291 (332)
T ss_pred CCcccCCCHHHHhc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=226.42 Aligned_cols=216 Identities=22% Similarity=0.297 Sum_probs=160.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc------ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV------PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++|||++++.+++..++. .++++||+ +++|.+++... .+++..++.++.|++.|+.+
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence 346789999999999999999998876554 89999999 67999988753 26789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+. .++.++|+||+|++
T Consensus 134 LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~ 205 (343)
T cd07851 134 IHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 205 (343)
T ss_pred HHHCC---eecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHH
Confidence 99999 999999999999999999999999998765432 1223577889999998653 57889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHH----------hhccchhhhhhc---cccCCc---hhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLY----------SIENNSLRQILN---FQVADE---SEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~~ 219 (259)
+|++++|..||.+..... ........ ............ ...... .....++.+.++|.+|
T Consensus 206 l~elltg~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~ 281 (343)
T cd07851 206 MAELLTGKTLFPGSDHID----QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKM 281 (343)
T ss_pred HHHHHhCCCCCCCCChHH----HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHh
Confidence 999999999997632210 00000000 000000000000 000000 0011246799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.+|+.
T Consensus 282 l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 282 LVLDPDKRITAAEALA 297 (343)
T ss_pred CCCChhhCCCHHHHhc
Confidence 9999999999999965
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=223.57 Aligned_cols=219 Identities=22% Similarity=0.298 Sum_probs=158.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.++++++||||+++++++... +..+++++++ +++|.+++.... +++..+..++.|++.|+.|
T Consensus 61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~~----l~~~~~~~i~~qi~~aL~~ 135 (345)
T cd07877 61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK----LTDDHVQFLIYQILRGLKY 135 (345)
T ss_pred HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcCC----CCHHHHHHHHHHHHHHHHH
Confidence 4577899999999999999999988643 3468888887 789988886532 5778999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 136 LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred HHHCC---eeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 99999 999999999999999999999999998754321 123357888999998866 457889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHH-------HHHHhhccchhhhhh---ccccC---CchhHHHHHHHHHHHHHhccc
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQ-------YFLYSIENNSLRQIL---NFQVA---DESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~~li~~~l~~ 222 (259)
+|+|++|..||.+....... ..... ............... ..... .......++.+.++|.+||+.
T Consensus 208 l~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 286 (345)
T cd07877 208 MAELLTGRTLFPGTDHIDQL-KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 286 (345)
T ss_pred HHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCC
Confidence 99999999999763221100 00000 000000000000000 00000 000001246789999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||+.+++.
T Consensus 287 dp~~R~t~~e~l~ 299 (345)
T cd07877 287 DSDKRITAAQALA 299 (345)
T ss_pred ChhhcCCHHHHhc
Confidence 9999999999875
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=227.21 Aligned_cols=220 Identities=17% Similarity=0.234 Sum_probs=156.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--------------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--------------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.++||||+++++++... ...+++|||++ ++|.+++... .+++..+..++.
T Consensus 47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~ 121 (342)
T cd07854 47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMY 121 (342)
T ss_pred HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHH
Confidence 4578899999999999999999876653 35789999996 5888887643 257789999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhcc-CCccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVIT-GKLTE 145 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~ 145 (259)
|++.|+.|||+.+ ++|+||+|+||+++ .++.++++|||.+.......... ......++..|+|||.+.+ ..++.
T Consensus 122 qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 198 (342)
T cd07854 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTK 198 (342)
T ss_pred HHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCc
Confidence 9999999999999 99999999999997 45578999999987653321111 1122357888999998754 45788
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc----------cchhhhhhccccCCch-----hHHHHH
Q 025011 146 KSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE----------NNSLRQILNFQVADES-----EMEEIE 210 (259)
Q Consensus 146 ~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~-----~~~~~~ 210 (259)
++|||||||++|+|++|+.||.+..... ........... ................ ....+.
T Consensus 199 ~~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (342)
T cd07854 199 AIDMWAAGCIFAEMLTGKPLFAGAHELE----QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNP 274 (342)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCH
Confidence 9999999999999999999997632211 00000000000 0000000000000000 012336
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHH
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
.+.+++.+||+.||.+|||+.+++
T Consensus 275 ~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 275 EALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HHHHHHHHHhCCCchhccCHHHHh
Confidence 688999999999999999999997
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=222.70 Aligned_cols=221 Identities=20% Similarity=0.272 Sum_probs=162.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++..+. ..+++|+|+ +++|.+++... .+++..+..++.|++.|+.|
T Consensus 59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~ 133 (343)
T cd07880 59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKY 133 (343)
T ss_pred HHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence 45789999999999999999999987654 348999999 77998888643 25788999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+.+ ++|+||+|+||+++.++.++++|||++...... .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 134 LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~l 205 (343)
T cd07880 134 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCI 205 (343)
T ss_pred HHhCC---eecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 99999 999999999999999999999999998754332 122356788999999876 347889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHH----------hhccchhhhhhcc---ccCC---chhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLY----------SIENNSLRQILNF---QVAD---ESEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~li~~~ 219 (259)
+|++++|..||.+..... ........ ............. .... ......++.+.++|.+|
T Consensus 206 l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 281 (343)
T cd07880 206 MAEMLTGKPLFKGHDHLD----QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKM 281 (343)
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHH
Confidence 999999999997632210 00000000 0000000000000 0000 00012345688999999
Q ss_pred cccCCCCCCCHHHHH--HHHHhc
Q 025011 220 LSLSGRRRPTMKQVS--EELDRL 240 (259)
Q Consensus 220 l~~~p~~Rpt~~~il--~~l~~~ 240 (259)
|+.||.+|||+.+++ ..++..
T Consensus 282 l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 282 LVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cCCChhhCCCHHHHhcCccHhhh
Confidence 999999999999998 444444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=223.66 Aligned_cols=222 Identities=21% Similarity=0.287 Sum_probs=160.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++.... ..++++||+. .+|..+... .+++..+..++.|++.|+.|
T Consensus 59 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~ 132 (342)
T cd07879 59 KRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMGH-----PLSEDKVQYLVYQMLCGLKY 132 (342)
T ss_pred hHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHcC-----CCCHHHHHHHHHHHHHHHHH
Confidence 45788999999999999999999987543 4589999995 477666521 25778899999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+.+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 133 LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvi 204 (342)
T cd07879 133 IHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCI 204 (342)
T ss_pred HHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHH
Confidence 99999 999999999999999999999999998754321 122356788999999866 457889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHH----------Hhhccchhhhhhcc---ccCCch---hHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFL----------YSIENNSLRQILNF---QVADES---EMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~~li~~~ 219 (259)
+|+|++|+.||.+..... ....... .............. ...... ....++.+.++|.+|
T Consensus 205 l~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 280 (342)
T cd07879 205 MAEMLTGKTLFKGKDYLD----QLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKM 280 (342)
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHH
Confidence 999999999998643211 0000000 00000000000000 000000 011235688999999
Q ss_pred cccCCCCCCCHHHHHH--HHHhccc
Q 025011 220 LSLSGRRRPTMKQVSE--ELDRLKI 242 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~--~l~~~~~ 242 (259)
|+.||.+|||+.+++. .++.+..
T Consensus 281 l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 281 LELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cCCChhhCcCHHHHhcCcchhhccc
Confidence 9999999999999984 4666654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=227.48 Aligned_cols=200 Identities=24% Similarity=0.260 Sum_probs=168.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
-+..|-.+|...+.|.||++|-.|.+++.+|++||-|-||.+++.+.+.+. ++..++.-++..++.|+.|||.++
T Consensus 466 Hv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF~~acv~EAfeYLH~k~-- 540 (732)
T KOG0614|consen 466 HVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARFYVACVLEAFEYLHRKG-- 540 (732)
T ss_pred HHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhhhHHHHHHHHHHHHhcC--
Confidence 367789999999999999999999999999999999999999999988765 677888899999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|++||+||+|.+++.+|-+||.|||+++.++.+ ..+..+.||+.|.|||++.....+.++|.|+||+++|||++|.
T Consensus 541 -iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 541 -IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS 616 (732)
T ss_pred -ceeccCChhheeeccCCceEEeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence 999999999999999999999999999988764 3557788999999999999999999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
+||.+.+....++.......... .+..+.....+||+++...+|.+|.-
T Consensus 617 pPFs~~dpmktYn~ILkGid~i~-----------------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 617 PPFSGVDPMKTYNLILKGIDKIE-----------------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred CCCCCCchHHHHHHHHhhhhhhh-----------------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 99998554332221111111111 11122355788999999999999975
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=209.14 Aligned_cols=206 Identities=23% Similarity=0.240 Sum_probs=165.2
Q ss_pred HHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
.|-++|+..+||.+..+.-.|...+++|+||||..||.|+-++.+... +++....-+...|+.||.|||+++ |+
T Consensus 217 TE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~---FsE~RtRFYGaEIvsAL~YLHs~~---iv 290 (516)
T KOG0690|consen 217 TENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV---FSEDRTRFYGAEIVSALGYLHSRN---IV 290 (516)
T ss_pred hHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc---ccchhhhhhhHHHHHHhhhhhhCC---ee
Confidence 477888899999999999999999999999999999999999977543 677888899999999999999999 99
Q ss_pred eCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCC
Q 025011 87 HGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166 (259)
Q Consensus 87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~ 166 (259)
+||+|.+|.++|++|.+|+.|||+.+.-...+ .....+.||+.|+|||++....|..++|.|.+|+++|+|.+|+.||
T Consensus 291 YRDlKLENLlLDkDGHIKitDFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPF 368 (516)
T KOG0690|consen 291 YRDLKLENLLLDKDGHIKITDFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPF 368 (516)
T ss_pred eeechhhhheeccCCceEeeecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcc
Confidence 99999999999999999999999987654432 2345678999999999999888999999999999999999999999
Q ss_pred CCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC--CHHHHHHHHHh
Q 025011 167 SGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP--TMKQVSEELDR 239 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp--t~~~il~~l~~ 239 (259)
.+.++.. .+.-.... .+. .+...+++...|+..+|..||++|. -.+++.+..+.
T Consensus 369 yn~dh~k--------LFeLIl~e---------d~k--FPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 369 YNKDHEK--------LFELILME---------DLK--FPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred cccchhH--------HHHHHHhh---------hcc--CCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence 8743321 01100000 000 1112236788899999999999995 34444444443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=192.25 Aligned_cols=220 Identities=20% Similarity=0.256 Sum_probs=167.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.-.+|+-+|+.++|.|||+++++...++...+|+|||. .+|..+...-+.. .+...+..++.|++.|+.++|+++
T Consensus 47 salreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~--~d~~~~rsfmlqllrgl~fchshn-- 121 (292)
T KOG0662|consen 47 SALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGD--LDPEIVRSFMLQLLRGLGFCHSHN-- 121 (292)
T ss_pred HHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCc--CCHHHHHHHHHHHHhhhhhhhhhh--
Confidence 35689999999999999999999999999999999994 4888887665443 577888999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh-
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~- 161 (259)
+.|+|+||+|.+++.+|.+++.|||+++-++-. ....+..+-|.+|++|.++.+.. |+...|+||.||++.++..
T Consensus 122 -vlhrdlkpqnllin~ngelkladfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 122 -VLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred -hhhccCCcceEEeccCCcEEecccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 999999999999999999999999999877642 23344557889999999999876 8999999999999999997
Q ss_pred CCCCCCCCccccccchhHHHHHHHh--hccchhhhhh---ccccCC-----chhH----HHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYS--IENNSLRQIL---NFQVAD-----ESEM----EEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~R 227 (259)
|++.|++.+... .....++.. ..+..+..+. +-.... .... .....-.+++.++|.-+|.+|
T Consensus 199 grplfpg~dvdd----qlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qr 274 (292)
T KOG0662|consen 199 GRPLFPGNDVDD----QLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQR 274 (292)
T ss_pred CCCCCCCCcHHH----HHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccc
Confidence 788888844322 111111111 1111111111 110000 0111 122445789999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
+++++.++
T Consensus 275 isaeaalq 282 (292)
T KOG0662|consen 275 ISAEAALQ 282 (292)
T ss_pred cCHHHHhc
Confidence 99998854
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=209.87 Aligned_cols=231 Identities=23% Similarity=0.340 Sum_probs=174.0
Q ss_pred hhHHHHHHHHHhcC--CCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQI--NHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
++.+.+|.++.+.. +|+||+.+++.-..++ .+|||++|.+.|||+|+|.... ++....++++..++.||+
T Consensus 247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v~~~~ml~LalS~AsGLa 322 (513)
T KOG2052|consen 247 ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----VTTEGMLKLALSIASGLA 322 (513)
T ss_pred hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----CCHHHHHHHHHHHhhhHH
Confidence 35689999999886 8999999999765544 4799999999999999998753 577899999999999999
Q ss_pred HHhh-----CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhccCC----c-
Q 025011 76 YLHS-----SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGK----L- 143 (259)
Q Consensus 76 ~lh~-----~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~----~- 143 (259)
+||. +|+|+|.|||||..||++.+++.+.|+|+|++......... ...+..+||..|||||++...- +
T Consensus 323 HLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fe 402 (513)
T KOG2052|consen 323 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFE 402 (513)
T ss_pred HHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhh
Confidence 9996 46788999999999999999999999999999877654322 2345678999999999986432 1
Q ss_pred c-cccchhhHHHHHHHHHh----------CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHH
Q 025011 144 T-EKSDVYSFGVLLAELLT----------GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETV 212 (259)
Q Consensus 144 ~-~~~DiwslG~il~~l~~----------g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 212 (259)
+ ..+||||||.++||++- -++||.+..........+.+.. -.....+.++...... +....+
T Consensus 403 syk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVV----Cv~~~RP~ipnrW~s~---~~l~~m 475 (513)
T KOG2052|consen 403 SYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVV----CVQKLRPNIPNRWKSD---PALRVM 475 (513)
T ss_pred hhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcce----eecccCCCCCcccccC---HHHHHH
Confidence 1 35999999999999874 2356665433222222222211 1122222222222222 233568
Q ss_pred HHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 025011 213 AGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 213 ~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~ 243 (259)
.++++.||..||..|.||-.+.+.|.++..+
T Consensus 476 ~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 476 AKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 8999999999999999999999999988764
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=210.42 Aligned_cols=237 Identities=24% Similarity=0.373 Sum_probs=175.5
Q ss_pred hhHHHHHHHHHhcC--CCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQI--NHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l--~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
++.|++|-++.+.. +|+||+++++.-.... ..+||++|.+.|+|.++|.... .+|....+++..+++||+
T Consensus 246 kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa 321 (534)
T KOG3653|consen 246 KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLA 321 (534)
T ss_pred HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHH
Confidence 46788888888775 8999999999876544 6899999999999999998775 488999999999999999
Q ss_pred HHhhCC------CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cc----
Q 025011 76 YLHSSA------SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LT---- 144 (259)
Q Consensus 76 ~lh~~~------~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~---- 144 (259)
|||+.- +++|+|||||..||++..++.+.|+|||++..+............+||..|||||++.+.- +.
T Consensus 322 ~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~A 401 (534)
T KOG3653|consen 322 HLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDA 401 (534)
T ss_pred HhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHH
Confidence 999743 5779999999999999999999999999998887654444455578999999999997643 22
Q ss_pred -cccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhh---------hccccCCchhHHHHHHHHH
Q 025011 145 -EKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQI---------LNFQVADESEMEEIETVAG 214 (259)
Q Consensus 145 -~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~ 214 (259)
.+.||||+|.++||+++...-+.. .....++..........+.-...... +....... .....+.+
T Consensus 402 fkr~DvYamgLVLWEi~SRC~~~~~-~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h---~~~~~l~e 477 (534)
T KOG3653|consen 402 FKRIDVYAMGLVLWEIASRCTDADP-GPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH---AGMAVLCE 477 (534)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccC-CCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC---ccHHHHHH
Confidence 368999999999999986544421 11112222222111111111111111 11111111 12356889
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHhccccccc
Q 025011 215 LASKCLSLSGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 215 li~~~l~~~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
.+..||+.||..|.|+.=+.+.+.++...-+.
T Consensus 478 t~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 478 TIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred HHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 99999999999999999999998888766643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=230.32 Aligned_cols=104 Identities=27% Similarity=0.358 Sum_probs=96.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+..|+.++..++||||+++++++...+..|+||||+.+++|.+++..... +++..++.++.||+.||.|||.++
T Consensus 49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~---l~~~~~~~i~~qil~aL~yLH~~g- 124 (669)
T cd05610 49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY---FDEEMAVKYISEVALALDYLHRHG- 124 (669)
T ss_pred HHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5688999999999999999999999999999999999999999999976543 577889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
|+|+||||+||+++.++.++|+|||+++
T Consensus 125 --IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred --EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=231.89 Aligned_cols=207 Identities=26% Similarity=0.337 Sum_probs=168.0
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
|..|-.+|..-+.+-|+.++-.|.+.+++|+||||++||+|..++.+.. .+++..+.-++..++.||..+|+.|
T Consensus 122 F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg--- 195 (1317)
T KOG0612|consen 122 FREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG--- 195 (1317)
T ss_pred HHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---
Confidence 7888999988899999999999999999999999999999999998887 2678999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----CCcccccchhhHHHHHHHH
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l 159 (259)
+|||||||+||++|..|+++|+|||..-....++ .......+|||.|.+||++.. +.|....|.||+|+++|+|
T Consensus 196 yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEM 274 (1317)
T KOG0612|consen 196 YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEM 274 (1317)
T ss_pred ceeccCCcceeEecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHH
Confidence 9999999999999999999999999987766543 334566789999999999852 4588899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC---HHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT---MKQVS 234 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il 234 (259)
+.|..||..-+... .-...... ...+..+....+++...+||.+.+ -+|..|.. +.++.
T Consensus 275 lyG~TPFYadslve--------TY~KIm~h-------k~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 275 LYGETPFYADSLVE--------TYGKIMNH-------KESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIK 336 (1317)
T ss_pred HcCCCcchHHHHHH--------HHHHHhch-------hhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHH
Confidence 99999998722211 11111111 112222233446788999999988 57777776 66654
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=227.69 Aligned_cols=219 Identities=25% Similarity=0.403 Sum_probs=180.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++..|+..+.++.|||++++++++..+. +.||++|+++|+|.++++..... ......+.|..||++|+.|||++.
T Consensus 743 ~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~--igsq~lLnw~~QIAkgM~YLe~qr- 818 (1177)
T KOG1025|consen 743 IELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDN--IGSQDLLNWCYQIAKGMKYLEEQR- 818 (1177)
T ss_pred HHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhcc--ccHHHHHHHHHHHHHHHHHHHhcc-
Confidence 57899999999999999999999998765 78999999999999999876443 345788999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++||||.+.||++.+.+.+++.|||+++....+.........--...|+|-|.+....++.++||||+|+++||++|
T Consensus 819 --lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTF 896 (1177)
T KOG1025|consen 819 --LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTF 896 (1177)
T ss_pred --hhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhc
Confidence 99999999999999999999999999988776544433333334567899999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..|+.+... ..+.+.+...-.-.-+..++-.+.-++.+||..|++.||+++++...+.++.
T Consensus 897 Ga~Py~gi~~------------------~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 897 GAKPYDGIPA------------------EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred CCCccCCCCH------------------HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 9999998432 2333333333223333345567888999999999999999999999998876
Q ss_pred cccc
Q 025011 242 ISHE 245 (259)
Q Consensus 242 ~~~~ 245 (259)
..-.
T Consensus 959 rdpq 962 (1177)
T KOG1025|consen 959 RDPQ 962 (1177)
T ss_pred cCcc
Confidence 5543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=209.62 Aligned_cols=212 Identities=25% Similarity=0.377 Sum_probs=163.8
Q ss_pred HHHHHHHhcCCCccccccceeEEeC-CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVVSQINHKNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
-+|.++-+.|.||-||++|++|.-+ ..+|-|+|||+|.+|.-+++.... .++.++..|+.||+.||.||.... ++
T Consensus 515 cREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl---mSEKEARSIiMQiVnAL~YLNEik-pP 590 (775)
T KOG1151|consen 515 CREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL---MSEKEARSIIMQIVNALKYLNEIK-PP 590 (775)
T ss_pred HHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh---hhHHHHHHHHHHHHHHHHHHhccC-CC
Confidence 4688999999999999999999854 578999999999999989877654 578999999999999999999876 78
Q ss_pred eEeCCCCCCCeEeCC---CCceEEeecCCcccccCCcccc-----ccccccCcccccCcchhccC----CcccccchhhH
Q 025011 85 IIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVITG----KLTEKSDVYSF 152 (259)
Q Consensus 85 i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~----~~~~~~Diwsl 152 (259)
|+|-||||.||++.. .|.+++.|||+++.+..+.... .+....||.+|++||.+.-. ..+.++||||+
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 999999999999954 4679999999999887643332 23455799999999998643 36889999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
|+|+|.++.|+.||.+...- . . ....+.+.. ......+..+..+....++|++||..-..+|....+
T Consensus 671 GVIFyQClYGrKPFGhnqsQ----Q---d----ILqeNTIlk--AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~q 737 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQ----Q---D----ILQENTILK--ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQ 737 (775)
T ss_pred ehhhhhhhccCCCCCCchhH----H---H----HHhhhchhc--ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHH
Confidence 99999999999999862110 0 0 011111100 011122222334477899999999999999988877
Q ss_pred HH
Q 025011 233 VS 234 (259)
Q Consensus 233 il 234 (259)
+.
T Consensus 738 LA 739 (775)
T KOG1151|consen 738 LA 739 (775)
T ss_pred Hc
Confidence 64
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=224.48 Aligned_cols=212 Identities=25% Similarity=0.346 Sum_probs=169.3
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.++.|..+|+.. .|||++.++++|.. ++.+|||||||.+||.-|+++.... ..+.|..+.-|++.++.|+.
T Consensus 59 deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g-~rl~E~~IaYI~re~lrgl~ 137 (953)
T KOG0587|consen 59 EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKG-NRLKEEWIAYILREILRGLA 137 (953)
T ss_pred cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 35688899999998 58999999999873 5679999999999999999988773 44788999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-----Ccccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-----KLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~Diw 150 (259)
+||.+. ++|+|+|-+||+++.++.+||+|||.+...... ....+...||+.|||||+.... .|+.++|+|
T Consensus 138 HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~W 212 (953)
T KOG0587|consen 138 HLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLW 212 (953)
T ss_pred HHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchh
Confidence 999999 999999999999999999999999998876653 2334556899999999998654 367789999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|||++..+|..|.+|+-++-.. ...+. ...+ ... .-..+..=+.++.++|..||..|..+||+.
T Consensus 213 sLGITaIEladG~PPl~DmHPm-------raLF~-IpRN-PPP-------kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~ 276 (953)
T KOG0587|consen 213 SLGITAIEMAEGAPPLCDMHPM-------RALFL-IPRN-PPP-------KLKRPKKWSKKFNDFISTCLVKDYEQRPST 276 (953)
T ss_pred hccceeehhcCCCCCccCcchh-------hhhcc-CCCC-CCc-------cccchhhHHHHHHHHHHHHHhhccccCcch
Confidence 9999999999999997663211 11111 1110 000 001122234779999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 277 ~~ll~ 281 (953)
T KOG0587|consen 277 EELLK 281 (953)
T ss_pred hhhcc
Confidence 98864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=202.80 Aligned_cols=220 Identities=22% Similarity=0.297 Sum_probs=164.5
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+-.+|..++..++|+||++++.+|.-.. ..|+|||++ ..+|...+.-. ++-.++..++.|++.|+.+|
T Consensus 61 ra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~e-----lDH~tis~i~yq~~~~ik~l 134 (369)
T KOG0665|consen 61 RAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVILME-----LDHETISYILYQMLCGIKHL 134 (369)
T ss_pred hhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHHHh-----cchHHHHHHHHHHHHHHHHH
Confidence 4568999999999999999999997543 569999999 55898888622 46688999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
|+.+ |+||||||+||++..+..+|+.|||+++..... .+.+..+.+..|+|||+..+..+...+||||+||++.
T Consensus 135 hs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 135 HSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred Hhcc---eeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 9999 999999999999999999999999999865432 3445567888999999999999999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHH----------HHHHHhhc-----c-----chhhhhh-ccccCC--chhHHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMV----------QYFLYSIE-----N-----NSLRQIL-NFQVAD--ESEMEEIETVAG 214 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~----------~~~~~~~~-----~-----~~~~~~~-~~~~~~--~~~~~~~~~~~~ 214 (259)
+|++|...|.|.+..+....... ........ . ....+.+ +..... ..+..-.....+
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 99999999998544332211111 10000000 0 0000111 000000 011112256889
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 025011 215 LASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 215 li~~~l~~~p~~Rpt~~~il~ 235 (259)
++.+||-.||++|.|+++++.
T Consensus 289 ll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHhhccChhhcccHHHHhc
Confidence 999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=202.97 Aligned_cols=221 Identities=22% Similarity=0.306 Sum_probs=176.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhh-----ccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIH-----DKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
.+..|.-++..+.|||+..+.+++-+ ...+++++.+...|+|..++. +.......+..+...++.|+..|+.||
T Consensus 333 ~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hl 412 (563)
T KOG1024|consen 333 LLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHL 412 (563)
T ss_pred HHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHH
Confidence 35667777778899999999998765 457899999999999999997 333333345577888999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
|+.+ ++|.||.+.|.++++.-++||+|-.+++..-...-.--......+..||+||.+....|+.++|+||||+++|
T Consensus 413 h~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllW 489 (563)
T KOG1024|consen 413 HNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLW 489 (563)
T ss_pred HhcC---cccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHH
Confidence 9999 9999999999999999999999988887543322222223345778899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 158 ELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 158 ~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
||+| |+.||...+. ......+..+..-..+.+++.++..++.-||...|++||+++++...
T Consensus 490 ELmtlg~~PyaeIDP------------------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 490 ELMTLGKLPYAEIDP------------------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred HHHhcCCCCccccCH------------------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 9999 8999876332 22233333333444455678999999999999999999999999999
Q ss_pred HHhcccccc
Q 025011 237 LDRLKISHE 245 (259)
Q Consensus 237 l~~~~~~~~ 245 (259)
|.++.....
T Consensus 552 LseF~~qlt 560 (563)
T KOG1024|consen 552 LSEFHTQLT 560 (563)
T ss_pred HHHHHHHHh
Confidence 998866543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=226.54 Aligned_cols=209 Identities=22% Similarity=0.284 Sum_probs=159.2
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..++|+..|+.- +|||||++++.-.++.+.||..|.| ..+|.++++.. ...........+..+.|++.||++||+.+
T Consensus 548 ~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~ 626 (903)
T KOG1027|consen 548 FAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK 626 (903)
T ss_pred HHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc
Confidence 357899999988 6999999999988899999999999 56999999874 11111121445778999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCC---C--CceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDD---N--YKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~---~--~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|+||||||+||+++. + ..++|+|||+++....+.... ......||.+|+|||.+.....+.++||||+||+
T Consensus 627 ---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 627 ---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred ---cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 999999999999976 2 468999999999887654332 2344569999999999999888889999999999
Q ss_pred HHHHHhC-CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLTG-LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+.++| ..||...-. +..........+..+. .. .+ ....+||.+|++++|..||+|.+|+
T Consensus 704 fyYvltgG~HpFGd~~~---------R~~NIl~~~~~L~~L~-----~~--~d--~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSLE---------RQANILTGNYTLVHLE-----PL--PD--CEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred EEEEecCCccCCCchHH---------hhhhhhcCccceeeec-----cC--ch--HHHHHHHHHhcCCCcccCCCHHHHh
Confidence 9999995 799886210 0000011111111110 00 00 1588999999999999999999996
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.9e-33 Score=204.54 Aligned_cols=215 Identities=23% Similarity=0.266 Sum_probs=159.8
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhcc--CCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK--SSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
++|..|.+...+- ++||||++||.+-.++..||.||.+ ..||..+...- -.....++.-+-+|....+.||.||-.
T Consensus 107 ~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~ 185 (361)
T KOG1006|consen 107 KRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE 185 (361)
T ss_pred HHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH
Confidence 5677888776665 6899999999999999999999999 55776655321 111224566667788888999999986
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC--CcccccchhhHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLA 157 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~ 157 (259)
.-. |+|||+||+||+++..|.+||+|||..-..-. ....+...|..+|+|||.+... .|+.++|+||||+++|
T Consensus 186 ~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~ 260 (361)
T KOG1006|consen 186 ELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLY 260 (361)
T ss_pred Hhh--hhhccCChhheEEecCCCEeeecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEe
Confidence 644 99999999999999999999999998754432 2233455799999999998643 3889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||..||.+++... +....... +....+ .......+.+..+..+|..||.+|...||...++.+
T Consensus 261 EvAtG~fPyr~w~svf-------eql~~Vv~-gdpp~l----~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 261 EVATGNFPYRKWDSVF-------EQLCQVVI-GDPPIL----LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eeecCCCCcchHHHHH-------HHHHHHHc-CCCCee----cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 9999999999864321 11111111 111111 111223445678999999999999999999999875
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=215.34 Aligned_cols=205 Identities=22% Similarity=0.299 Sum_probs=164.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+++|+.+|+++.||+||.+.--|++.+.+++|||.+ .|+..+++-..... .+++....-++.||+-||.|||-++
T Consensus 608 sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkg-RL~er~TkFlvtQIL~ALr~LH~kn- 684 (888)
T KOG4236|consen 608 SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKG-RLPERITKFLVTQILVALRYLHFKN- 684 (888)
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcc-cchHHHHHHHHHHHHHHHHHhhhcc-
Confidence 56899999999999999999999999999999999999 55777776443322 2566777788999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC---CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN---YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|+|+||+||++... -++||+|||+++.++.. .....-+||+.|+|||++..+.|+..-|+||+|+|+|.-
T Consensus 685 --IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVs 759 (888)
T KOG4236|consen 685 --IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVS 759 (888)
T ss_pred --eeeccCCchheeeccCCCCCceeeccccceeecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEE
Confidence 9999999999999754 46899999999988753 334455799999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhc--cccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILN--FQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++|..||..-... -.++.+ ...+.....++++...+||..+|+..-.+|-|.+.-+
T Consensus 760 LSGTFPFNEdEdI-------------------ndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 760 LSGTFPFNEDEDI-------------------NDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred ecccccCCCccch-------------------hHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 9999999751110 011111 1122233345567789999999999999998887654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=235.33 Aligned_cols=198 Identities=17% Similarity=0.177 Sum_probs=139.3
Q ss_pred HhcCCC-ccccccceeEE-------eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 12 VSQINH-KNVVKILGACL-------ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 12 l~~l~h-~~iv~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.++| +||++++++|. .+..++.++|++ +++|.+++.... ..+++.++..++.||+.||.|||+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred cchhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 345567 68999999883 334677889988 669999997542 23678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCc-------------------eEEeecCCcccccCCcc-------c-------cccccccCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYK-------------------AKVADFGSSVLISSDNQ-------T-------AMTTKKIGTF 130 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~-------------------~~l~df~~~~~~~~~~~-------~-------~~~~~~~~~~ 130 (259)
|+||||||+||+++..+. ++++|||+++....... . .......+|+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999965444 45555555543211000 0 0001134788
Q ss_pred cccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHH
Q 025011 131 VNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIE 210 (259)
Q Consensus 131 ~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (259)
.|+|||++.+..++.++|||||||++|||++|..|+..... ........ ... .......+
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~------~~~~~~~~---------~~~-----~~~~~~~~ 239 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR------TMSSLRHR---------VLP-----PQILLNWP 239 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH------HHHHHHHh---------hcC-----hhhhhcCH
Confidence 89999999988899999999999999999998887653110 00000000 000 00011124
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
...+++.+||+.+|.+|||+.++++
T Consensus 240 ~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 240 KEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHHhCCCChhhCcChHHHhh
Confidence 4678899999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=227.29 Aligned_cols=181 Identities=24% Similarity=0.337 Sum_probs=133.8
Q ss_pred ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 33 PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 33 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
+||-||||+...+.+.+..+.... .....|+++++|+.||+|+|+.| ++||||||.|||+++++.+||+|||+++
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt 745 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLAT 745 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHHhCc---eeeccCCcceeEEcCCCCeeecccccch
Confidence 489999999988888887765432 34789999999999999999999 9999999999999999999999999998
Q ss_pred ccc---C-------------CccccccccccCcccccCcchhccCC---cccccchhhHHHHHHHHHhCCCCCCCCcccc
Q 025011 113 LIS---S-------------DNQTAMTTKKIGTFVNLDPEYVITGK---LTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173 (259)
Q Consensus 113 ~~~---~-------------~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~p~~~~~~~~ 173 (259)
... . +......+..+||..|+|||++.+.. |+.|+|+||||++++||+. ||...
T Consensus 746 ~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts---- 818 (1351)
T KOG1035|consen 746 DLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS---- 818 (1351)
T ss_pred hhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch----
Confidence 721 0 01111234568999999999997665 8999999999999999985 55531
Q ss_pred ccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.-...+.... .+.+..- .....+..+.-..+|++|++.||++||||.+++.
T Consensus 819 ---MERa~iL~~LR-~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 819 ---MERASILTNLR-KGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---HHHHHHHHhcc-cCCCCCC------cccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111111111 1111110 1112223355678999999999999999999975
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=201.86 Aligned_cols=194 Identities=27% Similarity=0.315 Sum_probs=157.2
Q ss_pred HHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 8 E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
|-++|... +-|.++++...|.+-+.+|+||||+.||+|-..+++.+. +.+..+.-++..|+-||-+||+++ |+
T Consensus 399 EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---Ii 472 (683)
T KOG0696|consen 399 EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---II 472 (683)
T ss_pred hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---ee
Confidence 44555544 568899999999999999999999999999999987765 455788889999999999999999 99
Q ss_pred eCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCC
Q 025011 87 HGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166 (259)
Q Consensus 87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~ 166 (259)
+||||.+||+++..|.++|.|||+.+...... ..+..+.||+.|+|||++...+|+.++|.||+|+++|||+.|++||
T Consensus 473 YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPF 550 (683)
T KOG0696|consen 473 YRDLKLDNVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 550 (683)
T ss_pred eeeccccceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCC
Confidence 99999999999999999999999987644432 2344568999999999999999999999999999999999999999
Q ss_pred CCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 167 SGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
.+.+.. +.+ ..+.+.. ...+.+.+.+..++....|...|.+|.
T Consensus 551 dGeDE~--------elF---------~aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 551 DGEDED--------ELF---------QAIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred CCCCHH--------HHH---------HHHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 983321 111 1111111 122334456788899999999999995
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=208.91 Aligned_cols=157 Identities=23% Similarity=0.285 Sum_probs=136.8
Q ss_pred HHHHHHHHhcCC------CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 5 FQHELRVVSQIN------HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 5 ~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
=..|+++|++|+ --|+++++-.|...+++|||||.+ ..+|.+++++.+...-+....+..++.|+..||..|-
T Consensus 475 Gl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK 553 (752)
T KOG0670|consen 475 GLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK 553 (752)
T ss_pred hhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH
Confidence 357999999994 348999999999999999999999 5599999999887777788889999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
..+ |+|+||||+|||++++ +.++|||||.|-..+... .+...-+..|.|||++.|.+|+...|+||+||++|
T Consensus 554 ~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLY 626 (752)
T KOG0670|consen 554 KCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLY 626 (752)
T ss_pred hcC---eeecccCccceEeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeE
Confidence 999 9999999999999865 468999999986654321 22233456899999999999999999999999999
Q ss_pred HHHhCCCCCCCC
Q 025011 158 ELLTGLKPGSGM 169 (259)
Q Consensus 158 ~l~~g~~p~~~~ 169 (259)
+|.||+..|+|.
T Consensus 627 ElYtGkIlFpG~ 638 (752)
T KOG0670|consen 627 ELYTGKILFPGR 638 (752)
T ss_pred EeeccceecCCC
Confidence 999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=182.29 Aligned_cols=214 Identities=21% Similarity=0.280 Sum_probs=159.0
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
++.+++|+.+|+.|. ||||++++++..+ +..+.+++||+.+.++..+... ++...+.-++.+++.||.|+|
T Consensus 76 kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------l~d~dIryY~~elLkALdyCH 149 (338)
T KOG0668|consen 76 KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------LTDYDIRYYIYELLKALDYCH 149 (338)
T ss_pred HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------hchhhHHHHHHHHHHHHhHHH
Confidence 356899999999996 9999999999875 4578999999999888777654 344778889999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il 156 (259)
+.| |+|||+||.|++++. ...++|+|+|++..+..+... +.++.+..|-.||.+..-+ ++.+-|+|||||++
T Consensus 150 S~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~Gcml 223 (338)
T KOG0668|consen 150 SMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 223 (338)
T ss_pred hcC---cccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHH
Confidence 999 999999999999985 456999999999877654333 3345677778999987655 78899999999999
Q ss_pred HHHHhCCCCCCC-CccccccchhHHHH------------HHHh--------------hccchhhhhhccccCCchhHHHH
Q 025011 157 AELLTGLKPGSG-MALASNEGISMVQY------------FLYS--------------IENNSLRQILNFQVADESEMEEI 209 (259)
Q Consensus 157 ~~l~~g~~p~~~-~~~~~~~~~~~~~~------------~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~ 209 (259)
..|+..+.||.. .+.. ...... .... .....+..++...- ..-.+
T Consensus 224 A~miFrkepFFhG~dN~----DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n----~hl~~ 295 (338)
T KOG0668|consen 224 ASMIFRKEPFFHGHDNY----DQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSEN----QHLVS 295 (338)
T ss_pred HHHHhccCcccCCCCCH----HHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccc----cccCC
Confidence 999998888753 2221 111111 0000 00011111111110 11123
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 210 ETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 210 ~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++..+++.++|..|..+|+||+|...
T Consensus 296 peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 296 PEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHHHHHHHHHHhhccccccchHHHhc
Confidence 77899999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=202.89 Aligned_cols=159 Identities=23% Similarity=0.348 Sum_probs=139.0
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
.+.|-+||..-.++-||++|-.|.+.+.+|+||+|++||++-++|.+.+- +++..+.-++..+.-|+.+.|+.|
T Consensus 676 VKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgI---FeE~LARFYIAEltcAiesVHkmG--- 749 (1034)
T KOG0608|consen 676 VKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI---FEEDLARFYIAELTCAIESVHKMG--- 749 (1034)
T ss_pred hhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhcc---CHHHHHHHHHHHHHHHHHHHHhcc---
Confidence 46688999999999999999999999999999999999999999988764 678899999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccccc--CC-------ccccc-------------------------------cc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLIS--SD-------NQTAM-------------------------------TT 124 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~--~~-------~~~~~-------------------------------~~ 124 (259)
++||||||+|||||.+|.+||.|||+.+-+. ++ ...+. ..
T Consensus 750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah 829 (1034)
T KOG0608|consen 750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH 829 (1034)
T ss_pred ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence 9999999999999999999999999975321 11 00000 01
Q ss_pred cccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCC
Q 025011 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 125 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~ 169 (259)
..+||..|+|||++....++...|.||.|+|+|+|+.|++||...
T Consensus 830 slvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 830 SLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred hhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCC
Confidence 236999999999999999999999999999999999999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-29 Score=211.99 Aligned_cols=198 Identities=20% Similarity=0.224 Sum_probs=129.5
Q ss_pred EeCCcceEEEEecCCCChhhhhhccCCcc-----------------cCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCC
Q 025011 28 LETKVPLLVYEFVPNGTLFDHIHDKSSQV-----------------LRNWKTCLRIAAETASALDYLHSSASPPIIHGDV 90 (259)
Q Consensus 28 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-----------------~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di 90 (259)
..+...++++||+.+++|.+++....... ......+..++.|++.||.|||+++ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 34567899999999999999987543210 1122346689999999999999999 999999
Q ss_pred CCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCC----------------------ccccc
Q 025011 91 KSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK----------------------LTEKS 147 (259)
Q Consensus 91 ~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----------------------~~~~~ 147 (259)
||+||+++. ++.++|+|||+++...... ........+++.|+|||.+.... ++.++
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 999999985 5789999999997554321 12233456889999999764322 23456
Q ss_pred chhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhh-ccchhhhhhccccCCchh--H----HHHHHHHHHHHHhc
Q 025011 148 DVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSI-ENNSLRQILNFQVADESE--M----EEIETVAGLASKCL 220 (259)
Q Consensus 148 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~--~----~~~~~~~~li~~~l 220 (259)
||||+||++|+|+++..++... ............ ....+............. . .......+||.+||
T Consensus 361 DVwSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999999976654321 001100000000 000011111111000000 0 00123558999999
Q ss_pred ccCCCCCCCHHHHHH
Q 025011 221 SLSGRRRPTMKQVSE 235 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~ 235 (259)
+.||.+|||++++++
T Consensus 435 ~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 435 RFKGRQRISAKAALA 449 (566)
T ss_pred cCCcccCCCHHHHhC
Confidence 999999999999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=185.45 Aligned_cols=177 Identities=35% Similarity=0.555 Sum_probs=155.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++.++.++|++++++++++......++++|++.+++|.+++.... ...+...++.++.+++.++.+||+.+
T Consensus 36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~- 112 (215)
T cd00180 36 EELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEILRILLQILEGLEYLHSNG- 112 (215)
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 679999999999999999999999999899999999999899999997653 22577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|.||+++. ++.++++||+.+........ ......+...|.+||.+... ..+.++|+|++|++++++
T Consensus 113 --~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l- 187 (215)
T cd00180 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL- 187 (215)
T ss_pred --eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-
Confidence 999999999999999 89999999999876544321 12334577899999998776 678899999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..+.+++.+|++.+|.+||++.++++.
T Consensus 188 -------------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -------------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -------------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 348889999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=194.00 Aligned_cols=223 Identities=20% Similarity=0.295 Sum_probs=159.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++|..++|.|+....+...-.+ .+|+++|.+ ..+|...+-.- ..++.+.+.-++.||+.||+||
T Consensus 97 krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYL 172 (449)
T KOG0664|consen 97 KRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYL 172 (449)
T ss_pred HHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHH
Confidence 46889999999999999999999876432 467888888 44776666432 2356688888999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il 156 (259)
|+.+ |.||||||.|.+++.|..+|++|||+++....... ...+..+-|..|+|||.+.+.. |+.+.||||+||++
T Consensus 173 HsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF 248 (449)
T KOG0664|consen 173 HTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF 248 (449)
T ss_pred hhcc---hhhccCCCccEEeccCceEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence 9999 99999999999999999999999999987654422 2334456778999999998875 89999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHH---------HHHHHhhccchhhhhhccccCCch-h--------HHHHHHHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMV---------QYFLYSIENNSLRQILNFQVADES-E--------MEEIETVAGLASK 218 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~li~~ 218 (259)
.||+..+..|+.-.... +..+. +.....-++ ....++......+. . ..-.....+++..
T Consensus 249 aELLgRrILFQAq~Piq--QL~lItdLLGTPs~EaMr~ACEG-Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~ 325 (449)
T KOG0664|consen 249 AELLQRKILFQAAGPIE--QLQMIIDLLGTPSQEAMKYACEG-AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQK 325 (449)
T ss_pred HHHHhhhhhhhccChHH--HHHHHHHHhCCCcHHHHHHHhhh-hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHH
Confidence 99999889988632211 11111 111111111 11111111111110 0 0111345678899
Q ss_pred hcccCCCCCCCHHHHHHH
Q 025011 219 CLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 219 ~l~~~p~~Rpt~~~il~~ 236 (259)
++.+||.+|.+..+.+..
T Consensus 326 ~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 326 LLHFDPDKRISVEEALQH 343 (449)
T ss_pred HhCCCCcccccHhhhccc
Confidence 999999999998887643
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=181.69 Aligned_cols=162 Identities=23% Similarity=0.302 Sum_probs=131.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+++.+|+.+...- .+|.+|.+||.+...+.+||.||.+ ..||..+..+- ......++..+-+|+..++.|+.|||++
T Consensus 89 ~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k 167 (282)
T KOG0984|consen 89 KRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK 167 (282)
T ss_pred HHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH
Confidence 3456677766554 6999999999999999999999999 55887766432 2222356788889999999999999987
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc----CCcccccchhhHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT----GKLTEKSDVYSFGVLL 156 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il 156 (259)
-+ ++|||+||+||+++.+|++|++|||.+-...++- ..+-..|...|+|||.+.. ..|+.++||||||+++
T Consensus 168 L~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItm 242 (282)
T KOG0984|consen 168 LS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITM 242 (282)
T ss_pred hh--hhhccCCcceEEEccCCcEEEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhh
Confidence 65 9999999999999999999999999976544321 2223458899999998753 3589999999999999
Q ss_pred HHHHhCCCCCCCCc
Q 025011 157 AELLTGLKPGSGMA 170 (259)
Q Consensus 157 ~~l~~g~~p~~~~~ 170 (259)
.||.+++.||..+.
T Consensus 243 iElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 243 IEMAILRFPYESWG 256 (282)
T ss_pred hhhhhccccccccC
Confidence 99999999998753
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=181.05 Aligned_cols=168 Identities=21% Similarity=0.167 Sum_probs=123.9
Q ss_pred CChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccc
Q 025011 43 GTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122 (259)
Q Consensus 43 ~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 122 (259)
|+|.+++..... .+++..++.++.|++.||.|||+.+ ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 688899875432 3688999999999999999999876 999999999999998 99887654321
Q ss_pred cccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCC
Q 025011 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD 202 (259)
Q Consensus 123 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (259)
..++..|+|||++.+..++.++||||+|+++|+|++|..||........ ....... ...... ... .
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~---~~~~~~~-~~~~~~-----~~~--~ 129 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA---ILEILLN-GMPADD-----PRD--R 129 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH---HHHHHHH-HhccCC-----ccc--c
Confidence 2578999999999998999999999999999999999999865321110 0111110 000000 000 0
Q ss_pred chhHHHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 203 ESEMEEIE--TVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 203 ~~~~~~~~--~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
........ .+.+++.+||+.+|.+|||+.++++.+..+.
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 01112222 6999999999999999999999998876654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-28 Score=202.04 Aligned_cols=216 Identities=21% Similarity=0.217 Sum_probs=146.9
Q ss_pred HHHHHHHhcCCCcc-----ccccceeEEe--------CCcceEEEEecCCCChhhhhhccCC------------------
Q 025011 6 QHELRVVSQINHKN-----VVKILGACLE--------TKVPLLVYEFVPNGTLFDHIHDKSS------------------ 54 (259)
Q Consensus 6 ~~E~~~l~~l~h~~-----iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~------------------ 54 (259)
..|+.++.+++|.+ +++++++|.. .+..++|+||+++++|.+++.....
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 34777777776554 3677777653 3567999999999999999864311
Q ss_pred ---cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCccc
Q 025011 55 ---QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFV 131 (259)
Q Consensus 55 ---~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 131 (259)
....++..+..++.|++.+|.|+|+.+ ++|+||||+||+++.++.++|+|||++....... .........++.
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~ 375 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPR 375 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcc
Confidence 112356678899999999999999999 9999999999999999999999999986543321 111122235789
Q ss_pred ccCcchhccCCc----------------------ccccchhhHHHHHHHHHhCCC-CCCCCccccccc----hhHHHHHH
Q 025011 132 NLDPEYVITGKL----------------------TEKSDVYSFGVLLAELLTGLK-PGSGMALASNEG----ISMVQYFL 184 (259)
Q Consensus 132 y~aPE~~~~~~~----------------------~~~~DiwslG~il~~l~~g~~-p~~~~~~~~~~~----~~~~~~~~ 184 (259)
|+|||.+..... ..+.|+||+||++++|++|.. ||.+......+. .....|..
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 999998754321 124699999999999999875 665422211111 00111111
Q ss_pred HhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 025011 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG---RRRPTMKQVSE 235 (259)
Q Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rpt~~~il~ 235 (259)
..............++...+++.+||..+| .+|+|++++++
T Consensus 456 ----------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 456 ----------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ----------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111111112234779999999999866 68999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=187.71 Aligned_cols=204 Identities=24% Similarity=0.281 Sum_probs=158.1
Q ss_pred HHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+.|-.+..+- +||.+|.+...|.+...+++|.||++||+|--.++++.. +++..+.-+...|+.||.|||+.|
T Consensus 298 qtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---lpeeharfys~ei~lal~flh~rg--- 371 (593)
T KOG0695|consen 298 QTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEICLALNFLHERG--- 371 (593)
T ss_pred HhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---CcHHHhhhhhHHHHHHHHHHhhcC---
Confidence 3455555555 699999999999999999999999999999777765543 678899999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
|+++|+|.+|++++..|.+||.|+|+.+.-... ...++.+.||+.|.|||.+.+..|...+|.|+||+++++|..|+.
T Consensus 372 iiyrdlkldnvlldaeghikltdygmcke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrs 449 (593)
T KOG0695|consen 372 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRS 449 (593)
T ss_pred eeeeeccccceEEccCCceeecccchhhcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999998764443 234567789999999999999999999999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
||.-......+ .+...+.. .-++...+.-+. +.+-....+++..|++||++|.
T Consensus 450 pfdivgm~n~d-~ntedylf--------qvilekqiripr--slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 450 PFDIVGMDNPD-MNTEDYLF--------QVILEKQIRIPR--SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred CcceecCCCcc-cchhHHHH--------HHHhhhcccccc--eeehhhHHHHHHhhcCCcHHhc
Confidence 99753322111 11111111 111122211111 2223466789999999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=190.25 Aligned_cols=91 Identities=27% Similarity=0.417 Sum_probs=79.4
Q ss_pred hHHHHHHHHHhcCC-----C---ccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-----H---KNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAET 70 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-----h---~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i 70 (259)
|.-..|+++|+++. | .+||++++.|.. +.++|+|+|++ |.+|..+++....+. ++...+..|+.|+
T Consensus 119 EaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrG-lpl~~VK~I~~qv 196 (590)
T KOG1290|consen 119 EAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRG-LPLSCVKEICRQV 196 (590)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCC-CcHHHHHHHHHHH
Confidence 55678999999992 3 379999999985 45899999999 889999999887766 5778999999999
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEe
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLL 97 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~ 97 (259)
+.||.|||.... |+|.||||+|||+
T Consensus 197 L~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 197 LTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHHHHhcC--ccccCCCcceeee
Confidence 999999998754 9999999999999
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-28 Score=198.68 Aligned_cols=152 Identities=26% Similarity=0.370 Sum_probs=135.4
Q ss_pred HHHHHHhcCC---CccccccceeEEeCCcceEEEEec-CCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 7 HELRVVSQIN---HKNVVKILGACLETKVPLLVYEFV-PNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 7 ~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.|+++|..|+ |+||++++++|+++++.||+||.. +|-+|+++++..+. .++.++..|+.|++.|+++||+.+
T Consensus 615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~---m~E~eAk~IFkQV~agi~hlh~~~- 690 (772)
T KOG1152|consen 615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR---MDEPEAKLIFKQVVAGIKHLHDQG- 690 (772)
T ss_pred hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc---cchHHHHHHHHHHHhccccccccC-
Confidence 5999999996 999999999999999999999984 46799999988776 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
|+|||||-+|+.++++|.++|+|||.+....++. -..++||..|.|||++.+.+| ...-|||++|+++|-++.
T Consensus 691 --ivhrdikdenvivd~~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy 764 (772)
T KOG1152|consen 691 --IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY 764 (772)
T ss_pred --ceecccccccEEEecCCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe
Confidence 9999999999999999999999999987655432 234679999999999999886 456899999999999998
Q ss_pred CCCCCCC
Q 025011 162 GLKPGSG 168 (259)
Q Consensus 162 g~~p~~~ 168 (259)
...||.+
T Consensus 765 kenpyyn 771 (772)
T KOG1152|consen 765 KENPYYN 771 (772)
T ss_pred ccCCCcC
Confidence 8888764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=186.63 Aligned_cols=158 Identities=21% Similarity=0.281 Sum_probs=133.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.++.+|+++|..+ .+.||+++.+.+..++.+++|+||++.....++.... +...+..+++.++.||.++|.+|
T Consensus 79 ~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~l------~~~~i~~Yl~~ll~Al~~~h~~G 152 (418)
T KOG1167|consen 79 SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRSL------SLAEIRWYLRNLLKALAHLHKNG 152 (418)
T ss_pred hHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhcC------CHHHHHHHHHHHHHHhhhhhccC
Confidence 4678999999999 5899999999999999999999999999998888654 45889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCC------------------------------------------c
Q 025011 82 SPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSD------------------------------------------N 118 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~------------------------------------------~ 118 (259)
|+|||+||+|++++. .+...|+|||++...... .
T Consensus 153 ---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~ 229 (418)
T KOG1167|consen 153 ---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDG 229 (418)
T ss_pred ---ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCC
Confidence 999999999999974 467899999998721100 0
Q ss_pred cccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHhCCCCCCCC
Q 025011 119 QTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 119 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~ 169 (259)
.....-.+.||++|+|||++...+ .++++||||.|+++..+++++.||...
T Consensus 230 r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 230 RPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence 000112336999999999998765 789999999999999999999998653
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=175.48 Aligned_cols=216 Identities=21% Similarity=0.264 Sum_probs=155.4
Q ss_pred hHHHHHHHHHhcC-CCccccccce-eEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILG-ACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+|.+|...--.| .|.||+..|+ .|+..+..++++||++.|+|.+-+...+- .+.-..+++.|+++|+.|+|++
T Consensus 65 ~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~Gi----gE~~~K~v~~ql~SAi~fMHsk 140 (378)
T KOG1345|consen 65 ADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAGI----GEANTKKVFAQLLSAIEFMHSK 140 (378)
T ss_pred HHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcccc----cHHHHHHHHHHHHHHHHHhhcc
Confidence 4577777766666 4899998776 56777788899999999999999877543 4577789999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCC--CCceEEeecCCcccccCCccccccccccCcccccCcchhccC-----CcccccchhhHH
Q 025011 81 ASPPIIHGDVKSTNVLLDD--NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-----KLTEKSDVYSFG 153 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG 153 (259)
+ ++|||||.+||++-. .-++||+|||+++..+.-- ...-.+..|.+||+.... ...+.+|+|.||
T Consensus 141 n---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfG 212 (378)
T KOG1345|consen 141 N---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFG 212 (378)
T ss_pred c---hhhcccccceEEEecCCccEEEeeecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchhee
Confidence 9 999999999999953 3479999999998765422 222355678899876432 246789999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|.+++|..||+.........-....|..... ..+.+.+. ..++.+..++++-|..+|++|=-..++
T Consensus 213 Ii~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~--~~~P~~F~---------~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 213 IIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN--PALPKKFN---------PFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred eeeeeeecCCCcchhhhccCchHHHHHHHhcccC--ccCchhhc---------ccCHHHHHHHHHhcCCcccccchhHHH
Confidence 9999999999999964433322222222222111 11111111 123678899999999999999555555
Q ss_pred HHHHHhcc
Q 025011 234 SEELDRLK 241 (259)
Q Consensus 234 l~~l~~~~ 241 (259)
.+.....+
T Consensus 282 kk~rk~~w 289 (378)
T KOG1345|consen 282 KKMRKCLW 289 (378)
T ss_pred HHHHHHHH
Confidence 55544443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-26 Score=173.05 Aligned_cols=161 Identities=34% Similarity=0.501 Sum_probs=139.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|++.++.++|+|++++++++......++++|++++++|.+++...... .++..+..++.+++.++.+||+.+
T Consensus 41 ~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~ 118 (225)
T smart00221 41 REEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEARFYLRQILEALEYLHSLG 118 (225)
T ss_pred HHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357889999999999999999999999989999999999999999999765432 467899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchh-ccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYV-ITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+|++|.||+++.++.++++|||.+........ .......++..|++||.+ ....++.++|+|++|+++++|+
T Consensus 119 ---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~ 194 (225)
T smart00221 119 ---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELL 194 (225)
T ss_pred ---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999877654320 122334577889999998 5556788999999999999999
Q ss_pred hCCCCCCC
Q 025011 161 TGLKPGSG 168 (259)
Q Consensus 161 ~g~~p~~~ 168 (259)
+|+.||.+
T Consensus 195 ~g~~pf~~ 202 (225)
T smart00221 195 WGPEPFSG 202 (225)
T ss_pred HCCCCccc
Confidence 99999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-27 Score=194.40 Aligned_cols=209 Identities=26% Similarity=0.352 Sum_probs=163.5
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
++.|+-+++..+||||+.+++.+......+++||||.+|+|.+.....+. +++.++....+..+.+++|||+.+
T Consensus 59 iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgp---lselqiayvcRetl~gl~ylhs~g--- 132 (829)
T KOG0576|consen 59 IQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLKYLHSQG--- 132 (829)
T ss_pred cccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeeccc---chhHHHHHHHhhhhccchhhhcCC---
Confidence 56678888888999999999999999999999999999999988766543 688899999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHHHh
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~ 161 (259)
-+|||||-.||++++.|.+++.|||.+..++.. ....-.+.||+.|+|||+.. ...|...+|||++|+...++..
T Consensus 133 k~hRdiKGanilltd~gDvklaDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e 210 (829)
T KOG0576|consen 133 KIHRDIKGANILLTDEGDVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE 210 (829)
T ss_pred cccccccccceeecccCceeecccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence 899999999999999999999999998766542 22344568999999999875 3348899999999999999988
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
-++|-... ..++..+..-..........++... ++.+.++++.+|..+|++|||++.++.
T Consensus 211 Lqpplfdl-------hpmr~l~LmTkS~~qpp~lkDk~kw-------s~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 211 LQPPLFDL-------HPMRALFLMTKSGFQPPTLKDKTKW-------SEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred cCCccccc-------chHHHHHHhhccCCCCCcccCCccc-------hHHHHHHHHHHhcCCCccCCChhhhee
Confidence 77773321 1122222222222222222222211 266889999999999999999987653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=196.43 Aligned_cols=215 Identities=20% Similarity=0.250 Sum_probs=162.1
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+..|+-+-..++|||++.....+.+.....-.||||++ +|+.++..... +....+..++.|++.|+.|+|..|
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~G--- 440 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSMG--- 440 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhcC---
Confidence 34455666678999998888877765555555999999 99999987632 455788889999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhccCCccc-ccchhhHHHHHHHHHh
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGKLTE-KSDVYSFGVLLAELLT 161 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~ 161 (259)
+.|+|+|++|++++.+|.++++|||.+..+...... .......|+.+|+|||++.+..|.+ ..||||.|+++..|.+
T Consensus 441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~ 520 (601)
T KOG0590|consen 441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL 520 (601)
T ss_pred ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence 999999999999999999999999998776554443 5566678999999999999988876 5899999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
|+.||.......... .......... ............+.....+|..||+.||.+|.|+.+|++.
T Consensus 521 ~~~~Wk~a~~~~~~~--------~~~~~~~~~~--~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 521 GRFPWKVAKKSDNSF--------KTNNYSDQRN--IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred CCCccccccccccch--------hhhccccccc--cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 999997633221110 0000000000 0011111222334678889999999999999999999753
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=163.01 Aligned_cols=222 Identities=21% Similarity=0.211 Sum_probs=166.6
Q ss_pred HHHHHHHHHhcCCC----ccccccceeE-EeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 4 VFQHELRVVSQINH----KNVVKILGAC-LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 4 ~~~~E~~~l~~l~h----~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
.+..|..++..+.. ++++.+++.+ ..+...++||+.+ |.+|.++....+ ...++..+...++.|++.+|.++|
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH 139 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLH 139 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHH
Confidence 57889999999963 6899999998 4777889999999 889999987766 334788999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCC-----CceEEeecCCcc--cccCCcc----cc-c-cccccCcccccCcchhccCCccc
Q 025011 79 SSASPPIIHGDVKSTNVLLDDN-----YKAKVADFGSSV--LISSDNQ----TA-M-TTKKIGTFVNLDPEYVITGKLTE 145 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~-----~~~~l~df~~~~--~~~~~~~----~~-~-~~~~~~~~~y~aPE~~~~~~~~~ 145 (259)
+.| ++||||||+|+.+... ..+.++|||+++ .+..... .. . .....||..|.++....+...+.
T Consensus 140 ~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r 216 (322)
T KOG1164|consen 140 SKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGR 216 (322)
T ss_pred hcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCC
Confidence 999 9999999999999865 358999999998 4322211 11 1 22356999999999999999999
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 146 KSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 146 ~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+.|+||++.++.++..|..||.+....... ............ .. .....+..+.++...+-..+..
T Consensus 217 ~DDles~~Y~l~el~~g~LPW~~~~~~~~~-----~~~~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~~ 282 (322)
T KOG1164|consen 217 RDDLESLFYMLLELLKGSLPWEALEMTDLK-----SKFEKDPRKLLT----DR-----FGDLKPEEFAKILEYIDSLDYE 282 (322)
T ss_pred chhhhhHHHHHHHHhcCCCCCccccccchH-----HHHHHHhhhhcc----cc-----ccCCChHHHHHHHHHhhccCCc
Confidence 999999999999999999999774322110 000000000000 00 1111224566677766678999
Q ss_pred CCCCHHHHHHHHHhccccc
Q 025011 226 RRPTMKQVSEELDRLKISH 244 (259)
Q Consensus 226 ~Rpt~~~il~~l~~~~~~~ 244 (259)
.+|....+...+++.....
T Consensus 283 ~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 283 DKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred CCCCHHHHHHHHHHHHHhc
Confidence 9999999999987765543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-23 Score=180.68 Aligned_cols=206 Identities=21% Similarity=0.283 Sum_probs=151.2
Q ss_pred HhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCC
Q 025011 12 VSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVK 91 (259)
Q Consensus 12 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~ 91 (259)
...+++||++.+.-+...++..|+|-+|... +|+|.+...+ ++...+...|+.|++.|+..+|..| |+|||||
T Consensus 75 ~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIK 147 (1431)
T KOG1240|consen 75 FALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIK 147 (1431)
T ss_pred HHhhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccc
Confidence 4455899999998888888899999999955 9999996654 4677888999999999999999999 9999999
Q ss_pred CCCeEeCCCCceEEeecCCccccc--CCccccccc---cccCcccccCcchhccC----------C-cccccchhhHHHH
Q 025011 92 STNVLLDDNYKAKVADFGSSVLIS--SDNQTAMTT---KKIGTFVNLDPEYVITG----------K-LTEKSDVYSFGVL 155 (259)
Q Consensus 92 p~nil~~~~~~~~l~df~~~~~~~--~~~~~~~~~---~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~i 155 (259)
.+||+++.=+-+.|+||..-+..- .++...... ....-..|.|||.+... . .+++-||||+||+
T Consensus 148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV 227 (1431)
T KOG1240|consen 148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV 227 (1431)
T ss_pred cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence 999999999999999998764432 221111111 11244589999988541 1 4678999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhc-cchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIE-NNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+.||++ |++||.-. +.+.+... ......++. .+.. ..++.+|..|++.||++|.+|++.
T Consensus 228 iaELf~Eg~PlF~LS-----------QL~aYr~~~~~~~e~~Le-~Ied-------~~~Rnlil~Mi~rdPs~RlSAedy 288 (1431)
T KOG1240|consen 228 IAELFLEGRPLFTLS-----------QLLAYRSGNADDPEQLLE-KIED-------VSLRNLILSMIQRDPSKRLSAEDY 288 (1431)
T ss_pred HHHHHhcCCCcccHH-----------HHHhHhccCccCHHHHHH-hCcC-------ccHHHHHHHHHccCchhccCHHHH
Confidence 999998 68887631 11111111 111111111 1111 358889999999999999999999
Q ss_pred HHHHHhcccc
Q 025011 234 SEELDRLKIS 243 (259)
Q Consensus 234 l~~l~~~~~~ 243 (259)
++.-+.+.+.
T Consensus 289 L~~yrG~~FP 298 (1431)
T KOG1240|consen 289 LQKYRGLVFP 298 (1431)
T ss_pred HHhhhccccH
Confidence 9887666543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=163.96 Aligned_cols=221 Identities=23% Similarity=0.386 Sum_probs=163.9
Q ss_pred HhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCC
Q 025011 12 VSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVK 91 (259)
Q Consensus 12 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~ 91 (259)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+...... .++.....++.+++.|+.|+|.... .+|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~--~d~~F~~s~~rdi~~Gl~ylh~s~i--~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIK--LDYFFILSFIRDISKGLAYLHNSPI--GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccC--ccHHHHHHHHHHHHHHHHHHhcCcc--eeeeeec
Confidence 46789999999999999999999999999999999999874432 5778889999999999999998872 3999999
Q ss_pred CCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-------cccccchhhHHHHHHHHHhCCC
Q 025011 92 STNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-------LTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 92 p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DiwslG~il~~l~~g~~ 164 (259)
..|.+++....+|+.|||+.....................|.|||.+.... .+.+.||||+|++++++++...
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999976553211111122223556889999987642 3567999999999999999999
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~~ 244 (259)
||......... ......... ......++.+. ... ...+.+..++..||..+|.+||+++++...++.+....
T Consensus 157 ~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~----~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~ 228 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIE----LLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG 228 (484)
T ss_pred ccccccccCCh-HHHHHHHHh-cCCCCcCcchh----hhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence 99863332222 111111111 00111111111 000 23357899999999999999999999999999887753
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-22 Score=152.17 Aligned_cols=212 Identities=21% Similarity=0.329 Sum_probs=161.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..+|..|.-.|+-+.||||+.+++.|...-++.++..|++.|||+.++....... .+..++.+++.+++.|++|||+..
T Consensus 231 srdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vv-vd~sqav~faldiargmaflhsle 309 (448)
T KOG0195|consen 231 SRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVV-VDHSQAVRFALDIARGMAFLHSLE 309 (448)
T ss_pred cchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEE-EecchHHHHHHHHHhhHHHHhhcc
Confidence 4568889989999999999999999999999999999999999999998775543 466889999999999999999976
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEe--ecCCcccccCCccccccccccCcccccCcchhccCCc---ccccchhhHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVA--DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL---TEKSDVYSFGVLL 156 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~DiwslG~il 156 (259)
. -+.---++...+++|++-..++. |--++ .+.....-.+.|++||.+...+- -.++|+|||.+++
T Consensus 310 p-~ipr~~lns~hvmidedltarismad~kfs---------fqe~gr~y~pawmspealqrkped~n~raadmwsfaill 379 (448)
T KOG0195|consen 310 P-MIPRFYLNSKHVMIDEDLTARISMADTKFS---------FQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILL 379 (448)
T ss_pred h-hhhhhhcccceEEecchhhhheecccceee---------eeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHH
Confidence 2 23333577788999988766653 32221 12223346688999999987653 3579999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
|+|.|...||...+..... .++.-..+....++..+..+..|+.-|++.||.+||.++.|+-.
T Consensus 380 wel~trevpfadlspmecg-----------------mkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpi 442 (448)
T KOG0195|consen 380 WELNTREVPFADLSPMECG-----------------MKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPI 442 (448)
T ss_pred HHhhccccccccCCchhhh-----------------hhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhh
Confidence 9999999999875432210 01111222333344556789999999999999999999999988
Q ss_pred HHhcc
Q 025011 237 LDRLK 241 (259)
Q Consensus 237 l~~~~ 241 (259)
|+++.
T Consensus 443 lekm~ 447 (448)
T KOG0195|consen 443 LEKMI 447 (448)
T ss_pred HHHhc
Confidence 88753
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-20 Score=151.49 Aligned_cols=226 Identities=28% Similarity=0.383 Sum_probs=166.6
Q ss_pred hhHHHHHHHHHhcCCCc-cccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHK-NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.+.+|+.+++.+.|+ +++++.+.+...+..+++++++.++++.+++................++.|++.++.++|..
T Consensus 41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~ 120 (384)
T COG0515 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120 (384)
T ss_pred HHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 35688999999999988 79999999977777899999999999997776553212357789999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCcccc----ccccccCcccccCcchhcc---CCcccccchhhH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTA----MTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSF 152 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~---~~~~~~~Diwsl 152 (259)
+ ++|+|+||+||+++..+ .++++|||.+.......... ......++..|++||.+.+ ...+...|+|++
T Consensus 121 ~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred C---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 9 99999999999999988 79999999987554432221 2355679999999999987 568889999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
|++++++++|..||...... ................ .... .............+.+++..++..+|..|.+..+
T Consensus 198 g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~ 271 (384)
T COG0515 198 GITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-SLAS----PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271 (384)
T ss_pred HHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-cccc----ccCccccchhhHHHHHHHHHHHhcCchhcCCHHH
Confidence 99999999999997663321 0000111111111100 0000 0000000112256889999999999999999888
Q ss_pred HHHH
Q 025011 233 VSEE 236 (259)
Q Consensus 233 il~~ 236 (259)
....
T Consensus 272 ~~~~ 275 (384)
T COG0515 272 DLSH 275 (384)
T ss_pred Hhhc
Confidence 7764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-21 Score=146.77 Aligned_cols=218 Identities=17% Similarity=0.185 Sum_probs=168.8
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.|.+..+.| ..++|+.+|-+..++.+..||+|.+ |.||+|+..-.+.. ++..++..++.|++.-+.++|++.
T Consensus 69 QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--FSvKTV~miA~Qmi~rie~vH~k~- 144 (449)
T KOG1165|consen 69 QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--FSVKTVAMIAKQMITRIEYVHEKD- 144 (449)
T ss_pred hHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--ccHHhHHHHHHHHHHHHHHHHhcc-
Confidence 588899999999 4799999999999999999999999 99999998776553 588999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC-----CceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhhH
Q 025011 83 PPIIHGDVKSTNVLLDDN-----YKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSF 152 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~-----~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 152 (259)
+++|||||+|++|... +.+.++|||+++.+.+.... ...-...||..||+=....+...|.+.|+-||
T Consensus 145 --LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaL 222 (449)
T KOG1165|consen 145 --LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEAL 222 (449)
T ss_pred --eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHh
Confidence 9999999999999743 35899999999987654221 11224469999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc---hhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 153 GVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE---SEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|-++++.+-|.+||++..... ......++=+....+. .+.+.++++...+.-.-+.+-.+-|.
T Consensus 223 GHvFmYFLRGsLPWQGLKA~t--------------nK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 223 GHVFMYFLRGSLPWQGLKADT--------------NKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred hhhhhhhccCCCccccccCcc--------------hHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 999999999999999843221 1111222212221111 22234566777777777777778888
Q ss_pred HHHHHHHHHhcc
Q 025011 230 MKQVSEELDRLK 241 (259)
Q Consensus 230 ~~~il~~l~~~~ 241 (259)
.+-+...+.++-
T Consensus 289 Ydylr~Lf~dvl 300 (449)
T KOG1165|consen 289 YDYLRKLFDDVL 300 (449)
T ss_pred HHHHHHHHHHHH
Confidence 877777766553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=140.64 Aligned_cols=219 Identities=19% Similarity=0.184 Sum_probs=167.2
Q ss_pred HHHHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.-|.++...|++ .+|+.+..+..+.....+||+.+ |.||+++..-.... ++..+.+.++-|++.-+.|+|.++
T Consensus 56 qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmkTvLMLaDQml~RiEyvH~r~- 131 (341)
T KOG1163|consen 56 QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--FTMKTVLMLADQMLSRIEYVHLRN- 131 (341)
T ss_pred chhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhh--hhHHhHHHHHHHHHHHHHHHHhhc-
Confidence 35679999999975 78999999999999999999999 99999998765443 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC---CceEEeecCCcccccCCcc-----ccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN---YKAKVADFGSSVLISSDNQ-----TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
++|+||||+|+++.-+ +.+.++|||+++.+.+... ........||..|.+-....+...+.+.|+-|+|.
T Consensus 132 --fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgY 209 (341)
T KOG1163|consen 132 --FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGY 209 (341)
T ss_pred --cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcc
Confidence 9999999999999743 5689999999988765321 22233456999998887777778899999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhH---HHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEM---EEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
++.++.-|..||++... .....+...+.+.....+... ..|.++.-.+.-|-..--++-|...
T Consensus 210 vLmYfnrG~LPWQglka--------------~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ 275 (341)
T KOG1163|consen 210 VLMYFNRGSLPWQGLKA--------------ATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM 275 (341)
T ss_pred eeeeeecCCCcccccch--------------hhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence 99999999999999432 222233333333333332222 2345677777778777777888877
Q ss_pred HHHHHHHhccc
Q 025011 232 QVSEELDRLKI 242 (259)
Q Consensus 232 ~il~~l~~~~~ 242 (259)
-+...++-+-.
T Consensus 276 ylrqlFriLfr 286 (341)
T KOG1163|consen 276 YLRQLFRILFR 286 (341)
T ss_pred HHHHHHHHHHh
Confidence 77766655433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.8e-22 Score=160.75 Aligned_cols=174 Identities=26% Similarity=0.381 Sum_probs=131.5
Q ss_pred cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCc
Q 025011 32 VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111 (259)
Q Consensus 32 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 111 (259)
.++|.|++|...+|.+|+.........++.....++.|+..++.| ++ .+|+|++|.||++..+..++|.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999766555556778999999999999999 77 999999999999999999999999998
Q ss_pred ccccCCc----cccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHh
Q 025011 112 VLISSDN----QTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG-LKPGSGMALASNEGISMVQYFLYS 186 (259)
Q Consensus 112 ~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~ 186 (259)
....... .....+...||..|++||.+.+..|+.++|||+||+++++++.. ...|...
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------------- 466 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------------- 466 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------------
Confidence 7665543 12234456799999999999999999999999999999999973 2222210
Q ss_pred hccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 187 IENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
.....+-+..++.....+. +.-..|+.+|+...|.+||++.+
T Consensus 467 ---~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 ---ATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred ---HhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence 1111111111111111111 34567999999999999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=147.48 Aligned_cols=198 Identities=22% Similarity=0.241 Sum_probs=137.3
Q ss_pred CCccccccceeEEe---------------------------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHH
Q 025011 16 NHKNVVKILGACLE---------------------------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAA 68 (259)
Q Consensus 16 ~h~~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 68 (259)
+|||||++.++|.+ ....|+||...+. +|..++..... +......++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~----s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHR----SYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCC----chHHHHHHHH
Confidence 69999999987753 2346999998855 89999876654 4477788999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeC--CC--CceEEeecCCcccccCCc-ccccc---ccccCcccccCcchhcc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLD--DN--YKAKVADFGSSVLISSDN-QTAMT---TKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~--~~--~~~~l~df~~~~~~~~~~-~~~~~---~~~~~~~~y~aPE~~~~ 140 (259)
|+++|+.|||++| |.|+|+|.+||++. ++ -.+.++|||..---...+ ..... ...-|.-..+|||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999994 33 246888999763221110 00011 11225567789999864
Q ss_pred CC------cccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHH
Q 025011 141 GK------LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG 214 (259)
Q Consensus 141 ~~------~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (259)
.+ .-.++|.|+.|.+.||++....||.+.....-+. ..+.+ . .....+..+++.+.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~-------------r~Yqe---~-qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT-------------RTYQE---S-QLPALPSRVPPVARQ 488 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech-------------hhhhh---h-hCCCCcccCChHHHH
Confidence 33 1247999999999999999999998722111110 00100 0 011122234477999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHH
Q 025011 215 LASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 215 li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++...|+.||++|+++.-..+.+.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999876665543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.9e-21 Score=147.38 Aligned_cols=163 Identities=21% Similarity=0.210 Sum_probs=106.5
Q ss_pred ceEEEEecCCCChhhhhhc---cCCc-ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeec
Q 025011 33 PLLVYEFVPNGTLFDHIHD---KSSQ-VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108 (259)
Q Consensus 33 ~~lv~e~~~~~~L~~~l~~---~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 108 (259)
.+++|+-+ .++|.+++.. .... ..+.......+..|++..+++||..| ++|+||+|+|++++.+|.+.|+||
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~~~nfll~~~G~v~Lg~F 189 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIKPENFLLDQDGGVFLGDF 189 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEE-TTS-EEE--G
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccceeeEEEcCCCCEEEcCh
Confidence 36788888 5689888653 1111 11223344556689999999999999 999999999999999999999999
Q ss_pred CCcccccCCccccccccccCcccccCcchhccC--------CcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHH
Q 025011 109 GSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--------KLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180 (259)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 180 (259)
+.....+.... . ...+..|.|||..... .++.+.|.|+||+++|.|+++..||...........
T Consensus 190 ~~~~r~g~~~~---~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--- 261 (288)
T PF14531_consen 190 SSLVRAGTRYR---C--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--- 261 (288)
T ss_dssp GGEEETTEEEE---G--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG---
T ss_pred HHHeecCceee---c--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc---
Confidence 88766543211 1 2344778899976442 367899999999999999999999986433221110
Q ss_pred HHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
. ...+.+.++.+..||..+|+.||.+|
T Consensus 262 --------------~------f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 262 --------------D------FSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp --------------G------GTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred --------------c------chhcCCcCHHHHHHHHHHccCCcccC
Confidence 1 11122556889999999999999987
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-21 Score=156.14 Aligned_cols=196 Identities=28% Similarity=0.290 Sum_probs=157.4
Q ss_pred HHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
...|..++...+ ||.++++...+..++..++++++..+|.+...+..... +++.....+...++-++..+|+.+
T Consensus 43 t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---f~~~~~~~~~aelaLald~lh~l~-- 117 (612)
T KOG0603|consen 43 TKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---FDELDVAFYLAELALALDHLHKLG-- 117 (612)
T ss_pred cccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---hHHHHHHHHHHHHHHHHhhcchhH--
Confidence 345778888886 99999999999999999999999999999999876654 455667778889999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+|+|++||+++.+|.+++.|||+++..-..... .|+..|+|||+.. ....++|.||+|++.++|++|.
T Consensus 118 -iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~ 188 (612)
T KOG0603|consen 118 -IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGT 188 (612)
T ss_pred -HHHhcccccceeecccCccccCCchhhhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCC
Confidence 999999999999999999999999998876543222 6899999999987 4678899999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH--HHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM--KQVSEEL 237 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~--~~il~~l 237 (259)
.||.+ .....+..... ..+...+....+++..++..+|.+|.-. ..+.+..
T Consensus 189 ~pf~~---------------------~~~~~Il~~~~--~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 189 LPFGG---------------------DTMKRILKAEL--EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred CCCch---------------------HHHHHHhhhcc--CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 99886 11122222111 1233344678889999999999999755 3444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=146.68 Aligned_cols=122 Identities=20% Similarity=0.194 Sum_probs=94.6
Q ss_pred hHHHHHHHHHhcCCCccccc-cceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVK-ILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.|++|+++|++++|+|++. +++ .+..++||||++|++|... ... . ...++.+++.+|.|||+.+
T Consensus 66 ~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~~~------~---~~~~~~~i~~aL~~lH~~g 131 (365)
T PRK09188 66 HLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-RPH------G---DPAWFRSAHRALRDLHRAG 131 (365)
T ss_pred HHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-Ccc------c---hHHHHHHHHHHHHHHHHCC
Confidence 45899999999999999885 443 2457999999999998632 110 1 1467889999999999999
Q ss_pred CCCeEeCCC-CCCCeEeCCCCceEEeecCCcccccCCccccc------cccccCcccccCcchhccC
Q 025011 82 SPPIIHGDV-KSTNVLLDDNYKAKVADFGSSVLISSDNQTAM------TTKKIGTFVNLDPEYVITG 141 (259)
Q Consensus 82 ~~~i~h~di-~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~ 141 (259)
|+|||| ||+||+++.++.++|+|||+++.+........ .....+++.|++||.+...
T Consensus 132 ---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 132 ---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ---CeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999999 99999999999999999999987654321111 1234577788999987543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=4e-19 Score=131.02 Aligned_cols=148 Identities=16% Similarity=0.134 Sum_probs=111.9
Q ss_pred HHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+++|+++|++|. |+++++++++ +..+++|+|+.|.+|...... ....++.|++.++.++|++|
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G- 111 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG- 111 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc-
Confidence 5889999999995 5889999886 346999999999888654321 11347789999999999999
Q ss_pred CCeEeCCC-CCCCeEeCCCCceEEeecCCcccccCCccc----cc-------cccccCcccccCcchhccC-Ccc-cccc
Q 025011 83 PPIIHGDV-KSTNVLLDDNYKAKVADFGSSVLISSDNQT----AM-------TTKKIGTFVNLDPEYVITG-KLT-EKSD 148 (259)
Q Consensus 83 ~~i~h~di-~p~nil~~~~~~~~l~df~~~~~~~~~~~~----~~-------~~~~~~~~~y~aPE~~~~~-~~~-~~~D 148 (259)
|+|+|| +|+||+++.++.++|+|||++......... .. ......++.+++|+..... ..+ .+.+
T Consensus 112 --IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~ 189 (218)
T PRK12274 112 --VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIREL 189 (218)
T ss_pred --CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHH
Confidence 999999 799999999999999999999865433211 00 1122356667777654332 233 5678
Q ss_pred hhhHHHHHHHHHhCCCCCCC
Q 025011 149 VYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~ 168 (259)
.++.|+.+|.++|++.+.-+
T Consensus 190 w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 190 WFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHhcchHHHHHhccCCccc
Confidence 88999999999999988544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.1e-20 Score=137.44 Aligned_cols=128 Identities=12% Similarity=0.216 Sum_probs=99.9
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC--------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET--------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|++.+.++.||+|..+.+++... +..+++|||++|.+|.++.. .+. ....+++.++.
T Consensus 81 ~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~ 149 (232)
T PRK10359 81 YYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIE 149 (232)
T ss_pred HHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHH
Confidence 478999999999999999999886532 35799999999999977732 121 24569999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
.+|+.| ++|+|++|+||+++.++ ++++|||........... ..+.....+..++|+||||++
T Consensus 150 ~lH~~g---i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~ 211 (232)
T PRK10359 150 SLHQHG---MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYY 211 (232)
T ss_pred HHHHcC---CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEe
Confidence 999999 99999999999999988 999999987654321111 013334456679999999999
Q ss_pred HHHHH
Q 025011 156 LAELL 160 (259)
Q Consensus 156 l~~l~ 160 (259)
+..+.
T Consensus 212 ~~~~~ 216 (232)
T PRK10359 212 LLIYK 216 (232)
T ss_pred ehHHH
Confidence 87654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=140.68 Aligned_cols=220 Identities=20% Similarity=0.185 Sum_probs=156.9
Q ss_pred HHHhcCC---CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 10 RVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 10 ~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
+++.+|+ -+.|..+...+.-.+.-++|++|.+.|+|.+++..... .++...+.+..|++..+..||..+ |+
T Consensus 743 q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~---m~e~lv~~~~~qml~ive~lH~~~---II 816 (974)
T KOG1166|consen 743 QVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKV---MDEYLVMFFSCQMLRIVEHLHAMG---II 816 (974)
T ss_pred HHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCC---CCchhhhHHHHHHHHHHHHHHhcc---ee
Confidence 3444444 24555666655566677899999999999999984433 578889999999999999999999 99
Q ss_pred eCCCCCCCeEeC-------CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 87 HGDVKSTNVLLD-------DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 87 h~di~p~nil~~-------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
||||||+|+++. .+--++|+|||.+...........-....++-.+-.+|...|.+|+...|.|.++.+++.|
T Consensus 817 HgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~m 896 (974)
T KOG1166|consen 817 HGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVM 896 (974)
T ss_pred cccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHH
Confidence 999999999994 2345899999998655433333333445688888999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+.|+..= ...+..+..- .....-.. ..-..+++..+|+.|=..=|...++...++.
T Consensus 897 LFG~y~q-------------------~~~g~~~~~~--~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~ 952 (974)
T KOG1166|consen 897 LFGKYME-------------------VKNGSSWMVK--TNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEE 952 (974)
T ss_pred HHHHHHH-------------------hcCCcceecc--ccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHH
Confidence 9985430 0001111000 00000000 1335678888888444444899999999999
Q ss_pred ccccccchhhhhhhhhcccC
Q 025011 240 LKISHENYEHRRTEKRQSIC 259 (259)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~ 259 (259)
....+...-...-.+-++||
T Consensus 953 ~~~~~~~~~~~~i~~l~~~~ 972 (974)
T KOG1166|consen 953 VLAEHFTGLREAISKLNSIL 972 (974)
T ss_pred HHHHHHHHHHHHHHHhhhhc
Confidence 98888775555555555554
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.2e-17 Score=121.05 Aligned_cols=99 Identities=16% Similarity=0.217 Sum_probs=80.1
Q ss_pred hHHHHHHHHHhcC-----CCccccccceeEEeCC---cce-EEEEe--cCCCChhhhhhccCCcccCCHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-----NHKNVVKILGACLETK---VPL-LVYEF--VPNGTLFDHIHDKSSQVLRNWKTCLRIAAETA 71 (259)
Q Consensus 3 ~~~~~E~~~l~~l-----~h~~iv~~~~~~~~~~---~~~-lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~ 71 (259)
+.+.+|+++++.+ .||||++++++++++. .++ +|+|| +.+++|.+++++.. +++. ..++.+++
T Consensus 41 ~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----~~e~--~~~~~~~L 114 (210)
T PRK10345 41 KEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----YEED--VAQLRQLL 114 (210)
T ss_pred HHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----ccHh--HHHHHHHH
Confidence 4689999999999 5799999999999863 333 78999 55799999997642 3333 35678888
Q ss_pred HHH-HHHhhCCCCCeEeCCCCCCCeEeCC----CCceEEeecCC
Q 025011 72 SAL-DYLHSSASPPIIHGDVKSTNVLLDD----NYKAKVADFGS 110 (259)
Q Consensus 72 ~~l-~~lh~~~~~~i~h~di~p~nil~~~----~~~~~l~df~~ 110 (259)
.++ .|||+++ |+|+||||+||+++. +..++|+|++.
T Consensus 115 ~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 115 KKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred HHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 777 8999999 999999999999974 33799999543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.2e-17 Score=120.27 Aligned_cols=100 Identities=16% Similarity=0.183 Sum_probs=79.1
Q ss_pred HHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH-hhCCCCC
Q 025011 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL-HSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~~~~ 84 (259)
..|++.+..+.++++.....+... ..+|||||++++++........ .++...+..++.|++.+|.++ |+.+
T Consensus 67 ~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~g--- 138 (190)
T cd05147 67 EKEMRNLKRLVTAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDCR--- 138 (190)
T ss_pred HHHHHHHHHHHHCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---
Confidence 459999999988887554443222 2389999998877655432221 257788999999999999999 6889
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~ 114 (259)
++|+||||+||+++ ++.++|+|||++...
T Consensus 139 iiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 139 LVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99999999999998 478999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.2e-16 Score=118.99 Aligned_cols=100 Identities=25% Similarity=0.374 Sum_probs=88.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|++++..+.|++++....++...+..+++|||++|++|.+++.... . ....++.+++.++.++|+.+
T Consensus 44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~- 115 (211)
T PRK14879 44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG- 115 (211)
T ss_pred HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC-
Confidence 357889999999999999888887777788899999999999999986432 1 77889999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|+|++|.||+++ ++.++++|||.+..
T Consensus 116 --i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 116 --IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred --cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999999 78899999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-18 Score=148.00 Aligned_cols=209 Identities=22% Similarity=0.292 Sum_probs=161.6
Q ss_pred HHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhh-ccCCcccCCHHHHHHHHHHHHHHHHHHh-hCCC
Q 025011 6 QHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIH-DKSSQVLRNWKTCLRIAAETASALDYLH-SSAS 82 (259)
Q Consensus 6 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~ 82 (259)
..|..+-..+. |.|++++++........++.+++..++++++-+. ..... .+....-.++.|+..++.|+| ..+
T Consensus 68 ~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~--~~~~~~~~~~~ql~s~l~~~H~~~~- 144 (601)
T KOG0590|consen 68 DTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTG--TSSSSASRYLPQLNSGLSYLHPENG- 144 (601)
T ss_pred CccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccC--CCCcchhhhhhhhccCccccCcccc-
Confidence 34666677775 9999999999999999999999999999999884 33211 234667789999999999999 888
Q ss_pred CCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccC-CccccccccccC-cccccCcchhccC-CcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISS-DNQTAMTTKKIG-TFVNLDPEYVITG-KLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~-~~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ 158 (259)
+.|+|++|+|.+++.++ ..++.|||++..+.. .+.........| ++.|.|||.+.+. ...+..|+||+|+++..
T Consensus 145 --~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~ 222 (601)
T KOG0590|consen 145 --VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSA 222 (601)
T ss_pred --cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccc
Confidence 99999999999999999 999999999998877 555666666778 9999999999885 45678999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhcccc--CCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQV--ADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+++|..||........ ....+..... .............+++.+++..+|..|.+.+++..
T Consensus 223 ~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 223 MLTGELPWDFPSRKDG----------------RYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccCCCCccccccccc----------------cceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 9999999876332221 1111111100 01111122356788999999999999999988743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=116.78 Aligned_cols=101 Identities=18% Similarity=0.242 Sum_probs=81.1
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhh-hhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDH-IHDKSSQVLRNWKTCLRIAAETASALDYLHS-SAS 82 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~ 82 (259)
+++|.+.+.++.++++.....+... ..++||||++++++... +... ..+......++.|++.++.++|. .|
T Consensus 66 ~~~E~~~l~~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~----~~~~~~~~~i~~~l~~~l~~lH~~~g- 138 (190)
T cd05145 66 AEKEFRNLKRLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV----PLEEEEAEELYEQVVEQMRRLYQEAG- 138 (190)
T ss_pred HHHHHHHHHHHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhhc----cCCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4689999999999988655544333 24899999988755433 3322 24667889999999999999999 99
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 115 (259)
++|+||||+||+++ ++.++|+|||++....
T Consensus 139 --ivHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 139 --LVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred --EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999999 7899999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.1e-16 Score=123.17 Aligned_cols=201 Identities=22% Similarity=0.284 Sum_probs=138.3
Q ss_pred hcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 13 SQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 13 ~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
-++-|.|+++++.|+.+.+ ...++.||+..|++..+|++... +..+......+|+.||++||.|||+.. ++++
T Consensus 122 lqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppii 200 (458)
T KOG1266|consen 122 LQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPII 200 (458)
T ss_pred HHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cccc
Confidence 3446999999999887643 46899999999999999987532 233455677899999999999999986 7899
Q ss_pred eCCCCCCCeEeCCCCceEEeecCCccccc--CCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 87 HGDVKSTNVLLDDNYKAKVADFGSSVLIS--SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 87 h~di~p~nil~~~~~~~~l~df~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
|+++..+.|++..+|.+++.--.-..... ............+.++|.+||.-...+.+.++|||++|....+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 99999999999999888875321111111 1111222233457788999998777777889999999999999988754
Q ss_pred C-CCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 165 P-GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 165 p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
- -.+.+.... .......+- .. ....-.+++.+|++..|..||++++++--
T Consensus 281 q~tnseS~~~~--------------ee~ia~~i~-~l-------en~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 281 QSTNSESKVEV--------------EENIANVII-GL-------ENGLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred ccCCCcceeeh--------------hhhhhhhee-ec-------cCccccCcCcccccCCCCCCcchhhhhcC
Confidence 3 222111100 000000000 00 00223458899999999999999988643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.1e-15 Score=110.96 Aligned_cols=97 Identities=22% Similarity=0.365 Sum_probs=82.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.+.|+++.....++...+..+++|||++|++|.+++.... . .++.+++.++.++|+.+
T Consensus 42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~-------~---~~~~~i~~~l~~lH~~g- 110 (199)
T TIGR03724 42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN-------D---ELLREIGRLVGKLHKAG- 110 (199)
T ss_pred HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH-------H---HHHHHHHHHHHHHHHCC-
Confidence 456789999999998877666666666777899999999999998875431 1 78999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|+|++|.||+++ ++.++++|||++..
T Consensus 111 --i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 111 --IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred --eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999999999999 78999999998765
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.3e-15 Score=132.80 Aligned_cols=146 Identities=23% Similarity=0.263 Sum_probs=105.3
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-------------ccccccccCcccccCc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-------------TAMTTKKIGTFVNLDP 135 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-------------~~~~~~~~~~~~y~aP 135 (259)
+.+.++.|+|+-+ |+|+|+||+|.+++.-|.+|+.|||+.+....... ........||+.|.||
T Consensus 151 dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP 227 (1205)
T KOG0606|consen 151 DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP 227 (1205)
T ss_pred hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence 3478999999999 99999999999999999999999999875432211 1111223699999999
Q ss_pred chhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHH
Q 025011 136 EYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGL 215 (259)
Q Consensus 136 E~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 215 (259)
|+.....|...+|.|++|+|+|+.+-|+.||.+.... +.+.....+.. .+.+ .....+++..++
T Consensus 228 eVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg~visd~i--~wpE------~dea~p~Ea~dl 291 (1205)
T KOG0606|consen 228 EVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFGQVISDDI--EWPE------EDEALPPEAQDL 291 (1205)
T ss_pred hhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHhhhhhhhc--cccc------cCcCCCHHHHHH
Confidence 9999989999999999999999999999999882111 01111111000 0000 011223679999
Q ss_pred HHHhcccCCCCCCCHHHH
Q 025011 216 ASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 216 i~~~l~~~p~~Rpt~~~i 233 (259)
+..+|+.+|..|--....
T Consensus 292 i~~LL~qnp~~Rlgt~ga 309 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGA 309 (1205)
T ss_pred HHHHHHhChHhhcccchh
Confidence 999999999999643333
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.59 E-value=7e-15 Score=126.34 Aligned_cols=96 Identities=19% Similarity=0.314 Sum_probs=85.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.+|+++++.++|++++....++......+++|||+++++|.+++. ....++.+++.++.+||+.+
T Consensus 381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g- 448 (535)
T PRK09605 381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG- 448 (535)
T ss_pred HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999988877777778899999999999988884 34568999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|+|+||+||++ .++.++++|||+++.
T Consensus 449 --iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 449 --IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred --CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 9999999999999 577999999999864
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.6e-14 Score=119.60 Aligned_cols=146 Identities=19% Similarity=0.235 Sum_probs=111.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+..++-++-|+.++||||+++++.++.++..|||+|.+ . .|..++++.+ .......+.||+.||.+||+.++
T Consensus 54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV-~-Pl~~~lk~l~------~~~v~~Gl~qIl~AL~FL~~d~~ 125 (690)
T KOG1243|consen 54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV-R-PLETVLKELG------KEEVCLGLFQILAALSFLNDDCN 125 (690)
T ss_pred HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc-c-cHHHHHHHhH------HHHHHHHHHHHHHHHHHHhccCC
Confidence 44678888999999999999999999999999999988 3 5777776654 25566679999999999985554
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|++++.+.|+++..|..+|++|.+......... ......--..|..|+...... -..|.|.|||++++++.|
T Consensus 126 --lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 126 --LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 99999999999999999999999988755433221 111112223445565432211 346999999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.2e-14 Score=110.37 Aligned_cols=100 Identities=17% Similarity=0.239 Sum_probs=80.0
Q ss_pred hHHHHHHHHHhcCCCccc--cccceeEEeCC----cceEEEEecCC-CChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNV--VKILGACLETK----VPLLVYEFVPN-GTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~i--v~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
..+.+|++++..|.|+++ ++.+++..... ..++|||+++| .+|.+++.... ++.. .+.+++.++.
T Consensus 85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~~----l~~~----~~~~i~~~l~ 156 (239)
T PRK01723 85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEAP----LSEE----QWQAIGQLIA 156 (239)
T ss_pred hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcCC----CCHH----HHHHHHHHHH
Confidence 457889999999998775 67777654322 23599999997 68988886532 2322 3678999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
+||+.| |+|+||+|.||+++.++.++|+|||.+..
T Consensus 157 ~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 157 RFHDAG---VYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHHCC---CCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999 99999999999999988999999998765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.1e-14 Score=107.40 Aligned_cols=101 Identities=19% Similarity=0.236 Sum_probs=78.2
Q ss_pred HHHHHHHHHhcCCCc--cccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHK--NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+|+..+.++.+. .+++++++ . ..++||||+++.++........ ..+......++.|++.++.+||+.+
T Consensus 96 ~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~g 168 (237)
T smart00090 96 WAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKEG 168 (237)
T ss_pred HHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhcC
Confidence 467899999999753 33444432 2 3489999999988876553322 1344567889999999999999887
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccc
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~ 114 (259)
. ++|+||+|+||+++ ++.++++|||.+...
T Consensus 169 ~--iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 169 E--LVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred C--EEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 5 99999999999999 789999999987643
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=2.5e-13 Score=102.00 Aligned_cols=97 Identities=21% Similarity=0.245 Sum_probs=77.8
Q ss_pred HHHHHHHHHhcCCCcc--ccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
...+|..++..+.+++ +++.++ ....+++|||+++++|...... .....++.+++.++.++|+.+
T Consensus 79 ~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g 145 (198)
T cd05144 79 AAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG 145 (198)
T ss_pred HHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC
Confidence 4678999999997774 444443 2455899999999998765431 234568889999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
++|+||+|.||++++++.++|+|||.+.....
T Consensus 146 ---i~H~Dl~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 146 ---IIHGDLSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred ---CCcCCCCcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.2e-13 Score=112.84 Aligned_cols=203 Identities=23% Similarity=0.245 Sum_probs=145.6
Q ss_pred HHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHH----HHHHHhhCCC
Q 025011 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETAS----ALDYLHSSAS 82 (259)
Q Consensus 8 E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~----~l~~lh~~~~ 82 (259)
|+.....+ .|++.++.+..++.++..++-+|++ +.++.++...... .++...++..+.+... |+.++|..+
T Consensus 167 ~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~- 242 (524)
T KOG0601|consen 167 EFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN- 242 (524)
T ss_pred hhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc-
Confidence 44444444 4899999999999999999999999 5688777755432 2455777888888888 999999999
Q ss_pred CCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCcccc--c-cccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTA--M-TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~--~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|.|++|.||+..++ ..++++|||+...++...-.. . .....+...|++||.. ...++.++|++++|.++.+
T Consensus 243 --~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~ 319 (524)
T KOG0601|consen 243 --IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILE 319 (524)
T ss_pred --ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHh
Confidence 9999999999999999 889999999998887643221 1 2222678899999976 4467889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..++..+.... ....+.++-...+.....-..+..+...+..|++.+|..|++++.+.+
T Consensus 320 ~~l~~~~~~~g------------------~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 320 AILGSHLPSVG------------------KNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred hHhhcccccCC------------------CCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 98876543220 001111111111111111122244556899999999999999988754
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.43 E-value=8.7e-13 Score=94.55 Aligned_cols=101 Identities=22% Similarity=0.246 Sum_probs=85.2
Q ss_pred hHHHHHHHHHhcCCC--ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINH--KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
..+.+|+.+++.+++ .++++++.++..++..+++|||+.++++..+ +......++.+++.++..+|..
T Consensus 36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~~~~~~~~~~~l~~lh~~ 105 (155)
T cd05120 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEKEDIAEQLAELLAKLHQL 105 (155)
T ss_pred hHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHHHHHHHHHHHHHHHHhCC
Confidence 468899999999976 5899999988888889999999988777554 2356677889999999999985
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
...+++|+|++|.||++++.+.++++||+.+..
T Consensus 106 ~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 323399999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.8e-11 Score=96.98 Aligned_cols=208 Identities=21% Similarity=0.205 Sum_probs=137.1
Q ss_pred ceEEEEecCCC-Chhhhhh---ccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeec
Q 025011 33 PLLVYEFVPNG-TLFDHIH---DKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108 (259)
Q Consensus 33 ~~lv~e~~~~~-~L~~~l~---~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df 108 (259)
+-++|+.+++. .+..++. +....+.++|...+..+..++.+.+.||..| ..-||++++|+++++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcc
Confidence 56888887653 2233332 2233456789999999999999999999999 999999999999999999999986
Q ss_pred CCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHHHHHhC-CCCCCCCccccccchhHHHH
Q 025011 109 GSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLAELLTG-LKPGSGMALASNEGISMVQY 182 (259)
Q Consensus 109 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~ 182 (259)
..-.....+ ...-..+|...|.+||.-. +-.-+...|.|.||+++++++.| +.||.+..............
T Consensus 162 Dsfqi~~ng---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 162 DSFQINANG---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred cceeeccCC---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 554333221 1122346889999999754 22345679999999999999986 89999865443333222211
Q ss_pred HHHhhccchhhhhhcc-ccCCchhH-HHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHHhccccccc
Q 025011 183 FLYSIENNSLRQILNF-QVADESEM-EEIETVAGLASKCLSL--SGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 183 ~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~--~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
+....-....+.-... ......+. -.++.+..++..|+.. ++.-|||++.++..|..+..+...
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~ 306 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK 306 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence 1111000000000000 00011111 2246788899999875 467899999999999888876654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-11 Score=86.31 Aligned_cols=97 Identities=21% Similarity=0.354 Sum_probs=79.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+++-++|++++.+++--+|....=+..+.+...|+|||++|..|.+.+.... ..++..+-.-+.-||..+
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g 112 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG 112 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC
Confidence 3456789999999977677666666666677789999999999998887651 345667777788999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
|+|||+.++||.+.+++ +.++|||++.
T Consensus 113 ---ivHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 113 ---IVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred ---eecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999999999998774 9999999975
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.25 E-value=8e-11 Score=87.03 Aligned_cols=99 Identities=17% Similarity=0.215 Sum_probs=73.9
Q ss_pred HHHHHHHhcCCC--ccccccceeEEeCCcceEEEEecCCCChh-hhhhccCCcccCCHHHHHHHHHHHHHHHHHH-hhCC
Q 025011 6 QHELRVVSQINH--KNVVKILGACLETKVPLLVYEFVPNGTLF-DHIHDKSSQVLRNWKTCLRIAAETASALDYL-HSSA 81 (259)
Q Consensus 6 ~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l-h~~~ 81 (259)
++|++.|+++.. -++++++++ +..+|||||+.++.+. ..+... ..+......+..+++.++..+ |+.+
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g 145 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN 145 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 389999999953 456677764 4568999999664332 222221 123355667889999999988 8999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
++|||+++.||+++ ++.+.++|||.+....+
T Consensus 146 ---lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 146 ---LVHADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred ---eecCCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999999997 46899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.22 E-value=5.5e-11 Score=88.47 Aligned_cols=97 Identities=21% Similarity=0.306 Sum_probs=69.6
Q ss_pred HHHHHHHhcCCCcc--ccccceeEEeCCcceEEEEecCCCChhh-hhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 6 QHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFD-HIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 6 ~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
..|.+.+..+.+.+ ++++++. ...+++|||++++.+.. .+..... . ..+..++.+++.++.++|. .+
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~----~-~~~~~~~~~~~~~l~~lh~~~~ 135 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL----L-EDPEELYDQILELMRKLYREAG 135 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh----c-ccHHHHHHHHHHHHHHHhhccC
Confidence 45666666664432 4444433 24589999998854322 1211110 1 5667899999999999999 88
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCccccc
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 115 (259)
++|+||+|+||+++ ++.++++|||.+....
T Consensus 136 ---ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 136 ---LVHGDLSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred ---cCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence 99999999999999 8899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.5e-11 Score=103.76 Aligned_cols=153 Identities=22% Similarity=0.231 Sum_probs=104.6
Q ss_pred HHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccccc-------ccccCcccccCcch
Q 025011 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT-------TKKIGTFVNLDPEY 137 (259)
Q Consensus 65 ~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~-------~~~~~~~~y~aPE~ 137 (259)
.=+.+++.|+.++|...+ ++|++|.|++|++++++..|++.|+..........+... .-......|.|||+
T Consensus 103 ~nl~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~ 180 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEY 180 (700)
T ss_pred hhhhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchh
Confidence 345566688999998765 999999999999999999999999987655442222111 11235568999999
Q ss_pred hccCCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHH
Q 025011 138 VITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 138 ~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
+.+...+.++|++|+|+++|.+.. |+..+.+......+. .....+.........+.++++.+=+
T Consensus 181 ~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~---------------~~~~~~~~~~~~~s~~~p~el~~~l 245 (700)
T KOG2137|consen 181 LLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS---------------FSRNLLNAGAFGYSNNLPSELRESL 245 (700)
T ss_pred hccccccccccceeeeeEEEEEecCCcchhhccCCcchhh---------------hhhcccccccccccccCcHHHHHHH
Confidence 988778899999999999999995 555544321111100 0000011111111134457788999
Q ss_pred HHhcccCCCCCCCHHHHH
Q 025011 217 SKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il 234 (259)
.+++..++..||++..+.
T Consensus 246 ~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 246 KKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred HHHhcCCcccCcchhhhh
Confidence 999999999999766653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.1e-10 Score=94.90 Aligned_cols=103 Identities=18% Similarity=0.176 Sum_probs=72.4
Q ss_pred HHHHHHHHHhcCC-----Cccc--cccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHH-HHH
Q 025011 4 VFQHELRVVSQIN-----HKNV--VKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETAS-ALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~-----h~~i--v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~-~l~ 75 (259)
+|.+|++-+..+. ++++ ++++. ......+++|||++|++|.+........ . ....++..++. .+.
T Consensus 199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 199 DLRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLN 271 (437)
T ss_pred CHHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHH
Confidence 3667777777762 3433 33332 2234568999999999998876432111 1 12345555555 467
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
.+|..| ++|+|++|.||+++.++.++++|||++...+.
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 889999 99999999999999999999999999876553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.10 E-value=3.5e-10 Score=82.78 Aligned_cols=95 Identities=20% Similarity=0.126 Sum_probs=70.6
Q ss_pred HHHHHHHHHhcCCCcc-ccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC-
Q 025011 4 VFQHELRVVSQINHKN-VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA- 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~- 81 (259)
.+.+|+++++.+.+.+ +++++.+.. ...++|||+++|.++.+.. ......+.+++.++..||..+
T Consensus 38 ~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~~~~-----------~~~~~~~~~l~~~l~~LH~~~~ 104 (170)
T cd05151 38 NRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELLTED-----------FSDPENLEKIAKLLKKLHSSPL 104 (170)
T ss_pred CHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcccccc-----------ccCHHHHHHHHHHHHHHhCCCC
Confidence 4688999999996544 445555433 3458999999998875430 111235678999999999987
Q ss_pred -CCCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 82 -SPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 82 -~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
...++|+|++|.||+++ ++.++++||+.+.
T Consensus 105 ~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 105 PDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 12249999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.5e-11 Score=103.71 Aligned_cols=192 Identities=23% Similarity=0.252 Sum_probs=137.0
Q ss_pred CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeE
Q 025011 17 HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVL 96 (259)
Q Consensus 17 h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil 96 (259)
+|-+++....+......+++++|..+++|...+...+. .+..-....+..++.+..+||... +.|+|++|.|.+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l 936 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLL 936 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchh
Confidence 35555555555566678999999999999998876652 344455566778888999999998 999999999999
Q ss_pred eCCCCceEEeecCCcccccCC---------------------cc--------ccccccccCcccccCcchhccCCccccc
Q 025011 97 LDDNYKAKVADFGSSVLISSD---------------------NQ--------TAMTTKKIGTFVNLDPEYVITGKLTEKS 147 (259)
Q Consensus 97 ~~~~~~~~l~df~~~~~~~~~---------------------~~--------~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 147 (259)
...++...+.+|+.....+.- .. ........++..|.+||.+.+.....++
T Consensus 937 ~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~a 1016 (1205)
T KOG0606|consen 937 IAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAA 1016 (1205)
T ss_pred hcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcc
Confidence 999999999998733222110 00 0112233688999999999999999999
Q ss_pred chhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCC-chhHHHHHHHHHHHHHhcccCCCC
Q 025011 148 DVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD-ESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 148 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
|.|++|+++++.++|.+||...... .....+....... ..+...+....+++...+..+|.+
T Consensus 1017 d~~~~g~~l~e~l~g~pp~na~tpq-----------------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~q 1079 (1205)
T KOG0606|consen 1017 DWWSSGVCLFEVLTGIPPFNAETPQ-----------------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQ 1079 (1205)
T ss_pred hhhhhhhhhhhhhcCCCCCCCcchh-----------------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchh
Confidence 9999999999999999998862211 1111111111111 122233467888999999999999
Q ss_pred CCCHH
Q 025011 227 RPTMK 231 (259)
Q Consensus 227 Rpt~~ 231 (259)
|..+.
T Consensus 1080 r~~a~ 1084 (1205)
T KOG0606|consen 1080 RLGAK 1084 (1205)
T ss_pred ccCcc
Confidence 97765
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1e-09 Score=78.67 Aligned_cols=108 Identities=21% Similarity=0.304 Sum_probs=82.0
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCC-CChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPN-GTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+++-++|+++|.++.--+|.-..-++-+.+...|+|||++| .++.+++.........+ .....++.++-..+.-||.+
T Consensus 54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~n 132 (229)
T KOG3087|consen 54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDN 132 (229)
T ss_pred HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhC
Confidence 45678899999998665666666666677777899999976 47777776553333222 33367888999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCc---eEEeecCCccc
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYK---AKVADFGSSVL 113 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~ 113 (259)
+ ++||||..+||++..++. +.++|||++..
T Consensus 133 d---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 133 D---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred C---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 9 999999999999965543 48999999753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.4e-11 Score=97.42 Aligned_cols=200 Identities=18% Similarity=0.197 Sum_probs=136.2
Q ss_pred HHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 8 ELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 8 E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
|+.+...+ .|.++++.+..+......++=.|||+++++.....- ...+++..++++..|++.++.++|+.. ++
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~ 388 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FV 388 (524)
T ss_pred hhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hh
Confidence 44455555 588888877777766777899999999988777622 223567889999999999999999999 99
Q ss_pred eCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccc-cCcchhccCCcccccchhhHHHHHHHHHhCCC
Q 025011 87 HGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVN-LDPEYVITGKLTEKSDVYSFGVLLAELLTGLK 164 (259)
Q Consensus 87 h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y-~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 164 (259)
|.|++|+||++..+ +..++.||+......... .........| .++.......+..+.|++|||..+.+.+++..
T Consensus 389 ~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 389 HLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccccccceeeccchhhhhccccccccccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 99999999999886 677888998875432211 1111122223 34554445568889999999999999998754
Q ss_pred CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 165 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
.-... ..+..+......... .....+..+...++..++..||.+.++....+-
T Consensus 465 ls~~~--------------------~~~~~i~~~~~p~~~--~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 465 LSESG--------------------VQSLTIRSGDTPNLP--GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCccc--------------------ccceeeecccccCCC--chHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 32211 111111111111111 112567788999999999999999887655443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=84.32 Aligned_cols=106 Identities=17% Similarity=0.162 Sum_probs=80.6
Q ss_pred HHHHHHHHHhcCCCcccc--ccceeEEe-----CCcceEEEEecCCC-ChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNVV--KILGACLE-----TKVPLLVYEFVPNG-TLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv--~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|...+..+..-+|. .++.+.+. ....++|+|++++. +|.+++...... ..+......++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~-~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATN-PPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhccc-CCCHHHHHHHHHHHHHHHH
Confidence 367899999988544443 44555543 23468999999876 788888643221 1345677789999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCC-------CCceEEeecCCccc
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDD-------NYKAKVADFGSSVL 113 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~-------~~~~~l~df~~~~~ 113 (259)
-||..| ++|+|+++.||+++. +..+.++||+.++.
T Consensus 153 ~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999 999999999999975 46789999998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.2e-09 Score=80.44 Aligned_cols=101 Identities=25% Similarity=0.296 Sum_probs=66.9
Q ss_pred hhHHHHHHHHHhcCCCc--cccccceeEEeCCcceEEEEecC--CCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH-
Q 025011 2 NQVFQHELRVVSQINHK--NVVKILGACLETKVPLLVYEFVP--NGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY- 76 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~- 76 (259)
+...++|++.|..+..- ++++++++. ..+|||||++ |..+..+...... ......++.+++..+..
T Consensus 52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~~~-----~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 52 REWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVDLS-----PEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCGGG-----GSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcccc-----chhHHHHHHHHHHHHHHH
Confidence 35678999999999755 567776552 3479999998 5555444332211 13345567777775554
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCccccc
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 115 (259)
+|..| ++|||+++.||+++++ .+.++|||.+....
T Consensus 123 ~~~~g---ivHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 123 LHKAG---IVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHCTT---EEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred HHhcC---ceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 57999 9999999999999987 99999999886543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.9e-09 Score=84.53 Aligned_cols=136 Identities=21% Similarity=0.326 Sum_probs=102.8
Q ss_pred HHHHHhcCCCccccccceeEEe----CCcceEEEEecCC-CChhhhhhccC------------CcccCCHHHHHHHHHHH
Q 025011 8 ELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPN-GTLFDHIHDKS------------SQVLRNWKTCLRIAAET 70 (259)
Q Consensus 8 E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~~~~------------~~~~~~~~~~~~i~~~i 70 (259)
=+++++++.|+|+|++-++|.. +..+++|++|.++ ++|.++.-... ......+..+|.++.|+
T Consensus 323 lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QL 402 (655)
T KOG3741|consen 323 LVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQL 402 (655)
T ss_pred HHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHH
Confidence 3788899999999999998873 4578999999875 56666542211 12234678999999999
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchh
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVY 150 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 150 (259)
..||.++|+.| +..+-+.|.+|+++++.++++...|..-....+. + +.+.+ -.+-|.-
T Consensus 403 taaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~---------~-------~~le~---~Qq~D~~ 460 (655)
T KOG3741|consen 403 TAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP---------T-------EPLES---QQQNDLR 460 (655)
T ss_pred HHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCCC---------C-------cchhH---HhhhhHH
Confidence 99999999999 9999999999999999899998777653322211 0 11111 2357889
Q ss_pred hHHHHHHHHHhCCCC
Q 025011 151 SFGVLLAELLTGLKP 165 (259)
Q Consensus 151 slG~il~~l~~g~~p 165 (259)
.||.++..|.+|..-
T Consensus 461 ~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 461 DLGLLLLALATGTEN 475 (655)
T ss_pred HHHHHHHHHhhcccc
Confidence 999999999998654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.9e-09 Score=77.96 Aligned_cols=106 Identities=18% Similarity=0.235 Sum_probs=82.9
Q ss_pred hHHHHHHHHHhcCCCcc--ccccceeEEeCC----cceEEEEecCCC-ChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKN--VVKILGACLETK----VPLLVYEFVPNG-TLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~----~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
....+|...+..|..-+ .++++++.+... ..++|+|++++. +|.+++..... .+......++.+++..+.
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA 132 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence 35678888888885433 455666665532 348999999874 78898876433 244667889999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCC---ceEEeecCCcccc
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLI 114 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~ 114 (259)
-||..| ++|+|+++.||+++.++ .+.++||+.++..
T Consensus 133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999 99999999999999887 8999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.8e-09 Score=90.59 Aligned_cols=76 Identities=13% Similarity=0.150 Sum_probs=53.1
Q ss_pred CcceEEEEecCCCChhhh--hhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCC----ce
Q 025011 31 KVPLLVYEFVPNGTLFDH--IHDKSS-QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY----KA 103 (259)
Q Consensus 31 ~~~~lv~e~~~~~~L~~~--l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~ 103 (259)
...+++|||+.|+.+.+. +...+. ...+....+..++.|+ ...| ++|+|++|.||+++.++ .+
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~~G---ffHaDpHPGNIlv~~~g~~~~~i 303 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FRDG---FFHADMHPGNIFVSYDPPENPRY 303 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------HhCC---eeeCCCChHHeEEecCCCCCCeE
Confidence 455799999999999774 222221 1112222333344444 4578 99999999999999888 99
Q ss_pred EEeecCCcccccC
Q 025011 104 KVADFGSSVLISS 116 (259)
Q Consensus 104 ~l~df~~~~~~~~ 116 (259)
+++|||+....+.
T Consensus 304 ~llDFGivg~l~~ 316 (537)
T PRK04750 304 IALDFGIVGSLNK 316 (537)
T ss_pred EEEecceEEECCH
Confidence 9999999876654
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.76 E-value=5.8e-08 Score=74.13 Aligned_cols=107 Identities=27% Similarity=0.334 Sum_probs=76.7
Q ss_pred hHHHHHHHHHhcCCC--ccccccceeEEeC---CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINH--KNVVKILGACLET---KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
..+..|+++++.+.+ ..+++++.+.... +..+++|||++|.++.+.+.. ..++......++.+++.++..|
T Consensus 40 ~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~l 115 (223)
T cd05154 40 HDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PELSPEERRALARALADTLAAL 115 (223)
T ss_pred ccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999965 3467777776653 366899999999888775531 1134455555666666666666
Q ss_pred hhCC-----------------------------------------------------CCCeEeCCCCCCCeEeCC--CCc
Q 025011 78 HSSA-----------------------------------------------------SPPIIHGDVKSTNVLLDD--NYK 102 (259)
Q Consensus 78 h~~~-----------------------------------------------------~~~i~h~di~p~nil~~~--~~~ 102 (259)
|+.. ...++|+|+++.||+++. ++.
T Consensus 116 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~ 195 (223)
T cd05154 116 HSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRV 195 (223)
T ss_pred hCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcE
Confidence 6421 133799999999999998 566
Q ss_pred eEEeecCCccc
Q 025011 103 AKVADFGSSVL 113 (259)
Q Consensus 103 ~~l~df~~~~~ 113 (259)
+.++||+.+..
T Consensus 196 ~~iID~e~~~~ 206 (223)
T cd05154 196 VAVLDWELATL 206 (223)
T ss_pred EEEEecccccc
Confidence 89999988753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.6e-08 Score=73.85 Aligned_cols=97 Identities=19% Similarity=0.252 Sum_probs=71.6
Q ss_pred HHHHHHHHHhcCCCc--cccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 4 VFQHELRVVSQINHK--NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.-++|.+.|+.|... .+++.+++ +..++|||+++|..|...-- +......++..|+.-+..+-..|
T Consensus 155 ~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 155 AAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred HHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC
Confidence 467899999999655 78888876 45689999998866654431 11223334445555555555788
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCccccc
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 115 (259)
++|||+++-||+++++|.+.++||-.+....
T Consensus 223 ---iVHGDlSefNIlV~~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 223 ---IVHGDLSEFNILVTEDGDIVVIDWPQAVPIS 253 (304)
T ss_pred ---ccccCCchheEEEecCCCEEEEeCcccccCC
Confidence 9999999999999999999999998765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=2e-07 Score=69.30 Aligned_cols=107 Identities=19% Similarity=0.118 Sum_probs=81.2
Q ss_pred hHHHHHHHHHhcCCCc--cccccceeEEe-----CCcceEEEEecCC-CChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHK--NVVKILGACLE-----TKVPLLVYEFVPN-GTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~--~iv~~~~~~~~-----~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
..|.+|...|++|..- .++++. ++.. ....+||+|-+.+ .+|.+++...... ..+......++.+++.++
T Consensus 64 ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~i 141 (216)
T PRK09902 64 PTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAF 141 (216)
T ss_pred hHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHH
Confidence 5689999999999432 255555 3332 1245799997753 5888888664332 235567789999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCc--eEEeecCCcccc
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYK--AKVADFGSSVLI 114 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~~ 114 (259)
.-||+.| +.|+|+.+.||+++.++. +.++||.-++..
T Consensus 142 a~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 142 KKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred HHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 9999999 999999999999986667 999999876543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.55 E-value=5.2e-07 Score=66.81 Aligned_cols=106 Identities=21% Similarity=0.307 Sum_probs=82.0
Q ss_pred HHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
.+|.-+++.+.+ +++++++|+|-. +++.||...+++.............+|..+.+++.+++..+.+++......
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999976 699999999843 689999987766432111011112478999999999999999999855444
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~ 115 (259)
+.-+|++++|+.+++++.++++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 9999999999999999999999998765443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.43 E-value=5.8e-07 Score=67.19 Aligned_cols=67 Identities=22% Similarity=0.324 Sum_probs=51.9
Q ss_pred cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCc
Q 025011 32 VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111 (259)
Q Consensus 32 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 111 (259)
..+++|||++|..|.+...- ++ .+...+..++.-+|+.| ++|||++|.|++++++ .++++|++..
T Consensus 117 ~~~ll~EYIeG~~l~d~~~i-------~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i~iID~~~k 181 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIEDI-------DE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GIRIIDTQGK 181 (229)
T ss_pred EEEEEEEEecCeecccchhc-------CH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cEEEEECccc
Confidence 34689999999887665421 11 24456777899999999 9999999999999865 5999999775
Q ss_pred cc
Q 025011 112 VL 113 (259)
Q Consensus 112 ~~ 113 (259)
+.
T Consensus 182 ~~ 183 (229)
T PF06176_consen 182 RM 183 (229)
T ss_pred cc
Confidence 43
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.3e-05 Score=61.40 Aligned_cols=109 Identities=12% Similarity=0.179 Sum_probs=63.7
Q ss_pred hHHHHHHHHHhcCCCcc--ccccceeEEeCCcceEEEEecCCCC-hhhhhh--------------c----cCCc--ccCC
Q 025011 3 QVFQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGT-LFDHIH--------------D----KSSQ--VLRN 59 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~--------------~----~~~~--~~~~ 59 (259)
...++|.++++.+..-+ +++.+++...++...++|++++|.+ +...+. . -... ....
T Consensus 37 ~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~ 116 (226)
T TIGR02172 37 ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTST 116 (226)
T ss_pred HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 45789999999996433 5788888888778889999998863 211111 0 0000 0001
Q ss_pred HHHHH-HHHH----------HHHHH-HHHHhh-CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 60 WKTCL-RIAA----------ETASA-LDYLHS-SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 60 ~~~~~-~i~~----------~i~~~-l~~lh~-~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
..... .+.. .+... ..+|.. .....++|+|+.|.||++++++ +.++||+.+.
T Consensus 117 l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 117 FQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred HHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 01100 0000 01111 112211 1123479999999999999888 9999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=7.5e-06 Score=74.11 Aligned_cols=195 Identities=18% Similarity=0.203 Sum_probs=128.9
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
..-|...+..+.|+|++.++.|-.... ...+..+++...++.+.++.-+. .+....+.+..++..|+.++|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~---i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS---IPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc---cCHHHHHHHHHHHhhhHHHHHHh
Confidence 345777788889999999998876532 33466778888888888876654 35577888899999999999998
Q ss_pred CCCCeEeCCCCCC---CeEeCCCCceEEe--ecCCcccccCCccccccccccCcccccCcchhccCCccc--ccchhhHH
Q 025011 81 ASPPIIHGDVKST---NVLLDDNYKAKVA--DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTE--KSDVYSFG 153 (259)
Q Consensus 81 ~~~~i~h~di~p~---nil~~~~~~~~l~--df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DiwslG 153 (259)
. ..|.-+... +--.++.+.+... ||+.....+... .......+..+.++|......... ..|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHH
Confidence 6 555544443 3333444555555 777766554322 122233555667777766555443 47999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
.....+..|..+-... .....+.+.. ......+...+|+..++++|+++.++
T Consensus 380 ll~~~~~~~~~i~~~~--------------------~~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS--------------------AVPVSLLDVL--------STSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHhhhhhcCcccccc--------------------cchhhhhccc--------cchhhhhhhhhhcchhhhhccchhhh
Confidence 9999998875541110 0011111100 00147778899999999999999999
Q ss_pred HHH
Q 025011 234 SEE 236 (259)
Q Consensus 234 l~~ 236 (259)
+..
T Consensus 432 l~~ 434 (1351)
T KOG1035|consen 432 LTH 434 (1351)
T ss_pred hhc
Confidence 764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.10 E-value=3e-05 Score=60.18 Aligned_cols=45 Identities=11% Similarity=0.063 Sum_probs=35.5
Q ss_pred HHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhh
Q 025011 4 VFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDH 48 (259)
Q Consensus 4 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 48 (259)
.+.+|+++++.+. +--+++++++...++..++||++++|.++...
T Consensus 37 ~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 37 ELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred chHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 4778999999984 44566888887777778999999999877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.99 E-value=3.7e-05 Score=65.43 Aligned_cols=105 Identities=17% Similarity=0.168 Sum_probs=66.6
Q ss_pred HHHHHHHHhcC-----CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 5 FQHELRVVSQI-----NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 5 ~~~E~~~l~~l-----~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
|.+|+.-+.++ ..|++.-..=+.+-.+.-.++|||++|..+.+...-...+ .+...+...+.++. +.-+-.
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHH--HHHHHh
Confidence 56677766666 2444332222223344568999999999888874222211 23233333222221 233334
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
.| +.|+|.+|.||+++.+|.+.+.|||+....+.
T Consensus 284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 67 99999999999999999999999999876554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=4.9e-06 Score=70.83 Aligned_cols=149 Identities=20% Similarity=0.231 Sum_probs=106.1
Q ss_pred HHHHHHHHhcCCCcc-ccccceeEEeCCcceEEEEecCCC-ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 5 FQHELRVVSQINHKN-VVKILGACLETKVPLLVYEFVPNG-TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+-++++|.+++||| .+..++-++.+...++.++++.++ +-....... ...+.......+...-..+++++|+..
T Consensus 280 ~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~s--e~~~~~~~~~~~~r~et~~l~~l~~~~- 356 (829)
T KOG0576|consen 280 RRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVS--EIALEQYQFAYPLRKETRPLAELHSSY- 356 (829)
T ss_pred hHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChh--hHhhhhhhhhhhhhhhccccccccccc-
Confidence 466899999999999 777777777778889999999876 222222111 111222333445556667788998876
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
-+|+| ||+.++ +..+.++|+......... ......+++.++|||+.....+....|.|++|.--.++.-|
T Consensus 357 --~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~ 426 (829)
T KOG0576|consen 357 --KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPG 426 (829)
T ss_pred --ccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCC
Confidence 58887 666655 578889998876554322 34456799999999999888899999999999876677766
Q ss_pred CCCC
Q 025011 163 LKPG 166 (259)
Q Consensus 163 ~~p~ 166 (259)
-+|-
T Consensus 427 ~pPr 430 (829)
T KOG0576|consen 427 LPPR 430 (829)
T ss_pred CCCC
Confidence 6653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.95 E-value=7.4e-05 Score=56.87 Aligned_cols=99 Identities=17% Similarity=0.266 Sum_probs=68.0
Q ss_pred HHHHHHHhcCC--CccccccceeEEeCCcceEEEEecCCC-ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 6 QHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPNG-TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 6 ~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
.+|+.=|+++. +=.+++.+++.. ..|+|||+... .-.-.|..-+ .+......+..+++..+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~----~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVP----LELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCC----cCchhHHHHHHHHHHHHHHHHHhcC
Confidence 45777777773 345566666654 36999999543 1111122111 1222567778888888888776 77
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
++|+||+.-||++. ++.+.++|++.+....+
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccCC
Confidence 99999999999999 77999999999876553
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.00018 Score=65.61 Aligned_cols=43 Identities=16% Similarity=0.452 Sum_probs=33.6
Q ss_pred hHHHHHHHHHhcCC-Cccc--cccceeEEeC---CcceEEEEecCCCCh
Q 025011 3 QVFQHELRVVSQIN-HKNV--VKILGACLET---KVPLLVYEFVPNGTL 45 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~i--v~~~~~~~~~---~~~~lv~e~~~~~~L 45 (259)
..+.+|+++++.+. |+++ ++++.++.+. +..|+||||++|..+
T Consensus 83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 35889999999995 6665 7778877654 567999999988654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00032 Score=52.34 Aligned_cols=97 Identities=19% Similarity=0.241 Sum_probs=68.9
Q ss_pred hHHHHHHHHHhcCC------CccccccceeEEeCCcceEEEEecCC------CChhhhhhccCCcccCCHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN------HKNVVKILGACLETKVPLLVYEFVPN------GTLFDHIHDKSSQVLRNWKTCLRIAAET 70 (259)
Q Consensus 3 ~~~~~E~~~l~~l~------h~~iv~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~i~~~i 70 (259)
.+..+|+.-...+. +.+|.+++|+.+++...-+|+|.+.. .+|.+++.... ++. . +...+
T Consensus 56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~---~~~~L 127 (199)
T PF10707_consen 56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-E---LRQAL 127 (199)
T ss_pred HHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-H---HHHHH
Confidence 45677777777776 88999999999999888999998653 25667774432 222 2 33333
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCC----ceEEee-cCC
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNY----KAKVAD-FGS 110 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~----~~~l~d-f~~ 110 (259)
-.-..+|-+++ |+.+|++|.||++...+ .+.++| ||.
T Consensus 128 ~~f~~~l~~~~---Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 128 DEFKRYLLDHH---IVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred HHHHHHHHHcC---CeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence 44466788888 99999999999995432 577777 444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00016 Score=55.76 Aligned_cols=29 Identities=34% Similarity=0.520 Sum_probs=25.0
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
.++|+|+.+.|+++++++...++||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 38999999999999877666799999864
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0002 Score=60.10 Aligned_cols=164 Identities=18% Similarity=0.223 Sum_probs=91.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeC-CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
++.-.+.+++.+.|+|...++++-... ....+|+|++ +.|+++.+..... ...+ + + .++
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l-~~~s----------~---~----~~~- 87 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL-KDES----------L---L----AHG- 87 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc-chhh----------h---c----ccc-
Confidence 345567889999999999998876643 3578999999 6699999876542 1010 0 0 222
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
+.|-+ + .+.+| -++.. . |- +..+++||||+|.++.++.-|
T Consensus 88 --~~~~~-----~-------~~~td-~~~t~------~--------------~~-----~~~pKsdVwsl~~i~~el~L~ 127 (725)
T KOG1093|consen 88 --VLHLN-----I-------IYITD-HFLTK------Y--------------PS-----PIGPKSDVWSLGFIILELYLG 127 (725)
T ss_pred --cceeh-----h-------hhccc-ccccc------C--------------CC-----CCCcchhhhhHHHHHHHHHHh
Confidence 33321 1 12222 00000 0 00 011499999999999999998
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
...+..... .............+.......-.. .........+.++..+|+...|..||...+..
T Consensus 128 ~~l~~~~~~----s~~l~~i~k~~~~d~~~~~~a~e~---~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 128 ISLEAELTE----SEYLEILLKYYTDDQELLSTAMEH---LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred hHHHHHHHH----HHHHHHHHHhccCchhHHHHHHHH---HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 776554110 001111111111111111110000 22334457788999999999999999666553
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=7.5e-06 Score=76.22 Aligned_cols=164 Identities=12% Similarity=-0.003 Sum_probs=115.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcc-cCCHHHHHHHHHHHHHHHHHHh
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQV-LRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+|....|..-++..+|+++.....-... +...+..++|+.+|.+++.+.++.... .++..-+.....+.+....-+|
T Consensus 1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~l 1352 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVIL 1352 (2724)
T ss_pred HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhh
Confidence 4455566666677789888776654442 345689999999999999997664332 2232222222333355555554
Q ss_pred hCC--CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 79 SSA--SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~--~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
... ....+|.++++-|.++..+-.+++.++|+.+.... .....+...+++.|+.|+......++.++|+|..|+-+
T Consensus 1353 s~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1353 SLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSL 1430 (2724)
T ss_pred hcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHH
Confidence 432 34468999999999999999999999999872221 22334455678888999988888888889999999999
Q ss_pred HHHHhCCCCCC
Q 025011 157 AELLTGLKPGS 167 (259)
Q Consensus 157 ~~l~~g~~p~~ 167 (259)
|....|..+|-
T Consensus 1431 y~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1431 YLRSDGNAYFI 1441 (2724)
T ss_pred HHHhcccHHHH
Confidence 99888777654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00079 Score=53.86 Aligned_cols=102 Identities=25% Similarity=0.416 Sum_probs=64.9
Q ss_pred HHHHHHHHHhcCCC--ccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHH-HHHHHHHH---
Q 025011 4 VFQHELRVVSQINH--KNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA-AETASALD--- 75 (259)
Q Consensus 4 ~~~~E~~~l~~l~h--~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~-~~i~~~l~--- 75 (259)
...+|+++++.+.- --+.+.++.|.++. ..+.||++++|..+.+.+...... ...+ -.+...|+
T Consensus 67 ~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~--------~~~~~~~l~~~La~LH 138 (321)
T COG3173 67 DEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLG--------RQFALDALADFLAELH 138 (321)
T ss_pred HHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccch--------HHHHHHHHHHHHHHHh
Confidence 45678888888843 34556677776655 789999999885443332211110 0011 12222333
Q ss_pred -----------------------------------------------HHhhCC-----CCCeEeCCCCCCCeEeCCCCce
Q 025011 76 -----------------------------------------------YLHSSA-----SPPIIHGDVKSTNVLLDDNYKA 103 (259)
Q Consensus 76 -----------------------------------------------~lh~~~-----~~~i~h~di~p~nil~~~~~~~ 103 (259)
+++.+. .+.++|||+++.|++++.++.+
T Consensus 139 ~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~ 218 (321)
T COG3173 139 SIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPT 218 (321)
T ss_pred CCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCee
Confidence 333322 2458999999999999999999
Q ss_pred EEeecCCccc
Q 025011 104 KVADFGSSVL 113 (259)
Q Consensus 104 ~l~df~~~~~ 113 (259)
-|+||+++..
T Consensus 219 gVlDwe~~~l 228 (321)
T COG3173 219 GVLDWELATL 228 (321)
T ss_pred EEEecccccc
Confidence 9999999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00057 Score=52.41 Aligned_cols=45 Identities=24% Similarity=0.423 Sum_probs=31.2
Q ss_pred hHHHHHHHHHhcCCCc--cccccceeEEe---CCcceEEEEecCCCChhh
Q 025011 3 QVFQHELRVVSQINHK--NVVKILGACLE---TKVPLLVYEFVPNGTLFD 47 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~--~iv~~~~~~~~---~~~~~lv~e~~~~~~L~~ 47 (259)
..+.+|..+++.+... .+++++.+... ....+++|++++|..+..
T Consensus 35 ~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 35 ERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 4678899999988432 35677764432 345689999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00067 Score=57.94 Aligned_cols=86 Identities=20% Similarity=0.225 Sum_probs=57.5
Q ss_pred ccccceeEEeCCcceEEEEecCCCChhhh--hhccCCcccCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEeCCCCCCCeE
Q 025011 20 VVKILGACLETKVPLLVYEFVPNGTLFDH--IHDKSSQVLRNWKTCLRIAAETASALD-YLHSSASPPIIHGDVKSTNVL 96 (259)
Q Consensus 20 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~h~di~p~nil 96 (259)
|++++..+.. .-.|+|||++|..+.|. +.+.+- +.. .++..+..+.. -+-..| ++|+|-+|.||+
T Consensus 266 VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi----~~~---~i~~~l~~~~~~qIf~~G---ffHaDPHPGNil 333 (538)
T KOG1235|consen 266 VPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGI----SPH---DILNKLVEAYLEQIFKTG---FFHADPHPGNIL 333 (538)
T ss_pred CCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCC----CHH---HHHHHHHHHHHHHHHhcC---CccCCCCCCcEE
Confidence 6666665543 45799999999877655 333322 223 34444444322 234567 999999999999
Q ss_pred eC----CCCceEEeecCCcccccCC
Q 025011 97 LD----DNYKAKVADFGSSVLISSD 117 (259)
Q Consensus 97 ~~----~~~~~~l~df~~~~~~~~~ 117 (259)
+. .++.+.+.|||+.......
T Consensus 334 v~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 334 VRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred EecCCCCCccEEEEcccccccccHH
Confidence 98 3678999999998766543
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.001 Score=51.98 Aligned_cols=29 Identities=21% Similarity=0.241 Sum_probs=25.2
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.++|+|+.|.||++++++ +.++||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 389999999999999876 78999988753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0035 Score=50.20 Aligned_cols=43 Identities=16% Similarity=0.162 Sum_probs=34.1
Q ss_pred hHHHHHHHHHhcCC-C--ccccccceeEEe---CCcceEEEEecCCCCh
Q 025011 3 QVFQHELRVVSQIN-H--KNVVKILGACLE---TKVPLLVYEFVPNGTL 45 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h--~~iv~~~~~~~~---~~~~~lv~e~~~~~~L 45 (259)
..+..|++.|+.|. + -.++++++++.. .+..++|||++++.++
T Consensus 52 ~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 52 GVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred hHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 47899999999994 2 368888987754 3668999999988765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.00056 Score=54.35 Aligned_cols=96 Identities=22% Similarity=0.235 Sum_probs=68.3
Q ss_pred HHHHHHHHhcCC-C-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 5 FQHELRVVSQIN-H-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 5 ~~~E~~~l~~l~-h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
-.+|+..++.|. | --+++.+++. ..++|||++.+..|.....-... ..+...++..+--|-.+|
T Consensus 157 a~kEfafmkaL~e~gfpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d~---------~~ly~~lm~~Iv~la~~G- 222 (465)
T KOG2268|consen 157 ATKEFAFMKALYERGFPVPKPIDHN----RHCVVMELVDGYPLRQVRHVEDP---------PTLYDDLMGLIVRLANHG- 222 (465)
T ss_pred HHHHHHHHHHHHHcCCCCCCccccc----ceeeHHHhhcccceeeeeecCCh---------HHHHHHHHHHHHHHHHcC-
Confidence 456888888884 3 2356666653 45899999988877555432221 223444555566778899
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
++|||++--||++++++.++++||-......+
T Consensus 223 --lIHgDFNEFNimv~dd~~i~vIDFPQmvS~sh 254 (465)
T KOG2268|consen 223 --LIHGDFNEFNIMVKDDDKIVVIDFPQMVSTSH 254 (465)
T ss_pred --ceecccchheeEEecCCCEEEeechHhhccCC
Confidence 99999999999999999999999976544443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0041 Score=49.76 Aligned_cols=29 Identities=34% Similarity=0.449 Sum_probs=25.7
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
.++|+|+.|.|+++++++.+.++||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 39999999999999998777899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.0048 Score=49.99 Aligned_cols=72 Identities=19% Similarity=0.126 Sum_probs=57.0
Q ss_pred CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCC
Q 025011 31 KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110 (259)
Q Consensus 31 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~ 110 (259)
...|++|++. |+++... ....+.++..++++.+..+.-+..+-. .-|+|+..+||+++ .|++.|+||.+
T Consensus 299 ~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEeee
Confidence 3567888877 6665322 123568899999999998888877654 89999999999999 88999999999
Q ss_pred ccc
Q 025011 111 SVL 113 (259)
Q Consensus 111 ~~~ 113 (259)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 884
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.015 Score=42.28 Aligned_cols=95 Identities=13% Similarity=0.161 Sum_probs=67.0
Q ss_pred hhHHHHHHHHHhcCCCccc-cccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNV-VKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+..+..|+++|..++-.++ ++++.+..+ ++.|||+.|..|.++-.... .+-+..++.+..-|-..
T Consensus 59 r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~~----------rk~l~~vlE~a~~LD~~ 124 (201)
T COG2112 59 RRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGGD----------RKHLLRVLEKAYKLDRL 124 (201)
T ss_pred hhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhccc----------HHHHHHHHHHHHHHHHh
Confidence 3568899999999986665 455655443 46699999988877765431 12334555555566777
Q ss_pred CCCCeEeCCCC-CCCeEeCCCCceEEeecCCccc
Q 025011 81 ASPPIIHGDVK-STNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 81 ~~~~i~h~di~-p~nil~~~~~~~~l~df~~~~~ 113 (259)
| |-|+.|+ |...++.+++.+.|+||..++.
T Consensus 125 G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 125 G---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred c---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8 9999987 5666666666999999998864
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.011 Score=46.52 Aligned_cols=50 Identities=22% Similarity=0.184 Sum_probs=37.4
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 63 ~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
..+.+..+-.++.-.+... ..+||+|+.|+|++.++.+.+.|+||..+..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~-~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDD-LVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCc-eeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 3345555555566555540 1289999999999999989999999998764
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.018 Score=45.76 Aligned_cols=41 Identities=20% Similarity=0.268 Sum_probs=27.8
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCCcceEEEEecCCC
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNG 43 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~ 43 (259)
+.|..|++-|+.|. .-.+++++.+...++..++++||++.+
T Consensus 54 ~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 54 DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 46899999999993 446889999998888889999999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.77 E-value=0.044 Score=45.52 Aligned_cols=37 Identities=16% Similarity=0.231 Sum_probs=27.6
Q ss_pred HHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChh
Q 025011 6 QHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLF 46 (259)
Q Consensus 6 ~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 46 (259)
.+|.++++.+.. ..-+++++.+.. .++.||++|..+.
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 568999999954 455677777753 5999999987664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.023 Score=43.74 Aligned_cols=29 Identities=21% Similarity=0.365 Sum_probs=25.7
Q ss_pred CeEeCCCCCCCeEeCC-CCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDD-NYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~ 112 (259)
.++|+|+.+.||++++ ++.+.++||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 3899999999999998 5789999998764
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.13 Score=39.33 Aligned_cols=44 Identities=23% Similarity=0.357 Sum_probs=36.5
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCCcceEEEEecCCCChh
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNGTLF 46 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 46 (259)
+.|..|+.-|..|. .-.+++++.+....++.|+|++|++.+.+.
T Consensus 53 ~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 53 SMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred HHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 56888988888883 456889999988999999999999987664
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.51 E-value=0.044 Score=43.99 Aligned_cols=30 Identities=27% Similarity=0.338 Sum_probs=26.2
Q ss_pred CCeEeCCCCCCCeEeCCC----CceEEeecCCcc
Q 025011 83 PPIIHGDVKSTNVLLDDN----YKAKVADFGSSV 112 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~----~~~~l~df~~~~ 112 (259)
..++|+|+.+.||+++++ +.+.++||.++.
T Consensus 179 ~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 179 VVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred ceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 348999999999999985 789999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.013 Score=43.14 Aligned_cols=28 Identities=18% Similarity=0.191 Sum_probs=24.9
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.+|+|+.|.|+++++++ ++++||+.+..
T Consensus 79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 69999999999998877 88999998754
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.033 Score=44.84 Aligned_cols=30 Identities=33% Similarity=0.428 Sum_probs=26.3
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
..++|+|+++.|+++++++...++||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 349999999999999988777899998864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.027 Score=42.62 Aligned_cols=39 Identities=26% Similarity=0.275 Sum_probs=32.0
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCC
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~ 110 (259)
+.+|..+|+.. ...+|||..|+||+-|+.|-+||.|-+.
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 45677888433 3399999999999999999999999654
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.018 Score=43.63 Aligned_cols=29 Identities=24% Similarity=0.458 Sum_probs=20.9
Q ss_pred eEeCCCCCCCeEe-CCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLL-DDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~-~~~~~~~l~df~~~~~ 113 (259)
++|+|+.+.||++ +.++.++++||.++..
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 8999999999999 8889999999998753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.09 Score=42.33 Aligned_cols=28 Identities=32% Similarity=0.415 Sum_probs=24.3
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
.++|||+.+.||+++. +.+.++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 3899999999999987 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.023 Score=46.00 Aligned_cols=29 Identities=28% Similarity=0.399 Sum_probs=25.2
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
+++|+|+.|.||+++++....++||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 39999999999999977666899998864
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.31 Score=40.12 Aligned_cols=102 Identities=19% Similarity=0.228 Sum_probs=67.8
Q ss_pred HHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCCh-hhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTL-FDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
..|++=|.+|...+|+-..-+... ...|||+++.+... .-.|+.. .++...+..+-.+++.-+.-|-+...
T Consensus 214 EKE~RNLkRl~~aGIP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~----~ls~~ka~~~Y~~~v~~MR~lY~~c~-- 285 (520)
T KOG2270|consen 214 EKEMRNLKRLNNAGIPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDA----SLSTSKARELYQQCVRIMRRLYQKCR-- 285 (520)
T ss_pred HHHHHHHHHHHhcCCCCCCceeee--cceEeeeeccCCCCcCcccccc----cCChHHHHHHHHHHHHHHHHHHHHhc--
Confidence 457777888876666655554443 34699999943111 1112221 23445677777777777777655443
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~ 116 (259)
+||.||+--|+++-+ |.+.++|.+.+....+
T Consensus 286 LVHADLSEfN~Lyhd-G~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 286 LVHADLSEFNLLYHD-GKLYIIDVSQSVEHDH 316 (520)
T ss_pred eeccchhhhhheEEC-CEEEEEEccccccCCC
Confidence 999999999999875 5899999988765544
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.83 E-value=0.2 Score=40.68 Aligned_cols=28 Identities=43% Similarity=0.725 Sum_probs=25.2
Q ss_pred eEeCCCCCCCeEeCCCCc-eEEeecCCcc
Q 025011 85 IIHGDVKSTNVLLDDNYK-AKVADFGSSV 112 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~-~~l~df~~~~ 112 (259)
++|+|+.|+||+++.++. +.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 899999999999999885 8899998764
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.82 E-value=0.12 Score=42.38 Aligned_cols=30 Identities=17% Similarity=0.409 Sum_probs=25.7
Q ss_pred CeEeCCCCCCCeEeCC-CCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDD-NYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~-~~~~~l~df~~~~~ 113 (259)
.++|+|+++.||++++ ++.+.++||.++..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 3899999999999976 46799999988753
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.64 E-value=0.13 Score=41.48 Aligned_cols=41 Identities=20% Similarity=0.139 Sum_probs=25.8
Q ss_pred HHHHHHHHHHHHHHHHH-hhCCCCCeEeCCCCCCCeEeCCCC
Q 025011 61 KTCLRIAAETASALDYL-HSSASPPIIHGDVKSTNVLLDDNY 101 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~l-h~~~~~~i~h~di~p~nil~~~~~ 101 (259)
.-+..++.|++.-.-.+ .-.+-...+|.||||+||++-++.
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~ 320 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSD 320 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCC
Confidence 34556777876544233 222112299999999999995443
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.079 Score=39.62 Aligned_cols=29 Identities=24% Similarity=0.394 Sum_probs=24.2
Q ss_pred CeEeCCCCCCCeEeCCCC-----ceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNY-----KAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~-----~~~l~df~~~~ 112 (259)
.++|||+.+.|+++..++ .+.++||..+.
T Consensus 121 vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 121 VLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred EEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 389999999999997543 58899998764
|
subfamily of choline kinases |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=93.49 E-value=0.57 Score=35.12 Aligned_cols=84 Identities=31% Similarity=0.435 Sum_probs=57.9
Q ss_pred HHHHHHHHHhcCC---Cccc--cccceeEEeCC------------------cceEEEEecCCCChhhhhhccCCcccCCH
Q 025011 4 VFQHELRVVSQIN---HKNV--VKILGACLETK------------------VPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60 (259)
Q Consensus 4 ~~~~E~~~l~~l~---h~~i--v~~~~~~~~~~------------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 60 (259)
.|..|.+...+|+ +.++ ++.+||+.-.. ...||.||.+...
T Consensus 100 PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------------- 163 (207)
T PF13095_consen 100 PFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------------- 163 (207)
T ss_pred hHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------------
Confidence 4677888777774 4455 89999884321 1246777665532
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCc
Q 025011 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~ 111 (259)
.....-+.++.+-+..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 164 ~~~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 PLQIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ccchhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 111223556777788999999 999999999977 4588999864
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.47 E-value=0.066 Score=42.41 Aligned_cols=30 Identities=20% Similarity=0.594 Sum_probs=24.8
Q ss_pred CeEeCCCCCCCeEeCCCCc-eEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYK-AKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~-~~l~df~~~~~ 113 (259)
.++|+|+++.||++++++. ..|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997454 56999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.00 E-value=0.14 Score=41.39 Aligned_cols=55 Identities=20% Similarity=0.166 Sum_probs=32.9
Q ss_pred HHHHHHHHHHHHHHHHhhC-CCCCeEeCCCCCCCeEeCCCC------------------ceEEeecCCcccccC
Q 025011 62 TCLRIAAETASALDYLHSS-ASPPIIHGDVKSTNVLLDDNY------------------KAKVADFGSSVLISS 116 (259)
Q Consensus 62 ~~~~i~~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~------------------~~~l~df~~~~~~~~ 116 (259)
-+..++.|++.-.--+-+. +-...+|.||||+||++-++. .++|.||.+++..+-
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i 349 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI 349 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence 3455677775433112111 112299999999999995432 256778887765443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=92.99 E-value=1.1 Score=36.64 Aligned_cols=80 Identities=15% Similarity=0.135 Sum_probs=55.4
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc
Q 025011 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
...++++.+.+..|.-+... -.|-=+.|+||+++.++.+.+.-+|+-..++ |.=+.||.+..
T Consensus 85 ~~Klr~a~~~I~~l~e~~~t----r~~~~laPeNilf~~~l~p~~vH~Glk~~lp--------------Pye~tee~f~~ 146 (434)
T COG4499 85 TRKLRLALQNIATLSELNNT----RYTFFLAPENILFDGGLTPFFVHRGLKNSLP--------------PYEMTEERFLK 146 (434)
T ss_pred HHHHHHHHHHHHHHHHhhcc----ceeEEecchheEEcCCCceEEEecchhccCC--------------CCCCCHHHHHH
Confidence 55667788888877766544 3666788999999999999999888743221 11134554432
Q ss_pred CCcccccchhhHHHHHHHHHhCCCCCCC
Q 025011 141 GKLTEKSDVYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~g~~p~~~ 168 (259)
.+-+++..++.|..+|+.
T Consensus 147 ----------~ykA~~~~~fn~k~~Fe~ 164 (434)
T COG4499 147 ----------EYKALAIYAFNGKFSFES 164 (434)
T ss_pred ----------HHHHHHHHHHcCCccHHH
Confidence 456777888888888875
|
|
| >KOG4720 consensus Ethanolamine kinase [Lipid transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.96 E-value=0.44 Score=37.80 Aligned_cols=37 Identities=27% Similarity=0.351 Sum_probs=29.2
Q ss_pred HHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChh
Q 025011 6 QHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLF 46 (259)
Q Consensus 6 ~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 46 (259)
.+|+.-.+.| .|..-.++++.|.++ +|.||++|.+|.
T Consensus 126 e~Ev~afk~L~a~G~ap~Ly~tF~NG----Lvyefi~g~tL~ 163 (391)
T KOG4720|consen 126 ENEVIAFKLLAAYGFAPKLYGTFNNG----LVYEFIQGKTLE 163 (391)
T ss_pred HHHHHHHHHHHHcCcChhhhheecCc----eEEeeecCcccC
Confidence 3566666666 477888999999877 999999998874
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=92.88 E-value=0.099 Score=42.61 Aligned_cols=29 Identities=28% Similarity=0.391 Sum_probs=25.3
Q ss_pred eEeCCCCCCCeEeCC-CCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDD-NYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~-~~~~~l~df~~~~~ 113 (259)
++|+|+.+.||++++ ++.+.++||.++..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999974 57899999998753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.86 E-value=0.071 Score=42.98 Aligned_cols=30 Identities=17% Similarity=0.413 Sum_probs=26.8
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.+||+|+.++|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 399999999999999999999999987653
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 259 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-33 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-33 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-32 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 6e-32 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-27 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-24 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-20 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-17 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-17 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-16 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-16 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 6e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 9e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 6e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 8e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 9e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-14 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-14 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-14 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-14 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-14 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-14 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-14 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-14 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-13 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-13 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 7e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 7e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 9e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 9e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-12 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-12 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-11 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 5e-11 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 6e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-11 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 7e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 8e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-10 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-10 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-10 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 8e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 8e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 8e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 8e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 9e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-09 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-09 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 4e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 4e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-08 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 4e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-08 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 5e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 6e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-08 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-07 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 6e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 8e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 8e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 9e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-06 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-06 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 5e-06 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-05 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-05 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-05 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-05 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-05 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-05 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-05 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-05 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-05 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 6e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 6e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 7e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 7e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 8e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 9e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-05 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-04 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-04 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-04 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-04 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-04 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-04 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-04 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-04 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 2e-79
Identities = 85/234 (36%), Positives = 130/234 (55%), Gaps = 6/234 (2%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR-NWKTC 63
F+ E+ +S H ++V ++G C E +L+Y+++ NG L H++ + +W+
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
L I A L YLH+ IIH DVKS N+LLD+N+ K+ DFG S + +QT ++
Sbjct: 142 LEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT +DPEY I G+LTEKSDVYSFGV+L E+L +L +++ ++
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV-QSLPREM-VNLAEWA 256
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ S N L QI++ +AD+ E + A KCL+LS RP+M V +L
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-73
Identities = 75/230 (32%), Positives = 129/230 (56%), Gaps = 2/230 (0%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR-NWKTC 63
FQ E+ ++S H+N++++ G C+ LLVY ++ NG++ + ++ +W
Sbjct: 74 FQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKR 133
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
RIA +A L YLH P IIH DVK+ N+LLD+ ++A V DFG + L+ T +T
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM-DYKDTHVT 192
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T GT ++ PEY+ TGK +EK+DV+ +GV+L EL+TG + LA+++ + ++ +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
++ L +++ + + EE+E + +A C S RP M +V
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-73
Identities = 73/244 (29%), Positives = 127/244 (52%), Gaps = 18/244 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E++V+++ H+N+V++LG + LVY ++PNG+L D + +W
Sbjct: 77 FDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC 136
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+IA A+ +++LH IH D+KS N+LLD+ + AK++DFG + QT MT+
Sbjct: 137 KIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTS 193
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+ +GT + PE + G++T KSD+YSFGV+L E++TGL E ++
Sbjct: 194 RIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVD----EHREPQLLLDIKE 248
Query: 185 -YSIENNSLRQILNFQVAD----ESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239
E ++ D +++ +E + +AS+CL +RP +K+V + L
Sbjct: 249 EIEDEEKTIEDY-----IDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 240 LKIS 243
+ S
Sbjct: 304 MTAS 307
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 7e-56
Identities = 69/252 (27%), Positives = 120/252 (47%), Gaps = 32/252 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E+ ++ ++ H N+V +GA + +V E++ G+L+ +H ++ + + L
Sbjct: 81 FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRL 140
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+A + A ++YLH+ +PPI+H ++KS N+L+D Y KV DFG S L +S ++ +
Sbjct: 141 SMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA 199
Query: 125 KKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
GT + PE V+ + EKSDVYSFGV+L EL T +P +
Sbjct: 200 --AGTPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQPWGNL-------------- 242
Query: 184 LYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRRRPTMKQVSEELD 238
+ Q++ V + + EI VA + C + +RP+ + + L
Sbjct: 243 -------NPAQVV-AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
Query: 239 RLKISHENYEHR 250
L S +R
Sbjct: 295 PLIKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 8e-55
Identities = 69/243 (28%), Positives = 116/243 (47%), Gaps = 30/243 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F ELR +S++NH N+VK+ GACL P+ LV E+ G+L++ +H
Sbjct: 48 FIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHA 104
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYK-AKVADFGSSVLISSDNQTAM 122
+ + + + YLHS +IH D+K N+LL K+ DFG + D QT M
Sbjct: 105 MSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG----TACDIQTHM 160
Query: 123 TTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
T K G+ + PE V G +EK DV+S+G++L E++T KP + + + V
Sbjct: 161 TNNK-GSAAWMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAV- 217
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
+N R L ++ + + + L ++C S +RP+M+++ + + L
Sbjct: 218 -------HNGTRPPL---------IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL 261
Query: 241 KIS 243
Sbjct: 262 MRY 264
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 9e-55
Identities = 55/261 (21%), Positives = 101/261 (38%), Gaps = 34/261 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
++E+ + + H+N+++ +GA L+ F G+L D + + V+ +W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---ANVV-SW 120
Query: 61 KTCLRIAAETASALDYLHSSAS-------PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
IA A L YLH P I H D+KS NVLL +N A +ADFG ++
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYV-----ITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+ T ++GT + PE + + D+Y+ G++L EL + G
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADE---------SEMEEIETVAGLASKC 219
M+ + ++ SL + V + + + + +C
Sbjct: 241 PVDE-----YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEEC 295
Query: 220 LSLSGRRRPTMKQVSEELDRL 240
R + V E + ++
Sbjct: 296 WDHDAEARLSAGCVGERITQM 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-53
Identities = 63/243 (25%), Positives = 118/243 (48%), Gaps = 26/243 (10%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
Q F++E+ V+ + H N++ +G T L +V ++ +L+ H+H ++ K
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHASETKF--EMK 120
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ IA +TA +DYLH+ IIH D+KS N+ L ++ K+ DFG + S + +
Sbjct: 121 KLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSH 177
Query: 122 MTTKKIGTFVNLDPEYVITGKL----TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
+ G+ + + PE VI + + +SDVY+FG++L EL+TG P S +
Sbjct: 178 QFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-------- 228
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ + + SL L+ ++ + + L ++CL RP+ ++ E+
Sbjct: 229 NNRDQIIEMVGRGSLSPDLSKVRSNCP-----KRMKRLMAECLKKKRDERPSFPRILAEI 283
Query: 238 DRL 240
+ L
Sbjct: 284 EEL 286
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-52
Identities = 50/248 (20%), Positives = 104/248 (41%), Gaps = 43/248 (17%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLL--VYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F E + +H NV+ +LGAC P + ++P G+L++ +H+ ++ V+ +
Sbjct: 54 FNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQ 112
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
++ A + A + +LH+ P I + S +V++D++ A+++ +
Sbjct: 113 AVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARISMADVK-------FSFQ 164
Query: 123 TTKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGIS 178
+ ++ + PE + K +D++SF VLL EL+T P + +
Sbjct: 165 SPGRMYAPAWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL--------- 214
Query: 179 MVQYFLYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRRRPTMKQV 233
S +I +VA E I V+ L C++ +RP +
Sbjct: 215 ------------SNMEIG-MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMI 261
Query: 234 SEELDRLK 241
L++++
Sbjct: 262 VPILEKMQ 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-52
Identities = 72/246 (29%), Positives = 110/246 (44%), Gaps = 34/246 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q FQ E+ ++S +NH N+VK+ G P +V EFVP G L+ + DK+ + W
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPI--KWSV 123
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-----DNYKAKVADFGSSVLISSD 117
LR+ + A ++Y+ + +PPI+H D++S N+ L AKVADFG S
Sbjct: 124 KLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ---- 178
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKL---TEKSDVYSFGVLLAELLTGLKPGSGMALASN 174
+ +G F + PE I + TEK+D YSF ++L +LTG P S
Sbjct: 179 -SVHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY---SY 233
Query: 175 EGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
I F+ I LR + + + C S ++RP +
Sbjct: 234 GKIK----FINMIREEGLRPTIPEDCPPR--------LRNVIELCWSGDPKKRPHFSYIV 281
Query: 235 EELDRL 240
+EL L
Sbjct: 282 KELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-50
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 45/250 (18%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E ++ + + H N++ + G CL+ LV EF G L + K +
Sbjct: 53 VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILV 108
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLD--------DNYKAKVADFGSSVLISS 116
A + A ++YLH A PIIH D+KS+N+L+ N K+ DFG +
Sbjct: 109 NWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175
+ + G + + PE VI + ++ SDV+S+GVLL ELLTG P G+
Sbjct: 169 TTKMSAA----GAYAWMAPE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI------ 217
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRRRPTM 230
+ + VA I E A L C + RP+
Sbjct: 218 ---------------DGLAVA-YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSF 261
Query: 231 KQVSEELDRL 240
+ ++L +
Sbjct: 262 TNILDQLTTI 271
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-49
Identities = 56/259 (21%), Positives = 100/259 (38%), Gaps = 39/259 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F+ E+ Q H+NVV +GAC+ ++ TL+ + D + +
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVL--DVNKTR 133
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG----SSVLISSDNQT 120
+IA E + YLH + I+H D+KS NV D+ K + DFG S VL + +
Sbjct: 134 QIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRRED 189
Query: 121 AMTTKKIGTFVNLDPEYVITGKL----------TEKSDVYSFGVLLAELLTGLKPGSGMA 170
+ + G +L PE +I ++ SDV++ G + EL P
Sbjct: 190 KLRI-QNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ- 246
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230
E I ++ + + + E ++ + C + RPT
Sbjct: 247 --PAEAI------IWQMGTGMKPNLSQIGMGKE--------ISDILLFCWAFEQEERPTF 290
Query: 231 KQVSEELDRLKISHENYEH 249
++ + L++L + H
Sbjct: 291 TKLMDMLEKLPKRNRRLSH 309
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-47
Identities = 59/266 (22%), Positives = 101/266 (37%), Gaps = 35/266 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E++V+ + H NV+K +G + K + E++ GTL I SQ W +
Sbjct: 54 FLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY--PWSQRV 111
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A + AS + YLHS IIH D+ S N L+ +N VADFG + L+ +
Sbjct: 112 SFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168
Query: 125 KKIGTFVNLD------------PEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMAL 171
+ + PE +I G+ EK DV+SFG++L E++ +
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY-- 225
Query: 172 ASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231
L + + + +C L +RP+
Sbjct: 226 ------LPRTMDFGLNVRGFLDR--------YCPPNCPPSFFPITVRCCDLDPEKRPSFV 271
Query: 232 QVSEELDRLKISHENYEHRRTEKRQS 257
++ L+ L++ + + Q
Sbjct: 272 KLEHWLETLRMHLAGHLPLGPQLEQL 297
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 6e-44
Identities = 54/267 (20%), Positives = 114/267 (42%), Gaps = 34/267 (12%)
Query: 5 FQHELRV--VSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQVLR 58
+ E + + H+N++ + A ++ L+ ++ NG+L+D++ +
Sbjct: 76 WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTL---- 131
Query: 59 NWKTCLRIAAETASALDYLHSSAS-----PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ K+ L++A + S L +LH+ P I H D+KS N+L+ N +AD G +V
Sbjct: 132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK 191
Query: 114 ISS--DNQTAMTTKKIGTFVNLDPEYVITGKL-------TEKSDVYSFGVLLAELLTGLK 164
S + ++GT + PE V+ L +D+YSFG++L E+
Sbjct: 192 FISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 165 PGSGMA---LASNEGISM---VQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASK 218
G + L ++ + + + LR + + + + ++ L ++
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQM---GKLMTE 307
Query: 219 CLSLSGRRRPTMKQVSEELDRLKISHE 245
C + + R T +V + L ++ S +
Sbjct: 308 CWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-42
Identities = 48/260 (18%), Positives = 103/260 (39%), Gaps = 38/260 (14%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
EL + H+N++ + + + ++ L+ + G+L+D++ + + +C
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTL----DTVSC 107
Query: 64 LRIAAETASALDYLHSSAS-----PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
LRI AS L +LH P I H D+KS N+L+ N + +AD G +V+ S
Sbjct: 108 LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQST 167
Query: 119 QTAMT--TKKIGTFVNLDPEYVITGKL-------TEKSDVYSFGVLLAELLTGLKPGSGM 169
++GT + PE V+ + ++ D+++FG++L E+ + +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
Query: 170 ALASNEGISMVQYFLYSIENNSLRQILNFQV---------ADESEMEEIETVAGLASKCL 220
++ + S + + ++A L +C
Sbjct: 227 ------EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW 280
Query: 221 SLSGRRRPTMKQVSEELDRL 240
+ R T ++ + L ++
Sbjct: 281 YQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-41
Identities = 52/269 (19%), Positives = 107/269 (39%), Gaps = 40/269 (14%)
Query: 5 FQHELRV--VSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQVLR 58
+ E + + H+N++ + A + LV ++ +G+LFD+++ +
Sbjct: 81 WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----V 136
Query: 59 NWKTCLRIAAETASALDYLHSSAS-----PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ +++A TAS L +LH P I H D+KS N+L+ N +AD G +V
Sbjct: 137 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 114 ISSDNQTA--MTTKKIGTFVNLDPEYVITGKL-------TEKSDVYSFGVLLAELLTGLK 164
S T ++GT + PE V+ + +++D+Y+ G++ E+
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE---------SEMEEIETVAGL 215
G + Y+ + S+ ++ + E + +A +
Sbjct: 256 IGGIHED------YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 216 ASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+C +G R T ++ + L +L
Sbjct: 310 MRECWYANGAARLTALRIKKTLSQLSQQE 338
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 2e-40
Identities = 51/282 (18%), Positives = 99/282 (35%), Gaps = 47/282 (16%)
Query: 3 QVFQHELRV--VSQINHKNVVKILGACLETKVP-----LLVYEFVPNGTLFDHIHDKSSQ 55
Q F +E + V + H N+ + + LLV E+ PNG+L ++ +S
Sbjct: 50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS- 108
Query: 56 VLRNWKTCLRIAAETASALDYLHSSAS------PPIIHGDVKSTNVLLDDNYKAKVADFG 109
+W + R+A L YLH+ P I H D+ S NVL+ ++ ++DFG
Sbjct: 109 ---DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 110 SSVLISS------DNQTAMTTKKIGTFVNLDPEY-------VITGKLTEKSDVYSFGVLL 156
S+ ++ + ++GT + PE ++ D+Y+ G++
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 157 AELLTGLKPGSGMALASNEGISMVQ--YFLYSIENNSLRQILNFQVAD----------ES 204
E+ L E + Q + + + + + +
Sbjct: 226 WEIFMRCT-----DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKE 280
Query: 205 EMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISHEN 246
+ ++ C R T + E + L + E
Sbjct: 281 NSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-32
Identities = 46/164 (28%), Positives = 78/164 (47%), Gaps = 7/164 (4%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F+ E+ SQ++H+N+V ++ E LV E++ TL ++I + T +
Sbjct: 58 FEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAI 114
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + H I+H D+K N+L+D N K+ DFG + +S + T T
Sbjct: 115 NFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TN 170
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+GT PE E +D+YS G++L E+L G P +G
Sbjct: 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-31
Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 38/248 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E R++ Q +H N+V+++G C + + +V E V G + + +++ KT L
Sbjct: 159 FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARL--RVKTLL 216
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
++ + A+ ++YL S IH D+ + N L+ + K++DFG S + A
Sbjct: 217 QMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273
Query: 125 KKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGIS 178
+ + PE + G+ + +SDV+SFG+LL E + G P ++ +
Sbjct: 274 LR-----QVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ--QTRE 326
Query: 179 MVQ--YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236
V+ L E + V L +C + +RP+ + +E
Sbjct: 327 FVEKGGRLPCPELCP------------------DAVFRLMEQCWAYEPGQRPSFSTIYQE 368
Query: 237 LDRLKISH 244
L ++ H
Sbjct: 369 LQSIRKRH 376
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 52/264 (19%), Positives = 102/264 (38%), Gaps = 50/264 (18%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQV 56
+ Q E + NH N+++++ CL + L+ F GTL++ I +
Sbjct: 69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG 128
Query: 57 LR-NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
L + L+ +H+ H D+K TN+LL D + + D GS
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
Query: 116 SDNQTAMT-------TKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLAELLTGLK 164
+ + + T PE + + + + E++DV+S G +L ++ G
Sbjct: 186 IHVEGSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
Query: 165 P-------GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLAS 217
P G +ALA +S+ Q +S ++L Q+L +
Sbjct: 245 PYDMVFQKGDSVALAVQNQLSIPQSPRHS---SALWQLL--------------------N 281
Query: 218 KCLSLSGRRRPTMKQVSEELDRLK 241
+++ +RP + + +L+ L+
Sbjct: 282 SMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-30
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 30/260 (11%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E V+ +I H N+V++LG C ++ EF+ G L D++ + + Q + +
Sbjct: 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVV 319
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L +A + +SA++YL IH ++ + N L+ +N+ KVADFG S L++ D TA
Sbjct: 320 LLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQ 181
K PE + K + KSDV++FGVLL E+ T G+ P G+ L ++ +++
Sbjct: 377 AGAKFPIKWT-APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE 433
Query: 182 --YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239
Y + E E V L C + RP+ ++ + +
Sbjct: 434 KDYRMERPEGCP------------------EKVYELMRACWQWNPSDRPSFAEIHQAFET 475
Query: 240 L--KISHENYEHRRTEKRQS 257
+ + S + + KR +
Sbjct: 476 MFQESSISDEVEKELGKRGT 495
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-30
Identities = 39/173 (22%), Positives = 68/173 (39%), Gaps = 21/173 (12%)
Query: 5 FQHELRVVSQINHKNVVKIL-----GACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
E + ++++ H ++V+I V +V E+V +L K
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLP----- 180
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ E AL YLHS +++ D+K N++L + + K+ D G +S N
Sbjct: 181 VAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG---AVSRINS 233
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALA 172
GT PE ++ T +D+Y+ G LA L L +G +
Sbjct: 234 FGYL---YGTPGFQAPE-IVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD 282
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 40/265 (15%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E V+ +I H N+V++LG C ++ EF+ G L D++ + + Q + +
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVV 112
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L +A + +SA++YL IH D+ + N L+ +N+ KVADFG S L++ D TA
Sbjct: 113 LLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 123 TTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGIS 178
K T PE + K + KSDV++FGVLL E+ T G+ P G+ L+ +
Sbjct: 170 AGAKFPIKWT----APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYE 223
Query: 179 MVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
+++ Y + E + ++ M C + RP+ ++
Sbjct: 224 LLEKDYRMERPEGCPEKVYEL----------M----------RACWQWNPSDRPSFAEIH 263
Query: 235 EELDRLKISHENYEH--RRTEKRQS 257
+ + + + + KR +
Sbjct: 264 QAFETMFQESSISDEVEKELGKRGT 288
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 5e-29
Identities = 51/249 (20%), Positives = 93/249 (37%), Gaps = 47/249 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLE---------TKVPLLVY---EFVPNGTLFDHIHDKSSQ 55
E++ ++++ H +V+ A LE + + +Y + L D ++ + +
Sbjct: 53 EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTI 112
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
R CL I + A A+++LHS ++H D+K +N+ + KV DFG +
Sbjct: 113 EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 116 SDNQTAMT----------TKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLK 164
D + T ++GT + + PE I G + K D++S G++L ELL
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYPFS 228
Query: 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224
L + N + + E + LS S
Sbjct: 229 TQMERVRT-----------LTDVRNLKFPPLFTQKYPCEYV---------MVQDMLSPSP 268
Query: 225 RRRPTMKQV 233
RP +
Sbjct: 269 MERPEAINI 277
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 11/169 (6%)
Query: 5 FQHELRVVSQINHKNVVKIL----GACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
F+ E + + +NH +V + +P +V E+V TL D +H +
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 115
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
K + + A+ AL++ H + IIH DVK N+++ KV DFG + I+ +
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 121 AMTTKKI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
T + GT L PE + +SDVYS G +L E+LTG P +G
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 38/170 (22%), Positives = 66/170 (38%), Gaps = 9/170 (5%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
Q E R ++ +VV I + + L + + +
Sbjct: 81 MQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP---RAV 137
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
I + SALD H++ H DVK N+L+ + A + DFG + + + T
Sbjct: 138 AIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ-LG 193
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP--GSGMALA 172
+GT + PE T ++D+Y+ +L E LTG P G +++
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-29
Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 32/251 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ F E +V+ ++ H+ +V++ ++ P+ +V E++ G+L D + ++ + L
Sbjct: 224 EAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLP 280
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ +AA+ AS + Y+ +H D+++ N+L+ +N KVADFG + LI + TA
Sbjct: 281 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMV 180
K PE + G+ T KSDV+SFG+LL EL T G P GM E + V
Sbjct: 338 RQGAKFPIKWT-APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 394
Query: 181 Q--YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238
+ Y + E++ L +C RPT + + L+
Sbjct: 395 ERGYRMPCPPECP------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 436
Query: 239 RLKISHE-NYE 248
S E Y+
Sbjct: 437 DYFTSTEPQYQ 447
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 66/251 (26%), Positives = 114/251 (45%), Gaps = 32/251 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ F E +V+ ++ H+ +V++ ++ P+ +V E++ G+L D + ++ + L
Sbjct: 307 EAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYL-RLP 363
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ +AA+ AS + Y+ +H D+++ N+L+ +N KVADFG + LI + TA
Sbjct: 364 QLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 420
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMV 180
K PE + G+ T KSDV+SFG+LL EL T G P GM E + V
Sbjct: 421 RQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQV 477
Query: 181 Q--YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238
+ Y + E++ L +C RPT + + L+
Sbjct: 478 ERGYRMPCPPECP------------------ESLHDLMCQCWRKEPEERPTFEYLQAFLE 519
Query: 239 RLKISHE-NYE 248
S E Y+
Sbjct: 520 DYFTSTEPQYQ 530
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 59/242 (24%), Positives = 100/242 (41%), Gaps = 44/242 (18%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHI--HDK-SSQ 55
Q F+ E ++ + H N+V+ + T +LV E + +GTL ++ +
Sbjct: 70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK 129
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLI 114
VLR+W + L +LH+ +PPIIH D+K N+ + K+ D G + L
Sbjct: 130 VLRSW------CRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182
Query: 115 SSDNQTAMTTKKIGTFVNLDPEY----VITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
+ A+ IGT PE+ + K E DVY+FG+ + E+ T P S
Sbjct: 183 RASFAKAV----IGT-----PEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQ 233
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230
+ Q +Y + ++ +VA E IE C+ + R ++
Sbjct: 234 -------NAAQ--IYRRVTSGVKPASFDKVAIPEVKEIIE-------GCIRQNKDERYSI 277
Query: 231 KQ 232
K
Sbjct: 278 KD 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 57/253 (22%), Positives = 104/253 (41%), Gaps = 35/253 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E ++ +H NV+ +LG CL ++ L V ++ +G L + I +++ K
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDL 130
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + A + YL AS +H D+ + N +LD+ + KVADFG + + ++
Sbjct: 131 IGFGLQVAKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187
Query: 124 TKKIGTF-VN-LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMV 180
K V + E + T K T KSDV+SFGVLL EL+T G P + +
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTF----- 239
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEE----IETVAGLASKCLSLSGRRRPTMKQVSEE 236
I + + + + + + + KC RP+ ++
Sbjct: 240 -------------DITVY-LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
Query: 237 LDRLKISHENYEH 249
+ + + +
Sbjct: 286 ISAIFSTFIGEHY 298
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-27
Identities = 66/256 (25%), Positives = 122/256 (47%), Gaps = 44/256 (17%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRN 59
Q F E V++Q+ H N+V++LG +E K L +V E++ G+L D++ + VL
Sbjct: 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-G 115
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
L+ + + A++YL +H D+ + NVL+ ++ AKV+DFG ++ +
Sbjct: 116 GDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFG----LTKEAS 168
Query: 120 TAMTTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNE 175
+ T K+ T PE + K + KSDV+SFG+LL E+ + G P + L +
Sbjct: 169 STQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--D 222
Query: 176 GISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231
+ V+ Y + + + ++ ++ M+ C L RP+
Sbjct: 223 VVPRVEKGYKMDAPDGCPPAVYEV----------MKN----------CWHLDAAMRPSFL 262
Query: 232 QVSEELDRLKISHENY 247
Q+ E+L+ + +HE +
Sbjct: 263 QLREQLEHI-KTHELH 277
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-27
Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 9/169 (5%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E ++ +NH NV+ ++G L + +P ++ ++ +G L I K
Sbjct: 69 FLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNP--TVKDL 126
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + A ++YL A +H D+ + N +LD+++ KVADFG + I ++
Sbjct: 127 ISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 124 TKKIGTF-VN-LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ V E + T + T KSDV+SFGVLL ELLT G P +
Sbjct: 184 QHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHI 232
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 53/174 (30%), Positives = 92/174 (52%), Gaps = 17/174 (9%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRN 59
Q F E V++Q+ H N+V++LG +E K L +V E++ G+L D++ + VL
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-G 287
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
L+ + + A++YL + +H D+ + NVL+ ++ AKV+DFG ++ +
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFG----LTKEAS 340
Query: 120 TAMTTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ T K+ T PE + K + KSDV+SFG+LL E+ + G P +
Sbjct: 341 STQDTGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-27
Identities = 49/171 (28%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ F E V+ +++H +V++ G CLE LV EF+ +G L D++ + +T
Sbjct: 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLF--AAET 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L + + + YL +IH D+ + N L+ +N KV+DFG + + D T+
Sbjct: 106 LLGMCLDVCEGMAYL---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162
Query: 123 TTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
T K PE + + KSDV+SFGVL+ E+ + G P
Sbjct: 163 TGTKFPVKWA----SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 209
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 64/248 (25%), Positives = 104/248 (41%), Gaps = 35/248 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E V+ + H +VK+ TK P+ ++ EF+ G+L D +
Sbjct: 230 FLAEANVMKTLQHDKLVKLHAVV--TKEPIYIITEFMAKGSLLDFLKSDEGSKQ-PLPKL 286
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ +A+ A + ++ IH D+++ N+L+ + K+ADFG + +I + TA
Sbjct: 287 IDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQ- 181
K PE + G T KSDV+SFG+LL E++T G P GM+ E I ++
Sbjct: 344 GAKF-PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALER 400
Query: 182 -YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238
Y + EN L I M +C RPT + + LD
Sbjct: 401 GYRMPRPENCPEELYNI----------MM----------RCWKNRPEERPTFEYIQSVLD 440
Query: 239 RLKISHEN 246
+ E+
Sbjct: 441 DFYTATES 448
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 59/253 (23%), Positives = 103/253 (40%), Gaps = 37/253 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E ++ +H NV+ +LG CL ++ L V ++ +G L + I +++ K
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDL 194
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + A + +L AS +H D+ + N +LD+ + KVADFG + + ++
Sbjct: 195 IGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 251
Query: 124 TKKIGTF-VN-LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG-ISM 179
K V + E + T K T KSDV+SFGVLL EL+T G P + +
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVY 308
Query: 180 VQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235
+ L E + L ++ M KC RP+ ++
Sbjct: 309 LLQGRRLLQPEYCPDPLYEV----------M----------LKCWHPKAEMRPSFSELVS 348
Query: 236 ELDRLKISHENYE 248
+ + +
Sbjct: 349 RISAIFSTFIGEH 361
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 44/173 (25%), Positives = 84/173 (48%), Gaps = 21/173 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E V++ +++ +V ++LG CL + V L+ + +P G L D++ + + + L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLL 120
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A ++YL ++H D+ + NVL+ K+ DFG + L+ ++ +
Sbjct: 121 NWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 125 K-KIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K+ P E ++ T +SDV+S+GV + EL+T G KP G+
Sbjct: 178 GGKV-------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 3e-27
Identities = 43/171 (25%), Positives = 85/171 (49%), Gaps = 13/171 (7%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F E +V+ ++H+ +V++ G C + + ++ E++ NG L +++ + + +
Sbjct: 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQ 121
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L + + A++YL S +H D+ + N L++D KV+DFG S + D T+
Sbjct: 122 LLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178
Query: 123 TTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K + PE ++ K + KSD+++FGVL+ E+ + G P
Sbjct: 179 VGSKFPVRWS----PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 4e-27
Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 16/169 (9%)
Query: 1 MNQVFQ--HELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVL 57
Q E+ + S + H N++++ G + L+ E+ P GT++ + +
Sbjct: 50 AGVEHQLRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYREL--QKLSKF 106
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+T E A+AL Y HS +IH D+K N+LL + K+ADFG SV +
Sbjct: 107 DEQRTA-TYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVH--AP 160
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
+ GT L PE +I G++ EK D++S GVL E L G P
Sbjct: 161 SSRRTDL--CGTLDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-27
Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 13/171 (7%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F E + + +++H +VK G C + +V E++ NG L +++ +
Sbjct: 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGL--EPSQ 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
L + + + +L S IH D+ + N L+D + KV+DFG + + D +
Sbjct: 106 LLEMCYDVCEGMAFL---ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS 162
Query: 123 TTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K + PE K + KSDV++FG+L+ E+ + G P
Sbjct: 163 VGTKFPVKWS----APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 51/253 (20%), Positives = 113/253 (44%), Gaps = 38/253 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLET-KVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F+ E+ ++ + H N+VK G C + L L+ E++P G+L D++ ++ +
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIK 115
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L+ ++ ++YL + IH D+ + N+L+++ + K+ DFG + ++ D +
Sbjct: 116 LLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ F PE + K + SDV+SFGV+L EL T ++ I
Sbjct: 173 VKEPGESPIFW-YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIET-------------VAGLASKCLSLSGRRR 227
+ Q++ F + +E ++ + + ++C + + +R
Sbjct: 232 KQG----------QMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 276
Query: 228 PTMKQVSEELDRL 240
P+ + ++ +D++
Sbjct: 277 PSFRDLALRVDQI 289
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-27
Identities = 60/265 (22%), Positives = 108/265 (40%), Gaps = 40/265 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKV-PL-LVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
FQ E++++ ++ +VK G L LV E++P+G L D + +++ +
Sbjct: 71 FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL--DASR 128
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L +++ ++YL S +H D+ + N+L++ K+ADFG + L+ D
Sbjct: 129 LLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 121 AMTTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALAS 173
+ P E + + +SDV+SFGV+L EL T K S A
Sbjct: 186 VREPGQS-------PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA--- 235
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESE-MEEIET----VAGLASKCLSLSGRRRP 228
E + M+ + L ++L +E + + V L C + S + RP
Sbjct: 236 -EFLRMMGCERDVPALSRLLELL-----EEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 229 TMKQVSEELDRLKISHENYEHRRTE 253
+ + +LD L T
Sbjct: 290 SFSALGPQLDML---WSGSRGCETH 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 51/258 (19%), Positives = 113/258 (43%), Gaps = 38/258 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKV-PL-LVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
F+ E+ ++ + H N+VK G C L L+ E++P G+L D++ ++ +
Sbjct: 89 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI--DHIK 146
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L+ ++ ++YL + IH D+ + N+L+++ + K+ DFG + ++ D +
Sbjct: 147 LLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 203
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ F PE + K + SDV+SFGV+L EL T ++ I
Sbjct: 204 VKEPGESPIFW-YAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIET-------------VAGLASKCLSLSGRRR 227
+ Q++ F + +E ++ + + ++C + + +R
Sbjct: 263 KQG----------QMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR 307
Query: 228 PTMKQVSEELDRLKISHE 245
P+ + ++ +D+++
Sbjct: 308 PSFRDLALRVDQIRDQMA 325
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 46/184 (25%), Positives = 84/184 (45%), Gaps = 24/184 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFD----HIHDKSSQVLRNW 60
F +E V+ + N +VV++LG + + L++ E + G L ++ +
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 61 KTC---LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+ +++A E A + YL + +H D+ + N ++ +++ K+ DFG + I
Sbjct: 135 PSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191
Query: 118 NQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMAL 171
+ K + L PE + G T SDV+SFGV+L E+ T +P G+
Sbjct: 192 DYYRKGGKGL-----LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-- 244
Query: 172 ASNE 175
SNE
Sbjct: 245 -SNE 247
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 22/167 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
+ E+ + S + H N++++ + + L+ EF P G L+ + + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKEL--QKHGRFDEQRSA 117
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
E A AL Y H +IH D+K N+L+ + K+ADFG SV + + T
Sbjct: 118 -TFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRT 171
Query: 124 TKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
GT +Y +I GK EK D++ GVL E L G+ P
Sbjct: 172 M--CGT-----LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-26
Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 9/168 (5%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N++++ G ++ ++V E++ NG+L + Q +
Sbjct: 97 FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLV 154
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + YL +H D+ + NVL+D N KV+DFG S ++ D A TT
Sbjct: 155 GMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTT 211
Query: 125 KKIGTF-VN-LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
G + PE + + SDV+SFGV++ E+L G +P M
Sbjct: 212 TG-GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM 258
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-26
Identities = 67/253 (26%), Positives = 107/253 (42%), Gaps = 41/253 (16%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLL-VYEFVPNGTLFDHIHDKSSQVLRNWK 61
F E ++ Q+ H+ +V++ T+ P+ + E++ NG+L D + S L
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEYMENGSLVDFLKTPSGIKL-TIN 109
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
L +AA+ A + ++ IH D+++ N+L+ D K+ADFG + LI + TA
Sbjct: 110 KLLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166
Query: 122 MTTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGI 177
K T PE + G T KSDV+SFG+LL E++T G P GM E I
Sbjct: 167 REGAKFPIKWT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVI 220
Query: 178 SMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
++ Y + +N L Q+ M C RPT +
Sbjct: 221 QNLERGYRMVRPDNCPEELYQL----------M----------RLCWKERPEDRPTFDYL 260
Query: 234 SEELDRLKISHEN 246
L+ + E
Sbjct: 261 RSVLEDFFTATEG 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 41/193 (21%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPL-------------LVYEFVPNGTLFDHIHDK 52
E+ +++ +NH+ VV+ A LE + + + E+ NGTL+D IH +
Sbjct: 50 LSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE 109
Query: 53 SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112
+ R+ R+ + AL Y+HS IIH D+K N+ +D++ K+ DFG +
Sbjct: 110 NLNQQRD--EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAK 164
Query: 113 LISSDNQTAMT------------TKKIGTFVNLDPEY----VITGKLT--EKSDVYSFGV 154
+ T IGT Y V+ G EK D+YS G+
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGT-----AMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 155 LLAELLTGLKPGS 167
+ E++ G
Sbjct: 220 IFFEMIYPFSTGM 232
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-26
Identities = 51/249 (20%), Positives = 94/249 (37%), Gaps = 48/249 (19%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPL----------------LVYEFVPNGTL 45
N+ + E++ +++++H N+V G + EF GTL
Sbjct: 48 NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL 107
Query: 46 FDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKV 105
I + + L L + + +DY+HS +I+ D+K +N+ L D + K+
Sbjct: 108 EQWIEKRRGEKLDK-VLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKI 163
Query: 106 ADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLK 164
DFG + +D T+ GT + PE I+ + ++ D+Y+ G++LAELL
Sbjct: 164 GDFGLVTSLKNDG---KRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD 219
Query: 165 PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224
F + + + I + + L K LS
Sbjct: 220 TAFET-----------SKFFTDLRDGIISDIFDKKEKT------------LLQKLLSKKP 256
Query: 225 RRRPTMKQV 233
RP ++
Sbjct: 257 EDRPNTSEI 265
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 46/169 (27%), Positives = 87/169 (51%), Gaps = 11/169 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N++++ G ++K ++V E++ NG+L + +Q +
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLV 150
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ AS + YL +H D+ + N+L++ N KV+DFG ++ D + A TT
Sbjct: 151 GMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
Query: 125 KKIGTFVNLD---PEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ G + + PE + K T SDV+S+G++L E+++ G +P M
Sbjct: 208 R--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM 254
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-26
Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 9/166 (5%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLL--VYEFVPNGTLFDHI-HDKSSQVLRNWKT 62
E+ ++ ++ H N+V+ ++ L V E+ G L I + + +
Sbjct: 53 VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 63 CLRIAAETASALDYLHS--SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
LR+ + AL H ++H D+K NV LD K+ DFG + +++ D
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF 172
Query: 121 AMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
A T +GT + PE + EKSD++S G LL EL + P
Sbjct: 173 AKT--FVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-26
Identities = 35/172 (20%), Positives = 75/172 (43%), Gaps = 27/172 (15%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIH-----DKSSQVLRNWK 61
EL++++ I ++ + G + + ++YE++ N ++ DK+ +
Sbjct: 93 ELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN-QT 120
I ++ Y+H+ + I H DVK +N+L+D N + K++DFG S + +
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKG 209
Query: 121 AMTTKKIGTFVNLDPEY----VITGKLT---EKSDVYSFGVLLAELLTGLKP 165
+ GT E+ + + + K D++S G+ L + + P
Sbjct: 210 SR-----GT-----YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-26
Identities = 56/266 (21%), Positives = 112/266 (42%), Gaps = 47/266 (17%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E V++ +++ +V ++LG CL + V L+ + +P G L D++ + + + L
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI--GSQYLL 120
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A ++YL ++H D+ + NVL+ K+ DFG + L+ ++ +
Sbjct: 121 NWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 125 K-KIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG 176
K+ P E ++ T +SDV+S+GV + EL+T G KP G+ + E
Sbjct: 178 GGKV-------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EI 228
Query: 177 ISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232
S+++ L + I M KC + RP ++
Sbjct: 229 SSILEKGERLPQPPICTIDVYMI----------M----------VKCWMIDADSRPKFRE 268
Query: 233 VSEELDRLKISHENYEHRRTEKRQSI 258
+ E ++ + Y + ++R +
Sbjct: 269 LIIEFSKMARDPQRYLVIQGDERMHL 294
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-26
Identities = 42/161 (26%), Positives = 76/161 (47%), Gaps = 8/161 (4%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
+ E+ V++ + H N+V+ + E +V ++ G LF I+ + + + L
Sbjct: 71 RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQE-DQILD 129
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
+ AL ++H I+H D+KS N+ L + ++ DFG + +++S + A
Sbjct: 130 WFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC- 185
Query: 126 KIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
IGT L PE + K KSD+++ G +L EL T
Sbjct: 186 -IGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 50/161 (31%), Positives = 86/161 (53%), Gaps = 10/161 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKV-PL-LVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ E+ ++ + H+N+VK G C E + L+ EF+P+G+L +++ +++ N K
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI--NLKQ 127
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L+ A + +DYL S +H D+ + NVL++ ++ K+ DFG + I +D + T
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
+ F PE ++ K SDV+SFGV L ELLT
Sbjct: 185 VKDDRDSPVFW-YAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-26
Identities = 44/166 (26%), Positives = 87/166 (52%), Gaps = 7/166 (4%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ + ++H ++V++LG C + + LV +++P G+L DH+ + + L
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGAL--GPQLLL 118
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A + YL ++H ++ + NVLL + +VADFG + L+ D++ + +
Sbjct: 119 NWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ + E + GK T +SDV+S+GV + EL+T G +P +G+
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-26
Identities = 40/164 (24%), Positives = 76/164 (46%), Gaps = 12/164 (7%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRN 59
+ +V E+++ Q+ H +++++ E + LV E NG + ++ ++ +
Sbjct: 55 VQRVQN-EVKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSE 111
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + + + YLHS I+H D+ +N+LL N K+ADFG + + ++
Sbjct: 112 NEAR-HFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE 167
Query: 120 TAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTG 162
T GT + PE + T +SDV+S G + LL G
Sbjct: 168 KHYTL--CGTPNYISPE-IATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 49/240 (20%), Positives = 85/240 (35%), Gaps = 35/240 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
++R + + KN V L + + L D ++ + S R CL
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCL 167
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT- 123
I + A A+++LHS ++H D+K +N+ + KV DFG + D +
Sbjct: 168 HIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 224
Query: 124 ---------TKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
T ++GT + + PE I G + K D++S G++L ELL
Sbjct: 225 TPMPAYATHTGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR-- 281
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ + N + + E + LS S RP +
Sbjct: 282 ---------IITDVRNLKFPLLFTQKYPQEHM---------MVQDMLSPSPTERPEATDI 323
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 57/253 (22%), Positives = 116/253 (45%), Gaps = 39/253 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N++++ G + K +++ E++ NG L + +K + + +
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLV 150
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A+ + YL + +H D+ + N+L++ N KV+DFG S ++ D + TT
Sbjct: 151 GMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 207
Query: 125 KKIGTFVNLD---PEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASN-EGISM 179
G + + PE + K T SDV+SFG+++ E++T G +P + SN E +
Sbjct: 208 S--GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKA 262
Query: 180 VQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235
+ + L + + +++ Q+ M +C RRP +
Sbjct: 263 INDGFRLPTPMDCPSAIYQL----------M----------MQCWQQERARRPKFADIVS 302
Query: 236 ELDRLKISHENYE 248
LD+L + ++ +
Sbjct: 303 ILDKLIRAPDSLK 315
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 53/262 (20%), Positives = 101/262 (38%), Gaps = 43/262 (16%)
Query: 1 MNQVFQHELRVVSQI-NHKNVVKILGACLETKVP-------LLVYEFVPNGTLFDHIHDK 52
N+ E+ + ++ H N+V+ A K L+ + G L + +
Sbjct: 68 KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM 127
Query: 53 SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112
S+ + T L+I +T A+ ++H PPIIH D+K N+LL + K+ DFGS+
Sbjct: 128 ESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 113 LISSDNQTAMTTK----------KIGTFVNLDPEYV-ITGKL--TEKSDVYSFGVLLAEL 159
IS + + + + T + PE + + EK D+++ G +L L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219
P F E+ + +I+N + + + L
Sbjct: 247 CFRQHP-----------------F----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAM 285
Query: 220 LSLSGRRRPTMKQVSEELDRLK 241
L ++ R ++ +V +L +
Sbjct: 286 LQVNPEERLSIAEVVHQLQEIA 307
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 62/270 (22%), Positives = 109/270 (40%), Gaps = 57/270 (21%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
EL+V+S + NH N+V +LGAC L++ E+ G L + + K + + +
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 64 ---------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
L + + A + +L AS IH D+ + N+LL K+ DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDF 189
Query: 109 G-SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT- 161
G + + + N + L PE + T +SDV+S+G+ L EL +
Sbjct: 190 GLARDIKNDSNYVVKGNAR------LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 162 GLKPGSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLAS 217
G P GM + S + M++ + + S E+ + I M+
Sbjct: 244 GSSPYPGMPVDS-KFYKMIKEGFRMLSPEHAPAEMYDI----------MKT--------- 283
Query: 218 KCLSLSGRRRPTMKQVSEELDRLKISHENY 247
C +RPT KQ+ + +++ N+
Sbjct: 284 -CWDADPLKRPTFKQIVQLIEKQISESTNH 312
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 50/188 (26%), Positives = 83/188 (44%), Gaps = 31/188 (16%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLV-YEFVPNGTLFDHIHDKSSQVLRNWKT 62
EL+++ I +H NVV +LGAC + PL+V EF G L ++ K ++ +
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136
Query: 63 C-------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
+ + + A +++L AS IH D+ + N+LL + K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFG 193
Query: 110 -SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-G 162
+ + + + L PE + T +SDV+SFGVLL E+ + G
Sbjct: 194 LARDIYKDPDYVRKGDAR------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 247
Query: 163 LKPGSGMA 170
P G+
Sbjct: 248 ASPYPGVK 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 56/269 (20%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ + +
Sbjct: 87 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 146
Query: 64 -------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
+ + A ++YL AS IH D+ + NVL+ +N K+ADFG
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 203
Query: 111 SVLI-SSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GL 163
+ I + D T + L PE + T +SDV+SFGVL+ E+ T G
Sbjct: 204 ARDINNIDYYKKTTNGR------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 257
Query: 164 KPGSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKC 219
P G+ E +++ + + N N L + M + C
Sbjct: 258 SPYPGI--PVEELFKLLKEGHRMDKPANCTNELYMM----------MRD----------C 295
Query: 220 LSLSGRRRPTMKQVSEELDRLKISHENYE 248
+RPT KQ+ E+LDR+ N E
Sbjct: 296 WHAVPSQRPTFKQLVEDLDRILTLTTNEE 324
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-25
Identities = 52/256 (20%), Positives = 102/256 (39%), Gaps = 61/256 (23%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F ++S+++HK++V G C+ +LV EFV G+L ++ + + WK L
Sbjct: 59 FFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--L 116
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLD--------DNYKAKVADFGSSVLISS 116
+A + A+A+ +L +IHG+V + N+LL + K++D G S+ +
Sbjct: 117 EVAKQLAAAMHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
Query: 117 DNQ-------TAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT-GLKPGS 167
+ PE + K +D +SFG L E+ + G KP S
Sbjct: 174 KDILQERIPWVP-------------PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220
Query: 168 GMALASN-EGISMVQ--YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSG 224
+ + + + + L + + L + + + C+
Sbjct: 221 AL---DSQRKLQFYEDRHQLPAPKAAELANL----------I----------NNCMDYEP 257
Query: 225 RRRPTMKQVSEELDRL 240
RP+ + + +L+ L
Sbjct: 258 DHRPSFRAIIRDLNSL 273
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 54/266 (20%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI--HDKSSQVLRNWKT 62
FQ E +++ + H+++V+ G C E + L+V+E++ +G L + H +++L +
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 63 C----------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112
L +A++ A+ + YL A +H D+ + N L+ K+ DFG S
Sbjct: 150 VAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 206
Query: 113 LISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPG 166
I S + + + + L PE ++ K T +SDV+SFGV+L E+ T G +P
Sbjct: 207 DIYSTDYYRVGGRTM-----LPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW 261
Query: 167 SGMALASNEG-ISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLS 221
+ SN I + L + I M C
Sbjct: 262 YQL---SNTEAIDCITQGRELERPRACPPEVYAI----------MRG----------CWQ 298
Query: 222 LSGRRRPTMKQVSEELDRLKISHENY 247
++R ++K V L L + Y
Sbjct: 299 REPQQRHSIKDVHARLQALAQAPPVY 324
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 5e-25
Identities = 56/232 (24%), Positives = 97/232 (41%), Gaps = 23/232 (9%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-HDKSSQVLRNWKTCL 64
E+ ++ Q+NH NV+K + +E +V E G L I H K + L +T
Sbjct: 80 IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + SAL+++HS ++H D+K NV + K+ D G SS A +
Sbjct: 140 KYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL 196
Query: 125 KKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
+GT + PE I KSD++S G LL E+ P G + +++
Sbjct: 197 --VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG------DKMNLYSLC 247
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235
IE + + ++E + L + C++ +RP + V +
Sbjct: 248 -KKIEQCDYPPLPSDHYSEE--------LRQLVNMCINPDPEKRPDVTYVYD 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-25
Identities = 60/260 (23%), Positives = 105/260 (40%), Gaps = 55/260 (21%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
FQ E +++ + H+++VK G C + ++V+E++ +G L + +
Sbjct: 64 FQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 64 ------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSS 111
L IA++ AS + YL AS +H D+ + N L+ N K+ DFG S
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 112 VLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
+ S + + + L PE ++ K T +SDV+SFGV+L E+ T G +P
Sbjct: 181 RDVYSTDYYRVGGHTM-----LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
Query: 166 GSGMALASN-EGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCL 220
+ SN E I + L + + M C
Sbjct: 236 WFQL---SNTEVIECITQGRVLERPRVCPKEVYDV----------MLG----------CW 272
Query: 221 SLSGRRRPTMKQVSEELDRL 240
++R +K++ + L L
Sbjct: 273 QREPQQRLNIKEIYKILHAL 292
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-25
Identities = 31/177 (17%), Positives = 60/177 (33%), Gaps = 18/177 (10%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW-- 60
+ + + +K A L +LV E GTL + I+ + +
Sbjct: 112 YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA-----------KVADFG 109
+ A ++ +H IIHGD+K N +L + + + D G
Sbjct: 172 GLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228
Query: 110 SSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
S+ + + + T K T E +++ K + D + + +L G
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 8e-25
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 27/182 (14%)
Query: 5 FQHELRVVSQINHKNVVKILGACLE------TKVPLLVYEFVPNGTLFD----HIHDKSS 54
F E + + +H +V K++G L +P+++ F+ +G L ++
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVL 113
L +T +R + A ++YL +S IH D+ + N +L ++ VADFG S +
Sbjct: 132 FNLPL-QTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI 187
Query: 114 ISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGS 167
S D K L E + T SDV++FGV + E++T G P +
Sbjct: 188 YSGDYYRQGCASK------LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA 241
Query: 168 GM 169
G+
Sbjct: 242 GI 243
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 9e-25
Identities = 45/180 (25%), Positives = 79/180 (43%), Gaps = 24/180 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFD----HIHDKSSQ 55
F E + +H NV+++LG C+E P+++ F+ G L + +
Sbjct: 83 FLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPK 142
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
+ +T L+ + A ++YL ++ +H D+ + N +L D+ VADFG S I
Sbjct: 143 HIPL-QTLLKFMVDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 116 SDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
S + + E + T KSDV++FGV + E+ T G+ P G+
Sbjct: 199 SGDYYRQGRI-----AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGV 253
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 9e-25
Identities = 60/259 (23%), Positives = 106/259 (40%), Gaps = 52/259 (20%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ + +
Sbjct: 133 LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 64 -------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG- 109
+ + A ++YL AS IH D+ + NVL+ +N K+ADFG
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249
Query: 110 SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GL 163
+ + + D T + L PE + T +SDV+SFGVL+ E+ T G
Sbjct: 250 ARDINNIDYYKKTTNGR------LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303
Query: 164 KPGSGMALASNEGISMVQ--YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLS 221
P G+ E +++ + + N + + + C
Sbjct: 304 SPYPGI--PVEELFKLLKEGHRMDKPANCT------------------NELYMMMRDCWH 343
Query: 222 LSGRRRPTMKQVSEELDRL 240
+RPT KQ+ E+LDR+
Sbjct: 344 AVPSQRPTFKQLVEDLDRI 362
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-24
Identities = 48/171 (28%), Positives = 78/171 (45%), Gaps = 13/171 (7%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVP--LLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
++ E+ ++ + H++++K G C + LV E+VP G+L D++ S +
Sbjct: 80 WKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL----AQ 135
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--T 120
L A + + YLH+ IH D+ + NVLLD++ K+ DFG + + ++
Sbjct: 136 LLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMA 170
F PE + K SDV+SFGV L ELLT S
Sbjct: 193 VREDGDSPVFW-YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPT 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-24
Identities = 44/192 (22%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
F+HE + +++ H NVV +LG + + +++ + +G L + + +S
Sbjct: 59 FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 64 ------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-S 110
+ + A+ A+ ++YL +S ++H D+ + NVL+ D K++D G
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GL 163
+ ++D + + P E ++ GK + SD++S+GV+L E+ + GL
Sbjct: 176 REVYAADYYKLLGNSLL-------PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL 228
Query: 164 KPGSGMALASNE 175
+P G SN+
Sbjct: 229 QPYCGY---SNQ 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-24
Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 63/277 (22%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
FQ E ++++ ++ N+VK+LG C K L++E++ G L + + S + +
Sbjct: 97 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 64 --------------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA 103
L IA + A+ + YL + +H D+ + N L+ +N
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVV 213
Query: 104 KVADFG-SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLA 157
K+ADFG S + S+D A + PE + + T +SDV+++GV+L
Sbjct: 214 KIADFGLSRNIYSADYYKADGNDA------IPIRWMPPESIFYNRYTTESDVWAYGVVLW 267
Query: 158 ELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEE----IETV 212
E+ + GL+P GM ++E +++ + V D + + +
Sbjct: 268 EIFSYGLQPYYGM---AHE------------------EVIYY-VRDGNILACPENCPLEL 305
Query: 213 AGLASKCLSLSGRRRPTMKQVSEELDRLKISHENYEH 249
L C S RP+ + L R+ E
Sbjct: 306 YNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGTVG 342
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-24
Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E +++ Q+++ +V+++G C + +LV E G L + K ++
Sbjct: 57 MMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVA 113
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAM 122
+ + + + YL +H D+ + NVLL + + AK++DFG S + +D+ TA
Sbjct: 114 ELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 170
Query: 123 TTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+ K P E + K + +SDV+S+GV + E L+ G KP M
Sbjct: 171 SAGKW-------PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 46/175 (26%), Positives = 78/175 (44%), Gaps = 17/175 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E + Q +H ++VK++G E V ++ E G L + + + + + +
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSL--DLASLI 494
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A + ++AL YL S +H D+ + NVL+ N K+ DFG S + +
Sbjct: 495 LYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
Query: 125 KKI---GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNE 175
K+ PE + + T SDV+ FGV + E+L G+KP G+ N
Sbjct: 552 GKLPIKWM----APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNN 599
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 2e-24
Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRN 59
+ E+ + + H++VV G E + +V E +L + K + L
Sbjct: 84 QREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTE 140
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + YLH + +IH D+K N+ L+++ + K+ DFG + + D +
Sbjct: 141 PEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 196
Query: 120 TAMTTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
GT P Y V++ K + + DV+S G ++ LL G P
Sbjct: 197 RKKVL--CGT-----PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-24
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 20/172 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E + Q +H ++VK++G E V ++ E G L + + + + + +
Sbjct: 63 FLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DLASLI 119
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
A + ++AL YL S +H D+ + NVL+ N K+ DFG S + +
Sbjct: 120 LYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 125 KKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K+ P E + + T SDV+ FGV + E+L G+KP G+
Sbjct: 177 GKL-------PIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 221
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 63/267 (23%), Positives = 111/267 (41%), Gaps = 53/267 (19%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
EL+++S + H+N+V +LGAC L++ E+ G L + + KS + +
Sbjct: 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 64 -----------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SS 111
L +++ A + +L AS IH DV + NVLL + + AK+ DFG +
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 112 VLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKP 165
+++ N + L PE + T +SDV+S+G+LL E+ + GL P
Sbjct: 213 DIMNDSNYIVKGNAR------LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 166 GSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKCLS 221
G+ L +++ +V+ Y + ++ I M+ C +
Sbjct: 267 YPGI-LVNSKFYKLVKDGYQMAQPAFAPKNIYSI----------MQA----------CWA 305
Query: 222 LSGRRRPTMKQVSEELDRLKISHENYE 248
L RPT +Q+ L
Sbjct: 306 LEPTHRPTFQQICSFLQEQAQEDRRER 332
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-24
Identities = 38/172 (22%), Positives = 74/172 (43%), Gaps = 20/172 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ ++H ++VK++G E ++ E P G L ++ + + T +
Sbjct: 60 FMSEAVIMKNLDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSL--KVLTLV 116
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + A+ YL S +H D+ N+L+ K+ DFG S I ++ +
Sbjct: 117 LYSLQICKAMAYL---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASV 173
Query: 125 KKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
++ P E + + T SDV+ F V + E+L+ G +P +
Sbjct: 174 TRL-------PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWL 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 4e-24
Identities = 68/269 (25%), Positives = 111/269 (41%), Gaps = 56/269 (20%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ + L
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 64 -------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
+ A + A ++YL AS IH D+ + NVL+ ++ K+ADFG
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
Query: 111 SVLI-SSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GL 163
+ I D T + L PE + T +SDV+SFGVLL E+ T G
Sbjct: 238 ARDIHHIDYYKKTTNGR------LPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291
Query: 164 KPGSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKC 219
P G+ + E +++ + + N N L + M + C
Sbjct: 292 SPYPGVPVE--ELFKLLKEGHRMDKPSNCTNELYMM----------MRD----------C 329
Query: 220 LSLSGRRRPTMKQVSEELDRLKISHENYE 248
+RPT KQ+ E+LDR+ N E
Sbjct: 330 WHAVPSQRPTFKQLVEDLDRIVALTSNQE 358
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 5e-24
Identities = 45/174 (25%), Positives = 75/174 (43%), Gaps = 22/174 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E+ + ++H+N++++ G L + +V E P G+L D + L T
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLL--GTLS 124
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAM 122
R A + A + YL S IH D+ + N+LL K+ DFG + ++
Sbjct: 125 RYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 123 TTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
+K+ P E + T + SD + FGV L E+ T G +P G+
Sbjct: 182 EHRKV-------PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL 228
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 6e-24
Identities = 39/171 (22%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRN 59
+ E+ + + H++VV G E + +V E +L + K + L
Sbjct: 58 QREKMSMEISIHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH--KRRKALTE 114
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + YLH + +IH D+K N+ L+++ + K+ DFG + + D +
Sbjct: 115 PEAR-YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE 170
Query: 120 TAMTTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
GT P Y V++ K + + DV+S G ++ LL G P
Sbjct: 171 RKKVL--CGT-----PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-24
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 59/268 (22%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F EL V+ ++ +H N++ +LGAC L E+ P+G L D +
Sbjct: 72 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 131
Query: 64 -------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
L AA+ A +DYL + IH D+ + N+L+ +NY AK+ADFG
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL 188
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GL 163
S + T ++ P E + T SDV+S+GVLL E+++ G
Sbjct: 189 SR--GQEVYVKKTMGRL-------PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 239
Query: 164 KPGSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETVAGLASKC 219
P GM A E + Y L N + + + M + C
Sbjct: 240 TPYCGMTCA--ELYEKLPQGYRLEKPLNCDDEVYDL----------MRQ----------C 277
Query: 220 LSLSGRRRPTMKQVSEELDRLKISHENY 247
RP+ Q+ L+R+ + Y
Sbjct: 278 WREKPYERPSFAQILVSLNRMLEERKTY 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 8e-24
Identities = 47/199 (23%), Positives = 83/199 (41%), Gaps = 40/199 (20%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC- 63
E V+ Q+NH +V+K+ GAC + LL+ E+ G+L + + +
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 64 --------------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA 103
+ A + + + YL A ++H D+ + N+L+ + K
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKM 189
Query: 104 KVADFG-SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLA 157
K++DFG S + D+ + + + E + T +SDV+SFGVLL
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGR------IPVKWMAIESLFDHIYTTQSDVWSFGVLLW 243
Query: 158 ELLT-GLKPGSGMALASNE 175
E++T G P G+ E
Sbjct: 244 EIVTLGGNPYPGI---PPE 259
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 9e-24
Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 16/175 (9%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E +++ Q+++ +V+++G C + +LV E G L + K ++
Sbjct: 379 DTEEMMREAQIMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PV 435
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ- 119
+ + + + YL +H ++ + NVLL + + AK++DFG S + +D+
Sbjct: 436 SNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSY 492
Query: 120 -TAMTTKKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
TA + K PE + K + +SDV+S+GV + E L+ G KP M
Sbjct: 493 YTARSAGKWPLKWY----APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-23
Identities = 56/253 (22%), Positives = 96/253 (37%), Gaps = 47/253 (18%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN----W 60
F E ++S+ NH+N+V+ +G L++ ++ E + G L + + + +
Sbjct: 80 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSD 117
L +A + A YL IH D+ + N LL AK+ DFG + I
Sbjct: 140 LDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196
Query: 118 NQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMAL 171
+ + L PE + G T K+D +SFGVLL E+ + G P
Sbjct: 197 SYYRKGGCAM-----LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-- 249
Query: 172 ASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIE----TVAGLASKCLSLSGRRR 227
SN+ ++L F V M+ + V + ++C R
Sbjct: 250 -SNQ------------------EVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 289
Query: 228 PTMKQVSEELDRL 240
P + E ++
Sbjct: 290 PNFAIILERIEYC 302
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 3e-23
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E V+ Q+++ +V+++G C +LV E G L ++ K +
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKD---KNII 120
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAM 122
+ + + + YL +H D+ + NVLL + AK++DFG S + +D A
Sbjct: 121 ELVHQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 123 TTKKIGTFVNLDP------EYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
T K P E + K + KSDV+SFGVL+ E + G KP GM
Sbjct: 178 THGKW-------PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 3e-23
Identities = 56/253 (22%), Positives = 95/253 (37%), Gaps = 47/253 (18%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN----W 60
F E ++S+ NH+N+V+ +G L++ ++ E + G L + + + +
Sbjct: 121 FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAM 180
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSD 117
L +A + A YL IH D+ + N LL AK+ DFG + I
Sbjct: 181 LDLLHVARDIACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237
Query: 118 NQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMAL 171
+ L PE + G T K+D +SFGVLL E+ + G P
Sbjct: 238 GYYRKGGCAM-----LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK-- 290
Query: 172 ASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIET----VAGLASKCLSLSGRRR 227
SN+ ++L F V M+ + V + ++C R
Sbjct: 291 -SNQ------------------EVLEF-VTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDR 330
Query: 228 PTMKQVSEELDRL 240
P + E ++
Sbjct: 331 PNFAIILERIEYC 343
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 56/277 (20%), Positives = 109/277 (39%), Gaps = 62/277 (22%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
EL++++Q+ +H+N+V +LGAC + L++E+ G L +++ K + +
Sbjct: 95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY 154
Query: 64 --------------------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA 103
L A + A +++L +H D+ + NVL+
Sbjct: 155 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVV 211
Query: 104 KVADFG-SSVLISSDNQTAMTTKKIGTFVNL-----DPEYVITGKLTEKSDVYSFGVLLA 157
K+ DFG + ++S N + L PE + G T KSDV+S+G+LL
Sbjct: 212 KICDFGLARDIMSDSNYVVRGNAR------LPVKWMAPESLFEGIYTIKSDVWSYGILLW 265
Query: 158 ELLT-GLKPGSGMALASNEGISMVQ--YFLYSIEN--NSLRQILNFQVADESEMEEIETV 212
E+ + G+ P G+ + + ++Q + + + I M+
Sbjct: 266 EIFSLGVNPYPGIPVDA-NFYKLIQNGFKMDQPFYATEEIYII----------MQS---- 310
Query: 213 AGLASKCLSLSGRRRPTMKQVSEELDRLKISHENYEH 249
C + R+RP+ ++ L E +
Sbjct: 311 ------CWAFDSRKRPSFPNLTSFLGCQLADAEEAMY 341
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-22
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 22/170 (12%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT--- 62
EL + ++ +V + GA E + E + G+L Q+++
Sbjct: 98 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL--------GQLIKQMGCLPE 149
Query: 63 --CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQ 119
L + L+YLH+ I+HGDVK+ NVLL + +A + DFG ++ + D
Sbjct: 150 DRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
Query: 120 TAMTTKK---IGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
GT ++ PE V+ GK K D++S ++ +L G P
Sbjct: 207 GKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-22
Identities = 34/161 (21%), Positives = 60/161 (37%), Gaps = 26/161 (16%)
Query: 13 SQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS----QVLRNWKTCLRIAA 68
H V++ A E + L E +L H + + +
Sbjct: 112 KVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGY------LR 164
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+T AL +LHS ++H DVK N+ L + K+ DFG V + + + G
Sbjct: 165 DTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEG 218
Query: 129 TFVNLDPEY----VITGKLTEKSDVYSFGVLLAELLTGLKP 165
P Y ++ G +DV+S G+ + E+ ++
Sbjct: 219 D-----PRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-22
Identities = 42/185 (22%), Positives = 75/185 (40%), Gaps = 32/185 (17%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLET---KVPLLVYEFVPNGTLFDHIHDKSSQVL 57
V E V+ ++NHKN+VK+ A E + +L+ EF P G+L+ + + S+
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVL 113
L + + +++L + I+H ++K N++ D K+ DFG++
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEY----VITGKL---------TEKSDVYSFGVLLAELL 160
+ D Q + GT EY + + D++S GV
Sbjct: 166 LEDDEQ--FVS-LYGT-----EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 161 TGLKP 165
TG P
Sbjct: 218 TGSLP 222
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 3e-22
Identities = 48/174 (27%), Positives = 85/174 (48%), Gaps = 22/174 (12%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQV 56
N+V + E V+S+++H VK+ + L + NG L +I +
Sbjct: 71 ENKV-PYVTRERDVMSRLDHPFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYI--RKIGS 126
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
T AE SAL+YLH IIH D+K N+LL+++ ++ DFG++ ++S
Sbjct: 127 FDETCTRF-YTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 182
Query: 117 DNQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+++ A +GT +Y ++T K KS D+++ G ++ +L+ GL P
Sbjct: 183 ESKQARANSFVGT-----AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 47/271 (17%), Positives = 91/271 (33%), Gaps = 42/271 (15%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLET---KVPLLVYEFVPNGTLFDHIHDKSSQVL 57
V E V+ ++NHKN+VK+ A E + +L+ EF P G+L+ + + S+
Sbjct: 50 PVDVQMREFEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVL 113
L + + +++L + I+H ++K N++ D K+ DFG++
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEY----VITGKL---------TEKSDVYSFGVLLAELL 160
+ ++ + GT EY + + D++S GV
Sbjct: 166 L--EDDEQFVS-LYGT-----EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 161 TGLKPGSGMALASN----------EGISMVQYFLYSIENNSLRQILNFQVADESEMEEIE 210
TG P S + EN + + V+
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV 277
Query: 211 TVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+ + + L + Q E +
Sbjct: 278 LLTPVLANILEADQEKCWGFDQFFAETSDIL 308
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 27/180 (15%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETK-------VPLLVYEFVPNGTLFDHIHDKS 53
+ + E++++ ++NH NVV + +PLL E+ G L +++
Sbjct: 55 NRERWCLEIQIMKKLNHPNVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFE 113
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA---KVADFGS 110
+ + ++ +SAL YLH + IIH D+K N++L + K+ D G
Sbjct: 114 NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
+ + + T+ +GT +Y ++ K T D +SFG L E +TG +P
Sbjct: 171 AKELDQGE---LCTEFVGT-----LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 21/181 (11%), Positives = 51/181 (28%), Gaps = 27/181 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFV----PNGTLFDHIHDKSSQVLR 58
+V + + K++ L+ + ++ F L S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 59 N----WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114
+ L++ + L LH ++H ++ +++LD + F V
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 115 SSDNQTAMTTKKIGTFVNLDPEYV----------ITGKLTEKSDVYSFGVLLAELLTGLK 164
+ + + PE +T D ++ G+ + +
Sbjct: 262 GASAVS-PIGRGFAP-----PETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 165 P 165
P
Sbjct: 316 P 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-21
Identities = 59/236 (25%), Positives = 102/236 (43%), Gaps = 32/236 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
E+ V+ ++H N++K+ + + LV E G LFD I + +
Sbjct: 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQ 119
++ + S + YLH I+H D+K N+LL + + K+ DFG S + + +
Sbjct: 141 IIK---QVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
+++GT + PE V+ K EK DV+S GV+L LL G P G +++ I
Sbjct: 195 M---KERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEI-- 245
Query: 180 VQYFLYSIENNSLRQILNFQVA-DESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
LR++ + D E + + E L + L +RR + +Q
Sbjct: 246 ------------LRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-21
Identities = 57/234 (24%), Positives = 101/234 (43%), Gaps = 32/234 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E++++ Q++H N++K+ + LV E G LFD I + + +
Sbjct: 73 LLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARII 132
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTA 121
R + S + Y+H + I+H D+K N+LL + ++ DFG S + +
Sbjct: 133 R---QVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM- 185
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
KIGT + PE V+ G EK DV+S GV+L LL+G P +G A+ I
Sbjct: 186 --KDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNG---ANEYDI---- 235
Query: 182 YFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRPTMKQV 233
L+++ + + + +++ A L K L+ R + +
Sbjct: 236 ----------LKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-21
Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 32/236 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ +E+ ++ ++H N++K+ + K LV EF G LF+ I ++ +
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQ 119
++ S + YLH I+H D+K N+LL + K+ DFG S S D +
Sbjct: 151 IMKQIL---SGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK 204
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
++GT + PE V+ K EK DV+S GV++ LL G P G +++ I
Sbjct: 205 L---RDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGG---QNDQDI-- 255
Query: 180 VQYFLYSIENNSLRQILNFQVA-DESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
++++ + D ++ + I + L L+ +R T ++
Sbjct: 256 ------------IKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 6e-21
Identities = 45/175 (25%), Positives = 68/175 (38%), Gaps = 19/175 (10%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
Q EL V NH N+V + +V F+ G+ D I + L
Sbjct: 74 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNE----LA 129
Query: 66 IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
IA ALDY+H +H VK++++L+ + K ++ S++ + S Q
Sbjct: 130 IAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR 186
Query: 123 TTKK-----IGTFVNLDPEYVITGKL---TEKSDVYSFGVLLAELLTGLKPGSGM 169
+ L PE V+ L KSD+YS G+ EL G P M
Sbjct: 187 VVHDFPKYSVKVLPWLSPE-VLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 240
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 87.4 bits (216), Expect = 4e-20
Identities = 27/238 (11%), Positives = 60/238 (25%), Gaps = 29/238 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVP--LLVYEFVPNGTLFDHIHDKSSQVLRN--- 59
V+ + ++ + V LL+ + L +
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVDLELLFSTLDFVYVFRGDE 191
Query: 60 -WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
+ A+ L S ++HG N+ + + + + D + + +
Sbjct: 192 GILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG 248
Query: 119 QTAMTTKKIGTFVNLDPEYVITGK---LTEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175
+ V P + T + + G+ + + P +
Sbjct: 249 PASSVP------VTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
LR +A S + V L + L+ RRR +
Sbjct: 303 SWKRPS----------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 6e-20
Identities = 24/164 (14%), Positives = 44/164 (26%), Gaps = 37/164 (22%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+S+I+ V ++L L+V E++ G+L + S V +
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPV-----GAI 132
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
R A+A D H + + + V + + +A
Sbjct: 133 RAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------------- 174
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168
+ D+ G L LL P
Sbjct: 175 --------------TMPDANPQDDIRGIGASLYALLVNRWPLPE 204
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 6e-20
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E+ + + HKN+V+ LG+ E + E VP G+L + K + N +T
Sbjct: 67 HEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF 126
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTT 124
+ L YLH + I+H D+K NVL++ + K++DFG+S ++ N T
Sbjct: 127 YTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 125 KKIGTFVNLDPEYVITGKL---TEKSDVYSFGVLLAELLTGLKP 165
GT + PE +I + +D++S G + E+ TG P
Sbjct: 184 T--GTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-20
Identities = 51/174 (29%), Positives = 87/174 (50%), Gaps = 27/174 (15%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVL 57
+ ++F+ E+R++ +NH N+VK+ +ET+ L L+ E+ G +FD++ H + +
Sbjct: 58 LQKLFR-EVRIMKILNHPNIVKLF-EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKE-- 113
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
K + SA+ Y H I+H D+K+ N+LLD + K+ADFG S +
Sbjct: 114 ---KEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
K+ F P Y + GK + + DV+S GV+L L++G P
Sbjct: 168 -------GKLDAFCG-APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-19
Identities = 54/239 (22%), Positives = 90/239 (37%), Gaps = 39/239 (16%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLR-NWKT 62
+ E+ V+ ++H N++KI E + +V E G L + I ++ +
Sbjct: 67 IEAEIEVLKSLDHPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGY 125
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQ 119
+ + +AL Y HS ++H D+K N+L + K+ DFG + L SD
Sbjct: 126 VAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH 182
Query: 120 TAMTTKKIGTFVNLDPEY----VITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175
T GT Y V +T K D++S GV++ LLTG P
Sbjct: 183 --STNA-AGT-----ALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLP---------- 224
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
F + ++ + E + L + L+ RRP+ QV
Sbjct: 225 -------FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 1e-19
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 35/173 (20%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E+ + +NH+NVVK G L E+ G LFD I +
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDI-----------GM 102
Query: 67 AAETA--------SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
A + + YLH I H D+K N+LLD+ K++DFG + + +N
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 119 QTAMTTKKIGTFVNLDPEY----VITGKL--TEKSDVYSFGVLLAELLTGLKP 165
+ + K GT Y ++ + E DV+S G++L +L G P
Sbjct: 160 RERLLNKMCGT-----LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-19
Identities = 34/270 (12%), Positives = 71/270 (26%), Gaps = 56/270 (20%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVP--LLVYEFV--PNGTLFDHIHDKSS-QVLRN 59
F +V K ++++ + V +Y + T + + SS
Sbjct: 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLV 204
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
L++ + L LH ++H ++ +++LD + F V +
Sbjct: 205 HHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV 261
Query: 120 TAMTTKKIGTFVNLDPEYVIT-----------GKLTEKSDVYSFGVLLAELLTGLKPGSG 168
++ + PE +T D ++ G+++ + P
Sbjct: 262 SS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP--- 312
Query: 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228
I + + V L L R
Sbjct: 313 --------------ITKDAALGGSEWIFRS-CKNIP-----QPVRALLEGFLRYPKEDRL 352
Query: 229 TMKQVSEELDRLKISHENYEHRRTEKRQSI 258
Q + YE RTE ++
Sbjct: 353 LPLQA--------METPEYEQLRTELSAAL 374
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 3e-19
Identities = 43/244 (17%), Positives = 92/244 (37%), Gaps = 33/244 (13%)
Query: 1 MNQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
E++++ + + H NV++ + + + E TL +++ K
Sbjct: 60 CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK--DFAHL 116
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL-----DDNYKAKVADFG-SSVL 113
+ + +T S L +LHS I+H D+K N+L+ KA ++DFG L
Sbjct: 117 GLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYV---ITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
+ + + GT + PE + T D++S G + +++
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----- 228
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG-LASKCLSLSGRRRPT 229
F S++ + + + + + +A L K +++ ++RP+
Sbjct: 229 -----------PFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
Query: 230 MKQV 233
K V
Sbjct: 278 AKHV 281
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 3e-19
Identities = 59/234 (25%), Positives = 98/234 (41%), Gaps = 32/234 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E+ ++ +++H N++K+ ++ +V E G LFD I + + +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTA 121
+ S + Y+H I+H D+K N+LL + + K+ DFG S + +
Sbjct: 128 KQVF---SGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
M + IGT + PE V+ G EK DV+S GV+L LL+G P G + I
Sbjct: 180 MKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYG---KNEYDI---- 230
Query: 182 YFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRPTMKQV 233
L+++ + A D + I A L K L+ R T Q
Sbjct: 231 ----------LKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 4e-19
Identities = 41/165 (24%), Positives = 76/165 (46%), Gaps = 18/165 (10%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E +++++++ + +V L ETK L LV + G + HI++ +
Sbjct: 235 EKKILAKVHSRFIVS-LAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIF 293
Query: 67 -AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
A+ S L++LH II+ D+K NVLLDD+ +++D G +V + +
Sbjct: 294 YTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG-- 348
Query: 126 KIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT P + ++ G+ + S D ++ GV L E++ P
Sbjct: 349 YAGT-----PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-19
Identities = 47/172 (27%), Positives = 73/172 (42%), Gaps = 18/172 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E+ ++ ++NH ++KI +V E + G LFD +
Sbjct: 183 PALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRL---KE 238
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSD 117
TC + A+ YLH + IIH D+K NVLL +++ K+ DFG S ++
Sbjct: 239 ATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 293
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKL----TEKSDVYSFGVLLAELLTGLKP 165
+ M T GT L PE V+ D +S GV+L L+G P
Sbjct: 294 ETSLMRT-LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-19
Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 29/177 (16%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS------SQV 56
+ Q E+ V+SQ + V K G+ L+ ++ E++ G+ D + + +
Sbjct: 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATI 124
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
LR E LDYLHS IH D+K+ NVLL ++ + K+ADFG + ++
Sbjct: 125 LR----------EILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171
Query: 117 DNQTAMTTKKIGTFVN----LDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
T K TFV + PE + K+D++S G+ EL G P S +
Sbjct: 172 ------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-19
Identities = 36/175 (20%), Positives = 72/175 (41%), Gaps = 23/175 (13%)
Query: 5 FQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+++E+ ++++ + ++++ + + +V E N L + K S +
Sbjct: 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI---DPWE 128
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
A+ +H I+H D+K N L+ D K+ DFG + + D + +
Sbjct: 129 RKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVV 184
Query: 123 TTKKIGTFVNLDPEYVITG------------KLTEKSDVYSFGVLLAELLTGLKP 165
++GT + PE I K++ KSDV+S G +L + G P
Sbjct: 185 KDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 6e-19
Identities = 45/173 (26%), Positives = 70/173 (40%), Gaps = 35/173 (20%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E+ + +NH+NVVK G L E+ G LFD I +
Sbjct: 55 EICINKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDI-----------GM 102
Query: 67 AAETA--------SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN 118
A + + YLH I H D+K N+LLD+ K++DFG + + +N
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 119 QTAMTTKKIGTFVNLDPEY----VITGKL--TEKSDVYSFGVLLAELLTGLKP 165
+ + K GT Y ++ + E DV+S G++L +L G P
Sbjct: 160 RERLLNKMCGT-----LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 7e-19
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
++ +E+ V+ + + N+V L + L +V E++ G+L D + +T
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----------ET 111
Query: 63 CLR---IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
C+ IAA E AL++LHS+ +IH D+KS N+LL + K+ DFG I+
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
+ T +GT + PE V+T K K D++S G++ E++ G P
Sbjct: 169 EQSKRSTM--VGTPYWMAPE-VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-19
Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 16/171 (9%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC-- 63
E++ +SQ +H N+V + + LV + + G++ D I ++
Sbjct: 61 LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 64 LRIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
IA E L+YLH + IH DVK+ N+LL ++ ++ADFG S + +
Sbjct: 121 STIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFL-ATGGD 176
Query: 121 AMTTKKIGTFVN----LDPEYVITGKLT--EKSDVYSFGVLLAELLTGLKP 165
K TFV + PE V+ K+D++SFG+ EL TG P
Sbjct: 177 ITRNKVRKTFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 1e-18
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E +++ ++N + VV L ETK L LV + G L HI+ +
Sbjct: 234 EKQILEKVNSRFVVS-LAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF-Y 291
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AAE L+ LH I++ D+K N+LLDD+ +++D G +V + + QT +
Sbjct: 292 AAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKG--R 345
Query: 127 IGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+GT Y V+ + S D ++ G LL E++ G P
Sbjct: 346 VGT-----VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-18
Identities = 43/174 (24%), Positives = 75/174 (43%), Gaps = 27/174 (15%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E+ ++ Q + +VVK G+ + +V E+ G++ D ++R L
Sbjct: 72 IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD--------IIRLRNKTLT 123
Query: 66 ---IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
IA T L+YLH IH D+K+ N+LL+ AK+ADFG + ++
Sbjct: 124 EDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--- 177
Query: 120 TAMTTKKIGTFVN----LDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
T K T + + PE + +D++S G+ E+ G P + +
Sbjct: 178 ---TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADI 228
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-18
Identities = 53/169 (31%), Positives = 84/169 (49%), Gaps = 30/169 (17%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVLRNWKTCL 64
E++ + H +++K L + T +V E+V G LFD+I H + +
Sbjct: 61 EIQNLKLFRHPHIIK-LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEE-----MEAR 114
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN--QTAM 122
R+ + SA+DY H ++H D+K NVLLD + AK+ADFG S ++S +T+
Sbjct: 115 RLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS- 170
Query: 123 TTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
G+ P Y VI+G+L + D++S GV+L LL G P
Sbjct: 171 ----CGS-----PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-18
Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 34/183 (18%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ + E+ +++ +H +VK+LGA ++ EF P G + ++
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA--------IMLELDR 112
Query: 63 CLR---IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
L I + AL++LHS IIH D+K+ NVL+ ++ADFG S
Sbjct: 113 GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169
Query: 117 DNQTAMTTKKIGTFVN----LDPEYVITGKLT------EKSDVYSFGVLLAELLTGLKPG 166
T +K +F+ + PE V+ + K+D++S G+ L E+ P
Sbjct: 170 ------TLQKRDSFIGTPYWMAPE-VVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
Query: 167 SGM 169
+
Sbjct: 223 HEL 225
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 2e-18
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 21/168 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E+ ++ +++H N++K+ ++ +V E G LFD I + + +
Sbjct: 68 ILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARII 127
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTA 121
+ S + Y+H I+H D+K N+LL + + K+ DFG S + +
Sbjct: 128 KQV---FSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-- 179
Query: 122 MTTKKIGTFVNLDPEY----VITGKLTEKSDVYSFGVLLAELLTGLKP 165
M +IGT Y V+ G EK DV+S GV+L LL+G P
Sbjct: 180 MKD-RIGT-----AYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-18
Identities = 52/263 (19%), Positives = 94/263 (35%), Gaps = 50/263 (19%)
Query: 1 MNQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
+ E++++++ +H NV++ + + + E N L D + K+
Sbjct: 51 FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENL 109
Query: 60 WKTCLRIAAE----TASALDYLHSSASPPIIHGDVKSTNVLLD-------------DNYK 102
AS + +LHS IIH D+K N+L+ +N +
Sbjct: 110 KLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLR 166
Query: 103 AKVADFGSSVLISSDNQTAMTTKK--IGTFVNLDPEYVITG--------KLTEKSDVYSF 152
++DFG + S + T GT PE ++ +LT D++S
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE-LLEESNNLQTKRRLTRSIDIFSM 225
Query: 153 GVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIET 211
G + +L+ G P YS E+N +R I + +
Sbjct: 226 GCVFYYILSKGKHPFGDK---------------YSRESNIIRGIFSLDEMKCLHDRSLIA 270
Query: 212 VAG-LASKCLSLSGRRRPTMKQV 233
A L S+ + +RPT +V
Sbjct: 271 EATDLISQMIDHDPLKRPTAMKV 293
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-18
Identities = 44/168 (26%), Positives = 74/168 (44%), Gaps = 27/168 (16%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGT-LFDHI--HDKSSQVLRNWKTC 63
E+ ++S++ H N++K+L E + LV E +G LF I H + +
Sbjct: 79 EIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE-----PLA 132
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
I + SA+ YL IIH D+K N+++ +++ K+ DFGS+ +
Sbjct: 133 SYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG------ 183
Query: 124 TKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
K TF EY V+ G + +++S GV L L+ P
Sbjct: 184 -KLFYTFCG-TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 4e-18
Identities = 36/177 (20%), Positives = 72/177 (40%), Gaps = 23/177 (12%)
Query: 3 QVFQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+++E+ ++++ + ++++ + + +V E N L + K S +
Sbjct: 52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI---DP 107
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
A+ +H I+H D+K N L+ D K+ DFG + + D +
Sbjct: 108 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 163
Query: 121 AMTTKKIGTFVNLDPEYVITG------------KLTEKSDVYSFGVLLAELLTGLKP 165
+ ++GT + PE I K++ KSDV+S G +L + G P
Sbjct: 164 VVKDSQVGTVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 4e-18
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 19/164 (11%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E RV+ H + L +T L V E+ G LF H+ +V +
Sbjct: 198 ENRVLQNSRHPFLTA-LKYSFQTHDRLCFVMEYANGGELFFHLS--RERVFSEDRARF-Y 253
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AE SALDYLHS + +++ D+K N++LD + K+ DFG D T T
Sbjct: 254 GAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF-- 309
Query: 127 IGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT PEY V+ ++ D + GV++ E++ G P
Sbjct: 310 CGT-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 35/177 (19%), Positives = 71/177 (40%), Gaps = 23/177 (12%)
Query: 3 QVFQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+++E+ ++++ + ++++ + + +V E N L + K S +
Sbjct: 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSI---DP 154
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
A+ +H I+H D+K N L+ D K+ DFG + + D +
Sbjct: 155 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 210
Query: 121 AMTTKKIGTFVNLDPEYVITG------------KLTEKSDVYSFGVLLAELLTGLKP 165
+ ++G + PE I K++ KSDV+S G +L + G P
Sbjct: 211 VVKDSQVGAVNYMPPE-AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-18
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
++ +E+ ++ H NVV++ + L + ++ EF+ G L D + +
Sbjct: 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS----------QV 136
Query: 63 CLR---IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
L IA AL YLH+ +IH D+KS ++LL + + K++DFG IS
Sbjct: 137 RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK 193
Query: 117 DNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
D + +GT + PE VI+ L + D++S G+++ E++ G P
Sbjct: 194 DVPKRKSL--VGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 5e-18
Identities = 41/165 (24%), Positives = 71/165 (43%), Gaps = 15/165 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F+ E+ ++ ++H N++++ E + LV E G LF+ + K +
Sbjct: 53 FKQEIEIMKSLDHPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 111
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQT 120
++ SA+ Y H + H D+K N L + K+ DFG +
Sbjct: 112 MKDVL---SAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
M TK +GT + P+ V+ G + D +S GV++ LL G P
Sbjct: 165 -MRTK-VGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-18
Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 25/178 (14%)
Query: 1 MNQV--FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVL 57
+ F+ E V+ + K + L + L LV ++ G L + K L
Sbjct: 115 RAETACFREERDVLVNGDSKWITT-LHYAFQDDNNLYLVMDYYVGGDLLTLL-SKFEDRL 172
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
AE A+D +H +H D+K N+L+D N ++ADFGS + + D
Sbjct: 173 PEEMARF-YLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGKLTEKS------DVYSFGVLLAELLTGLKP 165
T ++ +GT P+Y ++ K D +S GV + E+L G P
Sbjct: 229 G-TVQSSVAVGT-----PDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 41/166 (24%), Positives = 71/166 (42%), Gaps = 22/166 (13%)
Query: 6 QHELRVVSQINHKNVVK---ILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
E+ ++ +++H NVVK +L E + +V+E V G + + K
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLKPLSE----DQ 138
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ ++YLH IIH D+K +N+L+ ++ K+ADFG S +
Sbjct: 139 ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195
Query: 123 TTKKIGT--FVNLDPEYVITGKLTE----KSDVYSFGVLLAELLTG 162
T +GT F+ PE ++ DV++ GV L + G
Sbjct: 196 NT--VGTPAFMA--PE-SLSETRKIFSGKALDVWAMGVTLYCFVFG 236
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 1e-17
Identities = 40/180 (22%), Positives = 71/180 (39%), Gaps = 29/180 (16%)
Query: 2 NQV--FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLR 58
+V F+ E V+ + + + + L + + L LV E+ G L + ++
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQ-LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA 161
Query: 59 NWKTCLRI-AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
R AE A+D +H +H D+K N+LLD ++ADFGS + + +D
Sbjct: 162 EM---ARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGKLTEKS--------DVYSFGVLLAELLTGLKP 165
+ +GT P+Y ++ D ++ GV E+ G P
Sbjct: 216 GTV-RSLVAVGT-----PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-17
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ + E+ ++ Q+ H NV+ + E + + L+ E V G LFD + K S
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSD 117
+ ++ + ++YLH+ I H D+K N++L K+ DFG + I +
Sbjct: 119 SFIKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--E 170
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ GT PE+ ++ + L ++D++S GV+ LL+G P
Sbjct: 171 DGVEFKN-IFGT-----PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 1e-17
Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 22/171 (12%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSS---QV 56
NQ+ + EL+V+ + N +V GA + ++ + E + G+L + Q+
Sbjct: 75 RNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPEQI 132
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLIS 115
L +++ L YL I+H DVK +N+L++ + K+ DFG S LI
Sbjct: 133 LG------KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184
Query: 116 SDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
S M +GT + PE + G + +SD++S G+ L E+ G P
Sbjct: 185 S-----MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-17
Identities = 51/186 (27%), Positives = 79/186 (42%), Gaps = 36/186 (19%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPL------LVYEFVPNGTLFDHIHDKSSQVL 57
+ E+ ++ + +H+N+ GA ++ P LV EF G++ D I + L
Sbjct: 67 IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL 126
Query: 58 R-NWKTCLRIAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ W IA E L +LH +IH D+K NVLL +N + K+ DFG S
Sbjct: 127 KEEW-----IAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 114 ISSDNQTAMTTKKIGTFVN----LDPEYVITGKLT------EKSDVYSFGVLLAELLTGL 163
+ T + TF+ + PE VI KSD++S G+ E+ G
Sbjct: 179 LDR------TVGRRNTFIGTPYWMAPE-VIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
Query: 164 KPGSGM 169
P M
Sbjct: 232 PPLCDM 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ + E+ ++ Q+ H N++ + E + + L+ E V G LFD + K S
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEAT 118
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSD 117
+ ++ + ++YLH+ I H D+K N++L K+ DFG + I +
Sbjct: 119 SFIKQILD---GVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--E 170
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ GT PE+ ++ + L ++D++S GV+ LL+G P
Sbjct: 171 DGVEFKN-IFGT-----PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 4e-17
Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ + E+ ++ +I H N++ + E K + L+ E V G LFD + +K S
Sbjct: 53 EEIEREVNILREIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT 111
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSD 117
L+ + + YLHS I H D+K N++L N + K+ DFG + I +
Sbjct: 112 QFLKQILD---GVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--E 163
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
GT PE+ ++ + L ++D++S GV+ LL+G P
Sbjct: 164 AGNEFKN-IFGT-----PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 8e-17
Identities = 39/168 (23%), Positives = 72/168 (42%), Gaps = 21/168 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLR-NWKTCLR 65
E + + H ++V++L + L +V+EF+ L I ++ +
Sbjct: 76 EASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAM 122
+ AL Y H + IIH DVK VLL +++ K+ FG ++ + ++
Sbjct: 135 YMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVA 190
Query: 123 TTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
++GT P + V+ + + DV+ GV+L LL+G P
Sbjct: 191 GG-RVGT-----PHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-16
Identities = 46/172 (26%), Positives = 74/172 (43%), Gaps = 18/172 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E+ ++ ++NH ++KI + + +V E + G LFD +
Sbjct: 58 PALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATC 116
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSD 117
K + A+ YLH + IIH D+K NVLL +++ K+ DFG S ++
Sbjct: 117 KLYFY---QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--G 168
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKL----TEKSDVYSFGVLLAELLTGLKP 165
+ M T GT L PE V+ D +S GV+L L+G P
Sbjct: 169 ETSLMRT-LCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 1e-16
Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 30/169 (17%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVLRNWKTCL 64
E++ + H +++K L + T + +V E+V G LFD+I + + + K
Sbjct: 66 EIQNLKLFRHPHIIK-LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE-----KESR 119
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN--QTAM 122
R+ + S +DY H ++H D+K NVLLD + AK+ADFG S ++S +T+
Sbjct: 120 RLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC 176
Query: 123 TTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
+ P Y VI+G+L + D++S GV+L LL G P
Sbjct: 177 GS----------PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 57/241 (23%), Positives = 105/241 (43%), Gaps = 41/241 (17%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ ++E+ V++Q++H N++++ A E+K + LV E+V G LFD I D+S +
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNL--TEL 187
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL--DDNYKAKVADFGSSVLISSDNQ 119
+ + + ++H I+H D+K N+L D + K+ DFG + +
Sbjct: 188 DTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPR 242
Query: 120 TAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKPGSGMALASN 174
+ GT PE+ V+ ++ +D++S GV+ LL+GL P
Sbjct: 243 EKLKV-NFGT-----PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP--------- 287
Query: 175 EGISMVQYFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRPTMKQ 232
FL + +L IL + ++ E ++I A SK L R + +
Sbjct: 288 --------FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASE 339
Query: 233 V 233
Sbjct: 340 A 340
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-16
Identities = 47/174 (27%), Positives = 79/174 (45%), Gaps = 29/174 (16%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDK-------SS 54
++E+ V+ +I H+N+V + E+ LV + V G LFD I ++ +S
Sbjct: 51 SSLENEIAVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSS 111
V++ SA+ YLH + I+H D+K N+L ++N K + DFG S
Sbjct: 110 LVIQQ----------VLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLS 156
Query: 112 VLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ Q + + GT + PE + ++ D +S GV+ LL G P
Sbjct: 157 KME----QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-16
Identities = 36/171 (21%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
++E+ +++Q++H ++ + A E K + L+ EF+ G LFD I + ++ +
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKM--SEA 149
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL--DDNYKAKVADFGSSVLISSDNQ 119
+ + L ++H + I+H D+K N++ K+ DFG + + +
Sbjct: 150 EVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPD 204
Query: 120 TAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ T E+ ++ + + +D+++ GVL LL+GL P
Sbjct: 205 EIVKV-TTAT-----AEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-16
Identities = 42/177 (23%), Positives = 72/177 (40%), Gaps = 39/177 (22%)
Query: 8 ELRVVSQINHKNVVKILG-ACLETKVPL-LVYEFVPNGT--LFDHIHDKSSQVLRNWKTC 63
E++++ ++ HKNV++++ E K + +V E+ G + D + +K
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK----------- 104
Query: 64 LRIAAETA--------SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
R A L+YLHS I+H D+K N+LL K++ G + +
Sbjct: 105 -RFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160
Query: 116 SDNQTAMTTKKIGTFVNLDPEY----VITGKLT---EKSDVYSFGVLLAELLTGLKP 165
G+ P + + G T K D++S GV L + TGL P
Sbjct: 161 PFAADDTCRTSQGS-----PAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-16
Identities = 42/180 (23%), Positives = 77/180 (42%), Gaps = 34/180 (18%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDK---S 53
N+V ++ EL+++ + H +V L + + + +V + + G L H+
Sbjct: 56 RNEV-RNVFKELQIMQGLEHPFLVN-LWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK 113
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
+ ++ + E ALDYL + IIH D+K N+LLD++ + DF + +
Sbjct: 114 EETVKLF------ICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEY----VITGKLTE---KS-DVYSFGVLLAELLTGLKP 165
+ + Q T GT Y + + + + D +S GV ELL G +P
Sbjct: 165 LPRETQ---ITTMAGT-----KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-16
Identities = 48/164 (29%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E RV+ H + L +T L V E+ G LF H+ +V +
Sbjct: 55 ESRVLQNTRHPFLTA-LKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARF-Y 110
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AE SAL+YLHS +++ D+K N++LD + K+ DFG SD T T
Sbjct: 111 GAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF-- 165
Query: 127 IGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT PEY V+ ++ D + GV++ E++ G P
Sbjct: 166 CGT-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 40/171 (23%), Positives = 80/171 (46%), Gaps = 22/171 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ + E++ +S + H +V + A E + ++YEF+ G LF+ + D+ +++ +
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKM--SED 255
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--KVADFGSSVLISSDNQ 119
+ + L ++H + +H D+K N++ K+ DFG + + D +
Sbjct: 256 EAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPK 310
Query: 120 TAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
++ GT E+ V GK + +D++S GVL LL+GL P
Sbjct: 311 QSVKV-TTGT-----AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-16
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ + E+ ++ +I H NV+ + E K + L+ E V G LFD + +K S
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEAT 117
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSD 117
L+ + YLHS I H D+K N++L + K+ DFG + I D
Sbjct: 118 EFLKQILN---GVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--D 169
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
GT PE+ ++ + L ++D++S GV+ LL+G P
Sbjct: 170 FGNEFKN-IFGT-----PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-16
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 13/167 (7%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q + E R+ + H N+V++ + E L+++ V G LF+ I + +
Sbjct: 55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH 114
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQ 119
C++ E A+ + H ++H ++K N+LL K+ADFG ++ + + Q
Sbjct: 115 CIQQILE---AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168
Query: 120 TAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP 165
GT L PE V+ + D+++ GV+L LL G P
Sbjct: 169 --AWFGFAGTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 4e-16
Identities = 38/173 (21%), Positives = 73/173 (42%), Gaps = 23/173 (13%)
Query: 3 QVFQHELRVVSQINH-KNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNW 60
HE+ V+ V+ + E + L+ E+ G +F + ++++ +
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMV-SE 130
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSD 117
+R+ + + YLH + I+H D+K N+LL K+ DFG S I
Sbjct: 131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI--G 185
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKP 165
+ + +GT PEY ++ +T +D+++ G++ LLT P
Sbjct: 186 HACELRE-IMGT-----PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-16
Identities = 44/173 (25%), Positives = 72/173 (41%), Gaps = 25/173 (14%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVL 57
+ Q+ +H E R++ +N +VK+ + + +V E+V G +F H+
Sbjct: 82 LKQI-EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR--IGRF 138
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
AA+ +YLHS +I+ D+K N+L+D +V DFG
Sbjct: 139 SEPHARF-YAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG---FAKRV 191
Query: 118 NQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
T GT PE +I K K+ D ++ GVL+ E+ G P
Sbjct: 192 KGRTWTL--CGT-----PEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 5e-16
Identities = 54/169 (31%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKS----SQVLRNWKT 62
E ++ ++NH +VK L +T+ L L+ +F+ G LF + + V
Sbjct: 76 ERDILVEVNHPFIVK-LHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV------ 128
Query: 63 CLRI-AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
+ AE A ALD+LHS II+ D+K N+LLD+ K+ DFG S + A
Sbjct: 129 --KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183
Query: 122 MTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+ GT EY V+ + +S D +SFGVL+ E+LTG P
Sbjct: 184 YSF--CGT-----VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-16
Identities = 49/176 (27%), Positives = 71/176 (40%), Gaps = 35/176 (19%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q E+R + ++ H N ++ G L LV E+ +S +L K
Sbjct: 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGS---------ASDLLEVHKK 149
Query: 63 CLR---IAA---ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
L+ IAA L YLHS +IH DVK+ N+LL + K+ DFGS+
Sbjct: 150 PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA----- 201
Query: 117 DNQTAMTTKK---IGTFVNLDPEYVITGKL----TEKSDVYSFGVLLAELLTGLKP 165
++ +GT + PE VI K DV+S G+ EL P
Sbjct: 202 ----SIMAPANSFVGTPYWMAPE-VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 6e-16
Identities = 50/237 (21%), Positives = 87/237 (36%), Gaps = 52/237 (21%)
Query: 15 INHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------SQVLRNWKTCLRIA 67
H N++ + + K +V E + G L D I + S VL
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT-------- 124
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQTAMT 123
++YLH+ ++H D+K +N+L + ++ DFG + + ++N MT
Sbjct: 125 --ITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 124 TKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGIS 178
T + V+ + D++S GVLL +LTG P + + E I
Sbjct: 180 --PCYT-----ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI- 231
Query: 179 MVQYFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRPTMKQV 233
L +I + + + + A L SK L + +R T V
Sbjct: 232 -------------LARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 49/179 (27%), Positives = 79/179 (44%), Gaps = 30/179 (16%)
Query: 1 MNQV--FQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQ 55
+ F E +++ N VV+ L + L +V E++P G L + + +D +
Sbjct: 110 RSDSAFFWEERDIMAFANSPWVVQ-LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK 168
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLIS 115
R + AE ALD +HS IH DVK N+LLD + K+ADFG+ + ++
Sbjct: 169 WARFY------TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219
Query: 116 SDNQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-----DVYSFGVLLAELLTGLKP 165
+ +GT P+Y V+ + + D +S GV L E+L G P
Sbjct: 220 KEGMV-RCDTAVGT-----PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 8e-16
Identities = 43/171 (25%), Positives = 78/171 (45%), Gaps = 22/171 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q + E R+ ++ H N+V++ + E LV++ V G LF+ I + +
Sbjct: 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 109
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQ 119
C++ ++ Y HS+ I+H ++K N+LL K+ADFG ++ + ++
Sbjct: 110 CIQQ---ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--NDS 161
Query: 120 TAMTTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
A GT P Y V+ ++ D+++ GV+L LL G P
Sbjct: 162 EAWHG-FAGT-----PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 9e-16
Identities = 46/238 (19%), Positives = 95/238 (39%), Gaps = 41/238 (17%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E+ +++ H+N++ + + E+ L +++EF+ +F+ I+ + ++ N + +
Sbjct: 49 KKEISILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFEL--NEREIV 105
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLL--DDNYKAKVADFGSSVLISSDNQTAM 122
+ AL +LHS I H D++ N++ + K+ +FG + +
Sbjct: 106 SYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNF 160
Query: 123 TTKKIGTFVNLDPEY----VITGK-LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
PEY V ++ +D++S G L+ LL+G+ P
Sbjct: 161 RL-LFTA-----PEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP------------ 202
Query: 178 SMVQYFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRPTMKQV 233
FL + I+N + DE +EI A + L + R T +
Sbjct: 203 -----FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 74.5 bits (184), Expect = 9e-16
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 1 MNQVFQH---ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQV 56
+ QV +H E ++S + H +++ + + + ++ +++ G LF + + SQ
Sbjct: 47 LKQV-EHTNDERLMLSIVTHPFIIR-MWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQR 102
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
N AAE AL+YLHS II+ D+K N+LLD N K+ DFG
Sbjct: 103 FPNPVAKF-YAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG---FAKY 155
Query: 117 DNQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
T GT P+Y V++ K KS D +SFG+L+ E+L G P
Sbjct: 156 VPDVTYTL--CGT-----PDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 28/169 (16%)
Query: 8 ELRVV-SQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL- 64
+L + ++ V GA E V + E + + +L DK + + + +
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDV-WICMELM-DTSL-----DKFYKQVIDKGQTIP 107
Query: 65 -----RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDN 118
+IA AL++LHS S +IH DVK +NVL++ + K+ DFG S L+
Sbjct: 108 EDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDD-- 163
Query: 119 QTAMTTKKIGTFVNLDPEYVITGKLTE-----KSDVYSFGVLLAELLTG 162
A G + PE I +L + KSD++S G+ + EL
Sbjct: 164 -VAKDI-DAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-15
Identities = 45/209 (21%), Positives = 70/209 (33%), Gaps = 56/209 (26%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E+R++ +++H N+ ++ + + LV E G L D ++ +
Sbjct: 75 IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 65 RIAAETA-------------------------------------SALDYLHSSASPPIIH 87
SAL YLH+ I H
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICH 191
Query: 88 GDVKSTNVLL--DDNYKAKVADFGSSVLISSDN--QTAMTTKKIGTFVNLDPEYV----- 138
D+K N L + +++ K+ DFG S N + T K GT P +V
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT-----PYFVAPEVL 246
Query: 139 --ITGKLTEKSDVYSFGVLLAELLTGLKP 165
K D +S GVLL LL G P
Sbjct: 247 NTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 1e-15
Identities = 42/164 (25%), Positives = 69/164 (42%), Gaps = 20/164 (12%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66
E ++ ++ H +V L +T L L+ E++ G LF + + C
Sbjct: 71 ERNILEEVKHPFIVD-LIYAFQTGGKLYLILEYLSGGELFMQLE--REGIFMEDTACF-Y 126
Query: 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKK 126
AE + AL +LH II+ D+K N++L+ K+ DFG D T
Sbjct: 127 LAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF-- 181
Query: 127 IGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT EY ++ ++ D +S G L+ ++LTG P
Sbjct: 182 CGT-----IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-15
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 1 MNQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
+ + E+ ++ +++ H N++++ LV++ + G LFD++ +K + +
Sbjct: 66 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ +R + LH I+H D+K N+LLDD+ K+ DFG S + +
Sbjct: 126 TRKIMRA---LLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 120 TAMTTKKIGTFVNLDPEYV-----------ITGKLTEKSDVYSFGVLLAELLTGLKP 165
+ GT P Y+ ++ D++S GV++ LL G P
Sbjct: 180 --LRE-VCGT-----PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVLRNWKTCL 64
E+ + + H +++K L + T + +V E+ G LFD+I + ++
Sbjct: 59 EISYLKLLRHPHIIK-LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE-----DEGR 111
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN--QTAM 122
R + A++Y H I+H D+K N+LLDDN K+ADFG S +++ N +T+
Sbjct: 112 RFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS- 167
Query: 123 TTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
G+ P Y VI GKL + DV+S G++L +L G P
Sbjct: 168 ----CGS-----PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKS-------S 54
++ + E+ V+ +++H N++K+ ET + LV E V G LFD I +K +
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSERDAA 151
Query: 55 QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSS 111
++ A+ YLH + I+H D+K N+L + K+ADFG S
Sbjct: 152 DAVKQ----------ILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLS 198
Query: 112 VLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKP 165
++ ++Q M T GT PE ++ G + D++S G++ LL G +P
Sbjct: 199 KIV--EHQVLMKT-VCGTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-15
Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 24/172 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
Q + E R+ ++ H N+V++ + + + LV++ V G LF+ I + +
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEADAS 131
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDN 118
C++ ++ Y HS+ I+H ++K N+LL K+ADFG ++ + ++
Sbjct: 132 HCIQQ---ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--ND 183
Query: 119 QTAMTTKKIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
A GT P Y V+ ++ D+++ GV+L LL G P
Sbjct: 184 SEAWHG-FAGT-----PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-15
Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 20/169 (11%)
Query: 6 QHELRVV-SQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
+L VV + +V+ G + T V + E + GT + + + + +
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDV-FIAMELM--GTCAEKLKKRMQGPIPE-RIL 126
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAM 122
++ AL YL +IH DVK +N+LLD+ + K+ DFG S L+ A
Sbjct: 127 GKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD---KAK 181
Query: 123 TTKKIGTFVNLDPEYVITGKL------TEKSDVYSFGVLLAELLTGLKP 165
G + PE I ++DV+S G+ L EL TG P
Sbjct: 182 DR-SAGCAAYMAPE-RIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-15
Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 35/165 (21%)
Query: 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------SQVLRNWKTCLRIAA 68
H N+VK+ + LV E + G LF+ I K S ++R
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR---------- 113
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTK 125
+ SA+ ++H ++H D+K N+L +DN + K+ DFG + L DNQ T
Sbjct: 114 KLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-- 168
Query: 126 KIGTFVNLDPEY----VITGKL-TEKSDVYSFGVLLAELLTGLKP 165
T Y ++ E D++S GV+L +L+G P
Sbjct: 169 PCFT-----LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-15
Identities = 49/166 (29%), Positives = 75/166 (45%), Gaps = 21/166 (12%)
Query: 8 ELRVV-SQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW---KT 62
+L VV + +V+ GA E + E + T FD + VL + +
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDC-WICMELM--STSFDKFYKYVYSVLDDVIPEEI 126
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTA 121
+I T AL++L + IIH D+K +N+LLD + K+ DFG S L+ S +
Sbjct: 127 LGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-- 182
Query: 122 MTTKKIGTFVNLDPEYVITGKLTE-----KSDVYSFGVLLAELLTG 162
T+ G + PE I + +SDV+S G+ L EL TG
Sbjct: 183 --TRDAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-15
Identities = 46/177 (25%), Positives = 72/177 (40%), Gaps = 40/177 (22%)
Query: 6 QHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
Q E+ + H N+V+ + T L ++ E+ G L++ I +
Sbjct: 64 QREIINHRSLRHPNIVR-FKEVILTPTHLAIIMEYASGGELYERICNAG----------- 111
Query: 65 RIAAETA--------SALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--KVADFGSSVLI 114
R + + A S + Y HS I H D+K N LLD + K+ DFG S
Sbjct: 112 RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
Query: 115 SSDNQTAMTTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
+Q +T +GT P Y V+ + + +DV+S GV L +L G P
Sbjct: 169 VLHSQ-PKST--VGT-----PAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 73.4 bits (180), Expect = 5e-15
Identities = 38/159 (23%), Positives = 68/159 (42%), Gaps = 13/159 (8%)
Query: 9 LRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
L +VS + +V + T L + + + G L H+ V A
Sbjct: 243 LSLVSTGDCPFIVC-MSYAFHTPDKLSFILDLMNGGDLHYHLS--QHGVFSEADMRF-YA 298
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
AE L+++H+ +++ D+K N+LLD++ +++D G + S +
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASV 351
Query: 128 GTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT + PE + G + S D +S G +L +LL G P
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 6e-15
Identities = 51/148 (34%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
L C +T L V EFV G L HI S+ + AAE SAL +LH
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARF-YAAEIISALMFLHDKG- 144
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY----V 138
II+ D+K NVLLD K+ADFG + T T GT P+Y +
Sbjct: 145 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--CGT-----PDYIAPEI 195
Query: 139 ITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+ L + D ++ GVLL E+L G P
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 8e-15
Identities = 51/148 (34%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
L +C +T L V E+V G L HI + AAE A L +L S
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVF-YAAEIAIGLFFLQSKG- 462
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY----V 138
II+ D+K NV+LD K+ADFG D T T GT P+Y +
Sbjct: 463 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGT-----PDYIAPEI 513
Query: 139 ITGKLTEKS-DVYSFGVLLAELLTGLKP 165
I + KS D ++FGVLL E+L G P
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-14
Identities = 39/162 (24%), Positives = 81/162 (50%), Gaps = 27/162 (16%)
Query: 16 NHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74
H +++ ++ + E+ + LV++ + G LFD++ +K + + ++ +R A+
Sbjct: 158 GHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRS---LLEAV 213
Query: 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLD 134
+LH++ I+H D+K N+LLDDN + +++DFG S + + + GT
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRE-LCGT----- 262
Query: 135 PEY----VITGKL-------TEKSDVYSFGVLLAELLTGLKP 165
P Y ++ + ++ D+++ GV+L LL G P
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 21/165 (12%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E V Q NH +V L +C +T+ L V E+V G L H+ + + L
Sbjct: 59 EKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF- 114
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
+AE + AL+YLH II+ D+K NVLLD K+ D+G T T
Sbjct: 115 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 170
Query: 126 KIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT P Y ++ G+ S D ++ GVL+ E++ G P
Sbjct: 171 -CGT-----PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-14
Identities = 51/174 (29%), Positives = 74/174 (42%), Gaps = 39/174 (22%)
Query: 8 ELRVVSQ-INHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E V+ + + H +V L +T L V +++ G LF H+ + R
Sbjct: 88 ERNVLLKNVKHPFLVG-LHFSFQTADKLYFVLDYINGGELFYHLQRE------------R 134
Query: 66 I---------AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
AAE ASAL YLHS I++ D+K N+LLD + DFG
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191
Query: 117 DNQTAMTTKKIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
N T T GT PEY V+ + +++ D + G +L E+L GL P
Sbjct: 192 HNSTTSTF--CGT-----PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-14
Identities = 46/148 (31%), Positives = 65/148 (43%), Gaps = 19/148 (12%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
+ +TK L V E++ G L HI + AAE L +LHS
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATF-YAAEIILGLQFLHSKG- 138
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY----V 138
I++ D+K N+LLD + K+ADFG + T GT P+Y +
Sbjct: 139 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CGT-----PDYIAPEI 189
Query: 139 ITGKLTEKS-DVYSFGVLLAELLTGLKP 165
+ G+ S D +SFGVLL E+L G P
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-14
Identities = 32/184 (17%), Positives = 62/184 (33%), Gaps = 35/184 (19%)
Query: 6 QHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI--HDKSSQVLRNWKT 62
E+ + + H +VV+ A E L+ E+ G+L D I + + +
Sbjct: 58 LREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE-AE 116
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDN-------------------YKA 103
+ + L Y+HS + ++H D+K +N+ +
Sbjct: 117 LKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMF 173
Query: 104 KVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL--TEKSDVYSFGVLLAELLT 161
K+ D G ISS + G L E V+ K+D+++ + +
Sbjct: 174 KIGDLGHVTRISSPQV------EEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAG 226
Query: 162 GLKP 165
Sbjct: 227 AEPL 230
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-14
Identities = 51/165 (30%), Positives = 74/165 (44%), Gaps = 21/165 (12%)
Query: 8 ELRVVSQI-NHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLR 65
E V Q NH +V L +C +T+ L V E+V G L H+ + + L
Sbjct: 102 EKHVFEQASNHPFLVG-LHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARF- 157
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTK 125
+AE + AL+YLH II+ D+K NVLLD K+ D+G T T
Sbjct: 158 YSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF- 213
Query: 126 KIGTFVNLDPEY----VITGKLTEKS-DVYSFGVLLAELLTGLKP 165
GT P Y ++ G+ S D ++ GVL+ E++ G P
Sbjct: 214 -CGT-----PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-14
Identities = 51/148 (34%), Positives = 66/148 (44%), Gaps = 19/148 (12%)
Query: 24 LGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82
L +C +T L V E+V G L HI + AAE A L +L S
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGRFKEPHAVF-YAAEIAIGLFFLQSKG- 141
Query: 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY----V 138
II+ D+K NV+LD K+ADFG D T T GT P+Y +
Sbjct: 142 --IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGT-----PDYIAPEI 192
Query: 139 ITGKLTEKS-DVYSFGVLLAELLTGLKP 165
I + KS D ++FGVLL E+L G P
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-14
Identities = 56/245 (22%), Positives = 93/245 (37%), Gaps = 47/245 (19%)
Query: 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------SQVLRNWKTCLRIAA 68
H+NV++++ E LV+E + G++ HIH + S V++
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQ---------- 118
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLIS-----SDNQT 120
+ ASALD+LH+ I H D+K N+L + K+ DF I S T
Sbjct: 119 DVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 121 AMTTKKIGTFVNLDPEYV----------ITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
G+ EY+ ++ D++S GV+L LL+G P G
Sbjct: 176 PELLTPCGS-----AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVA-DESEMEEIETVA-GLASKCLSLSGRRRP 228
+ + + +N I + + + I A L SK L ++R
Sbjct: 231 GS--DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL 288
Query: 229 TMKQV 233
+ QV
Sbjct: 289 SAAQV 293
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-14
Identities = 39/171 (22%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 8 ELRVVSQINHK--NVVKILGACLETKVPL-LVYEFV-PNGTLFDHI--HDKSSQVLRNWK 61
E+ ++ +++ V+++L E L+ E P LFD I + +
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE-----E 149
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQT 120
+ A+ + H+ ++H D+K N+L+D N + K+ DFGS L+ T
Sbjct: 150 LARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD---T 203
Query: 121 AMTTKKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
T GT Y I + V+S G+LL +++ G P
Sbjct: 204 VYTDF-DGT-----RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-13
Identities = 41/139 (29%), Positives = 66/139 (47%), Gaps = 21/139 (15%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
L+ +++ G LF H+ + + + E AL++LH II+ D+K N
Sbjct: 136 LILDYINGGELFTHL--SQRERFTEHEVQI-YVGEIVLALEHLHKLG---IIYRDIKLEN 189
Query: 95 VLLDDNYKAKVADFG-SSVLISSDNQTAMTTKKIGTFVNLDPEY----VITGKLT--EKS 147
+LLD N + DFG S ++ + + A GT EY ++ G + +K+
Sbjct: 190 ILLDSNGHVVLTDFGLSKEFVADETERAYDF--CGT-----IEYMAPDIVRGGDSGHDKA 242
Query: 148 -DVYSFGVLLAELLTGLKP 165
D +S GVL+ ELLTG P
Sbjct: 243 VDWWSLGVLMYELLTGASP 261
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-13
Identities = 41/162 (25%), Positives = 67/162 (41%), Gaps = 25/162 (15%)
Query: 16 NHKNVVKILGAC----LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETA 71
++V IL + L++ E + G LF I ++ Q + I +
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF-TEREAAEIMRDIG 138
Query: 72 SALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTKKIG 128
+A+ +LHS I H DVK N+L + + K+ DFG + + + A+ T
Sbjct: 139 TAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN---ALQT-PCY 191
Query: 129 TFVNLDPEYV-----ITGKLTEKSDVYSFGVLLAELLTGLKP 165
T P YV K + D++S GV++ LL G P
Sbjct: 192 T-----PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-13
Identities = 48/166 (28%), Positives = 67/166 (40%), Gaps = 32/166 (19%)
Query: 16 NHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAET- 70
++V+I+ L+V E + G LF I D+ Q R A+E
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE-----REASEIM 167
Query: 71 ---ASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTT 124
A+ YLHS I H DVK N+L N K+ DFG + +S N +TT
Sbjct: 168 KSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTT 222
Query: 125 KKIGTFVNLDPEYV-----ITGKLTEKSDVYSFGVLLAELLTGLKP 165
T P YV K + D++S GV++ LL G P
Sbjct: 223 -PCYT-----PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-13
Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 8/112 (7%)
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ + + + A +++L AS IH D+ + N+LL + K+ DFG + I D
Sbjct: 193 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD- 248
Query: 121 AMTTKKIGTF-VN-LDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGM 169
K + + PE + T +SDV+SFGVLL E+ + G P G+
Sbjct: 249 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 299
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-13
Identities = 42/167 (25%), Positives = 69/167 (41%), Gaps = 29/167 (17%)
Query: 10 RVVSQINHKNVVKILGACLETKVPL-LVYEF-VPNGTLFDHI--HDKSSQVLRNWKTCLR 65
+V + H V+++L ET+ LV E +P LFD+I +
Sbjct: 90 KVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGE-----GPSRC 143
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTT 124
+ +A+ + HS ++H D+K N+L+D AK+ DFGS L+ T
Sbjct: 144 FFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTD 197
Query: 125 KKIGTFVNLDPEY----VITGKLTE--KSDVYSFGVLLAELLTGLKP 165
GT Y I+ + V+S G+LL +++ G P
Sbjct: 198 F-DGT-----RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-11
Identities = 37/193 (19%), Positives = 73/193 (37%), Gaps = 49/193 (25%)
Query: 4 VFQH---------ELRVVSQINHKNVVKIL------GACLETKVPL-LVYEFVPNGTLFD 47
V Q ++ ++ ++H N+V++ G + L +V E+VP+ TL
Sbjct: 56 VIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR 114
Query: 48 HI--HDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAK 104
+ + + + + ++ LH S + H D+K NVL++ + K
Sbjct: 115 CCRNYYRRQVAPPPILIKVFLF-QLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK 172
Query: 105 VADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLTEKSDVYSF 152
+ DFGS+ +S Y+ + T D++S
Sbjct: 173 LCDFGSAKKLSPSE--PNV------------AYICSRYYRAPELIFGNQHYTTAVDIWSV 218
Query: 153 GVLLAELLTGLKP 165
G + AE++ G +P
Sbjct: 219 GCIFAEMMLG-EP 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 7e-11
Identities = 35/204 (17%), Positives = 65/204 (31%), Gaps = 70/204 (34%)
Query: 3 QVFQH---------ELRVVSQINHKNVVKILGACLETKVPL-----LVYEFVP------- 41
+ E+R+++ +H N++ + + + P LV E +
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI 124
Query: 42 --NGTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97
+ H + +L L LH + ++H D+ N+LL
Sbjct: 125 HDQRIVISPQHIQYFMYHILL--------------GLHVLHEAG---VVHRDLHPGNILL 167
Query: 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLTE 145
DN + DF + ++D T YV T+
Sbjct: 168 ADNNDITICDFNLAREDTADAN--KT------------HYVTHRWYRAPELVMQFKGFTK 213
Query: 146 KSDVYSFGVLLAELLTG--LKPGS 167
D++S G ++AE+ L GS
Sbjct: 214 LVDMWSAGCVMAEMFNRKALFRGS 237
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 44/192 (22%), Positives = 79/192 (41%), Gaps = 45/192 (23%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPL------LVYEFVPN--- 42
+++ FQ+ EL ++ +NHKN++ +L K +V E +
Sbjct: 58 LSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLC 117
Query: 43 ---GTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97
DH Q+L + +LHS+ IIH D+K +N+++
Sbjct: 118 QVIQMELDHERMSYLLYQMLC--------------GIKHLHSAG---IIHRDLKPSNIVV 160
Query: 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157
+ K+ DFG L + + M T + T PE ++ E D++S G ++
Sbjct: 161 KSDCTLKILDFG---LARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217
Query: 158 ELLTG--LKPGS 167
E++ G L PG+
Sbjct: 218 EMIKGGVLFPGT 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 44/205 (21%), Positives = 79/205 (38%), Gaps = 71/205 (34%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPL------LVYEF------ 39
+ + FQ ELR++ + H+NV+ +L + LV F
Sbjct: 58 LYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG 117
Query: 40 -VPNGTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVL 96
+ + Q+L+ L Y+H++ IIH D+K N+
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLK--------------GLRYIHAAG---IIHRDLKPGNLA 160
Query: 97 LDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLT 144
++++ + K+ DFG + S+ MT YV+T + T
Sbjct: 161 VNEDCELKILDFGLARQADSE----MT------------GYVVTRWYRAPEVILNWMRYT 204
Query: 145 EKSDVYSFGVLLAELLTG--LKPGS 167
+ D++S G ++AE++TG L GS
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGS 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 71/205 (34%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPL------LVYEF------ 39
+++ FQ ELR++ + H+NV+ +L + LV
Sbjct: 62 LSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN 121
Query: 40 -VPNGTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVL 96
+ H + Q+LR L Y+HS+ IIH D+K +N+
Sbjct: 122 NIVKCQKLTDDHVQFLIYQILR--------------GLKYIHSAD---IIHRDLKPSNLA 164
Query: 97 LDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLT 144
++++ + K+ DFG ++ MT YV T
Sbjct: 165 VNEDCELKILDFG----LARHTADEMT------------GYVATRWYRAPEIMLNWMHYN 208
Query: 145 EKSDVYSFGVLLAELLTG--LKPGS 167
+ D++S G ++AELLTG L PG+
Sbjct: 209 QTVDIWSVGCIMAELLTGRTLFPGT 233
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-10
Identities = 41/204 (20%), Positives = 76/204 (37%), Gaps = 70/204 (34%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPL------LVYEF------ 39
+++ FQ EL ++ + H+NV+ +L LV F
Sbjct: 57 LSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQ 116
Query: 40 --VPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97
+ + I Q+L+ L Y+HS+ ++H D+K N+ +
Sbjct: 117 KIMGLKFSEEKIQYLVYQMLK--------------GLKYIHSAG---VVHRDLKPGNLAV 159
Query: 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLTE 145
+++ + K+ DFG + ++ MT YV+T +
Sbjct: 160 NEDCELKILDFGLARHADAE----MT------------GYVVTRWYRAPEVILSWMHYNQ 203
Query: 146 KSDVYSFGVLLAELLTG--LKPGS 167
D++S G ++AE+LTG L G
Sbjct: 204 TVDIWSVGCIMAEMLTGKTLFKGK 227
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 3e-10
Identities = 44/203 (21%), Positives = 77/203 (37%), Gaps = 67/203 (33%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKIL-----GACLETKVPL-LVYEF------ 39
+++ FQ+ EL ++ +NHKN++ +L LE + LV E
Sbjct: 95 LSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC 154
Query: 40 -VPNGTLFD-HIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97
V L + Q+L + +LHS+ IIH D+K +N+++
Sbjct: 155 QVIQMELDHERMSYLLYQMLC--------------GIKHLHSAG---IIHRDLKPSNIVV 197
Query: 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----------GKLTEK 146
+ K+ DFG + ++ MT YV+T E
Sbjct: 198 KSDCTLKILDFGLAR--TAGTSFMMT------------PYVVTRYYRAPEVILGMGYKEN 243
Query: 147 SDVYSFGVLLAELLTG--LKPGS 167
D++S G ++ E++ L PG
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGR 266
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 5e-10
Identities = 49/193 (25%), Positives = 81/193 (41%), Gaps = 48/193 (24%)
Query: 4 VFQH------ELRVVSQINHKNVVKILGACLET-----KVPL-LVYEFVPNGTLFDHI-- 49
V Q EL+++ +++H N+V++ + +V L LV ++VP T++
Sbjct: 87 VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARH 145
Query: 50 HDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADF 108
+ ++ Q L L + + +L Y+HS I H D+K N+LLD D K+ DF
Sbjct: 146 YSRAKQTLPVIYVKLYMY-QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF 201
Query: 109 GSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG------------KLTEKSDVYSFGVLL 156
GS+ + Y+ + T DV+S G +L
Sbjct: 202 GSAKQLVRGE--PNV------------SYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 157 AELLTG--LKPGS 167
AELL G + PG
Sbjct: 248 AELLLGQPIFPGD 260
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 8e-10
Identities = 39/190 (20%), Positives = 73/190 (38%), Gaps = 59/190 (31%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL-----LVYEF-------VPNGTLFDHIHDKS-- 53
E++++ + H+N++ I + +V + + + H
Sbjct: 75 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL 134
Query: 54 SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113
Q+LR L Y+HS+ ++H D+K +N+LL+ K+ DFG + +
Sbjct: 135 YQILR--------------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 114 ISSDNQTA--MTTKKIGTFVNLDPEYVIT------------GKLTEKSDVYSFGVLLAEL 159
D+ +T EYV T T+ D++S G +LAE+
Sbjct: 178 ADPDHDHTGFLT------------EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
Query: 160 LTG--LKPGS 167
L+ + PG
Sbjct: 226 LSNRPIFPGK 235
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 42/201 (20%), Positives = 70/201 (34%), Gaps = 57/201 (28%)
Query: 4 VFQH---------ELRVVSQINHKNVVKILGACLETKVPL-----LVYEF-------VPN 42
F E++++ H+N++ I ++ E V +
Sbjct: 46 PFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS 105
Query: 43 GTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDN 100
+ H + Q LR A+ LH S +IH D+K +N+L++ N
Sbjct: 106 TQMLSDDHIQYFIYQTLR--------------AVKVLHGSN---VIHRDLKPSNLLINSN 148
Query: 101 YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------------GKLTEKSD 148
KV DFG + +I + + E+V T K + D
Sbjct: 149 CDLKVCDFGLARIIDESAADNSEPTGQQSGM---VEFVATRWYRAPEVMLTSAKYSRAMD 205
Query: 149 VYSFGVLLAELLTG--LKPGS 167
V+S G +LAEL + PG
Sbjct: 206 VWSCGCILAELFLRRPIFPGR 226
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-09
Identities = 37/217 (17%), Positives = 72/217 (33%), Gaps = 70/217 (32%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHI-- 49
+N++F+ E+ +++++ ++++ + + FD +
Sbjct: 59 VNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLII-----------PDDLLKFDELYI 107
Query: 50 ---------HD--KSSQVLRNWKTC------LRIAAETASALDYLHSSASPPIIHGDVKS 92
K+ L L +++H S IIH D+K
Sbjct: 108 VLEIADSDLKKLFKTPIFLTEEHIKTILYNLLL-------GENFIHESG---IIHRDLKP 157
Query: 93 TNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDP---------EYVIT--- 140
N LL+ + KV DFG + I+S+ T + +V+T
Sbjct: 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217
Query: 141 ---------GKLTEKSDVYSFGVLLAELLTGLKPGSG 168
T+ D++S G + AELL L+
Sbjct: 218 RAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-09
Identities = 31/128 (24%), Positives = 52/128 (40%), Gaps = 33/128 (25%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA------KVADFGSSVL----I 114
+I+ + LDY+H IIH D+K NVL++ K+AD G++
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192
Query: 115 SSDNQT----AMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLTG--LKPGS 167
++ QT + PE V+ G +D++S L+ EL+TG L
Sbjct: 193 TNSIQTREYRS-------------PE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238
Query: 168 GMALASNE 175
+ +
Sbjct: 239 EGHSYTKD 246
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-09
Identities = 40/160 (25%), Positives = 57/160 (35%), Gaps = 41/160 (25%)
Query: 16 NHKNVVKILGACLETKVP-----LLVYEFVPNGTLFDHIHDKSSQVL--RNWKTCLRIAA 68
++V+I+ E L+V E + G LF I D+ Q R ++
Sbjct: 69 QCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK--- 124
Query: 69 ETASALDYLHSSASPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTK 125
A+ YLHS I H DVK N+L N K+ DFG
Sbjct: 125 SIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG---------------- 165
Query: 126 KIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165
E K + D++S GV++ LL G P
Sbjct: 166 -------FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 5e-09
Identities = 37/163 (22%), Positives = 72/163 (44%), Gaps = 34/163 (20%)
Query: 16 NHKNVVKILGACL--ETKVPLLVYEFVPNGTLFDHIHDKSS---------QVLRNWKTCL 64
N++ + ++ P LV+E V N T F ++ + ++L+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHV-NNTDFKQLYQTLTDYDIRFYMYEILK------ 141
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMT 123
ALDY HS I+H DVK NV++D ++ K ++ D+G L +
Sbjct: 142 --------ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWG---LAEFYHPGQEY 187
Query: 124 TKKIGTFVNLDPEYVITGKLTEKS-DVYSFGVLLAELLTGLKP 165
++ + PE ++ ++ + S D++S G +LA ++ +P
Sbjct: 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-09
Identities = 41/213 (19%), Positives = 81/213 (38%), Gaps = 78/213 (36%)
Query: 4 VFQH---------ELRVVSQINHKNVVKIL------GACLETKVPL--------LVYEFV 40
V E++++ +++H N+VK+ G+ L V +V E++
Sbjct: 45 VLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM 104
Query: 41 P--------NGTLFD-HIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVK 91
G L + H Q+LR L Y+HS+ ++H D+K
Sbjct: 105 ETDLANVLEQGPLLEEHARLFMYQLLR--------------GLKYIHSAN---VLHRDLK 147
Query: 92 STNVLLD-DNYKAKVADFG--SSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-------- 140
N+ ++ ++ K+ DFG + ++ ++ E ++T
Sbjct: 148 PANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS------------EGLVTKWYRSPRL 195
Query: 141 ----GKLTEKSDVYSFGVLLAELLTG--LKPGS 167
T+ D+++ G + AE+LTG L G+
Sbjct: 196 LLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGA 228
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 20/106 (18%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--KVADFGSSVLISSDNQTAM 122
+ A LD LH + IIH D+K N+LL ++ KV DFGSS
Sbjct: 204 KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS---------CY 251
Query: 123 TTKKIGTFVNL----DPEYVITG-KLTEKSDVYSFGVLLAELLTGL 163
+++ T++ PE VI G + D++S G +LAELLTG
Sbjct: 252 EHQRVYTYIQSRFYRAPE-VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 48/182 (26%), Positives = 75/182 (41%), Gaps = 42/182 (23%)
Query: 8 ELRVVSQINHKNVVKIL-----GACLETKVPL-LVYEFVPNGTLFDHI--HDKSSQVLRN 59
EL+++ + H NVV + + +V L LV E+VP T++ + K Q +
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPM 140
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDN 118
L + + +L Y+HS I H D+K N+LLD + K+ DFGS
Sbjct: 141 LLIKLYMY-QLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS-------- 188
Query: 119 QTAMTTKKIGTFVNLDPEYVITG------------KLTEKSDVYSFGVLLAELLTG--LK 164
A V Y+ + T D++S G ++AEL+ G L
Sbjct: 189 --AKILIAGEPNV----SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242
Query: 165 PG 166
PG
Sbjct: 243 PG 244
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 2e-08
Identities = 41/174 (23%), Positives = 73/174 (41%), Gaps = 33/174 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E+R++ Q+ H N+V +L + LV+E+ + T+ + D+ + + I
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGV-PEHLVKSIT 108
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+T A+++ H IH DVK N+L+ + K+ DFG + L++ +
Sbjct: 109 WQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YD---- 160
Query: 128 GTFVNLDPEYVIT-----------GKLTEKS-DVYSFGVLLAELLTG--LKPGS 167
+ V T DV++ G + AELL+G L PG
Sbjct: 161 --------DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 2e-08
Identities = 40/174 (22%), Positives = 79/174 (45%), Gaps = 33/174 (18%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67
E++++ Q+ H+N+V +L C + K LV+EFV + T+ D + + + +++ +
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGL--DYQVVQKYL 130
Query: 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKI 127
+ + + + HS IIH D+K N+L+ + K+ DFG + +++ +
Sbjct: 131 FQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV-YD---- 182
Query: 128 GTFVNLDPEYVIT------------GKLTEKSDVYSFGVLLAELLTG--LKPGS 167
+ V T K + DV++ G L+ E+ G L PG
Sbjct: 183 --------DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGD 228
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-08
Identities = 30/106 (28%), Positives = 51/106 (48%), Gaps = 18/106 (16%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--KVADFGSSVLISSDNQTAM 122
+ A + +AL +L + IIH D+K N+LL + ++ K+ DFGSS +
Sbjct: 161 KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG------- 212
Query: 123 TTKKIGTFVNL----DPEYVITG-KLTEKSDVYSFGVLLAELLTGL 163
++I ++ PE V+ G D++S G +L E+ TG
Sbjct: 213 --QRIYQYIQSRFYRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 31/149 (20%), Positives = 59/149 (39%), Gaps = 36/149 (24%)
Query: 35 LVYEFVPNGTLFDHI--HDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKS 92
++ E+VP+ TL + +S + + + I + A+ ++HS I H D+K
Sbjct: 115 VIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIY-QLFRAVGFIHSLG---ICHRDIKP 169
Query: 93 TNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT----------- 140
N+L++ + K+ DFGS+ + Y+ +
Sbjct: 170 QNLLVNSKDNTLKLCDFGSAKKLIPSE--PSV------------AYICSRFYRAPELMLG 215
Query: 141 -GKLTEKSDVYSFGVLLAELLTG--LKPG 166
+ T D++S G + EL+ G L G
Sbjct: 216 ATEYTPSIDLWSIGCVFGELILGKPLFSG 244
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 6e-08
Identities = 32/117 (27%), Positives = 49/117 (41%), Gaps = 25/117 (21%)
Query: 73 ALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVN 132
+ YLHS ++H D+K +N+LL+ KVADFG S + +
Sbjct: 121 VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 133 LDP--------EYVIT------------GKLTEKSDVYSFGVLLAELLTG--LKPGS 167
+ +YV T K T+ D++S G +L E+L G + PGS
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.2 bits (119), Expect = 3e-07
Identities = 49/300 (16%), Positives = 90/300 (30%), Gaps = 107/300 (35%)
Query: 2 NQVFQ----------HELR-VVSQIN-HKNVV--KILGA---CLETKVPLLVYEFVPNGT 44
NQVF +LR + ++ KNV+ +LG+ + V L Y+
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV-CLSYKVQCK-- 179
Query: 45 LFDHIH-------DKSSQVLRN-WKTCLRIAAETASALDYLHSSASPPIIHGDVKS---- 92
+ I + VL K +I S D+ S++ + +++
Sbjct: 180 MDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH---SSNIKLRIHSIQAELRR 236
Query: 93 -------TNVL--LDDNYKAKVA---DFGSSVLISSDNQTAMTT--KKIGTFVNLDPEYV 138
N L L + AK + +L+ TT K++ F++
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILL--------TTRFKQVTDFLSAATTTH 288
Query: 139 ITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNF 198
I+ L L P +L L + L+
Sbjct: 289 IS---------------LDHHSMTLTPDEVKSL--------------------LLKYLDC 313
Query: 199 QVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISHENYEHRRTEKRQSI 258
+ D E+ T LS+ + + L +N++H +K +I
Sbjct: 314 RPQDLPR--EVLTTNPRR---LSIIAES------IRDGLATW----DNWKHVNCDKLTTI 358
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 5e-07
Identities = 51/262 (19%), Positives = 90/262 (34%), Gaps = 83/262 (31%)
Query: 1 MNQVFQH---------ELRVVSQINHKNVVKILGACLETKVPL-----LVYEFVP----- 41
+ +VF+ E+ +++++NH +VVK+L + V +V E
Sbjct: 86 ILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK 145
Query: 42 ----NGTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNV 95
L + +H K+ +L + Y+HS+ I+H D+K N
Sbjct: 146 LFRTPVYLTE-LHIKTLLYNLLV--------------GVKYVHSAG---ILHRDLKPANC 187
Query: 96 LLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDP--------------EYVIT- 140
L++ + KV DFG + + +++ +V+T
Sbjct: 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTR 247
Query: 141 -----------GKLTEKSDVYSFGVLLAELLTGLK-------------PG-SGMALASNE 175
TE DV+S G + AELL +K PG S L+ ++
Sbjct: 248 WYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQ 307
Query: 176 GISMVQYFLYSIENNSLRQILN 197
F + L I N
Sbjct: 308 KAGNDFKFHTRGNRDQLNVIFN 329
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 6e-07
Identities = 28/121 (23%), Positives = 48/121 (39%), Gaps = 36/121 (29%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL--------LVYEFVPN---------GTLFDHIH 50
E++++ + H+NVV ++ C P LV++F + F
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE 125
Query: 51 DKS--SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADF 108
K +L L Y+H + I+H D+K+ NVL+ + K+ADF
Sbjct: 126 IKRVMQMLLN--------------GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168
Query: 109 G 109
G
Sbjct: 169 G 169
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 29/118 (24%), Positives = 47/118 (39%), Gaps = 34/118 (28%)
Query: 9 LRVVSQINHKNVVKIL----GACLETKVPL-LVYEFVP----------NGTLFDHIHDKS 53
LR + H NVV+++ + + ++ + LV+E V K
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKD 124
Query: 54 --SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
Q LR LD+LH++ I+H D+K N+L+ K+ADFG
Sbjct: 125 LMRQFLR--------------GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFG 165
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 28/113 (24%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP---------NGTLFDHIHDKS--SQV 56
E+ ++ +++H N+V ++ + LV+EF+ N T K Q+
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQL 128
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
LR + + H I+H D+K N+L++ + K+ADFG
Sbjct: 129 LR--------------GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFG 164
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 46.7 bits (112), Expect = 2e-06
Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 28/113 (24%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP---------NGTLFDHIHDKS--SQV 56
E+ ++ ++ HKN+V++ K LV+EF D KS Q+
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
L+ L + HS ++H D+K N+L++ N + K+A+FG
Sbjct: 111 LK--------------GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFG 146
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 22/104 (21%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVPN--GTLFDHIHDKSSQVLRNWKTCLR 65
E+ ++ ++ H+N+V++ LV+EF+ N D ++
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 66 IAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
+ L + H + I+H D+K N+L++ + K+ DFG
Sbjct: 113 FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 3e-06
Identities = 27/130 (20%), Positives = 44/130 (33%), Gaps = 18/130 (13%)
Query: 35 LVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTN 94
+V EF G + + K L + T I + ++L +S H D+ N
Sbjct: 139 IVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGN 192
Query: 95 VLLDDNYKAKVAD-----------FGSSVLISSDNQTAMTTKKIGTFVNLD-PEYVITGK 142
VLL K+ G V I + + I F ++ E + TG
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 143 LTEKSDVYSF 152
+ D+Y
Sbjct: 253 GDYQFDIYRL 262
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 25/113 (22%), Positives = 47/113 (41%), Gaps = 28/113 (24%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP---------NGTLFDHIHDKS--SQV 56
E+ ++ ++ H N+VK+ K +LV+E + + + KS Q+
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
L + Y H ++H D+K N+L++ + K+ADFG
Sbjct: 110 LN--------------GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFG 145
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 4e-06
Identities = 29/107 (27%), Positives = 47/107 (43%), Gaps = 28/107 (26%)
Query: 14 QINHKNVVKILGACLETKVPLLVYEFVP---------NGTLFDHIHDKS--SQVLRNWKT 62
+++H N++ +L A LV++F+ N + H K+ L+
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ---- 123
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
L+YLH I+H D+K N+LLD+N K+ADFG
Sbjct: 124 ----------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFG 157
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 4e-06
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 29/114 (25%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFV----------PNGTLFDHIHDKS--SQ 55
E+ ++ ++NH N+VK+L LV+EF+ T KS Q
Sbjct: 52 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 56 VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
+L+ L + HS ++H D+K N+L++ K+ADFG
Sbjct: 112 LLQ--------------GLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFG 148
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 30/147 (20%), Positives = 46/147 (31%), Gaps = 56/147 (38%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLL--------------------------- 97
+I + LDYLH+ IIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 98 ----------------------DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDP 135
+ K K+AD G++ + T+ I T
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSL 262
Query: 136 EYVITGKLTEKSDVYSFGVLLAELLTG 162
E +I +D++S + EL TG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATG 289
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-06
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 28/113 (24%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP---------NGTLFDHIHDKS--SQV 56
E+ ++ + H N+V + K LV+E++ G + + + K Q+
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
LR L Y H ++H D+K N+L+++ + K+ADFG
Sbjct: 110 LR--------------GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFG 145
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 7e-06
Identities = 29/111 (26%), Positives = 51/111 (45%), Gaps = 20/111 (18%)
Query: 9 LRVVSQINHKNVVKIL----GACLETKVPL-LVYEFVPN--GTLFDHIHDK---SSQVLR 58
LR + H NVV++ + + + L LV+E V T D + + + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-- 122
Query: 59 NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG 109
K + + LD+LHS ++H D+K N+L+ + + K+ADFG
Sbjct: 123 --KDMMF---QLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 165
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 2e-05
Identities = 20/117 (17%), Positives = 44/117 (37%), Gaps = 32/117 (27%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPLLVYEFVP--------NGTLFDHIHDKS--SQVL 57
E+ ++ ++ H+N++++ L++E+ KS Q++
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 58 RNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA-----KVADFG 109
+++ HS +H D+K N+LL + + K+ DFG
Sbjct: 143 N--------------GVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 29/122 (23%), Positives = 44/122 (36%), Gaps = 37/122 (30%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA-------------------KV 105
+A + AL +LH + + H D+K N+L ++ +V
Sbjct: 127 HMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 106 ADFGSSVLISSDNQTAMTTKKIGTFVNL----DPEYVITG-KLTEKSDVYSFGVLLAELL 160
ADFGS+ + T V PE VI + DV+S G +L E
Sbjct: 184 ADFGSA---------TFDHEHHTTIVATRHYRPPE-VILELGWAQPCDVWSIGCILFEYY 233
Query: 161 TG 162
G
Sbjct: 234 RG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 36/128 (28%), Positives = 48/128 (37%), Gaps = 43/128 (33%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA--------------------- 103
E AL+YL + + H D+K N+LLDD Y
Sbjct: 141 LYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTK 197
Query: 104 ----KVADFGSSVLISSDNQTAMTTKKIGTFVNL----DPEYVITG-KLTEKSDVYSFGV 154
K+ DFG + S G+ +N PE VI SD++SFG
Sbjct: 198 STGIKLIDFGCATFKS---------DYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGC 247
Query: 155 LLAELLTG 162
+LAEL TG
Sbjct: 248 VLAELYTG 255
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 5e-05
Identities = 14/51 (27%), Positives = 30/51 (58%), Gaps = 5/51 (9%)
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKV--ADFG 109
++ L++A AL++LH + +HG+V + N+ +D +++V A +G
Sbjct: 159 RSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYG 206
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 7e-05
Identities = 17/53 (32%), Positives = 28/53 (52%), Gaps = 5/53 (9%)
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKV--ADFGSS 111
T L++ L+Y+H + +HGD+K+ N+LL +V AD+G S
Sbjct: 151 STVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLS 200
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 9e-05
Identities = 40/187 (21%), Positives = 72/187 (38%), Gaps = 49/187 (26%)
Query: 8 ELRVVSQINHKNVVKILGACLETKVPL--LVYEFVPNGTLFDH----IHDKSSQVLRNWK 61
E+ ++ ++ H NV+ + L L++++ +H I N K
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKK 121
Query: 62 TCLRIAAETAS-------ALDYLHSSASPPIIHGDVKSTNVLLDDNYKA----KVADFGS 110
S + YLH++ ++H D+K N+L+ K+AD G
Sbjct: 122 PVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 178
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVIT----------G--KLTEKSDVYSFGVLLAE 158
+ L +S + +LDP V+T G T+ D+++ G + AE
Sbjct: 179 ARLFNSPLK---------PLADLDPV-VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 228
Query: 159 LLTGLKP 165
LLT +P
Sbjct: 229 LLTS-EP 234
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 2e-04
Identities = 16/53 (30%), Positives = 30/53 (56%), Gaps = 5/53 (9%)
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKV--ADFGSS 111
KT L+++ L+Y+H +HGD+K++N+LL+ +V D+G +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 28/122 (22%), Positives = 47/122 (38%), Gaps = 37/122 (30%)
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA-------------------KV 105
++A + ++++LHS+ + H D+K N+L + KV
Sbjct: 122 KMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 106 ADFGSSVLISSDNQTAMTTKKIGTFVNL----DPEYVITG-KLTEKSDVYSFGVLLAELL 160
DFGS+ + T V+ PE VI ++ DV+S G +L E
Sbjct: 179 VDFGSATYDD---------EHHSTLVSTRHYRAPE-VILALGWSQPCDVWSIGCILIEYY 228
Query: 161 TG 162
G
Sbjct: 229 LG 230
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.17 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.97 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.89 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.88 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.5 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.33 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.0 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.96 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.4 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.33 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.07 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.03 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.97 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.78 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.55 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.7 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.83 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 93.65 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 93.53 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.28 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.86 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 92.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 92.29 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 91.92 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.07 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 87.61 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 85.82 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-55 Score=346.27 Aligned_cols=223 Identities=23% Similarity=0.368 Sum_probs=184.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC----------CcccCCHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----------SQVLRNWKTCLRIAAETA 71 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~i~~~i~ 71 (259)
++.|.+|++++++++|||||+++++|.+++..+|||||+++|+|.+++.... ....+++..+..++.|++
T Consensus 59 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 138 (299)
T 4asz_A 59 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA 138 (299)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence 3679999999999999999999999999999999999999999999997642 233578999999999999
Q ss_pred HHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhh
Q 025011 72 SALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 72 ~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
.||.|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||
T Consensus 139 ~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS 215 (299)
T 4asz_A 139 AGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 215 (299)
T ss_dssp HHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHhCC---cccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHH
Confidence 9999999999 9999999999999999999999999998765543333344456899999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 152 FGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 152 lG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|||++|||+| |+.||.+.... +....... +. ....+..+++.+.+|+.+||+.||++|||+
T Consensus 216 ~Gvvl~Ellt~G~~Pf~~~~~~--------~~~~~i~~-~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~ 277 (299)
T 4asz_A 216 LGVVLWEIFTYGKQPWYQLSNN--------EVIECITQ-GR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNI 277 (299)
T ss_dssp HHHHHHHHHTTTCCTTTTSCHH--------HHHHHHHH-TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHHHHHcCCCCCCCCCCHH--------HHHHHHHc-CC---------CCCCCccchHHHHHHHHHHcCCChhHCcCH
Confidence 9999999998 89999874311 11111111 10 011122345779999999999999999999
Q ss_pred HHHHHHHHhcccccc
Q 025011 231 KQVSEELDRLKISHE 245 (259)
Q Consensus 231 ~~il~~l~~~~~~~~ 245 (259)
++|.+.|+++....+
T Consensus 278 ~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 278 KGIHTLLQNLAKASP 292 (299)
T ss_dssp HHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHhcCC
Confidence 999999998865543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=343.21 Aligned_cols=219 Identities=23% Similarity=0.380 Sum_probs=182.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
++.|.+|+.++++++|||||+++++|.+++..+|||||+++|+|.+++..... ...+++..+..++.
T Consensus 73 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 152 (308)
T 4gt4_A 73 REEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 152 (308)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHH
Confidence 56899999999999999999999999999999999999999999999965321 23478899999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ |+||||||+||++++++.+||+|||+++...............||+.|+|||++.+..++.++|
T Consensus 153 qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksD 229 (308)
T 4gt4_A 153 QIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 229 (308)
T ss_dssp HHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccch
Confidence 9999999999999 9999999999999999999999999998765543444455567999999999999999999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
||||||++|||+| |..||.+.... . ...... .+. ..+.+..+++.+.+|+.+||+.||.+|
T Consensus 230 VwSfGvvl~El~t~g~~Pf~~~~~~-----~---~~~~i~-~~~---------~~~~p~~~~~~~~~li~~C~~~dP~~R 291 (308)
T 4gt4_A 230 IWSYGVVLWEVFSYGLQPYCGYSNQ-----D---VVEMIR-NRQ---------VLPCPDDCPAWVYALMIECWNEFPSRR 291 (308)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTCCHH-----H---HHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhhHHHHHHHHHhCCCCCCCCCCHH-----H---HHHHHH-cCC---------CCCCcccchHHHHHHHHHHcCCChhHC
Confidence 9999999999998 89999874311 1 111111 111 111122345779999999999999999
Q ss_pred CCHHHHHHHHHhcc
Q 025011 228 PTMKQVSEELDRLK 241 (259)
Q Consensus 228 pt~~~il~~l~~~~ 241 (259)
||+++|++.|+.+.
T Consensus 292 Ps~~ei~~~L~a~~ 305 (308)
T 4gt4_A 292 PRFKDIHSRLRAWG 305 (308)
T ss_dssp CCHHHHHHHHHTSC
T ss_pred cCHHHHHHHHHhcc
Confidence 99999999998753
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-54 Score=344.89 Aligned_cols=223 Identities=24% Similarity=0.381 Sum_probs=175.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC------------cccCCHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS------------QVLRNWKTCLRIAAE 69 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~~~~~~~~i~~~ 69 (259)
++.|.+|+++|++++|||||+++++|.+++..+|||||+++|+|.+++..... ...+++..++.++.|
T Consensus 87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 166 (329)
T 4aoj_A 87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166 (329)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence 46799999999999999999999999999999999999999999999976432 234789999999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccch
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDV 149 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 149 (259)
++.||.|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||
T Consensus 167 ia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDv 243 (329)
T 4aoj_A 167 VAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDV 243 (329)
T ss_dssp HHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHH
T ss_pred HHHHHHHHhcCC---eecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccc
Confidence 999999999999 99999999999999999999999999987654433334445679999999999999999999999
Q ss_pred hhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 150 YSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 150 wslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|||||++|||+| |+.||.+.... .. ........ ....+..+++.+.+|+.+||+.||++||
T Consensus 244 wS~Gvvl~Ellt~G~~Pf~~~~~~-----~~---~~~i~~g~----------~~~~p~~~~~~~~~li~~cl~~dP~~RP 305 (329)
T 4aoj_A 244 WSFGVVLWEIFTYGKQPWYQLSNT-----EA---IDCITQGR----------ELERPRACPPEVYAIMRGCWQREPQQRH 305 (329)
T ss_dssp HHHHHHHHHHHTTSCCTTCSSCHH-----HH---HHHHHHTC----------CCCCCTTCCHHHHHHHHHHCCSSTTTSC
T ss_pred cchHHHHHHHHcCCCCCCCCCCHH-----HH---HHHHHcCC----------CCCCcccccHHHHHHHHHHcCcChhHCc
Confidence 999999999999 89999874311 11 11111110 0111123447799999999999999999
Q ss_pred CHHHHHHHHHhcccccc
Q 025011 229 TMKQVSEELDRLKISHE 245 (259)
Q Consensus 229 t~~~il~~l~~~~~~~~ 245 (259)
|+++|++.|+.+...-+
T Consensus 306 s~~ei~~~L~~l~~~pp 322 (329)
T 4aoj_A 306 SIKDVHARLQALAQAPP 322 (329)
T ss_dssp CHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHHhhCCc
Confidence 99999999999865533
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=337.46 Aligned_cols=224 Identities=25% Similarity=0.409 Sum_probs=173.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++|||||++++++.+ +..+|||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 77 ~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~- 152 (307)
T 3omv_A 77 QAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN- 152 (307)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 579999999999999999999998865 568999999999999999976533 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||++++++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 153 --IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~El 230 (307)
T 3omv_A 153 --IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYEL 230 (307)
T ss_dssp --CBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHH
T ss_pred --ccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHH
Confidence 999999999999999999999999999876543333344556799999999998643 489999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+||+.||.+..... ............... ...+.++++.+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 231 ltg~~Pf~~~~~~~----~~~~~~~~~~~~p~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~ 297 (307)
T 3omv_A 231 MTGELPYSHINNRD----QIIFMVGRGYASPDL---------SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL 297 (307)
T ss_dssp HHSSCTTTTCCCHH----HHHHHHHTTCCCCCS---------TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred HHCCCCCCCCChHH----HHHHHHhcCCCCCCc---------ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999998633110 000111000000000 01112344779999999999999999999999999998
Q ss_pred cccccc
Q 025011 240 LKISHE 245 (259)
Q Consensus 240 ~~~~~~ 245 (259)
+..+.+
T Consensus 298 l~~~lp 303 (307)
T 3omv_A 298 LQHSLP 303 (307)
T ss_dssp HHTTCC
T ss_pred HhccCC
Confidence 876543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-54 Score=344.48 Aligned_cols=210 Identities=23% Similarity=0.342 Sum_probs=173.6
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++|+|||||++++++.+++.+|||||||+||+|.+++...... .+++..++.++.||+.||.|||+++
T Consensus 67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~ 145 (350)
T 4b9d_A 67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVHDRK 145 (350)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999999999999999999999999999999999999999765432 3678899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 146 ---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemlt 220 (350)
T 4b9d_A 146 ---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220 (350)
T ss_dssp ---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---eeeccCCHHHEEECCCCCEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998654321 12234569999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+.... +........ ... ..+...++.+.+||.+||+.||++|||+.++++
T Consensus 221 G~~PF~~~~~~--------~~~~~i~~~---------~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 221 LKHAFEAGSMK--------NLVLKIISG---------SFP-PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SSCSCCCSSHH--------HHHHHHHHT---------CCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCcCHH--------HHHHHHHcC---------CCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999873211 111111110 000 111223477999999999999999999999976
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=334.99 Aligned_cols=207 Identities=24% Similarity=0.365 Sum_probs=174.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++|++++|||||+++++|.+++.+||||||++||+|.+++.+.+. +++..+..++.||+.||.|||+++
T Consensus 77 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~---l~e~~~~~~~~qi~~al~ylH~~~- 152 (311)
T 4aw0_A 77 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG- 152 (311)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999987543 788999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 153 --IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 230 (311)
T 4aw0_A 153 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230 (311)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS
T ss_pred --CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999999999999999999999877654444445567899999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
..||.+.+.. ....... ...... +...++.+.+||.+||..||++|||++|++
T Consensus 231 ~~PF~~~~~~--------~~~~~i~---------~~~~~~--p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 231 LPPFRAGNEG--------LIFAKII---------KLEYDF--PEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp SCSSCCSSHH--------HHHHHHH---------HTCCCC--CTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCCCCCCCHH--------HHHHHHH---------cCCCCC--CcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 9999863211 1111111 111110 112346799999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=334.61 Aligned_cols=209 Identities=21% Similarity=0.314 Sum_probs=173.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++|++++|||||+++++|.+++.+|||||||+||+|.+++.... +++..+..++.||+.||.|||+++
T Consensus 115 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~----l~e~~~~~~~~qi~~aL~ylH~~~ 190 (346)
T 4fih_A 115 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG 190 (346)
T ss_dssp GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3568899999999999999999999999999999999999999999997642 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..|+.++||||+||++|+|++
T Consensus 191 ---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 265 (346)
T 4fih_A 191 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 265 (346)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---cccccCCHHHEEECCCCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998765432 22345679999999999999899999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... +........ . .. ........++.+.+||.+||..||++|||+.|+++
T Consensus 266 G~~PF~~~~~~--------~~~~~i~~~-~-----~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 266 GEPPYFNEPPL--------KAMKMIRDN-L-----PP--RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SSCTTTTSCHH--------HHHHHHHHS-S-----CC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCcCHH--------HHHHHHHcC-C-----CC--CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999873211 111111000 0 00 01111234477999999999999999999999965
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=331.35 Aligned_cols=218 Identities=22% Similarity=0.274 Sum_probs=174.0
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
..+|+.+++.++|||||++++++.+++.+||||||++||+|.+++.+.+. +++..+..++.|++.||.|||+++
T Consensus 97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~--- 170 (336)
T 4g3f_A 97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRALYYLGQALEGLEYLHTRR--- 170 (336)
T ss_dssp CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT---
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 35799999999999999999999999999999999999999999987543 788999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCcccc---ccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 85 IIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTA---MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 85 i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.+| .+||+|||+++......... ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 171 IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyeml 250 (336)
T 4g3f_A 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHML 250 (336)
T ss_dssp EECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999887 69999999998765432111 223356999999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
+|+.||.+.....- ...... ...... ..+...++.+.++|.+||+.||.+|||+.|+++.+...
T Consensus 251 tG~~Pf~~~~~~~~----~~~i~~---~~~~~~---------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 251 NGCHPWTQYFRGPL----CLKIAS---EPPPIR---------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp HSSCSSTTTCCSCC----HHHHHH---SCCGGG---------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HCcCCCCCCCHHHH----HHHHHc---CCCCch---------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 99999987432210 000000 000000 01122347799999999999999999999999888766
Q ss_pred cccc
Q 025011 241 KISH 244 (259)
Q Consensus 241 ~~~~ 244 (259)
....
T Consensus 315 l~~~ 318 (336)
T 4g3f_A 315 LQEV 318 (336)
T ss_dssp HHHT
T ss_pred Hhhh
Confidence 5443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=326.78 Aligned_cols=209 Identities=24% Similarity=0.368 Sum_probs=165.4
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
++.|.+|++++++++|||||+++++|.. ++.+||||||+++|+|.+++.+... +++..+..++.||+.||.||
T Consensus 69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~yl 145 (290)
T 3fpq_A 69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFL 145 (290)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Confidence 3569999999999999999999999875 3457999999999999999986543 68899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
|+++ ++|+||||||+||+++. ++.+||+|||+++..... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 146 H~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 146 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCM 219 (290)
T ss_dssp HTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHH
T ss_pred HHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHH
Confidence 9875 34999999999999984 789999999999754322 2334579999999998865 699999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+|++|+.||.+..... .. ...... ... ....+...++.+.+||.+||..||++|||++++++
T Consensus 220 yelltg~~Pf~~~~~~~----~~---~~~i~~-~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 220 LEMATSEYPYSECQNAA----QI---YRRVTS-GVK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHHSSCTTTTCSSHH----HH---HHHHTT-TCC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHCCCCCCCCCcHH----HH---HHHHHc-CCC--------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 99999999997632110 01 111111 000 00111112367999999999999999999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=335.65 Aligned_cols=209 Identities=21% Similarity=0.317 Sum_probs=173.1
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+++.... +++..+..++.||+.||.|||+++
T Consensus 192 ~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~----l~e~~~~~~~~qil~aL~ylH~~~ 267 (423)
T 4fie_A 192 RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR----MNEEQIAAVCLAVLQALSVLHAQG 267 (423)
T ss_dssp GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC----CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578999999999999999999999999999999999999999999997543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 268 ---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 342 (423)
T 4fie_A 268 ---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD 342 (423)
T ss_dssp ---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---eecccCCHHHEEEcCCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999998765432 22345679999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... +........ . ... .......++.+.+||.+||..||.+|||+.|+++
T Consensus 343 G~~PF~~~~~~--------~~~~~i~~~-~-----~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 343 GEPPYFNEPPL--------KAMKMIRDN-L-----PPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCTTTTSCHH--------HHHHHHHHS-C-----CCC--CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCcCHH--------HHHHHHHcC-C-----CCC--CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999863211 111111100 0 000 0111123477999999999999999999999965
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=316.89 Aligned_cols=205 Identities=22% Similarity=0.328 Sum_probs=161.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++.+++..|+||||+ +|+|.+++.+.+. +++..+..++.|++.||.|||+++
T Consensus 57 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~ 132 (275)
T 3hyh_A 57 QGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK---MSEQEARRFFQQIISAVEYCHRHK 132 (275)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356899999999999999999999999999999999999 6799999976543 788999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.++.+||+|||+++...... ......||+.|+|||++.+..+ +.++||||+||++|+|+
T Consensus 133 ---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~ll 206 (275)
T 3hyh_A 133 ---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206 (275)
T ss_dssp ---CCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHH
T ss_pred ---cccccCChHHeEECCCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHH
Confidence 9999999999999999999999999997654322 2234579999999999988876 57999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+.||.+.... ........ .... .+...++.+.+||.+||+.||++|||++|+++
T Consensus 207 tg~~PF~~~~~~--------~~~~~i~~---------~~~~--~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 207 CRRLPFDDESIP--------VLFKNISN---------GVYT--LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp HSSCSSCCSSHH--------HHHHHHHH---------TCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCCCHH--------HHHHHHHc---------CCCC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 999999863211 11111100 0000 01123467999999999999999999999975
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=335.17 Aligned_cols=221 Identities=24% Similarity=0.382 Sum_probs=179.5
Q ss_pred hHHHHHHHHHhcCCC-ccccccceeEEeC-CcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHH
Q 025011 3 QVFQHELRVVSQINH-KNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIA 67 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~ 67 (259)
+.|.+|+++|.+++| ||||+++++|... +.++||||||++|+|.+++..... ...+++..+..++
T Consensus 112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 191 (353)
T 4ase_A 112 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191 (353)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHH
Confidence 568999999999965 9999999999764 568999999999999999975422 2346889999999
Q ss_pred HHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCccccc
Q 025011 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS 147 (259)
Q Consensus 68 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 147 (259)
.||+.||.|||+++ |+||||||+||++++++.+||+|||+++...............||+.|+|||++.+..++.++
T Consensus 192 ~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ks 268 (353)
T 4ase_A 192 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 268 (353)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHhHhhCC---eecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcc
Confidence 99999999999999 999999999999999999999999999876554444444556789999999999999999999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 148 DVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 148 DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
|||||||++|||+| |..||.+..... ...... ..+ .....+...++.+.+++.+||+.||++
T Consensus 269 DVwS~Gv~l~El~t~G~~Pf~~~~~~~----~~~~~i----~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~ 331 (353)
T 4ase_A 269 DVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRL----KEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQ 331 (353)
T ss_dssp HHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHH----HHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred cEeehHHHHHHHHhCCCCCCCCCCHHH----HHHHHH----HcC---------CCCCCCccCCHHHHHHHHHHcCcChhH
Confidence 99999999999998 899998743211 111111 111 011111123477999999999999999
Q ss_pred CCCHHHHHHHHHhcccc
Q 025011 227 RPTMKQVSEELDRLKIS 243 (259)
Q Consensus 227 Rpt~~~il~~l~~~~~~ 243 (259)
|||+.+|++.|+++-.+
T Consensus 332 RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 332 RPTFSELVEHLGNLLQA 348 (353)
T ss_dssp SCCHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHHH
Confidence 99999999999987544
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=325.46 Aligned_cols=201 Identities=26% Similarity=0.279 Sum_probs=160.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
..+.+|++++++++|||||++++++.+++.+|+||||++||+|.+++.+... +++..+..++.|++.||.|||+++
T Consensus 71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~ylH~~~- 146 (304)
T 3ubd_A 71 VRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEEDVKFYLAELALALDHLHSLG- 146 (304)
T ss_dssp C------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 3578899999999999999999999999999999999999999999987543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 147 --IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG 222 (304)
T 3ubd_A 147 --IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222 (304)
T ss_dssp --CCCSSCCGGGEEECTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --CcCCCCCHHHeEEcCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhC
Confidence 9999999999999999999999999998654322 223445799999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
+.||.+.+.. +...... ..... .+...++.+.+||.+||+.||++|||+
T Consensus 223 ~~PF~~~~~~--------~~~~~i~---------~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 223 TLPFQGKDRK--------ETMTMIL---------KAKLG--MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp SCSSCCSSHH--------HHHHHHH---------HCCCC--CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred CCCCCCcCHH--------HHHHHHH---------cCCCC--CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 9999873211 1111111 11111 111234779999999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=315.82 Aligned_cols=211 Identities=24% Similarity=0.385 Sum_probs=160.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCC------------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETK------------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAE 69 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~ 69 (259)
++.+.+|+++|++++|||||++++++.+.+ .+|++||||++|+|.+++.........++..++.++.|
T Consensus 47 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~q 126 (299)
T 4g31_A 47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126 (299)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHH
Confidence 356889999999999999999999987644 36999999999999999987765555667788999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc----------ccccccCcccccCcchhc
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA----------MTTKKIGTFVNLDPEYVI 139 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~~ 139 (259)
|+.||.|||+++ |+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.
T Consensus 127 i~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~ 203 (299)
T 4g31_A 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIH 203 (299)
T ss_dssp HHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHT
T ss_pred HHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHc
Confidence 999999999999 9999999999999999999999999998765432111 122346999999999999
Q ss_pred cCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHh
Q 025011 140 TGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 140 ~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 219 (259)
+..++.++|||||||++|+|++ ||.+.. ....... ...... ........++.+.+||.+|
T Consensus 204 ~~~y~~~~DiwSlGvilyell~---Pf~~~~-------~~~~~~~---------~~~~~~-~p~~~~~~~~~~~~li~~~ 263 (299)
T 4g31_A 204 GNSYSHKVDIFSLGLILFELLY---PFSTQM-------ERVRTLT---------DVRNLK-FPPLFTQKYPCEYVMVQDM 263 (299)
T ss_dssp TCCCCTHHHHHHHHHHHHHHHS---CCSSHH-------HHHHHHH---------HHHTTC-CCHHHHHHCHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHHHHHcc---CCCCcc-------HHHHHHH---------HHhcCC-CCCCCcccCHHHHHHHHHH
Confidence 9999999999999999999996 765411 0000000 000000 1112223446678899999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 264 L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 264 LSPSPMERPEAINIIE 279 (299)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred cCCChhHCcCHHHHhc
Confidence 9999999999999976
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=311.18 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=167.6
Q ss_pred HHHHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 6 QHELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 6 ~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.|+..+.+++||||+++++++..++ ..+|||||+++|+|.+++...+ +++..+.+++.|++.||.|||++.
T Consensus 45 e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----l~~~~~~~i~~~ia~gl~ylH~~~ 120 (303)
T 3hmm_A 45 EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEI 120 (303)
T ss_dssp HHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCB
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhCC----CCHHHHHHHHHHHHHHHHHHHHhh
Confidence 34566667889999999999998754 4799999999999999997653 578999999999999999999871
Q ss_pred -----CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccC------Ccccccc
Q 025011 82 -----SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITG------KLTEKSD 148 (259)
Q Consensus 82 -----~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~------~~~~~~D 148 (259)
.++|+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+. .++.++|
T Consensus 121 ~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~D 200 (303)
T 3hmm_A 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRAD 200 (303)
T ss_dssp CSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHH
T ss_pred hhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHh
Confidence 1229999999999999999999999999998765433221 22345799999999998764 3678999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCccccccch------hHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhccc
Q 025011 149 VYSFGVLLAELLTGLKPGSGMALASNEGI------SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 222 (259)
||||||++|||+||..||........... ..................+... ......+..+.+|+.+||+.
T Consensus 201 VwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~ 277 (303)
T 3hmm_A 201 IYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYA 277 (303)
T ss_dssp HHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCS
T ss_pred hhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHccc
Confidence 99999999999999887754322111000 0001111111111111100000 11223456789999999999
Q ss_pred CCCCCCCHHHHHHHHHhcccc
Q 025011 223 SGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 223 ~p~~Rpt~~~il~~l~~~~~~ 243 (259)
||++|||+.+|++.|+++..+
T Consensus 278 dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 278 NGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SGGGSCCHHHHHHHHHHHHHC
T ss_pred CHhHCcCHHHHHHHHHHHHHH
Confidence 999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=307.10 Aligned_cols=222 Identities=18% Similarity=0.254 Sum_probs=165.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++|+.++|||||++++++.. .+.+||||||++ |+|.+++.... .+++..+..++.||+.||.|
T Consensus 98 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~y 173 (398)
T 4b99_A 98 KRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKY 173 (398)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHH
Confidence 457899999999999999999998764 357899999995 68999997654 37889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc--cccccccccCcccccCcchhccCC-cccccchhhHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN--QTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFG 153 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG 153 (259)
||+++ |+||||||+||+++.++.+|++|||+++...... .........||+.|+|||++.+.. ++.++||||+|
T Consensus 174 lH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG 250 (398)
T 4b99_A 174 MHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVG 250 (398)
T ss_dssp HHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHH
T ss_pred HHHCc---CcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhH
Confidence 99999 9999999999999999999999999998764321 122334568999999999988764 68999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--c--------hhhhhh---ccccCCc---hhHHHHHHHHHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--N--------SLRQIL---NFQVADE---SEMEEIETVAGLAS 217 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~--------~~~~~~---~~~~~~~---~~~~~~~~~~~li~ 217 (259)
|++|+|++|+.||.+.+... ............ . ...... ....... .....++.+.+||.
T Consensus 251 ~il~ell~G~~pF~g~~~~~----~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~ 326 (398)
T 4b99_A 251 CIFGEMLARRQLFPGKNYVH----QLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLG 326 (398)
T ss_dssp HHHHHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCHHH----HHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHH
Confidence 99999999999998743211 111110000000 0 000000 0000000 00112467899999
Q ss_pred HhcccCCCCCCCHHHHHH
Q 025011 218 KCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 218 ~~l~~~p~~Rpt~~~il~ 235 (259)
+||..||.+|||+.++++
T Consensus 327 ~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 327 RMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHSCSSTTTSCCHHHHTT
T ss_pred HHCcCChhHCcCHHHHhc
Confidence 999999999999999975
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=304.98 Aligned_cols=157 Identities=20% Similarity=0.269 Sum_probs=135.8
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..+.+|+++|+.+ +||||++++++|.+.+.+|+||||+++|+|.+++.. +++..+..++.|++.||.|||+++
T Consensus 64 ~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------l~~~~~~~~~~qll~al~ylH~~g 137 (361)
T 4f9c_A 64 IRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQEVREYMLNLFKALKRIHQFG 137 (361)
T ss_dssp HHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578999999998 699999999999999999999999999999999942 577999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCcc--------------------------ccccccccCcccccC
Q 025011 82 SPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQ--------------------------TAMTTKKIGTFVNLD 134 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~--------------------------~~~~~~~~~~~~y~a 134 (259)
|+||||||+||+++.+ +.++|+|||+++....... ........||+.|+|
T Consensus 138 ---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 214 (361)
T 4f9c_A 138 ---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRA 214 (361)
T ss_dssp ---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCC
T ss_pred ---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccC
Confidence 9999999999999876 7999999999976543211 011223469999999
Q ss_pred cchhccCC-cccccchhhHHHHHHHHHhCCCCCCC
Q 025011 135 PEYVITGK-LTEKSDVYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 135 PE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~ 168 (259)
||++.+.. ++.++||||+||++|+|++|+.||.+
T Consensus 215 PE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 215 PEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp HHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred HHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence 99998764 89999999999999999999999965
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=292.03 Aligned_cols=236 Identities=36% Similarity=0.552 Sum_probs=192.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+++
T Consensus 80 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 159 (321)
T 2qkw_B 80 EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA 159 (321)
T ss_dssp HHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC
Confidence 5689999999999999999999999999999999999999999999976532 224688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++................|+..|+|||++.+..++.++||||||+++|+|++
T Consensus 160 ---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 236 (321)
T 2qkw_B 160 ---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236 (321)
T ss_dssp ---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHH
T ss_pred ---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHh
Confidence 99999999999999999999999999976544333333344458999999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|+.||.+.... .......+..............+...........++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 237 g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l 314 (321)
T 2qkw_B 237 ARSAIVQSLPR--EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL 314 (321)
T ss_dssp CCTTCSCSSSS--SCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccccCcH--HHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 99999864322 1122233333333334444444444455556677889999999999999999999999999999875
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 315 ~~ 316 (321)
T 2qkw_B 315 RL 316 (321)
T ss_dssp HS
T ss_pred hc
Confidence 43
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=312.03 Aligned_cols=211 Identities=21% Similarity=0.310 Sum_probs=171.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++|+.++||||++++++|.+++.+||+|||++||+|.+++..... .+++..+..++.||+.||.|||+++
T Consensus 198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~ 275 (573)
T 3uto_A 198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN 275 (573)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688999999999999999999999999999999999999999999965432 2678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCC--CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDN--YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||+++.+ +.+||+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|
T Consensus 276 ---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyem 349 (573)
T 3uto_A 276 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 349 (573)
T ss_dssp ---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHH
T ss_pred ---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999854 899999999998765432 22344699999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... +......... ...........++.+.+||.+||..||.+|||+.|+++
T Consensus 350 l~G~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 350 LSGLSPFGGENDD--------ETLRNVKSCD-------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp HHSCCSSCCSSHH--------HHHHHHHTTC-------CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHCCCCCCCcCHH--------HHHHHHHhCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999873211 0111110000 00111111223477999999999999999999999975
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=292.27 Aligned_cols=237 Identities=32% Similarity=0.566 Sum_probs=199.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhC--
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSS-- 80 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~-- 80 (259)
.+.+|+++++.++||||+++++++...+..++||||+++++|.+++.... ....+++..+..++.|++.||.|||++
T Consensus 73 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 152 (326)
T 3uim_A 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152 (326)
T ss_dssp HHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 68999999999999999999999999999999999999999999997754 233478899999999999999999999
Q ss_pred -CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 -ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 -~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++....... ........|+..|+|||++.+..++.++||||+|+++|+|
T Consensus 153 ~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 153 PK---IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp SC---EECCCCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred CC---eEeCCCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence 8 9999999999999999999999999998765432 2233344599999999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||...............+..............+...........++.+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 99999997543333334444555555555566666666666666667778899999999999999999999999999987
Q ss_pred ccccc
Q 025011 240 LKISH 244 (259)
Q Consensus 240 ~~~~~ 244 (259)
.....
T Consensus 309 ~~~~~ 313 (326)
T 3uim_A 309 DGLAE 313 (326)
T ss_dssp SSCSS
T ss_pred cchhh
Confidence 65554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=309.75 Aligned_cols=202 Identities=20% Similarity=0.223 Sum_probs=163.6
Q ss_pred HHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
.++.+++.++|||||+++++|.+.+.+|+||||++||+|.+++.+.+. +++..+..++.||+.||.|||+++ |+
T Consensus 241 ~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~---l~E~~a~~y~~qIl~aL~yLH~~g---Ii 314 (689)
T 3v5w_A 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VV 314 (689)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred HHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 346777788999999999999999999999999999999999987643 788999999999999999999999 99
Q ss_pred eCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHhCCCC
Q 025011 87 HGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGLKP 165 (259)
Q Consensus 87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p 165 (259)
||||||+||+++.+|.+||+|||+++..... ......||+.|+|||++.+ ..|+.++|+|||||++|+|++|..|
T Consensus 315 HRDLKPeNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P 390 (689)
T 3v5w_A 315 YRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390 (689)
T ss_dssp CCCCSGGGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred ccCCchHHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543 2344579999999999964 5799999999999999999999999
Q ss_pred CCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 025011 166 GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVS 234 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il 234 (259)
|.+...... ....... ...... .+...++.+.+||.+||..||.+|++ +++|+
T Consensus 391 F~~~~~~~~-----~~i~~~i---------~~~~~~--~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~ 448 (689)
T 3v5w_A 391 FRQHKTKDK-----HEIDRMT---------LTMAVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 448 (689)
T ss_dssp TCGGGCCCH-----HHHHHHH---------HHCCCC--CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred CCCCChHHH-----HHHHHhh---------cCCCCC--CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence 986322110 0101000 000000 11123477999999999999999998 56664
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=295.90 Aligned_cols=221 Identities=27% Similarity=0.406 Sum_probs=180.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+++|+|.+++..... ...+++..++.++.
T Consensus 131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 210 (370)
T 2psq_A 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210 (370)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence 4688999999999 899999999999999999999999999999999976532 12367889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++|
T Consensus 211 qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 211 QLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp HHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred HHHHHHHHHHhCC---eeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 9999999999999 9999999999999999999999999998665443333334445778999999999988999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+..... . ..... .......+...++.+.++|.+||+.||.+|
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~-----~---~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 349 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEE-----L---FKLLK----------EGHRMDKPANCTNELYMMMRDCWHAVPSQR 349 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGG-----H---HHHHH----------TTCCCCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHH-----H---HHHHh----------cCCCCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999 999998732110 1 11000 000111112234679999999999999999
Q ss_pred CCHHHHHHHHHhccccc
Q 025011 228 PTMKQVSEELDRLKISH 244 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~ 244 (259)
||+.++++.|+++....
T Consensus 350 pt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 350 PTFKQLVEDLDRILTLT 366 (370)
T ss_dssp CCHHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHHh
Confidence 99999999999886543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=282.45 Aligned_cols=233 Identities=30% Similarity=0.522 Sum_probs=185.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++..++..+++|||+++++|.+++........+++..++.++.|++.||.|||+++
T Consensus 74 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 153 (307)
T 2nru_A 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH 153 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 35789999999999999999999999999999999999999999999976544445788999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++................++..|+|||.+.+ .++.++||||||+++|+|++
T Consensus 154 ---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~ 229 (307)
T 2nru_A 154 ---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT 229 (307)
T ss_dssp ---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred ---eecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence 99999999999999999999999999987654433333445578999999998865 57899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHH-hhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLY-SIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+....... ..+... ..........++.... ......++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 230 g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 230 GLPAVDEHREPQLL----LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp CCCSBCTTBSSSBT----THHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccCcchHHH----HHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 99999874322111 111111 1111223333333222 23445678899999999999999999999999999988
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
..+
T Consensus 305 ~~s 307 (307)
T 2nru_A 305 TAS 307 (307)
T ss_dssp C--
T ss_pred hcC
Confidence 653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=288.73 Aligned_cols=226 Identities=29% Similarity=0.421 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++...+..++||||+++++|.+++........+++..++.++.|++.||.|||+++
T Consensus 79 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~- 157 (309)
T 3p86_A 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN- 157 (309)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-
Confidence 4688999999999999999999999999999999999999999999987655445788999999999999999999986
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++++|+||||+||+++.++.++|+|||+++..... ........|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 158 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 235 (309)
T 3p86_A 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL 235 (309)
T ss_dssp SCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHC
T ss_pred CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 34999999999999999999999999998754432 1123345689999999999998899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
..||.+.... .......... .....+...++.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus 236 ~~Pf~~~~~~-----~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 236 QQPWGNLNPA-----QVVAAVGFKC------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CCTTTTSCHH-----HHHHHHHHSC------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CCCCCCCCHH-----HHHHHHHhcC------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 9999863211 0000000000 0011111234679999999999999999999999999999887
Q ss_pred cccchh
Q 025011 243 SHENYE 248 (259)
Q Consensus 243 ~~~~~~ 248 (259)
+.....
T Consensus 299 ~~~p~~ 304 (309)
T 3p86_A 299 SAVPPP 304 (309)
T ss_dssp ------
T ss_pred hCCCCC
Confidence 655443
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=289.33 Aligned_cols=223 Identities=25% Similarity=0.350 Sum_probs=177.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~- 171 (325)
T 3kul_A 95 RDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG- 171 (325)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976533 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 172 --ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 249 (325)
T 3kul_A 172 --YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLA 249 (325)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred --eeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHc
Confidence 9999999999999999999999999998765432221 2223346778999999998889999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+..... ...... .......+...++.+.+++.+||+.||.+|||+.++++.|+.+
T Consensus 250 ~g~~p~~~~~~~~--------~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 250 YGERPYWNMTNRD--------VISSVE----------EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp TSCCTTTTSCHHH--------HHHHHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccCCHHH--------HHHHHH----------cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 999997632110 011000 0111111223347799999999999999999999999999998
Q ss_pred cccccchh
Q 025011 241 KISHENYE 248 (259)
Q Consensus 241 ~~~~~~~~ 248 (259)
.....+..
T Consensus 312 ~~~~~~~~ 319 (325)
T 3kul_A 312 IRSPESLR 319 (325)
T ss_dssp HHSCC---
T ss_pred HhCccccc
Confidence 77655543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=286.11 Aligned_cols=219 Identities=24% Similarity=0.388 Sum_probs=178.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------cccCCHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS---------------------QVLRNWK 61 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~ 61 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... ...+++.
T Consensus 71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (314)
T 2ivs_A 71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150 (314)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHH
T ss_pred HHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHH
Confidence 5688999999999999999999999999999999999999999999976532 1236788
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC
Q 025011 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG 141 (259)
Q Consensus 62 ~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 141 (259)
.++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus 151 ~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 227 (314)
T 2ivs_A 151 DLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227 (314)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHHCC---CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence 99999999999999999999 999999999999999999999999999876544333333444577889999999988
Q ss_pred CcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhc
Q 025011 142 KLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 142 ~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
.++.++||||||+++|+|++ |..||.+..... ...... .......+...++.+.+++.+||
T Consensus 228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-----~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l 289 (314)
T 2ivs_A 228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER-----LFNLLK-------------TGHRMERPDNCSEEMYRLMLQCW 289 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----HHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHHhh-------------cCCcCCCCccCCHHHHHHHHHHc
Confidence 89999999999999999999 999998633211 001000 00011111223477999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhccc
Q 025011 221 SLSGRRRPTMKQVSEELDRLKI 242 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~~l~~~~~ 242 (259)
+.||.+|||+.++++.|+++..
T Consensus 290 ~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 290 KQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=296.53 Aligned_cols=218 Identities=24% Similarity=0.389 Sum_probs=175.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++||||+++++++..++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~- 233 (377)
T 3cbl_A 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC- 233 (377)
T ss_dssp TTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999999999999976432 2578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 234 --ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~ 311 (377)
T 3cbl_A 234 --CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSL 311 (377)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred --cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876543221111222335678999999998889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... ...... . .......+...++.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus 312 g~~p~~~~~~~-----~~~~~~---~----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 312 GASPYPNLSNQ-----QTREFV---E----------KGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp SCCSSTTSCHH-----HHHHHH---H----------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH-----HHHHHH---H----------cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 99999873211 011110 0 00011111123467999999999999999999999999999986
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 374 ~~ 375 (377)
T 3cbl_A 374 KR 375 (377)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=280.35 Aligned_cols=209 Identities=22% Similarity=0.366 Sum_probs=171.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... +++..+..++.|++.||.|||+++
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ 136 (297)
T 3fxz_A 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ 136 (297)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC----CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3568899999999999999999999999999999999999999999997653 578999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+..++.++||||+|+++|+|++
T Consensus 137 ---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 211 (297)
T 3fxz_A 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (297)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHH
T ss_pred ---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999876654322 2334569999999999999899999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+..... . ........ ......+...++.+.++|.+||+.||.+|||+.++++
T Consensus 212 g~~pf~~~~~~~----~----~~~~~~~~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 212 GEPPYLNENPLR----A----LYLIATNG--------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp SSCTTTTSCHHH----H----HHHHHHHC--------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHHH----H----HHHHHhCC--------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 999997632110 0 00000000 0000111223467999999999999999999999975
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=279.56 Aligned_cols=223 Identities=25% Similarity=0.410 Sum_probs=178.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 52 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~- 128 (310)
T 3s95_A 52 RTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN- 128 (310)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5688999999999999999999999999999999999999999999987533 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc------------ccccccCcccccCcchhccCCcccccchh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA------------MTTKKIGTFVNLDPEYVITGKLTEKSDVY 150 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 150 (259)
++|+||||+||+++.++.++|+|||++.......... ......|++.|+|||++.+..++.++|||
T Consensus 129 --ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~ 206 (310)
T 3s95_A 129 --IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206 (310)
T ss_dssp --EECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHH
T ss_pred --ccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHH
Confidence 9999999999999999999999999998765432211 11144689999999999998899999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccc-hhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEG-ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|+|+++|+|++|..||.......... ........ ... +...++.+.+++.+||+.||.+|||
T Consensus 207 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-------------~~~----~~~~~~~l~~li~~~l~~dP~~Rps 269 (310)
T 3s95_A 207 SFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-------------RYC----PPNCPPSFFPITVRCCDLDPEKRPS 269 (310)
T ss_dssp HHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-------------HTC----CTTCCTTHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-------------ccC----CCCCCHHHHHHHHHHccCChhhCcC
Confidence 99999999999999987633221111 00000000 000 0112256899999999999999999
Q ss_pred HHHHHHHHHhccccccch
Q 025011 230 MKQVSEELDRLKISHENY 247 (259)
Q Consensus 230 ~~~il~~l~~~~~~~~~~ 247 (259)
+.++++.|+++.......
T Consensus 270 ~~~l~~~L~~l~~~~~~~ 287 (310)
T 3s95_A 270 FVKLEHWLETLRMHLAGH 287 (310)
T ss_dssp HHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHHhccCc
Confidence 999999999998765543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=292.29 Aligned_cols=225 Identities=28% Similarity=0.405 Sum_probs=183.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+++|+|.+++..... ...+++..++.++.
T Consensus 119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 198 (382)
T 3tt0_A 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198 (382)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHH
Confidence 5688999999999 999999999999999999999999999999999976542 12478899999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|
T Consensus 199 qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 275 (382)
T 3tt0_A 199 QVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275 (382)
T ss_dssp HHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHH
T ss_pred HHHHHHHHHHhCC---EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhH
Confidence 9999999999999 9999999999999999999999999998765443333344456788999999999988999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+.... ........ ......+...++.+.+++.+||+.||.+|
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R 337 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVE--------ELFKLLKE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQR 337 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHH--------HHHHHHHT----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHH--------HHHHHHHc----------CCCCCCCccCCHHHHHHHHHHcCCChhhC
Confidence 9999999999999 99999863211 11111111 00111111234679999999999999999
Q ss_pred CCHHHHHHHHHhccccccchh
Q 025011 228 PTMKQVSEELDRLKISHENYE 248 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~~~ 248 (259)
||+.++++.|+++.....+..
T Consensus 338 ps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 338 PTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp CCHHHHHHHHHHHHHHSCSCC
T ss_pred cCHHHHHHHHHHHHHHHhcCC
Confidence 999999999999976655443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=288.52 Aligned_cols=223 Identities=26% Similarity=0.398 Sum_probs=177.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------cccCCHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS---------------------QVLRNWK 61 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~~ 61 (259)
+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..... ...+++.
T Consensus 95 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 174 (343)
T 1luf_A 95 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174 (343)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHH
Confidence 5689999999999999999999999999999999999999999999976421 1347889
Q ss_pred HHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC
Q 025011 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG 141 (259)
Q Consensus 62 ~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 141 (259)
.++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+.
T Consensus 175 ~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 175 EQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 99999999999999999999 999999999999999999999999999876543332333445678899999999988
Q ss_pred CcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhc
Q 025011 142 KLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 142 ~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
.++.++||||||+++|+|++ |..||.+.... ....... .... ...+...++.+.+++.+||
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--------~~~~~~~-~~~~---------~~~~~~~~~~l~~li~~~l 313 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--------EVIYYVR-DGNI---------LACPENCPLELYNLMRLCW 313 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHHH-TTCC---------CCCCTTCCHHHHHHHHHHT
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChH--------HHHHHHh-CCCc---------CCCCCCCCHHHHHHHHHHc
Confidence 89999999999999999999 99999863211 1111111 1110 0011123467999999999
Q ss_pred ccCCCCCCCHHHHHHHHHhccccccc
Q 025011 221 SLSGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
+.||.+|||+.++++.|+++......
T Consensus 314 ~~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 314 SKLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp CSSGGGSCCHHHHHHHHHHTTC----
T ss_pred ccCcccCCCHHHHHHHHHHHHhhhhh
Confidence 99999999999999999998766543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=278.88 Aligned_cols=217 Identities=25% Similarity=0.373 Sum_probs=176.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 50 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~- 126 (269)
T 4hcu_A 50 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC- 126 (269)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5689999999999999999999999999999999999999999999976543 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 127 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~ 203 (269)
T 4hcu_A 127 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 203 (269)
T ss_dssp --CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eecCCcchheEEEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcC
Confidence 9999999999999999999999999997654331 112233456778999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... ......... .....+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 204 g~~p~~~~~~~--------~~~~~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 204 GKIPYENRSNS--------EVVEDISTG----------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp SCCTTTTCCHH--------HHHHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH--------HHHHHHhcC----------ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 89999863211 001100000 000111112367999999999999999999999999999886
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
.+
T Consensus 266 ~~ 267 (269)
T 4hcu_A 266 ES 267 (269)
T ss_dssp HC
T ss_pred Hc
Confidence 54
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=276.91 Aligned_cols=217 Identities=22% Similarity=0.335 Sum_probs=176.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 124 (268)
T 3sxs_A 48 DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ- 124 (268)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976532 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 125 --i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (268)
T 3sxs_A 125 --FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSL 201 (268)
T ss_dssp --EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTT
T ss_pred --eecCCcCcceEEECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcC
Confidence 99999999999999999999999999976654322 22233446778999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||....... ......... ....+...++.+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 202 g~~p~~~~~~~~--------~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 202 GKMPYDLYTNSE--------VVLKVSQGH----------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TCCTTTTSCHHH--------HHHHHHTTC----------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CCCCccccChHH--------HHHHHHcCC----------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999997632110 000000000 00001112367999999999999999999999999999987
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 264 ~~ 265 (268)
T 3sxs_A 264 EK 265 (268)
T ss_dssp C-
T ss_pred hc
Confidence 54
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=284.28 Aligned_cols=229 Identities=23% Similarity=0.331 Sum_probs=175.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCc----ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKV----PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
.+..|+.++++++||||+++++++..... .++||||+++|+|.+++.... +++..++.++.|++.||.|||+
T Consensus 64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~al~~LH~ 139 (322)
T 3soc_A 64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHE 139 (322)
T ss_dssp HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----CCHHHHHHHHHHHHHHHHHHHh
Confidence 45668899999999999999999987543 699999999999999997643 5789999999999999999999
Q ss_pred C----------CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-----Ccc
Q 025011 80 S----------ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-----KLT 144 (259)
Q Consensus 80 ~----------~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~ 144 (259)
. + ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+. .++
T Consensus 140 ~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 216 (322)
T 3soc_A 140 DIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAF 216 (322)
T ss_dssp CEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHH
T ss_pred hccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCC
Confidence 9 8 999999999999999999999999999876654333334445799999999999763 467
Q ss_pred cccchhhHHHHHHHHHhCCCCCCCCccccccch--------hHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHH
Q 025011 145 EKSDVYSFGVLLAELLTGLKPGSGMALASNEGI--------SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 145 ~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
.++||||||+++|+|++|+.||.+......... .......... ........... ......++.+.++|
T Consensus 217 ~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~l~~li 292 (322)
T 3soc_A 217 LRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV-HKKKRPVLRDY---WQKHAGMAMLCETI 292 (322)
T ss_dssp HHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHT-TSCCCCCCCGG---GGSSHHHHHHHHHH
T ss_pred ccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhh-cccCCCCcccc---ccccchHHHHHHHH
Confidence 789999999999999999999987432211100 0000000000 00000000000 01123456799999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHhcccc
Q 025011 217 SKCLSLSGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il~~l~~~~~~ 243 (259)
.+||+.||.+|||+.++++.|+++...
T Consensus 293 ~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 293 EECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 999999999999999999999988643
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=285.96 Aligned_cols=217 Identities=23% Similarity=0.381 Sum_probs=174.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++ .+++++|+.+|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 62 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~- 137 (327)
T 3poz_A 62 KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR- 137 (327)
T ss_dssp HHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 56899999999999999999999998754 7899999999999999977543 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 138 --ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~ 215 (327)
T 3poz_A 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTF 215 (327)
T ss_dssp --CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhc
Confidence 99999999999999999999999999987765433333344457889999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ....+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 216 g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 216 GSKPYDGIPASE------------------ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp SCCTTTTCCGGG------------------HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCCHHH------------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 999998732211 11111111111111223467999999999999999999999999999886
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 278 ~~ 279 (327)
T 3poz_A 278 RD 279 (327)
T ss_dssp TS
T ss_pred hh
Confidence 54
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=283.91 Aligned_cols=211 Identities=25% Similarity=0.360 Sum_probs=171.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~g- 125 (323)
T 3tki_A 50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG- 125 (323)
T ss_dssp -CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976533 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++................|++.|+|||++.+..+ +.++||||||+++|+|++
T Consensus 126 --ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 203 (323)
T 3tki_A 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (323)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred --ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh
Confidence 99999999999999999999999999986654433333445679999999999987775 789999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+...... ....+. ............++.+.++|.+||+.||.+|||+.++++
T Consensus 204 g~~pf~~~~~~~~---~~~~~~-------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 204 GELPWDQPSDSCQ---EYSDWK-------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp SSCSCSSSCTTSH---HHHHHH-------------TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCchHHH---HHHHHh-------------cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 9999986432211 000000 000011111123467889999999999999999999965
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=281.62 Aligned_cols=226 Identities=23% Similarity=0.368 Sum_probs=176.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 56 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 131 (294)
T 4eqm_A 56 KRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHDMR- 131 (294)
T ss_dssp HHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++....... ........|++.|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 132 --i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g 208 (294)
T 4eqm_A 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG 208 (294)
T ss_dssp --CCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred --cccCCCCHHHEEECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999997654321 1223344689999999999998899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhcc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-TMKQVSEELDRLK 241 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~~~~ 241 (259)
..||.+..... .......... ... .. ......++.+.++|.+||+.||.+|| +++++.+.|+++.
T Consensus 209 ~~pf~~~~~~~--------~~~~~~~~~~-~~~-~~----~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 209 EPPFNGETAVS--------IAIKHIQDSV-PNV-TT----DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp SCSSCSSCHHH--------HHHHHHSSCC-CCH-HH----HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CCCCCCCChHH--------HHHHHhhccC-CCc-ch----hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 99998732111 0000000000 000 00 00112346799999999999999998 9999999999987
Q ss_pred ccccchhh
Q 025011 242 ISHENYEH 249 (259)
Q Consensus 242 ~~~~~~~~ 249 (259)
......+.
T Consensus 275 ~~~~~~~~ 282 (294)
T 4eqm_A 275 HENRANED 282 (294)
T ss_dssp SSSSTTCC
T ss_pred hhccCCcc
Confidence 76655443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=287.51 Aligned_cols=225 Identities=24% Similarity=0.433 Sum_probs=179.2
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc--------------------ccCCH
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ--------------------VLRNW 60 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~~~ 60 (259)
.+.+.+|+.+++++ +||||+++++++..++..++||||+++|+|.+++...... ..+++
T Consensus 92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 171 (344)
T 1rjb_A 92 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171 (344)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCH
Confidence 35689999999999 8999999999999999999999999999999999765431 23678
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc
Q 025011 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+
T Consensus 172 ~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 899999999999999999999 99999999999999999999999999987654433333444557789999999988
Q ss_pred CCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHh
Q 025011 141 GKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 219 (259)
..++.++||||||+++|+|++ |..||.+..... ....... .......+...++.+.+++.+|
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~ 311 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA----NFYKLIQ-------------NGFKMDQPFYATEEIYIIMQSC 311 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH----HHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHH
Confidence 889999999999999999998 999998743211 0111110 0111111112347799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhccccccc
Q 025011 220 LSLSGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
|+.||.+|||+.++++.|+.+......
T Consensus 312 l~~dp~~Rps~~~l~~~l~~~~~~~~~ 338 (344)
T 1rjb_A 312 WAFDSRKRPSFPNLTSFLGCQLADAEE 338 (344)
T ss_dssp TCSSGGGSCCHHHHHHHHHHHC-----
T ss_pred cCCCchhCcCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999998766543
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=283.42 Aligned_cols=205 Identities=26% Similarity=0.355 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 59 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~~~~~~qi~~al~~lH~~~- 134 (328)
T 3fe3_A 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEKEARSKFRQIVSAVQYCHQKR- 134 (328)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578999999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcc-cccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLT-EKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+. .++||||+|+++|+|++
T Consensus 135 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 209 (328)
T 3fe3_A 135 --IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209 (328)
T ss_dssp --CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH
T ss_pred --EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh
Confidence 9999999999999999999999999997665432 23445699999999999887764 79999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... ........ .... .+...++.+.+++.+||..||.+|||++++++
T Consensus 210 g~~pf~~~~~~--------~~~~~i~~---------~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 210 GSLPFDGQNLK--------ELRERVLR---------GKYR--IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp SSCSSCCSSHH--------HHHHHHHH---------CCCC--CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHH--------HHHHHHHh---------CCCC--CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999873211 11111100 0000 01123467899999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=283.35 Aligned_cols=221 Identities=26% Similarity=0.390 Sum_probs=166.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcc------eEEEEecCCCChhhhhhccC---CcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVP------LLVYEFVPNGTLFDHIHDKS---SQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~ 73 (259)
+.+.+|++++++++||||+++++++...... +++|||+.+++|.+++.... ....+++..++.++.|++.|
T Consensus 70 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~a 149 (323)
T 3qup_A 70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149 (323)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHH
Confidence 5688999999999999999999999876655 99999999999999996542 11236889999999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
|.|||+++ ++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||
T Consensus 150 l~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 226 (323)
T 3qup_A 150 MEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFG 226 (323)
T ss_dssp HHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHcCC---cccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHH
Confidence 99999999 999999999999999999999999999876544333333344577889999999998899999999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
+++|+|++ |..||.+..... . ........ ....+...++.+.+++.+||+.||.+|||+.+
T Consensus 227 ~il~ell~~g~~p~~~~~~~~-----~---~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 288 (323)
T 3qup_A 227 VTMWEIMTRGQTPYAGIENAE-----I---YNYLIGGN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTC 288 (323)
T ss_dssp HHHHHHHTTSCCTTTTCCGGG-----H---HHHHHTTC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHH
T ss_pred HHHHHHHhCCCCCccccChHH-----H---HHHHhcCC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHH
Confidence 99999999 899998733211 0 00000000 01111223467999999999999999999999
Q ss_pred HHHHHHhccccc
Q 025011 233 VSEELDRLKISH 244 (259)
Q Consensus 233 il~~l~~~~~~~ 244 (259)
+++.++++....
T Consensus 289 l~~~l~~~l~~~ 300 (323)
T 3qup_A 289 LRMELENILGHL 300 (323)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHHHh
Confidence 999999876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=284.01 Aligned_cols=224 Identities=25% Similarity=0.400 Sum_probs=182.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCc---------------ccCCHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQ---------------VLRNWKTCLRI 66 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------------~~~~~~~~~~i 66 (259)
+.+.+|+++++++ +||||+++++++..++..++||||+++++|.+++...... ..+++..++.+
T Consensus 71 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (313)
T 1t46_A 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (313)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred HHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHH
Confidence 5689999999999 9999999999999999999999999999999999765421 23688999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
+.|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.+
T Consensus 151 ~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 227 (313)
T 1t46_A 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227 (313)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChH
Confidence 999999999999999 99999999999999999999999999987665433333444557788999999998889999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 147 SDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 147 ~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+||||||+++|+|++ |..||.+..... ........ ......+...++.+.+++.+||+.||.
T Consensus 228 ~Di~slG~il~ellt~g~~p~~~~~~~~----~~~~~~~~-------------~~~~~~~~~~~~~l~~li~~~l~~dp~ 290 (313)
T 1t46_A 228 SDVWSYGIFLWELFSLGSSPYPGMPVDS----KFYKMIKE-------------GFRMLSPEHAPAEMYDIMKTCWDADPL 290 (313)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSH----HHHHHHHH-------------TCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcccchh----HHHHHhcc-------------CCCCCCcccCCHHHHHHHHHHcCCCch
Confidence 999999999999999 999998743211 01111110 001111112346799999999999999
Q ss_pred CCCCHHHHHHHHHhccccccc
Q 025011 226 RRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 226 ~Rpt~~~il~~l~~~~~~~~~ 246 (259)
+|||+.++++.|+++..+..+
T Consensus 291 ~Rps~~ell~~L~~~~~~~~~ 311 (313)
T 1t46_A 291 KRPTFKQIVQLIEKQISESTN 311 (313)
T ss_dssp GSCCHHHHHHHHHHHHHHTCC
T ss_pred hCcCHHHHHHHHHHHHHHhhc
Confidence 999999999999988765443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=283.66 Aligned_cols=207 Identities=24% Similarity=0.312 Sum_probs=169.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++
T Consensus 60 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g- 135 (361)
T 2yab_A 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK- 135 (361)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 578999999999999999999999999999999999999999999997653 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||||+||+++.++ .++|+|||++....... ......|++.|+|||++.+..++.++||||+|+++|+
T Consensus 136 --ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ 210 (361)
T 2yab_A 136 --IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYI 210 (361)
T ss_dssp --EECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHH
Confidence 99999999999998777 79999999998765422 2234569999999999998889999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCC--chhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD--ESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+.... ..... +....... ......++.+.++|.+||..||.+|||+.++++
T Consensus 211 ll~g~~Pf~~~~~~--------~~~~~---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 211 LLSGASPFLGDTKQ--------ETLAN---------ITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHSCCSSCCSSHH--------HHHHH---------HHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhCCCCCCCCCHH--------HHHHH---------HHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999999863211 00000 00000000 011123467999999999999999999999964
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=291.09 Aligned_cols=222 Identities=22% Similarity=0.334 Sum_probs=178.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC----cccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS----QVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.++++++||||+++++++..++..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||
T Consensus 119 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 198 (367)
T 3l9p_A 119 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198 (367)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH
Confidence 3588999999999999999999999999999999999999999999976532 234688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
+++ |+||||||+||+++.++ .++|+|||+++...............++..|+|||++.+..++.++|||||||+
T Consensus 199 ~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~i 275 (367)
T 3l9p_A 199 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275 (367)
T ss_dssp HTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred hCC---eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHH
Confidence 999 99999999999999555 599999999976544333333444568889999999999899999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... .......... ....+...++.+.+++.+||+.||.+|||+.+|+
T Consensus 276 l~ellt~g~~pf~~~~~~--------~~~~~i~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil 337 (367)
T 3l9p_A 276 LWEIFSLGYMPYPSKSNQ--------EVLEFVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337 (367)
T ss_dssp HHHHHTTSCCSSTTCCHH--------HHHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCCCCCCHH--------HHHHHHHcCC----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 999998 99999863211 1111111100 1111112346799999999999999999999999
Q ss_pred HHHHhcccccc
Q 025011 235 EELDRLKISHE 245 (259)
Q Consensus 235 ~~l~~~~~~~~ 245 (259)
+.++.+.....
T Consensus 338 ~~l~~~~~~~~ 348 (367)
T 3l9p_A 338 ERIEYCTQDPD 348 (367)
T ss_dssp HHHHHHHHCHH
T ss_pred HHHHHHhhChh
Confidence 99998876544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=278.50 Aligned_cols=218 Identities=23% Similarity=0.343 Sum_probs=165.0
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ 136 (281)
T 1mp8_A 60 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR 136 (281)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356889999999999999999999984 5678999999999999999976532 2678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 137 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 212 (281)
T 1mp8_A 137 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212 (281)
T ss_dssp ---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred ---eecccccHHHEEECCCCCEEECccccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence 9999999999999999999999999997665432 112233346778999999988889999999999999999997
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+..... ... ..... . ....+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 213 ~g~~pf~~~~~~~-----~~~---~i~~~-~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 213 HGVKPFQGVKNND-----VIG---RIENG-E---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp TSCCTTTTCCGGG-----HHH---HHHTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHH-----HHH---HHHcC-C---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 899998632211 000 00000 0 0011122347799999999999999999999999999998
Q ss_pred cccc
Q 025011 241 KISH 244 (259)
Q Consensus 241 ~~~~ 244 (259)
..+.
T Consensus 275 ~~~~ 278 (281)
T 1mp8_A 275 LEEE 278 (281)
T ss_dssp HHHH
T ss_pred HHHh
Confidence 6543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=287.47 Aligned_cols=219 Identities=24% Similarity=0.362 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.++++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 91 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~- 167 (373)
T 2qol_A 91 RDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG- 167 (373)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976532 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 168 --ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt 245 (373)
T 2qol_A 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245 (373)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred --eeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHh
Confidence 9999999999999999999999999998765432111 1122235678999999998899999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... . ....... ......+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 246 ~g~~P~~~~~~~-----~---~~~~i~~----------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 246 YGERPYWEMSNQ-----D---VIKAVDE----------GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp TC-CTTTTCCHH-----H---HHHHHHT----------TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-----H---HHHHHHc----------CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 99999763211 0 1111100 001111122346799999999999999999999999999998
Q ss_pred cccc
Q 025011 241 KISH 244 (259)
Q Consensus 241 ~~~~ 244 (259)
....
T Consensus 308 ~~~~ 311 (373)
T 2qol_A 308 IRNP 311 (373)
T ss_dssp HHCG
T ss_pred HhCc
Confidence 6543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=277.39 Aligned_cols=217 Identities=22% Similarity=0.356 Sum_probs=176.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 64 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~- 140 (283)
T 3gen_A 64 DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ- 140 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976432 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 141 --i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~ 217 (283)
T 3gen_A 141 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217 (283)
T ss_dssp --CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTT
T ss_pred --ccCCCCccceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999997654321 112233346778999999998889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|+.||....... . ...... ......+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 218 g~~p~~~~~~~~-----~---~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 218 GKMPYERFTNSE-----T---AEHIAQ----------GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp TCCTTTTSCHHH-----H---HHHHHT----------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccccChhH-----H---HHHHhc----------ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 999998633110 0 000000 0001111112367999999999999999999999999999886
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
..
T Consensus 280 ~~ 281 (283)
T 3gen_A 280 DE 281 (283)
T ss_dssp HH
T ss_pred hc
Confidence 54
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=288.60 Aligned_cols=221 Identities=24% Similarity=0.372 Sum_probs=177.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCC-cceEEEEecCCCChhhhhhccCC--------------------------
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSS-------------------------- 54 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~-------------------------- 54 (259)
+.+.+|+++++++ +||||+++++++...+ ..++||||+++|+|.+++.....
T Consensus 70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (359)
T 3vhe_A 70 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149 (359)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------
T ss_pred HHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhh
Confidence 4689999999999 7899999999998755 48999999999999999976532
Q ss_pred -------------------------------------cccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEe
Q 025011 55 -------------------------------------QVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL 97 (259)
Q Consensus 55 -------------------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~ 97 (259)
...+++..++.++.|++.||.|||+++ ++|+||||+||++
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll 226 (359)
T 3vhe_A 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 226 (359)
T ss_dssp ----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred hccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEE
Confidence 112688899999999999999999999 9999999999999
Q ss_pred CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-CCCCCCCCccccccc
Q 025011 98 DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEG 176 (259)
Q Consensus 98 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~ 176 (259)
+.++.++|+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 227 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 303 (359)
T 3vhe_A 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--- 303 (359)
T ss_dssp CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH---
T ss_pred cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH---
Confidence 9999999999999987654433334445568889999999999889999999999999999998 999998743211
Q ss_pred hhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcccc
Q 025011 177 ISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~ 243 (259)
........ . .....+...++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus 304 -~~~~~~~~----~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 304 -EFCRRLKE----G---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -HHHHHHHH----T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHHHHc----C---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 00010100 0 00011112336799999999999999999999999999988654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=279.61 Aligned_cols=208 Identities=17% Similarity=0.279 Sum_probs=170.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 46 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~g- 122 (321)
T 1tki_A 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN- 122 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976532 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC--CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD--NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||||+||+++. ++.++|+|||++....... ......+++.|+|||++.+..++.++||||+|+++|+|+
T Consensus 123 --ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp --EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred --CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999987 7899999999998765332 223346899999999998888899999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||.+.... . ... .+........ .....++.+.++|.+||..||.+|||+.++++
T Consensus 198 ~g~~pf~~~~~~-----~---~~~---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 198 SGINPFLAETNQ-----Q---IIE---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HSSCTTCCSSHH-----H---HHH---------HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCcCCCHH-----H---HHH---------HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 999999863211 0 000 0111111100 11123467999999999999999999999976
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=285.61 Aligned_cols=210 Identities=21% Similarity=0.285 Sum_probs=170.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+.+..... +++..+..++.|++.||.|||+++
T Consensus 55 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---~~e~~~~~i~~qil~aL~~lH~~g- 130 (444)
T 3soa_A 55 QKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEADASHCIQQILEAVLHCHQMG- 130 (444)
T ss_dssp HHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC---CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|+||||+||+++ .++.++|+|||++....... .......|++.|+|||++.+..++.++||||+|+++|+|
T Consensus 131 --ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 206 (444)
T 3soa_A 131 --VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYIL 206 (444)
T ss_dssp --CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred --ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHH
Confidence 99999999999998 56789999999997665432 222345699999999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ......... .. ..........++.+.++|.+||+.||.+|||+.++++
T Consensus 207 l~G~~Pf~~~~~~-----~~~~~i~~~----~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 207 LVGYPPFWDEDQH-----RLYQQIKAG----AY------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp HHSSCSCCCSSHH-----HHHHHHHHT----CC------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCccHH-----HHHHHHHhC----CC------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999763211 111111000 00 0000111123467999999999999999999999975
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=282.65 Aligned_cols=219 Identities=23% Similarity=0.383 Sum_probs=170.0
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.+++.++||||+++++++..+. .+++++++.+|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ 137 (327)
T 3lzb_A 61 NKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR 137 (327)
T ss_dssp HHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 357899999999999999999999998754 7899999999999999976543 2578999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 138 ---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~ 214 (327)
T 3lzb_A 138 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214 (327)
T ss_dssp ---CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987654433333344457788999999999999999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+..... ....+........+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 215 ~g~~p~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 276 (327)
T 3lzb_A 215 FGSKPYDGIPASE------------------ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276 (327)
T ss_dssp TSCCTTTTCCGGG------------------HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH------------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 999998733211 1111111111111122346799999999999999999999999999998
Q ss_pred cccc
Q 025011 241 KISH 244 (259)
Q Consensus 241 ~~~~ 244 (259)
....
T Consensus 277 ~~~~ 280 (327)
T 3lzb_A 277 ARDP 280 (327)
T ss_dssp HTSH
T ss_pred HhCc
Confidence 7543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=295.62 Aligned_cols=219 Identities=28% Similarity=0.428 Sum_probs=178.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.++++++||||+++++++..++..++||||+++|+|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 261 ~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~- 338 (495)
T 1opk_A 261 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN- 338 (495)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcC-CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 57899999999999999999999999999999999999999999999865433 2678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...... ........++..|+|||++.+..++.++||||||+++|+|++
T Consensus 339 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 339 --FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp --EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCChhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 112223346678999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ..... ........+...++.+.++|.+||+.||.+|||+.+|++.|+++.
T Consensus 416 g~~p~~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 416 GMSPYPGIDLSQ-----VYELL-------------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp SCCSSTTCCGGG-----HHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCCCCCCHHH-----HHHHH-------------HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 999998743211 11111 111111112233477999999999999999999999999999986
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 478 ~~~ 480 (495)
T 1opk_A 478 QES 480 (495)
T ss_dssp SSS
T ss_pred hcc
Confidence 543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=282.35 Aligned_cols=210 Identities=23% Similarity=0.314 Sum_probs=169.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+.+.... ....+++..++.++.|++.||.|||+++
T Consensus 71 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (351)
T 3c0i_A 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN 150 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999999999999999999999999999999988876532 2234688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||||+||+++.++. ++|+|||++....... .......|++.|+|||++.+..++.++||||||+++|+
T Consensus 151 ---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ 225 (351)
T 3c0i_A 151 ---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225 (351)
T ss_dssp ---EECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred ---ceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHH
Confidence 999999999999986654 9999999998765432 22334569999999999998889999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+... .. ... +........ .....++.+.++|.+||..||.+|||+.++++
T Consensus 226 ll~g~~pf~~~~~------~~---~~~---------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 226 LLSGCLPFYGTKE------RL---FEG---------IIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHSSCSSCSSHH------HH---HHH---------HHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHCCCCCCCcHH------HH---HHH---------HHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 9999999987311 00 000 000000000 00123467999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=281.35 Aligned_cols=221 Identities=22% Similarity=0.367 Sum_probs=178.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------cccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------QVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||.
T Consensus 73 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 152 (322)
T 1p4o_A 73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152 (322)
T ss_dssp HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence 4588999999999999999999999999999999999999999999975321 133578999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||++
T Consensus 153 ~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 229 (322)
T 1p4o_A 153 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229 (322)
T ss_dssp HHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCC---CccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHH
Confidence 999999 99999999999999999999999999986654333333344457889999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... ........ ... ...+...++.+.+++.+||+.||.+|||+.+++
T Consensus 230 l~el~~~g~~p~~~~~~~--------~~~~~~~~-~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l 291 (322)
T 1p4o_A 230 LWEIATLAEQPYQGLSNE--------QVLRFVME-GGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291 (322)
T ss_dssp HHHHHHTSCCTTTTSCHH--------HHHHHHHT-TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhcCCCccccCCHH--------HHHHHHHc-CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 999999 88998763211 00110000 000 011112346799999999999999999999999
Q ss_pred HHHHhccccc
Q 025011 235 EELDRLKISH 244 (259)
Q Consensus 235 ~~l~~~~~~~ 244 (259)
+.|+++....
T Consensus 292 ~~L~~~~~~~ 301 (322)
T 1p4o_A 292 SSIKEEMEPG 301 (322)
T ss_dssp HHHGGGSCTT
T ss_pred HHHHHhhccC
Confidence 9999875543
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=281.37 Aligned_cols=223 Identities=27% Similarity=0.422 Sum_probs=179.5
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+++++|.+++..... ...+++..++.++.
T Consensus 85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 164 (334)
T 2pvf_A 85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164 (334)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence 4688999999999 899999999999999999999999999999999976542 12367889999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||++.+..++.++|
T Consensus 165 qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 165 QLARGMEYLASQK---CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp HHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHhCC---eeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence 9999999999999 9999999999999999999999999998765433333334445778899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+.... ....... .. .....+...+..+.+++.+||+.||.+|
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVE-----ELFKLLK---EG----------HRMDKPANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHH---HT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHH-----HHHHHHh---cC----------CCCCCCccCCHHHHHHHHHHccCChhhC
Confidence 9999999999999 99999863211 1111110 00 0001111234679999999999999999
Q ss_pred CCHHHHHHHHHhccccccc
Q 025011 228 PTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~ 246 (259)
||+.++++.|+++.....+
T Consensus 304 ps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 304 PTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp CCHHHHHHHHHHHHHHHC-
T ss_pred cCHHHHHHHHHHHHhcccc
Confidence 9999999999998765443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=284.12 Aligned_cols=218 Identities=26% Similarity=0.428 Sum_probs=173.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++. ++..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 135 (325)
T 3kex_A 60 QAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWGVQIAKGMYYLEEHG- 135 (325)
T ss_dssp CSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 35678999999999999999999986 4568999999999999999976532 3577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 136 --ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 213 (325)
T 3kex_A 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213 (325)
T ss_dssp --CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --CCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhC
Confidence 99999999999999999999999999987765443333444567889999999998899999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ...... . ......+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 214 g~~p~~~~~~~~-----~~~~~~---~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 214 GAEPYAGLRLAE-----VPDLLE---K----------GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp SCCTTTTSCTTH-----HHHHHH---T----------TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCccccCHHH-----HHHHHH---c----------CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 999998733211 001110 0 0000011112345888999999999999999999999999986
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 276 ~~~ 278 (325)
T 3kex_A 276 RDP 278 (325)
T ss_dssp TSH
T ss_pred hcc
Confidence 543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=290.68 Aligned_cols=215 Identities=27% Similarity=0.427 Sum_probs=174.0
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCC-cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.|.+|++++++++||||+++++++.... ..++||||+++|+|.+++...... .+++..++.++.|++.||.|||++
T Consensus 230 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 230 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTT-TCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 367999999999999999999999987665 789999999999999999876432 257889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||||+||+++.++.++|+|||+++..... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 309 ~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~ 380 (450)
T 1k9a_A 309 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380 (450)
T ss_dssp T---EECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred C---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9 999999999999999999999999998754322 11224678899999999888999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |..||.+..... . ...... ......+..+++.+.++|.+||+.||.+|||+.++++.|++
T Consensus 381 t~g~~P~~~~~~~~-----~---~~~i~~----------~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~ 442 (450)
T 1k9a_A 381 SFGRVPYPRIPLKD-----V---VPRVEK----------GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH 442 (450)
T ss_dssp TTTCCSSTTSCTTT-----H---HHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH-----H---HHHHHc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 8 999998743211 0 000000 01111112344779999999999999999999999999998
Q ss_pred cccc
Q 025011 240 LKIS 243 (259)
Q Consensus 240 ~~~~ 243 (259)
+...
T Consensus 443 i~~~ 446 (450)
T 1k9a_A 443 IRTH 446 (450)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 8643
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=277.39 Aligned_cols=221 Identities=28% Similarity=0.424 Sum_probs=180.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..++||||+++++|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 54 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~- 131 (288)
T 3kfa_A 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN- 131 (288)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTT-TSCHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccC-CccHhHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999999999999999999999999999999999999875443 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 132 --i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~ 208 (288)
T 3kfa_A 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208 (288)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --ccCCCCCcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998665432 122233446778999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ..... ........+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 209 g~~p~~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 209 GMSPYPGIDLSQ-----VYELL-------------EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp SCCSSTTCCGGG-----HHHHH-------------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHH-----HHHHH-------------hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 999998733211 11111 011111111223477999999999999999999999999999887
Q ss_pred ccccc
Q 025011 242 ISHEN 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.....
T Consensus 271 ~~~~~ 275 (288)
T 3kfa_A 271 QESSI 275 (288)
T ss_dssp HHHHH
T ss_pred Hhccc
Confidence 65443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=273.85 Aligned_cols=237 Identities=20% Similarity=0.251 Sum_probs=180.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++.... ..++||||+++++|.+++........+++..++.++.|++.||.|||++
T Consensus 52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 131 (319)
T 4euu_A 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (319)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56789999999999999999999998755 7799999999999999998765544478899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEe----CCCCceEEeecCCcccccCCccccccccccCcccccCcchhc--------cCCcccccc
Q 025011 81 ASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI--------TGKLTEKSD 148 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~D 148 (259)
+ ++|+||||+||++ +.++.++|+|||+++...... ......++..|+|||++. +..++.++|
T Consensus 132 ~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 205 (319)
T 4euu_A 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205 (319)
T ss_dssp T---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHH
T ss_pred C---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHH
Confidence 9 9999999999999 778889999999998765432 223346899999999986 467899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhh----------h-ccccCCchhHHHHHHHHHHHH
Q 025011 149 VYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQI----------L-NFQVADESEMEEIETVAGLAS 217 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-~~~~~~~~~~~~~~~~~~li~ 217 (259)
|||||+++|+|++|..||...................... ..+... . ............++.+.+++.
T Consensus 206 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~ 284 (319)
T 4euu_A 206 LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS-GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (319)
T ss_dssp HHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCT-TCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCc-ccchhhhcccCCccccCccCCcccccchhHHHHhHHHHH
Confidence 9999999999999999997643322222222222211110 000000 0 001111233456688999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhccccccc
Q 025011 218 KCLSLSGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 218 ~~l~~~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
+||+.||.+|||++++++...+.....++
T Consensus 285 ~~L~~dP~~R~s~~ell~h~~d~~~~~~~ 313 (319)
T 4euu_A 285 NILEADQEKCWGFDQFFAETSDILHRGNS 313 (319)
T ss_dssp HHSCCCTTTSCCHHHHHHHHHHHTC----
T ss_pred HhccCChhhhccHHHhhhccHHHhhcCCc
Confidence 99999999999999999988876654443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=286.23 Aligned_cols=221 Identities=26% Similarity=0.420 Sum_probs=178.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-----------cccCCHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-----------QVLRNWKTCLRIAAET 70 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------~~~~~~~~~~~i~~~i 70 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+++|+|.+++..... ...+++..++.++.|+
T Consensus 94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi 173 (333)
T 2i1m_A 94 EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173 (333)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHH
Confidence 5688999999999 899999999999999999999999999999999975421 1235789999999999
Q ss_pred HHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchh
Q 025011 71 ASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVY 150 (259)
Q Consensus 71 ~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 150 (259)
+.||.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||
T Consensus 174 ~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 250 (333)
T 2i1m_A 174 AQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVW 250 (333)
T ss_dssp HHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHhcCC---cccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHH
Confidence 99999999999 999999999999999999999999999866544333333444577889999999988899999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 151 SFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 151 slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|||+++|+|++ |..||.+..... ....... .......+...++.+.+++.+||+.||.+|||
T Consensus 251 slG~il~el~t~g~~p~~~~~~~~----~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps 313 (333)
T 2i1m_A 251 SYGILLWEIFSLGLNPYPGILVNS----KFYKLVK-------------DGYQMAQPAFAPKNIYSIMQACWALEPTHRPT 313 (333)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCSSH----HHHHHHH-------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHHHHHHHHHcCCCCCCcccchhH----HHHHHHh-------------cCCCCCCCCCCCHHHHHHHHHHhccChhhCcC
Confidence 99999999998 899998633211 0011110 00001111112367999999999999999999
Q ss_pred HHHHHHHHHhcccc
Q 025011 230 MKQVSEELDRLKIS 243 (259)
Q Consensus 230 ~~~il~~l~~~~~~ 243 (259)
+.++++.|+++...
T Consensus 314 ~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 314 FQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999987654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=280.52 Aligned_cols=222 Identities=29% Similarity=0.425 Sum_probs=178.2
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-------------CcccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-------------SQVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++++ +||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.
T Consensus 70 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 149 (327)
T 1fvr_A 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149 (327)
T ss_dssp CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHH
Confidence 4688999999999 89999999999999999999999999999999997653 123468899999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++..... .......++..|+|||.+.+..++.++|
T Consensus 150 qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~D 223 (327)
T 1fvr_A 150 DVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSD 223 (327)
T ss_dssp HHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhc
Confidence 9999999999999 999999999999999999999999998643221 1222334678899999998888999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |..||.+.... ........ ......+...++.+.++|.+||+.||.+|
T Consensus 224 i~slG~il~ellt~g~~pf~~~~~~--------~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~R 285 (327)
T 1fvr_A 224 VWSYGVLLWEIVSLGGTPYCGMTCA--------ELYEKLPQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYER 285 (327)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCHH--------HHHHHGGG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGS
T ss_pred chHHHHHHHHHHcCCCCCCCCCcHH--------HHHHHhhc----------CCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 9999999999998 99999863211 00111100 00111112234679999999999999999
Q ss_pred CCHHHHHHHHHhccccccchh
Q 025011 228 PTMKQVSEELDRLKISHENYE 248 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~~~ 248 (259)
||+.++++.|+++........
T Consensus 286 ps~~ell~~L~~~~~~~~~~~ 306 (327)
T 1fvr_A 286 PSFAQILVSLNRMLEERKTYV 306 (327)
T ss_dssp CCHHHHHHHHHHHHHSSSCSB
T ss_pred cCHHHHHHHHHHHHHhhcCcc
Confidence 999999999999877766554
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=293.83 Aligned_cols=220 Identities=23% Similarity=0.390 Sum_probs=176.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.|.+|+.++++++||||+++++++. ++..++||||+++|+|.+++...... ..++..++.++.|++.||.|||+++
T Consensus 227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 227 VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 357999999999999999999999986 66789999999999999999764321 2577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++...... ........++..|+|||++....++.++||||||+++|+|++
T Consensus 305 ---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t 380 (454)
T 1qcf_A 305 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380 (454)
T ss_dssp ---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHh
Confidence 9999999999999999999999999998754321 111223346778999999998889999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ...... ... .....+...++.+.++|.+||+.||.+|||+.+|++.|+++
T Consensus 381 ~g~~P~~~~~~~-----~~~~~i---~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~ 442 (454)
T 1qcf_A 381 YGRIPYPGMSNP-----EVIRAL---ERG----------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442 (454)
T ss_dssp TSCCSSTTCCHH-----HHHHHH---HHT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred CCCCCCCCCCHH-----HHHHHH---HcC----------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 99999873211 111111 000 01111123447799999999999999999999999999998
Q ss_pred ccccc
Q 025011 241 KISHE 245 (259)
Q Consensus 241 ~~~~~ 245 (259)
.....
T Consensus 443 ~~~~~ 447 (454)
T 1qcf_A 443 YTATE 447 (454)
T ss_dssp SSSSC
T ss_pred Hhccc
Confidence 76543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=280.75 Aligned_cols=236 Identities=23% Similarity=0.315 Sum_probs=180.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++.+. ...++||||+++++|.+++.... +++..++.++.|++.||.|||+.
T Consensus 78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~ 153 (318)
T 3lxp_A 78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQ 153 (318)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhC
Confidence 5689999999999999999999999874 56799999999999999997654 57899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|
T Consensus 154 ~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 230 (318)
T 3lxp_A 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230 (318)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred C---ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543222 123344577889999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||........ ....+......................+...++.+.++|.+||+.||.+|||+.++++.|++
T Consensus 231 l~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 307 (318)
T 3lxp_A 231 LTHCDSSQSPPTKFL---ELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307 (318)
T ss_dssp HTTTCGGGSHHHHHH---HHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCcccccchhhh---hhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 999999875211100 00000000000011111122222222223345789999999999999999999999999999
Q ss_pred ccccccchh
Q 025011 240 LKISHENYE 248 (259)
Q Consensus 240 ~~~~~~~~~ 248 (259)
+.....+..
T Consensus 308 l~~~~~~~~ 316 (318)
T 3lxp_A 308 VHEKYQGQA 316 (318)
T ss_dssp HHHHHHC--
T ss_pred HHHhhccCC
Confidence 987766544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=273.74 Aligned_cols=210 Identities=24% Similarity=0.318 Sum_probs=169.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++
T Consensus 58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~ 134 (326)
T 2y0a_A 58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ 134 (326)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3568999999999999999999999999999999999999999999997643 2678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCC----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
++|+||||+||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|
T Consensus 135 ---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 208 (326)
T 2y0a_A 135 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208 (326)
T ss_dssp ---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHH
Confidence 99999999999999887 79999999998765332 123346999999999998888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+.... ......... .. ..........++.+.++|.+||..||.+|||+.++++
T Consensus 209 ~ll~g~~pf~~~~~~-----~~~~~~~~~--~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 209 ILLSGASPFLGDTKQ-----ETLANVSAV--NY--------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHHSCCSSCCSSHH-----HHHHHHHHT--CC--------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHCcCCCCCCCHH-----HHHHHHHhc--CC--------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999763211 000000000 00 0000011123467899999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=272.61 Aligned_cols=217 Identities=25% Similarity=0.360 Sum_probs=176.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..+++|||+++++|.+++..... .+++..++.++.|++.||.+||+++
T Consensus 48 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 124 (267)
T 3t9t_A 48 EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC- 124 (267)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5789999999999999999999999999999999999999999999976533 3578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||++.+..++.++||||+|+++|+|++
T Consensus 125 --i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~ 201 (267)
T 3t9t_A 125 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201 (267)
T ss_dssp --CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCchheEEECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhcc
Confidence 9999999999999999999999999987654321 112233456788999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... . ........ .....+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 202 g~~p~~~~~~~-----~---~~~~i~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 202 GKIPYENRSNS-----E---VVEDISTG----------FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp SCCTTTTCCHH-----H---HHHHHHTT----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHH-----H---HHHHHhcC----------CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 89998863211 0 01100000 000011122367999999999999999999999999999886
Q ss_pred cc
Q 025011 242 IS 243 (259)
Q Consensus 242 ~~ 243 (259)
.+
T Consensus 264 ~~ 265 (267)
T 3t9t_A 264 ES 265 (267)
T ss_dssp HC
T ss_pred hc
Confidence 53
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=279.08 Aligned_cols=231 Identities=20% Similarity=0.377 Sum_probs=172.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++..... .+++..++.++.|++.||.|||++
T Consensus 56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~ 133 (295)
T 3ugc_A 56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK 133 (295)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcC
Confidence 568899999999999999999999864 3568999999999999999976543 267899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 134 ~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 210 (295)
T 3ugc_A 134 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210 (295)
T ss_dssp T---CCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred C---cccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543221 122233467789999999998999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhc----cchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIE----NNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||....... ......... ................+...++.+.+++.+||+.||.+|||+.++++
T Consensus 211 ~~g~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 211 FTYIEKSKSPPAEF------MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHTTCTTCSHHHHH------HHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhcccccCCChHHH------HhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999987521100 000000000 00001111111111122234577999999999999999999999999
Q ss_pred HHHhccccc
Q 025011 236 ELDRLKISH 244 (259)
Q Consensus 236 ~l~~~~~~~ 244 (259)
.|+++....
T Consensus 285 ~L~~l~~~l 293 (295)
T 3ugc_A 285 RVDQIRDNM 293 (295)
T ss_dssp HHHHHHHC-
T ss_pred HHHHHHHhc
Confidence 999987653
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=275.94 Aligned_cols=222 Identities=24% Similarity=0.376 Sum_probs=168.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC-----cceEEEEecCCCChhhhhhcc---CCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDK---SSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+.++++++||||+++++++...+ ..+++|||+++++|.+++... .....+++..++.++.|++.||
T Consensus 81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 160 (313)
T 3brb_A 81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160 (313)
T ss_dssp HHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHH
Confidence 46889999999999999999999998654 349999999999999998532 2223478899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.|||+++ ++|+||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++||||||+
T Consensus 161 ~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 237 (313)
T 3brb_A 161 EYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 237 (313)
T ss_dssp HHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHH
T ss_pred HHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHH
Confidence 9999999 9999999999999999999999999998765433223333445778999999999888999999999999
Q ss_pred HHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 155 LLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 155 il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
++|+|++ |..||.+..... .... .... .....+...++.+.+++.+||+.||.+|||+.++
T Consensus 238 il~el~~~g~~p~~~~~~~~-----~~~~---~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 299 (313)
T 3brb_A 238 TMWEIATRGMTPYPGVQNHE-----MYDY---LLHG----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVL 299 (313)
T ss_dssp HHHHHHTTSCCSSTTCCGGG-----HHHH---HHTT----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHH
T ss_pred HHHHHHhcCCCCCccCCHHH-----HHHH---HHcC----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9999999 889987632211 0000 0000 0001111234679999999999999999999999
Q ss_pred HHHHHhcccccc
Q 025011 234 SEELDRLKISHE 245 (259)
Q Consensus 234 l~~l~~~~~~~~ 245 (259)
++.|+++..+.+
T Consensus 300 ~~~L~~l~~~lp 311 (313)
T 3brb_A 300 RLQLEKLLESLP 311 (313)
T ss_dssp HHHHHHHHHHC-
T ss_pred HHHHHHHHHhcC
Confidence 999999876543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=271.58 Aligned_cols=213 Identities=28% Similarity=0.403 Sum_probs=165.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++... .+++..++.++.|++.|+.|||+++.
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~ 126 (271)
T 3dtc_A 51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAI 126 (271)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56889999999999999999999999999999999999999999998643 26789999999999999999999984
Q ss_pred CCeEeCCCCCCCeEeCC--------CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 83 PPIIHGDVKSTNVLLDD--------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~--------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.+++|+||||+||+++. ++.++|+|||++....... .....++..|+|||.+.+..++.++||||+|+
T Consensus 127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 202 (271)
T 3dtc_A 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202 (271)
T ss_dssp SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHH
T ss_pred CceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHH
Confidence 45789999999999986 6789999999987654321 22346899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++|+|++|+.||.+..... ..... .........+...++.+.+++.+||+.||.+|||+.+++
T Consensus 203 ~l~~l~~g~~p~~~~~~~~--------~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 265 (271)
T 3dtc_A 203 LLWELLTGEVPFRGIDGLA--------VAYGV---------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNIL 265 (271)
T ss_dssp HHHHHHHCCCTTTTSCHHH--------HHHHH---------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCCHHH--------HHHhh---------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHH
Confidence 9999999999998732110 00000 000111111122346799999999999999999999999
Q ss_pred HHHHhc
Q 025011 235 EELDRL 240 (259)
Q Consensus 235 ~~l~~~ 240 (259)
+.|+++
T Consensus 266 ~~L~~l 271 (271)
T 3dtc_A 266 DQLTTI 271 (271)
T ss_dssp HHHHC-
T ss_pred HHHhcC
Confidence 999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=273.72 Aligned_cols=221 Identities=25% Similarity=0.343 Sum_probs=176.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+++++.++||||+++++++ ..+..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ 137 (291)
T 1xbb_A 62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137 (291)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999999999999 56778999999999999999987543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 138 ---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 214 (291)
T 1xbb_A 138 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214 (291)
T ss_dssp ---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHH
Confidence 9999999999999999999999999998765432211 122234668899999998888999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |..||.+.... ....... . .. ....+...++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 215 ~~g~~p~~~~~~~-----~~~~~~~---~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 276 (291)
T 1xbb_A 215 SYGQKPYRGMKGS-----EVTAMLE---K-GE---------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 276 (291)
T ss_dssp TTTCCSSTTCCHH-----HHHHHHH---T-TC---------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hcCCCCCCCCCHH-----HHHHHHH---c-CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 9 99999873211 1111100 0 00 011112234779999999999999999999999999999
Q ss_pred ccccccch
Q 025011 240 LKISHENY 247 (259)
Q Consensus 240 ~~~~~~~~ 247 (259)
+-.+....
T Consensus 277 ~~~~~~~~ 284 (291)
T 1xbb_A 277 YYYDVVNE 284 (291)
T ss_dssp HHHHHHHH
T ss_pred HHHHHhhc
Confidence 86655443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=277.67 Aligned_cols=222 Identities=23% Similarity=0.356 Sum_probs=172.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 91 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~- 167 (333)
T 1mqb_A 91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN- 167 (333)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999976532 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 168 --ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 245 (333)
T 1mqb_A 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245 (333)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred --eeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHc
Confidence 9999999999999999999999999998765432211 1222346778999999988889999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... . ........ .....+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 246 ~g~~pf~~~~~~-----~---~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 246 YGERPYWELSNH-----E---VMKAINDG----------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp TSCCTTTTCCHH-----H---HHHHHHTT----------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCCHH-----H---HHHHHHCC----------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999763211 0 01111000 00111112346799999999999999999999999999988
Q ss_pred cccccch
Q 025011 241 KISHENY 247 (259)
Q Consensus 241 ~~~~~~~ 247 (259)
.......
T Consensus 308 ~~~~~~~ 314 (333)
T 1mqb_A 308 IRAPDSL 314 (333)
T ss_dssp HHSGGGG
T ss_pred Hhcchhh
Confidence 7655443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=273.35 Aligned_cols=222 Identities=23% Similarity=0.351 Sum_probs=178.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++ ..+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 55 ~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 130 (287)
T 1u59_A 55 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN- 130 (287)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999 55678999999999999999975432 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 131 --i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 208 (287)
T 1u59_A 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 208 (287)
T ss_dssp --EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred --EeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHc
Confidence 999999999999999999999999999876543221 12233356789999999988889999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ....... . .. ....+...++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 209 ~g~~p~~~~~~~-----~~~~~i~---~-~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 209 YGQKPYKKMKGP-----EVMAFIE---Q-GK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp TSCCTTTTCCTH-----HHHHHHH---T-TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccCCHH-----HHHHHHh---c-CC---------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 99999763211 1111110 0 00 0111123347799999999999999999999999999999
Q ss_pred cccccchh
Q 025011 241 KISHENYE 248 (259)
Q Consensus 241 ~~~~~~~~ 248 (259)
-.+.....
T Consensus 271 ~~~~~~~~ 278 (287)
T 1u59_A 271 YYSLASKV 278 (287)
T ss_dssp HHHHHTTC
T ss_pred HHhcCCcc
Confidence 77765543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=271.97 Aligned_cols=221 Identities=23% Similarity=0.312 Sum_probs=174.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcc-eEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVP-LLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++||||+++++++...+.. +++|||+.+++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 67 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ 144 (298)
T 3pls_A 67 EAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK 144 (298)
T ss_dssp HHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5688999999999999999999999876654 999999999999999976433 3577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc--ccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||+++....... ........++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 145 ---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 221 (298)
T 3pls_A 145 ---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221 (298)
T ss_dssp ---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred ---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHH
Confidence 99999999999999999999999999976544321 1122334578899999999988899999999999999999
Q ss_pred HhCCCC-CCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LTGLKP-GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++|..| |...... ....... .......+...++.+.+++.+||+.||.+|||+.++++.|+
T Consensus 222 ~~g~~~~~~~~~~~-----~~~~~~~-------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~ 283 (298)
T 3pls_A 222 LTRGAPPYRHIDPF-----DLTHFLA-------------QGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVE 283 (298)
T ss_dssp HHTSCCTTTTSCGG-----GHHHHHH-------------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhCCCCCCccCCHH-----HHHHHhh-------------cCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 996554 4442111 0111000 00011111123367999999999999999999999999999
Q ss_pred hccccccc
Q 025011 239 RLKISHEN 246 (259)
Q Consensus 239 ~~~~~~~~ 246 (259)
++......
T Consensus 284 ~~~~~l~~ 291 (298)
T 3pls_A 284 QIVSALLG 291 (298)
T ss_dssp HHHHHCCS
T ss_pred HHHHHHhc
Confidence 98766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=282.34 Aligned_cols=229 Identities=21% Similarity=0.244 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++....... +++..+..++.|++.||.|||+++
T Consensus 71 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~~LH~~~- 148 (389)
T 3gni_B 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG-MNELAIAYILQGVLKALDYIHHMG- 148 (389)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTC-CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccC-CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 568889999999999999999999999999999999999999999997753333 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-----cccccccCcccccCcchhcc--CCcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~i 155 (259)
|+|+||||+||+++.++.++|+|||.+......... .......++..|+|||++.+ ..++.++|||||||+
T Consensus 149 --ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 149 --YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp --EECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 999999999999999999999999987654332111 11223468899999999987 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhcc------------------chhhhhh---------ccccCCchhHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIEN------------------NSLRQIL---------NFQVADESEMEE 208 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~---------~~~~~~~~~~~~ 208 (259)
+|+|++|..||.+..................... ....... ............
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 9999999999987433211110000000000000 0000000 000000111223
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 209 IETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 209 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++.+.+||.+||+.||.+|||+.++++
T Consensus 307 s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 467999999999999999999999974
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=272.39 Aligned_cols=206 Identities=24% Similarity=0.265 Sum_probs=168.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++...+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 125 (337)
T 1o6l_A 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD- 125 (337)
T ss_dssp HHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578999999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 126 --ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 201 (337)
T 1o6l_A 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp --CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred --eecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcC
Confidence 9999999999999999999999999987543221 123345689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+.... .. ...... .... .+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 202 ~~Pf~~~~~~-----~~---~~~i~~---------~~~~--~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 202 RLPFYNQDHE-----RL---FELILM---------EEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCSSCCSSHH-----HH---HHHHHH---------CCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCHH-----HH---HHHHHc---------CCCC--CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 9999763211 00 110000 0000 0112346799999999999999999 8888864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=273.64 Aligned_cols=210 Identities=24% Similarity=0.376 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC---------------------------------------------------
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--------------------------------------------------- 31 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--------------------------------------------------- 31 (259)
+.+.+|++++++++||||+++++++.+..
T Consensus 49 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (332)
T 3qd2_B 49 EKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQ 128 (332)
T ss_dssp HHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------------------------------------
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccccccc
Confidence 56899999999999999999999986543
Q ss_pred ------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEE
Q 025011 32 ------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKV 105 (259)
Q Consensus 32 ------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l 105 (259)
..+++|||+++++|.+++.........++..++.++.|++.||.|||+++ ++|+||||+||+++.++.++|
T Consensus 129 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL 205 (332)
T 3qd2_B 129 PSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 205 (332)
T ss_dssp ---CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEE
T ss_pred CCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEE
Confidence 27999999999999999988766666677789999999999999999999 999999999999999999999
Q ss_pred eecCCcccccCCccc----------cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCcccccc
Q 025011 106 ADFGSSVLISSDNQT----------AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNE 175 (259)
Q Consensus 106 ~df~~~~~~~~~~~~----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~ 175 (259)
+|||+++........ .......|+..|+|||.+.+..++.++||||+|+++|+|++|..|+...
T Consensus 206 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------ 279 (332)
T 3qd2_B 206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------ 279 (332)
T ss_dssp CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------
T ss_pred eecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------
Confidence 999999876543211 1223446999999999999988999999999999999999987663220
Q ss_pred chhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..... . .............++.+.++|.+||+.||.+|||+.++++
T Consensus 280 ----~~~~~---------~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 280 ----VRIIT---------D-VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ----HHHHH---------H-HHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ----HHHHH---------H-hhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 00000 0 0011111222344567899999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=273.07 Aligned_cols=219 Identities=26% Similarity=0.390 Sum_probs=171.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE-eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.++++++||||+++++++. .++..+++|||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~ 148 (298)
T 3f66_A 71 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK 148 (298)
T ss_dssp HHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 56889999999999999999999854 55688999999999999999976433 2578899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 149 ---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 225 (298)
T 3f66_A 149 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225 (298)
T ss_dssp ---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ---ccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHH
Confidence 999999999999999999999999999866543211 122334577889999999988999999999999999999
Q ss_pred Hh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++ |.+||.+..... ..... ... .....+...++.+.+++.+||+.||.+|||+.++++.|+
T Consensus 226 ~~~~~~~~~~~~~~~-----~~~~~---~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~ 287 (298)
T 3f66_A 226 MTRGAPPYPDVNTFD-----ITVYL---LQG----------RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 287 (298)
T ss_dssp HTTSCCSSTTSCTTT-----HHHHH---HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhCCCCCCccCCHHH-----HHHHH---hcC----------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99 556666532211 00000 000 000011112367999999999999999999999999999
Q ss_pred hccccc
Q 025011 239 RLKISH 244 (259)
Q Consensus 239 ~~~~~~ 244 (259)
++....
T Consensus 288 ~~~~~~ 293 (298)
T 3f66_A 288 AIFSTF 293 (298)
T ss_dssp HHHHTS
T ss_pred HHHHhh
Confidence 986654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=270.99 Aligned_cols=208 Identities=21% Similarity=0.341 Sum_probs=170.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.|||+++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~- 161 (321)
T 2c30_A 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG- 161 (321)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56889999999999999999999999999999999999999999998753 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||++........ ......|+..|+|||++.+..++.++||||||+++|+|++|
T Consensus 162 --ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g 237 (321)
T 2c30_A 162 --VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237 (321)
T ss_dssp --EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876654321 22345699999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+.... ....... . .. .... ......++.+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~pf~~~~~~-----~~~~~~~---~-~~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 238 EPPYFSDSPV-----QAMKRLR---D-SP-----PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp SCTTTTSCHH-----HHHHHHH---H-SS-----CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCHH-----HHHHHHh---c-CC-----CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999763211 0000000 0 00 0000 011123467999999999999999999999976
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=276.64 Aligned_cols=209 Identities=22% Similarity=0.336 Sum_probs=168.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.|||+++
T Consensus 73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~- 148 (362)
T 2bdw_A 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG- 148 (362)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 468899999999999999999999999999999999999999999997653 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|+||||+||+++.++ .++|+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 149 --ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 223 (362)
T 2bdw_A 149 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223 (362)
T ss_dssp --CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred --eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 99999999999998654 59999999997665322 22345699999999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ........ ... ..........++.+.++|.+||+.||.+|||+.++++
T Consensus 224 l~g~~Pf~~~~~~-----~~~~~i~~----~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 224 LVGYPPFWDEDQH-----RLYAQIKA----GAY------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp HHSSCSSCCSSHH-----HHHHHHHH----TCC------CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCCCHH-----HHHHHHHh----CCC------CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999863211 11110000 000 0001111123467999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=274.43 Aligned_cols=220 Identities=27% Similarity=0.435 Sum_probs=170.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh--
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-- 79 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-- 79 (259)
++.+.+|++++++++||||+++++++. +..++||||+++++|.+++........++...++.++.|++.||.|||+
T Consensus 45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 122 (307)
T 2eva_A 45 RKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122 (307)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356899999999999999999999876 4589999999999999999877655557889999999999999999999
Q ss_pred -CCCCCeEeCCCCCCCeEeCCCCc-eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 80 -SASPPIIHGDVKSTNVLLDDNYK-AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 80 -~~~~~i~h~di~p~nil~~~~~~-~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
++ ++|+||||+||+++.++. ++|+|||++...... .....++..|+|||++.+..++.++||||||+++|
T Consensus 123 ~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 194 (307)
T 2eva_A 123 PKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194 (307)
T ss_dssp SSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHH
T ss_pred CCC---eecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHH
Confidence 67 999999999999988876 799999998754432 12335899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
+|++|+.||....... ......... .. ........++.+.+++.+||+.||.+|||+.++++.|
T Consensus 195 el~~g~~p~~~~~~~~------~~~~~~~~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L 258 (307)
T 2eva_A 195 EVITRRKPFDEIGGPA------FRIMWAVHN-GT---------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258 (307)
T ss_dssp HHHHTCCTTTTTCSSH------HHHHHHHHT-TC---------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHCCCCchhhCccH------HHHHHHHhc-CC---------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHH
Confidence 9999999997532110 000000000 00 0011112346799999999999999999999999999
Q ss_pred Hhccccccch
Q 025011 238 DRLKISHENY 247 (259)
Q Consensus 238 ~~~~~~~~~~ 247 (259)
+++.......
T Consensus 259 ~~~~~~~~~~ 268 (307)
T 2eva_A 259 THLMRYFPGA 268 (307)
T ss_dssp HHHGGGCCCT
T ss_pred HHHHHhccCC
Confidence 9987665443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=271.55 Aligned_cols=220 Identities=25% Similarity=0.385 Sum_probs=174.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++. ++..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||+++
T Consensus 53 ~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~- 129 (279)
T 1qpc_A 53 DAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN- 129 (279)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 57899999999999999999999986 4568999999999999999976432 13678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 130 --i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred --eeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765432 122233446778999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... .. ....... .....+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 207 g~~p~~~~~~~-----~~---~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 268 (279)
T 1qpc_A 207 GRIPYPGMTNP-----EV---IQNLERG----------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (279)
T ss_dssp TCCSSTTCCHH-----HH---HHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccCHH-----HH---HHHHhcc----------cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 89999763211 00 1100000 001111123467999999999999999999999999999986
Q ss_pred ccccc
Q 025011 242 ISHEN 246 (259)
Q Consensus 242 ~~~~~ 246 (259)
.....
T Consensus 269 ~~~~~ 273 (279)
T 1qpc_A 269 TATEG 273 (279)
T ss_dssp HHC--
T ss_pred HhccC
Confidence 65443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=267.68 Aligned_cols=211 Identities=25% Similarity=0.354 Sum_probs=170.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~- 125 (276)
T 2yex_A 50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHGIG- 125 (276)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5689999999999999999999999999999999999999999999975432 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||.+................++..|+|||.+.+..+ +.++||||||+++|+|++
T Consensus 126 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 126 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred --eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 99999999999999999999999999986654333333445568999999999987665 789999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+...... ....+.. ...........++.+.++|.+||+.||.+|||+.++++
T Consensus 204 g~~p~~~~~~~~~---~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 204 GELPWDQPSDSCQ---EYSDWKE-------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SSCCCSCSCTTSH---HHHHHHT-------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCchHHH---HHHHhhh-------------cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 9999986432111 0001000 00000011123467899999999999999999999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=271.74 Aligned_cols=221 Identities=26% Similarity=0.441 Sum_probs=163.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||++++++. .....++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 65 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~- 140 (289)
T 3og7_A 65 QAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS- 140 (289)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5689999999999999999999965 55678999999999999999965533 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||++................++..|+|||.+. +..++.++||||||+++|+|
T Consensus 141 --i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el 218 (289)
T 3og7_A 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYEL 218 (289)
T ss_dssp --CCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHH
T ss_pred --cccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHH
Confidence 9999999999999999999999999987655432233334456899999999986 55688899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||.+..... ................ ......++.+.+++.+||+.||.+|||+.++++.|++
T Consensus 219 ~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~ 285 (289)
T 3og7_A 219 MTGQLPYSNINNRD----QIIEMVGRGSLSPDLS---------KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEE 285 (289)
T ss_dssp HHSSCTTSSCCCHH----HHHHHHHHTSCCCCTT---------SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHCCCCccccchHH----HHHHHhcccccCcchh---------hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence 99999997632211 1111111100000000 0111234779999999999999999999999999998
Q ss_pred ccc
Q 025011 240 LKI 242 (259)
Q Consensus 240 ~~~ 242 (259)
+..
T Consensus 286 l~~ 288 (289)
T 3og7_A 286 LAR 288 (289)
T ss_dssp TTC
T ss_pred Hhh
Confidence 764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=272.35 Aligned_cols=218 Identities=20% Similarity=0.278 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+ +..+++|||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 58 ~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 133 (281)
T 3cc6_A 58 EKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN- 133 (281)
T ss_dssp HHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 568899999999999999999999865 456999999999999999976543 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 134 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~ 210 (281)
T 3cc6_A 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSF 210 (281)
T ss_dssp --CCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --cccCCCccceEEECCCCcEEeCccCCCccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhC
Confidence 9999999999999999999999999987654422 112233456788999999988889999999999999999998
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||....... ........ . ....+...++.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 211 g~~p~~~~~~~~-----~~~~~~~~---~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 211 GKQPFFWLENKD-----VIGVLEKG---D----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TCCTTTTSCGGG-----HHHHHHHT---C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCcccCChHH-----HHHHHhcC---C----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 999997532211 11111000 0 00011123367999999999999999999999999999886
Q ss_pred cccc
Q 025011 242 ISHE 245 (259)
Q Consensus 242 ~~~~ 245 (259)
....
T Consensus 273 ~~~~ 276 (281)
T 3cc6_A 273 QMEK 276 (281)
T ss_dssp HHHH
T ss_pred Hhhh
Confidence 6543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=290.96 Aligned_cols=219 Identities=27% Similarity=0.408 Sum_probs=171.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++||||+++++++.. +..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++
T Consensus 224 ~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~- 300 (452)
T 1fmk_A 224 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN- 300 (452)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 578999999999999999999999876 678999999999999999975422 22678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 301 --ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~ 377 (452)
T 1fmk_A 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 377 (452)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --eeCCCCChhhEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhC
Confidence 9999999999999999999999999998654321 112223346778999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... +....... ......+...++.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus 378 g~~P~~~~~~~--------~~~~~i~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 378 GRVPYPGMVNR--------EVLDQVER----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp TCCSSTTCCHH--------HHHHHHHT----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCHH--------HHHHHHHc----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 99999873211 01111110 0011111234477999999999999999999999999999987
Q ss_pred cccc
Q 025011 242 ISHE 245 (259)
Q Consensus 242 ~~~~ 245 (259)
.+..
T Consensus 440 ~~~~ 443 (452)
T 1fmk_A 440 TSTE 443 (452)
T ss_dssp SCSC
T ss_pred ccCC
Confidence 5543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=271.85 Aligned_cols=224 Identities=17% Similarity=0.147 Sum_probs=176.7
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+ +++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 49 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 49 PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4588999999999 9999999999999999999999999 9999999986522 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCc-----eEEeecCCcccccCCcccc-----ccccccCcccccCcchhccCCcccccchhh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYK-----AKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
++|+||||+||+++.++. ++|+|||+++......... ......||..|+|||++.+..++.++||||
T Consensus 126 ---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 202 (330)
T 2izr_A 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA 202 (330)
T ss_dssp ---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred ---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence 999999999999998887 9999999998765432211 123457999999999999988999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||+++|+|++|..||.+...... ................... .... +.+.+++..||+.||.+|||+.
T Consensus 203 lG~il~ell~g~~Pf~~~~~~~~--~~~~~~i~~~~~~~~~~~~---------~~~~-p~~~~li~~~l~~~p~~RP~~~ 270 (330)
T 2izr_A 203 LGHMFMYFLRGSLPWQGLKADTL--KERYQKIGDTKRATPIEVL---------CENF-PEMATYLRYVRRLDFFEKPDYD 270 (330)
T ss_dssp HHHHHHHHHHSSCTTTTCCCSSH--HHHHHHHHHHHHHSCHHHH---------TTTC-HHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHHhcCCCCccccccccH--HHHHHHHHhhhccCCHHHH---------hccC-hHHHHHHHHHHhCCCCCCCCHH
Confidence 99999999999999987432110 0000000000000000000 0011 3799999999999999999999
Q ss_pred HHHHHHHhccccc
Q 025011 232 QVSEELDRLKISH 244 (259)
Q Consensus 232 ~il~~l~~~~~~~ 244 (259)
+|.+.|+++....
T Consensus 271 ~l~~~l~~~~~~~ 283 (330)
T 2izr_A 271 YLRKLFTDLFDRK 283 (330)
T ss_dssp HHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHc
Confidence 9999998876543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=269.60 Aligned_cols=229 Identities=18% Similarity=0.199 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~- 154 (309)
T 2h34_A 79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAAG- 154 (309)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCc-
Confidence 5688999999999999999999999999999999999999999999986543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 155 --i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 155 --ATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp --CCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred --CCcCCCChHHEEEcCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 9999999999999999999999999987654331 1222345689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHHhcc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-TMKQVSEELDRLK 241 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~l~~~~ 241 (259)
..||.+.... ...... ....... .......++.+.++|.+||+.||.+|| |++++++.|++..
T Consensus 232 ~~pf~~~~~~-----~~~~~~---~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 232 SPPYQGDQLS-----VMGAHI---NQAIPRP--------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp SCSSCSCHHH-----HHHHHH---HSCCCCG--------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred CCCCCCchHH-----HHHHHh---ccCCCCc--------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 9999863211 000000 0000000 001112336699999999999999999 9999999999987
Q ss_pred ccccchhhhhhhh
Q 025011 242 ISHENYEHRRTEK 254 (259)
Q Consensus 242 ~~~~~~~~~~~~~ 254 (259)
........+...+
T Consensus 296 ~~~~~~~~~~~~~ 308 (309)
T 2h34_A 296 ATADQDRATDILR 308 (309)
T ss_dssp C------------
T ss_pred Hhhcccchhhhhh
Confidence 7776655554443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-42 Score=277.34 Aligned_cols=204 Identities=23% Similarity=0.337 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++...+..++||||+ +|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 54 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g- 128 (336)
T 3h4j_B 54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---MTEDEGRRFFQQIICAIEYCHRHK- 128 (336)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 56899999999999999999999999999999999999 7799998876543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus 129 --ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 203 (336)
T 3h4j_B 129 --IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203 (336)
T ss_dssp --CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH
T ss_pred --eEecCCchhhEEEcCCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh
Confidence 9999999999999999999999999987654332 2234569999999999988775 689999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+...... ...+..... ..+...++.+.++|.+||+.||.+|||+.++++
T Consensus 204 g~~Pf~~~~~~~~-----------------~~~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 204 GRLPFDDEFIPNL-----------------FKKVNSCVY--VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp SSCSSBCSSSTTC-----------------BCCCCSSCC--CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCccHHHH-----------------HHHHHcCCC--CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 9999976321110 000000000 011123467899999999999999999999965
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=275.08 Aligned_cols=228 Identities=25% Similarity=0.386 Sum_probs=175.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++... +..+++|||+++++|.+++..... .+++..++.++.|++.||.|||++
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcC
Confidence 5689999999999999999999999876 668999999999999999965533 267899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 146 ~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp T---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred C---cccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543322 223345678889999999998899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHh---hccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYS---IENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
++|..|+...... ........ ..................+...++.+.+++.+||+.||.+|||+.++++.
T Consensus 223 ~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 296 (302)
T 4e5w_A 223 LTYCDSDSSPMAL------FLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296 (302)
T ss_dssp HTTTCGGGSHHHH------HHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHccCCCcchhhH------HhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 9999886541100 00000000 00000111111111111222344779999999999999999999999999
Q ss_pred HHhcc
Q 025011 237 LDRLK 241 (259)
Q Consensus 237 l~~~~ 241 (259)
|+++-
T Consensus 297 L~~ll 301 (302)
T 4e5w_A 297 FEALL 301 (302)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 98763
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=272.51 Aligned_cols=207 Identities=20% Similarity=0.294 Sum_probs=164.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++.. ++..++||||+++++|.+++... .+++..++.++.|++.||.|||++
T Consensus 81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~ 156 (298)
T 2zv2_A 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ 156 (298)
T ss_dssp CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 468899999999999999999999986 56789999999999998876432 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC---cccccchhhHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK---LTEKSDVYSFGVLLA 157 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~ 157 (259)
+ ++|+||||+||+++.++.++|+|||++........ ......+++.|+|||.+.+.. ++.++||||||+++|
T Consensus 157 ~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~ 231 (298)
T 2zv2_A 157 K---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLY 231 (298)
T ss_dssp T---EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHH
T ss_pred C---eeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHH
Confidence 9 99999999999999999999999999987654321 223456999999999987654 377899999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+.... . ....... ...........++.+.++|.+||+.||.+|||+.++++
T Consensus 232 ~l~~g~~pf~~~~~~-----~---~~~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 232 CFVFGQCPFMDERIM-----C---LHSKIKS---------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHSSCSSCCSSHH-----H---HHHHHHH---------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHCCCCCCCccHH-----H---HHHHHhc---------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 999999999763211 0 0000000 00000111123367999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=281.88 Aligned_cols=220 Identities=25% Similarity=0.385 Sum_probs=165.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE-eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL-ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.|.+|+.++++++||||+++++++. .++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 135 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ 212 (373)
T 3c1x_A 135 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK 212 (373)
T ss_dssp HHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56889999999999999999999865 45678999999999999999976543 2477899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|+|
T Consensus 213 ---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 213 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp ---CCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ---EecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999999765432211 112233567889999999998999999999999999999
Q ss_pred Hh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
++ |.+||.+..... ..... .... ....+...++.+.+++.+||+.||.+|||+.++++.|+
T Consensus 290 lt~~~~p~~~~~~~~-----~~~~~---~~~~----------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~ 351 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFD-----ITVYL---LQGR----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 351 (373)
T ss_dssp HTTSCCSCTTSCSSC-----HHHHH---HTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HhCcCCCCCCCCHHH-----HHHHH---HcCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99 677887632211 00000 0000 00011123467999999999999999999999999999
Q ss_pred hcccccc
Q 025011 239 RLKISHE 245 (259)
Q Consensus 239 ~~~~~~~ 245 (259)
++..+..
T Consensus 352 ~i~~~~~ 358 (373)
T 3c1x_A 352 AIFSTFI 358 (373)
T ss_dssp HHHHTCC
T ss_pred HHHHhcc
Confidence 9876544
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=276.49 Aligned_cols=230 Identities=17% Similarity=0.160 Sum_probs=176.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+..++.++||||+++++++.. +...++||||+ +++|.+++.... .+++..++.++.|++.||.|||
T Consensus 93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH 168 (345)
T 2v62_A 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIH 168 (345)
T ss_dssp HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH
Confidence 346788899999999999999999988 67899999999 999999997654 3688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC--ceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhh
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY--KAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
+++ ++|+||||+||+++.++ .++|+|||+++........ .......++..|+|||++.+..++.++||||
T Consensus 169 ~~~---ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 245 (345)
T 2v62_A 169 ENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEI 245 (345)
T ss_dssp HTT---EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHH
T ss_pred hCC---eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHH
Confidence 999 99999999999998877 9999999999876533211 1113446999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||+++|+|++|..||.+...... .... ....... ........... ....++.+.+++.+||+.||.+|||+.
T Consensus 246 lG~il~ell~g~~pf~~~~~~~~---~~~~-~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ 317 (345)
T 2v62_A 246 LGYCMLRWLCGKLPWEQNLKDPV---AVQT-AKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQ 317 (345)
T ss_dssp HHHHHHHHHHSSCTTGGGTTCHH---HHHH-HHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred HHHHHHHHHhCCCCccccccccH---HHHH-HHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHH
Confidence 99999999999999965211110 0000 0000000 00000000000 002336799999999999999999999
Q ss_pred HHHHHHHhccccccch
Q 025011 232 QVSEELDRLKISHENY 247 (259)
Q Consensus 232 ~il~~l~~~~~~~~~~ 247 (259)
+|++.|+++.......
T Consensus 318 ~l~~~L~~~~~~~~~~ 333 (345)
T 2v62_A 318 ALKKILNPHGIPLGPL 333 (345)
T ss_dssp HHHHHHCTTCCCCCCC
T ss_pred HHHHHHhccCCcccCC
Confidence 9999999988755444
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=277.66 Aligned_cols=210 Identities=25% Similarity=0.268 Sum_probs=165.5
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|..++.++ +||||+++++++.+.+..++||||+++|+|.+++..... +++..+..++.||+.||.|||+++
T Consensus 97 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~g 173 (396)
T 4dc2_A 97 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG 173 (396)
T ss_dssp CHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3478899999887 899999999999999999999999999999999986543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 174 ---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~ 248 (396)
T 4dc2_A 174 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 248 (396)
T ss_dssp ---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---EEeccCCHHHEEECCCCCEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHh
Confidence 999999999999999999999999998753322 122345579999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||................... .+....... +...++.+.++|.+||+.||.+||++
T Consensus 249 G~~Pf~~~~~~~~~~~~~~~~~~~--------~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 249 GRSPFDIVGSSDNPDQNTEDYLFQ--------VILEKQIRI--PRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp SSCSSTTTTC------CCHHHHHH--------HHHHCCCCC--CTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred CCCCCcccccccccchhhHHHHHH--------HHhccccCC--CCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 999997533221111110111110 011111111 11234679999999999999999997
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=278.73 Aligned_cols=212 Identities=22% Similarity=0.293 Sum_probs=159.8
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 60 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~ 136 (361)
T 3uc3_A 60 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEARFFFQQLLSGVSYCHSMQ 136 (361)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35688999999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCc--eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc-cchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYK--AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK-SDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~~ 158 (259)
++||||||+||+++.++. ++|+|||+++..... .......|++.|+|||++.+..++.+ +||||+|+++|+
T Consensus 137 ---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 137 ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp ---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHH
T ss_pred ---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHH
Confidence 999999999999987765 999999998743322 12233469999999999988777555 899999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|+.||.+....... ...... +.............++.+.+||.+||..||.+|||+.++++
T Consensus 211 ll~g~~Pf~~~~~~~~~----~~~~~~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDY----RKTIQR---------ILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp HHHSSCSCC----CCCH----HHHHHH---------HHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhCCCCCCCCccHHHH----HHHHHH---------HhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 99999999874322111 111111 11111111111123367999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=267.55 Aligned_cols=226 Identities=15% Similarity=0.150 Sum_probs=178.7
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.+ +|+|++++++++..+...+++|||+ +++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 50 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ 126 (298)
T 1csn_A 50 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS 126 (298)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4588999999999 7999999999999999999999999 9999999986533 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCc-----eEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYK-----AKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
++|+||||+||+++.++. ++|+|||+++........ .......|+..|+|||.+.+..++.++||||
T Consensus 127 ---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 203 (298)
T 1csn_A 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 203 (298)
T ss_dssp ---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred ---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH
Confidence 999999999999987766 999999999876543221 1233456999999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||+++|+|++|..||.+....... .................. ....++.+.+++.+||+.||.+|||++
T Consensus 204 lG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~RP~~~ 272 (298)
T 1csn_A 204 LGHVFMYFLRGSLPWQGLKAATNK--QKYERIGEKKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYD 272 (298)
T ss_dssp HHHHHHHHHHSSCTTSSCCSCCHH--HHHHHHHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred HHHHHHHHHcCCCCcchhhccccH--HHHHHHHhhccCccHHHH---------HhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence 999999999999999874322111 000101000000000000 011236799999999999999999999
Q ss_pred HHHHHHHhcccccc
Q 025011 232 QVSEELDRLKISHE 245 (259)
Q Consensus 232 ~il~~l~~~~~~~~ 245 (259)
+|++.|+++.....
T Consensus 273 ~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 273 YLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999876544
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=277.24 Aligned_cols=222 Identities=24% Similarity=0.375 Sum_probs=177.3
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCC-cceEEEEecCCCChhhhhhccCCc-------------ccCCHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQ-------------VLRNWKTCLRIA 67 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~-------------~~~~~~~~~~i~ 67 (259)
+.+.+|+++++++ +||||+++++++...+ ..+++|||+++++|.+++...... ..+++..++.++
T Consensus 75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (316)
T 2xir_A 75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154 (316)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHH
T ss_pred HHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHH
Confidence 4688999999999 7899999999988754 589999999999999999875431 125788999999
Q ss_pred HHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCccccc
Q 025011 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS 147 (259)
Q Consensus 68 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 147 (259)
.|++.||.|||+++ ++|+||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++
T Consensus 155 ~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~ 231 (316)
T 2xir_A 155 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 231 (316)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCC---cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchh
Confidence 99999999999999 999999999999999999999999999876544333334445678899999999988899999
Q ss_pred chhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 148 DVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 148 DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
||||||+++|+|++ |..||.+..... ........ .. ....+...++.+.+++.+||+.||.+
T Consensus 232 Di~slG~il~~l~t~g~~p~~~~~~~~----~~~~~~~~----~~---------~~~~~~~~~~~l~~li~~~l~~dp~~ 294 (316)
T 2xir_A 232 DVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLKE----GT---------RMRAPDYTTPEMYQTMLDCWHGEPSQ 294 (316)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSH----HHHHHHHH----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred HHHHHHHHHHHHHhCCCCCCcccchhH----HHHHHhcc----Cc---------cCCCCCCCCHHHHHHHHHHcCCChhh
Confidence 99999999999998 999997633211 00010000 00 00011112367999999999999999
Q ss_pred CCCHHHHHHHHHhccccc
Q 025011 227 RPTMKQVSEELDRLKISH 244 (259)
Q Consensus 227 Rpt~~~il~~l~~~~~~~ 244 (259)
|||+.++++.|+++....
T Consensus 295 Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 295 RPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp SCCHHHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHhhh
Confidence 999999999999887543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=268.71 Aligned_cols=214 Identities=21% Similarity=0.332 Sum_probs=170.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+.++++++||||+++++++... +..+++|||+++++|.+++...... .+++..++.++.|++.||.|||++
T Consensus 52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~ 130 (271)
T 3kmu_A 52 RDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF-VVDQSQAVKFALDMARGMAFLHTL 130 (271)
T ss_dssp HHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSC-CCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred HHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccC-CCCHHHHHHHHHHHHHHHHHHhcC
Confidence 4689999999999999999999999876 7889999999999999999875432 368899999999999999999986
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCccc---ccchhhHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTE---KSDVYSFGVLLA 157 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~ 157 (259)
+ .+++|+||+|+||+++.++.+++.||++...... ....+++.|+|||.+.+..++. ++||||||+++|
T Consensus 131 ~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 202 (271)
T 3kmu_A 131 E-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLW 202 (271)
T ss_dssp S-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHH
T ss_pred C-CceecCCCccceEEEcCCcceeEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHH
Confidence 5 3489999999999999999999998887643221 2345889999999998765544 799999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
+|++|..||.+..... ...... ........+...++.+.+++.+||+.||.+|||+.++++.|
T Consensus 203 el~~g~~p~~~~~~~~--------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L 265 (271)
T 3kmu_A 203 ELVTREVPFADLSNME--------IGMKVA---------LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265 (271)
T ss_dssp HHHHCSCTTTTSCHHH--------HHHHHH---------HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHhCCCCccccChHH--------HHHHHH---------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9999999998632111 000000 00111111122346799999999999999999999999999
Q ss_pred Hhccc
Q 025011 238 DRLKI 242 (259)
Q Consensus 238 ~~~~~ 242 (259)
+++..
T Consensus 266 ~~l~~ 270 (271)
T 3kmu_A 266 EKMQD 270 (271)
T ss_dssp HHHCC
T ss_pred HHhhc
Confidence 98864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=277.53 Aligned_cols=223 Identities=22% Similarity=0.332 Sum_probs=176.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC----cccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS----QVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||
T Consensus 78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH 157 (327)
T 2yfx_A 78 LDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157 (327)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence 4688999999999999999999999999999999999999999999976532 133678899999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
+++ ++|+||+|+||+++. +..++|+|||++................++..|+|||.+.+..++.++||||||++
T Consensus 158 ~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 234 (327)
T 2yfx_A 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234 (327)
T ss_dssp HTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred hCC---eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHH
Confidence 999 999999999999984 44699999999876544333333344567889999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++ |..||.+.... . ......... ....+...++.+.++|.+||+.||.+|||+.+++
T Consensus 235 l~ellt~g~~p~~~~~~~-----~---~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 296 (327)
T 2yfx_A 235 LWEIFSLGYMPYPSKSNQ-----E---VLEFVTSGG----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296 (327)
T ss_dssp HHHHHTTSCCSSTTCCHH-----H---HHHHHHTTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCCCCCCCcCHH-----H---HHHHHhcCC----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHH
Confidence 999998 89998763211 0 011111000 0011112346799999999999999999999999
Q ss_pred HHHHhccccccc
Q 025011 235 EELDRLKISHEN 246 (259)
Q Consensus 235 ~~l~~~~~~~~~ 246 (259)
+.++.+......
T Consensus 297 ~~l~~~~~~~~~ 308 (327)
T 2yfx_A 297 ERIEYCTQDPDV 308 (327)
T ss_dssp HHHHHHHHCHHH
T ss_pred HHHHHHhcCHHH
Confidence 999988765543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=267.92 Aligned_cols=202 Identities=27% Similarity=0.351 Sum_probs=167.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|..+++.++||||+++++++.+.+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 126 (318)
T 1fot_A 51 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD- 126 (318)
T ss_dssp HHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578899999999999999999999999999999999999999999986543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 127 --ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 199 (318)
T 1fot_A 127 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199 (318)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred --ccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC
Confidence 999999999999999999999999999765432 2345689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il 234 (259)
..||.+.... ..... +....... +...++.+.++|.+||..||.+|| ++++++
T Consensus 200 ~~pf~~~~~~--------~~~~~---------i~~~~~~~--p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~ 257 (318)
T 1fot_A 200 YTPFYDSNTM--------KTYEK---------ILNAELRF--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 257 (318)
T ss_dssp SCTTCCSSHH--------HHHHH---------HHHCCCCC--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred CCCCCCCCHH--------HHHHH---------HHhCCCCC--CCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence 9999763211 00111 11111100 112336799999999999999999 888886
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=271.24 Aligned_cols=216 Identities=27% Similarity=0.408 Sum_probs=167.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.+.+|++++++++||||+++++++.. ++..+++|||+++++|.+++..... ..+++..++.++.|++.||.|||++
T Consensus 58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 58 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999999999998754 4578999999999999999976532 2257788999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 137 ~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 208 (278)
T 1byg_A 137 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208 (278)
T ss_dssp T---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred C---ccccCCCcceEEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHH
Confidence 9 999999999999999999999999998754432 12234678899999998888999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |..||....... ....... ......+...++.+.++|.+||+.||.+|||+.++++.|++
T Consensus 209 t~g~~p~~~~~~~~--------~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~ 270 (278)
T 1byg_A 209 SFGRVPYPRIPLKD--------VVPRVEK----------GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 270 (278)
T ss_dssp TTSCCSCTTSCGGG--------HHHHHTT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHH--------HHHHHhc----------CCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence 8 999998632110 0000000 00111112234779999999999999999999999999999
Q ss_pred ccccc
Q 025011 240 LKISH 244 (259)
Q Consensus 240 ~~~~~ 244 (259)
+....
T Consensus 271 i~~~~ 275 (278)
T 1byg_A 271 IKTHE 275 (278)
T ss_dssp HHHHC
T ss_pred HHhhh
Confidence 86543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=278.08 Aligned_cols=215 Identities=25% Similarity=0.296 Sum_probs=171.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++...+..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 131 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~- 207 (373)
T 2x4f_A 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESY--NLTELDTILFMKQICEGIRHMHQMY- 207 (373)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999998865432 3678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEe--CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLL--DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~--~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||||+||++ +.++.++|+|||+++...... ......|++.|+|||++.+..++.++||||||+++|+|+
T Consensus 208 --ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 282 (373)
T 2x4f_A 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282 (373)
T ss_dssp --EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHH
T ss_pred --cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHH
Confidence 9999999999999 667889999999998765432 223346999999999998888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE--ELD 238 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~--~l~ 238 (259)
+|..||.+.... ........ ... ..........++.+.++|.+||+.||.+|||+.++++ .+.
T Consensus 283 tg~~pf~~~~~~----~~~~~i~~----~~~-------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~ 347 (373)
T 2x4f_A 283 SGLSPFLGDNDA----ETLNNILA----CRW-------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLS 347 (373)
T ss_dssp HSSCTTCCSSHH----HHHHHHHH----TCC-------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred hCCCCCCCCCHH----HHHHHHHh----ccC-------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcC
Confidence 999999873211 00000000 000 0001111123477999999999999999999999986 454
Q ss_pred hc
Q 025011 239 RL 240 (259)
Q Consensus 239 ~~ 240 (259)
+.
T Consensus 348 ~~ 349 (373)
T 2x4f_A 348 DH 349 (373)
T ss_dssp CH
T ss_pred CC
Confidence 43
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=270.02 Aligned_cols=221 Identities=18% Similarity=0.231 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++ +|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 64 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~- 139 (311)
T 3niz_A 64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR- 139 (311)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999975 88888876543 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++...... .......++..|+|||++.+ ..++.++||||+|+++|+|++
T Consensus 140 --ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 215 (311)
T 3niz_A 140 --ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215 (311)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred --cccCCCchHhEEECCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence 9999999999999999999999999998765322 22234468999999999876 458999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh--ccchhhh------hhccc---cCC----chhHHHHHHHHHHHHHhcccCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI--ENNSLRQ------ILNFQ---VAD----ESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~---~~~----~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
|..||.+...... ......... ....+.. +.... ... ......++.+.+||.+||+.||.+
T Consensus 216 g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 216 GKPLFPGVTDDDQ----LPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp SSCSCCCSSTTTH----HHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred CCCCCCCCChHHH----HHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 9999987433211 111111000 0000000 00000 000 000112367899999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
|||++++++
T Consensus 292 Rpt~~ell~ 300 (311)
T 3niz_A 292 RISARDAMN 300 (311)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=273.33 Aligned_cols=217 Identities=24% Similarity=0.356 Sum_probs=168.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|++++++++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~ 133 (289)
T 4fvq_A 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT 133 (289)
T ss_dssp HHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 35689999999999999999999999999999999999999999999976543 2578899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCc--------eEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYK--------AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSF 152 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~--------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diwsl 152 (259)
++|+||||+||+++.++. ++|+|||++...... ....++..|+|||.+.+ ..++.++||||+
T Consensus 134 ---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl 204 (289)
T 4fvq_A 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSF 204 (289)
T ss_dssp ---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHH
T ss_pred ---eECCCcCcceEEEecCCcccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHH
Confidence 999999999999998877 999999998654322 12347788999999987 568999999999
Q ss_pred HHHHHHHHhCC-CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 153 GVLLAELLTGL-KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 153 G~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
|+++|+|++|. +||...... . .......... ... ..++.+.+++.+||+.||.+|||+.
T Consensus 205 G~il~el~~g~~~~~~~~~~~-----~---~~~~~~~~~~--------~~~----~~~~~l~~li~~~l~~dp~~Rps~~ 264 (289)
T 4fvq_A 205 GTTLWEICSGGDKPLSALDSQ-----R---KLQFYEDRHQ--------LPA----PKAAELANLINNCMDYEPDHRPSFR 264 (289)
T ss_dssp HHHHHHHHTTTCCTTTTSCHH-----H---HHHHHHTTCC--------CCC----CSSCTTHHHHHHHSCSSGGGSCCHH
T ss_pred HHHHHHHHcCCCCCccccchH-----H---HHHHhhccCC--------CCC----CCCHHHHHHHHHHcCCChhHCcCHH
Confidence 99999999965 554442110 0 0000000000 000 1124588999999999999999999
Q ss_pred HHHHHHHhccccccchhh
Q 025011 232 QVSEELDRLKISHENYEH 249 (259)
Q Consensus 232 ~il~~l~~~~~~~~~~~~ 249 (259)
++++.|+++..+......
T Consensus 265 ~ll~~l~~l~~p~~~~~~ 282 (289)
T 4fvq_A 265 AIIRDLNSLFTPDLVPRG 282 (289)
T ss_dssp HHHHHHHTCC--------
T ss_pred HHHHHHHHhcCCCCCCCC
Confidence 999999999887665543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=277.05 Aligned_cols=238 Identities=22% Similarity=0.303 Sum_probs=176.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE--eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL--ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|++++++++||||+++++++. ..+..++||||+++++|.+++..... .+++..++.++.|++.||.|||++
T Consensus 69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~ 146 (327)
T 3lxl_A 69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSR 146 (327)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46899999999999999999999886 45668999999999999999976432 268899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|
T Consensus 147 ~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 223 (327)
T 3lxl_A 147 R---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223 (327)
T ss_dssp T---EECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred C---ccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHH
Confidence 9 999999999999999999999999999876543222 123344578889999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||.......... .........................+...++.+.+++.+||+.||.+|||+.++++.|+.
T Consensus 224 l~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 300 (327)
T 3lxl_A 224 FTYCDKSCSPSAEFLRM---MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDM 300 (327)
T ss_dssp HTTTCGGGSHHHHHHHH---CC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HhCCCCCccccchhhhh---cccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 99999987522110000 000000000001111111111112222345779999999999999999999999999999
Q ss_pred ccccccchh
Q 025011 240 LKISHENYE 248 (259)
Q Consensus 240 ~~~~~~~~~ 248 (259)
+........
T Consensus 301 ~~~~~~~~~ 309 (327)
T 3lxl_A 301 LWSGSRGCE 309 (327)
T ss_dssp C--------
T ss_pred HHhhhcCcc
Confidence 987665543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=267.83 Aligned_cols=225 Identities=21% Similarity=0.312 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhc--CCCccccccceeEEeC----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQ--INHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~--l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+..|.+++.. ++||||+++++++... ...++||||+++|+|.++++.. .+++..++.++.|++.||.|
T Consensus 45 ~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~ 120 (301)
T 3q4u_A 45 KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAH 120 (301)
T ss_dssp HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHH
Confidence 345667777777 7999999999987643 4579999999999999999654 26789999999999999999
Q ss_pred Hh--------hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccC-----
Q 025011 77 LH--------SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITG----- 141 (259)
Q Consensus 77 lh--------~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----- 141 (259)
|| +.+ ++|+||||+||+++.++.++|+|||+++......... ......|+..|+|||.+.+.
T Consensus 121 lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (301)
T 3q4u_A 121 LHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDC 197 (301)
T ss_dssp HHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred HHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCc
Confidence 99 888 9999999999999999999999999997655432221 12334699999999999876
Q ss_pred -CcccccchhhHHHHHHHHHhC----------CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHH
Q 025011 142 -KLTEKSDVYSFGVLLAELLTG----------LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIE 210 (259)
Q Consensus 142 -~~~~~~DiwslG~il~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (259)
.++.++||||+|+++|+|++| ..||................ ........... ........++
T Consensus 198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~~~~~~~~ 270 (301)
T 3q4u_A 198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKV---VCVDQQRPNIP----NRWFSDPTLT 270 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH---HTTSCCCCCCC----GGGGGSHHHH
T ss_pred ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHH---HhccCCCCCCC----hhhccCccHH
Confidence 456799999999999999999 77776532222111111111 10000000000 0011224567
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
.+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 271 ~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 271 SLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 8999999999999999999999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-41 Score=274.86 Aligned_cols=210 Identities=20% Similarity=0.318 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 93 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g- 169 (387)
T 1kob_A 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS- 169 (387)
T ss_dssp HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999976532 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC--CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD--NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~--~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||||+||+++. ++.++|+|||+++...... ......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 170 --ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 170 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp --EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred --eeecccchHHeEEecCCCCceEEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 999999999999974 5679999999998765432 122346899999999999888999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||.+.... . ......... ...........++.+.++|.+||..||.+|||+.++++
T Consensus 245 tg~~Pf~~~~~~-----~---~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 245 SGLSPFAGEDDL-----E---TLQNVKRCD-------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp HSCCSSCCSSHH-----H---HHHHHHHCC-------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHH-----H---HHHHHHhCC-------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 999999873211 0 000000000 00001111123467999999999999999999999976
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=273.21 Aligned_cols=208 Identities=23% Similarity=0.285 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+.+..++||||+.+|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 60 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~g- 135 (384)
T 4fr4_A 60 RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH---FKEETVKLFICELVMALDYLQNQR- 135 (384)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999999999999986543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc---CCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l 159 (259)
|+|+||||+||+++.++.++|+|||++...... .......||+.|+|||++.. ..++.++|||||||++|+|
T Consensus 136 --ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~el 210 (384)
T 4fr4_A 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210 (384)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHH
T ss_pred --ceeccCcHHHeEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHH
Confidence 999999999999999999999999999865432 22344569999999999864 3488999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-MKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-~~~il~ 235 (259)
++|..||........ ......... ... ..+...++.+.++|.+||+.||.+||+ ++++++
T Consensus 211 ltG~~Pf~~~~~~~~-----~~~~~~~~~---------~~~--~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 211 LRGRRPYHIRSSTSS-----KEIVHTFET---------TVV--TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp HHSSCSSCCCTTSCH-----HHHHHHHHH---------CCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred HhCCCCCCCCCCccH-----HHHHHHHhh---------ccc--CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 999999976322110 000000000 000 011123367999999999999999998 666653
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=274.38 Aligned_cols=201 Identities=28% Similarity=0.287 Sum_probs=161.7
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|..+++.+ +||||+++++++.+.+..|+||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 68 ~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g 144 (353)
T 3txo_A 68 ECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FDEARARFYAAEIISALMFLHDKG 144 (353)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4577899999988 799999999999999999999999999999999977543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 145 ---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 219 (353)
T 3txo_A 145 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219 (353)
T ss_dssp ---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH
T ss_pred ---CcccCCCHHHEEECCCCCEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh
Confidence 999999999999999999999999998754322 122344579999999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||.+.... ..... +....... +...++.+.++|.+||+.||.+||++
T Consensus 220 G~~Pf~~~~~~--------~~~~~---------i~~~~~~~--p~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 220 GHAPFEAENED--------DLFEA---------ILNDEVVY--PTWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp SSCSSCCSSHH--------HHHHH---------HHHCCCCC--CTTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred CCCCCCCCCHH--------HHHHH---------HHcCCCCC--CCCCCHHHHHHHHHHhhhCHHHccCC
Confidence 99999873211 01111 11111111 11133679999999999999999998
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=264.23 Aligned_cols=206 Identities=24% Similarity=0.327 Sum_probs=167.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~~i~~~l~~lH~~~- 126 (277)
T 3f3z_A 51 DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDAARIMKDVLSAVAYCHKLN- 126 (277)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5789999999999999999999999999999999999999999999876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||++ +.++.++|+|||++....... ......+++.|+|||.+.+. ++.++||||+|+++|+|
T Consensus 127 --i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l 200 (277)
T 3f3z_A 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVL 200 (277)
T ss_dssp --EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHH
T ss_pred --ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHH
Confidence 9999999999999 788899999999987655332 22344689999999998654 89999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... . .... +........ .....++.+.++|.+||+.||.+|||+.++++
T Consensus 201 ~~g~~p~~~~~~~-----~---~~~~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 201 LCGYPPFSAPTDS-----E---VMLK---------IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHSSCSSCCSSHH-----H---HHHH---------HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHCCCCCCCCCHH-----H---HHHH---------HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 9999999863211 0 0000 000000000 01123477999999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=270.22 Aligned_cols=210 Identities=24% Similarity=0.328 Sum_probs=169.7
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~~ 135 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---LSEEEATSFIKQILDGVNYLHTKK 135 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---EEHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999999999999999999999999999999999976532 578999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCC----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++ .++|+|||++....... ......+++.|+|||++.+..++.++||||||+++|
T Consensus 136 ---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 209 (321)
T 2a2a_A 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209 (321)
T ss_dssp ---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ---eecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHH
Confidence 99999999999999887 79999999997665432 223346899999999998888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+.... .......... ...........++.+.++|.+||+.||.+|||+.++++
T Consensus 210 ~l~~g~~pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 210 ILLSGASPFLGDTKQ--------ETLANITSVS-------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHSCCSSCCSSHH--------HHHHHHHTTC-------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCCHH--------HHHHHHHhcc-------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 999999999763211 0000000000 00000001123467999999999999999999999975
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=296.67 Aligned_cols=218 Identities=25% Similarity=0.333 Sum_probs=172.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++.. +..++||||+++|+|.+++..... +++..++.++.||+.||.|||+++
T Consensus 414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~ 489 (635)
T 4fl3_A 414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 489 (635)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3679999999999999999999999964 567999999999999999976533 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+|+||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 490 ---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 566 (635)
T 4fl3_A 490 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 566 (635)
T ss_dssp ---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999876543221 1222334678899999999989999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |+.||.+.... . ... .+........+...++.+.++|.+||+.||.+|||+.+|++.|++
T Consensus 567 t~G~~Pf~~~~~~-----~---~~~----------~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 567 SYGQKPYRGMKGS-----E---VTA----------MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp TTTCCSSTTCCHH-----H---HHH----------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH-----H---HHH----------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 8 99999873221 0 011 111111111112344779999999999999999999999999998
Q ss_pred ccccc
Q 025011 240 LKISH 244 (259)
Q Consensus 240 ~~~~~ 244 (259)
+-.+.
T Consensus 629 ~~~~l 633 (635)
T 4fl3_A 629 YYYDV 633 (635)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 76543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=271.02 Aligned_cols=228 Identities=22% Similarity=0.288 Sum_probs=169.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++.... ....+++..++.++.|++.||.|||+++
T Consensus 77 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (310)
T 2wqm_A 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156 (310)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence 568899999999999999999999999999999999999999999997531 1233678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 157 ---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~ 231 (310)
T 2wqm_A 157 ---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231 (310)
T ss_dssp ---CCCCCCCGGGEEECTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred ---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654322 12233468899999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+..... ........ .... ........++.+.+++.+||+.||.+|||+.++++.++++.
T Consensus 232 g~~p~~~~~~~~------~~~~~~~~-~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~ 296 (310)
T 2wqm_A 232 LQSPFYGDKMNL------YSLCKKIE-QCDY--------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296 (310)
T ss_dssp SSCTTC---CCH------HHHHHHHH-TTCS--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCcccchhH------HHHHHHhh-cccC--------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 999997632110 00111000 0000 00011123467999999999999999999999999999998
Q ss_pred ccccchhhh
Q 025011 242 ISHENYEHR 250 (259)
Q Consensus 242 ~~~~~~~~~ 250 (259)
...+.....
T Consensus 297 ~~~~~~~~~ 305 (310)
T 2wqm_A 297 ACTASSLEH 305 (310)
T ss_dssp HHHC-----
T ss_pred Hhhhhhhhh
Confidence 877665443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=271.23 Aligned_cols=210 Identities=25% Similarity=0.274 Sum_probs=165.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|..+++++ +||||+++++++.+.+..++||||+++|+|.+++..... +++..++.++.|++.||.|||+++
T Consensus 54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---l~~~~~~~~~~qi~~aL~~LH~~~ 130 (345)
T 3a8x_A 54 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG 130 (345)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578899999988 899999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 131 ---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 205 (345)
T 3a8x_A 131 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 205 (345)
T ss_dssp ---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---ceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHh
Confidence 9999999999999999999999999987543221 12344579999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||.................... +...... .+...++.+.++|.+||+.||.+||++
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 206 GRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQIR--IPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp SSCTTTTTTC-------CHHHHHHH--------HHHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred CCCCcCCcccccccccccHHHHHHH--------HHcCCCC--CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 9999975322111110000111100 0011111 111234679999999999999999996
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=273.76 Aligned_cols=203 Identities=22% Similarity=0.284 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~- 161 (350)
T 1rdq_E 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD- 161 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678899999999999999999999999999999999999999999986543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|+||||+++|+|++|
T Consensus 162 --ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 234 (350)
T 1rdq_E 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --cccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC
Confidence 999999999999999999999999999865432 2334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
..||.+.... ....... ..... .+...++.+.++|.+||+.||.+||+ ++++++
T Consensus 235 ~~Pf~~~~~~--------~~~~~i~---------~~~~~--~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 235 YPPFFADQPI--------QIYEKIV---------SGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCSSCCSSHH--------HHHHHHH---------HCCCC--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCHH--------HHHHHHH---------cCCCC--CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 9999863211 0111111 00000 01123467999999999999999998 777743
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=274.15 Aligned_cols=226 Identities=15% Similarity=0.164 Sum_probs=172.4
Q ss_pred HHHHHHHHhcCCCccccccceeEEeC----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+..|+..++.++||||+++++++... ...++||||+ +++|.+++..... .+++..++.++.|++.||.|||++
T Consensus 95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~ 171 (364)
T 3op5_A 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK--RFSRKTVLQLSLRILDILEYIHEH 171 (364)
T ss_dssp HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566677778899999999998764 4589999999 9999999977532 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeC--CCCceEEeecCCcccccCCcccc-----ccccccCcccccCcchhccCCcccccchhhHH
Q 025011 81 ASPPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
+ |+|+||||+||+++ .++.++|+|||+++......... ......||..|+|||++.+..++.++||||||
T Consensus 172 ~---iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 248 (364)
T 3op5_A 172 E---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248 (364)
T ss_dssp T---EECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred C---eEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHH
Confidence 9 99999999999998 88999999999997765432111 11234599999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|+|++|..||.+..... .......... ......+.+..... ...++.+.+++..||+.||.+|||+.+|
T Consensus 249 ~~l~el~~g~~Pf~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l 320 (364)
T 3op5_A 249 YCMIQWLTGHLPWEDNLKDP----KYVRDSKIRY-RENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENL 320 (364)
T ss_dssp HHHHHHHHSCCTTGGGTTCH----HHHHHHHHHH-HHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHhCCCCccccccCH----HHHHHHHHHh-hhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHH
Confidence 99999999999998632211 1111111111 11122222211110 1123679999999999999999999999
Q ss_pred HHHHHhccccc
Q 025011 234 SEELDRLKISH 244 (259)
Q Consensus 234 l~~l~~~~~~~ 244 (259)
++.|+++....
T Consensus 321 ~~~l~~~~~~~ 331 (364)
T 3op5_A 321 RDILLQGLKAI 331 (364)
T ss_dssp HHHHHHHHHHT
T ss_pred HHHHHHHHHHc
Confidence 99998876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=293.39 Aligned_cols=221 Identities=22% Similarity=0.345 Sum_probs=173.6
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.|.+|++++++++||||+++++++.. +..++||||+.+|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 380 ~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 380 TEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3578999999999999999999999976 568999999999999999975432 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+|+||||+||+++.++.++|+|||+++........ .......++..|+|||++.+..++.++||||||+++|+|+
T Consensus 457 ---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp ---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred ---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999876533211 1122233567899999999889999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |..||.+.... ...... .. ......+..+++.+.++|.+||+.||.+|||+.+|++.|++
T Consensus 534 t~G~~Pf~~~~~~-----~~~~~i---~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 595 (613)
T 2ozo_A 534 SYGQKPYKKMKGP-----EVMAFI---EQ----------GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA 595 (613)
T ss_dssp TTSCCTTTTCCSH-----HHHHHH---HT----------TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred HCCCCCCCCCCHH-----HHHHHH---Hc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 8 99999874321 111111 10 00111112344779999999999999999999999999999
Q ss_pred ccccccc
Q 025011 240 LKISHEN 246 (259)
Q Consensus 240 ~~~~~~~ 246 (259)
+..+...
T Consensus 596 ~~~~~~~ 602 (613)
T 2ozo_A 596 CYYSLAS 602 (613)
T ss_dssp HHHHHSC
T ss_pred HHHHhcc
Confidence 8665543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=272.57 Aligned_cols=216 Identities=24% Similarity=0.318 Sum_probs=151.4
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.+. ||||+++++++.+++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~ 126 (325)
T 3kn6_A 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETEASYIMRKLVSAVSHMHDVG 126 (325)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 56789999999997 99999999999999999999999999999999987533 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||||+||+++.++ .++|+|||+++....... ......++..|+|||++.+..++.++||||+|+++|+
T Consensus 127 ---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp ---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHH
T ss_pred ---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 99999999999997665 799999999976543321 2233458999999999998889999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
|++|..||.+........ ........... +. ...........++.+.++|.+||+.||.+|||+.+++
T Consensus 202 ll~g~~pf~~~~~~~~~~-~~~~~~~~i~~-~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSLTCT-SAVEIMKKIKK-GD------FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp HHHSSCTTC-------CC-CHHHHHHHHTT-TC------CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred HHhCCCCCCCCccccccc-cHHHHHHHHHc-CC------CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 999999998743211110 00111111100 00 0011111123457899999999999999999999986
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=266.05 Aligned_cols=221 Identities=22% Similarity=0.284 Sum_probs=164.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++ +|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 120 (288)
T 1ob3_A 45 STTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR- 120 (288)
T ss_dssp HHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999965 89998876532 2578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++||||+|+++|+|++
T Consensus 121 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 196 (288)
T 1ob3_A 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (288)
T ss_dssp --CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred --eecCCCCHHHEEEcCCCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654321 122334689999999998764 48999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchhhhh-----hccccC-------CchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI-----LNFQVA-------DESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-----~~~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||.+..... ........... ...+... .+.... .......++.+.++|.+||+.||.+|
T Consensus 197 g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 272 (288)
T 1ob3_A 197 GTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272 (288)
T ss_dssp SSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTS
T ss_pred CCCCCCCCCHHH----HHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccC
Confidence 999998743211 11111110000 0000000 000000 00001234678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 273 pt~~e~l~ 280 (288)
T 1ob3_A 273 ITAKQALE 280 (288)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=270.50 Aligned_cols=215 Identities=26% Similarity=0.285 Sum_probs=164.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-----------------------------
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS----------------------------- 53 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------- 53 (259)
+.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++....
T Consensus 73 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (345)
T 3hko_A 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152 (345)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHS
T ss_pred HHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccc
Confidence 568899999999999999999999999999999999999999999985310
Q ss_pred --------CcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCC--ceEEeecCCcccccCCc--ccc
Q 025011 54 --------SQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY--KAKVADFGSSVLISSDN--QTA 121 (259)
Q Consensus 54 --------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~--~~~ 121 (259)
....+++..++.++.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||++....... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 229 (345)
T 3hko_A 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229 (345)
T ss_dssp CC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---
T ss_pred ccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccc
Confidence 0112346778899999999999999999 99999999999998776 89999999998654321 111
Q ss_pred ccccccCcccccCcchhcc--CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccc
Q 025011 122 MTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQ 199 (259)
Q Consensus 122 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (259)
......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..... .......... .
T Consensus 230 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~~~~~-------~ 294 (345)
T 3hko_A 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--------TISQVLNKKL-------C 294 (345)
T ss_dssp -----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-------C
T ss_pred cccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--------HHHHHHhccc-------c
Confidence 2344569999999999875 568899999999999999999999998733211 0011100000 0
Q ss_pred cCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 200 VADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 200 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.........++.+.++|.+||+.||.+|||+.++++
T Consensus 295 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 295 FENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp TTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 011111123467999999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=265.25 Aligned_cols=213 Identities=31% Similarity=0.500 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+.. +++|||+++++|.+.+..... .+++..++.++.|++.||.|||+++
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~- 142 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN- 142 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-
Confidence 67899999999999999999999986544 799999999999998876543 3688999999999999999999976
Q ss_pred CCeEeCCCCCCCeEeCCCCc-----eEEeecCCcccccCCccccccccccCcccccCcchhc--cCCcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYK-----AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI--TGKLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~-----~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~i 155 (259)
++++|+||||+||+++.++. ++|+|||+++.... ......++..|+|||++. ...++.++||||+|++
T Consensus 143 ~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 217 (287)
T 4f0f_A 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217 (287)
T ss_dssp SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHH
T ss_pred CCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHH
Confidence 34899999999999988776 99999999875433 223356899999999984 4457889999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+|++|..||........ ...... .. .......+...++.+.+++.+||+.||.+|||+.++++
T Consensus 218 l~~l~~g~~pf~~~~~~~~---~~~~~~---~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 218 LYTILTGEGPFDEYSYGKI---KFINMI---RE---------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHSSCTTTTCCCCHH---HHHHHH---HH---------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCCCCccccccHH---HHHHHH---hc---------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999986332110 000000 00 01111111223467999999999999999999999999
Q ss_pred HHHhc
Q 025011 236 ELDRL 240 (259)
Q Consensus 236 ~l~~~ 240 (259)
.|+++
T Consensus 283 ~L~~l 287 (287)
T 4f0f_A 283 ELSEL 287 (287)
T ss_dssp HHHTC
T ss_pred HHHhC
Confidence 99874
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=282.70 Aligned_cols=205 Identities=26% Similarity=0.377 Sum_probs=169.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 61 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qi~~aL~~LH~~g- 136 (476)
T 2y94_A 61 GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDEKESRRLFQQILSGVDYCHRHM- 136 (476)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSS---CCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976533 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus 137 --ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 211 (476)
T 2y94_A 137 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC 211 (476)
T ss_dssp --EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred --CCcccccHHHEEEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh
Confidence 9999999999999999999999999998754321 2234469999999999988765 689999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... .. ... +....... +...++.+.++|.+||+.||.+|||+.++++
T Consensus 212 G~~Pf~~~~~~-----~~---~~~---------i~~~~~~~--p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 212 GTLPFDDDHVP-----TL---FKK---------ICDGIFYT--PQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp SSCSSCCSSSH-----HH---HHH---------HHTTCCCC--CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCHH-----HH---HHH---------HhcCCcCC--CccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 99999863211 00 110 00100000 1112367999999999999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=261.41 Aligned_cols=209 Identities=22% Similarity=0.327 Sum_probs=168.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+.+..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~- 125 (284)
T 3kk8_A 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEADASHCIQQILESIAYCHSNG- 125 (284)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999998876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 126 --i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 200 (284)
T 3kk8_A 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 200 (284)
T ss_dssp --EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred --cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHH
Confidence 999999999999986655 9999999997655432 22335689999999999998899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ........... ..........++.+.+++.+||+.||.+|||+.++++
T Consensus 201 ~~g~~pf~~~~~~-----~~~~~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 201 LVGYPPFWDEDQH-----RLYAQIKAGAY----------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp HHSSCSSCCSSHH-----HHHHHHHHTCC----------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHCCCCCCCCchh-----HHHHHHHhccc----------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999763211 11110000000 0000011123467999999999999999999999966
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=268.28 Aligned_cols=219 Identities=23% Similarity=0.356 Sum_probs=172.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..+. .++++||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~- 141 (291)
T 1u46_A 66 DDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR- 141 (291)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 56889999999999999999999998754 8999999999999999976532 3678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 142 --i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 219 (291)
T 1u46_A 142 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219 (291)
T ss_dssp --EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred --cccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999876543222 12233457778999999988889999999999999999999
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ......... ......+...++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus 220 ~g~~p~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 220 YGQEPWIGLNGS--------QILHKIDKE---------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp TSCCTTTTCCHH--------HHHHHHHTS---------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCcccCCHH--------HHHHHHHcc---------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 99999863211 011111000 001111122347799999999999999999999999999988
Q ss_pred cccc
Q 025011 241 KISH 244 (259)
Q Consensus 241 ~~~~ 244 (259)
....
T Consensus 283 ~~~~ 286 (291)
T 1u46_A 283 QPTD 286 (291)
T ss_dssp C---
T ss_pred Cccc
Confidence 7543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=277.90 Aligned_cols=234 Identities=20% Similarity=0.247 Sum_probs=179.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++...+ ..++||||+++++|.+++........+++..++.++.|++.||.|||++
T Consensus 52 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 131 (396)
T 4eut_A 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN 131 (396)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 56789999999999999999999998755 6799999999999999998765444478899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEe----CCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc--------CCcccccc
Q 025011 81 ASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT--------GKLTEKSD 148 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~D 148 (259)
+ ++|+||||+||++ +.++.++|+|||+++...... ......|+..|+|||++.+ ..++.++|
T Consensus 132 ~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~D 205 (396)
T 4eut_A 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVD 205 (396)
T ss_dssp T---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHH
T ss_pred C---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHH
Confidence 9 9999999999999 777889999999998765432 2233568999999999865 45788999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhh----------hh-ccccCCchhHHHHHHHHHHHH
Q 025011 149 VYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQ----------IL-NFQVADESEMEEIETVAGLAS 217 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~-~~~~~~~~~~~~~~~~~~li~ 217 (259)
|||||+++|+|++|..||.+..........+........ ...+.. +. ............++.+.+++.
T Consensus 206 iwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~ 284 (396)
T 4eut_A 206 LWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP-SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284 (396)
T ss_dssp HHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC-TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC-cccchhheeccCCCcccCccCCcccccchHHHhhchHHHH
Confidence 999999999999999999764332222111111111110 000000 00 001111223456688999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHhcccc
Q 025011 218 KCLSLSGRRRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 218 ~~l~~~p~~Rpt~~~il~~l~~~~~~ 243 (259)
+||+.||.+|||++++++.++++-..
T Consensus 285 ~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 285 NILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HhhccChhhhccHHHHHHHHHHHhhc
Confidence 99999999999999999999887554
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=292.28 Aligned_cols=219 Identities=27% Similarity=0.410 Sum_probs=175.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++||||+++++++.+ +..++||||+.+|+|.+++..... ..+++..++.++.|++.||.|||+++
T Consensus 307 ~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~- 383 (535)
T 2h8h_A 307 EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN- 383 (535)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 579999999999999999999999876 678999999999999999975422 22678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh-
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT- 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 161 (259)
++|+||||+||+++.++.++|+|||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 384 --ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~ 460 (535)
T 2h8h_A 384 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 460 (535)
T ss_dssp --CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred --eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 9999999999999999999999999997654321 111223346778999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||.+.... +........ .....+..+++.+.+||.+||+.||.+|||+.+|++.|+++-
T Consensus 461 g~~P~~~~~~~--------~~~~~i~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 461 GRVPYPGMVNR--------EVLDQVERG----------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp TCCSSTTCCHH--------HHHHHHHTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred CCCCCCCCCHH--------HHHHHHHcC----------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 89999873211 111111100 001111223467999999999999999999999999999986
Q ss_pred cccc
Q 025011 242 ISHE 245 (259)
Q Consensus 242 ~~~~ 245 (259)
.+..
T Consensus 523 ~~~~ 526 (535)
T 2h8h_A 523 TSTE 526 (535)
T ss_dssp CCCS
T ss_pred hccC
Confidence 5543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=269.52 Aligned_cols=226 Identities=24% Similarity=0.281 Sum_probs=163.8
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.+.+|++++.++ +||||+++++++.+++..++||||+++++|.+++..... +++..+..++.|++.||.|||++
T Consensus 54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~ 130 (316)
T 2ac3_A 54 RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELEASVVVQDVASALDFLHNK 130 (316)
T ss_dssp HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 45789999999985 799999999999999999999999999999999976543 67899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCccc-----cccccccCcccccCcchhcc-----CCccccc
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVIT-----GKLTEKS 147 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~-----~~~~~~~ 147 (259)
+ ++|+||||+||+++.++. ++|+|||++......... .......++..|+|||++.+ ..++.++
T Consensus 131 ~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 207 (316)
T 2ac3_A 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRC 207 (316)
T ss_dssp T---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTH
T ss_pred C---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCccc
Confidence 9 999999999999998776 999999998765432111 11223458999999999875 4578899
Q ss_pred chhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCch--hHHHHHHHHHHHHHhcccCCC
Q 025011 148 DVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADES--EMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 148 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~ 225 (259)
||||||+++|+|++|..||.+............... .........+......... ....++.+.++|.+||+.||.
T Consensus 208 DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 285 (316)
T 2ac3_A 208 DLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP--ACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAK 285 (316)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH--HHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTT
T ss_pred ccHhHHHHHHHHHHCCCCCcccccccccccccccch--hHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChh
Confidence 999999999999999999987432210000000000 0000000011111111110 012346799999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.++++
T Consensus 286 ~Rps~~e~l~ 295 (316)
T 2ac3_A 286 QRLSAAQVLQ 295 (316)
T ss_dssp TSCCHHHHHH
T ss_pred hCCCHHHHhc
Confidence 9999999965
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=271.19 Aligned_cols=205 Identities=26% Similarity=0.301 Sum_probs=167.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|..++..+ +||||+++++++.+.+..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 62 ~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ 138 (345)
T 1xjd_A 62 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG 138 (345)
T ss_dssp HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3577899999887 999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 139 ---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 213 (345)
T 1xjd_A 139 ---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213 (345)
T ss_dssp ---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhc
Confidence 9999999999999999999999999987543221 12344579999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK-QVS 234 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il 234 (259)
|..||.+.... .. ....... ... .+...++.+.++|.+||..||.+||++. +++
T Consensus 214 g~~Pf~~~~~~-----~~---~~~i~~~---------~~~--~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 214 GQSPFHGQDEE-----EL---FHSIRMD---------NPF--YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp SSCSSCCSSHH-----HH---HHHHHHC---------CCC--CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCCCCHH-----HH---HHHHHhC---------CCC--CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 99999863211 00 1111000 000 0111336799999999999999999997 554
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=274.50 Aligned_cols=210 Identities=24% Similarity=0.308 Sum_probs=156.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 93 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~L~~LH~~~- 168 (349)
T 2w4o_A 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDAADAVKQILEAVAYLHENG- 168 (349)
T ss_dssp ------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++. ++.++|+|||+++...... ......|++.|+|||++.+..++.++||||||+++|+|
T Consensus 169 --ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 243 (349)
T 2w4o_A 169 --IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYIL 243 (349)
T ss_dssp --CCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred --eEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 999999999999975 8899999999987654321 22334689999999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+..... .. ....... .. ..........+..+.++|.+||+.||.+|||+.++++
T Consensus 244 l~g~~pf~~~~~~~----~~---~~~i~~~-~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 244 LCGFEPFYDERGDQ----FM---FRRILNC-EY------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp HHSSCTTCCTTCHH----HH---HHHHHTT-CC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCcccH----HH---HHHHHhC-CC------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999997632110 00 0000000 00 0000111123467999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=265.40 Aligned_cols=219 Identities=19% Similarity=0.257 Sum_probs=167.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC---CcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS---SQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+++++.++||||+++++++..++..++||||++ ++|.+++.... ....+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~ 126 (317)
T 2pmi_A 48 STAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126 (317)
T ss_dssp HHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 568899999999999999999999999999999999997 59999886542 12236788999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~ 158 (259)
++ ++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+. .++.++||||||+++|+
T Consensus 127 ~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 127 NK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 99 9999999999999999999999999998664321 122344689999999999764 58999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhh--ccchh---------------------hhhhccccCCchhHHHHHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSL---------------------RQILNFQVADESEMEEIETVAGL 215 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~l 215 (259)
|++|..||.+..... .......... ....+ ......... ...++.+.++
T Consensus 202 l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~l 273 (317)
T 2pmi_A 202 MITGKPLFPGTNDEE----QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK----EPLDGNLMDF 273 (317)
T ss_dssp HHHSSCSCCCSSHHH----HHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCS----SCCCHHHHHH
T ss_pred HHhCCCCCCCCChHH----HHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhccccc----ccCCHHHHHH
Confidence 999999998743211 0101100000 00000 000000000 0123679999
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 025011 216 ASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 216 i~~~l~~~p~~Rpt~~~il~ 235 (259)
|.+||+.||.+|||+.++++
T Consensus 274 i~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 274 LHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp HHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCcccCCCHHHHhC
Confidence 99999999999999999975
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=265.19 Aligned_cols=205 Identities=29% Similarity=0.403 Sum_probs=165.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.+++.++||||+++++++.+.+..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~ 129 (279)
T 3fdn_A 53 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 129 (279)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35688999999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 130 ---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (279)
T 3fdn_A 130 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202 (279)
T ss_dssp ---CEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ---EecccCChHhEEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHH
Confidence 999999999999999999999999988654332 1233468999999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+..... ....... . ... .+...++.+.++|.+||+.||.+|||+.++++
T Consensus 203 g~~p~~~~~~~~-----~~~~~~~--~--------~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 203 GKPPFEANTYQE-----TYKRISR--V--------EFT----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp SSCTTCCSSHHH-----HHHHHHH--T--------CCC----CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCcHHH-----HHHHHHh--C--------CCC----CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 999998632110 0000000 0 000 01112367899999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=266.97 Aligned_cols=222 Identities=18% Similarity=0.193 Sum_probs=164.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.+++..++||||+++ ++.+.+..... .+++..++.++.|++.||.|||+++
T Consensus 46 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~- 121 (292)
T 3o0g_A 46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN- 121 (292)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5688999999999999999999999999999999999965 66666654332 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++...... ........++..|+|||++.+.. ++.++||||+|+++|+|++
T Consensus 122 --ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 197 (292)
T 3o0g_A 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred --eecCCCCHHHEEEcCCCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999866432 22233456899999999998766 7999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhh--ccchhhhhhc------------cccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSI--ENNSLRQILN------------FQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|..||....... ........... ....+..... ...........++.+.++|.+||+.||.+|
T Consensus 198 ~~~p~~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 274 (292)
T 3o0g_A 198 AGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp TSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred cCCCCcCCCCHH---HHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhC
Confidence 887754321111 11111111000 0000000000 000000111234678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||++++++
T Consensus 275 ~t~~e~l~ 282 (292)
T 3o0g_A 275 ISAEEALQ 282 (292)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=265.76 Aligned_cols=215 Identities=25% Similarity=0.391 Sum_probs=171.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----------------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----------------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i 66 (259)
+.+.+|+++++.++||||+++++++.. ....+++|||+++++|.+++...... .+++..++.+
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i 127 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALEL 127 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGS-CCCHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCC-CCCHHHHHHH
Confidence 467899999999999999999998864 34579999999999999999765322 3688999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
+.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..++.+
T Consensus 128 ~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp HHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred HHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcch
Confidence 999999999999999 9999999999999999999999999987765432 2233468999999999998889999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 147 SDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 147 ~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+||||||+++|+|++|..|+.... .... ......... ..++.+.++|.+||+.||.+
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~~~----------~~~~---------~~~~~~~~~----~~~~~~~~li~~~l~~dp~~ 258 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFETS----------KFFT---------DLRDGIISD----IFDKKEKTLLQKLLSKKPED 258 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHHHH----------HHHH---------HHHTTCCCT----TSCHHHHHHHHHHTCSSGGG
T ss_pred hhhHHHHHHHHHHHhcCCcchhHH----------HHHH---------Hhhcccccc----cCCHHHHHHHHHHccCChhh
Confidence 999999999999999988854310 0000 000111111 12356889999999999999
Q ss_pred CCCHHHHHHHHHhccccccch
Q 025011 227 RPTMKQVSEELDRLKISHENY 247 (259)
Q Consensus 227 Rpt~~~il~~l~~~~~~~~~~ 247 (259)
|||+.++++.++.+..+....
T Consensus 259 Rps~~e~l~~l~~~~~~~~~~ 279 (284)
T 2a19_B 259 RPNTSEILRTLTVWKKSPEKN 279 (284)
T ss_dssp SCCHHHHHHHHHHHTC-----
T ss_pred CcCHHHHHHHHHHHhhCCCcc
Confidence 999999999999998776554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=267.77 Aligned_cols=206 Identities=23% Similarity=0.288 Sum_probs=160.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 66 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~al~~lH~~~- 141 (327)
T 3a62_A 66 AHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI---FMEDTACFYLAEISMALGHLHQKG- 141 (327)
T ss_dssp -----HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 3477899999999999999999999999999999999999999999976543 577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|+|||+++...... .......|++.|+|||++.+..++.++||||||+++|+|++|
T Consensus 142 --ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 217 (327)
T 3a62_A 142 --IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217 (327)
T ss_dssp --CCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --EEcccCCHHHeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC
Confidence 9999999999999999999999999987543321 123345689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+.... . .... +...... .+...++.+.++|.+||..||.+|| ++.++++
T Consensus 218 ~~pf~~~~~~-----~---~~~~---------i~~~~~~--~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 218 APPFTGENRK-----K---TIDK---------ILKCKLN--LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp SCSCCCSSHH-----H---HHHH---------HHHTCCC--CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCCCCCCHH-----H---HHHH---------HHhCCCC--CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 9999863211 0 0000 0000000 0112336799999999999999999 6667653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=275.26 Aligned_cols=209 Identities=24% Similarity=0.328 Sum_probs=168.1
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+.+++.++||||+++++++.+++..|+||||+++|+|.+++.... +++..+..++.|++.||.|||+++
T Consensus 115 ~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~----~~e~~~~~~~~qi~~aL~~LH~~g-- 188 (410)
T 3v8s_A 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKWARFYTAEVVLALDAIHSMG-- 188 (410)
T ss_dssp THHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC----CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 47899999999999999999999999999999999999999999997643 578999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC----cccccchhhHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK----LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~~l 159 (259)
|+||||||+||+++.++.++|+|||+++...... ........||+.|+|||++.+.. ++.++|+||||+++|+|
T Consensus 189 -ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyel 266 (410)
T 3v8s_A 189 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266 (410)
T ss_dssp -EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHH
T ss_pred -eEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHH
Confidence 9999999999999999999999999997665432 12233557999999999998665 78999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~ 235 (259)
++|..||.+.+.. ............ ...+.....++.+.+||.+||..+|.+ ||++++|++
T Consensus 267 l~G~~Pf~~~~~~--------~~~~~i~~~~~~-------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 267 LVGDTPFYADSLV--------GTYSKIMNHKNS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHSSCTTCCSSHH--------HHHHHHHTHHHH-------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HhCCCCCCCCChh--------hHHHHHHhcccc-------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 9999999863211 001111000000 000011123367999999999999988 999999964
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=266.03 Aligned_cols=228 Identities=24% Similarity=0.355 Sum_probs=169.4
Q ss_pred HHHHHHHHHhcC--CCccccccceeEEeC----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI--NHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 4 ~~~~E~~~l~~l--~h~~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
.+..|.+++..+ +||||+++++++... ...++||||+++|+|.+++.... +++..++.++.|++.||.||
T Consensus 75 ~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~l 150 (337)
T 3mdy_A 75 SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHL 150 (337)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHH
T ss_pred hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHH
Confidence 355666666665 899999999999887 67899999999999999997643 57899999999999999999
Q ss_pred hhC--------CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccCCcccc-
Q 025011 78 HSS--------ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITGKLTEK- 146 (259)
Q Consensus 78 h~~--------~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~- 146 (259)
|++ + ++|+||||+||+++.++.++|+|||++.......... ......|+..|+|||++.+...+.+
T Consensus 151 H~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 227 (337)
T 3mdy_A 151 HTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227 (337)
T ss_dssp HSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCT
T ss_pred HHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccc
Confidence 998 8 9999999999999999999999999997665432211 1224569999999999987665554
Q ss_pred -----cchhhHHHHHHHHHhC----------CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHH
Q 025011 147 -----SDVYSFGVLLAELLTG----------LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIET 211 (259)
Q Consensus 147 -----~DiwslG~il~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (259)
+||||||+++|+|++| ..||................ ........... .......+++.
T Consensus 228 ~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~ 300 (337)
T 3mdy_A 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI----VCIKKLRPSFP---NRWSSDECLRQ 300 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH----HTTSCCCCCCC---GGGGGSHHHHH
T ss_pred cCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHH----HhhhccCcccc---ccchhhHHHHH
Confidence 9999999999999999 55655432211111111110 00000000000 00112256688
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHhcccccc
Q 025011 212 VAGLASKCLSLSGRRRPTMKQVSEELDRLKISHE 245 (259)
Q Consensus 212 ~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~~~ 245 (259)
+.+++.+||+.||.+|||+.++++.|+++..+.+
T Consensus 301 l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 9999999999999999999999999999877653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-41 Score=270.01 Aligned_cols=227 Identities=19% Similarity=0.284 Sum_probs=173.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++++.++||||+++++++.. .+..++||||+.+++|.+++... .....+++..++.++.|++.||.||
T Consensus 71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 150 (317)
T 2buj_A 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150 (317)
T ss_dssp HHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 568899999999999999999999873 34789999999999999999763 1223468899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-------ccccccCcccccCcchhccCC---ccccc
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-------MTTKKIGTFVNLDPEYVITGK---LTEKS 147 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~---~~~~~ 147 (259)
|+++ ++|+||+|+||+++.++.++|+|||++.......... ......++..|+|||.+.+.. ++.++
T Consensus 151 H~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 227 (317)
T 2buj_A 151 HAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227 (317)
T ss_dssp HHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHH
T ss_pred HhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchh
Confidence 9999 9999999999999999999999999987543211110 012234789999999987554 68899
Q ss_pred chhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 148 DVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 148 DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
||||||+++|+|++|..||......... .................++.+.++|.+||+.||.+|
T Consensus 228 Di~slG~il~el~~g~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R 291 (317)
T 2buj_A 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDS----------------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291 (317)
T ss_dssp HHHHHHHHHHHHHHSSCTTHHHHHTTSC----------------HHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred hHHHHHHHHHHHHhCCCChhhhhcccch----------------hhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhC
Confidence 9999999999999999998642111000 000000000111111234679999999999999999
Q ss_pred CCHHHHHHHHHhccccccchh
Q 025011 228 PTMKQVSEELDRLKISHENYE 248 (259)
Q Consensus 228 pt~~~il~~l~~~~~~~~~~~ 248 (259)
||+.++++.|+++........
T Consensus 292 ps~~~ll~~L~~~~~~~~~~~ 312 (317)
T 2buj_A 292 PHIPLLLSQLEALQPPAPGQH 312 (317)
T ss_dssp CCHHHHHHHHHHTCCCCCC--
T ss_pred CCHHHHHHHhhhcCCCCCCCC
Confidence 999999999999987666543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=270.31 Aligned_cols=201 Identities=26% Similarity=0.281 Sum_probs=164.6
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|..++..+ +||||+++++++.+.+..|+||||+++|+|.+++..... +++..++.++.|++.||.|||+++
T Consensus 65 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g 141 (353)
T 2i0e_A 65 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG 141 (353)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4578899999988 799999999999999999999999999999999986543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||++...... ........||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 142 ---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 216 (353)
T 2i0e_A 142 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216 (353)
T ss_dssp ---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHH
T ss_pred ---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHc
Confidence 999999999999999999999999998754322 122344579999999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||.+.... ..... +....... +...++.+.++|.+||..||.+||++
T Consensus 217 G~~Pf~~~~~~--------~~~~~---------i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 217 GQAPFEGEDED--------ELFQS---------IMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp SSCSSCCSSHH--------HHHHH---------HHHCCCCC--CTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred CCCCCCCCCHH--------HHHHH---------HHhCCCCC--CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 99999863211 01111 11111110 11234679999999999999999964
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=276.09 Aligned_cols=215 Identities=25% Similarity=0.277 Sum_probs=161.2
Q ss_pred hHHHHHHHHHhc-CCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQ-INHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~-l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.++.+ .+||||+++++++.. ++..|+||||+++|+|.+++...... .+++..+..++.|++.||.||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~-~l~~~~~~~i~~qi~~aL~~L 177 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 177 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHH
Confidence 457889998754 589999999999876 56789999999999999999875432 368899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
|+++ |+|+||||+||+++. ++.++|+|||+++...... ......+|..|+|||++.+..++.++|||||||
T Consensus 178 H~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 251 (400)
T 1nxk_A 178 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251 (400)
T ss_dssp HHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHH
T ss_pred HHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHH
Confidence 9999 999999999999997 7889999999998654321 223456899999999998888999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++|+|++|..||.+......... ....... +.. ..........++.+.+||.+||+.||.+|||+.+++
T Consensus 252 il~ell~g~~pf~~~~~~~~~~~-~~~~i~~----~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil 320 (400)
T 1nxk_A 252 IMYILLCGYPPFYSNHGLAISPG-MKTRIRM----GQY------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFM 320 (400)
T ss_dssp HHHHHHHSSCSCCCCTTCSSCCS-HHHHHHH----TCC------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred HHHHHHhCCCCCCCCccccccHH-HHHHHHc----Ccc------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 99999999999986432211100 0000000 000 000001112346799999999999999999999998
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 321 ~ 321 (400)
T 1nxk_A 321 N 321 (400)
T ss_dssp H
T ss_pred c
Confidence 6
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=268.72 Aligned_cols=199 Identities=23% Similarity=0.329 Sum_probs=166.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCC-ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNG-TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.+|+.+++.++||||+++++++.+.+..++||||+.+| +|.+++..... +++..++.++.|++.||.|||+++
T Consensus 75 ~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~---l~~~~~~~i~~qi~~~L~~LH~~~- 150 (335)
T 3dls_A 75 KVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR---LDEPLASYIFRQLVSAVGYLRLKD- 150 (335)
T ss_dssp EEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4678999999999999999999999999999999998766 99999976643 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++....... ......|+..|+|||++.+..+ +.++||||||+++|+|++
T Consensus 151 --ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 225 (335)
T 3dls_A 151 --IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225 (335)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred --eEEeccCHHHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence 9999999999999999999999999998665432 2233468999999999988776 789999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
|..||....... ...... +...++.+.++|.+||+.||.+|||+.++++.
T Consensus 226 g~~pf~~~~~~~-------------------~~~~~~------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 226 EENPFCELEETV-------------------EAAIHP------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp SSCSCSSGGGGT-------------------TTCCCC------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred CCCchhhHHHHH-------------------hhccCC------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 999997622110 000000 00123679999999999999999999999763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=273.60 Aligned_cols=209 Identities=19% Similarity=0.281 Sum_probs=159.5
Q ss_pred hHHHHHHHHHhcCCC--ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINH--KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+.+++.++| |||+++++++..++..++|||+ .+++|.+++..... +++..+..++.|++.||.|||++
T Consensus 52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~al~~lH~~ 127 (343)
T 3dbq_A 52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH 127 (343)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCC---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 568899999999976 9999999999999999999995 58899999987543 67889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----------CCcccccch
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----------GKLTEKSDV 149 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di 149 (259)
+ |+|+||||+||+++ ++.++|+|||+++...............|++.|+|||++.+ ..++.++||
T Consensus 128 ~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di 203 (343)
T 3dbq_A 128 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 203 (343)
T ss_dssp T---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHH
T ss_pred C---eecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhH
Confidence 9 99999999999997 57899999999987654433333445579999999999865 568889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
||||+++|+|++|+.||.+..... ... ............+...++.+.+++.+||+.||.+|||
T Consensus 204 wslG~il~ell~g~~pf~~~~~~~-------~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt 267 (343)
T 3dbq_A 204 WSLGCILYYMTYGKTPFQQIINQI-------SKL---------HAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 267 (343)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCSHH-------HHH---------HHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHHHHHhCCCcchhhhhHH-------HHH---------HHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCC
Confidence 999999999999999997632110 000 1111111111111111256899999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
+.++++
T Consensus 268 ~~e~l~ 273 (343)
T 3dbq_A 268 IPELLA 273 (343)
T ss_dssp HHHHHT
T ss_pred HHHHHh
Confidence 999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=268.52 Aligned_cols=221 Identities=25% Similarity=0.370 Sum_probs=163.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcc----eEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVP----LLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~----~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.++++++||||+++++++...... ++||||+++++|.+++..... +++..++.++.|++.||.|||
T Consensus 57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH 133 (311)
T 3ork_A 57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 133 (311)
T ss_dssp HHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 4688999999999999999999999876544 999999999999999976543 678999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
+++ ++|+||||+||+++.++.++|+|||++......... .......|+..|+|||.+.+..++.++||||||+++|
T Consensus 134 ~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~ 210 (311)
T 3ork_A 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210 (311)
T ss_dssp HTT---CCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred HCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHH
Confidence 999 999999999999999999999999999866543221 2233446899999999999988999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH-HHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM-KQVSEE 236 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~-~~il~~ 236 (259)
+|++|..||.+..... .............. ......++.+.++|.+||+.||.+||++ +++.+.
T Consensus 211 ~ll~g~~pf~~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 275 (311)
T 3ork_A 211 EVLTGEPPFTGDSPVS--------VAYQHVREDPIPPS-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275 (311)
T ss_dssp HHHHSSCSCCCSSHHH--------HHHHHHHCCCCCHH-------HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHhCCCCCCCCChHH--------HHHHHhcCCCCCcc-------cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHH
Confidence 9999999998632110 01111110000000 0001134679999999999999999954 455566
Q ss_pred HHhccccc
Q 025011 237 LDRLKISH 244 (259)
Q Consensus 237 l~~~~~~~ 244 (259)
+.++....
T Consensus 276 l~~~~~~~ 283 (311)
T 3ork_A 276 LVRVHNGE 283 (311)
T ss_dssp HHHHHTTC
T ss_pred HHHHhcCC
Confidence 66654433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=263.56 Aligned_cols=207 Identities=21% Similarity=0.284 Sum_probs=149.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 132 (278)
T 3cok_A 56 QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK--PFSENEARHFMHQIITGMLYLHSHG- 132 (278)
T ss_dssp HHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSS--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5789999999999999999999999999999999999999999999976532 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 133 --i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp --EECSSCCGGGEEECTTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHS
T ss_pred --eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999876543221 12234688999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||......... ......... .+...+..+.++|.+||+.||.+|||+.++++
T Consensus 209 ~~p~~~~~~~~~~-----------------~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 209 RPPFDTDTVKNTL-----------------NKVVLADYE--MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCSSCCCSCC----------------------CCSSCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCChhHHHHH-----------------HHHhhcccC--CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 9999763321100 000000000 01123367899999999999999999999965
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-41 Score=267.47 Aligned_cols=225 Identities=21% Similarity=0.295 Sum_probs=164.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~i~~~l~~~l~~lH~~~ 122 (311)
T 4agu_A 46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEHLVKSITWQTLQAVNFCHKHN 122 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35678999999999999999999999999999999999999999888865533 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~ 160 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+ ..++.++||||+|+++|+|+
T Consensus 123 ---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 197 (311)
T 4agu_A 123 ---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197 (311)
T ss_dssp ---EECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHH
T ss_pred ---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHH
Confidence 99999999999999999999999999976553221 2234468899999999876 45799999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHH-------HHhhccchh-hh--hhccccCCc---hhHHHHHHHHHHHHHhcccCCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYF-------LYSIENNSL-RQ--ILNFQVADE---SEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~--~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
+|..||.+........ ...... ......... .. ......... .....++.+.+++.+||+.||.+|
T Consensus 198 ~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (311)
T 4agu_A 198 SGVPLWPGKSDVDQLY-LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTER 276 (311)
T ss_dssp HSSCSCCCSSHHHHHH-HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred hCCCCCCCCCHHHHHH-HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhc
Confidence 9999998743211100 000000 000000000 00 000000000 001234678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||++++++
T Consensus 277 pt~~ell~ 284 (311)
T 4agu_A 277 LTCEQLLH 284 (311)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhc
Confidence 99999974
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=264.13 Aligned_cols=210 Identities=26% Similarity=0.364 Sum_probs=161.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+++
T Consensus 65 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 144 (285)
T 3is5_A 65 EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH 144 (285)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999999999999999999999999999999999986531 1233688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~ 158 (259)
++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+. ..++.++||||||+++|+
T Consensus 145 ---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ 217 (285)
T 3is5_A 145 ---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYF 217 (285)
T ss_dssp ---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHH
T ss_pred ---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHH
Confidence 9999999999999 456789999999997654321 223446899999999885 468899999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+..... ...... ...... .......++.+.+++.+||+.||.+|||+.++++
T Consensus 218 ll~g~~pf~~~~~~~-----~~~~~~--~~~~~~---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 218 LLTGCLPFTGTSLEE-----VQQKAT--YKEPNY---------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp HHHSSCSSCCSSHHH-----HHHHHH--HCCCCC---------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHhCCCCCCCCCHHH-----HHhhhc--cCCccc---------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999998732110 000000 000000 0000012367899999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=262.70 Aligned_cols=205 Identities=27% Similarity=0.361 Sum_probs=169.4
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+++++.++||||+++++++.+++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ 134 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDEQRSATFMEELADALHYCHERK 134 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 35689999999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++...... ......++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 135 ---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 207 (284)
T 2vgo_A 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207 (284)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred ---ceecCCCHHHEEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHH
Confidence 999999999999999999999999998655432 1233468999999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||....... ..... ...... .+...++.+.++|.+||+.||.+|||+.++++
T Consensus 208 g~~pf~~~~~~~--------~~~~~---------~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 208 GMPPFDSPSHTE--------THRRI---------VNVDLK--FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp SSCTTCCSSHHH--------HHHHH---------HTTCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHhH--------HHHHH---------hccccC--CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 999998632110 00000 000000 01123367899999999999999999999975
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=275.42 Aligned_cols=209 Identities=18% Similarity=0.274 Sum_probs=160.4
Q ss_pred hHHHHHHHHHhcCC--CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++ ||||+++++++..++..++||| +.+++|.+++..... +++..+..++.|++.||.|||++
T Consensus 99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~lH~~ 174 (390)
T 2zmd_A 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH 174 (390)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999996 5999999999999999999999 458899999987542 57788999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----------CCcccccch
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----------GKLTEKSDV 149 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di 149 (259)
+ |+||||||+||+++ ++.++|+|||+++...............|++.|+|||++.+ ..++.++||
T Consensus 175 ~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di 250 (390)
T 2zmd_A 175 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 250 (390)
T ss_dssp T---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHH
T ss_pred C---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhH
Confidence 9 99999999999996 57899999999987654333323345579999999999865 358889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
|||||++|+|++|..||.+..... .... .+.........+...++.+.++|.+||+.||.+|||
T Consensus 251 wSlGvil~ell~G~~Pf~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps 314 (390)
T 2zmd_A 251 WSLGCILYYMTYGKTPFQQIINQI-------SKLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 314 (390)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCCHH-------HHHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHHHHHHCCCcchhhhHHH-------HHHH---------HHhCccccCCCCccchHHHHHHHHHHcccChhhCCC
Confidence 999999999999999997632110 0011 111111000001111357899999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
+.++++
T Consensus 315 ~~ell~ 320 (390)
T 2zmd_A 315 IPELLA 320 (390)
T ss_dssp HHHHHT
T ss_pred HHHHhh
Confidence 999975
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.42 Aligned_cols=207 Identities=26% Similarity=0.386 Sum_probs=170.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+
T Consensus 65 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~- 139 (303)
T 3a7i_A 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK- 139 (303)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 57899999999999999999999999999999999999999999999753 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 140 --i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 215 (303)
T 3a7i_A 140 --KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG 215 (303)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CccCCCChheEEECCCCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC
Confidence 9999999999999999999999999997665432 122345689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..||...... .. ...... .. ........++.+.+++.+||+.||.+|||+.++++.
T Consensus 216 ~~p~~~~~~~-----~~---~~~~~~-~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 216 EPPHSELHPM-----KV---LFLIPK-NN---------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCTTTTSCHH-----HH---HHHHHH-SC---------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred CCCCCCcCHH-----HH---HHHhhc-CC---------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 9999763211 00 000000 00 000111223679999999999999999999999763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=271.86 Aligned_cols=230 Identities=20% Similarity=0.373 Sum_probs=174.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++...+ ..++||||+++++|.+++..... .+++..++.++.|++.||.+||++
T Consensus 87 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~ 164 (326)
T 2w1i_A 87 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTK 164 (326)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence 56899999999999999999999987543 78999999999999999987543 257899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|
T Consensus 165 ~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 241 (326)
T 2w1i_A 165 R---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 241 (326)
T ss_dssp T---EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred C---EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHH
Confidence 9 9999999999999999999999999998765432221 12234567789999999988899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhh----ccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSI----ENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||...... ......... ........+........+...++.+.++|.+||+.||.+|||+.++++
T Consensus 242 ~tg~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 242 FTYIEKSKSPPAE------FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHTTCGGGSHHHH------HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhcCCCCCCCHHH------HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999987642100 000000000 000011111111111112234477999999999999999999999999
Q ss_pred HHHhcccc
Q 025011 236 ELDRLKIS 243 (259)
Q Consensus 236 ~l~~~~~~ 243 (259)
.|+++...
T Consensus 316 ~L~~l~~~ 323 (326)
T 2w1i_A 316 RVDQIRDQ 323 (326)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 99998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=264.83 Aligned_cols=213 Identities=25% Similarity=0.365 Sum_probs=167.8
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++.........++..+..++.|++.||.|||+++
T Consensus 63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 142 (295)
T 2clq_A 63 SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142 (295)
T ss_dssp -HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC
Confidence 35689999999999999999999999999999999999999999999987654444678899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAE 158 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ 158 (259)
++|+||+|+||+++. ++.++|+|||++....... .......++..|+|||++.+.. ++.++||||||+++|+
T Consensus 143 ---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 217 (295)
T 2clq_A 143 ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217 (295)
T ss_dssp ---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHH
T ss_pred ---EEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHH
Confidence 999999999999987 8899999999987654321 1223446899999999987654 7889999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||....... .. ....... ......+...++.+.++|.+||+.||.+|||+.++++
T Consensus 218 l~~g~~pf~~~~~~~---~~---~~~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 218 MATGKPPFYELGEPQ---AA---MFKVGMF----------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp HHHTSCTTGGGSSHH---HH---HHHHHHH----------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred HHHCCCCccCCCchh---HH---HHhhccc----------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999987522110 00 0000000 0000111123467999999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=258.44 Aligned_cols=216 Identities=25% Similarity=0.345 Sum_probs=169.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~ 128 (283)
T 3bhy_A 52 REEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKES---LTEDEATQFLKQILDGVHYLHSKR 128 (283)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999999999999999999999999999999999999999999976432 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCC----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++ .++|+|||++....... ......++..|+|||++.+..++.++||||||+++|
T Consensus 129 ---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 202 (283)
T 3bhy_A 129 ---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202 (283)
T ss_dssp ---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ---ccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHH
Confidence 99999999999998877 79999999987654322 123345899999999998888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE-- 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~-- 235 (259)
+|++|..||.+.... ......... . ...........++.+.+++.+||..||.+|||+.++++
T Consensus 203 ~l~~g~~p~~~~~~~--------~~~~~~~~~-~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~ 267 (283)
T 3bhy_A 203 ILLSGASPFLGETKQ--------ETLTNISAV-N------YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHS 267 (283)
T ss_dssp HHHHSSCTTCCSSHH--------HHHHHHHTT-C------CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCH
T ss_pred HHHHCCCCCCCcchH--------HHHHHhHhc-c------cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCH
Confidence 999999999863211 000000000 0 00000011123467999999999999999999999986
Q ss_pred HHHhcc
Q 025011 236 ELDRLK 241 (259)
Q Consensus 236 ~l~~~~ 241 (259)
.++.+.
T Consensus 268 ~~~~~~ 273 (283)
T 3bhy_A 268 WIKAIR 273 (283)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 455443
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=268.65 Aligned_cols=211 Identities=21% Similarity=0.287 Sum_probs=165.4
Q ss_pred HHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
..+|++++.++ +||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---~~~~~~~~~~~qi~~al~~lH~~g-- 136 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSEREASAVLFTITKTVEYLHAQG-- 136 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT---CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 46789999888 799999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCC----CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDN----YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~----~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||++..+ +.++|+|||++........ ......+++.|+|||++.+..++.++||||||+++|+|
T Consensus 137 -ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 213 (342)
T 2qr7_A 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213 (342)
T ss_dssp -EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred -cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHH
Confidence 9999999999998543 3499999999986654322 22345689999999999887899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+..... .......... +.. ..........++.+.++|.+||..||.+|||+.++++
T Consensus 214 l~g~~Pf~~~~~~~-----~~~~~~~i~~-~~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 214 LTGYTPFANGPDDT-----PEEILARIGS-GKF------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHSSCSSCSSTTSC-----HHHHHHHHHH-CCC------CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hcCCCCCCCCCcCC-----HHHHHHHHcc-CCc------ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999997632111 0111111100 000 0001111123477999999999999999999999875
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=271.12 Aligned_cols=236 Identities=20% Similarity=0.319 Sum_probs=167.1
Q ss_pred HHHHHHHHHh--cCCCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVS--QINHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 4 ~~~~E~~~l~--~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
.+..|.+++. .++||||+++++.+.. ....++||||+++|+|.+++..... ++..++.++.|++.||.|
T Consensus 51 ~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~~~~~~~i~~qi~~~L~~ 126 (336)
T 3g2f_A 51 NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAY 126 (336)
T ss_dssp HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCCB----CHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhccc----chhHHHHHHHHHHHHHHH
Confidence 4455555544 5799999999986543 2356899999999999999976543 678899999999999999
Q ss_pred HhhC---------CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc------ccccccccCcccccCcchhcc-
Q 025011 77 LHSS---------ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ------TAMTTKKIGTFVNLDPEYVIT- 140 (259)
Q Consensus 77 lh~~---------~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------~~~~~~~~~~~~y~aPE~~~~- 140 (259)
||+. + ++|+||||+||+++.++.++|+|||++........ ........|+..|+|||++.+
T Consensus 127 LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 127 LHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp HHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred HHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 9999 8 99999999999999999999999999987654211 112224469999999999976
Q ss_pred ------CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHH---------HHHhhccchhhhhhccccCCchh
Q 025011 141 ------GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQY---------FLYSIENNSLRQILNFQVADESE 205 (259)
Q Consensus 141 ------~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~ 205 (259)
..++.++||||||+++|+|++|..||................ .............+... ....
T Consensus 204 ~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 281 (336)
T 3g2f_A 204 VNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKEN 281 (336)
T ss_dssp CCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCC
T ss_pred cccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccc
Confidence 356788999999999999999976654322211111111000 00000000000000000 1112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhccccccchh
Q 025011 206 MEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISHENYE 248 (259)
Q Consensus 206 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~~~~~~ 248 (259)
...++.+.++|.+||+.||.+|||++++++.|+++........
T Consensus 282 ~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 282 SLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp SHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred cchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 2355789999999999999999999999999999876655443
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=260.57 Aligned_cols=206 Identities=21% Similarity=0.303 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~- 135 (294)
T 2rku_A 60 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR- 135 (294)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||+|+++|+|++|
T Consensus 136 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 211 (294)
T 2rku_A 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 211 (294)
T ss_dssp --EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred --ccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999999999999999976543221 22334689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+..... ....... .... .+...++.+.+++.+||+.||.+|||+.++++
T Consensus 212 ~~p~~~~~~~~--------~~~~~~~---------~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 212 KPPFETSCLKE--------TYLRIKK---------NEYS--IPKHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp SCTTCCSSHHH--------HHHHHHT---------TCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCCCCCCHHH--------HHHHHhh---------ccCC--CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 99997632110 0000000 0000 01122367899999999999999999999976
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=265.85 Aligned_cols=206 Identities=21% Similarity=0.331 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 86 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---l~~~~~~~i~~qi~~aL~~LH~~~- 161 (335)
T 2owb_A 86 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA---LTEPEARYYLRQIVLGCQYLHRNR- 161 (335)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999876533 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+..++.++||||||+++|+|++|
T Consensus 162 --ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 237 (335)
T 2owb_A 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG 237 (335)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS
T ss_pred --CEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC
Confidence 99999999999999999999999999986643221 22334689999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||...... ......... . ... +...++.+.++|.+||+.||.+|||+.++++
T Consensus 238 ~~pf~~~~~~--------~~~~~~~~~-~------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 238 KPPFETSCLK--------ETYLRIKKN-E------YSI----PKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp SCTTCCSSHH--------HHHHHHHHT-C------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCCCCCCCHH--------HHHHHHhcC-C------CCC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999763211 000000000 0 000 1112366899999999999999999999976
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=271.02 Aligned_cols=204 Identities=25% Similarity=0.355 Sum_probs=164.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++..++..++||||+. |++.+++..... .+++..+..++.|++.||.|||+++
T Consensus 99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~- 174 (348)
T 1u5q_A 99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN- 174 (348)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999996 588888865432 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||++...... ....|++.|+|||++. ...++.++||||||+++|+|
T Consensus 175 --ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~el 246 (348)
T 1u5q_A 175 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246 (348)
T ss_dssp --CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHH
Confidence 999999999999999999999999998765432 2346899999999985 45688999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+..... ......... .........++.+.++|.+||+.||.+|||+.++++
T Consensus 247 l~g~~p~~~~~~~~--------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 247 AERKPPLFNMNAMS--------ALYHIAQNE---------SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp HHSSCTTTTSCHHH--------HHHHHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HhCCCCCCCCChHH--------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 99999997632110 011111000 000011122367899999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=271.92 Aligned_cols=230 Identities=15% Similarity=0.206 Sum_probs=175.9
Q ss_pred hHHHHHHHHHhcCCCccccc---------------cceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVK---------------ILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRI 66 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i 66 (259)
+.+.+|++++++++||||++ +++++.. ++..++||||+ +++|.+++..... ..+++..++.+
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~-~~l~~~~~~~i 164 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK-HVLSERSVLQV 164 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG-GCCCHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc-CCCCHHHHHHH
Confidence 35889999999999999988 5667766 67889999999 9999999986532 23688999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCC--ceEEeecCCcccccCCcccc-----ccccccCcccccCcchhc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY--KAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVI 139 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~ 139 (259)
+.|++.||.|||+++ ++|+||||+||+++.++ .++|+|||+++......... ......++..|+|||++.
T Consensus 165 ~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 241 (352)
T 2jii_A 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHK 241 (352)
T ss_dssp HHHHHHHHHHHHHTT---CBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHT
T ss_pred HHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHc
Confidence 999999999999999 99999999999999998 89999999997665432211 123346899999999999
Q ss_pred cCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHh
Q 025011 140 TGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 140 ~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 219 (259)
+..++.++||||||+++|+|++|..||.+..... ............ .......... .....++.+.+++.+|
T Consensus 242 ~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~~l~~li~~~ 313 (352)
T 2jii_A 242 GCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT---EDIMKQKQKFVD--KPGPFVGPCG---HWIRPSETLQKYLKVV 313 (352)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH---HHHHHHHHHHHH--SCCCEECTTS---CEECCCHHHHHHHHHH
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH---HHHHHHHHhccC--Chhhhhhhcc---ccCCCcHHHHHHHHHH
Confidence 8889999999999999999999999998643111 111111110000 0000000000 0001236799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhcccccc
Q 025011 220 LSLSGRRRPTMKQVSEELDRLKISHE 245 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~l~~~~~~~~ 245 (259)
|+.||.+|||+.++++.|+++.....
T Consensus 314 l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 314 MALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp HTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 99999999999999999999876654
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=262.20 Aligned_cols=221 Identities=21% Similarity=0.269 Sum_probs=167.1
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCC-----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETK-----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
..+.+|+.+++.++ ||||+++++++.... ..+++|||+. ++|.+++....... +++..++.++.|++.||
T Consensus 56 ~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~al 133 (308)
T 3g33_A 56 ISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPG-LPAETIKDLMRQFLRGL 133 (308)
T ss_dssp HHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTC-SCHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCC-CCHHHHHHHHHHHHHHH
Confidence 46788998888875 999999999998765 4799999996 59999998765433 68899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
.|||+++ ++|+||||+||+++.++.++|+|||+++...... ......++..|+|||++.+..++.++||||||+
T Consensus 134 ~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 207 (308)
T 3g33_A 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207 (308)
T ss_dssp HHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHH
T ss_pred HHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHH
Confidence 9999999 9999999999999999999999999997654322 223456899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchhhh-------hhccccCC---chhHHHHHHHHHHHHHhccc
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSLRQ-------ILNFQVAD---ESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~---~~~~~~~~~~~~li~~~l~~ 222 (259)
++|+|++|..||.+..... .......... ....+.. .+...... ......++.+.++|.+||+.
T Consensus 208 il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 283 (308)
T 3g33_A 208 IFAEMFRRKPLFCGNSEAD----QLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTF 283 (308)
T ss_dssp HHHHTTTSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCS
T ss_pred HHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcC
Confidence 9999999999998733211 1111111000 0000000 00000000 00012346789999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||+.++++
T Consensus 284 dP~~R~t~~e~l~ 296 (308)
T 3g33_A 284 NPHKRISAFRALQ 296 (308)
T ss_dssp STTTSCCHHHHHT
T ss_pred CCccCCCHHHHhc
Confidence 9999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=277.44 Aligned_cols=206 Identities=23% Similarity=0.251 Sum_probs=161.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-CC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-SA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~ 81 (259)
+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+ .+
T Consensus 193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~g 269 (446)
T 4ejn_A 193 AHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSEDRARFYGAEIVSALDYLHSEKN 269 (446)
T ss_dssp --------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 3467899999999999999999999999999999999999999999976543 6889999999999999999998 89
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+|+||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 270 ---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 344 (446)
T 4ejn_A 270 ---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344 (446)
T ss_dssp ---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ---EEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhh
Confidence 9999999999999999999999999987543321 22334579999999999998889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
|+.||.+.... .. ...... .... .+...++.+.++|.+||+.||.+|| |++++++
T Consensus 345 g~~Pf~~~~~~-----~~---~~~i~~---------~~~~--~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 345 GRLPFYNQDHE-----KL---FELILM---------EEIR--FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp SSCSSCCSSHH-----HH---HHHHHH---------CCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCCCCHH-----HH---HHHHHh---------CCCC--CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 99999763211 00 000000 0000 0112336799999999999999999 9999864
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=276.25 Aligned_cols=208 Identities=25% Similarity=0.366 Sum_probs=166.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++...+..++||||+.+++|.+.+..... +++..+..++.|++.||.|||+++
T Consensus 66 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~al~~lH~~~- 141 (486)
T 3mwu_A 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHN- 141 (486)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999876543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC---CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|+||||+||+++ .++.++|+|||++....... ......|++.|+|||++.+ .++.++||||+|+++|+|
T Consensus 142 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 215 (486)
T 3mwu_A 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215 (486)
T ss_dssp --CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHH
T ss_pred --eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHH
Confidence 99999999999995 45679999999997654322 2234569999999999865 589999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ....... .... ....+.....++.+.++|.+||+.||.+|||+.++++
T Consensus 216 l~g~~pf~~~~~~-----~~~~~i~---~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 216 LSGTPPFYGKNEY-----DILKRVE---TGKY-------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp HHSSCSSCCSSHH-----HHHHHHH---HTCC-------CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCCCHH-----HHHHHHH---hCCC-------CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 9999999873211 1111110 0000 0001111223477999999999999999999999987
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=276.36 Aligned_cols=158 Identities=23% Similarity=0.339 Sum_probs=131.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++++.++||||+++++++... +..|+||||+. ++|.+++..... +++..+..++.||+.||.||
T Consensus 70 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---l~~~~~~~i~~qil~aL~~L 145 (432)
T 3n9x_A 70 KRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIF---LTEEHIKTILYNLLLGENFI 145 (432)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCC---CCHHHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999999766 56899999995 599999976532 68899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc--------------------cccccccCcccccCcch
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT--------------------AMTTKKIGTFVNLDPEY 137 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~--------------------~~~~~~~~~~~y~aPE~ 137 (259)
|+++ |+||||||+||+++.++.++|+|||+++........ .......+|..|+|||+
T Consensus 146 H~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 222 (432)
T 3n9x_A 146 HESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL 222 (432)
T ss_dssp HHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHH
T ss_pred HHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHH
Confidence 9999 999999999999999999999999999876543211 12345578999999998
Q ss_pred h-ccCCcccccchhhHHHHHHHHHhCCCCCC
Q 025011 138 V-ITGKLTEKSDVYSFGVLLAELLTGLKPGS 167 (259)
Q Consensus 138 ~-~~~~~~~~~DiwslG~il~~l~~g~~p~~ 167 (259)
+ ....++.++||||+||++|+|++|..||.
T Consensus 223 ~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 223 ILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp HTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred HhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 6 45568999999999999999998554443
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.12 Aligned_cols=206 Identities=26% Similarity=0.369 Sum_probs=167.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 91 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~- 166 (504)
T 3q5i_A 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---FDECDAANIMKQILSGICYLHKHN- 166 (504)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++ .++|+|||++....... ......|++.|+|||++. ..++.++||||+|+++|+|
T Consensus 167 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~l 240 (504)
T 3q5i_A 167 --IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYIL 240 (504)
T ss_dssp --EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHH
T ss_pred --eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHH
Confidence 99999999999998776 69999999998765432 223456999999999986 4689999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... . ...... ....... .....++.+.++|.+||..||.+|||+.++++
T Consensus 241 l~g~~pf~~~~~~-----~---~~~~i~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 241 LCGYPPFGGQNDQ-----D---IIKKVE---------KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHSSCSSCCSSHH-----H---HHHHHH---------HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCCCCCCCHH-----H---HHHHHH---------cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999873211 0 111110 0000000 01123477999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=271.75 Aligned_cols=221 Identities=22% Similarity=0.319 Sum_probs=163.0
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCC--cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETK--VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+.+++.+. ||||+++++++...+ ..|+||||++ ++|.+++... .+++..+..++.|++.||.|||+
T Consensus 53 ~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~ 127 (388)
T 3oz6_A 53 QRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHS 127 (388)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHh
Confidence 45778999999997 999999999997544 6899999996 5899998764 25778999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc-------------------cccccccccCcccccCcchhcc
Q 025011 80 SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN-------------------QTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
.+ |+||||||+||+++.++.++|+|||+++...... .........||..|+|||++.+
T Consensus 128 ~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 128 GG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp TT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred CC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 99 9999999999999999999999999998654311 1112234479999999999977
Q ss_pred -CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhh-----------hhh----------cc
Q 025011 141 -GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLR-----------QIL----------NF 198 (259)
Q Consensus 141 -~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~----------~~ 198 (259)
..++.++||||+||++|+|++|+.||.+.+.... ...... ........ ... ..
T Consensus 205 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~----~~~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (388)
T 3oz6_A 205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ----LERIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQS 279 (388)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC----
T ss_pred CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCC
Confidence 5689999999999999999999999987432211 101100 00000000 000 00
Q ss_pred ccCCc------------hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 025011 199 QVADE------------SEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236 (259)
Q Consensus 199 ~~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 236 (259)
..... .....++.+.+|+.+||..||.+|||+.++++-
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 280 NKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp -CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCC
Confidence 00000 000223679999999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=266.07 Aligned_cols=228 Identities=23% Similarity=0.336 Sum_probs=174.2
Q ss_pred hHHHHHHHHHhc--CCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQ--INHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~--l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|++++.. ++||||+++++++...+ ..++||||+++|+|.+++.... +++..++.++.|++.||.|
T Consensus 79 ~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~~i~~~l~~ 154 (342)
T 1b6c_B 79 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAH 154 (342)
T ss_dssp HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhccC----ccHHHHHHHHHHHHHHHHH
Confidence 457789999988 68999999999998776 7899999999999999997643 5789999999999999999
Q ss_pred Hh--------hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccC-----
Q 025011 77 LH--------SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITG----- 141 (259)
Q Consensus 77 lh--------~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~----- 141 (259)
|| +.+ ++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++.+.
T Consensus 155 lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 231 (342)
T 1b6c_B 155 LHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH 231 (342)
T ss_dssp HHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC
T ss_pred HHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc
Confidence 99 888 9999999999999999999999999997765432211 22345699999999998765
Q ss_pred -CcccccchhhHHHHHHHHHhC----------CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHH
Q 025011 142 -KLTEKSDVYSFGVLLAELLTG----------LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIE 210 (259)
Q Consensus 142 -~~~~~~DiwslG~il~~l~~g----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (259)
.++.++||||||+++|+|++| ..||............. ..... .......+... ......++
T Consensus 232 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~---~~~~~~~~ 304 (342)
T 1b6c_B 232 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM---RKVVC-EQKLRPNIPNR---WQSCEALR 304 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHH---HHHHT-TSCCCCCCCGG---GGTSHHHH
T ss_pred cccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHH---HHHHH-HHHhCCCCccc---ccchhHHH
Confidence 344789999999999999999 67776532221111111 11110 11110000000 01224557
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHHhccccc
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~~~~ 244 (259)
.+.+++.+||+.||.+|||+.++++.|+++..+.
T Consensus 305 ~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 305 VMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence 8999999999999999999999999999987654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=273.76 Aligned_cols=212 Identities=22% Similarity=0.288 Sum_probs=168.2
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|..++..++||||++++++|.+++..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 120 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g-- 195 (437)
T 4aw2_A 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH-- 195 (437)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 388999999999999999999999999999999999999999999986432 2688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLAE 158 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~~ 158 (259)
|+||||||+||+++.++.++|+|||+++...... ........||+.|+|||++. ...++.++||||+||++|+
T Consensus 196 -iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e 273 (437)
T 4aw2_A 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273 (437)
T ss_dssp -EECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred -eEecccCHHHeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence 9999999999999999999999999997655432 22233457999999999987 4568999999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR--RPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rpt~~~il~ 235 (259)
|++|..||.+.+... .............+ . . .....++.+.+||.+||..+|++ ||+++++++
T Consensus 274 lltG~~Pf~~~~~~~--------~~~~i~~~~~~~~~-p-~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 274 MLYGETPFYAESLVE--------TYGKIMNHKERFQF-P-T----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHSSCTTCCSSHHH--------HHHHHHTHHHHCCC-C-S----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred HHhCCCCCCCCChhH--------HHHhhhhccccccC-C-c----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 999999998732111 01111000000000 0 0 00113367999999999988888 999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.14 Aligned_cols=208 Identities=27% Similarity=0.380 Sum_probs=166.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+.+..... +++..+..++.|++.||.|||+++
T Consensus 81 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~- 156 (494)
T 3lij_A 81 SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEVDAAVIIKQVLSGVTYLHKHN- 156 (494)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999998876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC---CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN---YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+|+||||+||+++.. +.++|+|||++....... ......|++.|+|||++. ..++.++||||+||++|+|
T Consensus 157 --ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~l 230 (494)
T 3lij_A 157 --IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFIL 230 (494)
T ss_dssp --EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHH
T ss_pred --ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHH
Confidence 9999999999999764 459999999997765432 233456999999999885 4689999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ........... ..........++.+.++|.+||+.||.+|||+.++++
T Consensus 231 l~g~~pf~~~~~~--------~~~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 231 LAGYPPFGGQTDQ--------EILRKVEKGKY-------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp HHSSCSSCCSSHH--------HHHHHHHHTCC-------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCCCCCCCCCHH--------HHHHHHHhCCC-------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 9999999873211 01111100000 0001111123467999999999999999999999874
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=262.38 Aligned_cols=226 Identities=19% Similarity=0.199 Sum_probs=174.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeE-EeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGAC-LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++|++++..+..+ ..++..+++|||+ +++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (296)
T 4hgt_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4588999999999988776666555 6677889999999 9999999975433 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhhHH
Q 025011 82 SPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
++|+||||+||++ +.++.++|+|||+++........ .......++..|+|||.+.+..++.++||||+|
T Consensus 126 ---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 202 (296)
T 4hgt_A 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 202 (296)
T ss_dssp ---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHH
T ss_pred ---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHH
Confidence 9999999999999 78899999999999876543221 122345689999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|+|++|+.||.+......... ........... ..... ....++.+.+++.+||+.||.+|||+.++
T Consensus 203 ~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~-~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l 271 (296)
T 4hgt_A 203 YVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMST-PIEVL---------CKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHHHHHHHSSCTTSSCCCSSSSSH-HHHHHHHHHHS-CHHHH---------TTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred HHHHHHhcCCCCCcccchhhhhhh-hhhhhcccccc-hhhhh---------hccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence 999999999999987443221111 01100000000 00000 00123679999999999999999999999
Q ss_pred HHHHHhcccccc
Q 025011 234 SEELDRLKISHE 245 (259)
Q Consensus 234 l~~l~~~~~~~~ 245 (259)
++.|+++..+..
T Consensus 272 ~~~l~~~~~~~~ 283 (296)
T 4hgt_A 272 RQLFRNLFHRQG 283 (296)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHhC
Confidence 999999876554
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=270.83 Aligned_cols=221 Identities=22% Similarity=0.359 Sum_probs=164.1
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+.+
T Consensus 69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~qi~~~l~~LH~~~- 144 (331)
T 4aaa_A 69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHSHN- 144 (331)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4578999999999999999999999999999999999999888887665433 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++........ ......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 145 --ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp --CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred --EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999976544221 22344689999999999775 68999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHH-----------hhccchhhhhhccccCCc-----hhHHHHHHHHHHHHHhcccCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLY-----------SIENNSLRQILNFQVADE-----SEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~ 225 (259)
|..||.+...... ....... .................. .....++.+.++|.+||+.||.
T Consensus 221 g~~pf~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 296 (331)
T 4aaa_A 221 GEPLFPGDSDIDQ----LYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296 (331)
T ss_dssp SSCSCCCSSHHHH----HHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred CCCCCCCCCcHHH----HHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcc
Confidence 9999987432111 0000000 000000000000000000 0112347799999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.++++
T Consensus 297 ~Rpt~~ell~ 306 (331)
T 4aaa_A 297 KRPFCAELLH 306 (331)
T ss_dssp GSCCGGGGGG
T ss_pred cCCCHHHHhc
Confidence 9999999965
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=280.08 Aligned_cols=211 Identities=23% Similarity=0.271 Sum_probs=170.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++.+.+..++||||++||+|.+++...... .+++..+..++.||+.||.|||+++
T Consensus 229 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~-~l~e~~~~~i~~qIl~aL~yLH~~g- 306 (576)
T 2acx_A 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA-GFPEARAVFYAAEICCGLEDLHRER- 306 (576)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSC-CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 45789999999999999999999999999999999999999999999775433 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.++|+|||++....... ......||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 307 --IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG 381 (576)
T 2acx_A 307 --IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG 381 (576)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS
T ss_pred --EeccCCchheEEEeCCCCeEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC
Confidence 9999999999999999999999999998765332 12334799999999999988899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+....... .......... . ...+...++.+.++|.+||+.||.+|| ++.++++
T Consensus 382 ~~PF~~~~~~~~~-~~i~~~i~~~--~------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 382 QSPFQQRKKKIKR-EEVERLVKEV--P------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp SCSSSCSSSCCCH-HHHHHHHHHC--C------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred CCCCcccccchhH-HHHHHHhhcc--c------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 9999874321110 0011100000 0 000112346799999999999999999 6777753
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=276.11 Aligned_cols=217 Identities=20% Similarity=0.257 Sum_probs=160.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++...+ ..|+||||+++ ++.+.+... +++..+..++.|++.||.|
T Consensus 106 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~~-----l~~~~~~~~~~qil~aL~~ 179 (464)
T 3ttj_A 106 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKH 179 (464)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTSC-----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhhc-----CCHHHHHHHHHHHHHHHHH
Confidence 56789999999999999999999997553 46999999965 576666432 5788999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ |+||||||+||+++.++.++|+|||+++..... .......+|..|+|||++.+..++.++||||+||++
T Consensus 180 lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 253 (464)
T 3ttj_A 180 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 253 (464)
T ss_dssp HHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHH
Confidence 99999 999999999999999999999999999865432 123445789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhc------------------------cchhhhhhcccc---CCchhHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIE------------------------NNSLRQILNFQV---ADESEMEEI 209 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~---~~~~~~~~~ 209 (259)
|+|++|+.||.+.+.... .......... .......+.... ........+
T Consensus 254 ~ell~g~~pF~g~~~~~~----~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 329 (464)
T 3ttj_A 254 GEMVRHKILFPGRDYIDQ----WNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKA 329 (464)
T ss_dssp HHHHHSSCSSCCSSHHHH----HHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHH----HHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccC
Confidence 999999999987432211 0000000000 000001111000 011112235
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 210 ETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 210 ~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.+.+||.+||..||.+|||++++++
T Consensus 330 ~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 330 SQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 77999999999999999999999975
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=261.04 Aligned_cols=208 Identities=25% Similarity=0.369 Sum_probs=163.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.+++.++||||+++++++.. +...++||||+++++|.+++..... +++..++.++.|++.||.|||
T Consensus 70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH 146 (290)
T 1t4h_A 70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH 146 (290)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC---CCHHHHHHHHHHHHHHHHHHH
Confidence 568899999999999999999999875 3468999999999999999976533 678999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
+.+ .+++|+||+|+||+++ .++.++|+|||++...... ......++..|+|||.+.+ .++.++||||+|+++|
T Consensus 147 ~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 147 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 220 (290)
T ss_dssp TSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred cCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHH
Confidence 875 3499999999999997 7889999999998654332 2233468999999998864 5899999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+..... ........... ........++.+.++|.+||+.||.+|||+.++++
T Consensus 221 ~l~~g~~pf~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 221 EMATSEYPYSECQNAA-------QIYRRVTSGVK---------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp HHHHSSCTTTTCSSHH-------HHHHHHTTTCC---------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCcCcHH-------HHHHHHhccCC---------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 9999999997632211 00110000000 00111112256999999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=266.91 Aligned_cols=157 Identities=27% Similarity=0.350 Sum_probs=139.9
Q ss_pred hHHHHHHHHHhcCC-----CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-----HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-----h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+..|+.+++.+. ||||+++++++...+..++||||+ +++|.+++....... +++..+..++.|++.||.||
T Consensus 76 ~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~i~~qi~~aL~~L 153 (360)
T 3llt_A 76 RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG-FHIEDIKLYCIEILKALNYL 153 (360)
T ss_dssp HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHH
Confidence 45778999999996 999999999999999999999999 899999998765433 67899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC-------------------------CCceEEeecCCcccccCCccccccccccCcccc
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD-------------------------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVN 132 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~-------------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y 132 (259)
|+++ |+|+||||+||+++. ++.++|+|||++...... .....++..|
T Consensus 154 H~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y 225 (360)
T 3llt_A 154 RKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQY 225 (360)
T ss_dssp HHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGG
T ss_pred HHCC---eeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccc
Confidence 9999 999999999999975 788999999999764332 2345689999
Q ss_pred cCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCC
Q 025011 133 LDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169 (259)
Q Consensus 133 ~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~ 169 (259)
+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 226 ~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 226 RAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp CCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999999999999999863
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=272.76 Aligned_cols=223 Identities=22% Similarity=0.258 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC-C
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS-A 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~ 81 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+. +
T Consensus 76 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~~i~~~l~~lh~~~~ 152 (360)
T 3eqc_A 76 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKHK 152 (360)
T ss_dssp HHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 5689999999999999999999999999999999999999999999976543 67899999999999999999985 8
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||++...... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 153 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 225 (360)
T 3eqc_A 153 ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAV 225 (360)
T ss_dssp ---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHH
T ss_pred ---EEcCCccHHHEEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999998755322 2233468999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHH---------------------HHHHhhccc----hhhhhhccccCCchhHHHHHHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQ---------------------YFLYSIENN----SLRQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~---------------------~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
|..||............... +........ ..................++.+.++|
T Consensus 226 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 305 (360)
T 3eqc_A 226 GRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFV 305 (360)
T ss_dssp TSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHH
Confidence 99999863321100000000 000000000 00000111111111112346799999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 025011 217 SKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il~ 235 (259)
.+||+.||.+|||+.++++
T Consensus 306 ~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 306 NKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp HHHHCSSTTTSCCHHHHHT
T ss_pred HHHhhcChhhCCCHHHHhh
Confidence 9999999999999999975
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=263.71 Aligned_cols=201 Identities=20% Similarity=0.202 Sum_probs=157.1
Q ss_pred HHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+..|+..+..+ +||||+++++++.+++..++||||+ +++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 103 ~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~-- 177 (311)
T 3p1a_A 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG-- 177 (311)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 44455555554 8999999999999999999999999 7799998876543 3688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... ......|++.|+|||++.+ .++.++||||+|+++|+|++|.
T Consensus 178 -ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 178 -LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp -EECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred -EecCCCCHHHEEECCCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987654322 2233458999999999876 7899999999999999999997
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.|+.+... ...+.............++.+.++|.+||+.||.+|||+.++++
T Consensus 253 ~~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 253 ELPHGGEG--------------------WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp CCCSSHHH--------------------HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCccH--------------------HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 76554110 00000111111111123477999999999999999999999974
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.99 Aligned_cols=217 Identities=24% Similarity=0.348 Sum_probs=171.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.++++++||||+++++++. ++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 435 ~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g 511 (656)
T 2j0j_A 435 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKF--SLDLASLILYAYQLSTALAYLESKR 511 (656)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTT--TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 367899999999999999999999985 4678999999999999999976532 2578999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.++|+|||+++...... ........++..|+|||++.+..++.++||||+|+++|+|++
T Consensus 512 ---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 587 (656)
T 2j0j_A 512 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 587 (656)
T ss_dssp ---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccccchHhEEEeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHH
Confidence 9999999999999999999999999998764432 112233456788999999988889999999999999999997
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ...... .... ....+...++.+.++|.+||+.||.+|||+.++++.|+++
T Consensus 588 ~g~~Pf~~~~~~-----~~~~~i---~~~~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 588 HGVKPFQGVKNN-----DVIGRI---ENGE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp TSCCTTTTCCHH-----HHHHHH---HHTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCHH-----HHHHHH---HcCC----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 99999873211 111111 0000 0011112347799999999999999999999999999988
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
...
T Consensus 650 l~~ 652 (656)
T 2j0j_A 650 LEE 652 (656)
T ss_dssp HHH
T ss_pred HHH
Confidence 643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=264.63 Aligned_cols=208 Identities=25% Similarity=0.375 Sum_probs=167.6
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.+.+|+.+++.+ +||||+++++++...+..++||||+++++|.+++..... +++..+..++.|++.||.|||+.
T Consensus 143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~~ 219 (365)
T 2y7j_A 143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA---LSEKETRSIMRSLLEAVSFLHAN 219 (365)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC
Confidence 35688999999999 799999999999999999999999999999999976432 67899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC------CcccccchhhHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG------KLTEKSDVYSFGV 154 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~ 154 (259)
+ ++|+||+|+||+++.++.++|+|||++....... ......|++.|+|||++.+. .++.++||||||+
T Consensus 220 g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 293 (365)
T 2y7j_A 220 N---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGV 293 (365)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHH
T ss_pred C---eecCCCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHH
Confidence 9 9999999999999999999999999987665332 22345689999999998642 5788999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCch--hHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADES--EMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|+|++|..||.+.... ........ ....... ....++.+.++|.+||+.||.+|||+.+
T Consensus 294 il~ell~g~~pf~~~~~~-----~~~~~i~~------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 294 ILFTLLAGSPPFWHRRQI-----LMLRMIME------------GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHHHHHHSSCSSCCSSHH-----HHHHHHHH------------TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCCCHH-----HHHHHHHh------------CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 999999999999763211 11111000 0000000 0112367999999999999999999999
Q ss_pred HHH
Q 025011 233 VSE 235 (259)
Q Consensus 233 il~ 235 (259)
+++
T Consensus 357 ll~ 359 (365)
T 2y7j_A 357 ALQ 359 (365)
T ss_dssp HHH
T ss_pred Hhc
Confidence 975
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=278.62 Aligned_cols=208 Identities=25% Similarity=0.356 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++...+..++||||+.+++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 71 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~- 146 (484)
T 3nyv_A 71 ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSEVDAARIIRQVLSGITYMHKNK- 146 (484)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---CBHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5689999999999999999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||++ +.++.++|+|||++....... ......|++.|+|||++.+ .++.++||||+|+++|+|
T Consensus 147 --ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~l 220 (484)
T 3nyv_A 147 --IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYIL 220 (484)
T ss_dssp --CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHH
T ss_pred --eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHH
Confidence 9999999999999 567899999999987665432 2233469999999999866 689999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... .. ......... ....+.....++.+.++|.+||+.||.+|||+.++++
T Consensus 221 l~g~~pf~~~~~~-----~~---~~~i~~~~~-------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 221 LSGCPPFNGANEY-----DI---LKKVEKGKY-------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp HHSSCSSCCSSHH-----HH---HHHHHHCCC-------CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCHH-----HH---HHHHHcCCC-------CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 9999999873211 01 111100000 0001111223477999999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=271.86 Aligned_cols=204 Identities=25% Similarity=0.273 Sum_probs=159.8
Q ss_pred HHHHHHH-HhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 5 FQHELRV-VSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 5 ~~~E~~~-l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
+.+|..+ ++.++||||+++++++.+.+..|+||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 85 ~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g-- 159 (373)
T 2r5t_A 85 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARFYAAEIASALGYLHSLN-- 159 (373)
T ss_dssp ------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4556665 5678999999999999999999999999999999999976543 577899999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCC
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 163 (259)
|+||||||+||+++.++.++|+|||+++..... ........||+.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 160 -ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 236 (373)
T 2r5t_A 160 -IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236 (373)
T ss_dssp -CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred -ceecCCCHHHEEECCCCCEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCC
Confidence 999999999999999999999999998764332 12234457999999999999988999999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.||.+.... . ... .+....... +...++.+.++|.+||+.||.+||++.+..+
T Consensus 237 ~Pf~~~~~~-----~---~~~---------~i~~~~~~~--~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 237 PPFYSRNTA-----E---MYD---------NILNKPLQL--KPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp CTTCCSBHH-----H---HHH---------HHHHSCCCC--CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred CCCCCCCHH-----H---HHH---------HHHhcccCC--CCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 999863211 0 010 111111110 1123367999999999999999999864433
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=262.38 Aligned_cols=210 Identities=24% Similarity=0.302 Sum_probs=169.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+
T Consensus 69 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~- 145 (314)
T 3com_A 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR- 145 (314)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 5689999999999999999999999999999999999999999999974332 2678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|+|++|
T Consensus 146 --i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 221 (314)
T 3com_A 146 --KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221 (314)
T ss_dssp --EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred --CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999997655421 122344689999999999888899999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+..... ......... . .....+...++.+.++|.+||+.||.+|||+.++++
T Consensus 222 ~~p~~~~~~~~--------~~~~~~~~~-~-------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 222 KPPYADIHPMR--------AIFMIPTNP-P-------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SCTTTTSCHHH--------HHHHHHHSC-C-------CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCCChHH--------HHHHHhcCC-C-------cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99997632110 000000000 0 000011122367999999999999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=274.08 Aligned_cols=211 Identities=21% Similarity=0.265 Sum_probs=166.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+++|..++..++||||+++++++.+++..|+||||+++|+|.+++.+... .+++..+..++.|++.||.|||+++
T Consensus 107 ~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g-- 182 (412)
T 2vd5_A 107 CFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG-- 182 (412)
T ss_dssp CHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 478999999999999999999999999999999999999999999976532 3678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-------cCCcccccchhhHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-------TGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il 156 (259)
|+||||||+||+++.++.++|+|||+++....... .......||+.|+|||++. ...++.++|+|||||++
T Consensus 183 -iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvil 260 (412)
T 2vd5_A 183 -YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFA 260 (412)
T ss_dssp -EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHH
T ss_pred -eeecccCHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHH
Confidence 99999999999999999999999999987654321 1223457999999999987 34689999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC---CCHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR---PTMKQV 233 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---pt~~~i 233 (259)
|+|++|+.||.+..... . ......... ... . .......++.+.++|.+||. +|.+| |+++++
T Consensus 261 yelltG~~Pf~~~~~~~-----~---~~~i~~~~~---~~~--~-p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei 325 (412)
T 2vd5_A 261 YEMFYGQTPFYADSTAE-----T---YGKIVHYKE---HLS--L-PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325 (412)
T ss_dssp HHHHHSSCTTCCSSHHH-----H---HHHHHTHHH---HCC--C-C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH
T ss_pred HHHHhCCCCCCCCCHHH-----H---HHHHHhccc---CcC--C-CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH
Confidence 99999999998732110 0 000000000 000 0 00011234779999999999 99998 588888
Q ss_pred HH
Q 025011 234 SE 235 (259)
Q Consensus 234 l~ 235 (259)
++
T Consensus 326 ~~ 327 (412)
T 2vd5_A 326 RT 327 (412)
T ss_dssp HT
T ss_pred hc
Confidence 54
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=278.68 Aligned_cols=161 Identities=24% Similarity=0.341 Sum_probs=131.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++|+.++||||+++++++... +..|+||||+ +++|.+++..... +++..+..++.||+.||.||
T Consensus 97 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---l~~~~~~~~~~qi~~aL~~L 172 (458)
T 3rp9_A 97 KRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNLLVGVKYV 172 (458)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCC---CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCC---CCHHHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999998543 5689999998 5799999976533 68899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-------------------------cccccccCcccc
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-------------------------AMTTKKIGTFVN 132 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-------------------------~~~~~~~~~~~y 132 (259)
|+.+ |+||||||+||+++.++.++|+|||+++........ .......||..|
T Consensus 173 H~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 249 (458)
T 3rp9_A 173 HSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249 (458)
T ss_dssp HHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTT
T ss_pred HhCC---cCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccc
Confidence 9999 999999999999999999999999999876432111 112334689999
Q ss_pred cCcchh-ccCCcccccchhhHHHHHHHHHh-----------CCCCCCCCc
Q 025011 133 LDPEYV-ITGKLTEKSDVYSFGVLLAELLT-----------GLKPGSGMA 170 (259)
Q Consensus 133 ~aPE~~-~~~~~~~~~DiwslG~il~~l~~-----------g~~p~~~~~ 170 (259)
+|||++ .+..++.++|||||||++|+|++ |.++|.+.+
T Consensus 250 ~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSS 299 (458)
T ss_dssp CCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC---
T ss_pred cChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCc
Confidence 999986 45569999999999999999998 667776643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=276.77 Aligned_cols=208 Identities=20% Similarity=0.210 Sum_probs=167.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++||||+++++++...+..|+||||++||+|.+++..... ...+++..+..++.||+.||.|||+++
T Consensus 230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g 309 (543)
T 3c4z_A 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309 (543)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC
Confidence 4578899999999999999999999999999999999999999999976532 234788999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 310 ---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt 384 (543)
T 3c4z_A 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384 (543)
T ss_dssp ---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ---CcccCCChHHEEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh
Confidence 9999999999999999999999999998765432 12233479999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||.+....... ........ ..... .+...++.+.++|.+||+.||.+||++
T Consensus 385 G~~PF~~~~~~~~~----~~~~~~i~---------~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 385 ARGPFRARGEKVEN----KELKQRVL---------EQAVT--YPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp SSCSSCCTTCCCCH----HHHHHHHH---------HCCCC--CCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCCCCCCCccchhH----HHHHHHHh---------hcccC--CCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 99999874321110 01111110 00000 111234779999999999999999975
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=255.89 Aligned_cols=227 Identities=19% Similarity=0.185 Sum_probs=174.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeE-EeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGAC-LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+.+++.++|++++..+.++ ..++..+++|||+ +++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 49 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4689999999999988766655555 5677889999999 8999999975432 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeC---CCCceEEeecCCcccccCCcccc-----ccccccCcccccCcchhccCCcccccchhhHH
Q 025011 82 SPPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
++|+||||+||+++ .++.++|+|||++.......... ......++..|+|||.+.+..++.++||||||
T Consensus 126 ---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 202 (296)
T 3uzp_A 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 202 (296)
T ss_dssp ---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHH
Confidence 99999999999994 78899999999998765432211 12345699999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|+|++|+.||.+......... ............ ... .....++.+.+++.+||+.||.+|||+.++
T Consensus 203 ~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~-~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 271 (296)
T 3uzp_A 203 YVLMYFNLGSLPWQGLKAATKRQK-YERISEKKMSTP-IEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYL 271 (296)
T ss_dssp HHHHHHHHSSCTTSSCCCSSSSSH-HHHHHHHHHHSC-HHH---------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred HHHHHHHhCCCCCCCcCchhhhhh-hhhhcccccCCc-hHH---------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHH
Confidence 999999999999987433221110 011110000000 000 001123679999999999999999999999
Q ss_pred HHHHHhccccccc
Q 025011 234 SEELDRLKISHEN 246 (259)
Q Consensus 234 l~~l~~~~~~~~~ 246 (259)
++.|+++......
T Consensus 272 ~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 272 RQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHhcCC
Confidence 9999998765543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=270.38 Aligned_cols=222 Identities=23% Similarity=0.345 Sum_probs=166.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++...+..+++|||+++++|.+++..... .+++..++.++.|++.||.|||+++
T Consensus 74 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~- 150 (319)
T 2y4i_B 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHAKG- 150 (319)
T ss_dssp CCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCC--CCCSHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4567899999999999999999999999999999999999999999976542 3577999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCc---cccccccccCcccccCcchhcc---------CCcccccchh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDN---QTAMTTKKIGTFVNLDPEYVIT---------GKLTEKSDVY 150 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~Diw 150 (259)
++|+||+|+||+++ ++.++|+|||++....... .........++..|+|||.+.+ ..++.++|||
T Consensus 151 --i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~ 227 (319)
T 2y4i_B 151 --ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVF 227 (319)
T ss_dssp --CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHH
T ss_pred --ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHH
Confidence 99999999999998 6799999999987553221 1112233458899999999864 3478899999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|||+++|+|++|..||.+.... ........ ..... ......++.+.+++.+||+.||.+|||+
T Consensus 228 slG~il~el~~g~~p~~~~~~~--------~~~~~~~~-~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 290 (319)
T 2y4i_B 228 ALGTIWYELHAREWPFKTQPAE--------AIIWQMGT-GMKPN--------LSQIGMGKEISDILLFCWAFEQEERPTF 290 (319)
T ss_dssp HHHHHHHHHHHSSCSSSSCCHH--------HHHHHHHT-TCCCC--------CCCSSCCTTHHHHHHHHHCSSTTTSCCH
T ss_pred HHHHHHHHHHhCCCCCCCCCHH--------HHHHHhcc-CCCCC--------CCcCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 9999999999999999863211 00110000 00000 0011123568999999999999999999
Q ss_pred HHHHHHHHhccccccch
Q 025011 231 KQVSEELDRLKISHENY 247 (259)
Q Consensus 231 ~~il~~l~~~~~~~~~~ 247 (259)
.++++.|+++.......
T Consensus 291 ~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 291 TKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp HHHHHHHTTC-------
T ss_pred HHHHHHHHHHHHhhccC
Confidence 99999999998775544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=264.12 Aligned_cols=216 Identities=20% Similarity=0.278 Sum_probs=165.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++...+ ..++||||+ +++|.+++.... +++..+..++.|++.||.|
T Consensus 69 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----l~~~~~~~~~~qi~~~L~~ 143 (367)
T 1cm8_A 69 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRY 143 (367)
T ss_dssp HHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHH
Confidence 56889999999999999999999998653 459999999 889999997632 5789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .....++..|+|||++.+ ..++.++||||+||+
T Consensus 144 LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 215 (367)
T 1cm8_A 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 215 (367)
T ss_dssp HHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHH
Confidence 99999 999999999999999999999999999865432 233468999999999887 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh----------ccchhhhhhcc------ccCCchhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI----------ENNSLRQILNF------QVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~ 219 (259)
+++|++|+.||.+.+... .......... ........... ..........++.+.+|+.+|
T Consensus 216 l~ell~g~~pf~~~~~~~----~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~m 291 (367)
T 1cm8_A 216 MAEMITGKTLFKGSDHLD----QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291 (367)
T ss_dssp HHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHH
Confidence 999999999998743211 0111000000 00000000000 000000112346799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|..||.+|||+.++++
T Consensus 292 L~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 292 LVLDAEQRVTAGEALA 307 (367)
T ss_dssp SCSSTTTSCCHHHHHH
T ss_pred ccCChhHCCCHHHHhc
Confidence 9999999999999987
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=262.69 Aligned_cols=208 Identities=25% Similarity=0.337 Sum_probs=167.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++..++..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 126 (304)
T 2jam_A 51 SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDASLVIQQVLSAVKYLHENG- 126 (304)
T ss_dssp -HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4588999999999999999999999999999999999999999999876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++||||+|+++|+|
T Consensus 127 --i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (304)
T 2jam_A 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYIL 200 (304)
T ss_dssp --CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHH
T ss_pred --ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999 78889999999998654322 12234589999999999888899999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... .. ...... ... ..........++.+.++|.+||..||.+|||+.++++
T Consensus 201 ~~g~~pf~~~~~~-----~~---~~~i~~-~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 201 LCGYPPFYEETES-----KL---FEKIKE-GYY------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp HHSSCTTTTSCHH-----HH---HHHHHH-CCC------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHCCCCCCCCCHH-----HH---HHHHHc-CCC------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 9999999763211 00 000000 000 0000111123467999999999999999999999986
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=260.35 Aligned_cols=203 Identities=19% Similarity=0.223 Sum_probs=161.4
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-cccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-QVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+..+..+ +||||+++++++.+++..++||||+++++|.+++..... ...+++..++.++.|++.||.|||++
T Consensus 55 ~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 134 (289)
T 1x8b_A 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM 134 (289)
T ss_dssp HHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678899999999 999999999999999999999999999999999976422 12368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCC-------------------CceEEeecCCcccccCCccccccccccCcccccCcchhccC
Q 025011 81 ASPPIIHGDVKSTNVLLDDN-------------------YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG 141 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~-------------------~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 141 (259)
+ ++|+||||+||+++.+ ..++|+|||.+...... ....++..|+|||.+.+.
T Consensus 135 ~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 135 S---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQEN 205 (289)
T ss_dssp T---EECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTC
T ss_pred C---EeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCC
Confidence 9 9999999999999844 47999999998765432 223489999999999776
Q ss_pred -CcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhc
Q 025011 142 -KLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 142 -~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
.++.++||||||+++|+|++|..++..... .. ....... ...+...++.+.+++.+||
T Consensus 206 ~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-------~~-----~~~~~~~---------~~~~~~~~~~~~~li~~~l 264 (289)
T 1x8b_A 206 YTHLPKADIFALALTVVCAAGAEPLPRNGDQ-------WH-----EIRQGRL---------PRIPQVLSQEFTELLKVMI 264 (289)
T ss_dssp CTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-------HH-----HHHTTCC---------CCCSSCCCHHHHHHHHHHT
T ss_pred CCCCchhhHHHHHHHHHHHhcCCCCCcchhH-------HH-----HHHcCCC---------CCCCcccCHHHHHHHHHHh
Confidence 467899999999999999999877654210 00 0000100 0011123367999999999
Q ss_pred ccCCCCCCCHHHHHH
Q 025011 221 SLSGRRRPTMKQVSE 235 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~ 235 (259)
+.||.+|||+.++++
T Consensus 265 ~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 265 HPDPERRPSAMALVK 279 (289)
T ss_dssp CSSGGGSCCHHHHHT
T ss_pred CCCcccCCCHHHHhh
Confidence 999999999999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=264.91 Aligned_cols=215 Identities=22% Similarity=0.394 Sum_probs=165.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|++++++++||||+++++++.. ++..++||||+++++|.+++.... ....+++..++.++.|++.||.|||+
T Consensus 50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 129 (279)
T 2w5a_A 50 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129 (279)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 568999999999999999999998854 567899999999999999997642 22336889999999999999999998
Q ss_pred CC--CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 80 SA--SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 80 ~~--~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
.+ ..+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|
T Consensus 130 ~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 207 (279)
T 2w5a_A 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 207 (279)
T ss_dssp HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHH
Confidence 76 23499999999999999999999999999876543211 122345889999999999888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 237 (259)
+|++|..||.+.... ...... ...... ..+...++.+.++|.+||+.||.+|||+.++++..
T Consensus 208 ~l~~g~~p~~~~~~~-----~~~~~i----~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 208 ELCALMPPFTAFSQK-----ELAGKI----REGKFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHHHSSCSSCCSSHH-----HHHHHH----HHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHHHCCCCCcccCHH-----HHHHHH----hhcccc---------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 999999999873211 011100 001100 01112346799999999999999999999997643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=265.69 Aligned_cols=220 Identities=16% Similarity=0.218 Sum_probs=159.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||++ ++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~i~~ql~~~l~~LH~~~- 152 (329)
T 3gbz_A 78 GTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD---VSMRVIKSFLYQLINGVNFCHSRR- 152 (329)
T ss_dssp --CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred hhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 457799999999999999999999999999999999996 599999977643 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC-----CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD-----DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLL 156 (259)
Q Consensus 83 ~~i~h~di~p~nil~~-----~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il 156 (259)
++|+||||+||+++ .++.++|+|||+++...... .......++..|+|||++.+.. ++.++||||||+++
T Consensus 153 --ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 228 (329)
T 3gbz_A 153 --CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIW 228 (329)
T ss_dssp --CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred --EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHH
Confidence 99999999999994 45569999999997665321 1223346799999999998754 89999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchhh---------hhhccccCC----chhHHHHHHHHHHHHHhcc
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSLR---------QILNFQVAD----ESEMEEIETVAGLASKCLS 221 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---------~~~~~~~~~----~~~~~~~~~~~~li~~~l~ 221 (259)
|+|++|..||.+..... .......... ....+. ......... ......++.+.+||.+||+
T Consensus 229 ~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 304 (329)
T 3gbz_A 229 AEMLMKTPLFPGDSEID----QLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLE 304 (329)
T ss_dssp HHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTC
T ss_pred HHHHHCCCCcCCCCHHH----HHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHcc
Confidence 99999999998733211 1111111000 000000 000000000 0001123678999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025011 222 LSGRRRPTMKQVSE 235 (259)
Q Consensus 222 ~~p~~Rpt~~~il~ 235 (259)
.||.+|||+.++++
T Consensus 305 ~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 305 MDPVKRISAKNALE 318 (329)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhC
Confidence 99999999999964
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=265.56 Aligned_cols=218 Identities=20% Similarity=0.300 Sum_probs=168.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhh------hhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDH------IHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999998 54422 2347889999999999999999
Q ss_pred Hhh-CCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-Cccc-ccchhhHH
Q 025011 77 LHS-SASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTE-KSDVYSFG 153 (259)
Q Consensus 77 lh~-~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG 153 (259)
||+ ++ ++|+||+|+||+++.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++||||+|
T Consensus 167 lH~~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 239 (348)
T 2pml_X 167 IHNEKN---ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239 (348)
T ss_dssp HHHTSC---EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHH
T ss_pred HhccCC---EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHH
Confidence 999 99 999999999999999999999999999765432 23345689999999999877 5665 99999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccc-hhh----hhh---ccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENN-SLR----QIL---NFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+++|+|++|..||.+..... .. ........ ... ... ............++.+.+++.+||+.||.
T Consensus 240 ~il~~l~~g~~pf~~~~~~~----~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 312 (348)
T 2pml_X 240 ICLYVMFYNVVPFSLKISLV----EL---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312 (348)
T ss_dssp HHHHHHHHSSCSSCCSSCSH----HH---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhCCCCCCCCCcHH----HH---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChh
Confidence 99999999999998643210 00 00000000 000 000 00000000122347799999999999999
Q ss_pred CCCCHHHHHH
Q 025011 226 RRPTMKQVSE 235 (259)
Q Consensus 226 ~Rpt~~~il~ 235 (259)
+|||+.++++
T Consensus 313 ~Rps~~e~l~ 322 (348)
T 2pml_X 313 ERITSEDALK 322 (348)
T ss_dssp GSCCHHHHHT
T ss_pred hCCCHHHHhc
Confidence 9999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=265.52 Aligned_cols=221 Identities=23% Similarity=0.255 Sum_probs=167.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++...+..++||||+++ +|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 57 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~- 132 (346)
T 1ua2_A 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYLHQHW- 132 (346)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCS--SCCSSHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4678999999999999999999999999999999999975 88888876542 2567889999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++.++.++|+|||+++...... .......++..|+|||++.+. .++.++||||||+++|+|++
T Consensus 133 --ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 208 (346)
T 1ua2_A 133 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 208 (346)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred --EECCCCCHHHEEEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH
Confidence 9999999999999999999999999998664322 222345689999999998764 47899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchhhhh------hccccCCch-----hHHHHHHHHHHHHHhcccCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI------LNFQVADES-----EMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|.+||.+.... ............ ...+... ......... ....++.+.++|.+||..||.+||
T Consensus 209 g~~~~~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 284 (346)
T 1ua2_A 209 RVPFLPGDSDL----DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 284 (346)
T ss_dssp SSCSSCCSSHH----HHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred CCCCCCCCCHH----HHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC
Confidence 99998873211 111111111000 0000000 000000000 012246799999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|+.++++
T Consensus 285 t~~ell~ 291 (346)
T 1ua2_A 285 TATQALK 291 (346)
T ss_dssp CHHHHHT
T ss_pred CHHHHhc
Confidence 9999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=269.43 Aligned_cols=221 Identities=24% Similarity=0.308 Sum_probs=155.9
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEe--------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLE--------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASA 73 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~ 73 (259)
+.+.+|+.+++++. ||||+++++++.. ....+++|||+. |+|.+++........+++..++.++.|++.|
T Consensus 70 ~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~ 148 (337)
T 3ll6_A 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148 (337)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence 46889999999996 9999999999843 345799999995 6999988764333347889999999999999
Q ss_pred HHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc----------ccccccCcccccCcchh---cc
Q 025011 74 LDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA----------MTTKKIGTFVNLDPEYV---IT 140 (259)
Q Consensus 74 l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~----------~~~~~~~~~~y~aPE~~---~~ 140 (259)
|.|||+++ ++++|+||||+||+++.++.++|+|||++.......... ......++..|+|||++ .+
T Consensus 149 l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (337)
T 3ll6_A 149 VQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227 (337)
T ss_dssp HHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTT
T ss_pred HHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcccc
Confidence 99999875 349999999999999999999999999998765432211 11134588999999998 45
Q ss_pred CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhc
Q 025011 141 GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 220 (259)
..++.++||||||+++|+|++|..||.+..... ..............+..+.+++.+||
T Consensus 228 ~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~li~~~l 286 (337)
T 3ll6_A 228 FPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR---------------------IVNGKYSIPPHDTQYTVFHSLIRAML 286 (337)
T ss_dssp SCSSHHHHHHHHHHHHHHHHHSSCCC---------------------------------CCCCTTCCSSGGGHHHHHHHS
T ss_pred CCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH---------------------hhcCcccCCcccccchHHHHHHHHHc
Confidence 568899999999999999999999997622110 00000000111111245889999999
Q ss_pred ccCCCCCCCHHHHHHHHHhccccccc
Q 025011 221 SLSGRRRPTMKQVSEELDRLKISHEN 246 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~~l~~~~~~~~~ 246 (259)
+.||.+|||+.++++.|+.+......
T Consensus 287 ~~~p~~Rps~~e~l~~l~~~~~~~~~ 312 (337)
T 3ll6_A 287 QVNPEERLSIAEVVHQLQEIAAARNV 312 (337)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred cCChhhCcCHHHHHHHHHHHHhccCC
Confidence 99999999999999999998765443
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=265.32 Aligned_cols=216 Identities=16% Similarity=0.183 Sum_probs=175.5
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCCcceEEEEecCCCChhhhhhccC--CcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS--SQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+..|+++++.++ |+||+++++++..++..++||||+++|+|.+++.... ....+++..++.++.|++.||.||
T Consensus 109 ~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~l 188 (365)
T 3e7e_A 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188 (365)
T ss_dssp HHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHH
Confidence 46788999999986 9999999999999999999999999999999997531 223478899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC-----------CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD-----------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~-----------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
|+++ |+||||||+||+++. ++.++|+|||+++...............||..|+|||++.+..++.+
T Consensus 189 H~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 265 (365)
T 3e7e_A 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQ 265 (365)
T ss_dssp HTTT---EECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTH
T ss_pred hhCC---eecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCcc
Confidence 9999 999999999999998 89999999999976553333334455679999999999999889999
Q ss_pred cchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 147 SDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 147 ~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+||||||+++|+|++|+.||....... ......+.. . ...+.+.+++..||+.+|.+
T Consensus 266 ~DiwslG~il~elltg~~pf~~~~~~~----------------~~~~~~~~~-~------~~~~~~~~~~~~~l~~~p~~ 322 (365)
T 3e7e_A 266 IDYFGVAATVYCMLFGTYMKVKNEGGE----------------CKPEGLFRR-L------PHLDMWNEFFHVMLNIPDCH 322 (365)
T ss_dssp HHHHHHHHHHHHHHHSSCCCEEEETTE----------------EEECSCCTT-C------SSHHHHHHHHHHHHCCCCTT
T ss_pred ccHHHHHHHHHHHHhCCCccccCCCCc----------------eeechhccc-c------CcHHHHHHHHHHHcCCCCCC
Confidence 999999999999999999986522110 000010000 0 11356889999999999999
Q ss_pred C-CCHHHHHHHHHhccccc
Q 025011 227 R-PTMKQVSEELDRLKISH 244 (259)
Q Consensus 227 R-pt~~~il~~l~~~~~~~ 244 (259)
| |+++++.+.|+++-...
T Consensus 323 r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 323 HLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp CCCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHHHHHh
Confidence 8 68888888888876553
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=270.16 Aligned_cols=208 Identities=25% Similarity=0.352 Sum_probs=156.8
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|++++++++||||+++++++.. +..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 186 ~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~-- 259 (419)
T 3i6u_A 186 NVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG-- 259 (419)
T ss_dssp CHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCC---CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 47899999999999999999999854 557999999999999999876543 688999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCC---ceEEeecCCcccccCCccccccccccCcccccCcchhcc---CCcccccchhhHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNY---KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~---~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~ 157 (259)
++|+||||+||+++.++ .++|+|||+++..... .......|++.|+|||++.+ ..++.++||||||+++|
T Consensus 260 -ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ 335 (419)
T 3i6u_A 260 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335 (419)
T ss_dssp -CCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHH
T ss_pred -ccccCCChHhEEEecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHH
Confidence 99999999999997544 5999999999875432 12234568999999999853 55788999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+...... ....... .... .........++.+.++|.+||+.||.+|||+.++++
T Consensus 336 ~lltg~~pf~~~~~~~~----~~~~i~~----~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 336 ICLSGYPPFSEHRTQVS----LKDQITS----GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp HHHHSSCSSCCCSSSCC----HHHHHHT----TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCCCCcchHH----HHHHHhc----CCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 99999999976322111 0000000 0000 000001123467999999999999999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=261.61 Aligned_cols=212 Identities=21% Similarity=0.288 Sum_probs=166.6
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.+.+|+.+++.+. ||||+++++++...+..++||||+++++|.+++...... .+++..++.++.|++.||.|||++
T Consensus 72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~i~~ql~~~L~~LH~~ 150 (327)
T 3lm5_A 72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE-MVSENDVIRLIKQILEGVYYLHQN 150 (327)
T ss_dssp HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-C-CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 357889999999994 699999999999999999999999999999998654332 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
+ ++|+||||+||+++. ++.++|+|||+++...... ......+++.|+|||++.+..++.++||||||+++|
T Consensus 151 g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224 (327)
T ss_dssp T---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred C---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHH
Confidence 9 999999999999998 7899999999998765332 223346899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+..... ........ ............++.+.++|.+||+.||.+|||+.++++
T Consensus 225 ~ll~g~~pf~~~~~~~-----~~~~i~~~----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 225 MLLTHTSPFVGEDNQE-----TYLNISQV----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp HHHHSSCSSCCSSHHH-----HHHHHHHT----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCCCCchH-----HHHHHHhc----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 9999999997632110 00000000 000111111123467999999999999999999999965
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=266.52 Aligned_cols=218 Identities=20% Similarity=0.299 Sum_probs=161.0
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
+.+|+++++.++||||+++++++..++..++||||++ ++|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 47 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--- 120 (324)
T 3mtl_A 47 AIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK--- 120 (324)
T ss_dssp CCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---
Confidence 4579999999999999999999999999999999996 589998876543 3678999999999999999999999
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHhCC
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGL 163 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~ 163 (259)
++|+||||+||+++.++.++|+|||++....... .......++..|+|||++.+ ..++.++||||+|+++|+|++|+
T Consensus 121 ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (324)
T 3mtl_A 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198 (324)
T ss_dssp EEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCcCHHHEEECCCCCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987554321 12233468999999999876 45899999999999999999999
Q ss_pred CCCCCCccccccchhHHHHHHHhhc---cchhhhhhc---------cccCCc----hhHHHHHHHHHHHHHhcccCCCCC
Q 025011 164 KPGSGMALASNEGISMVQYFLYSIE---NNSLRQILN---------FQVADE----SEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 164 ~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~---------~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
.||.+..... .......... ...+..... ...... .....++.+.+||.+||+.||.+|
T Consensus 199 ~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 273 (324)
T 3mtl_A 199 PLFPGSTVEE-----QLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNR 273 (324)
T ss_dssp CSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCHHH-----HHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccC
Confidence 9998743211 1111111000 000000000 000000 001224678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||+.++++
T Consensus 274 ~t~~e~l~ 281 (324)
T 3mtl_A 274 ISAEDAMK 281 (324)
T ss_dssp CCHHHHTT
T ss_pred CCHHHHhc
Confidence 99999976
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=265.46 Aligned_cols=221 Identities=23% Similarity=0.336 Sum_probs=158.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-----CCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-----SSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++... .....+++..++.++.|++.||.||
T Consensus 58 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 137 (303)
T 2vwi_A 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137 (303)
T ss_dssp --------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45788999999999999999999999999999999999999999998642 1223468899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc---ccccccccCcccccCcchhcc-CCcccccchhhHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ---TAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFG 153 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG 153 (259)
|+++ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||++.+ ..++.++||||||
T Consensus 138 H~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 214 (303)
T 2vwi_A 138 HKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214 (303)
T ss_dssp HHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHH
T ss_pred HhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHH
Confidence 9999 99999999999999999999999999876543221 111233468999999999875 4588999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
+++|+|++|..||.+...... ..... ................ ....++.+.+++.+||+.||.+|||+.++
T Consensus 215 ~il~~l~~g~~pf~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~l 285 (303)
T 2vwi_A 215 ITAIELATGAAPYHKYPPMKV----LMLTL-QNDPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAEL 285 (303)
T ss_dssp HHHHHHHHSSCTTTTSCGGGH----HHHHH-TSSCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHHHHhCCCCCccCchhhH----HHHHh-ccCCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHH
Confidence 999999999999987432110 00000 0000000000000000 01123678999999999999999999999
Q ss_pred HH
Q 025011 234 SE 235 (259)
Q Consensus 234 l~ 235 (259)
++
T Consensus 286 l~ 287 (303)
T 2vwi_A 286 LR 287 (303)
T ss_dssp HT
T ss_pred hh
Confidence 75
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=260.80 Aligned_cols=218 Identities=20% Similarity=0.272 Sum_probs=165.4
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
++.+.+|+++++.++ ||||+++++++.. ....+++|||+.+++|.+++.. +++..+..++.|++.||.|||
T Consensus 74 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH 147 (330)
T 3nsz_A 74 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCH 147 (330)
T ss_dssp HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHH
Confidence 357899999999997 9999999999987 6678999999999999999854 467899999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il 156 (259)
+++ ++|+||||+||+++.++ .++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 148 ~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 221 (330)
T 3nsz_A 148 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCML 221 (330)
T ss_dssp HTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred hCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHH
Confidence 999 99999999999999776 89999999997655332 2234468899999999877 5689999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhh-----------------------ccccCCchhHHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQIL-----------------------NFQVADESEMEEIETVA 213 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~ 213 (259)
|+|++|..||........ ....... ........... ............++.+.
T Consensus 222 ~~ll~g~~p~~~~~~~~~---~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (330)
T 3nsz_A 222 ASMIFRKEPFFHGHDNYD---QLVRIAK-VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL 297 (330)
T ss_dssp HHHHHTCSSSSCCSSHHH---HHHHHHH-HHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHH
T ss_pred HHHHhCCCCcccCCchHH---HHHHHHH-hcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHH
Confidence 999999999854221110 1110000 00000000000 00001111112347899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|.+||+.||.+|||++++++
T Consensus 298 ~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 298 DFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCcccCCCHHHHhc
Confidence 9999999999999999999975
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=258.70 Aligned_cols=209 Identities=21% Similarity=0.272 Sum_probs=163.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE--eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL--ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|+++++.++||||+++++++. +.+..++||||+.++ +.+++...... .+++..++.++.|++.||.|||++
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~ 128 (305)
T 2wtk_C 51 ANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYLHSQ 128 (305)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTC-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccc-ccCHHHHHHHHHHHHHHHHHHHHC
Confidence 56889999999999999999999984 456789999999775 77777664433 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAE 158 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~ 158 (259)
+ ++|+||+|+||+++.++.++|+|||++................++..|+|||++.+.. ++.++||||||+++|+
T Consensus 129 ~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~ 205 (305)
T 2wtk_C 129 G---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYN 205 (305)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHH
T ss_pred C---eeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHH
Confidence 9 9999999999999999999999999998765432233334456899999999987644 4779999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|..||.+.... ........ .. .. .+...++.+.++|.+||+.||.+|||+.++++
T Consensus 206 l~~g~~p~~~~~~~--------~~~~~i~~-~~--------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 206 ITTGLYPFEGDNIY--------KLFENIGK-GS--------YA--IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp HHHSSCSCCCSSHH--------HHHHHHHH-CC--------CC--CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCchHH--------HHHHHHhc-CC--------CC--CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999863211 00110000 00 00 01123367899999999999999999999985
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=256.99 Aligned_cols=205 Identities=26% Similarity=0.364 Sum_probs=160.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~- 131 (276)
T 2h6d_A 56 GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEEMEARRLFQQILSAVDYCHRHM- 131 (276)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 4688999999999999999999999999999999999999999999976543 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||.+.+..+ +.++||||||+++|+|++
T Consensus 132 --i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~ 206 (276)
T 2h6d_A 132 --VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC 206 (276)
T ss_dssp --SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred --CccCCCChhhEEECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence 9999999999999999999999999987654321 1233468899999999987765 689999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.... .. ...... . ... .+...+..+.++|.+||+.||.+|||+.++++
T Consensus 207 g~~p~~~~~~~-----~~---~~~~~~-~--------~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 207 GTLPFDDEHVP-----TL---FKKIRG-G--------VFY--IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp SSCSSCCSSHH-----HH---HHHHHH-C--------CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCcHH-----HH---HHHhhc-C--------ccc--CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 99999763210 00 000000 0 000 01112366899999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=264.31 Aligned_cols=210 Identities=24% Similarity=0.353 Sum_probs=160.4
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEe------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLE------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.+.+|+.+++.+ +||||+++++++.. .+..++||||+++++|.+++..... ..+++..++.++.|++.||.
T Consensus 65 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~ 143 (326)
T 2x7f_A 65 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLS 143 (326)
T ss_dssp HHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-GCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc-CCCCHHHHHHHHHHHHHHHH
Confidence 5689999999999 79999999999987 4678999999999999999986532 23678899999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchh
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVY 150 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~Diw 150 (259)
|||+++ ++|+||+|+||+++.++.++|+|||++....... .......++..|+|||++. +..++.++|||
T Consensus 144 ~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999999 9999999999999999999999999987654321 1223346899999999987 45688999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|||+++|+|++|..||.+..... ........ .. ........++.+.++|.+||..||.+|||+
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 281 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPMR--------ALFLIPRN-PA--------PRLKSKKWSKKFQSFIESCLVKNHSQRPAT 281 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHS-CC--------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcC-cc--------ccCCccccCHHHHHHHHHHhccChhhCCCH
Confidence 99999999999999997632110 00000000 00 000011123679999999999999999999
Q ss_pred HHHHH
Q 025011 231 KQVSE 235 (259)
Q Consensus 231 ~~il~ 235 (259)
.++++
T Consensus 282 ~~ll~ 286 (326)
T 2x7f_A 282 EQLMK 286 (326)
T ss_dssp HHHHT
T ss_pred HHHhh
Confidence 99987
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=269.25 Aligned_cols=164 Identities=22% Similarity=0.336 Sum_probs=130.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC------CcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS------SQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+.+++.++||||+++++++.. +...++||||+. ++|.+++.... ....+++..++.++.||+.||
T Consensus 63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 141 (405)
T 3rgf_A 63 MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141 (405)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 568899999999999999999999954 668899999995 58888875321 122368899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEe----CCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccC-Ccccccc
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLL----DDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITG-KLTEKSD 148 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~----~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~-~~~~~~D 148 (259)
.|||+++ |+|+||||+||++ +.++.++|+|||+++........ .......|+..|+|||++.+. .++.++|
T Consensus 142 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 218 (405)
T 3rgf_A 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID 218 (405)
T ss_dssp HHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred HHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhh
Confidence 9999999 9999999999999 67789999999999876543211 223345689999999999874 4899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCc
Q 025011 149 VYSFGVLLAELLTGLKPGSGMA 170 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~~ 170 (259)
||||||++|+|++|..||.+..
T Consensus 219 iwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 219 IWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp HHHHHHHHHHHHHSSCTTCCCC
T ss_pred hHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999997643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=271.03 Aligned_cols=208 Identities=15% Similarity=0.137 Sum_probs=158.2
Q ss_pred hHHHHHHH---HHhcCCCccccccc-------eeEEeCCc-----------------ceEEEEecCCCChhhhhhccCCc
Q 025011 3 QVFQHELR---VVSQINHKNVVKIL-------GACLETKV-----------------PLLVYEFVPNGTLFDHIHDKSSQ 55 (259)
Q Consensus 3 ~~~~~E~~---~l~~l~h~~iv~~~-------~~~~~~~~-----------------~~lv~e~~~~~~L~~~l~~~~~~ 55 (259)
+.+.+|+. +++.++||||++++ +++...+. .+++|||+ +|+|.+++......
T Consensus 118 ~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~ 196 (377)
T 3byv_A 118 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 196 (377)
T ss_dssp HHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc
Confidence 56889994 55555899999998 66665532 78999999 67999999764221
Q ss_pred ----ccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCccc
Q 025011 56 ----VLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFV 131 (259)
Q Consensus 56 ----~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 131 (259)
..+++..++.++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++.... ......| ..
T Consensus 197 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~ 267 (377)
T 3byv_A 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RG 267 (377)
T ss_dssp TTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TT
T ss_pred ccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cC
Confidence 11235788889999999999999999 99999999999999999999999999875332 2233457 99
Q ss_pred ccCcchhccC-----------CcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhcccc
Q 025011 132 NLDPEYVITG-----------KLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQV 200 (259)
Q Consensus 132 y~aPE~~~~~-----------~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (259)
|+|||++.+. .++.++||||||+++|+|++|..||.+...... ...+....
T Consensus 268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~-----------------~~~~~~~~- 329 (377)
T 3byv_A 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG-----------------SEWIFRSC- 329 (377)
T ss_dssp CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CC-----------------SGGGGSSC-
T ss_pred ccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccc-----------------hhhhhhhc-
Confidence 9999999887 789999999999999999999999976322110 00111100
Q ss_pred CCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHHhcccc
Q 025011 201 ADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE--ELDRLKIS 243 (259)
Q Consensus 201 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~--~l~~~~~~ 243 (259)
...++.+.++|.+||+.||.+|||+.++++ .++++...
T Consensus 330 -----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 369 (377)
T 3byv_A 330 -----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 369 (377)
T ss_dssp -----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred -----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence 112367999999999999999999999986 55554433
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=264.51 Aligned_cols=217 Identities=20% Similarity=0.282 Sum_probs=157.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++...+ ..++||||+.+ +|.+.+... +++..+..++.|++.||.|
T Consensus 69 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~i~~qi~~al~~ 142 (371)
T 2xrw_A 69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME-----LDHERMSYLLYQMLCGIKH 142 (371)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHSC-----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhhc-----cCHHHHHHHHHHHHHHHHH
Confidence 46789999999999999999999998655 67999999964 788888532 5778999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .......++..|+|||++.+..++.++||||+|+++
T Consensus 143 lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 216 (371)
T 2xrw_A 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 216 (371)
T ss_dssp HHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred HHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHH
Confidence 99999 999999999999999999999999999765432 122345689999999999998899999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHH------------------hh-c-----cchhhhhhccc---cCCchhHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLY------------------SI-E-----NNSLRQILNFQ---VADESEMEEI 209 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------~~-~-----~~~~~~~~~~~---~~~~~~~~~~ 209 (259)
|+|++|..||.+.+.... ....... .. . ........... .........+
T Consensus 217 ~el~~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (371)
T 2xrw_A 217 GEMIKGGVLFPGTDHIDQ----WNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKA 292 (371)
T ss_dssp HHHHHSSCSSCCSSHHHH----HHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHHH----HHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCccccccccccc
Confidence 999999999987432110 0000000 00 0 00000000000 0111122346
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 210 ETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 210 ~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.+.+||.+||..||.+|||++++++
T Consensus 293 ~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 293 SQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 78999999999999999999999976
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-40 Score=265.88 Aligned_cols=211 Identities=24% Similarity=0.292 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.+ +||||+++++++..++..++||||+++++|.+++..... +++..+..++.|++.||.|||+++
T Consensus 103 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~~ 179 (355)
T 1vzo_A 103 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG 179 (355)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999 699999999999999999999999999999999976543 678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC--CcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG--KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~~l 159 (259)
++|+||||+||+++.++.++|+|||+++...... ........|+..|+|||++.+. .++.++||||||+++|+|
T Consensus 180 ---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~el 255 (355)
T 1vzo_A 180 ---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 255 (355)
T ss_dssp ---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred ---cccCCCCHHHEEECCCCcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999987654321 2223345699999999999863 478899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVS 234 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il 234 (259)
++|..||......... ......... .. ...+...++.+.++|.+||..||.+|| |+++++
T Consensus 256 l~g~~pf~~~~~~~~~----~~~~~~~~~---------~~--~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell 320 (355)
T 1vzo_A 256 LTGASPFTVDGEKNSQ----AEISRRILK---------SE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 320 (355)
T ss_dssp HHSSCTTSCTTSCCCH----HHHHHHHHH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred HHCCCCCccCCccchH----HHHHHHHhc---------cC--CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHH
Confidence 9999999753221111 011110000 00 001112336789999999999999999 888885
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 321 ~ 321 (355)
T 1vzo_A 321 E 321 (355)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=262.50 Aligned_cols=225 Identities=20% Similarity=0.280 Sum_probs=164.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|+++++.++||||+++++++.. ++..++||||+++ +|.+.+...... +++..++.++.|++.||
T Consensus 61 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~--~~~~~~~~i~~qi~~~l 137 (351)
T 3mi9_A 61 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVK--FTLSEIKRVMQMLLNGL 137 (351)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSC--CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCC--CCHHHHHHHHHHHHHHH
Confidence 467899999999999999999999987 4468999999965 787777655332 68899999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc--ccccccccCcccccCcchhccC-Ccccccchhh
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ--TAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYS 151 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws 151 (259)
.|||+++ ++|+||||+||+++.++.++|+|||+++....... ........+++.|+|||++.+. .++.++||||
T Consensus 138 ~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 214 (351)
T 3mi9_A 138 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 214 (351)
T ss_dssp HHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHH
T ss_pred HHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHH
Confidence 9999999 99999999999999999999999999987653221 1222345689999999998764 5799999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhh--------hccccC-Cchh------HHHHHHHHHHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQI--------LNFQVA-DESE------MEEIETVAGLA 216 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~------~~~~~~~~~li 216 (259)
||+++|+|++|..||.+...... ................... ...... .... ...++.+.+||
T Consensus 215 lG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 292 (351)
T 3mi9_A 215 AGCIMAEMWTRSPIMQGNTEQHQ--LALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLI 292 (351)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHH
Confidence 99999999999999987332110 0000000000000000000 000000 0000 01135689999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 025011 217 SKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il~ 235 (259)
.+||+.||.+|||+.++++
T Consensus 293 ~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 293 DKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHSCSSGGGSCCHHHHHT
T ss_pred HHHhcCChhhCCCHHHHhC
Confidence 9999999999999999965
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=254.10 Aligned_cols=210 Identities=24% Similarity=0.362 Sum_probs=167.7
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.+.+|+++++++. ||||+++++++..++..++||||+++++|.+++..... +++..++.++.|++.||.|||++
T Consensus 67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH~~ 143 (298)
T 1phk_A 67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKL 143 (298)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHC
Confidence 356889999999995 99999999999999999999999999999999976532 67899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc------cCCcccccchhhHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI------TGKLTEKSDVYSFGV 154 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~ 154 (259)
+ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++. ...++.++||||||+
T Consensus 144 ~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~ 217 (298)
T 1phk_A 144 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 217 (298)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred C---cccCCCCcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHH
Confidence 9 9999999999999999999999999987655322 223346899999999985 345788999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++|+|++|..||.+.... ....... .. .. ..........++.+.+++.+||+.||.+|||+.+++
T Consensus 218 ~l~~l~~g~~p~~~~~~~-----~~~~~~~---~~-~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 218 IMYTLLAGSPPFWHRKQM-----LMLRMIM---SG-NY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHHHSSCSSCCSSHH-----HHHHHHH---HT-CC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHHHHHCCCCCcCccHH-----HHHHHHh---cC-Cc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 999999999999763211 0000000 00 00 000011122346799999999999999999999996
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 283 ~ 283 (298)
T 1phk_A 283 A 283 (298)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=271.01 Aligned_cols=221 Identities=22% Similarity=0.218 Sum_probs=159.5
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCCc------ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETKV------PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
..+|+++++.++||||+++++++...+. .++||||++++.+............+++..+..++.|++.||.|||
T Consensus 79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH 158 (394)
T 4e7w_A 79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158 (394)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3479999999999999999999965443 7899999976443333322222233678999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il 156 (259)
+++ |+||||||+||+++ .++.++|+|||+++...... ......++..|+|||++.+. .++.++||||+||++
T Consensus 159 ~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il 232 (394)
T 4e7w_A 159 SIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVM 232 (394)
T ss_dssp HTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 999 99999999999998 78999999999998754322 22344689999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhc---------cchhh-hhhccccCCc----hhHHHHHHHHHHHHHhccc
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIE---------NNSLR-QILNFQVADE----SEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~-~~~~~~~~~~----~~~~~~~~~~~li~~~l~~ 222 (259)
|+|++|+.||.+.+... ........... ..... ..+....... .....++.+.+||.+||..
T Consensus 233 ~ell~g~~pf~~~~~~~----~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 233 AELMQGQPLFPGESGID----QLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 99999999998743211 11111110000 00000 0000000000 0011346799999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||+.++++
T Consensus 309 dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 309 TPSARLTAIEALC 321 (394)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=260.36 Aligned_cols=210 Identities=23% Similarity=0.293 Sum_probs=163.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++...... +++..++.++.|++.||.|||+++
T Consensus 61 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~- 137 (302)
T 2j7t_A 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVVCRQMLEALNFLHSKR- 137 (302)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSC--CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccC--CCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 56889999999999999999999999999999999999999999998764332 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||++...... ........++..|+|||++. +..++.++||||||+++|
T Consensus 138 --i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 213 (302)
T 2j7t_A 138 --IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213 (302)
T ss_dssp --CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHH
T ss_pred --cccCCCCHHHEEECCCCCEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHH
Confidence 999999999999999999999999987543221 11123346899999999984 556889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||....... .......... .....+...+..+.++|.+||+.||.+|||+.++++
T Consensus 214 ~l~~g~~p~~~~~~~~--------~~~~~~~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 214 EMAQIEPPHHELNPMR--------VLLKIAKSDP--------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp HHHHSSCTTTTSCHHH--------HHHHHHHSCC--------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred HHhcCCCCCccCCHHH--------HHHHHhccCC--------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 9999999998632110 0000000000 000111123467999999999999999999999965
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=266.37 Aligned_cols=223 Identities=22% Similarity=0.246 Sum_probs=166.0
Q ss_pred hHHHHHHHHHhcCC--------CccccccceeEE----eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN--------HKNVVKILGACL----ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAET 70 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--------h~~iv~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i 70 (259)
+.+.+|+++++.++ |+||+++++++. .+...++||||+ ++++.+.+...... .+++..++.++.|+
T Consensus 78 ~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~-~~~~~~~~~i~~qi 155 (397)
T 1wak_A 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ-GLPLPCVKKIIQQV 155 (397)
T ss_dssp HHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTS-CCCHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccC-CCCHHHHHHHHHHH
Confidence 56889999999995 788999999988 455789999999 66777777654332 26889999999999
Q ss_pred HHHHHHHhhC-CCCCeEeCCCCCCCeEeCCCC------------------------------------------------
Q 025011 71 ASALDYLHSS-ASPPIIHGDVKSTNVLLDDNY------------------------------------------------ 101 (259)
Q Consensus 71 ~~~l~~lh~~-~~~~i~h~di~p~nil~~~~~------------------------------------------------ 101 (259)
+.||.|||++ + |+|+||||+||+++.++
T Consensus 156 ~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (397)
T 1wak_A 156 LQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK 232 (397)
T ss_dssp HHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred HHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence 9999999998 9 99999999999999775
Q ss_pred -ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccc-hhH
Q 025011 102 -KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEG-ISM 179 (259)
Q Consensus 102 -~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~-~~~ 179 (259)
.++|+|||++...... .....+|..|+|||++.+..++.++|||||||++|+|++|..||.+........ ...
T Consensus 233 ~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 233 LKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp CCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred cceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999765432 233468999999999999889999999999999999999999998643321110 000
Q ss_pred HHHHHHhhccc--------h-hhhhhcc----------c---------cCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 180 VQYFLYSIENN--------S-LRQILNF----------Q---------VADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 180 ~~~~~~~~~~~--------~-~~~~~~~----------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
........... . ....... . .........++.+.+||.+||+.||.+|||+.
T Consensus 308 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 387 (397)
T 1wak_A 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387 (397)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred HHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence 00000000000 0 0000000 0 00012345567899999999999999999999
Q ss_pred HHHH
Q 025011 232 QVSE 235 (259)
Q Consensus 232 ~il~ 235 (259)
++++
T Consensus 388 e~l~ 391 (397)
T 1wak_A 388 ECLR 391 (397)
T ss_dssp HHHT
T ss_pred HHhh
Confidence 9974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=280.92 Aligned_cols=201 Identities=26% Similarity=0.287 Sum_probs=166.2
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|..++..+ +||+|+++++++.+.+..|+||||+++|+|.+++..... +++..+..++.||+.||.|||+++
T Consensus 386 ~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---~~~~~~~~~~~qi~~aL~~LH~~g 462 (674)
T 3pfq_A 386 ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FKEPHAVFYAAEIAIGLFFLQSKG 462 (674)
T ss_dssp HHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTS
T ss_pred HHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4578899999988 799999999999999999999999999999999987543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|+||||+++|+|++
T Consensus 463 ---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt 537 (674)
T 3pfq_A 463 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537 (674)
T ss_dssp ---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH
T ss_pred ---eEeccCChhhEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc
Confidence 9999999999999999999999999997543321 22345579999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 230 (259)
|..||.+.+.. .... .+....... +...++.+.+||.+||+.||.+||++
T Consensus 538 G~~Pf~~~~~~--------~~~~---------~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 538 GQAPFEGEDED--------ELFQ---------SIMEHNVAY--PKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp SSCSSCCSSHH--------HHHH---------HHHSSCCCC--CTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred CCCCCCCCCHH--------HHHH---------HHHhCCCCC--CccCCHHHHHHHHHHccCCHHHCCCC
Confidence 99999873211 1111 111111111 11234779999999999999999997
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=261.89 Aligned_cols=208 Identities=26% Similarity=0.362 Sum_probs=162.3
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
.+.+|+++++.++||||+++++++..++ .++||||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 61 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~-- 134 (322)
T 2ycf_A 61 NVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKR---LKEATCKLYFYQMLLAVQYLHENG-- 134 (322)
T ss_dssp CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCC---CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHCC--
Confidence 4789999999999999999999987654 7999999999999999875433 678999999999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCccccccccccCcccccCcchhc---cCCcccccchhhHHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI---TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||++. ...++.++||||||+++|
T Consensus 135 -ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~ 210 (322)
T 2ycf_A 135 -IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 210 (322)
T ss_dssp -EECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHH
T ss_pred -eeccCCCHHHEEEecCCCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHH
Confidence 999999999999987665 9999999997654321 122345899999999974 456889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||.+...... ....... .... .........++.+.++|.+||+.||.+|||+.++++
T Consensus 211 ~l~~g~~pf~~~~~~~~----~~~~~~~----~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 211 ICLSGYPPFSEHRTQVS----LKDQITS----GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHHHSSCSSCSTTCSSC----HHHHHHH----TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhCCCCCcccchHHH----HHHHHHh----Cccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 99999999976332111 0011100 0000 000001123467999999999999999999999974
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=262.35 Aligned_cols=221 Identities=20% Similarity=0.278 Sum_probs=165.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|++++++++||||+++++++... ...+++|||+. ++|.+++.... +++..+..++.|++.||.||
T Consensus 70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~~----~~~~~~~~i~~qi~~aL~~L 144 (364)
T 3qyz_A 70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQH----LSNDHICYFLYQILRGLKYI 144 (364)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhCC----CCHHHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999999764 36799999996 59999987643 67899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
|+++ ++|+||||+||+++.++.++|+|||++.......... ......|++.|+|||++.+. .++.++||||+|++
T Consensus 145 H~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 221 (364)
T 3qyz_A 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCI 221 (364)
T ss_dssp HHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHH
T ss_pred HHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHH
Confidence 9999 9999999999999999999999999998765432211 23445799999999987544 48999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--chh--------hhhh----ccccCC--chhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--NSL--------RQIL----NFQVAD--ESEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~--------~~~~----~~~~~~--~~~~~~~~~~~~li~~~ 219 (259)
+|+|++|+.||.+....... .......... ... .... ...... ......++.+.++|.+|
T Consensus 222 l~ell~g~~pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 297 (364)
T 3qyz_A 222 LAEMLSNRPIFPGKHYLDQL----NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297 (364)
T ss_dssp HHHHHHSSCSSCCSSGGGHH----HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHH----HHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHH
Confidence 99999999999874322111 1110000000 000 0000 000000 00012246799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 298 L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 298 LTFNPHKRIEVEQALA 313 (364)
T ss_dssp TCSSTTTSCCHHHHHT
T ss_pred cCCChhhCCCHHHHhc
Confidence 9999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=265.97 Aligned_cols=157 Identities=28% Similarity=0.387 Sum_probs=138.3
Q ss_pred hHHHHHHHHHhcC------CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI------NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l------~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.+ .|+||+++++++...+..+++|||+. ++|.+++....... +++..+..++.|++.||.|
T Consensus 138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~i~~qi~~aL~~ 215 (429)
T 3kvw_A 138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDA 215 (429)
T ss_dssp HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCC-CCHHHHHHHHHHHHHHHHH
Confidence 4577899998887 57799999999999999999999995 69999998765433 6889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCc--eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYK--AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
||+++ |+|+||||+||+++.++. ++|+|||+++..... .....++..|+|||++.+..++.++|||||||
T Consensus 216 LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 287 (429)
T 3kvw_A 216 LHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGC 287 (429)
T ss_dssp HHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHH
T ss_pred HHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHH
Confidence 99999 999999999999999887 999999998754322 23356899999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCC
Q 025011 155 LLAELLTGLKPGSGM 169 (259)
Q Consensus 155 il~~l~~g~~p~~~~ 169 (259)
++|+|++|..||.+.
T Consensus 288 il~elltG~~pf~~~ 302 (429)
T 3kvw_A 288 ILAELLTGYPLLPGE 302 (429)
T ss_dssp HHHHHHHSSCSSCCS
T ss_pred HHHHHHhCCCCCCCC
Confidence 999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=257.30 Aligned_cols=218 Identities=20% Similarity=0.282 Sum_probs=166.9
Q ss_pred hHHHHHHHHHhcCCCcc------ccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKN------VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++|++ ++++++++...+..++||||+ +++|.+++...... .+++..+..++.|++.||.|
T Consensus 56 ~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~ 133 (339)
T 1z57_A 56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFL-PFRLDHIRKMAYQICKSVNF 133 (339)
T ss_dssp HHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCC-CCcHHHHHHHHHHHHHHHHH
Confidence 56889999999997654 999999999999999999999 88999999776532 36789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCC-------------------CCceEEeecCCcccccCCccccccccccCcccccCcch
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDD-------------------NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY 137 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~-------------------~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 137 (259)
||+++ ++|+||||+||+++. ++.++|+|||+++..... .....++..|+|||+
T Consensus 134 lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~ 205 (339)
T 1z57_A 134 LHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEV 205 (339)
T ss_dssp HHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHH
T ss_pred HHHCC---CcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHH
Confidence 99999 999999999999987 668999999998764322 233468999999999
Q ss_pred hccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc---chhhh-----h--------------
Q 025011 138 VITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN---NSLRQ-----I-------------- 195 (259)
Q Consensus 138 ~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-----~-------------- 195 (259)
+.+..++.++||||||+++|+|++|..||.+.+... ........... ..... .
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (339)
T 1z57_A 206 ILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-----HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSA 280 (339)
T ss_dssp HTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-----HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHH
T ss_pred hhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccc
Confidence 998889999999999999999999999998743211 00000000000 00000 0
Q ss_pred ---hc-----cccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 196 ---LN-----FQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 196 ---~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.. ...........++.+.++|.+||+.||.+|||+.++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 281 GRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhc
Confidence 00 00000111234578999999999999999999999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=265.48 Aligned_cols=224 Identities=17% Similarity=0.200 Sum_probs=173.8
Q ss_pred hHHHHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|+++++.++| +++..+..++..++..++||||+ +++|.+++..... .+++..++.++.||+.||.|||+++
T Consensus 47 ~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g 123 (483)
T 3sv0_A 47 PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS 123 (483)
T ss_dssp CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 458899999999986 56667777777888899999999 9999999975433 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEe---CCCCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhhHH
Q 025011 82 SPPIIHGDVKSTNVLL---DDNYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 82 ~~~i~h~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
|+|+||||+||++ +.++.++|+|||+++........ .......|+..|+|||++.+..++.++||||||
T Consensus 124 ---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlG 200 (483)
T 3sv0_A 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLG 200 (483)
T ss_dssp ---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHH
Confidence 9999999999999 58889999999999876543221 122255699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
|++|+|++|..||.+........ ................+ ....++.+.+++..||+.||.+||++.+|
T Consensus 201 vil~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~~~~~~~l---------~~~~p~~l~~li~~cl~~dP~~RPs~~el 269 (483)
T 3sv0_A 201 YVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKVATSIEAL---------CRGYPTEFASYFHYCRSLRFDDKPDYSYL 269 (483)
T ss_dssp HHHHHHHHSSCTTSSCCCSSHHH--HHHHHHHHHHHSCHHHH---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred HHHHHHHhCCCCCccccchhHHH--HHHHHhhccccccHHHH---------hcCCcHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99999999999998743321111 00000000000000010 01223679999999999999999999999
Q ss_pred HHHHHhcccc
Q 025011 234 SEELDRLKIS 243 (259)
Q Consensus 234 l~~l~~~~~~ 243 (259)
++.|+++...
T Consensus 270 ~~~L~~l~~~ 279 (483)
T 3sv0_A 270 KRLFRDLFIR 279 (483)
T ss_dssp HHHHHHHHHH
T ss_pred HHHHHHHHHH
Confidence 9999988543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=257.62 Aligned_cols=209 Identities=21% Similarity=0.247 Sum_probs=152.7
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhC-C
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSS-A 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~ 81 (259)
.+..+...++.++||||+++++++..++..++||||++ ++|.+++... .....+++..++.++.|++.||.|||++ +
T Consensus 52 ~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~ 130 (290)
T 3fme_A 52 LLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 130 (290)
T ss_dssp HHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 34556666888899999999999999999999999996 4888877542 1123368899999999999999999998 9
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchh----ccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYV----ITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~ 157 (259)
++|+||||+||+++.++.++|+|||++....... ......++..|+|||.+ .+..++.++||||+|+++|
T Consensus 131 ---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~ 204 (290)
T 3fme_A 131 ---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204 (290)
T ss_dssp ---CCCCCCSGGGCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHH
T ss_pred ---eecCCCCHHHEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHH
Confidence 9999999999999999999999999987654332 22233589999999996 4556889999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||....... .. .. ...............++.+.+++.+||+.||.+|||+.++++
T Consensus 205 ~l~~g~~p~~~~~~~~---~~----~~---------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 205 ELAILRFPYDSWGTPF---QQ----LK---------QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHTSCSSCCCSCHH---HH----HH---------HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHCCCCccccCchH---HH----HH---------HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 9999999997532111 00 00 001111111111123467999999999999999999999976
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=260.33 Aligned_cols=216 Identities=22% Similarity=0.287 Sum_probs=151.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++... +..++++|++ +++|.+++... .+++..+..++.|++.||.|
T Consensus 73 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~ 147 (367)
T 2fst_X 73 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKY 147 (367)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999998754 5679999999 78999988653 26889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .....++..|+|||++.+ ..++.++||||+||+
T Consensus 148 LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 219 (367)
T 2fst_X 148 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 219 (367)
T ss_dssp HHHTT---CCCCCCCGGGEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHH
T ss_pred HHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHH
Confidence 99999 999999999999999999999999999765432 233468999999999877 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh----------ccchhhhhhccc--cCCch----hHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI----------ENNSLRQILNFQ--VADES----EMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~--~~~~~----~~~~~~~~~~li~~~ 219 (259)
+|+|++|+.||.+.+... .......... ............ ..... ....++.+.+||.+|
T Consensus 220 l~ell~g~~pf~~~~~~~----~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~m 295 (367)
T 2fst_X 220 MAELLTGRTLFPGTDHID----QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKM 295 (367)
T ss_dssp HHHHHHSSCSCCCSSHHH----HHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHh
Confidence 999999999998743211 0111100000 000000000000 00000 011246789999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|..||.+|||+.++++
T Consensus 296 L~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 296 LVLDSDKRITAAQALA 311 (367)
T ss_dssp SCSSGGGSCCHHHHHT
T ss_pred CCCCcccCcCHHHHhc
Confidence 9999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=253.91 Aligned_cols=211 Identities=24% Similarity=0.382 Sum_probs=156.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-------------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-------------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAE 69 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~ 69 (259)
+.+.+|+.+++.++||||+++++++.+ .+..++||||+++++|.+++..... ..++..++.++.|
T Consensus 47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~q 124 (303)
T 1zy4_A 47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL--NQQRDEYWRLFRQ 124 (303)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCG--GGCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcccc--ccchHHHHHHHHH
Confidence 468899999999999999999998865 3567999999999999999986543 2567889999999
Q ss_pred HHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc------------ccccccccCcccccCcch
Q 025011 70 TASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ------------TAMTTKKIGTFVNLDPEY 137 (259)
Q Consensus 70 i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~------------~~~~~~~~~~~~y~aPE~ 137 (259)
++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........ ........++..|+|||.
T Consensus 125 i~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 201 (303)
T 1zy4_A 125 ILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEV 201 (303)
T ss_dssp HHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHH
T ss_pred HHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCccc
Confidence 999999999999 99999999999999999999999999876543211 112234468899999999
Q ss_pred hccC-CcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHH
Q 025011 138 VITG-KLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLA 216 (259)
Q Consensus 138 ~~~~-~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 216 (259)
+.+. .++.++||||+|+++|+|++ ||.... ............ ............++.+.++|
T Consensus 202 ~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~-------~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li 264 (303)
T 1zy4_A 202 LDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM-------ERVNILKKLRSV-------SIEFPPDFDDNKMKVEKKII 264 (303)
T ss_dssp HTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH-------HHHHHHHHHHST-------TCCCCTTCCTTTSHHHHHHH
T ss_pred ccCCCCCcchhhHHHHHHHHHHHHh---ccCCch-------hHHHHHHhcccc-------ccccCccccccchHHHHHHH
Confidence 9765 58999999999999999998 544210 000111110000 00011111122346689999
Q ss_pred HHhcccCCCCCCCHHHHHH
Q 025011 217 SKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 217 ~~~l~~~p~~Rpt~~~il~ 235 (259)
.+||+.||.+|||+.++++
T Consensus 265 ~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 265 RLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCcccCcCHHHHhC
Confidence 9999999999999999965
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=265.59 Aligned_cols=212 Identities=13% Similarity=0.073 Sum_probs=146.6
Q ss_pred hHHHHHHHHHhcC--CCccccccc-------eeEEeCC-----------------cceEEEEecCCCChhhhhhccCCcc
Q 025011 3 QVFQHELRVVSQI--NHKNVVKIL-------GACLETK-----------------VPLLVYEFVPNGTLFDHIHDKSSQV 56 (259)
Q Consensus 3 ~~~~~E~~~l~~l--~h~~iv~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~ 56 (259)
+.+++|+.+++.+ +||||++++ +++...+ ..++||||++ ++|.+++......
T Consensus 107 ~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~- 184 (371)
T 3q60_A 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV- 184 (371)
T ss_dssp HHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS-
T ss_pred HHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc-
Confidence 4577885544444 699987755 4554433 3799999997 8999999865322
Q ss_pred cCCHHHH------HHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcc
Q 025011 57 LRNWKTC------LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTF 130 (259)
Q Consensus 57 ~~~~~~~------~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 130 (259)
++...+ ..++.|++.||.|||+++ |+|+||||+||+++.++.++|+|||+++..+.. .....++.
T Consensus 185 -~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~ 255 (371)
T 3q60_A 185 -YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPV 255 (371)
T ss_dssp -CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCG
T ss_pred -cchhhhhhhhhHHHHHHHHHHHHHHHHHCC---CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCc
Confidence 233444 677799999999999999 999999999999999999999999999865432 11345679
Q ss_pred cccCcchhcc--CCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHH
Q 025011 131 VNLDPEYVIT--GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEE 208 (259)
Q Consensus 131 ~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (259)
.|+|||++.+ ..++.++||||||+++|+|++|+.||.+........ ......................
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~ 325 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS----------WKRPSLRVPGTDSLAFGSCTPL 325 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTC----------CCBCCTTSCCCCSCCCTTSSCC
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccc----------hhhhhhhhccccccchhhccCC
Confidence 9999999987 568999999999999999999999998743221100 0000000000011111111123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 209 IETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 209 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++.+.++|.+||+.||.+|||+.++++
T Consensus 326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 326 PDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 477999999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=258.04 Aligned_cols=209 Identities=19% Similarity=0.279 Sum_probs=157.9
Q ss_pred hHHHHHHHHHhcCC--CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
+.+.+|++++++++ ||||+++++++..++..+++||+ .+++|.+++..... +++..++.++.|++.||.|||++
T Consensus 71 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~aL~~LH~~ 146 (313)
T 3cek_A 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQH 146 (313)
T ss_dssp HHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHC
Confidence 56899999999997 59999999999999999999994 58899999986543 57889999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-----------CCcccccch
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-----------GKLTEKSDV 149 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~Di 149 (259)
+ ++|+||+|+||++++ +.++|+|||++................++..|+|||.+.+ ..++.++||
T Consensus 147 ~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di 222 (313)
T 3cek_A 147 G---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDV 222 (313)
T ss_dssp T---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHH
T ss_pred C---ceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHH
Confidence 9 999999999999965 7999999999987654333223334568999999999865 357889999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT 229 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 229 (259)
||||+++|+|++|..||....... .... ...........+...++.+.++|.+||+.||.+|||
T Consensus 223 ~slG~il~el~~g~~pf~~~~~~~-------~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 286 (313)
T 3cek_A 223 WSLGCILYYMTYGKTPFQQIINQI-------SKLH---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS 286 (313)
T ss_dssp HHHHHHHHHHHHSSCTTTTCCSHH-------HHHH---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHHHHHhCCCchhhHHHHH-------HHHH---------HHHhcccccCCcccchHHHHHHHHHHccCCcccCcC
Confidence 999999999999999997632110 0000 011110000001111367999999999999999999
Q ss_pred HHHHHH
Q 025011 230 MKQVSE 235 (259)
Q Consensus 230 ~~~il~ 235 (259)
+.++++
T Consensus 287 ~~ell~ 292 (313)
T 3cek_A 287 IPELLA 292 (313)
T ss_dssp HHHHHT
T ss_pred HHHHhc
Confidence 999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=249.95 Aligned_cols=208 Identities=25% Similarity=0.359 Sum_probs=165.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++...+..+++|||+++++|.+++..... +++..++.++.|++.||.|||+++
T Consensus 66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~- 141 (287)
T 2wei_A 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEHDAARIIKQVFSGITYMHKHN- 141 (287)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999998876543 678999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC---CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN---YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~---~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++|+||+|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ .++.++||||||+++|+|
T Consensus 142 --i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l 215 (287)
T 2wei_A 142 --IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYIL 215 (287)
T ss_dssp --CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHH
T ss_pred --eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHH
Confidence 9999999999999754 469999999987654322 1223357889999998865 488999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... .. ...... ... ..........++.+.++|.+||+.||.+|||+.++++
T Consensus 216 ~~g~~p~~~~~~~-----~~---~~~~~~-~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 216 LSGTPPFYGKNEY-----DI---LKRVET-GKY------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp HHSSCSSCCSSHH-----HH---HHHHHH-CCC------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCHH-----HH---HHHHHc-CCC------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 9999999863211 00 110000 000 0000111123467999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=261.38 Aligned_cols=220 Identities=20% Similarity=0.242 Sum_probs=158.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|++++++++||||+++++++.. ....++||||+. |+|.+++..... .+++..+..++.|++.||.||
T Consensus 74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~l 150 (362)
T 3pg1_A 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--VISPQHIQYFMYHILLGLHVL 150 (362)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHH
Confidence 678999999999999999999999854 335799999996 588888875432 368899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il 156 (259)
|+++ ++|+||||+||+++.++.++|+|||++....... ......++..|+|||++.+ ..++.++||||+|+++
T Consensus 151 H~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 151 HEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred HHCc---CEecCCChHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 9999 9999999999999999999999999987544321 2234468899999999877 5689999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhh----------ccchhhhhhcccc---CC----chhHHHHHHHHHHHHHh
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSI----------ENNSLRQILNFQV---AD----ESEMEEIETVAGLASKC 219 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~---~~----~~~~~~~~~~~~li~~~ 219 (259)
|+|++|+.||.+..... .......... ............. .. ......++.+.++|.+|
T Consensus 225 ~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 300 (362)
T 3pg1_A 225 AEMFNRKALFRGSTFYN----QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300 (362)
T ss_dssp HHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCHHH----HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHH
Confidence 99999999998743211 0000000000 0000001100000 00 00112246799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 301 L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 301 LEFNPQRRISTEQALR 316 (362)
T ss_dssp TCSSGGGSCCHHHHHT
T ss_pred hcCChhhCCCHHHHHc
Confidence 9999999999999975
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=268.15 Aligned_cols=215 Identities=21% Similarity=0.262 Sum_probs=156.9
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCccc----CCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVL----RNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~----~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++++++ +||||+++++++.+++..++||||+. |+|.+++........ .++..++.++.|++.||.||
T Consensus 53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 131 (434)
T 2rio_A 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131 (434)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence 4578899999886 89999999999999999999999995 699999976543211 12234578999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCC-------------CceEEeecCCcccccCCcccc--ccccccCcccccCcchhcc--
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDN-------------YKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVIT-- 140 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~-------------~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-- 140 (259)
|+++ |+|+||||+||+++.+ +.++|+|||++.......... ......|++.|+|||++.+
T Consensus 132 H~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 208 (434)
T 2rio_A 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESN 208 (434)
T ss_dssp HHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCC
T ss_pred HHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccc
Confidence 9999 9999999999999654 479999999998765432211 1234469999999999965
Q ss_pred -----CCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHH
Q 025011 141 -----GKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG 214 (259)
Q Consensus 141 -----~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 214 (259)
..++.++|||||||++|+|++ |..||.+..... ........ .. ...........++.+.+
T Consensus 209 ~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~~i~~~~~---~~-----~~~~~~~~~~~~~~~~~ 274 (434)
T 2rio_A 209 NLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE------SNIIRGIF---SL-----DEMKCLHDRSLIAEATD 274 (434)
T ss_dssp TTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH------HHHHHTCC---CC-----CCCTTCCCHHHHHHHHH
T ss_pred ccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH------HHHhcCCC---Cc-----ccccccccccchHHHHH
Confidence 568899999999999999999 899997522110 00000000 00 01111123355678999
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 025011 215 LASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 215 li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|.+||+.||.+|||+.++++
T Consensus 275 li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 275 LISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhhCChhhCCCHHHHHh
Confidence 999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=254.02 Aligned_cols=227 Identities=20% Similarity=0.261 Sum_probs=169.2
Q ss_pred HHHHHHHHHhcC---CCccccccceeEE-----eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI---NHKNVVKILGACL-----ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l---~h~~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|+.+++.+ +||||+++++++. .....+++|||+. ++|.+++....... +++..++.++.|++.||.
T Consensus 57 ~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~~~~qi~~~l~ 134 (326)
T 1blx_A 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG-VPTETIKDMMFQLLRGLD 134 (326)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTC-SCHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCC-CCHHHHHHHHHHHHHHHH
Confidence 577888888877 8999999999987 4567899999996 69999997764432 678999999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++.+..++.++||||||++
T Consensus 135 ~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 208 (326)
T 1blx_A 135 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208 (326)
T ss_dssp HHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHH
Confidence 999999 9999999999999999999999999987654321 2234568999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh--ccchhhh-------hhccc---cCCchhHHHHHHHHHHHHHhcccC
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI--ENNSLRQ-------ILNFQ---VADESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~---~~~~~~~~~~~~~~~li~~~l~~~ 223 (259)
+|+|++|..||.+..... .......... ....+.. ..... .........++.+.++|.+||+.|
T Consensus 209 l~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 284 (326)
T 1blx_A 209 FAEMFRRKPLFRGSSDVD----QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 284 (326)
T ss_dssp HHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHcCCCCCCCCCHHH----HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCC
Confidence 999999999998743211 1111111000 0000000 00000 000011123467899999999999
Q ss_pred CCCCCCHHHHHH--HHHhccc
Q 025011 224 GRRRPTMKQVSE--ELDRLKI 242 (259)
Q Consensus 224 p~~Rpt~~~il~--~l~~~~~ 242 (259)
|.+|||+.++++ .++++..
T Consensus 285 P~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 285 PAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp TTTSCCHHHHHTSGGGTTCCC
T ss_pred cccCCCHHHHhcCccccccch
Confidence 999999999984 3444443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=256.92 Aligned_cols=215 Identities=20% Similarity=0.277 Sum_probs=160.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcc------eEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVP------LLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++...+.. ++||||+. ++|.+.+... +++..+..++.|++.||.|
T Consensus 86 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~i~~qi~~aL~~ 159 (371)
T 4exu_A 86 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME-----FSEEKIQYLVYQMLKGLKY 159 (371)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC-----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcC-----CCHHHHHHHHHHHHHHHHH
Confidence 5688999999999999999999999877655 99999996 5888887432 6789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+++ ++|+||||+||+++.++.++|+|||+++..... .....++..|+|||++.+ ..++.++||||||++
T Consensus 160 LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (371)
T 4exu_A 160 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 231 (371)
T ss_dssp HHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHH
T ss_pred HHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHH
Confidence 99999 999999999999999999999999999765432 233468999999999877 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhc----------cchhhhhhcc---ccCCc---hhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIE----------NNSLRQILNF---QVADE---SEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~---~~~~~---~~~~~~~~~~~li~~~ 219 (259)
+|+|++|..||.+..... ........... .......... ..... .....++.+.+||.+|
T Consensus 232 l~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 307 (371)
T 4exu_A 232 MAEMLTGKTLFKGKDYLD----QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 307 (371)
T ss_dssp HHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCChHH----HHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHH
Confidence 999999999998743211 01111000000 0000000000 00000 0012247799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 308 L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 308 LELDVDKRLTAAQALT 323 (371)
T ss_dssp SCSCTTTSCCHHHHHT
T ss_pred CCCChhhcCCHHHHhc
Confidence 9999999999999965
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=256.15 Aligned_cols=218 Identities=19% Similarity=0.229 Sum_probs=164.8
Q ss_pred hHHHHHHHHHhcCCCcc------ccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKN------VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~------iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++|++ ++.+++++...+..++||||+ ++++.+++...... .+++..++.++.|++.||.|
T Consensus 61 ~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~-~~~~~~~~~i~~qi~~~L~~ 138 (355)
T 2eu9_A 61 EAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQ-PYPLPHVRHMAYQLCHALRF 138 (355)
T ss_dssp HHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCC-CCCHHHHHHHHHHHHHHHHH
Confidence 56889999999997665 899999999999999999999 66787877665432 26889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEe-------------------CCCCceEEeecCCcccccCCccccccccccCcccccCcch
Q 025011 77 LHSSASPPIIHGDVKSTNVLL-------------------DDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEY 137 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~-------------------~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 137 (259)
||+++ ++|+||||+||++ +.++.++|+|||++...... .....++..|+|||+
T Consensus 139 lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~ 210 (355)
T 2eu9_A 139 LHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEV 210 (355)
T ss_dssp HHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHH
T ss_pred HHHCC---cccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCee
Confidence 99999 9999999999999 56788999999999764332 233468999999999
Q ss_pred hccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc---chhhh--------------------
Q 025011 138 VITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN---NSLRQ-------------------- 194 (259)
Q Consensus 138 ~~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~-------------------- 194 (259)
+.+..++.++||||||+++|+|++|..||.+..... ........... .....
T Consensus 211 ~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (355)
T 2eu9_A 211 ILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-----HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSD 285 (355)
T ss_dssp HTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHH
T ss_pred eecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccch
Confidence 998889999999999999999999999998733211 00000000000 00000
Q ss_pred --hhcc-----ccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 195 --ILNF-----QVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 195 --~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.... ..........+..+.+||.+||+.||.+|||+.++++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 286 GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL 333 (355)
T ss_dssp HHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 0000111233567999999999999999999999973
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=258.84 Aligned_cols=221 Identities=21% Similarity=0.275 Sum_probs=164.0
Q ss_pred hHHHHHHHHHhcCC-----------CccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-----------HKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIA 67 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~ 67 (259)
+.+.+|+++++.++ ||||+++++++...+ ..+++||++ +++|.+++....... +++..+..++
T Consensus 60 ~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~i~ 137 (373)
T 1q8y_A 60 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRG-IPLIYVKQIS 137 (373)
T ss_dssp HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSC-CCHHHHHHHH
T ss_pred hhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccC-CcHHHHHHHH
Confidence 56789999999886 899999999998654 789999999 889999998754333 6789999999
Q ss_pred HHHHHHHHHHhhC-CCCCeEeCCCCCCCeEeC------CCCceEEeecCCcccccCCccccccccccCcccccCcchhcc
Q 025011 68 AETASALDYLHSS-ASPPIIHGDVKSTNVLLD------DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 68 ~~i~~~l~~lh~~-~~~~i~h~di~p~nil~~------~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
.|++.||.|||++ + ++|+||||+||+++ ..+.++|+|||++...... .....++..|+|||++.+
T Consensus 138 ~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~ 209 (373)
T 1q8y_A 138 KQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLG 209 (373)
T ss_dssp HHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHT
T ss_pred HHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhC
Confidence 9999999999998 9 99999999999994 4447999999999765432 233468999999999999
Q ss_pred CCcccccchhhHHHHHHHHHhCCCCCCCCccccc--cchhHHHHHHHhhcc-------ch-h------------------
Q 025011 141 GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASN--EGISMVQYFLYSIEN-------NS-L------------------ 192 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~-------~~-~------------------ 192 (259)
..++.++||||||+++|+|++|..||.+...... ............... .. .
T Consensus 210 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (373)
T 1q8y_A 210 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 289 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccc
Confidence 8899999999999999999999999986432111 001111111100000 00 0
Q ss_pred ---hhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 193 ---RQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 193 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
...... ....+...++.+.+||.+||+.||.+|||+.++++
T Consensus 290 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 290 WPLEDVLTE--KYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 333 (373)
T ss_dssp CCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred cchhhhhhh--cccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence 000000 01123456788999999999999999999999976
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=255.58 Aligned_cols=222 Identities=21% Similarity=0.233 Sum_probs=160.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc-------ceEEEEecCCCChhhhhhc-cCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV-------PLLVYEFVPNGTLFDHIHD-KSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
+.+.+|++.++.++||||+++++++...+. .++||||+++ +|.+.+.. .......++..+..++.|++.|+
T Consensus 64 ~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al 142 (360)
T 3e3p_A 64 NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI 142 (360)
T ss_dssp CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 456788888899999999999999976443 7899999976 55544432 22333467889999999999999
Q ss_pred HHHh--hCCCCCeEeCCCCCCCeEeCC-CCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchh
Q 025011 75 DYLH--SSASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVY 150 (259)
Q Consensus 75 ~~lh--~~~~~~i~h~di~p~nil~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diw 150 (259)
.||| +++ ++|+||||+||+++. ++.++|+|||++....... ......++..|+|||++.+.. ++.++|||
T Consensus 143 ~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~ 216 (360)
T 3e3p_A 143 GCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIW 216 (360)
T ss_dssp HHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHH
Confidence 9999 999 999999999999996 8999999999998665432 223346899999999986654 89999999
Q ss_pred hHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--chhh---------hhhccc------cCCchhHHHHHHHH
Q 025011 151 SFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--NSLR---------QILNFQ------VADESEMEEIETVA 213 (259)
Q Consensus 151 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~---------~~~~~~------~~~~~~~~~~~~~~ 213 (259)
|||+++|+|++|..||.+..... ............ .... ...... .........++.+.
T Consensus 217 slG~il~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (360)
T 3e3p_A 217 SVGCIFAEMMLGEPIFRGDNSAG----QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAY 292 (360)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHH
T ss_pred HHHHHHHHHHhCCCCcCCCChHH----HHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHH
Confidence 99999999999999998743211 111111100000 0000 000000 00001111357799
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+||.+||+.||.+|||+.++++
T Consensus 293 ~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 293 DLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHhccCccccCCHHHHhc
Confidence 9999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=255.37 Aligned_cols=221 Identities=22% Similarity=0.260 Sum_probs=162.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++++.++||||+++++++..+ +..+++|||+. ++|.+++... .+++..+..++.|++.||.||
T Consensus 54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~L 128 (353)
T 2b9h_A 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVL 128 (353)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999988754 67899999996 5899988763 267899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--------ccccccCcccccCcchhcc-CCcccccc
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--------MTTKKIGTFVNLDPEYVIT-GKLTEKSD 148 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~-~~~~~~~D 148 (259)
|+++ ++|+||||+||+++.++.++|+|||++.......... ......|+..|+|||++.+ ..++.++|
T Consensus 129 H~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 205 (353)
T 2b9h_A 129 HGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMD 205 (353)
T ss_dssp HHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHH
T ss_pred HHCC---eecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhh
Confidence 9999 9999999999999999999999999998765322111 1223468999999998765 56899999
Q ss_pred hhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc-----------cchhhhhhccc---cCC---chhHHHHHH
Q 025011 149 VYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE-----------NNSLRQILNFQ---VAD---ESEMEEIET 211 (259)
Q Consensus 149 iwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~---~~~---~~~~~~~~~ 211 (259)
|||||+++|+|++|..||.+.+... ........... ........... ... ......++.
T Consensus 206 i~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (353)
T 2b9h_A 206 VWSCGCILAELFLRRPIFPGRDYRH----QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPK 281 (353)
T ss_dssp HHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHH
Confidence 9999999999999999998743211 00000000000 00000000000 000 000123467
Q ss_pred HHHHHHHhcccCCCCCCCHHHHHH
Q 025011 212 VAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 212 ~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+.++|.+||+.||.+|||+.++++
T Consensus 282 ~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 282 GIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCcCcccCCCHHHHhc
Confidence 899999999999999999999976
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=262.26 Aligned_cols=220 Identities=23% Similarity=0.252 Sum_probs=158.8
Q ss_pred HHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhcc-CCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 5 FQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDK-SSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+|+++++.++||||+++++++...+ ..++||||+++ ++.+.+... .....+++..+..++.|++.||.||
T Consensus 94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 94 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 457999999999999999999886421 36799999965 676666432 1122368889999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
|+++ |+||||||+||+++.+ +.++|+|||+++...... ......++..|+|||++.+. .++.++|||||||+
T Consensus 173 H~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i 246 (420)
T 1j1b_A 173 HSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 246 (420)
T ss_dssp HTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence 9999 9999999999999965 568999999998654322 12334689999999998765 68999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--chhh-------hhhccccCCc-----hhHHHHHHHHHHHHHhcc
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--NSLR-------QILNFQVADE-----SEMEEIETVAGLASKCLS 221 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~-------~~~~~~~~~~-----~~~~~~~~~~~li~~~l~ 221 (259)
+|+|++|+.||.+.... ............. ..+. .......... .....++.+.+||.+||.
T Consensus 247 l~ell~G~~pf~~~~~~----~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~ 322 (420)
T 1j1b_A 247 LAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLE 322 (420)
T ss_dssp HHHHHHSSCSSCCSSHH----HHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSC
T ss_pred HHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhcc
Confidence 99999999999874321 1111111110000 0000 0000000000 001224679999999999
Q ss_pred cCCCCCCCHHHHHH
Q 025011 222 LSGRRRPTMKQVSE 235 (259)
Q Consensus 222 ~~p~~Rpt~~~il~ 235 (259)
.||.+|||+.++++
T Consensus 323 ~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 323 YTPTARLTPLEACA 336 (420)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhHCCCHHHHhC
Confidence 99999999999974
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=258.48 Aligned_cols=220 Identities=20% Similarity=0.232 Sum_probs=160.5
Q ss_pred HHHHHHHHhcCCCccccccceeEEeC--------------------------------------CcceEEEEecCCCChh
Q 025011 5 FQHELRVVSQINHKNVVKILGACLET--------------------------------------KVPLLVYEFVPNGTLF 46 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~--------------------------------------~~~~lv~e~~~~~~L~ 46 (259)
..+|+++++.++||||+++++++... ...++||||++ ++|.
T Consensus 47 ~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 125 (383)
T 3eb0_A 47 KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLH 125 (383)
T ss_dssp CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHH
T ss_pred HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHH
Confidence 45799999999999999999998543 34789999997 5887
Q ss_pred hhhhcc-CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccc
Q 025011 47 DHIHDK-SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTT 124 (259)
Q Consensus 47 ~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~ 124 (259)
+.+... .....+++..+..++.|++.||.|||+++ ++|+||||+||+++ .++.++|+|||+++...... ...
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~ 199 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSV 199 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCC
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCc
Confidence 777542 11223688999999999999999999999 99999999999997 68899999999998654332 223
Q ss_pred cccCcccccCcchhccCC-cccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhcc---------chhhh
Q 025011 125 KKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIEN---------NSLRQ 194 (259)
Q Consensus 125 ~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~ 194 (259)
...++..|+|||++.+.. ++.++||||+||++|+|++|+.||.+..... ............ .....
T Consensus 200 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~i~~~~g~p~~~~~~~~~~~~~~ 275 (383)
T 3eb0_A 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSID----QLVRIIQIMGTPTKEQMIRMNPHYTE 275 (383)
T ss_dssp CCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCTTC--
T ss_pred CcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCCHHHHHHhCccccc
Confidence 446889999999987754 8999999999999999999999998743211 111111100000 00000
Q ss_pred hhccccCCc-----hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 195 ILNFQVADE-----SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 195 ~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..-...... .+...++.+.+||.+||..||.+|||+.++++
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 276 VRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA 321 (383)
T ss_dssp CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 01113467999999999999999999999973
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=253.32 Aligned_cols=215 Identities=21% Similarity=0.270 Sum_probs=160.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc------ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV------PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+.+++.++||||+++++++...+. .+++|||+. ++|.+++... +++..+..++.|++.||.|
T Consensus 68 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~i~~qi~~al~~ 141 (353)
T 3coi_A 68 KRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGLK-----FSEEKIQYLVYQMLKGLKY 141 (353)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTSC-----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcCC-----CCHHHHHHHHHHHHHHHHH
Confidence 568899999999999999999999987654 499999996 5888887532 6789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~i 155 (259)
||+++ ++|+||+|+||+++.++.++|+|||++...... .....++..|+|||++.+ ..++.++||||+|++
T Consensus 142 LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~i 213 (353)
T 3coi_A 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCI 213 (353)
T ss_dssp HHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHH
T ss_pred HHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHH
Confidence 99999 999999999999999999999999998764432 223468999999999877 568999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhc----------cchhhhhhc---cc---cCCchhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIE----------NNSLRQILN---FQ---VADESEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~---~~~~~~~~~~~~~~~li~~~ 219 (259)
+|+|++|..||.+..... ........... ......... .. .........++.+.++|.+|
T Consensus 214 l~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 289 (353)
T 3coi_A 214 MAEMLTGKTLFKGKDYLD----QLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKM 289 (353)
T ss_dssp HHHHHHSSCSSBSSCHHH----HHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHH
Confidence 999999999998743211 00110000000 000000000 00 00001112347799999999
Q ss_pred cccCCCCCCCHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSE 235 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+|||+.++++
T Consensus 290 L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 290 LELDVDKRLTAAQALT 305 (353)
T ss_dssp SCSCTTTSCCHHHHHT
T ss_pred cCCCcccCCCHHHHhc
Confidence 9999999999999975
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=249.52 Aligned_cols=221 Identities=17% Similarity=0.266 Sum_probs=160.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEE--------------eCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACL--------------ETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~ 68 (259)
+.+.+|+++++.++||||+++++++. ..+..++||||++ ++|.+++.... +++..++.++.
T Consensus 53 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~----~~~~~~~~~~~ 127 (320)
T 2i6l_A 53 KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGP----LLEEHARLFMY 127 (320)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTTCC----CCHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhcCC----ccHHHHHHHHH
Confidence 56889999999999999999999873 3467899999996 59999996532 57789999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhcc-CCccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVIT-GKLTE 145 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~-~~~~~ 145 (259)
|++.||.|||+++ ++|+||||+||+++ .++.++|+|||+++....... ........++..|+|||.+.+ ..++.
T Consensus 128 qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 204 (320)
T 2i6l_A 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTK 204 (320)
T ss_dssp HHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCH
T ss_pred HHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCc
Confidence 9999999999999 99999999999997 567999999999986543211 112233457889999998865 56899
Q ss_pred ccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc--cchhhhh-------hcccc--CC----chhHHHHH
Q 025011 146 KSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI-------LNFQV--AD----ESEMEEIE 210 (259)
Q Consensus 146 ~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~--~~----~~~~~~~~ 210 (259)
++||||||+++|+|++|+.||.+..... ........... ....... ..... .. ......++
T Consensus 205 ~~Di~slG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (320)
T 2i6l_A 205 AIDMWAAGCIFAEMLTGKTLFAGAHELE----QMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISR 280 (320)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCH
T ss_pred hhhhHhHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhH
Confidence 9999999999999999999998743211 00110000000 0000000 00000 00 00012347
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 211 TVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 211 ~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.+.++|.+||+.||.+|||+.++++
T Consensus 281 ~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 281 EAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHcCCCccccCCHHHHhC
Confidence 7999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=254.91 Aligned_cols=208 Identities=22% Similarity=0.259 Sum_probs=139.7
Q ss_pred HHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCC
Q 025011 9 LRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPP 84 (259)
Q Consensus 9 ~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~ 84 (259)
...++.++||||+++++++.. ++..++||||+++|+|.+++...... .+++..++.++.|++.||.|||+++
T Consensus 73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~-~l~~~~~~~i~~ql~~~l~~LH~~~--- 148 (336)
T 3fhr_A 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQ-AFTEREAAEIMRDIGTAIQFLHSHN--- 148 (336)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CC-CCBHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 334566799999999999986 44589999999999999999876433 3688999999999999999999999
Q ss_pred eEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 85 IIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 85 i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++|+||||+||+++. ++.++|+|||++...... ......+++.|+|||++.+..++.++||||||+++|+|++
T Consensus 149 ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 224 (336)
T 3fhr_A 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 224 (336)
T ss_dssp EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999976 445999999998765432 1223457899999999988889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+.......... ... .... ............++.+.++|.+||+.||.+|||+.++++
T Consensus 225 g~~pf~~~~~~~~~~~~-~~~----~~~~------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 225 GFPPFYSNTGQAISPGM-KRR----IRLG------QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp SSCCC--------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCCccchhhhhhH-HHh----hhcc------ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 99999763221100000 000 0000 000000111123467999999999999999999999987
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=261.02 Aligned_cols=210 Identities=21% Similarity=0.278 Sum_probs=155.1
Q ss_pred HHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.+|+++++.+ +||||+++++++.+++..++||||+. |+|.+++...... .....++.++.|++.||.|||+++
T Consensus 63 ~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~~- 138 (432)
T 3p23_A 63 FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLEPITLLQQTTSGLAHLHSLN- 138 (432)
T ss_dssp ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--CCSSCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--ccchhHHHHHHHHHHHHHHHHHCc-
Confidence 357899999999 79999999999999999999999995 5999999766432 233456789999999999999999
Q ss_pred CCeEeCCCCCCCeEeCC-----CCceEEeecCCcccccCCccc-cccccccCcccccCcchhcc---CCcccccchhhHH
Q 025011 83 PPIIHGDVKSTNVLLDD-----NYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFG 153 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~-----~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG 153 (259)
|+||||||+||+++. ...++|+|||+++........ .......||+.|+|||++.+ ..++.++||||+|
T Consensus 139 --ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG 216 (432)
T 3p23_A 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAG 216 (432)
T ss_dssp --CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHH
T ss_pred --CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHH
Confidence 999999999999953 235789999999876543211 22334569999999999873 4577899999999
Q ss_pred HHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 154 VLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 154 ~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
|++|+|++ |..||...... ............ ........+..+.++|.+||+.||.+|||+.+
T Consensus 217 ~il~ellt~g~~pf~~~~~~---------~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 280 (432)
T 3p23_A 217 CVFYYVISEGSHPFGKSLQR---------QANILLGACSLD-------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKH 280 (432)
T ss_dssp HHHHHHHTTSCBTTBSTTTH---------HHHHHTTCCCCT-------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHcCCCCCcchhhHH---------HHHHHhccCCcc-------ccCccccccHHHHHHHHHHHhCCHhhCCCHHH
Confidence 99999999 88998642110 000000000000 00111233466889999999999999999999
Q ss_pred HHH
Q 025011 233 VSE 235 (259)
Q Consensus 233 il~ 235 (259)
+++
T Consensus 281 vl~ 283 (432)
T 3p23_A 281 VLK 283 (432)
T ss_dssp HHT
T ss_pred HHh
Confidence 983
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=269.59 Aligned_cols=234 Identities=23% Similarity=0.253 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++++.++||||+++++++.. ++..++||||+++++|.+++........+++..++.++.|++.||.|
T Consensus 57 ~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~y 136 (676)
T 3qa8_A 57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136 (676)
T ss_dssp HHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 568899999999999999999998765 66789999999999999999876554446788999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCc---eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYK---AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~---~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
||+.+ ++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+..++.++||||+|
T Consensus 137 LHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLG 210 (676)
T 3qa8_A 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG 210 (676)
T ss_dssp HHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHH
T ss_pred HHHCC---CccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHH
Confidence 99999 999999999999997765 8999999998765432 22345689999999999888899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHH-hhccchhhh--hhcc--ccCCchhHHHHHHHHHHHHHhcccCCCCCC
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLY-SIENNSLRQ--ILNF--QVADESEMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
+++|+|++|..||.+................. ......... .... ..........++.+.++|.+||..||.+||
T Consensus 211 viLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP 290 (676)
T 3qa8_A 211 TLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG 290 (676)
T ss_dssp HHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---
T ss_pred HHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc
Confidence 99999999999997621100000000000000 000000000 0000 001112223557899999999999999999
Q ss_pred CHHH-----HHHHHHhccc
Q 025011 229 TMKQ-----VSEELDRLKI 242 (259)
Q Consensus 229 t~~~-----il~~l~~~~~ 242 (259)
|+.+ +.+.++++..
T Consensus 291 Ta~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 291 TDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp CCTTCCCCTTHHHHHHHHC
T ss_pred CHHHHhcCHHHHHHHHHHh
Confidence 9987 4445554443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=250.28 Aligned_cols=157 Identities=26% Similarity=0.351 Sum_probs=135.1
Q ss_pred hHHHHHHHHHhcCC-Cc-----cccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-HK-----NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+..|+++++.++ |+ +|+++++++...+..++||||+. ++|.+++....... +++..+..++.|++.||.|
T Consensus 95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~-~~~~~~~~i~~qi~~al~~ 172 (382)
T 2vx3_A 95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALLF 172 (382)
T ss_dssp HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSC-CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCC-CCHHHHHHHHHHHHHHHHH
Confidence 45678999998884 44 49999999999999999999995 59999998764333 6889999999999999999
Q ss_pred Hh--hCCCCCeEeCCCCCCCeEeC--CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhH
Q 025011 77 LH--SSASPPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSF 152 (259)
Q Consensus 77 lh--~~~~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl 152 (259)
|| +.+ |+|+||||+||+++ .++.++|+|||+++..... .....++..|+|||++.+..++.++|||||
T Consensus 173 lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSl 244 (382)
T 2vx3_A 173 LATPELS---IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSL 244 (382)
T ss_dssp HTSTTTC---EECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred hccCCCC---EEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHH
Confidence 99 467 99999999999994 5778999999999875432 234568999999999999899999999999
Q ss_pred HHHHHHHHhCCCCCCCC
Q 025011 153 GVLLAELLTGLKPGSGM 169 (259)
Q Consensus 153 G~il~~l~~g~~p~~~~ 169 (259)
||++|+|++|..||.+.
T Consensus 245 G~il~elltg~~pf~~~ 261 (382)
T 2vx3_A 245 GCILVEMHTGEPLFSGA 261 (382)
T ss_dssp HHHHHHHHHSSCSSCCS
T ss_pred HHHHHHHHhCCCCCCCC
Confidence 99999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=250.91 Aligned_cols=198 Identities=22% Similarity=0.331 Sum_probs=163.1
Q ss_pred hHHHHHHHHHhcCC--CccccccceeEEeCCcceEEEEecCC-CChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPN-GTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+.+++.++ ||||+++++++..++..++++|++.+ ++|.+++..... +++..++.++.|++.||.|||+
T Consensus 91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~---l~~~~~~~i~~qi~~~L~~LH~ 167 (320)
T 3a99_A 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHN 167 (320)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHH
Confidence 34678999999996 59999999999999999999999976 899999976533 6789999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLA 157 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~ 157 (259)
++ ++|+||||+||+++ .++.++|+|||++...... ......++..|+|||++.+..+ +.++||||||+++|
T Consensus 168 ~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ 240 (320)
T 3a99_A 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLY 240 (320)
T ss_dssp TT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHH
T ss_pred CC---cEeCCCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHH
Confidence 99 99999999999998 7789999999998766532 1223468999999999887665 78899999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||..... ...... .. ....++.+.++|.+||+.||.+|||+.++++
T Consensus 241 el~~g~~pf~~~~~--------------~~~~~~-------~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 241 DMVCGDIPFEHDEE--------------IIRGQV-------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHSSCSCCSHHH--------------HHHCCC-------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHCCCCCCChhh--------------hhcccc-------cc----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 99999999976210 000000 00 0112367999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=252.81 Aligned_cols=212 Identities=23% Similarity=0.297 Sum_probs=143.1
Q ss_pred HHHHHHH-HHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc--CCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 4 VFQHELR-VVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK--SSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 4 ~~~~E~~-~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+..|+. +++.++||||+++++++..++..++||||+.+ +|.+++... .....+++..+..++.|++.||.|||++
T Consensus 66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 144 (327)
T 3aln_A 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144 (327)
T ss_dssp HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc
Confidence 3445555 77778999999999999999999999999975 888877631 1123367899999999999999999998
Q ss_pred -CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchh----ccCCcccccchhhHHHH
Q 025011 81 -ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYV----ITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 81 -~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~i 155 (259)
+ ++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++ .+..++.++||||||++
T Consensus 145 ~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 218 (327)
T 3aln_A 145 LK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGIT 218 (327)
T ss_dssp HS---CCCSCCCGGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHH
T ss_pred CC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHH
Confidence 9 9999999999999999999999999987654321 12233689999999998 45568899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+|++|..||.+....... ..... ..... ..........++.+.+++.+||+.||.+|||+.++++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~-------~~~~~-~~~~~-----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 219 LYELATGRFPYPKWNSVFDQ-------LTQVV-KGDPP-----QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp HHHHHHSCCCSSCC--------------CCCC-CSCCC-----CCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchHHHH-------HHHHh-cCCCC-----CCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 99999999999763211100 00000 00000 0000011123367999999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=247.48 Aligned_cols=197 Identities=24% Similarity=0.347 Sum_probs=158.3
Q ss_pred HHHHHHHHHhcC----CCccccccceeEEeCCcceEEEEe-cCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 4 VFQHELRVVSQI----NHKNVVKILGACLETKVPLLVYEF-VPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 4 ~~~~E~~~l~~l----~h~~iv~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
.+.+|+.++.++ +||||+++++++...+..++++|+ +.+++|.+++..... +++..++.++.|++.||.|||
T Consensus 80 ~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~---~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 80 TCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP---LGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp CCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 356799999998 899999999999999999999999 789999999977543 688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il 156 (259)
+++ ++|+||+|+||+++ .++.++|+|||++....... .....++..|+|||++.+..+ +.++||||||+++
T Consensus 157 ~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 229 (312)
T 2iwi_A 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229 (312)
T ss_dssp HHT---EECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHH
T ss_pred HCC---eeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHH
Confidence 999 99999999999998 88999999999988665421 233458999999999877665 4589999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+|++|+.||..... .. .... .. +...+..+.++|.+||+.||.+|||+.++++
T Consensus 230 ~~l~~g~~pf~~~~~----------~~---~~~~--------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 230 YDMVCGDIPFERDQE----------IL---EAEL--------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHHHHSSCSCCSHHH----------HH---HTCC--------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHCCCCCCChHH----------Hh---hhcc--------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 999999999976210 00 0000 00 1112367899999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=246.80 Aligned_cols=208 Identities=21% Similarity=0.296 Sum_probs=151.0
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC-CC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS-AS 82 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~ 82 (259)
.+..+..+++.++||||+++++++..++..++||||+ ++.+..+...... .+++..++.++.|++.||.|||++ +
T Consensus 70 ~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~- 145 (318)
T 2dyl_A 70 ILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQG--PIPERILGKMTVAIVKALYYLKEKHG- 145 (318)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhhCC-
Confidence 3555666788889999999999999999999999999 6566666554322 257899999999999999999995 8
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ 157 (259)
++|+||+|+||+++.++.++|+|||++....... ......++..|+|||++. ...++.++||||+|+++|
T Consensus 146 --i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 220 (318)
T 2dyl_A 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220 (318)
T ss_dssp --CCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHH
T ss_pred --EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHH
Confidence 9999999999999999999999999987654321 122345889999999984 445788999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|..||....... ........... . ........++.+.++|.+||+.||.+|||+.++++
T Consensus 221 ~l~~g~~pf~~~~~~~-------~~~~~~~~~~~-~-------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 221 ELATGQFPYKNCKTDF-------EVLTKVLQEEP-P-------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHHSSCTTTTCCSHH-------HHHHHHHHSCC-C-------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHhCCCCCCCCCccH-------HHHHHHhccCC-C-------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 9999999997632110 00111110000 0 00001112367999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=266.79 Aligned_cols=198 Identities=25% Similarity=0.326 Sum_probs=159.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCc-----ceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKV-----PLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|++++++++||||+++++++...+. .|+||||+++++|.+++.. .+++..++.++.|++.||.||
T Consensus 124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~l 198 (681)
T 2pzi_A 124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYL 198 (681)
T ss_dssp HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999999999999999988665 6999999999999988754 268899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
|+++ |+|+||||+||+++.+ .++|+|||+++..... ....||+.|+|||++.+.. +.++||||||+++|
T Consensus 199 H~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~ 267 (681)
T 2pzi_A 199 HSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLA 267 (681)
T ss_dssp HHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHH
T ss_pred HHCC---CeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHH
Confidence 9999 9999999999999986 8999999999765432 3346899999999987654 88999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-TMKQVSEE 236 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~ 236 (259)
+|++|..||.+..... . .........++.+.++|.+||+.||.+|| +++++.+.
T Consensus 268 ~l~~g~~~~~~~~~~~------------------~-------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~ 322 (681)
T 2pzi_A 268 ALTLDLPTRNGRYVDG------------------L-------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQ 322 (681)
T ss_dssp HHHSCCCEETTEECSS------------------C-------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHhCCCCCccccccc------------------c-------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHH
Confidence 9999988877521110 0 01111223346789999999999999999 56677776
Q ss_pred HHhcc
Q 025011 237 LDRLK 241 (259)
Q Consensus 237 l~~~~ 241 (259)
+..+.
T Consensus 323 l~~~~ 327 (681)
T 2pzi_A 323 LTGVL 327 (681)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 66553
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-36 Score=237.16 Aligned_cols=192 Identities=26% Similarity=0.284 Sum_probs=148.7
Q ss_pred hHHHHHHHHH-hcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVV-SQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l-~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+.++ +.++||||+++++++.. ++..++||||+++++|.+++...... .+++..++.++.|++.||.||
T Consensus 55 ~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTC-CCBHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHH
Confidence 4678899998 55699999999999987 67789999999999999999876432 368899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
|+++ ++|+||||+||+++. ++.++|+|||++.... +..++.++||||+|+
T Consensus 134 H~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~ 186 (299)
T 3m2w_A 134 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGV 186 (299)
T ss_dssp HHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHH
T ss_pred HhCC---cccCCCCHHHEEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHH
Confidence 9999 999999999999998 7889999999985432 234688999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|+|++|..||.+....... ............... .....++.+.+++.+||+.||.+|||+.+
T Consensus 187 il~el~tg~~pf~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e 253 (299)
T 3m2w_A 187 IMYILLCGYPPFYSNHGLAIS-------------PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 253 (299)
T ss_dssp HHHHHHHSSCSCCC--------------------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHHHHCCCCCCCCcchhhh-------------HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHH
Confidence 999999999999763211100 000000000000000 01123477999999999999999999999
Q ss_pred HHH
Q 025011 233 VSE 235 (259)
Q Consensus 233 il~ 235 (259)
+++
T Consensus 254 ~l~ 256 (299)
T 3m2w_A 254 FMN 256 (299)
T ss_dssp HHT
T ss_pred Hhc
Confidence 986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=238.61 Aligned_cols=191 Identities=15% Similarity=0.135 Sum_probs=150.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++.+++||||+++++++..++..|+||||+++++|.++++... ....+..++.|++.||.|||+++
T Consensus 76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-----~~~~~~~i~~ql~~aL~~lH~~g- 149 (286)
T 3uqc_A 76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP-----SPVGAIRAMQSLAAAADAAHRAG- 149 (286)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTCC-----CHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcCC-----ChHHHHHHHHHHHHHHHHHHHCC-
Confidence 578999999999999999999999999999999999999999999996532 34578889999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++|+||||+||+++.++.++|++++. ++ .++.++||||||+++|+|++|
T Consensus 150 --ivH~Dikp~NIll~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg 198 (286)
T 3uqc_A 150 --VALSIDHPSRVRVSIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVN 198 (286)
T ss_dssp --CCCCCCSGGGEEEETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHS
T ss_pred --CccCCCCcccEEEcCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHC
Confidence 99999999999999999999874432 22 268899999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCC--chhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVAD--ESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
+.||.+........ ............ ......++.+.++|.+||+.||.+| |+.++++.|+++
T Consensus 199 ~~Pf~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~ 263 (286)
T 3uqc_A 199 RWPLPEAGVRSGLA--------------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA 263 (286)
T ss_dssp EECSCCCSBCCCSE--------------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred CCCCCcCCcchhhH--------------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence 99998743221000 000000000000 0011234679999999999999999 999999999998
Q ss_pred ccccc
Q 025011 241 KISHE 245 (259)
Q Consensus 241 ~~~~~ 245 (259)
.....
T Consensus 264 ~~~~~ 268 (286)
T 3uqc_A 264 TAVAD 268 (286)
T ss_dssp HC---
T ss_pred hccCC
Confidence 77654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=239.53 Aligned_cols=200 Identities=16% Similarity=0.128 Sum_probs=147.1
Q ss_pred hHHHHHHHHHhcCCC-ccccccc---------------------eeEEe-----CCcceEEEEecCCCChhhhhhcc---
Q 025011 3 QVFQHELRVVSQINH-KNVVKIL---------------------GACLE-----TKVPLLVYEFVPNGTLFDHIHDK--- 52 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~---------------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--- 52 (259)
+.|++|+.+++.++| +|..... .++.. ....+++|+++ +++|.++++..
T Consensus 123 ~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~ 201 (413)
T 3dzo_A 123 KQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH 201 (413)
T ss_dssp HHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcc
Confidence 568999999999976 3221111 11111 22457777776 67999998521
Q ss_pred -CCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCccc
Q 025011 53 -SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFV 131 (259)
Q Consensus 53 -~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 131 (259)
.....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+++..+.. .....| ..
T Consensus 202 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~ 272 (413)
T 3dzo_A 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RG 272 (413)
T ss_dssp TTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TT
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-Cc
Confidence 12233567788999999999999999999 999999999999999999999999998765432 233457 99
Q ss_pred ccCcchh----------ccCCcccccchhhHHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccC
Q 025011 132 NLDPEYV----------ITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVA 201 (259)
Q Consensus 132 y~aPE~~----------~~~~~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (259)
|+|||++ .+..++.++|||||||++|+|++|+.||.+..... .....+....
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~-----------------~~~~~~~~~~- 334 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG-----------------GSEWIFRSCK- 334 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS-----------------CSGGGGSSCC-
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh-----------------hHHHHHhhcc-
Confidence 9999999 44558889999999999999999999998632211 0111111110
Q ss_pred CchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 202 DESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 202 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..++.+.++|.+||+.||.+|||+.++++
T Consensus 335 -----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 335 -----NIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp -----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12367999999999999999999877754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=237.25 Aligned_cols=200 Identities=16% Similarity=0.185 Sum_probs=150.7
Q ss_pred hHHHHHHHHHhcCC--------------------------CccccccceeEEe-------------CCcceEEEEecCCC
Q 025011 3 QVFQHELRVVSQIN--------------------------HKNVVKILGACLE-------------TKVPLLVYEFVPNG 43 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--------------------------h~~iv~~~~~~~~-------------~~~~~lv~e~~~~~ 43 (259)
+.+.+|+.+++.++ ||||+++++++.. ++..++||||+++|
T Consensus 68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g 147 (336)
T 2vuw_A 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147 (336)
T ss_dssp HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence 67899999999986 5666666666654 67899999999999
Q ss_pred ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh-hCCCCCeEeCCCCCCCeEeCCCC--------------------c
Q 025011 44 TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH-SSASPPIIHGDVKSTNVLLDDNY--------------------K 102 (259)
Q Consensus 44 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh-~~~~~~i~h~di~p~nil~~~~~--------------------~ 102 (259)
++.+.+.+. .+++..+..++.|++.||.||| +++ |+||||||+||+++.++ .
T Consensus 148 ~ll~~~~~~----~~~~~~~~~i~~qi~~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (336)
T 2vuw_A 148 IDLEQMRTK----LSSLATAKSILHQLTASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQ 220 (336)
T ss_dssp EETGGGTTT----CCCHHHHHHHHHHHHHHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEE
T ss_pred ccHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCce
Confidence 777766442 2588999999999999999999 899 99999999999999887 8
Q ss_pred eEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH-HHHHHhCCCCCCCCccccccchhHHH
Q 025011 103 AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL-LAELLTGLKPGSGMALASNEGISMVQ 181 (259)
Q Consensus 103 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i-l~~l~~g~~p~~~~~~~~~~~~~~~~ 181 (259)
++|+|||+++..... ...||+.|+|||++.+.. +.++||||+|++ .+++++|..||.+. .
T Consensus 221 vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----------~ 281 (336)
T 2vuw_A 221 VSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----------L 281 (336)
T ss_dssp EEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----------H
T ss_pred EEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----------h
Confidence 999999999865432 236899999999998766 889999998777 67788898887531 0
Q ss_pred HHHHhhccchhhh-hhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 182 YFLYSIENNSLRQ-ILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 182 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
|..... ...... ..............++.+.+||.+||+.| |+.+++
T Consensus 282 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 282 WLHYLT-DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHH-HHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred hhhHHH-HhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 000000 000000 01111122234457788999999999977 998887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=9.2e-34 Score=242.73 Aligned_cols=151 Identities=21% Similarity=0.208 Sum_probs=114.6
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++|.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++...+. ++.. .++.||+.||.|+|++|
T Consensus 286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~---l~~~---~I~~QIl~AL~ylH~~G 359 (569)
T 4azs_A 286 YELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEE---IDRE---KILGSLLRSLAALEKQG 359 (569)
T ss_dssp HHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCC---CCHH---HHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCC---CCHH---HHHHHHHHHHHHHHHCC
Confidence 5699999999999 799999999999999999999999999999999987654 3443 58899999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.+|.+||+|||+++...... .......||+.|+|||++.+ .+..++|+||+|++.+.+.+
T Consensus 360 ---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 360 ---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp ---CEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred ---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 9999999999999999999999999998665432 22334579999999999876 45678999999999887766
Q ss_pred CCCC
Q 025011 162 GLKP 165 (259)
Q Consensus 162 g~~p 165 (259)
+..+
T Consensus 434 ~~~~ 437 (569)
T 4azs_A 434 PWSN 437 (569)
T ss_dssp THHH
T ss_pred ccch
Confidence 5443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-26 Score=194.08 Aligned_cols=148 Identities=16% Similarity=0.163 Sum_probs=125.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.+|++++++++||||+++..++...+..++||||+++++|.+++.. +..++.|++.+|.|||+++
T Consensus 384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g- 451 (540)
T 3en9_A 384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND- 451 (540)
T ss_dssp HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc-
Confidence 5689999999999999999777777788888999999999999999975 4579999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-----ccccccCcccccCcchhcc--CCcccccchhhHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-----MTTKKIGTFVNLDPEYVIT--GKLTEKSDVYSFGVL 155 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~i 155 (259)
|+|+||||+||+++. .++|+|||+++......... ......||+.|+|||++.. ..|+..+|+|+..+-
T Consensus 452 --IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~ 527 (540)
T 3en9_A 452 --VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILE 527 (540)
T ss_dssp --EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHH
T ss_pred --CccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHH
Confidence 999999999999998 99999999998765432211 1234569999999999976 557888999999988
Q ss_pred HHHHHhCCCCC
Q 025011 156 LAELLTGLKPG 166 (259)
Q Consensus 156 l~~l~~g~~p~ 166 (259)
..+-..++.+|
T Consensus 528 ~l~~v~~r~rY 538 (540)
T 3en9_A 528 LMKDVERRARY 538 (540)
T ss_dssp HHHHHHTCSCC
T ss_pred HHHHHHhcccc
Confidence 88887776665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=9e-20 Score=143.24 Aligned_cols=93 Identities=16% Similarity=0.245 Sum_probs=79.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++ | +++.+++.. +..++||||+++++|.+ +.. .....++.|++.|+.+||+.+
T Consensus 149 ~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g- 213 (282)
T 1zar_A 149 RSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG- 213 (282)
T ss_dssp HHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC-
Confidence 45889999999999 5 777776654 56799999999999988 421 223469999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|+||||+||+++ ++.++|+|||+++.
T Consensus 214 --iiHrDlkp~NILl~-~~~vkl~DFG~a~~ 241 (282)
T 1zar_A 214 --IVHGDLSQYNVLVS-EEGIWIIDFPQSVE 241 (282)
T ss_dssp --EECSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred --CEeCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence 99999999999999 99999999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=116.75 Aligned_cols=96 Identities=19% Similarity=0.252 Sum_probs=75.9
Q ss_pred HHHHHHHHHhcCCCccc--cccceeEEeCCcceEEEEecCC-C----ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQINHKNV--VKILGACLETKVPLLVYEFVPN-G----TLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~i--v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
.+.+|+.+++.+.|+++ +.++++ +..++||||+.+ | +|.++.... ++..+..++.|++.++.+
T Consensus 116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~------~~~~~~~i~~qi~~~l~~ 185 (258)
T 1zth_A 116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL------KELDVEGIFNDVVENVKR 185 (258)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG------GGSCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc------ChHHHHHHHHHHHHHHHH
Confidence 68899999999988764 333332 357899999942 3 566554321 234567899999999999
Q ss_pred Hh-hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccc
Q 025011 77 LH-SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLI 114 (259)
Q Consensus 77 lh-~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~ 114 (259)
|| +.+ ++|+||||+||+++. .++|+|||++...
T Consensus 186 lH~~~g---ivHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 186 LYQEAE---LVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHHTSC---EECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred HHHHCC---EEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99 999 999999999999998 9999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.31 E-value=1.9e-12 Score=104.80 Aligned_cols=96 Identities=14% Similarity=0.143 Sum_probs=68.4
Q ss_pred HHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
+|...|.++.+.++.-..-+.. +..+|||||++|++|..+... .....++.|++.++.+||+.| ++
T Consensus 162 kE~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IV 227 (397)
T 4gyi_A 162 KEFAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LI 227 (397)
T ss_dssp HHHHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---Cc
Confidence 4566666664444322221211 234799999999888665421 223567899999999999999 99
Q ss_pred eCCCCCCCeEeCCCCc----------eEEeecCCcccccC
Q 025011 87 HGDVKSTNVLLDDNYK----------AKVADFGSSVLISS 116 (259)
Q Consensus 87 h~di~p~nil~~~~~~----------~~l~df~~~~~~~~ 116 (259)
||||||.||++++++. +.++||+.+....+
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETTS
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccCCC
Confidence 9999999999987763 88999998765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.17 E-value=4.9e-11 Score=92.51 Aligned_cols=102 Identities=18% Similarity=0.160 Sum_probs=80.6
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..+.+|+++++.+. +..++++++++...+..++|||+++|.++.+.+... .....++.++..++..||+..
T Consensus 54 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~ 125 (263)
T 3tm0_A 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSID 125 (263)
T ss_dssp TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSC
T ss_pred HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCC
Confidence 35889999999994 677889999999988999999999999987763211 223467788888999999810
Q ss_pred --------------------------------------------------------CCCeEeCCCCCCCeEeCCCCceEE
Q 025011 82 --------------------------------------------------------SPPIIHGDVKSTNVLLDDNYKAKV 105 (259)
Q Consensus 82 --------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l 105 (259)
...++|+|++|.||++++++.+.|
T Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l 205 (263)
T 3tm0_A 126 ISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGF 205 (263)
T ss_dssp CTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEE
T ss_pred cccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEE
Confidence 023899999999999987656679
Q ss_pred eecCCcc
Q 025011 106 ADFGSSV 112 (259)
Q Consensus 106 ~df~~~~ 112 (259)
+||+.+.
T Consensus 206 IDwe~a~ 212 (263)
T 3tm0_A 206 IDLGRSG 212 (263)
T ss_dssp CCCTTCE
T ss_pred EEchhcc
Confidence 9998764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.97 E-value=2e-09 Score=87.26 Aligned_cols=106 Identities=22% Similarity=0.324 Sum_probs=81.9
Q ss_pred hHHHHHHHHHhcCC--CccccccceeEEeC---CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN--HKNVVKILGACLET---KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~--h~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
..+.+|+.+++.+. +..+++++.++.+. +..++||||++|..+.+... ..++......++.+++.+|..|
T Consensus 81 ~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~L 155 (359)
T 3dxp_A 81 HAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAM 155 (359)
T ss_dssp -CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHH
Confidence 35788999999996 45578889888776 45899999999887754211 1135677788899999999999
Q ss_pred hhCC-------------------------------------------------------CCCeEeCCCCCCCeEeCCCCc
Q 025011 78 HSSA-------------------------------------------------------SPPIIHGDVKSTNVLLDDNYK 102 (259)
Q Consensus 78 h~~~-------------------------------------------------------~~~i~h~di~p~nil~~~~~~ 102 (259)
|+.. ...++|+|+++.||+++.++.
T Consensus 156 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~ 235 (359)
T 3dxp_A 156 HTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEP 235 (359)
T ss_dssp HHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSS
T ss_pred hCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCC
Confidence 9731 134999999999999997753
Q ss_pred --eEEeecCCccc
Q 025011 103 --AKVADFGSSVL 113 (259)
Q Consensus 103 --~~l~df~~~~~ 113 (259)
+.++||+.+..
T Consensus 236 ~v~~viDwe~a~~ 248 (359)
T 3dxp_A 236 RVLAVLDWELSTL 248 (359)
T ss_dssp CEEEECCCTTCEE
T ss_pred cEEEEECcccccc
Confidence 68999998764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.89 E-value=1.3e-09 Score=86.38 Aligned_cols=158 Identities=19% Similarity=0.261 Sum_probs=96.2
Q ss_pred hHHHHHHHHHhcC-CCcc--ccccceeEEeCC---cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKN--VVKILGACLETK---VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~--iv~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
..+.+|+++++.+ .+.. +++++.....++ ..|+||++++|.++.+..... ++......++.+++..+..
T Consensus 55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~~-----l~~~~~~~~~~~l~~~la~ 129 (304)
T 3sg8_A 55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLNN-----LPKQSQNQAAKDLARFLSE 129 (304)
T ss_dssp HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHHT-----SCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccccc-----CCHHHHHHHHHHHHHHHHH
Confidence 4688999999988 3433 445554443332 358999999998886533211 2445556666777777776
Q ss_pred HhhCC-------------------------------------------------------CCCeEeCCCCCCCeEeCC--
Q 025011 77 LHSSA-------------------------------------------------------SPPIIHGDVKSTNVLLDD-- 99 (259)
Q Consensus 77 lh~~~-------------------------------------------------------~~~i~h~di~p~nil~~~-- 99 (259)
||+.. .+.++|+|++|.||+++.
T Consensus 130 LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 209 (304)
T 3sg8_A 130 LHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEK 209 (304)
T ss_dssp HHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTT
T ss_pred HHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCC
Confidence 66511 133899999999999998
Q ss_pred CCceEEeecCCcccccCCccccccccc---cC---------cccccC-cchhccCCcccccchhhHHHHHHHHHhCCCCC
Q 025011 100 NYKAKVADFGSSVLISSDNQTAMTTKK---IG---------TFVNLD-PEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166 (259)
Q Consensus 100 ~~~~~l~df~~~~~~~~~~~~~~~~~~---~~---------~~~y~a-PE~~~~~~~~~~~DiwslG~il~~l~~g~~p~ 166 (259)
++.+.++||+.+.......+....... .+ ...... |+.... .....+.|++|.+++.+.+|..+|
T Consensus 210 ~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 210 NTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 556789999987653221111000000 00 001111 221111 122368999999999999998775
Q ss_pred C
Q 025011 167 S 167 (259)
Q Consensus 167 ~ 167 (259)
.
T Consensus 288 ~ 288 (304)
T 3sg8_A 288 Y 288 (304)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.88 E-value=2e-09 Score=83.08 Aligned_cols=99 Identities=19% Similarity=0.207 Sum_probs=73.3
Q ss_pred hHHHHHHHHHhcCCCcc--ccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 3 QVFQHELRVVSQINHKN--VVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
..+.+|+.+++.+.+.+ +++++++...++..++||||++|.++. ... .+ ...++.+++..+..||+.
T Consensus 58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~ 126 (264)
T 1nd4_A 58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTL 126 (264)
T ss_dssp SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTS
T ss_pred hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCC
Confidence 35789999999995434 567888888888889999999998874 211 11 124566677777777764
Q ss_pred C-------------------------------------------------------CCCeEeCCCCCCCeEeCCCCceEE
Q 025011 81 A-------------------------------------------------------SPPIIHGDVKSTNVLLDDNYKAKV 105 (259)
Q Consensus 81 ~-------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l 105 (259)
. ...++|+|++|.||++++++.+.+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l 206 (264)
T 1nd4_A 127 DPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGF 206 (264)
T ss_dssp CGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEE
T ss_pred CCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEE
Confidence 2 112999999999999987766679
Q ss_pred eecCCcc
Q 025011 106 ADFGSSV 112 (259)
Q Consensus 106 ~df~~~~ 112 (259)
+||+.+.
T Consensus 207 iD~~~a~ 213 (264)
T 1nd4_A 207 IDCGRLG 213 (264)
T ss_dssp CCCTTCE
T ss_pred Ecchhcc
Confidence 9999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=4e-07 Score=70.65 Aligned_cols=104 Identities=18% Similarity=0.215 Sum_probs=74.8
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
..+..|+.+|+.+. +--+++++.++.+++..++||++++|.++.+...... .....+..++...+..||...
T Consensus 64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~ 136 (272)
T 4gkh_A 64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------DSGENIVDALAVFLRRLHSIP 136 (272)
T ss_dssp HHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------GGHHHHHHHHHHHHHHHHTSC
T ss_pred hHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------HHHHHHHHHHHHHHHHhcCCC
Confidence 35788999999884 3347788999999999999999999988877654321 122234445555555555411
Q ss_pred -------------------------------------------------------CCCeEeCCCCCCCeEeCCCCceEEe
Q 025011 82 -------------------------------------------------------SPPIIHGDVKSTNVLLDDNYKAKVA 106 (259)
Q Consensus 82 -------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l~ 106 (259)
...++|+|+++.||+++.++.+-|+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~vi 216 (272)
T 4gkh_A 137 VCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCI 216 (272)
T ss_dssp GGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEE
Confidence 1127999999999999988777899
Q ss_pred ecCCccc
Q 025011 107 DFGSSVL 113 (259)
Q Consensus 107 df~~~~~ 113 (259)
||+.+..
T Consensus 217 Dwe~a~~ 223 (272)
T 4gkh_A 217 DVGRVGI 223 (272)
T ss_dssp CCTTCEE
T ss_pred ECccccc
Confidence 9988753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=3e-06 Score=66.97 Aligned_cols=45 Identities=13% Similarity=0.159 Sum_probs=34.6
Q ss_pred hHHHHHHHHHhcCCCc---cccccceeEE-eCCcceEEEEecCCCChhh
Q 025011 3 QVFQHELRVVSQINHK---NVVKILGACL-ETKVPLLVYEFVPNGTLFD 47 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~---~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~ 47 (259)
..+.+|+++|+.+.+. .+++++.+.. ..+..+++|++++|.++.+
T Consensus 54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~ 102 (306)
T 3tdw_A 54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE 102 (306)
T ss_dssp HHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred HHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence 4688999999999642 3667777764 4556789999999988765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.00 E-value=0.00014 Score=53.64 Aligned_cols=102 Identities=10% Similarity=0.010 Sum_probs=66.5
Q ss_pred ChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccccc
Q 025011 44 TLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123 (259)
Q Consensus 44 ~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 123 (259)
+|.+.|+..+. ++++.++|.++.|.+.+|.-+-.... -...=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 34 SLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred cHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc-----------
Confidence 78888887765 36999999999999999887632211 12333457889999998888764 1110
Q ss_pred ccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCC
Q 025011 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP 165 (259)
Q Consensus 124 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 165 (259)
.....+.|||.+. ...+.+.-|||||+++|.-+--..|
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1223455787652 3456788999999999999875555
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.4e-05 Score=63.04 Aligned_cols=45 Identities=13% Similarity=0.197 Sum_probs=33.8
Q ss_pred hHHHHHHHHHhcCC-C--ccccccceeEEeC---CcceEEEEecCCCChhh
Q 025011 3 QVFQHELRVVSQIN-H--KNVVKILGACLET---KVPLLVYEFVPNGTLFD 47 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h--~~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~ 47 (259)
..+.+|+.+++.+. + -.+++++.++.++ +..++|||+++|..+.+
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChhh
Confidence 35789999999984 3 3577888887655 35689999999877653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00053 Score=54.65 Aligned_cols=28 Identities=29% Similarity=0.375 Sum_probs=25.8
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
++|+|+++.||+++.++.+.++||+.+.
T Consensus 224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 224 LCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 9999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00083 Score=53.01 Aligned_cols=43 Identities=16% Similarity=0.193 Sum_probs=36.0
Q ss_pred hHHHHHHHHHhcCC---CccccccceeEEeCCcceEEEEecCCCCh
Q 025011 3 QVFQHELRVVSQIN---HKNVVKILGACLETKVPLLVYEFVPNGTL 45 (259)
Q Consensus 3 ~~~~~E~~~l~~l~---h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 45 (259)
..+..|++.|+.|. ...+++++.+....+..++|||++++..+
T Consensus 73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 73 SMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46889999999983 35688999988888889999999998765
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0015 Score=52.04 Aligned_cols=31 Identities=26% Similarity=0.336 Sum_probs=26.6
Q ss_pred CeEeCCCCCCCeEeCCC----CceEEeecCCcccc
Q 025011 84 PIIHGDVKSTNVLLDDN----YKAKVADFGSSVLI 114 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~----~~~~l~df~~~~~~ 114 (259)
.++|||+.+.||+++.+ +.+.++||+.+...
T Consensus 184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 39999999999999874 67899999987643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0024 Score=52.16 Aligned_cols=28 Identities=25% Similarity=0.503 Sum_probs=24.4
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|||+.+.||+++.+ .+.++||..+..
T Consensus 229 L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 229 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp EECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred eeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 9999999999999876 489999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0023 Score=50.12 Aligned_cols=29 Identities=24% Similarity=0.260 Sum_probs=24.6
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.++|+|+.+.||+ ..++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5566789999998754
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0016 Score=52.89 Aligned_cols=106 Identities=16% Similarity=0.181 Sum_probs=63.1
Q ss_pred HHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhh-h-------------hc---c--CCcccCC--HH
Q 025011 4 VFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDH-I-------------HD---K--SSQVLRN--WK 61 (259)
Q Consensus 4 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-l-------------~~---~--~~~~~~~--~~ 61 (259)
...+|.++++.|. +.-.+++++.+.+ .+|+||++|..+..- + .+ . ....... +.
T Consensus 99 ~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~ 174 (379)
T 3feg_A 99 SLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFG 174 (379)
T ss_dssp HHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHH
Confidence 4568999999884 3334677776643 299999988655311 0 00 0 0011111 23
Q ss_pred HHHHHHHHHHH-------------------HHHH----HhhCC-CCCeEeCCCCCCCeEeCCC----CceEEeecCCccc
Q 025011 62 TCLRIAAETAS-------------------ALDY----LHSSA-SPPIIHGDVKSTNVLLDDN----YKAKVADFGSSVL 113 (259)
Q Consensus 62 ~~~~i~~~i~~-------------------~l~~----lh~~~-~~~i~h~di~p~nil~~~~----~~~~l~df~~~~~ 113 (259)
.+.+|..++-. .+.. |...+ ...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 175 ~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 175 TMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 44455444322 1222 22221 2348999999999999876 6899999998753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.013 Score=48.12 Aligned_cols=28 Identities=29% Similarity=0.493 Sum_probs=25.6
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|||++|.||+++.++ +.++||+.+..
T Consensus 234 liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 99999999999998876 99999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.83 E-value=0.023 Score=44.69 Aligned_cols=29 Identities=24% Similarity=0.313 Sum_probs=25.0
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
.++|+|+++.||++++++.+.++||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 39999999999999987666899998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.65 E-value=0.086 Score=41.53 Aligned_cols=27 Identities=22% Similarity=0.394 Sum_probs=24.0
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|||+++.||+++ + .+.++||+.+..
T Consensus 197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 197 RLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp ECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 89999999999999 4 899999988754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=93.53 E-value=0.074 Score=42.33 Aligned_cols=30 Identities=23% Similarity=0.471 Sum_probs=26.8
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.++|+|+.+.||+++.++.+.++||+.+..
T Consensus 207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 399999999999999888899999987754
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.28 E-value=0.26 Score=36.27 Aligned_cols=117 Identities=11% Similarity=0.045 Sum_probs=72.3
Q ss_pred CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCe
Q 025011 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNV 95 (259)
Q Consensus 16 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~ni 95 (259)
.||+.+.. .+-.+++.+.+.++.-+.+-=+..+.+ .+....++++..|+....+++. -+|--++|+|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik~------~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIKS------FTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGGG------SCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHHh------cCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 57777765 454555554454444332211222332 3568889999999887744432 47889999999
Q ss_pred EeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCC
Q 025011 96 LLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 96 l~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~ 168 (259)
+++.++.+++.--|+.. -++|. ..+...=.-..=|++..+++++..|..
T Consensus 111 ~f~~~~~p~i~~RGik~-------------------~l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQN-------------------VVDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp EECTTSCEEESCCEETT-------------------TBSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred EEcCCCCEEEEEccCcc-------------------CCCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999987555421 11222 122222333566888889998888764
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.86 E-value=0.058 Score=43.40 Aligned_cols=29 Identities=21% Similarity=0.401 Sum_probs=24.1
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.++|+|+.+.||++++++ +.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 389999999999998654 89999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=92.61 E-value=0.15 Score=42.48 Aligned_cols=36 Identities=22% Similarity=0.228 Sum_probs=25.6
Q ss_pred HHHHHHHhcCCCccc-cccceeEEeCCcceEEEEecCCCCh
Q 025011 6 QHELRVVSQINHKNV-VKILGACLETKVPLLVYEFVPNGTL 45 (259)
Q Consensus 6 ~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L 45 (259)
.+|+.+++.|...++ +++++.+. + ..|++|++|.++
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 589999999964444 57777763 2 259999987554
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=92.29 E-value=0.058 Score=44.52 Aligned_cols=39 Identities=15% Similarity=0.236 Sum_probs=26.5
Q ss_pred hHHHHHHHHHhcCCCcc-ccccceeEEeCCcceEEEEecCCCCh
Q 025011 3 QVFQHELRVVSQINHKN-VVKILGACLETKVPLLVYEFVPNGTL 45 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e~~~~~~L 45 (259)
+.+.+|+.+++.|...+ .+++++.+.+ .+|++|++|.++
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 45668999999884333 4677766542 389999987444
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=91.92 E-value=0.37 Score=35.56 Aligned_cols=116 Identities=11% Similarity=0.033 Sum_probs=71.5
Q ss_pred CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH-HHhhCCCCCeEeCCCCCCC
Q 025011 16 NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD-YLHSSASPPIIHGDVKSTN 94 (259)
Q Consensus 16 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~-~lh~~~~~~i~h~di~p~n 94 (259)
.||++ -..+-.+++.+.+.++.-+++.=+..+++ .+...+++++..++.... +++ . -+|--++|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeCce
Confidence 46777 33444566666666665433333334433 356888888888877555 333 3 5888999999
Q ss_pred eEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhCCCCCCC
Q 025011 95 VLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG 168 (259)
Q Consensus 95 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p~~~ 168 (259)
++++.++.+++.-.|.-. .++|.- .+...=.-..=|++..++.++..|..
T Consensus 115 L~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp EEECTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred EEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999999998655421 122321 12222223566788888888777654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.07 E-value=0.13 Score=41.94 Aligned_cols=29 Identities=31% Similarity=0.468 Sum_probs=24.9
Q ss_pred eEeCCCCCCCeEe------CCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLL------DDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~------~~~~~~~l~df~~~~~ 113 (259)
++|+|+.+.||++ ++++.+.++||.++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567799999998754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=87.61 E-value=0.27 Score=40.40 Aligned_cols=29 Identities=21% Similarity=0.449 Sum_probs=25.7
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
.++|+|+.+.||+ +.++.+.++||..+..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3899999999999 7788999999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=85.82 E-value=0.78 Score=35.28 Aligned_cols=39 Identities=18% Similarity=0.130 Sum_probs=26.5
Q ss_pred hHHHHHHHHHhcCC-Cc--cccccceeEEeCCcceEEEEecCCCCh
Q 025011 3 QVFQHELRVVSQIN-HK--NVVKILGACLETKVPLLVYEFVPNGTL 45 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~--~iv~~~~~~~~~~~~~lv~e~~~~~~L 45 (259)
..|..|++.|+.|. .. -+++++.+. ..+++||+++++..
T Consensus 56 ~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 56 GLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDERPP 97 (288)
T ss_dssp THHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCCCCC
T ss_pred hHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecccCC
Confidence 46889999999984 22 245555442 34799999987654
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 259 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-52 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-49 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 7e-48 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-47 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-45 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-45 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 9e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-44 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-44 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-44 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-43 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-42 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-42 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-42 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-40 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-40 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-39 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-39 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-37 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-35 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-31 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-31 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-30 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-27 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-26 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-25 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-21 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-20 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-10 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 5e-58
Identities = 58/244 (23%), Positives = 113/244 (46%), Gaps = 22/244 (9%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q F++E+ V+ + H N++ +G ++ +V ++ +L+ H+H ++
Sbjct: 49 QAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKF--EMIK 105
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ IA +TA +DYLH+ IIH D+KS N+ L ++ K+ DFG + + S + +
Sbjct: 106 LIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ 162
Query: 123 TTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
+ G+ + + PE + + +SDVY+FG++L EL+TG P S + +
Sbjct: 163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------NN 214
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239
++ + L L + + + L ++CL RP Q+ ++
Sbjct: 215 RDQIIFMVGRGYLSPDL-----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269
Query: 240 LKIS 243
L S
Sbjct: 270 LARS 273
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-52
Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 28/244 (11%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLRNWK 61
Q F E V++Q+ H N+V++LG +E K L +V E++ G+L D++ + VL
Sbjct: 45 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-GGD 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
L+ + + A++YL +H D+ + NVL+ ++ AKV+DFG + SS T
Sbjct: 104 CLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 160
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
PE + K + KSDV+SFG+LL E+ + +
Sbjct: 161 K-----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV---------------- 199
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
I + + ++ V + C L RP+ Q+ E+L+ +K
Sbjct: 200 -PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
Query: 242 ISHE 245
+HE
Sbjct: 259 -THE 261
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-49
Identities = 52/260 (20%), Positives = 106/260 (40%), Gaps = 24/260 (9%)
Query: 2 NQVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVL 57
+ + E+ + H+N++ + A + LV ++ +G+LFD+++ +
Sbjct: 41 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---- 96
Query: 58 RNWKTCLRIAAETASALDYLHSSA-----SPPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112
+ +++A TAS L +LH P I H D+KS N+L+ N +AD G +V
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 113 LISSDNQT--AMTTKKIGTFVNLDPEYVIT------GKLTEKSDVYSFGVLLAELLTGLK 164
S T ++GT + PE + + +++D+Y+ G++ E+
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 165 PGSGMALASNEGISMV--QYFLYSIENNSLRQILNFQVADE-SEMEEIETVAGLASKCLS 221
G +V + + Q L + + E + +A + +C
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 222 LSGRRRPTMKQVSEELDRLK 241
+G R T ++ + L +L
Sbjct: 277 ANGAARLTALRIKKTLSQLS 296
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 7e-48
Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 23/241 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q+ H+ +V++ + + ++ E++ NG+L D + S L L
Sbjct: 55 FLAEANLMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKL-TINKLL 112
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+AA+ A + ++ IH D+++ N+L+ D K+ADFG + LI DN+
Sbjct: 113 DMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTARE 168
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
PE + G T KSDV+SFG+LL E++T + G++ + +
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRI-------PYPGMTNPE--V 219
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
R + +E + L C RPT + L+ +
Sbjct: 220 IQNLERGYRMVRPDNCPEE--------LYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271
Query: 245 E 245
E
Sbjct: 272 E 272
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (394), Expect = 5e-47
Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 22/236 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E V+ +I H N+V++LG C ++ EF+ G L D++ + + Q + + L
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV-SAVVLL 118
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+A + +SA++YL IH D+ + N L+ +N+ KVADFG S L++ D TA
Sbjct: 119 YMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 175
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
K PE + K + KSDV++FGVLL E+ T
Sbjct: 176 AK-FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS-----------------PY 217
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
I+ + + ++L E E V L C + RP+ ++ + + +
Sbjct: 218 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 5e-47
Identities = 54/236 (22%), Positives = 99/236 (41%), Gaps = 23/236 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E V+ +++H +V++ G CLE LV+EF+ +G L D++ + + L +T L
Sbjct: 47 FIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ--RGLFAAETLL 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + YL +IH D+ + N L+ +N KV+DFG + + D T +T
Sbjct: 105 GMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SST 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
PE + + KSDV+SFGVL+ E+ + K
Sbjct: 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI-----------------PY 203
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
+ N+ + + ++ V + + C RP ++ +L +
Sbjct: 204 ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-46
Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 23/241 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +V+ ++ H+ +V++ E + +V E++ G+L D + ++ + +
Sbjct: 59 FLQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLV 116
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+AA+ AS + Y+ +H D+++ N+L+ +N KVADFG + LI + TA
Sbjct: 117 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
K PE + G+ T KSDV+SFG+LL EL T +
Sbjct: 174 AK-FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV-----------------PY 215
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKISH 244
+ N + + E E++ L +C RPT + + L+ S
Sbjct: 216 PGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
Query: 245 E 245
E
Sbjct: 276 E 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 155 bits (391), Expect = 2e-46
Identities = 52/257 (20%), Positives = 97/257 (37%), Gaps = 41/257 (15%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR------ 58
FQ E ++++ ++ N+VK+LG C K L++E++ G L + + S +
Sbjct: 63 FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122
Query: 59 ---------------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKA 103
+ L IA + A+ + YL +H D+ + N L+ +N
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179
Query: 104 KVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGL 163
K+ADFG S I S + + PE + + T +SDV+++GV+L E+ +
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 164 KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLS 223
+ + + + + E + L C S
Sbjct: 240 LQ----------------PYYGMAHEEVIYYVRDGNILACPE-NCPLELYNLMRLCWSKL 282
Query: 224 GRRRPTMKQVSEELDRL 240
RP+ + L R+
Sbjct: 283 PADRPSFCSIHRILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-46
Identities = 52/254 (20%), Positives = 91/254 (35%), Gaps = 34/254 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
EL+V+ + N +V GA + E + G+L + +
Sbjct: 51 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRI---PEQILG 107
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+++ L YL I+H DVK +N+L++ + K+ DFG S + M
Sbjct: 108 KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 161
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP----------------GSG 168
+GT + PE + + +SD++S G+ L E+ G P G
Sbjct: 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221
Query: 169 MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG---------LASKC 219
A + L S +S + F++ D E + +KC
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281
Query: 220 LSLSGRRRPTMKQV 233
L + R +KQ+
Sbjct: 282 LIKNPAERADLKQL 295
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-45
Identities = 53/236 (22%), Positives = 102/236 (43%), Gaps = 25/236 (10%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLR-N 59
Q+ E+ ++ ++ H N+V+ ++ +V E+ G L I + + +
Sbjct: 48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 107
Query: 60 WKTCLRIAAETASALDYLH--SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+ LR+ + AL H S ++H D+K NV LD K+ DFG + +++ D
Sbjct: 108 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
T+ +GT + PE + EKSD++S G LL EL + P + +
Sbjct: 168 --TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---- 221
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
I R+I ++ +DE + + ++ L+L RP+++++
Sbjct: 222 -----LAGKIREGKFRRI-PYRYSDE--------LNEIITRMLNLKDYHRPSVEEI 263
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 5e-45
Identities = 51/254 (20%), Positives = 98/254 (38%), Gaps = 35/254 (13%)
Query: 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR--- 58
+ EL+V+S + NH N+V +LGAC L++ E+ G L + + K +
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 59 ------------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVA 106
+ + L + + A + +L S IH D+ + N+LL K+
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKIC 187
Query: 107 DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166
DFG + I +D+ + + PE + T +SDV+S+G+ L EL +
Sbjct: 188 DFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS- 246
Query: 167 SGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226
+ ++ +++ S + + C +
Sbjct: 247 ---------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLK 291
Query: 227 RPTMKQVSEELDRL 240
RPT KQ+ + +++
Sbjct: 292 RPTFKQIVQLIEKQ 305
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 7e-45
Identities = 50/258 (19%), Positives = 103/258 (39%), Gaps = 23/258 (8%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
N+ E V++ +++ +V ++LG CL + V L+ + +P G L D++ +
Sbjct: 54 ANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDN--IGS 110
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ L + A ++YL ++H D+ + NVL+ K+ DFG + L+ ++ +
Sbjct: 111 QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ E ++ T +SDV+S+GV + EL+T
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK--------------- 212
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
I + + IL V + KC + RP +++ E ++
Sbjct: 213 --PYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
Query: 241 KISHENYEHRRTEKRQSI 258
+ Y + ++R +
Sbjct: 271 ARDPQRYLVIQGDERMHL 288
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 9e-45
Identities = 57/258 (22%), Positives = 111/258 (43%), Gaps = 42/258 (16%)
Query: 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN-- 59
+ EL++++Q+ +H+N+V +LGAC + L++E+ G L +++ K + +
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 60 ------------------WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNY 101
++ L A + A +++L +H D+ + NVL+
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGK 201
Query: 102 KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161
K+ DFG + I SD+ + + PE + G T KSDV+S+G+LL E+ +
Sbjct: 202 VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
Query: 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220
G+ P G+ + +N Y + N + F +E + + C
Sbjct: 262 LGVNPYPGIPVDAN---------FYKLIQNGFKMDQPFYATEE--------IYIIMQSCW 304
Query: 221 SLSGRRRPTMKQVSEELD 238
+ R+RP+ ++ L
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 9e-45
Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 30/236 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLR 58
Q F+ E ++ + H N+V+ + T K +LV E + +GTL ++
Sbjct: 53 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVM--- 109
Query: 59 NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDD-NYKAKVADFGSSVLISSD 117
K + L +LH+ +PPIIH D+K N+ + K+ D G + L +
Sbjct: 110 KIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 168
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
IGT + PE + K E DVY+FG+ + E+ T P S
Sbjct: 169 ----FAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSEC-------- 215
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
R++ + + I V + C+ + R ++K +
Sbjct: 216 --------QNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 2e-44
Identities = 51/245 (20%), Positives = 97/245 (39%), Gaps = 26/245 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H NV+ + G ++ +++ EF+ NG+L + Q +
Sbjct: 74 FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQ--FTVIQLV 131
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A+ + YL +H D+ + N+L++ N KV+DFG S + D T
Sbjct: 132 GMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188
Query: 125 KKIG---TFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
+G PE + K T SDV+S+G+++ E+++ +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER---------------- 232
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+ + N + + M+ + L C RP Q+ LD++
Sbjct: 233 -PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM- 290
Query: 242 ISHEN 246
I + N
Sbjct: 291 IRNPN 295
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-44
Identities = 52/237 (21%), Positives = 104/237 (43%), Gaps = 23/237 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E ++ Q +H N++++ G + K +++ E++ NG L + +K + + +
Sbjct: 56 FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEF--SVLQLV 113
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ A+ + YL + +H D+ + N+L++ N KV+DFG S ++ D + TT
Sbjct: 114 GMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTT 170
Query: 125 KKI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
PE + K T SDV+SFG+++ E++T +
Sbjct: 171 SGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER-----------------P 213
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
+ + N+ + + +N + M+ + L +C RRP + LD+L
Sbjct: 214 YWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 5e-44
Identities = 52/253 (20%), Positives = 96/253 (37%), Gaps = 30/253 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E +++ Q+++ +V+++G C + + +LV E G L + K ++
Sbjct: 56 MMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI--PVSNVA 112
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + + YL +H D+ + NVLL + + AK++DFG S + +D+
Sbjct: 113 ELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 169
Query: 125 KKI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQY 182
PE + K + +SDV+S+GV + E L+ G KP M
Sbjct: 170 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM------------- 216
Query: 183 FLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLKI 242
+ + + E E + L S C RP V + +
Sbjct: 217 -----KGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
Query: 243 SH----ENYEHRR 251
S E + H
Sbjct: 272 SLASKVEGHHHHH 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 6e-44
Identities = 59/229 (25%), Positives = 96/229 (41%), Gaps = 29/229 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E+ + S + H N++++ G + L+ E+ P GT++ + S + +
Sbjct: 53 LRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF---DEQRTA 109
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
E A+AL Y HS +IH D+K N+LL + K+ADFG SV S T
Sbjct: 110 TYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RT 162
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GT L PE + EK D++S GVL E L G P F
Sbjct: 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP-----------------FE 205
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ + ++I + + E L S+ L + +RP +++V
Sbjct: 206 ANTYQETYKRISRVEFTFPDFVT--EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-44
Identities = 50/233 (21%), Positives = 98/233 (42%), Gaps = 23/233 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E +V+ ++H+ +V++ G C + + ++ E++ NG L +++ + + + L
Sbjct: 46 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRF--QTQQLL 103
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + A++YL S +H D+ + N L++D KV+DFG S + D T+
Sbjct: 104 EMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
K PE ++ K + KSD+++FGVL+ E+ + K +
Sbjct: 161 SK-FPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM----------------PYE 203
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ + I + E V + C RPT K + +
Sbjct: 204 RFTNSETAEHIAQGLRLYRPHLAS-EKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-43
Identities = 59/250 (23%), Positives = 107/250 (42%), Gaps = 27/250 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETK-VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
F E ++ +H NV+ +LG CL ++ PL+V ++ +G L + I +++ K
Sbjct: 75 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDL 132
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + A + +L S +H D+ + N +LD+ + KVADFG + + ++
Sbjct: 133 IGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 124 --TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
T + E + T K T KSDV+SFGVLL EL+T P ++
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-------PYPDVNTFD 242
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+Y ++ L Q + + + KC RP+ ++ + +
Sbjct: 243 ITVYLLQGRRLLQPEYC----------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
Query: 242 IS--HENYEH 249
+ E+Y H
Sbjct: 293 STFIGEHYVH 302
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-43
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 25/235 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ + E+ + +NH+NVVK G E + L E+ G LFD I
Sbjct: 46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGM---PE 102
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
R + + + YLH I H D+K N+LLD+ K++DFG + + +N+
Sbjct: 103 PDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 121 AMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
+ K GT + PE + + E DV+S G++L +L G
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL--------------- 204
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
+ ++ + + ++I L K L + R T+ +
Sbjct: 205 --PWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDI 257
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (367), Expect = 9e-43
Identities = 52/234 (22%), Positives = 83/234 (35%), Gaps = 32/234 (13%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
Q E+R + ++ H N ++ G L LV E+ K
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVE 116
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ L YLHS +IH DVK+ N+LL + K+ DFGS+ +++
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167
Query: 123 TTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
+GT + PE ++ G+ K DV+S G+ EL P M
Sbjct: 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---------N 218
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
LY I N + + ++ CL + RPT + +
Sbjct: 219 AMSALYHIAQNESPALQSGHWSEY--------FRNFVDSCLQKIPQDRPTSEVL 264
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 2e-42
Identities = 49/234 (20%), Positives = 88/234 (37%), Gaps = 25/234 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E V+ Q+++ +V+++G C E + +LV E G L ++ K +
Sbjct: 55 LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHV---KDKNII 110
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + + YL S +H D+ + NVLL + AK++DFG S + +D
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167
Query: 125 KKI-GTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
PE + K + KSDV+SFGVL+ E + +
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK-----------------P 210
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
++ + + +L + L + C + RP V L
Sbjct: 211 YRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-42
Identities = 52/238 (21%), Positives = 92/238 (38%), Gaps = 23/238 (9%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F E+ + ++H+N++++ G L + +V E P G+L D + L T
Sbjct: 58 FIREVNAMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLS 114
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFG-SSVLISSDNQTAMT 123
R A + A + YL S IH D+ + N+LL K+ DFG L +D+ M
Sbjct: 115 RYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 171
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
+ F PE + T + SD + FGV L E+ T + +
Sbjct: 172 EHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE----------------PW 215
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
+ + L +I + + + + +C + RPT + + L +
Sbjct: 216 IGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-42
Identities = 50/232 (21%), Positives = 98/232 (42%), Gaps = 27/232 (11%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
++ +E+ V+ + + N+V L + L +V E++ G+L D + + +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQ 117
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAM 122
+ E AL++LHS+ +IH D+KS N+LL + K+ DFG I+ +
Sbjct: 118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K 172
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQY 182
+ +GT + PE V K D++S G++ E++ G P
Sbjct: 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP----------------- 215
Query: 183 FLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
+L +L I + E++ ++CL + +R + K++
Sbjct: 216 YLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 8e-42
Identities = 63/257 (24%), Positives = 105/257 (40%), Gaps = 37/257 (14%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK----------- 52
F EL V+ ++ +H N++ +LGAC L E+ P+G L D +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 53 --SSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
S+ + + L AA+ A +DYL IH D+ + N+L+ +NY AK+ADFG
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGL 173
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
S + M + E + T SDV+S+GVLL E+++
Sbjct: 174 SRGQEVYVKKTMGR---LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----- 225
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230
G++ + + + L + LN + V L +C RP+
Sbjct: 226 --PYCGMTCAELYEKLPQGYRLEKPLNCD----------DEVYDLMRQCWREKPYERPSF 273
Query: 231 KQVSEELDRLKISHENY 247
Q+ L+R+ + Y
Sbjct: 274 AQILVSLNRMLEERKTY 290
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 9e-42
Identities = 52/235 (22%), Positives = 90/235 (38%), Gaps = 30/235 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E+ +++ +H N+VK+L A ++ EF G + + + +
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPL--TESQIQ 113
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ +T AL+YLH + IIH D+K+ N+L + K+ADFG S + Q +
Sbjct: 114 VVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 170
Query: 125 KKIGTFVNLDPEYVIT-----GKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
IGT + PE V+ K+DV+S G+ L E+ P +
Sbjct: 171 --IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--------- 219
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
L +I + ++ KCL + R T Q+
Sbjct: 220 --------PMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-40
Identities = 51/237 (21%), Positives = 96/237 (40%), Gaps = 25/237 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E V+S+++H VK+ + + + NG L +I S +
Sbjct: 55 VTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTR 111
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AE SAL+YLH IIH D+K N+LL+++ ++ DFG++ ++S +++ A
Sbjct: 112 FYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+GT + PE + + SD+++ G ++ +L+ GL P F
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP-----------------FR 211
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241
E ++I+ + + L K L L +R +++
Sbjct: 212 AGNEYLIFQKIIKLEYDFPEKF--FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-40
Identities = 59/250 (23%), Positives = 101/250 (40%), Gaps = 34/250 (13%)
Query: 5 FQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR----- 58
E+ ++ I HKN++ +LGAC + ++ E+ G L +++ + L
Sbjct: 65 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 124
Query: 59 --------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGS 110
+ K + A + A ++YL S IH D+ + NVL+ ++ K+ADFG
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 111 SVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMA 170
+ I + TT + PE + T +SDV+SFGVLL E+ T
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----- 236
Query: 171 LASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTM 230
+ L ++L + + + C +RPT
Sbjct: 237 ------------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 284
Query: 231 KQVSEELDRL 240
KQ+ E+LDR+
Sbjct: 285 KQLVEDLDRI 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 9e-40
Identities = 48/240 (20%), Positives = 101/240 (42%), Gaps = 27/240 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN----- 59
F +E V+ + N +VV++LG + + L++ E + G L ++ + N
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 60 --WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSD 117
+++A E A + YL+++ +H D+ + N ++ +++ K+ DFG + I
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 118 NQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGI 177
+ K + + PE + G T SDV+SFGV+L E+ T +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------------ 234
Query: 178 SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEEL 237
+ LR ++ + D+ + + + L C + + RP+ ++ +
Sbjct: 235 ----PYQGLSNEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-39
Identities = 52/240 (21%), Positives = 93/240 (38%), Gaps = 24/240 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ + F E + Q +H ++VK++G E V ++ E G L + + + +
Sbjct: 51 VREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSL--DL 107
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ + A + ++AL YL S +H D+ + NVL+ N K+ DFG S +
Sbjct: 108 ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+K + PE + + T SDV+ FGV + E+L +G+
Sbjct: 165 -KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK-------PFQGVKNN 216
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240
L N T+ L +KC + RRP ++ +L +
Sbjct: 217 DVIGRIENGERLPMPPNCP----------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 136 bits (343), Expect = 7e-39
Identities = 50/235 (21%), Positives = 96/235 (40%), Gaps = 29/235 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ + E++ +S + H +V + A + +++YEF+ G LF+ + D+ +++ +
Sbjct: 68 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM--SEDE 125
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLL--DDNYKAKVADFGSSVLISSDNQT 120
+ + L ++H +H D+K N++ + + K+ DFG + +
Sbjct: 126 AVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+TT GT PE + +D++S GVL LL+GL P G
Sbjct: 183 KVTT---GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---------- 229
Query: 181 QYFLYSIENNSLRQILNFQVA-DESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
++ +LR + + D+S I E K L R T+ Q
Sbjct: 230 -------DDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 1e-37
Identities = 41/235 (17%), Positives = 94/235 (40%), Gaps = 29/235 (12%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
+ + E+ +++ H+N++ + + + ++++EF+ +F+ I+ + ++ N +
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFEL--NERE 103
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQT 120
+ + AL +LH S I H D++ N++ + K+ +FG + + +
Sbjct: 104 IVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ PE ++ +D++S G L+ LL+G+ P
Sbjct: 161 RLL---FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP--------------- 202
Query: 181 QYFLYSIENNSLRQILNFQVA-DESEMEEI-ETVAGLASKCLSLSGRRRPTMKQV 233
FL + I+N + DE +EI + L + R T +
Sbjct: 203 --FLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 132 bits (332), Expect = 3e-37
Identities = 45/233 (19%), Positives = 93/233 (39%), Gaps = 29/233 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
++E+ +++Q++H ++ + A + +L+ EF+ G LFD I + ++ + +
Sbjct: 73 VKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKM--SEAEVI 130
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQTAM 122
+ L ++H I+H D+K N++ + K+ DFG + ++ D +
Sbjct: 131 NYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV 187
Query: 123 TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQY 182
TT T PE V + +D+++ GVL LL+GL P +G
Sbjct: 188 TT---ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED------------ 232
Query: 183 FLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQV 233
+ +L+ + + + L R+R T+
Sbjct: 233 -----DLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 280
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 8e-37
Identities = 55/254 (21%), Positives = 102/254 (40%), Gaps = 34/254 (13%)
Query: 2 NQVFQHELRVVSQINH-KNVVKILGACLETKVPL-LVYEFVPNGTLFDHIHDKSSQVLR- 58
++ EL+++ I H NVV +LGAC + PL ++ EF G L ++ K ++ +
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 59 ------------NWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVA 106
+ + + + A +++L S IH D+ + N+LL + K+
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKIC 176
Query: 107 DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166
DFG + I D + PE + T +SDV+SFGVLL E+ +
Sbjct: 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS- 235
Query: 167 SGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226
G+ + + F ++ + + ++ + + C +
Sbjct: 236 ------PYPGVKIDEEFCRRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQ 280
Query: 227 RPTMKQVSEELDRL 240
RPT ++ E L L
Sbjct: 281 RPTFSELVEHLGNL 294
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 128 bits (322), Expect = 2e-36
Identities = 54/242 (22%), Positives = 102/242 (42%), Gaps = 35/242 (14%)
Query: 1 MNQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
+ + E+ ++ +++ H N++++ LV++ + G LFD++ +K + +
Sbjct: 52 LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LS 108
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
K +I + LH I+H D+K N+LLDD+ K+ DFG S +
Sbjct: 109 EKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE- 164
Query: 120 TAMTTKKIGTFVNLDPEYVITG------KLTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
+ GT L PE + ++ D++S GV++ LL G P
Sbjct: 165 --KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-------- 214
Query: 174 NEGISMVQYFLYSIENNSLRQIL--NFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231
F + + LR I+ N+Q + +TV L S+ L + ++R T +
Sbjct: 215 ---------FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAE 265
Query: 232 QV 233
+
Sbjct: 266 EA 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-35
Identities = 45/231 (19%), Positives = 82/231 (35%), Gaps = 25/231 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
++E+ V+ +I H N+V + L+ + V G LFD I +K +
Sbjct: 54 MENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDAS 110
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
R+ + A+ YLH LD++ K ++DFG S + + + +
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLS 167
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GT + PE + ++ D +S GV+ LL G P
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN-------------- 213
Query: 185 YSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQV 233
+ QIL + +S + ++ + +R T +Q
Sbjct: 214 ---DAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQA 261
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 124 bits (313), Expect = 4e-35
Identities = 61/244 (25%), Positives = 98/244 (40%), Gaps = 31/244 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLET----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
F+ E + + +NH +V + +P +V E+V TL D +H +
Sbjct: 54 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTP 110
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSV-LISSDNQ 119
K + + A+ AL++ H IIH DVK N+++ KV DFG + + S N
Sbjct: 111 KRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 167
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
T IGT L PE + +SDVYS G +L E+LTG P +G +
Sbjct: 168 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------- 218
Query: 180 VQYFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRP-TMKQVSEE 236
+ Q + S E + + K L+ + R T ++ +
Sbjct: 219 --------PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
Query: 237 LDRL 240
L R+
Sbjct: 271 LVRV 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-32
Identities = 53/245 (21%), Positives = 99/245 (40%), Gaps = 22/245 (8%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+N+ E++++ +++H N++ +L A LV++F+ +
Sbjct: 43 INRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTP 99
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
T L+YLH I+H D+K N+LLD+N K+ADFG + S N+
Sbjct: 100 SHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
Query: 121 AMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISM 179
T ++ T PE + ++ D+++ G +LAELL + G + + ++
Sbjct: 157 --YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD--SDLDQLTR 212
Query: 180 VQYFLYSI------ENNSLRQILNFQVADESEMEEIETVAG-----LASKCLSLSGRRRP 228
+ L + + SL + F+ + I + AG L + R
Sbjct: 213 IFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272
Query: 229 TMKQV 233
T Q
Sbjct: 273 TATQA 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 2e-31
Identities = 52/233 (22%), Positives = 80/233 (34%), Gaps = 32/233 (13%)
Query: 3 QVFQHELRVVS-QINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ E RV+S H + + + V E++ G L HI +
Sbjct: 47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLS 103
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA 121
AAE L +LHS I++ D+K N+LLD + K+ADFG +
Sbjct: 104 RATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160
Query: 122 MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
T GT + PE ++ K D +SFGVLL E+L G P G
Sbjct: 161 NTF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ------------ 206
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQ 232
++ + D + L K +R ++
Sbjct: 207 ---------DEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRG 250
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (290), Expect = 2e-31
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 30/232 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E ++S + H ++++ G + + ++ +++ G LF +
Sbjct: 51 TNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAK 107
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AAE AL+YLHS II+ D+K N+LLD N K+ DFG + + T
Sbjct: 108 FYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL--- 161
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
GT + PE V T + D +SFG+L+ E+L G P F
Sbjct: 162 --CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP-----------------FY 202
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236
S + +ILN ++ E V L S+ ++ +R Q E
Sbjct: 203 DSNTMKTYEKILNAELRFPPFFN--EDVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 2e-31
Identities = 51/251 (20%), Positives = 89/251 (35%), Gaps = 22/251 (8%)
Query: 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLF---DHIHDKSSQVLRNWKTC 63
LR + H NVV++ C ++ + + DK + +T
Sbjct: 59 AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 118
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + LD+LHS ++H D+K N+L+ + + K+ADFG L +
Sbjct: 119 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG---LARIYSFQMAL 172
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
T + T PE ++ D++S G + AE+ G + G +
Sbjct: 173 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAG--------LASKCLSLSGRRRPTMKQVSE 235
L E+ L Q + IE L KCL+ + +R +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
Query: 236 -----ELDRLK 241
+L+R K
Sbjct: 293 HPYFQDLERCK 303
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (288), Expect = 9e-31
Identities = 42/233 (18%), Positives = 81/233 (34%), Gaps = 27/233 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ L +VS + +V + A + + + G L H+ +
Sbjct: 54 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMR 110
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AAE L+++H + +++ D+K N+LLD++ +++D G + S
Sbjct: 111 FYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPH 163
Query: 125 KKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYF 183
+GT + PE + G +D +S G +L +LL G P
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---------- 213
Query: 184 LYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEE 236
+ I+ +L + + E+ L L RR +
Sbjct: 214 KHEIDRMTLTMAVELPDSFSPELRS------LLEGLLQRDVNRRLGCLGRGAQ 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 6e-30
Identities = 53/235 (22%), Positives = 90/235 (38%), Gaps = 32/235 (13%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E+ ++ +I H NV+ + +L+ E V G LFD + +K S +
Sbjct: 60 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL---TEEEAT 116
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDN----YKAKVADFGSSVLISSDNQT 120
+ + + YLH S I H D+K N++L D + K+ DFG + I N+
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE- 172
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
GT + PE V L ++D++S GV+ LL+G P
Sbjct: 173 --FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP--------------- 215
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQV 233
FL + +L + E E + L ++R T++
Sbjct: 216 --FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 7e-30
Identities = 54/240 (22%), Positives = 85/240 (35%), Gaps = 26/240 (10%)
Query: 2 NQVFQHELRVVSQI-NHKNVVKILGAC----LETKVPLLVYEFVPNGTLFDHIHDKSSQV 56
+ E+ + + ++V+I+ K L+V E + G LF I D+ Q
Sbjct: 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA 107
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD---DNYKAKVADFGSSVL 113
+ I A+ YLHS I H DVK N+L N K+ DFG +
Sbjct: 108 F-TEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 163
Query: 114 ISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALAS 173
+S N T + PE + K + D++S GV++ LL G P
Sbjct: 164 TTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN---H 217
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
IS + +V++E V L L +R T+ +
Sbjct: 218 GLAISPGMKTRIRMGQYEFPNPEWSEVSEE--------VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (277), Expect = 3e-29
Identities = 44/248 (17%), Positives = 79/248 (31%), Gaps = 22/248 (8%)
Query: 3 QVFQHELRVVSQINHKNVVKILGACLETKVP------LLVYEFVPNGTLFDHIHDKSSQV 56
+ EL+++ +++H N+V++ + LV ++VP H ++
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVK-STNVLLDDNYKAKVADFGSSVLIS 115
+ +L Y+H S I H D+K +L D K+ DFGS+ +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174
Query: 116 SDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG------- 168
+ + T DV+S G +LAELL G G
Sbjct: 175 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 169 ---MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225
+ + ++ + QI L S+ L +
Sbjct: 233 VEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPT 292
Query: 226 RRPTMKQV 233
R T +
Sbjct: 293 ARLTPLEA 300
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 108 bits (269), Expect = 1e-28
Identities = 45/243 (18%), Positives = 87/243 (35%), Gaps = 17/243 (6%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E+ ++ ++ H N+VK+ K +LV+E + +
Sbjct: 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LES 99
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
T + + + Y H ++H D+K N+L++ + K+ADFG + +
Sbjct: 100 VTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASN-----E 175
+ + + K + D++S G + AE++ G G++ A
Sbjct: 157 YTHEIVT-LWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRRRPTM 230
+ + + NF V + E E+ L SK L L +R T
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 231 KQV 233
KQ
Sbjct: 276 KQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 6e-28
Identities = 49/253 (19%), Positives = 94/253 (37%), Gaps = 30/253 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVP--------LLVYEFVPNGTLFDHIHDKSSQV 56
E++++ + H+NVV ++ C P LV++F + +
Sbjct: 56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-- 113
Query: 57 LRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISS 116
R+ + L Y+H I+H D+K+ NVL+ + K+ADFG + S
Sbjct: 114 -FTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169
Query: 117 DNQTAMT--TKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSG----- 168
+ T ++ T PE ++ + D++ G ++AE+ T G
Sbjct: 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 169 -MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG-------LASKCL 220
+AL S S+ +++N L + L + ++++ L K L
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
Query: 221 SLSGRRRPTMKQV 233
L +R
Sbjct: 290 VLDPAQRIDSDDA 302
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 106 bits (264), Expect = 9e-28
Identities = 40/253 (15%), Positives = 74/253 (29%), Gaps = 26/253 (10%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E ++ + + + C ++ + +L D + S + +
Sbjct: 45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF--SL 102
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVL---LDDNYKAKVADFGSSVLISSD 117
KT L +A + S ++Y+HS IH DVK N L + DFG +
Sbjct: 103 KTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159
Query: 118 NQTAM-----TTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG-LKPGSGMAL 171
GT + + + + D+ S G +L G L A
Sbjct: 160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219
Query: 172 ASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231
+ + S L + + A + C SL +P
Sbjct: 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFAT------------YLNFCRSLRFDDKPDYS 267
Query: 232 QVSEELDRLKISH 244
+ + L
Sbjct: 268 YLRQLFRNLFHRQ 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 2e-27
Identities = 43/247 (17%), Positives = 95/247 (38%), Gaps = 25/247 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGAC----LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
E++++ + H+N++ I +E + + + L+ + + +
Sbjct: 53 TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSN 108
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ L Y+HS+ ++H D+K +N+LL+ K+ DFG + + D+
Sbjct: 109 DHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165
Query: 121 AMT-TKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGM-------AL 171
T+ + T PE ++ K T+ D++S G +LAE+L+ G +
Sbjct: 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI 225
Query: 172 ASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRR 226
G + I + +L+ ++ + L K L+ + +
Sbjct: 226 LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK 285
Query: 227 RPTMKQV 233
R ++Q
Sbjct: 286 RIEVEQA 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-27
Identities = 43/233 (18%), Positives = 90/233 (38%), Gaps = 38/233 (16%)
Query: 5 FQHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKT 62
E+ ++ +++ V+++L +L+ E + + +
Sbjct: 54 VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGAL--QEEL 111
Query: 63 CLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTA 121
+ A+ + H+ ++H D+K N+L+D + + K+ DFGS L+
Sbjct: 112 ARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---- 164
Query: 122 MTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMV 180
+ T GT V PE++ + + V+S G+LL +++ G P
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP--------------- 209
Query: 181 QYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233
+ + +R + F+ SE + L CL+L RPT +++
Sbjct: 210 ----FEHDEEIIRGQVFFRQRVSSECQH------LIRWCLALRPSDRPTFEEI 252
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 7e-27
Identities = 42/243 (17%), Positives = 86/243 (35%), Gaps = 16/243 (6%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNW 60
+ E+ ++ ++NH N+VK+L LV+EF+ D S+
Sbjct: 44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPL 101
Query: 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT 120
+ L + HS ++H D+K N+L++ K+ADFG + +T
Sbjct: 102 PLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 121 AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASN-----E 175
T + + + + + D++S G + AE++T G +
Sbjct: 159 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
Query: 176 GISMVQYFLYSIENNSLRQILNFQVADESEMEEI-----ETVAGLASKCLSLSGRRRPTM 230
+ ++ + +F + ++ E L S+ L +R +
Sbjct: 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277
Query: 231 KQV 233
K
Sbjct: 278 KAA 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 5e-26
Identities = 36/241 (14%), Positives = 80/241 (33%), Gaps = 20/241 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E+ ++ ++ HKN+V++ K LV+EF + +
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVK 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ L + HS ++H D+K N+L++ N + K+A+FG + + +
Sbjct: 105 SFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSA 160
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQYFL 184
+ + + + D++S G + AEL +P ++ + + L
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP-LFPGNDVDDQLKRIFRLL 219
Query: 185 YSIENNSLRQILNFQVADESEMEEIETVAG------------LASKCLSLSGRRRPTMKQ 232
+ + M T L L + +R + ++
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 233 V 233
Sbjct: 280 A 280
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (251), Expect = 5e-26
Identities = 32/246 (13%), Positives = 75/246 (30%), Gaps = 26/246 (10%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+ E R + + + + + ++ + +L D + + + KT
Sbjct: 47 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF--SVKTVA 104
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYK-----AKVADFGSSVLISSDNQ 119
A + + + +H +++ D+K N L+ V DFG
Sbjct: 105 MAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161
Query: 120 TAMTTKK-----IGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGMALASN 174
+ GT + + + + + D+ + G + L G P G+ A+N
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 175 EGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234
+ ++ LR+ L +E +L+ P +
Sbjct: 222 --KQKYERIGEKKQSTPLRE-LCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQ 270
Query: 235 EELDRL 240
++
Sbjct: 271 GLFSKV 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 1e-25
Identities = 44/165 (26%), Positives = 67/165 (40%), Gaps = 8/165 (4%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
E RV+ H + + A V E+ G LF H+ + + +
Sbjct: 52 TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE---RVFTEERAR 108
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AE SAL+YLHS +++ D+K N++LD + K+ DFG SD T T
Sbjct: 109 FYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF 165
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
GT L PE + D + GV++ E++ G P
Sbjct: 166 --CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.0 bits (238), Expect = 8e-24
Identities = 47/281 (16%), Positives = 100/281 (35%), Gaps = 34/281 (12%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLR-NWKTC 63
ELR++ + H+NV+ +L + +F K + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
+ + L Y+H+ IIH D+K N+ ++++ + K+ DFG + S+ MT
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE----MT 176
Query: 124 TKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSG----------MALAS 173
+ + + + T+ D++S G ++AE++TG G M +
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236
Query: 174 NEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG--LASKCLSLSGRRRPTMK 231
VQ N ++ + + D + + + L K L L +R T
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296
Query: 232 QVSE--------------ELDRLKISHENYEHRRTEKRQSI 258
+ ++ + S ++ + E ++
Sbjct: 297 EALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 92.9 bits (230), Expect = 1e-22
Identities = 40/165 (24%), Positives = 71/165 (43%), Gaps = 11/165 (6%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
+E R++ +N +VK+ + + +V E+V G +F H+ +
Sbjct: 88 TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHAR 144
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
AA+ +YLHS +I+ D+K N+L+D +V DFG + + T
Sbjct: 145 FYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-- 199
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM 169
GT L PE +++ + D ++ GVL+ E+ G P
Sbjct: 200 ---GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.0 bits (217), Expect = 6e-21
Identities = 54/237 (22%), Positives = 84/237 (35%), Gaps = 29/237 (12%)
Query: 5 FQHELRVVSQINHK-NVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTC 63
+ E +V+ I +V + A L+ +++ G LF H+ +
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEV 131
Query: 64 LRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMT 123
E AL++LH II+ D+K N+LLD N + DFG S +D
Sbjct: 132 QIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RA 187
Query: 124 TKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEGISMVQ 181
GT + P+ V G + D +S GVL+ ELLTG P
Sbjct: 188 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP---------------- 231
Query: 182 YFLYSIENNSLRQILNFQVADESEMEEI--ETVAGLASKCLSLSGRRRPTMKQVSEE 236
F E NS +I + E + L + L ++R +
Sbjct: 232 -FTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDAD 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 87.6 bits (216), Expect = 8e-21
Identities = 43/253 (16%), Positives = 91/253 (35%), Gaps = 36/253 (14%)
Query: 5 FQHELRVVSQIN-HKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWK 61
+ E++++ + N++ + + ++ P LV+E V N +
Sbjct: 76 IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------DY 129
Query: 62 TCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQT 120
E ALDY HS I+H DVK NV++D ++ K ++ D+G + +
Sbjct: 130 DIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 121 AMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLTGLKP-------------- 165
++ + PE ++ ++ D++S G +LA ++ +P
Sbjct: 187 ---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 166 ----GSGMALASNEGISMVQYFLY-SIENNSLRQILNFQVADESEMEEIETVAGLASKCL 220
G+ + ++ + I R+ V E++ K L
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 221 SLSGRRRPTMKQV 233
+ R T ++
Sbjct: 304 RYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 6e-20
Identities = 45/252 (17%), Positives = 90/252 (35%), Gaps = 29/252 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
EL ++ +NHKN++ +L K + L D + Q+ + +
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS 122
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + +LH S IIH D+K +N+++ + K+ DFG L + + M T
Sbjct: 123 YLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG---LARTAGTSFMMT 176
Query: 125 KKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKP-----------------GS 167
+ T PE ++ E D++S G ++ E++ G+
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 168 GMALASNEGISMVQYFLYS------IENNSLRQILNFQVADESEMEEIETVAGLASKCLS 221
+ V+ ++ + + L F E + L SK L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 222 LSGRRRPTMKQV 233
+ +R ++
Sbjct: 297 IDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 3e-19
Identities = 45/246 (18%), Positives = 87/246 (35%), Gaps = 28/246 (11%)
Query: 5 FQHELRVVSQINHKNVVKILGAC-----LETKVPLLVYEFVPNGTLFDHIHDKSSQVLRN 59
ELR++ + H+NV+ +L LE + + + L + + +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LT 119
Query: 60 WKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ 119
+ + L Y+HS IIH D+K +N+ ++++ + K+ DFG + +
Sbjct: 120 DDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 120 TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPGSGM-------ALA 172
+ T + + + D++S G ++AELLTG G +
Sbjct: 177 GYVAT----RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 173 SNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAG-----LASKCLSLSGRRR 227
G + ++ I + + + A L K L L +R
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 292
Query: 228 PTMKQV 233
T Q
Sbjct: 293 ITAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 77.8 bits (190), Expect = 4e-17
Identities = 45/276 (16%), Positives = 89/276 (32%), Gaps = 45/276 (16%)
Query: 1 MNQVFQHELRVVSQINHKNVVKILGACLETKVPLLVY-------------EFVPNGTLFD 47
+ + E++++ ++N + K + LL + F G
Sbjct: 52 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 111
Query: 48 HIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLD-DNYKAKVA 106
+ K +I+ + LDY+H IIH D+K NVL++ + +
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLI 169
Query: 107 DFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTGLKPG 166
+ L ++ T I T PE ++ +D++S L+ EL+TG
Sbjct: 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 167 SG----MALASNEGISMVQYFLYSIENNSLRQILNFQVADESEM---------------- 206
++ I+ + L + + LR + S
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 207 ---------EEIETVAGLASKCLSLSGRRRPTMKQV 233
+E + ++ S L L R+R +
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.2 bits (132), Expect = 6e-10
Identities = 19/123 (15%), Positives = 41/123 (33%), Gaps = 10/123 (8%)
Query: 5 FQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCL 64
F ++ + + K+ G + Y + N L + I K +
Sbjct: 53 FSVLAIRSARNEFRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYR-VRVENPD 106
Query: 65 RIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTT 124
+ + + I+HGD+ NVL+ + + DF SV + + +
Sbjct: 107 EVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILE 162
Query: 125 KKI 127
+ +
Sbjct: 163 RDV 165
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 259 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.74 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.28 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.96 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.08 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.05 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 92.54 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=325.92 Aligned_cols=211 Identities=25% Similarity=0.344 Sum_probs=172.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+++
T Consensus 48 ~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~- 123 (271)
T d1nvra_ 48 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG- 123 (271)
T ss_dssp -CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 468899999999999999999999999999999999999999999997543 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus 124 --IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp --EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred --CccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence 99999999999999999999999999987765444444556679999999999988775 678999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+....... .. . ..............++.+.+||.+||+.||++|||++++++
T Consensus 202 G~~pf~~~~~~~~~---~~----~---------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 202 GELPWDQPSDSCQE---YS----D---------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp SSCSCSSSSTTSHH---HH----H---------HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCChHHHH---HH----H---------HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 99999763321100 00 0 00000011111223467899999999999999999999954
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-51 Score=324.84 Aligned_cols=218 Identities=22% Similarity=0.348 Sum_probs=168.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+++|++++||||+++++++..++..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 72 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~- 148 (299)
T d1jpaa_ 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN- 148 (299)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC-
Confidence 5689999999999999999999999999999999999999999998876543 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc---ccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA---MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++||||||+||+++.++.+||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|+|
T Consensus 149 --iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el 226 (299)
T d1jpaa_ 149 --YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEV 226 (299)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred --CccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHH
Confidence 9999999999999999999999999998765432211 11223578899999999988999999999999999999
Q ss_pred Hh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 025011 160 LT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 160 ~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 238 (259)
+| |..||.+.... . ....... ....+.+...++.+.+|+.+||+.||.+|||+.+|++.|+
T Consensus 227 ~t~g~~Pf~~~~~~-----~---~~~~i~~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 227 MSYGERPYWDMTNQ-----D---VINAIEQ----------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HTTSCCTTTTCCHH-----H---HHHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HhCCCCCCCCCCHH-----H---HHHHHHc----------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence 98 89999873211 1 1111111 1111112234577999999999999999999999999999
Q ss_pred hcccc
Q 025011 239 RLKIS 243 (259)
Q Consensus 239 ~~~~~ 243 (259)
++...
T Consensus 289 ~~l~~ 293 (299)
T d1jpaa_ 289 KMIRN 293 (299)
T ss_dssp HHHHS
T ss_pred HHhcC
Confidence 87654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=319.87 Aligned_cols=223 Identities=26% Similarity=0.409 Sum_probs=171.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|++|++++++++||||+++++++. ++..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 49 ~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~- 124 (276)
T d1uwha_ 49 QAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS- 124 (276)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC-
Confidence 57899999999999999999999875 4568999999999999999976543 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC---CcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG---KLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|+|
T Consensus 125 --ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el 202 (276)
T d1uwha_ 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202 (276)
T ss_dssp --CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHH
T ss_pred --EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHH
Confidence 999999999999999999999999999876544333344556799999999998643 478999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|+.||.+..... ................. .+.+.++.+.+++.+||+.||++|||+++|++.|+.
T Consensus 203 ~tg~~Pf~~~~~~~----~~~~~~~~~~~~p~~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~ 269 (276)
T d1uwha_ 203 MTGQLPYSNINNRD----QIIFMVGRGYLSPDLSK---------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269 (276)
T ss_dssp HHSSCTTTTCCCHH----HHHHHHHHTSCCCCGGG---------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHCCCCCCCCChHH----HHHHHHhcCCCCCcchh---------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99999998743211 11111111111111100 111234679999999999999999999999999998
Q ss_pred ccccc
Q 025011 240 LKISH 244 (259)
Q Consensus 240 ~~~~~ 244 (259)
+..+.
T Consensus 270 l~~~~ 274 (276)
T d1uwha_ 270 LARSL 274 (276)
T ss_dssp HHHTC
T ss_pred HHHcC
Confidence 87543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=317.30 Aligned_cols=205 Identities=28% Similarity=0.401 Sum_probs=171.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+++++.++||||+++++++.+++..++||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~---l~e~~~~~i~~qi~~al~~lH~~~ 126 (263)
T d2j4za1 50 EHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYCHSKR 126 (263)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45688999999999999999999999999999999999999999999986543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||++...... ......||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 127 ---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 199 (263)
T d2j4za1 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199 (263)
T ss_dssp ---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred ---eeeeeeccccceecCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc
Confidence 999999999999999999999999999765432 2234569999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|+.||.+.... ....... ..... .+...++.+.+||.+||+.||.+|||++++++
T Consensus 200 G~~Pf~~~~~~--------~~~~~i~---------~~~~~--~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 200 GKPPFEANTYQ--------ETYKRIS---------RVEFT--FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SSCTTCCSSHH--------HHHHHHH---------TTCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHH--------HHHHHHH---------cCCCC--CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 99999863211 1111100 00000 11123477999999999999999999999975
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=316.25 Aligned_cols=209 Identities=22% Similarity=0.365 Sum_probs=172.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++.+++..|+||||+++|+|.+++.+.. +++..+..++.||+.||.|||+++
T Consensus 61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~----l~~~~~~~i~~qi~~aL~yLH~~~ 136 (293)
T d1yhwa1 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQ 136 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC----CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC----CCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3568999999999999999999999999999999999999999999887542 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++
T Consensus 137 ---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemlt 211 (293)
T d1yhwa1 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIE 211 (293)
T ss_dssp ---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHH
T ss_pred ---CcccCCcHHHeEECCCCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhh
Confidence 9999999999999999999999999998765432 22345579999999999999889999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|..||.+..... .......... .....+...++.+.+||.+||+.||.+|||++|+++
T Consensus 212 G~~Pf~~~~~~~--------~~~~~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 212 GEPPYLNENPLR--------ALYLIATNGT--------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSCTTTTSCHHH--------HHHHHHHHCS--------CCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCCHHH--------HHHHHHhCCC--------CCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999998632110 0110000000 001111223477999999999999999999999965
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-51 Score=317.12 Aligned_cols=218 Identities=25% Similarity=0.373 Sum_probs=167.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|++++++++||||+++++++..++..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~ 121 (263)
T d1sm2a_ 44 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC 121 (263)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc
Confidence 46799999999999999999999999999999999999999999999876543 3578899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++....... .......||..|+|||++.+..++.++||||+|+++|+|++
T Consensus 122 ---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t 197 (263)
T d1sm2a_ 122 ---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS 197 (263)
T ss_dssp ---CCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---eeecccchhheeecCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHH
Confidence 99999999999999999999999999987654322 22233468899999999999999999999999999999999
Q ss_pred C-CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 G-LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
+ .+||.+... .......... .....+...++.+.+++.+||+.||++|||+++|++.|+++
T Consensus 198 ~~~~~~~~~~~-----~~~~~~i~~~-------------~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 198 EGKIPYENRSN-----SEVVEDISTG-------------FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSCCTTCSCCH-----HHHHHHHHHT-------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCH-----HHHHHHHHhc-------------CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 5 555554211 1111111110 00111112346799999999999999999999999999988
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
..+
T Consensus 260 ~es 262 (263)
T d1sm2a_ 260 AES 262 (263)
T ss_dssp HHH
T ss_pred HhC
Confidence 644
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-51 Score=318.22 Aligned_cols=217 Identities=24% Similarity=0.332 Sum_probs=174.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|++++++++||||+++++++.. +..++||||+++|+|.+++..... +++..+..++.||+.||.|||+++
T Consensus 52 ~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~---l~~~~~~~i~~qi~~gl~ylH~~~ 127 (277)
T d1xbba_ 52 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 127 (277)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTT---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccC---CCHHHHHHHHHHHHHHHhhHHhCC
Confidence 3579999999999999999999999965 467899999999999999976543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.++.++++|||+++........ .......||+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 128 ---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp ---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred ---cccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 999999999999999999999999999876543222 2233456889999999999999999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |+.||.+.... .. ...... + .....+...++.+.+||.+||+.||++|||+++|.+.|+.
T Consensus 205 t~g~~Pf~~~~~~-----~~---~~~i~~-~---------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 205 SYGQKPYRGMKGS-----EV---TAMLEK-G---------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp TTTCCSSTTCCHH-----HH---HHHHHT-T---------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred hCCCCCCCCCCHH-----HH---HHHHHc-C---------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 8 89999873211 11 111111 1 1111122344779999999999999999999999999887
Q ss_pred cccc
Q 025011 240 LKIS 243 (259)
Q Consensus 240 ~~~~ 243 (259)
+-.+
T Consensus 267 ~~~~ 270 (277)
T d1xbba_ 267 YYYD 270 (277)
T ss_dssp HHHH
T ss_pred HHhh
Confidence 6543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-51 Score=319.12 Aligned_cols=219 Identities=28% Similarity=0.395 Sum_probs=177.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.|.+|++++++++||||+++++++.+++..+++|||+++|+|.+++...... .+++..+..++.|++.||.|||+++
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~-~~~~~~~~~i~~qi~~gL~yLH~~~ 135 (287)
T d1opja_ 57 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKN 135 (287)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTT-TSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcccc-chHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999999999999999999999999999999999999765443 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||+||++|+|++
T Consensus 136 ---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 136 ---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred ---cccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 999999999999999999999999999876543222 2233457889999999999999999999999999999999
Q ss_pred CCCCCC-CCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLKPGS-GMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||. +.+. ....+ .+........+...++.+.+|+.+||+.||.+|||+++|++.|+.+
T Consensus 212 ~~~p~~~~~~~-----~~~~~-------------~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 212 YGMSPYPGIDL-----SQVYE-------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp TSCCSSTTCCH-----HHHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCCcchH-----HHHHH-------------HHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 766654 3211 01111 1111111111223447799999999999999999999999999887
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
...
T Consensus 274 ~~~ 276 (287)
T d1opja_ 274 FQE 276 (287)
T ss_dssp TSS
T ss_pred HHh
Confidence 543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=324.39 Aligned_cols=217 Identities=24% Similarity=0.459 Sum_probs=177.1
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC--------------------cccCCH
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS--------------------QVLRNW 60 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~ 60 (259)
++.+.+|+.++.++ +|||||++++++.+.+..++||||+++|+|.+++..... ...+++
T Consensus 84 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 163 (325)
T d1rjba_ 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163 (325)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCH
T ss_pred HHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCH
Confidence 35688999999998 899999999999999999999999999999999976432 124688
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc
Q 025011 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||+++...............+|+.|+|||++.+
T Consensus 164 ~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 164 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 899999999999999999999 99999999999999999999999999987665444334445568999999999999
Q ss_pred CCcccccchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHh
Q 025011 141 GKLTEKSDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 219 (259)
..++.++|||||||++|+|++ |..||.+..... .... ++........+...++.+.+||.+|
T Consensus 241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~----~~~~-------------~~~~~~~~~~p~~~~~~l~~li~~c 303 (325)
T d1rjba_ 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA----NFYK-------------LIQNGFKMDQPFYATEEIYIIMQSC 303 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH----HHHH-------------HHHTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH----HHHH-------------HHhcCCCCCCCCcCCHHHHHHHHHH
Confidence 999999999999999999998 899998743211 1111 1111111111223447799999999
Q ss_pred cccCCCCCCCHHHHHHHHH
Q 025011 220 LSLSGRRRPTMKQVSEELD 238 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~l~ 238 (259)
|+.||++|||+++|++.|.
T Consensus 304 l~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 304 WAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCSSGGGSCCHHHHHHHHH
T ss_pred cCCChhHCcCHHHHHHHHh
Confidence 9999999999999999885
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=316.76 Aligned_cols=219 Identities=23% Similarity=0.355 Sum_probs=177.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++||||+++++++.. +..++||||+++|+|.+++..... .+++..+..++.|++.||.|||+++
T Consensus 54 ~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~- 129 (285)
T d1u59a_ 54 EEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN- 129 (285)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 568999999999999999999999865 567999999999999999865433 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||+||++|+|++
T Consensus 130 --iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt 207 (285)
T d1u59a_ 130 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 207 (285)
T ss_dssp --EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred --eecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHh
Confidence 999999999999999999999999999877653322 22234468899999999998899999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... ...... .. +. ....+...++.+.+||.+||+.||++|||+.+|.+.|+.+
T Consensus 208 ~G~~Pf~~~~~~-----~~~~~i---~~-~~---------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 208 YGQKPYKKMKGP-----EVMAFI---EQ-GK---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp TSCCTTTTCCTH-----HHHHHH---HT-TC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHH-----HHHHHH---Hc-CC---------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 89999873211 111111 11 11 1111223447799999999999999999999999999887
Q ss_pred ccccc
Q 025011 241 KISHE 245 (259)
Q Consensus 241 ~~~~~ 245 (259)
..+..
T Consensus 270 ~~~~~ 274 (285)
T d1u59a_ 270 YYSLA 274 (285)
T ss_dssp HHHHH
T ss_pred HHHhh
Confidence 65443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=318.46 Aligned_cols=208 Identities=24% Similarity=0.358 Sum_probs=169.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..|+||||+++|+|.+++...+. +++..+..++.|++.||.|||+++
T Consensus 53 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~---l~e~~~~~~~~qi~~al~ylH~~~- 128 (288)
T d1uu3a_ 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDETCTRFYTAEIVSALEYLHGKG- 128 (288)
T ss_dssp HHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC---CCHHHHHHHHHHHHHHHHhhcccc-
Confidence 5689999999999999999999999999999999999999999999876643 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||++++++.++|+|||+++...............||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 129 --iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g 206 (288)
T d1uu3a_ 129 --IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206 (288)
T ss_dssp --EECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred --EEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC
Confidence 999999999999999999999999999877654444444556799999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
..||.+.... ...... ...... .+...++.+.+||.+||+.||.+|||++|+++
T Consensus 207 ~~Pf~~~~~~--------~~~~~i---------~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 207 LPPFRAGNEY--------LIFQKI---------IKLEYD--FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp SCSSCCSSHH--------HHHHHH---------HTTCCC--CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCCCCCcCHH--------HHHHHH---------HcCCCC--CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 9999863211 001110 111100 01123477999999999999999999998743
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-50 Score=310.71 Aligned_cols=208 Identities=25% Similarity=0.368 Sum_probs=164.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.|.+|++++++++||||+++++++.. ++.+++||||+++|+|.+++.+... +++..+..++.|++.||.|||
T Consensus 53 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---~~~~~~~~~~~qi~~gl~yLH 129 (270)
T d1t4ha_ 53 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFLH 129 (270)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc---ccHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999999999999875 3467999999999999999976543 688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeC-CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLD-DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~-~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
+++ .+|+||||||+||+++ .++.+||+|||+++..... ......||+.|+|||++.+ .++.++||||+||++|
T Consensus 130 ~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily 203 (270)
T d1t4ha_ 130 TRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 203 (270)
T ss_dssp TSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence 875 3499999999999996 5789999999999754322 2234579999999998865 5899999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|+.||.+..... .. ...... +.. ....+...++.+.++|.+||+.||++|||++|+++
T Consensus 204 el~~g~~Pf~~~~~~~----~~---~~~i~~-~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 204 EMATSEYPYSECQNAA----QI---YRRVTS-GVK--------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHHHSSCTTTTCSSHH----HH---HHHHTT-TCC--------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHCCCCCCCcccHH----HH---HHHHHc-CCC--------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 9999999997632111 00 011110 000 00011112366899999999999999999999965
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-50 Score=314.86 Aligned_cols=210 Identities=24% Similarity=0.291 Sum_probs=169.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++.+... .+++..+..++.|++.||.|||+++
T Consensus 54 ~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~- 130 (288)
T d2jfla1 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK- 130 (288)
T ss_dssp GGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999999865432 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhc-----cCCcccccchhhHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVI-----TGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~ 157 (259)
|+||||||+||+++.++.++|+|||+++..... ........||+.|+|||++. +..++.++||||+||++|
T Consensus 131 --ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvily 206 (288)
T d2jfla1 131 --IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 206 (288)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHH
T ss_pred --EEEeecChhheeECCCCCEEEEechhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHH
Confidence 999999999999999999999999998754432 11233457999999999984 345789999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|+.||.+..... . ....... .. .....+...++.+.+||.+||+.||.+|||++|+++
T Consensus 207 emltg~~Pf~~~~~~~----~----~~~i~~~-~~-------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 207 EMAEIEPPHHELNPMR----V----LLKIAKS-EP-------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHSSCTTTTSCGGG----H----HHHHHHS-CC-------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHhhCCCCCCCCCHHH----H----HHHHHcC-CC-------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999998742211 0 1100000 00 011112234477999999999999999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-51 Score=316.26 Aligned_cols=213 Identities=23% Similarity=0.394 Sum_probs=158.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--CCcceEEEEecCCCChhhhhhccC-CcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKS-SQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|++++++++||||+++++++.+ ++.+|+||||+++|+|.+++.+.. ....+++..++.++.|++.||.|||+
T Consensus 48 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~ 127 (269)
T d2java1 48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR 127 (269)
T ss_dssp HHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 568999999999999999999999864 456899999999999999986532 22347889999999999999999998
Q ss_pred CC--CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 80 SA--SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 80 ~~--~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
.+ ..+|+||||||+||+++.++.++|+|||+++...... .......||+.|+|||++.+..++.++|||||||++|
T Consensus 128 ~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvily 205 (269)
T d2java1 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLY 205 (269)
T ss_dssp HCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHH
Confidence 54 1239999999999999999999999999998765432 2233457999999999999989999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|+.||.+.+.. +.... ....... ..+...++.+.+||.+||+.||.+|||++++++
T Consensus 206 el~tg~~Pf~~~~~~--------~~~~~-i~~~~~~---------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 206 ELCALMPPFTAFSQK--------ELAGK-IREGKFR---------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHSSCSCCCSSHH--------HHHHH-HHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhCCCCCCCCCHH--------HHHHH-HHcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 999999999873211 01111 1111110 111123477999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=321.33 Aligned_cols=229 Identities=22% Similarity=0.241 Sum_probs=172.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh-C
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS-S 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~ 80 (259)
++.+.+|+.+|++++||||++++++|.+++..|+||||+++|+|.+++.+... +++..+..++.|++.||.|||+ +
T Consensus 48 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~---l~~~~~~~~~~qil~aL~yLH~~~ 124 (322)
T d1s9ja_ 48 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLREKH 124 (322)
T ss_dssp HHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC---CCHHHHHHHHHHHHHHHHHHHHhC
Confidence 35789999999999999999999999999999999999999999999976543 6889999999999999999997 5
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ |+||||||+||+++.++.++|+|||+++..... ......||+.|+|||++.+..++.++||||+||++|+|+
T Consensus 125 ~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell 197 (322)
T d1s9ja_ 125 K---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 197 (322)
T ss_dssp C---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHH
T ss_pred C---EEccccCHHHeeECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 8 999999999999999999999999999865432 223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHH---------------------Hhhccch----hhhhhccccCCchhHHHHHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFL---------------------YSIENNS----LRQILNFQVADESEMEEIETVAGL 215 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~l 215 (259)
+|+.||.+.+.............. ....... .................+..+.++
T Consensus 198 ~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 277 (322)
T d1s9ja_ 198 VGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277 (322)
T ss_dssp HSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHH
T ss_pred HCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHH
Confidence 999999874321110000000000 0000000 000000000000011123679999
Q ss_pred HHHhcccCCCCCCCHHHHHH--HHHhc
Q 025011 216 ASKCLSLSGRRRPTMKQVSE--ELDRL 240 (259)
Q Consensus 216 i~~~l~~~p~~Rpt~~~il~--~l~~~ 240 (259)
|.+||..||.+|||++|+++ .+++.
T Consensus 278 i~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 278 VNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp HHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 99999999999999999986 45443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=311.46 Aligned_cols=216 Identities=25% Similarity=0.362 Sum_probs=171.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|++++++++||||+++++++.+ +..++||||+++|+|.+++...... .+++..+..++.|++.||.|||+++
T Consensus 52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~-~l~~~~~~~i~~qi~~gl~~lH~~~ 129 (272)
T d1qpca_ 52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN 129 (272)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHH-TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3579999999999999999999998754 5679999999999999988655432 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||++++++.+||+|||+++..... .........++..|+|||++.+..++.++|||||||++|+|+|
T Consensus 130 ---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt 205 (272)
T d1qpca_ 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205 (272)
T ss_dssp ---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHT
T ss_pred ---cccCccchhheeeecccceeeccccceEEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHh
Confidence 999999999999999999999999999876543 2223334568899999999998889999999999999999999
Q ss_pred CCC-CCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 GLK-PGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|.. ||..... .. ....... ......+...++.+.+|+.+||+.||++|||+++|++.|+++
T Consensus 206 ~~~~~~~~~~~-----~~---~~~~i~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 206 HGRIPYPGMTN-----PE---VIQNLER----------GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp TTCCSSTTCCH-----HH---HHHHHHT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCH-----HH---HHHHHHh----------cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 654 4443211 00 1111100 011111122346799999999999999999999999999875
Q ss_pred c
Q 025011 241 K 241 (259)
Q Consensus 241 ~ 241 (259)
-
T Consensus 268 f 268 (272)
T d1qpca_ 268 F 268 (272)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=307.01 Aligned_cols=215 Identities=22% Similarity=0.378 Sum_probs=176.7
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|+.++++++||||+++++++.+++..++||||+++|+|.+++...... .++..++.++.|++.||.|||+++
T Consensus 43 ~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~--~~~~~~~~i~~qi~~gl~~LH~~~ 120 (258)
T d1k2pa_ 43 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR--FQTQQLLEMCKDVCEAMEYLESKQ 120 (258)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGC--CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccC--CcHHHHHHHHHHHHHHHHHHhhcC
Confidence 467999999999999999999999999999999999999999999997665432 577899999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+|+||||+||+++.++.++|+|||+++..... .........++..|+|||.+.+..++.++||||||+++|+|+|
T Consensus 121 ---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 121 ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp ---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---cccccccceeEEEcCCCcEEECcchhheeccCC-CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 999999999999999999999999999866543 2223334568999999999999999999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|+.||.+.... +........ .....+...++.+.++|.+||+.||.+|||+++|++.|.+|
T Consensus 197 ~g~~Pf~~~~~~--------~~~~~i~~~----------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 197 LGKMPYERFTNS--------ETAEHIAQG----------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TSCCTTTTSCHH--------HHHHHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred cCCCCCCCCCHH--------HHHHHHHhC----------CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 89999874321 111111110 01111112346799999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=309.12 Aligned_cols=220 Identities=23% Similarity=0.312 Sum_probs=169.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|++++++++||||+++++++.+.+..+++|||+.++++.+.+..... .+++..+..++.|++.|+.|||+++
T Consensus 54 ~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~- 130 (283)
T d1mqba_ 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN- 130 (283)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc-
Confidence 4689999999999999999999999999999999999999999998876543 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++........ .......||..|+|||++.+..++.++||||||+++|+|++
T Consensus 131 --iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t 208 (283)
T d1mqba_ 131 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 208 (283)
T ss_dssp --CCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHT
T ss_pred --cccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHh
Confidence 999999999999999999999999999876543222 22333468899999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..|+...... . +.... +......+.+...++.+.+||.+||+.||++|||+.+|++.|+++.
T Consensus 209 ~~~~~~~~~~~----~---~~~~~----------i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 271 (283)
T d1mqba_ 209 YGERPYWELSN----H---EVMKA----------INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271 (283)
T ss_dssp TSCCTTTTCCH----H---HHHHH----------HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCccccCCH----H---HHHHH----------HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHh
Confidence 66554431100 0 11111 1111111122234477999999999999999999999999999876
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
...
T Consensus 272 ~~p 274 (283)
T d1mqba_ 272 RAP 274 (283)
T ss_dssp HSG
T ss_pred hCc
Confidence 543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-49 Score=313.51 Aligned_cols=209 Identities=22% Similarity=0.322 Sum_probs=158.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++...+. +++..+..++.|++.||.|||+++
T Consensus 52 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~al~ylH~~~- 127 (307)
T d1a06a_ 52 GSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLG- 127 (307)
T ss_dssp ---CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC---CCHHHHHHHHHHHHHHHHhhhhce-
Confidence 4578899999999999999999999999999999999999999999976543 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC---CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD---DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||++. .++.++|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|
T Consensus 128 --iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyel 202 (307)
T d1a06a_ 128 --IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYIL 202 (307)
T ss_dssp --CCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHH
T ss_pred --eeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHH
Confidence 99999999999995 57889999999997654322 22345699999999999998999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+..... ......... ...........++.+.+||.+||+.||++|||++|+++
T Consensus 203 l~g~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 203 LCGYPPFYDENDAK--------LFEQILKAE-------YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp HHSSCSCCCSSHHH--------HHHHHHTTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCHHH--------HHHHHhccC-------CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 99999998632110 001111000 00111111234477999999999999999999999976
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-49 Score=313.82 Aligned_cols=204 Identities=24% Similarity=0.310 Sum_probs=166.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|++++++++||||+++++++.+++..|+||||+.+|++..++.... .+++..++.++.||+.||.|||+++
T Consensus 60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~- 135 (309)
T d1u5ra_ 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN- 135 (309)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 468899999999999999999999999999999999999998877665543 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc---CCcccccchhhHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT---GKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||+++.++.++|+|||++..... .....||+.|+|||++.+ ..++.++||||+||++|+|
T Consensus 136 --iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel 207 (309)
T d1u5ra_ 136 --MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (309)
T ss_dssp --CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHH
T ss_pred --EeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHH
Confidence 99999999999999999999999999976433 233569999999999864 3488999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|..||.+.... ....... ............++.+.+||.+||+.||.+|||++++++
T Consensus 208 ~~g~~Pf~~~~~~--------~~~~~i~---------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 208 AERKPPLFNMNAM--------SALYHIA---------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HHSSCTTTTSCHH--------HHHHHHH---------HSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHCCCCCCCCCHH--------HHHHHHH---------hCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 9999999863211 0011110 111111111223477999999999999999999999975
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=308.39 Aligned_cols=217 Identities=24% Similarity=0.343 Sum_probs=165.8
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|++++++++||||+++++++. ++..++||||+++|++.+++..... .+++..++.++.|++.||.|||+++
T Consensus 52 ~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~ 128 (273)
T d1mp8a_ 52 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR 128 (273)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC
Confidence 357899999999999999999999996 5678999999999999998765543 2588999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.+||+|||+++..... .........+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 129 ---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt 204 (273)
T d1mp8a_ 129 ---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 204 (273)
T ss_dssp ---CCCSCCSGGGEEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred ---eeccccchhheeecCCCcEEEccchhheeccCC-cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHh
Confidence 999999999999999999999999999865433 2223334468899999999999999999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|.+||.+..... ... .... +. ..+.+.+.++.+.+||.+||+.||.+|||+.+|++.|+++
T Consensus 205 ~g~~P~~~~~~~~-----~~~---~i~~-~~---------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 205 HGVKPFQGVKNND-----VIG---RIEN-GE---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TSCCTTTTCCGGG-----HHH---HHHT-TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHH-----HHH---HHHc-CC---------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 889988743211 111 1111 10 0111223447799999999999999999999999999987
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
...
T Consensus 267 ~~~ 269 (273)
T d1mp8a_ 267 LEE 269 (273)
T ss_dssp HHH
T ss_pred HHH
Confidence 544
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.3e-48 Score=309.81 Aligned_cols=211 Identities=21% Similarity=0.309 Sum_probs=171.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|+.++++++||||+++++++.+++..|+||||+++|+|.+++..... .+++..+..++.||+.||.|||+++
T Consensus 67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~ 144 (350)
T d1koaa2 67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN 144 (350)
T ss_dssp HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 35688999999999999999999999999999999999999999999965432 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeC--CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
++||||||+||+++ .++.++|+|||+++...... ......||+.|+|||++.+..++.++||||+||++|+|
T Consensus 145 ---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyel 218 (350)
T d1koaa2 145 ---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYIL 218 (350)
T ss_dssp ---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHH
T ss_pred ---CeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHH
Confidence 99999999999995 46789999999998765432 22345699999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
++|+.||.+.... +......... ...........++.+.+||.+||+.||++|||++++++
T Consensus 219 l~G~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 219 LSGLSPFGGENDD--------ETLRNVKSCD-------WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp HHSSCSSCCSSHH--------HHHHHHHHTC-------CCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCHH--------HHHHHHHhCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999999873211 1111110000 00111111233477999999999999999999999976
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=305.41 Aligned_cols=215 Identities=28% Similarity=0.429 Sum_probs=167.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
.+.|.+|++++++++||||+++++++.+ .+..++||||+++|+|.+++...... .+++..++.++.||+.|+.|||++
T Consensus 44 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~-~l~~~~~~~i~~~i~~al~ylH~~ 122 (262)
T d1byga_ 44 AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122 (262)
T ss_dssp -HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHH-HCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCC-CCCHHHHHHHHHHHHhhccccccC
Confidence 4679999999999999999999998854 46789999999999999999764322 368899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
+ ++|+||+|+||+++.++.++++|||+++..... .....++..|+|||++.+..++.++||||||+++|+|+
T Consensus 123 ~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~ 194 (262)
T d1byga_ 123 N---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 194 (262)
T ss_dssp T---CCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred c---eeccccchHhheecCCCCEeecccccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHH
Confidence 9 999999999999999999999999998764432 22335788999999999989999999999999999999
Q ss_pred h-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 161 T-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 161 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
+ |++||...... ...... . .......+...++.+.+||.+||+.||.+|||+.++++.|++
T Consensus 195 t~~~~p~~~~~~~-----~~~~~i----~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~ 256 (262)
T d1byga_ 195 SFGRVPYPRIPLK-----DVVPRV----E---------KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256 (262)
T ss_dssp TTSCCSCTTSCGG-----GHHHHH----T---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HCCCCCCCCCCHH-----HHHHHH----H---------cCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence 8 68887763211 111111 0 111111122234779999999999999999999999999998
Q ss_pred cccc
Q 025011 240 LKIS 243 (259)
Q Consensus 240 ~~~~ 243 (259)
++..
T Consensus 257 i~~~ 260 (262)
T d1byga_ 257 IKTH 260 (262)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 8643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-48 Score=305.69 Aligned_cols=210 Identities=25% Similarity=0.335 Sum_probs=171.2
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.+.+|++++++++||||+++++++.+++..|+||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---l~~~~~~~~~~qi~~al~yLH~~~ 133 (293)
T d1jksa_ 57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGVYYLHSLQ 133 (293)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccc---cchhHHHHHHHHHHHHHHhhhhcc
Confidence 46799999999999999999999999999999999999999999999977543 688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCC----ceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNY----KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~----~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
|+||||||+||+++.++ .++++|||++....... ......+++.|+|||++.+..++.++||||+||++|
T Consensus 134 ---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvily 207 (293)
T d1jksa_ 134 ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207 (293)
T ss_dssp ---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHH
T ss_pred ---eeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHH
Confidence 99999999999998776 49999999998765432 223456899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|++|+.||.+.... +......... ...........++.+.+||.+||+.||++|||++++++
T Consensus 208 ell~g~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 208 ILLSGASPFLGDTKQ--------ETLANVSAVN-------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHSSCSSCCSSHH--------HHHHHHHTTC-------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHcCCCCCCCCCHH--------HHHHHHHhcC-------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999999873211 0011000000 00001111123467899999999999999999999975
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.9e-48 Score=308.91 Aligned_cols=210 Identities=20% Similarity=0.318 Sum_probs=171.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++|++++||||++++++|.+++.+|+||||+++|+|.+++..... .+++..++.++.||+.||.|||+++
T Consensus 71 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~- 147 (352)
T d1koba_ 71 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS- 147 (352)
T ss_dssp HHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence 5688999999999999999999999999999999999999999998865533 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeC--CCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLD--DNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~--~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++ .++.++|+|||++....... ......+++.|+|||++.+..++.++||||+||++|+|+
T Consensus 148 --iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 222 (352)
T d1koba_ 148 --IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 222 (352)
T ss_dssp --EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred --eeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHH
Confidence 99999999999997 67899999999998765432 223346899999999999999999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|+.||.+..... ......... ...........++.+.+||.+||+.||.+|||++++++
T Consensus 223 tG~~Pf~~~~~~~--------~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 223 SGLSPFAGEDDLE--------TLQNVKRCD-------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp HSCCSSCCSSHHH--------HHHHHHHCC-------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hCCCCCCCCCHHH--------HHHHHHhCC-------CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 9999998732110 011110000 00111111234477999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=310.55 Aligned_cols=218 Identities=22% Similarity=0.367 Sum_probs=173.4
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.|.+|++++++++||||+++++++.++ ..+++++++.+++|.+.+..... .+++..++.++.|++.||.|||+++
T Consensus 55 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~ 131 (317)
T d1xkka_ 55 NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR 131 (317)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 35799999999999999999999999765 56788999999999998876543 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+|
T Consensus 132 ---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t 208 (317)
T d1xkka_ 132 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208 (317)
T ss_dssp ---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHH
Confidence 99999999999999999999999999987765443333444568999999999999999999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+..... ...... .......+...++.+.+++.+||+.||.+|||+.+|++.++.+
T Consensus 209 ~g~~p~~~~~~~~-----~~~~i~-------------~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 209 FGSKPYDGIPASE-----ISSILE-------------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp TSCCTTTTSCGGG-----HHHHHH-------------HTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHH-----HHHHHH-------------cCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 789988743211 111111 1111111122347799999999999999999999999998877
Q ss_pred ccc
Q 025011 241 KIS 243 (259)
Q Consensus 241 ~~~ 243 (259)
...
T Consensus 271 ~~~ 273 (317)
T d1xkka_ 271 ARD 273 (317)
T ss_dssp HHS
T ss_pred HhC
Confidence 543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=306.33 Aligned_cols=206 Identities=25% Similarity=0.264 Sum_probs=171.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+|+.++||||+++++++.+++.+|+||||+++|+|.+++..... +++..+..++.|++.||.|||+++
T Consensus 50 ~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~---~~e~~~~~~~~qil~al~ylH~~~- 125 (337)
T d1o6la_ 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTEERARFYGAEIVSALEYLHSRD- 125 (337)
T ss_dssp HHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC---CcHHHHHHHHHHHhhhhhhhhhcC-
Confidence 4578999999999999999999999999999999999999999999987654 678899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.+|.++|+|||+++...... .......||+.|+|||++.+..++.++|+||+||++|+|++|
T Consensus 126 --iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G 201 (337)
T d1o6la_ 126 --VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 201 (337)
T ss_dssp --CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS
T ss_pred --ccccccCHHHeEecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHC
Confidence 9999999999999999999999999998654322 223445799999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
..||.+.+.. .. .... ...... .+...++.+.+||.+||+.||.+||+ ++++++
T Consensus 202 ~~pf~~~~~~-----~~---~~~i---------~~~~~~--~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 202 RLPFYNQDHE-----RL---FELI---------LMEEIR--FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SCSSCCSSHH-----HH---HHHH---------HHCCCC--CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCCCCCcCHH-----HH---HHHH---------hcCCCC--CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 9999874321 11 1111 111111 11123477999999999999999995 777765
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-48 Score=305.87 Aligned_cols=219 Identities=26% Similarity=0.381 Sum_probs=176.5
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC---------------------cccCCH
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS---------------------QVLRNW 60 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~~~~~ 60 (259)
+++|.+|++++++++||||+++++++...+..+++|||+++|+|.+++..... ...+++
T Consensus 60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 139 (301)
T d1lufa_ 60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139 (301)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred HHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence 35799999999999999999999999999999999999999999999965321 123678
Q ss_pred HHHHHHHHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc
Q 025011 61 KTCLRIAAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT 140 (259)
Q Consensus 61 ~~~~~i~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 140 (259)
..++.++.|++.||+|||+++ ++||||||+||+++.++.+||+|||+++...............+++.|+|||.+.+
T Consensus 140 ~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (301)
T d1lufa_ 140 AEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 216 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc
Confidence 899999999999999999999 99999999999999999999999999987655444444455678899999999999
Q ss_pred CCcccccchhhHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHh
Q 025011 141 GKLTEKSDVYSFGVLLAELLTGL-KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 141 ~~~~~~~DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 219 (259)
..++.++|||||||++|+|++|. +||.+.... +..... ..+.. ...+...++.+.+|+.+|
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~--------e~~~~v-~~~~~---------~~~p~~~~~~~~~li~~c 278 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE--------EVIYYV-RDGNI---------LACPENCPLELYNLMRLC 278 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--------HHHHHH-HTTCC---------CCCCTTCCHHHHHHHHHH
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCCCHH--------HHHHHH-HcCCC---------CCCCccchHHHHHHHHHH
Confidence 99999999999999999999985 677663211 111111 11111 111122346799999999
Q ss_pred cccCCCCCCCHHHHHHHHHhcc
Q 025011 220 LSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|+.||++|||+.+|.+.|+++.
T Consensus 279 l~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 279 WSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=303.55 Aligned_cols=220 Identities=24% Similarity=0.355 Sum_probs=168.6
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++.|.+|+.++++++||||+++++++. ++..++||||+++|+|..++...... .+++..++.++.|++.||+|||+++
T Consensus 56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~ 133 (285)
T d1fmka3 56 PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN 133 (285)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh
Confidence 367999999999999999999999985 45679999999999999888654332 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.++|+|||+++...... ........+++.|+|||++....++.++||||+|+++|+|++
T Consensus 134 ---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t 209 (285)
T d1fmka3 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 209 (285)
T ss_dssp ---CCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ---eecccccceEEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHh
Confidence 9999999999999999999999999998665332 223334568999999999999999999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhcc
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRLK 241 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 241 (259)
|..||...... .+....... ....+.+...++.+.++|.+||+.||++|||+++|++.|+..-
T Consensus 210 ~~~p~~~~~~~-------~~~~~~i~~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 210 KGRVPYPGMVN-------REVLDQVER----------GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TTCCSSTTCCH-------HHHHHHHHT----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCCH-------HHHHHHHHh----------cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 66554431110 011111111 1111112234477999999999999999999999999998865
Q ss_pred ccc
Q 025011 242 ISH 244 (259)
Q Consensus 242 ~~~ 244 (259)
.+.
T Consensus 273 ~~~ 275 (285)
T d1fmka3 273 TST 275 (285)
T ss_dssp SCS
T ss_pred cCC
Confidence 443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-48 Score=300.05 Aligned_cols=215 Identities=24% Similarity=0.347 Sum_probs=171.6
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.|.+|+.++++++||||+++++++.+ +..++||||+++|++.+++..... .+++..+..++.|++.||.|||+++
T Consensus 56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~- 131 (273)
T d1u46a_ 56 DDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR- 131 (273)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC-
Confidence 578999999999999999999999965 567999999999999998876533 3688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc-ccccccCcccccCcchhccCCcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA-MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|+|++
T Consensus 132 --iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt 209 (273)
T d1u46a_ 132 --FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209 (273)
T ss_dssp --EECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred --EeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHh
Confidence 9999999999999999999999999998765543222 2233457789999999999999999999999999999998
Q ss_pred -CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHhc
Q 025011 162 -GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDRL 240 (259)
Q Consensus 162 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 240 (259)
|..||.+.... +....... .....+.+...++.+.+||.+||+.||++|||+.+|.+.|++.
T Consensus 210 ~G~~Pf~~~~~~--------~~~~~i~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 210 YGQEPWIGLNGS--------QILHKIDK---------EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSCCTTTTCCHH--------HHHHHHHT---------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCCCCCcCHH--------HHHHHHHh---------CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 89999863211 11111111 1111111223346799999999999999999999999998764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=303.07 Aligned_cols=218 Identities=27% Similarity=0.417 Sum_probs=179.2
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIAA 68 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~~ 68 (259)
..+.+|+..+.++ +||||+++++++.+++..++||||+++|+|.+++..... ...+++..++.++.
T Consensus 63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 142 (299)
T d1fgka_ 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 142 (299)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHH
Confidence 4578899999888 799999999999999999999999999999999975532 23468899999999
Q ss_pred HHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccc
Q 025011 69 ETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSD 148 (259)
Q Consensus 69 ~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 148 (259)
|++.||.|||+++ ++||||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|
T Consensus 143 qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 143 QVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp HHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHhhhCC---EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhh
Confidence 9999999999999 9999999999999999999999999998776554444455567899999999999999999999
Q ss_pred hhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 149 VYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 149 iwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|||||+++|+|++ |.+||.+.... ...... .. ......+...++.+.+||.+||+.||.+|
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~-----~~~~~i----~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~R 281 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVE-----ELFKLL----KE---------GHRMDKPSNCTNELYMMMRDCWHAVPSQR 281 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHH----HT---------TCCCCCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred hHHhHHHHHHhccCCCCCCCCCCHH-----HHHHHH----Hc---------CCCCCCCccchHHHHHHHHHHccCCHhHC
Confidence 9999999999998 78888763211 111111 11 11111112234679999999999999999
Q ss_pred CCHHHHHHHHHhcc
Q 025011 228 PTMKQVSEELDRLK 241 (259)
Q Consensus 228 pt~~~il~~l~~~~ 241 (259)
||+.+|++.|+++-
T Consensus 282 ps~~eil~~L~~i~ 295 (299)
T d1fgka_ 282 PTFKQLVEDLDRIV 295 (299)
T ss_dssp CCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHh
Confidence 99999999998873
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=304.73 Aligned_cols=222 Identities=29% Similarity=0.419 Sum_probs=177.3
Q ss_pred hhHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-------------CCcccCCHHHHHHHH
Q 025011 2 NQVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-------------SSQVLRNWKTCLRIA 67 (259)
Q Consensus 2 ~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~~~~i~ 67 (259)
.+.|.+|+++|+++ +||||+++++++.+++..++||||+++|+|.+++... .....+++..+..++
T Consensus 54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 133 (309)
T d1fvra_ 54 HRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133 (309)
T ss_dssp -CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHH
Confidence 35799999999999 7999999999999999999999999999999999754 223447889999999
Q ss_pred HHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCccccc
Q 025011 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS 147 (259)
Q Consensus 68 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 147 (259)
.|++.|+.|+|+++ ++||||||+||+++.++.+||+|||+++...... ......++..|+|||.+.+..++.++
T Consensus 134 ~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~s 207 (309)
T d1fvra_ 134 ADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNS 207 (309)
T ss_dssp HHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHH
T ss_pred HHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccc
Confidence 99999999999999 9999999999999999999999999987554322 12234588999999999999999999
Q ss_pred chhhHHHHHHHHHhCC-CCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 148 DVYSFGVLLAELLTGL-KPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 148 DiwslG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
||||||+++|+|++|. +||.+.... ...... .. ......+...++.+.+||.+||+.||++
T Consensus 208 DvwSfGvil~ell~~~~~p~~~~~~~-----~~~~~i---~~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~ 269 (309)
T d1fvra_ 208 DVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL---PQ----------GYRLEKPLNCDDEVYDLMRQCWREKPYE 269 (309)
T ss_dssp HHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHG---GG----------TCCCCCCTTBCHHHHHHHHHHTCSSGGG
T ss_pred eeehhHHHHHHHHhcCCCCCCCCCHH-----HHHHHH---Hh----------cCCCCCCccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999975 567653211 111111 10 1111112234478999999999999999
Q ss_pred CCCHHHHHHHHHhccccccch
Q 025011 227 RPTMKQVSEELDRLKISHENY 247 (259)
Q Consensus 227 Rpt~~~il~~l~~~~~~~~~~ 247 (259)
|||+.+|++.|+++.....+.
T Consensus 270 RPs~~eil~~L~~i~~~~~~~ 290 (309)
T d1fvra_ 270 RPSFAQILVSLNRMLEERKTY 290 (309)
T ss_dssp SCCHHHHHHHHHHHHHSSSCS
T ss_pred CcCHHHHHHHHHHHHhcCcCC
Confidence 999999999999987655443
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.6e-47 Score=298.38 Aligned_cols=210 Identities=23% Similarity=0.353 Sum_probs=170.9
Q ss_pred hhHHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 2 NQVFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++++.+|+.++++++ ||||+++++++.+++.+|+||||+++|+|.+++..... +++..+..++.||+.||.|||++
T Consensus 53 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 53 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHc
Confidence 356889999999996 99999999999999999999999999999999976543 68999999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc------CCcccccchhhHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT------GKLTEKSDVYSFGV 154 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~ 154 (259)
+ ++||||||+||+++.++.++|+|||+++...... ......||..|+|||.+.+ ..++.++||||+||
T Consensus 130 ~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGv 203 (277)
T d1phka_ 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGV 203 (277)
T ss_dssp T---EECSCCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHH
T ss_pred C---CcccccccceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccch
Confidence 9 9999999999999999999999999998765432 2234569999999999863 23678999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
++|+|++|+.||.+.... ......... . ...........++.+.+++.+||+.||.+|||+.+++
T Consensus 204 ilyeml~g~~Pf~~~~~~--------~~~~~i~~~-~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 204 IMYTLLAGSPPFWHRKQM--------LMLRMIMSG-N------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHHHHSSCSSCCSSHH--------HHHHHHHHT-C------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred hhhhhccCCCCCCCCCHH--------HHHHHHHhC-C------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 999999999999873211 001101100 0 0111112223557899999999999999999999986
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 269 ~ 269 (277)
T d1phka_ 269 A 269 (277)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-47 Score=295.96 Aligned_cols=219 Identities=26% Similarity=0.391 Sum_probs=168.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.|.+|+++++.++||||+++++++...+ ..|+||||++|++|.+++..... +++..+..++.|++.||.|||
T Consensus 52 ~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~---l~~~~~~~i~~qi~~al~~lH 128 (277)
T d1o6ya_ 52 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH 128 (277)
T ss_dssp HHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC---CCHHHHHHHHHHHHHHHHHHH
Confidence 46899999999999999999999998654 37899999999999999877653 688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcc-ccccccccCcccccCcchhccCCcccccchhhHHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQ-TAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLA 157 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 157 (259)
+++ ++||||||+||+++.++..+++|||.+........ ........||+.|+|||++.+..++.++||||+||++|
T Consensus 129 ~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvily 205 (277)
T d1o6ya_ 129 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 205 (277)
T ss_dssp HTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred hCC---ccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHH
Confidence 999 99999999999999999999999999875543222 22334456999999999999988999999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-TMKQVSEE 236 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-t~~~il~~ 236 (259)
+|++|+.||.+.... +............. .......++.+.++|.+||+.||.+|| |++++++.
T Consensus 206 elltG~~Pf~~~~~~--------~~~~~~~~~~~~~~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~ 270 (277)
T d1o6ya_ 206 EVLTGEPPFTGDSPV--------SVAYQHVREDPIPP-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270 (277)
T ss_dssp HHHHSSCSCCCSSHH--------HHHHHHHHCCCCCG-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHhCCCCCCCcCHH--------HHHHHHHhcCCCCC-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHH
Confidence 999999999863211 11111111111000 001112347799999999999999999 89999999
Q ss_pred HHhccc
Q 025011 237 LDRLKI 242 (259)
Q Consensus 237 l~~~~~ 242 (259)
|.++..
T Consensus 271 l~r~~n 276 (277)
T d1o6ya_ 271 LVRVHN 276 (277)
T ss_dssp HHHHHC
T ss_pred HHHHhC
Confidence 988753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.9e-46 Score=297.54 Aligned_cols=203 Identities=27% Similarity=0.360 Sum_probs=169.5
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|..++..... .++..+..++.||+.||.|||+++
T Consensus 49 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~~~~~~~~~qi~~al~~lH~~~- 124 (316)
T d1fota_ 49 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPNPVAKFYAAEVCLALEYLHSKD- 124 (316)
T ss_dssp HHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCHHHHHHHHHHHHHHHHHHHTTT-
T ss_pred HHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---ccccHHHHHHHHHHHhhhhhccCc-
Confidence 5688999999999999999999999999999999999999999999987654 567888899999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 125 --iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 125 --IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp --EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred --EEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 999999999999999999999999999876432 2345799999999999998999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
+.||.+.+.. .... .+...... .+...++.+.+++.+||..||.+|| |++++++
T Consensus 198 ~~Pf~~~~~~--------~~~~---------~i~~~~~~--~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 198 YTPFYDSNTM--------KTYE---------KILNAELR--FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SCTTCCSSHH--------HHHH---------HHHHCCCC--CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCcCHH--------HHHH---------HHHcCCCC--CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 9999873211 0011 11111110 1112346799999999999999996 8999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-47 Score=302.13 Aligned_cols=213 Identities=25% Similarity=0.277 Sum_probs=168.6
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEe----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLE----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+++|+.++.++ +||||++++++|.+ +..+|+|||||+||+|.+++...+.. .+++..+..++.|++.||.||
T Consensus 49 ~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~-~l~e~~~~~i~~qi~~al~yl 127 (335)
T d2ozaa1 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYL 127 (335)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCC-CEEHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCC-CcCHHHHHHHHHHHHHHHHHH
Confidence 5678999987654 89999999999976 45789999999999999999865433 368899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGV 154 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 154 (259)
|+++ |+||||||+||+++. ++.++|+|||+++...... ......||+.|+|||++.+..++.++||||+||
T Consensus 128 H~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGv 201 (335)
T d2ozaa1 128 HSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 201 (335)
T ss_dssp HHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHH
T ss_pred HHcC---CccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhch
Confidence 9999 999999999999985 4579999999998765432 233456999999999999988999999999999
Q ss_pred HHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhcc--ccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 025011 155 LLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNF--QVADESEMEEIETVAGLASKCLSLSGRRRPTMKQ 232 (259)
Q Consensus 155 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 232 (259)
++|+|++|+.||.+........ .....+... ..........++.+.+||.+||+.||++|||+.+
T Consensus 202 ily~lltg~~Pf~~~~~~~~~~-------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 268 (335)
T d2ozaa1 202 IMYILLCGYPPFYSNHGLAISP-------------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268 (335)
T ss_dssp HHHHHTTSSCSCEETTCC---------------------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred hHHHHhhCCCCCCCCCHHHHHH-------------HHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHH
Confidence 9999999999997632211000 000001111 1111222345678999999999999999999999
Q ss_pred HHH
Q 025011 233 VSE 235 (259)
Q Consensus 233 il~ 235 (259)
+++
T Consensus 269 il~ 271 (335)
T d2ozaa1 269 FMN 271 (335)
T ss_dssp HHH
T ss_pred HHc
Confidence 987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=301.04 Aligned_cols=220 Identities=24% Similarity=0.364 Sum_probs=168.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeC-CcceEEEEecCCCChhhhhhccCC-------------cccCCHHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLET-KVPLLVYEFVPNGTLFDHIHDKSS-------------QVLRNWKTCLRIA 67 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~-------------~~~~~~~~~~~i~ 67 (259)
+.+.+|..++.++ +|+||+.+++++... +..+++|||+++|+|.+++..... ...+++..+..++
T Consensus 61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 140 (299)
T d1ywna1 61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 140 (299)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred HHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence 4577788888877 689999999987654 468999999999999999965421 2246889999999
Q ss_pred HHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCccccc
Q 025011 68 AETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKS 147 (259)
Q Consensus 68 ~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 147 (259)
.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++
T Consensus 141 ~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s 217 (299)
T d1ywna1 141 FQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQS 217 (299)
T ss_dssp HHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccc
Confidence 99999999999999 999999999999999999999999999876554444444556799999999999999999999
Q ss_pred chhhHHHHHHHHHhC-CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 148 DVYSFGVLLAELLTG-LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 148 DiwslG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
||||+||++|+|++| ..||.+..... ....... .+. ....+...++.+.++|.+||+.||.+
T Consensus 218 DiwS~Gvil~ellt~~~~p~~~~~~~~----~~~~~~~----~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~ 280 (299)
T d1ywna1 218 DVWSFGVLLWEIFSLGASPYPGVKIDE----EFCRRLK----EGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQ 280 (299)
T ss_dssp HHHHHHHHHHHHHTTSCCSSTTCCCSH----HHHHHHH----HTC---------CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred ceeehHHHHHHHHhCCCCCCCCCCHHH----HHHHHHh----cCC---------CCCCCccCCHHHHHHHHHHcCCChhH
Confidence 999999999999996 46777633211 1111111 000 01111123467999999999999999
Q ss_pred CCCHHHHHHHHHhccc
Q 025011 227 RPTMKQVSEELDRLKI 242 (259)
Q Consensus 227 Rpt~~~il~~l~~~~~ 242 (259)
|||++++++.|+++..
T Consensus 281 Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 281 RPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SCCHHHHHHHHHHHHH
T ss_pred CcCHHHHHHHHHHHHh
Confidence 9999999999998753
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=302.62 Aligned_cols=221 Identities=25% Similarity=0.411 Sum_probs=179.1
Q ss_pred hHHHHHHHHHhcC-CCccccccceeEEeCCcceEEEEecCCCChhhhhhccC---------------CcccCCHHHHHHH
Q 025011 3 QVFQHELRVVSQI-NHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKS---------------SQVLRNWKTCLRI 66 (259)
Q Consensus 3 ~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~~~~i 66 (259)
+.|.+|+.+++.+ +||||+++++++.+++..+++|||+++|+|.+++.... ....+++..+..+
T Consensus 71 ~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 150 (311)
T d1t46a_ 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150 (311)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHH
Confidence 4688999999999 69999999999999999999999999999999997542 2234688999999
Q ss_pred HHHHHHHHHHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccc
Q 025011 67 AAETASALDYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEK 146 (259)
Q Consensus 67 ~~~i~~~l~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 146 (259)
+.||+.|++|||+++ ++||||||+||+++.++.++++|||.++...............+++.|+|||++.+..++.+
T Consensus 151 ~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 227 (311)
T d1t46a_ 151 SYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227 (311)
T ss_dssp HHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCC---eeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCc
Confidence 999999999999999 99999999999999999999999999987765544445556678999999999999899999
Q ss_pred cchhhHHHHHHHHHh-CCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCC
Q 025011 147 SDVYSFGVLLAELLT-GLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGR 225 (259)
Q Consensus 147 ~DiwslG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 225 (259)
+||||||+++|+|++ |.+||.+..... . ...++........+...++.+.+||.+||+.||.
T Consensus 228 ~DIwS~G~~l~ellt~g~p~~~~~~~~~----~-------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~ 290 (311)
T d1t46a_ 228 SDVWSYGIFLWELFSLGSSPYPGMPVDS----K-------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290 (311)
T ss_dssp HHHHHHHHHHHHHHTTTCCSSTTCCSSH----H-------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGG
T ss_pred ccccchHHHHHHHHhCCCCCCCCCCHHH----H-------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChh
Confidence 999999999999999 556665532211 0 1111111111111122347799999999999999
Q ss_pred CCCCHHHHHHHHHhcccc
Q 025011 226 RRPTMKQVSEELDRLKIS 243 (259)
Q Consensus 226 ~Rpt~~~il~~l~~~~~~ 243 (259)
+|||+.+|++.|+++..+
T Consensus 291 ~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 291 KRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp GSCCHHHHHHHHHHHHHH
T ss_pred HCcCHHHHHHHHHHhhcc
Confidence 999999999999876543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=299.58 Aligned_cols=208 Identities=18% Similarity=0.282 Sum_probs=169.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++|+.++||||+++++++.+++.+|+|||||+||+|.+++...+. .+++.++..++.||+.||.|||+++
T Consensus 46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~- 122 (321)
T d1tkia_ 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN- 122 (321)
T ss_dssp HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC-
Confidence 4588999999999999999999999999999999999999999999976542 2688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCC--CceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHH
Q 025011 83 PPIIHGDVKSTNVLLDDN--YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~--~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.+ ..++++|||+++...... ......+++.|+|||...+..++.++||||+||++|+|+
T Consensus 123 --iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp --EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred --CCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 9999999999999854 479999999998654322 223346899999999999989999999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCc--hhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADE--SEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+|..||.+.... .... .+........ .....++.+.+||.+||..||.+|||++|+++
T Consensus 198 ~G~~Pf~~~~~~--------~~~~---------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 198 SGINPFLAETNQ--------QIIE---------NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HSSCTTCCSSHH--------HHHH---------HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hCCCCCCCCCHH--------HHHH---------HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 999999873211 0111 1111111111 11123467999999999999999999999987
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-47 Score=299.10 Aligned_cols=221 Identities=21% Similarity=0.245 Sum_probs=167.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+.++++++||||+++++++.+++..|+||||+.++++..+..... .+++..+..++.||+.||.|||+++
T Consensus 45 ~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~---~l~~~~~~~~~~qil~aL~~lH~~~- 120 (299)
T d1ua2a_ 45 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQHW- 120 (299)
T ss_dssp THHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS---SCCSSHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhccc---CCCHHHHHHHHHHHHHHHHHhhccc-
Confidence 568899999999999999999999999999999999998877766664432 2577899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~ 161 (259)
++||||||+||+++.++.+||+|||+++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++
T Consensus 121 --iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 196 (299)
T d1ua2a_ 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL 196 (299)
T ss_dssp --CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred --eecccCCcceEEecCCCccccccCccccccCCCcc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh
Confidence 99999999999999999999999999976654322 22345699999999998755 57999999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchhhhh------hcc-ccCCch----hHHHHHHHHHHHHHhcccCCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI------LNF-QVADES----EMEEIETVAGLASKCLSLSGRRRP 228 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~------~~~-~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp 228 (259)
|..||.+..... ........... ...+... ... ...... ....++.+.+||.+||+.||++||
T Consensus 197 g~~pf~~~~~~~----~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~ 272 (299)
T d1ua2a_ 197 RVPFLPGDSDLD----QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI 272 (299)
T ss_dssp SSCSSCCSSHHH----HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC
T ss_pred CcCCCCCCCHHH----HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc
Confidence 999998733211 11111110000 0000000 000 000000 012246799999999999999999
Q ss_pred CHHHHHH
Q 025011 229 TMKQVSE 235 (259)
Q Consensus 229 t~~~il~ 235 (259)
|++|+++
T Consensus 273 sa~e~L~ 279 (299)
T d1ua2a_ 273 TATQALK 279 (299)
T ss_dssp CHHHHHT
T ss_pred CHHHHhC
Confidence 9999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-46 Score=296.80 Aligned_cols=219 Identities=25% Similarity=0.372 Sum_probs=174.4
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe-CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE-TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
++|.+|++++++++||||+++++++.. ++..++||||+++|+|.+++...... .++..+..++.|++.||.|+|+.+
T Consensus 73 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~--~~~~~~~~i~~qia~gL~~lH~~~ 150 (311)
T d1r0pa_ 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMKFLASKK 150 (311)
T ss_dssp HHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCC--CBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcccccc--chHHHHHHHHHHHHHhhhhhcccC
Confidence 569999999999999999999999875 56889999999999999998765443 466888999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccCCcccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l 159 (259)
|+||||||+||++++++.++|+|||+++......... ......|+..|+|||.+....++.++||||||+++|+|
T Consensus 151 ---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El 227 (311)
T d1r0pa_ 151 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 227 (311)
T ss_dssp ---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred ---cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHH
Confidence 9999999999999999999999999998765432221 22334688999999999999999999999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSEELDR 239 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~ 239 (259)
++|..||....... ...... ... . ....+...++.+.+||.+||+.||++|||+.+|++.|++
T Consensus 228 ~t~~~p~~~~~~~~----~~~~~i---~~g-~---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~ 290 (311)
T d1r0pa_ 228 MTRGAPPYPDVNTF----DITVYL---LQG-R---------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290 (311)
T ss_dssp HTTSCCSCC----------CHHHH---HTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHCCCCCCCCCCHH----HHHHHH---HcC-C---------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 99877776522111 001111 111 0 001111234679999999999999999999999999999
Q ss_pred cccc
Q 025011 240 LKIS 243 (259)
Q Consensus 240 ~~~~ 243 (259)
+..+
T Consensus 291 i~~~ 294 (311)
T d1r0pa_ 291 IFST 294 (311)
T ss_dssp HHHT
T ss_pred HHHh
Confidence 9755
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-46 Score=301.19 Aligned_cols=203 Identities=22% Similarity=0.284 Sum_probs=169.9
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+.+.+|+++|+.++||||+++++++...+..++||||+.+|+|.+++..... +++..+..++.||+.||.|||+++
T Consensus 86 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~---l~e~~~~~i~~qi~~aL~yLH~~~- 161 (350)
T d1rdqe_ 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHSLD- 161 (350)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4688999999999999999999999999999999999999999999977643 688999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
|+||||||+||+++.++.++|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 162 --iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG 234 (350)
T d1rdqe_ 162 --LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234 (350)
T ss_dssp --EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --EecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC
Confidence 999999999999999999999999999876432 2345699999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRP-----TMKQVSE 235 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----t~~~il~ 235 (259)
..||.+.... ....... ..... .+...++.+.++|.+||..||.+|+ |++++++
T Consensus 235 ~~Pf~~~~~~--------~~~~~i~---------~~~~~--~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 235 YPPFFADQPI--------QIYEKIV---------SGKVR--FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SCSSCCSSHH--------HHHHHHH---------HCCCC--CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCcCHH--------HHHHHHh---------cCCCC--CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 9999873211 1111110 11100 1112347799999999999999994 8999875
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-46 Score=300.69 Aligned_cols=203 Identities=20% Similarity=0.221 Sum_probs=163.5
Q ss_pred HHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCCCeE
Q 025011 7 HELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASPPII 86 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~~i~ 86 (259)
+|+++++.++||||+++++++.+++..|+||||+++|+|.+++..... +++..++.++.||+.||.|||+++ ++
T Consensus 56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~---~~e~~~~~~~~qi~~aL~ylH~~~---ii 129 (364)
T d1omwa3 56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV---FSEADMRFYAAEIILGLEHMHNRF---VV 129 (364)
T ss_dssp HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc---ccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 347777788999999999999999999999999999999999977543 578999999999999999999999 99
Q ss_pred eCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhcc-CCcccccchhhHHHHHHHHHhCCCC
Q 025011 87 HGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLLAELLTGLKP 165 (259)
Q Consensus 87 h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~p 165 (259)
||||||+||+++.++.++|+|||+++..... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.|
T Consensus 130 HrDlKP~NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P 205 (364)
T d1omwa3 130 YRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 205 (364)
T ss_dssp CCCCSGGGEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ceeeccceeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence 9999999999999999999999999876543 2334569999999999965 4689999999999999999999999
Q ss_pred CCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 025011 166 GSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVSE 235 (259)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il~ 235 (259)
|.+...... ........ ... ...+...++.+.+||.+||+.||.+||| ++++++
T Consensus 206 f~~~~~~~~-----~~~~~~~~---------~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 206 FRQHKTKDK-----HEIDRMTL---------TMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SCSSCSSCH-----HHHHHHSS---------SCC--CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCHHHH-----HHHHHhcc---------cCC--CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 987432110 00000000 000 0011123477999999999999999999 678764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=294.94 Aligned_cols=220 Identities=22% Similarity=0.354 Sum_probs=179.3
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhcc-------CCcccCCHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDK-------SSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
+.|.+|+.++++++||||+++++++..++..++||||+++|+|.+++... ......++..+..++.|++.||.
T Consensus 68 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~ 147 (308)
T d1p4oa_ 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 147 (308)
T ss_dssp HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence 45899999999999999999999999999999999999999999998543 22234578899999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ |+||||||+||++++++.+||+|||+++...............+++.|+|||.+.+..++.++||||+|++
T Consensus 148 ~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~i 224 (308)
T d1p4oa_ 148 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 224 (308)
T ss_dssp HHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHhhCC---eeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHH
Confidence 999999 99999999999999999999999999987765544444555678999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 025011 156 LAELLTG-LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVS 234 (259)
Q Consensus 156 l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il 234 (259)
+|+|++| ..||.+.... +........ . ....+...++.+.++|.+||+.||.+|||+.+|+
T Consensus 225 l~El~t~~~~p~~~~~~~--------~~~~~i~~~-~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il 286 (308)
T d1p4oa_ 225 LWEIATLAEQPYQGLSNE--------QVLRFVMEG-G---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 286 (308)
T ss_dssp HHHHHHTSCCTTTTSCHH--------HHHHHHHTT-C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHhCCCCCCCCCCHH--------HHHHHHHhC-C---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999998 4777663211 111111111 1 0111112346799999999999999999999999
Q ss_pred HHHHhcccc
Q 025011 235 EELDRLKIS 243 (259)
Q Consensus 235 ~~l~~~~~~ 243 (259)
+.|++....
T Consensus 287 ~~L~~~~~~ 295 (308)
T d1p4oa_ 287 SSIKEEMEP 295 (308)
T ss_dssp HHHGGGSCT
T ss_pred HHHHHhcCC
Confidence 999877543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-46 Score=295.96 Aligned_cols=204 Identities=26% Similarity=0.284 Sum_probs=166.1
Q ss_pred HHHHHHHHHh-cCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 4 VFQHELRVVS-QINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 4 ~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
.+.+|..++. .++||||+++++++.+++..|+||||+++|+|.+++..... +++..+..++.||+.||.|||+++
T Consensus 48 ~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~---~~e~~~~~~~~qi~~al~ylH~~~- 123 (320)
T d1xjda_ 48 CTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG- 123 (320)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC---CCHHHHHHHHHHHHHHHHHHHhCC-
Confidence 4566666655 68999999999999999999999999999999999976543 578999999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHHHHHHhC
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLLAELLTG 162 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 162 (259)
++||||||+||++++++.++|+|||+++...... .......||+.|+|||++.+..++.++||||+||++|+|++|
T Consensus 124 --iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp --CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --eeeccCcccceeecCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 9999999999999999999999999997654322 223345799999999999999999999999999999999999
Q ss_pred CCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 025011 163 LKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK-QVS 234 (259)
Q Consensus 163 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il 234 (259)
+.||.+.+.. ........ ... ..+...++.+.+||.+||..||.+|||+. +++
T Consensus 200 ~~PF~~~~~~--------~~~~~i~~---------~~~--~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 200 QSPFHGQDEE--------ELFHSIRM---------DNP--FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp SCSSCCSSHH--------HHHHHHHH---------CCC--CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCCCCCCHH--------HHHHHHHc---------CCC--CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 9999873211 01111100 000 01112347799999999999999999996 665
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=291.33 Aligned_cols=228 Identities=19% Similarity=0.226 Sum_probs=169.9
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|++++++++||||+++++++.+++..|+||||+.+ ++.+++...... .+++..+..++.|++.||.|||+++
T Consensus 45 ~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~-~l~e~~~~~~~~qil~~L~yLH~~~ 122 (298)
T d1gz8a_ 45 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALT-GIPLPLIKSYLFQLLQGLAFCHSHR 122 (298)
T ss_dssp CHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTT-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhccc-CCCHHHHHHHHHHHHHHHHHhhcCC
Confidence 46789999999999999999999999999999999999965 555555443322 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.++.++++|||.++...... .......|++.|+|||++.... ++.++||||+||++|+|+
T Consensus 123 ---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp ---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred ---EEccccCchheeecccCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHh
Confidence 9999999999999999999999999998765432 2334457999999999987766 578999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhc--cchhhhh---------hccccCCc---hhHHHHHHHHHHHHHhcccCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI---------LNFQVADE---SEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---------~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+|+.||.+.+.. ............ ....... ........ .....++.+.+|+.+||..||++
T Consensus 198 ~G~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~ 273 (298)
T d1gz8a_ 198 TRRALFPGDSEI----DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273 (298)
T ss_dssp HSSCSCCCSSHH----HHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTT
T ss_pred hCCCCCCCCCHH----HHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhH
Confidence 999999864211 111111111000 0000000 00000000 01123467899999999999999
Q ss_pred CCCHHHHHHH--HHhc
Q 025011 227 RPTMKQVSEE--LDRL 240 (259)
Q Consensus 227 Rpt~~~il~~--l~~~ 240 (259)
|||++|+++- ++++
T Consensus 274 R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 274 RISAKAALAHPFFQDV 289 (298)
T ss_dssp SCCHHHHHTSGGGTTC
T ss_pred CcCHHHHhCCHhhccC
Confidence 9999999763 4444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=284.40 Aligned_cols=231 Identities=23% Similarity=0.310 Sum_probs=167.0
Q ss_pred HHHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC-
Q 025011 7 HELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA- 81 (259)
Q Consensus 7 ~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~- 81 (259)
.|+..+.+++||||+++++++...+ ..++||||+++|+|.+++.+.. +++..++.++.|++.|+.|+|...
T Consensus 46 ~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~----l~~~~~~~~~~~ia~gl~~lH~~~~ 121 (303)
T d1vjya_ 46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 121 (303)
T ss_dssp HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBC
T ss_pred HHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHhhh
Confidence 3445556779999999999998654 5799999999999999998653 578999999999999999999731
Q ss_pred ----CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccCC------cccccch
Q 025011 82 ----SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITGK------LTEKSDV 149 (259)
Q Consensus 82 ----~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~------~~~~~Di 149 (259)
.++|+||||||+||+++.++.+||+|||+++......... ......||+.|+|||++.+.. ++.++||
T Consensus 122 ~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di 201 (303)
T d1vjya_ 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201 (303)
T ss_dssp STTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred hhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhh
Confidence 1229999999999999999999999999998776543222 233457999999999987643 5778999
Q ss_pred hhHHHHHHHHHhCCCCCCCCccccccch------hHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccC
Q 025011 150 YSFGVLLAELLTGLKPGSGMALASNEGI------SMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 150 wslG~il~~l~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 223 (259)
|||||++|+|++|..||........... ..................+. ...........+.+++.+||+.|
T Consensus 202 ~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T d1vjya_ 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP---NRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC---GGGGGCHHHHHHHHHHHTTCCSS
T ss_pred hhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCC---cccCChHHHHHHHHHHHHHcccC
Confidence 9999999999999888754222111100 00011111111111111000 01112234467999999999999
Q ss_pred CCCCCCHHHHHHHHHhccccc
Q 025011 224 GRRRPTMKQVSEELDRLKISH 244 (259)
Q Consensus 224 p~~Rpt~~~il~~l~~~~~~~ 244 (259)
|++|||+.+|++.|+++....
T Consensus 279 p~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 279 GAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp GGGSCCHHHHHHHHHHHHHHH
T ss_pred HhHCcCHHHHHHHHHHHHHhc
Confidence 999999999999999887543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-45 Score=283.67 Aligned_cols=197 Identities=23% Similarity=0.328 Sum_probs=161.8
Q ss_pred HHHHHHHHHhcCC--CccccccceeEEeCCcceEEEEecCC-CChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhC
Q 025011 4 VFQHELRVVSQIN--HKNVVKILGACLETKVPLLVYEFVPN-GTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSS 80 (259)
Q Consensus 4 ~~~~E~~~l~~l~--h~~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 80 (259)
++.+|+.++++++ ||||+++++++.+++..++||||+.+ +++.+++..... +++..+..++.|++.||.|||++
T Consensus 53 ~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~---l~e~~~~~~~~qi~~al~~lH~~ 129 (273)
T d1xwsa_ 53 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNC 129 (273)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS---CCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC---CCHHHHHHHHHHHHHHHHHHHHC
Confidence 3668999999996 89999999999999999999999975 577888866543 68899999999999999999999
Q ss_pred CCCCeEeCCCCCCCeEeCCC-CceEEeecCCcccccCCccccccccccCcccccCcchhccCCc-ccccchhhHHHHHHH
Q 025011 81 ASPPIIHGDVKSTNVLLDDN-YKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKL-TEKSDVYSFGVLLAE 158 (259)
Q Consensus 81 ~~~~i~h~di~p~nil~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~~ 158 (259)
+ |+||||||+||+++.+ +.++|+|||+++..... ......||+.|+|||++.+..+ +.++||||+||++|+
T Consensus 130 ~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilye 202 (273)
T d1xwsa_ 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYD 202 (273)
T ss_dssp T---EECSCCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHH
T ss_pred C---CccccCcccceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehh
Confidence 9 9999999999999854 78999999999765432 2334579999999999987764 678999999999999
Q ss_pred HHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 159 LLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 159 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
|++|+.||.+... ...... .. +...++.+.++|.+||+.||++|||++|+++
T Consensus 203 ll~g~~Pf~~~~~--------------i~~~~~-------~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 203 MVCGDIPFEHDEE--------------IIRGQV-------FF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHSSCSCCSHHH--------------HHHCCC-------CC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCCchH--------------Hhhccc-------CC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 9999999986210 000000 00 0112367999999999999999999999976
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=286.64 Aligned_cols=226 Identities=21% Similarity=0.245 Sum_probs=165.3
Q ss_pred HHHHHHHHHhcC---CCccccccceeEEe-----CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHH
Q 025011 4 VFQHELRVVSQI---NHKNVVKILGACLE-----TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALD 75 (259)
Q Consensus 4 ~~~~E~~~l~~l---~h~~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~ 75 (259)
.+.+|+.+++.| +||||++++++|.. ....+++|||+.++++......... .+++..+..++.|++.||.
T Consensus 53 ~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~--~~~~~~~~~~~~qi~~aL~ 130 (305)
T d1blxa_ 53 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP--GVPTETIKDMMFQLLRGLD 130 (305)
T ss_dssp THHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTT--CSCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCC--CCCHHHHHHHHHHHHHHHH
Confidence 467888888776 79999999999863 3467999999988766544443322 2578899999999999999
Q ss_pred HHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHH
Q 025011 76 YLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVL 155 (259)
Q Consensus 76 ~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i 155 (259)
|||+++ |+||||||+||+++.++.++++|||++...... .......||+.|+|||++.+..++.++||||+||+
T Consensus 131 yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~i 204 (305)
T d1blxa_ 131 FLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204 (305)
T ss_dssp HHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHH
Confidence 999999 999999999999999999999999998754432 23345679999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhhcc--chh-------hhhhcccc---CCchhHHHHHHHHHHHHHhcccC
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSIEN--NSL-------RQILNFQV---ADESEMEEIETVAGLASKCLSLS 223 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~-------~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~ 223 (259)
+|+|++|+.||.+..... ............ ..+ ........ ........++.+.+||.+||+.|
T Consensus 205 l~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~d 280 (305)
T d1blxa_ 205 FAEMFRRKPLFRGSSDVD----QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFN 280 (305)
T ss_dssp HHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSS
T ss_pred HHHHHHCCCCCCCCCHHH----HHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCC
Confidence 999999999998743211 111111100000 000 00000000 00011123467899999999999
Q ss_pred CCCCCCHHHHHH--HHHhcc
Q 025011 224 GRRRPTMKQVSE--ELDRLK 241 (259)
Q Consensus 224 p~~Rpt~~~il~--~l~~~~ 241 (259)
|++|||++|+++ .++++.
T Consensus 281 P~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 281 PAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp TTTSCCHHHHHTSGGGTTCC
T ss_pred hhHCcCHHHHhcChhhcCch
Confidence 999999999976 355544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=9e-44 Score=279.45 Aligned_cols=222 Identities=21% Similarity=0.249 Sum_probs=164.3
Q ss_pred hhHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 2 NQVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 2 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
.+.+.+|+.++++++||||+++++++..++..+++++++.++.+..+..... .+++..+..++.|++.||.|||+.+
T Consensus 44 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~ 120 (286)
T d1ob3a_ 44 PSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR 120 (286)
T ss_dssp CHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc
Confidence 4578999999999999999999999999999999999997766666655443 3688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELL 160 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~ 160 (259)
|+||||||+||+++.++.++++|||.+....... .......+++.|+|||.+.+.. ++.++||||+||++|+|+
T Consensus 121 ---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~ 195 (286)
T d1ob3a_ 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195 (286)
T ss_dssp ---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred ---EEecCCCCceeeEcCCCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHH
Confidence 9999999999999999999999999998765432 1233346889999999987654 689999999999999999
Q ss_pred hCCCCCCCCccccccchhHHHHHHHhhc--cchhhhh---------hccc---cCCchhHHHHHHHHHHHHHhcccCCCC
Q 025011 161 TGLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQI---------LNFQ---VADESEMEEIETVAGLASKCLSLSGRR 226 (259)
Q Consensus 161 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---------~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~ 226 (259)
+|+.||.+..... ........... ...+... .... .........++.+.+||.+||+.||++
T Consensus 196 ~G~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~ 271 (286)
T d1ob3a_ 196 NGTPLFPGVSEAD----QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQ 271 (286)
T ss_dssp HSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTT
T ss_pred HCCCCCCCCCHHH----HHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhH
Confidence 9999998643211 11111110000 0000000 0000 000001122367899999999999999
Q ss_pred CCCHHHHHH
Q 025011 227 RPTMKQVSE 235 (259)
Q Consensus 227 Rpt~~~il~ 235 (259)
|||++|+++
T Consensus 272 R~s~~ell~ 280 (286)
T d1ob3a_ 272 RITAKQALE 280 (286)
T ss_dssp SCCHHHHHT
T ss_pred CcCHHHHhc
Confidence 999999963
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-43 Score=284.11 Aligned_cols=227 Identities=23% Similarity=0.243 Sum_probs=162.6
Q ss_pred HHHHHHHHhcCCCccccccceeEEeC------CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 5 FQHELRVVSQINHKNVVKILGACLET------KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 5 ~~~E~~~l~~l~h~~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+|+++|++++||||++++++|... .+.++||||++++.+..+.........+++..+..++.|++.||.|||
T Consensus 60 ~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH 139 (350)
T d1q5ka_ 60 KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139 (350)
T ss_dssp CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45799999999999999999998643 247899999976544443332223334788999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il 156 (259)
+++ |+||||||+||+++.++ .++|+|||++....... ......|+..|+|||.+.+. .++.++||||+||++
T Consensus 140 ~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il 213 (350)
T d1q5ka_ 140 SFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 213 (350)
T ss_dssp TTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred hcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEE
Confidence 999 99999999999999775 89999999987664332 22345699999999988754 589999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHH-----------hhcc---chhhhhhccccCCchhHHHHHHHHHHHHHhccc
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLY-----------SIEN---NSLRQILNFQVADESEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 222 (259)
|+|++|+.||.+..... ........ .... ...................++.+.+||.+||..
T Consensus 214 ~el~~g~~pf~~~~~~~----~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~ 289 (350)
T d1q5ka_ 214 AELLLGQPIFPGDSGVD----QLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 289 (350)
T ss_dssp HHHHHTSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCS
T ss_pred EehhhCCCCCCCCCHHH----HHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccC
Confidence 99999999998643211 11111100 0000 000000000000001112346799999999999
Q ss_pred CCCCCCCHHHHHH--HHHhcc
Q 025011 223 SGRRRPTMKQVSE--ELDRLK 241 (259)
Q Consensus 223 ~p~~Rpt~~~il~--~l~~~~ 241 (259)
||.+|||+.|+++ .++++.
T Consensus 290 dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 290 TPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp SGGGSCCHHHHHTSGGGGGGG
T ss_pred ChhHCcCHHHHhcCHhhcccc
Confidence 9999999999985 355543
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=278.75 Aligned_cols=224 Identities=19% Similarity=0.259 Sum_probs=163.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC----cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHh
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK----VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLH 78 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh 78 (259)
+.+.+|+.+|++++||||+++++++.... ..+++++++.+|+|.+++.... +++..+..++.|++.||.|||
T Consensus 51 ~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~~----l~~~~i~~i~~qil~al~yLH 126 (345)
T d1pmea_ 51 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH----LSNDHICYFLYQILRGLKYIH 126 (345)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcCC----CCHHHHHHHHHHHHHHHHHHH
Confidence 46889999999999999999999997643 2345555666999999997542 688999999999999999999
Q ss_pred hCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccc-cccccccCcccccCcchhcc-CCcccccchhhHHHHH
Q 025011 79 SSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQT-AMTTKKIGTFVNLDPEYVIT-GKLTEKSDVYSFGVLL 156 (259)
Q Consensus 79 ~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il 156 (259)
+++ |+||||||+||+++.++.++|+|||++......... .......|++.|+|||++.. ..++.++||||+||++
T Consensus 127 ~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il 203 (345)
T d1pmea_ 127 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203 (345)
T ss_dssp HTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHH
T ss_pred HCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCcee
Confidence 999 999999999999999999999999999765543222 22345569999999999854 4578999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhccc---------hhhhh--hccccCCc---hhHHHHHHHHHHHHHhccc
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIENN---------SLRQI--LNFQVADE---SEMEEIETVAGLASKCLSL 222 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~--~~~~~~~~---~~~~~~~~~~~li~~~l~~ 222 (259)
|+|++|+.||.+............ ........ ..... ........ .....++.+.+|+.+||+.
T Consensus 204 ~eml~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 204 AEMLSNRPIFPGKHYLDQLNHILG--ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHH--HHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred hHHhhCCCCCCCCCHHHHHHHHhh--hccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence 999999999987432111000000 00000000 00000 00000000 0011235689999999999
Q ss_pred CCCCCCCHHHHHH
Q 025011 223 SGRRRPTMKQVSE 235 (259)
Q Consensus 223 ~p~~Rpt~~~il~ 235 (259)
||.+|||++++++
T Consensus 282 dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 282 NPHKRIEVEQALA 294 (345)
T ss_dssp STTTSCCHHHHHT
T ss_pred ChhHCcCHHHHhc
Confidence 9999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-41 Score=274.10 Aligned_cols=222 Identities=21% Similarity=0.274 Sum_probs=166.7
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCC------cceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETK------VPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+.+.+|+++|++++||||++++++|...+ ..|+||||+ +.+|..+..... +++..+..++.|++.||.|
T Consensus 62 ~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~----l~~~~~~~~~~qi~~aL~~ 136 (346)
T d1cm8a_ 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEK----LGEDRIQFLVYQMLKGLRY 136 (346)
T ss_dssp HHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHCC----CCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhcc----ccHHHHHHHHHHHHHHHHH
Confidence 46889999999999999999999998654 469999999 668887775432 6889999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccC-CcccccchhhHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITG-KLTEKSDVYSFGVL 155 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~i 155 (259)
||+++ |+||||||+||+++.++.++++|||+++..... .....+++.|+|||++.+. .++.++||||+||+
T Consensus 137 LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 208 (346)
T d1cm8a_ 137 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCI 208 (346)
T ss_dssp HHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHH
T ss_pred HHhCC---CcccccCcchhhcccccccccccccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHH
Confidence 99999 999999999999999999999999999865432 2345799999999998765 47899999999999
Q ss_pred HHHHHhCCCCCCCCccccccchhHHHHHHHhh----------ccchh---hhhhcc---ccCCchhHHHHHHHHHHHHHh
Q 025011 156 LAELLTGLKPGSGMALASNEGISMVQYFLYSI----------ENNSL---RQILNF---QVADESEMEEIETVAGLASKC 219 (259)
Q Consensus 156 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~~~~~---~~~~~~~~~~~~~~~~li~~~ 219 (259)
+|+|++|+.||.+..... .......... ..... ...... ..........++.+.+||.+|
T Consensus 209 l~ell~g~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 284 (346)
T d1cm8a_ 209 MAEMITGKTLFKGSDHLD----QLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284 (346)
T ss_dssp HHHHHHSSCSSCCSSHHH----HHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHH
T ss_pred HHHHHHCcCCCCCCChHH----HHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHH
Confidence 999999999998743211 0000000000 00000 000000 000000112346788999999
Q ss_pred cccCCCCCCCHHHHHHH--HHhcc
Q 025011 220 LSLSGRRRPTMKQVSEE--LDRLK 241 (259)
Q Consensus 220 l~~~p~~Rpt~~~il~~--l~~~~ 241 (259)
|..||.+|||++++++- ++++.
T Consensus 285 L~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 285 LVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp SCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CcCChhHCcCHHHHhcChhhCcCC
Confidence 99999999999999863 55443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=275.78 Aligned_cols=211 Identities=24% Similarity=0.288 Sum_probs=167.6
Q ss_pred hHHHHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+.+|++++++++| |||+++++++.+.+..+++|||+.+|+|.+++..... ..+..+..++.|++.|+.|+|+++
T Consensus 73 ~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~~e~~~~~~~~Qi~~al~~lH~~~ 149 (322)
T d1vzoa_ 73 EHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHLHKLG 149 (322)
T ss_dssp GGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---ccHHHHHHHHHHHHHHHHHhhcCC
Confidence 567899999999976 8999999999999999999999999999999987654 467889999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC--cccccchhhHHHHHHHH
Q 025011 82 SPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK--LTEKSDVYSFGVLLAEL 159 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~~l 159 (259)
++||||||+||+++.++.++|+|||+++...... ........+++.|+|||.+.+.. ++.++||||+||++|+|
T Consensus 150 ---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyel 225 (322)
T d1vzoa_ 150 ---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYEL 225 (322)
T ss_dssp ---CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHH
T ss_pred ---EEeccCCccceeecCCCCEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHH
Confidence 9999999999999999999999999997665432 22334457999999999997653 67899999999999999
Q ss_pred HhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCC-----HHHHH
Q 025011 160 LTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPT-----MKQVS 234 (259)
Q Consensus 160 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt-----~~~il 234 (259)
++|..||.+......... ....... .. ...+...++.+.++|.+||+.||.+||| ++|++
T Consensus 226 ltG~~PF~~~~~~~~~~~----i~~~~~~---------~~--~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil 290 (322)
T d1vzoa_ 226 LTGASPFTVDGEKNSQAE----ISRRILK---------SE--PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIK 290 (322)
T ss_dssp HHSSCTTSCTTSCCCHHH----HHHHHHH---------CC--CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHH
T ss_pred HhCCCCCCCCCHHHHHHH----HHHhccc---------CC--CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHH
Confidence 999999987433221110 0000000 00 0011123478999999999999999994 77876
Q ss_pred H
Q 025011 235 E 235 (259)
Q Consensus 235 ~ 235 (259)
+
T Consensus 291 ~ 291 (322)
T d1vzoa_ 291 E 291 (322)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-42 Score=272.77 Aligned_cols=222 Identities=19% Similarity=0.215 Sum_probs=160.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe--------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE--------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASAL 74 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l 74 (259)
+++.+|+++|++++||||+++++++.. .+..+++|||+.++.+........ .+++..+..++.|++.||
T Consensus 54 ~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l 130 (318)
T d3blha1 54 ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGL 130 (318)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHH
Confidence 568899999999999999999998854 346799999997766554443332 257789999999999999
Q ss_pred HHHhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCcccc--ccccccCcccccCcchhccC-Ccccccchhh
Q 025011 75 DYLHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTA--MTTKKIGTFVNLDPEYVITG-KLTEKSDVYS 151 (259)
Q Consensus 75 ~~lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~Diws 151 (259)
.|||+++ |+||||||+||+++.++.++++|||++.......... ......||+.|+|||++.+. .++.++||||
T Consensus 131 ~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwS 207 (318)
T d3blha1 131 YYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWG 207 (318)
T ss_dssp HHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHH
T ss_pred HHhccCC---EEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHccc
Confidence 9999999 9999999999999999999999999997665432221 22234699999999998765 5899999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhc---cchhhh--------hhccc-cCCch------hHHHHHHHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIE---NNSLRQ--------ILNFQ-VADES------EMEEIETVA 213 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--------~~~~~-~~~~~------~~~~~~~~~ 213 (259)
+||++|+|++|+.||.+..... .......... ...... ..... ..... ....++.+.
T Consensus 208 lGvil~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (318)
T d3blha1 208 AGCIMAEMWTRSPIMQGNTEQH-----QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYAL 282 (318)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHH
T ss_pred CCceeeeHhhCCCCCCCCCHHH-----HHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHH
Confidence 9999999999999998632111 1011100000 000000 00000 00000 011235678
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+||.+||+.||++|||++|+++
T Consensus 283 dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 283 DLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHCcCChhHCcCHHHHHc
Confidence 9999999999999999999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.4e-42 Score=272.91 Aligned_cols=221 Identities=19% Similarity=0.259 Sum_probs=163.6
Q ss_pred hHHHHHHHHHhcCC-CccccccceeEEe--CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhh
Q 025011 3 QVFQHELRVVSQIN-HKNVVKILGACLE--TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHS 79 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~ 79 (259)
+.+.+|+++|++++ ||||++++++|.. .+..++||||+.+++|..+.+ .+++..+..++.||+.||.|||+
T Consensus 74 ~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~ 147 (328)
T d3bqca1 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHS 147 (328)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhh
Confidence 56889999999995 9999999999985 356899999999999977653 26789999999999999999999
Q ss_pred CCCCCeEeCCCCCCCeEeCCCC-ceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHH
Q 025011 80 SASPPIIHGDVKSTNVLLDDNY-KAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLA 157 (259)
Q Consensus 80 ~~~~~i~h~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~ 157 (259)
++ |+||||||+||+++.++ .++++|||+++...... ......+|..|+|||.+.+.. ++.++||||+||+++
T Consensus 148 ~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~ 221 (328)
T d3bqca1 148 MG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 221 (328)
T ss_dssp TT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred cc---cccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhH
Confidence 99 99999999999998654 68999999998665432 234456899999999987764 799999999999999
Q ss_pred HHHhCCCCCCCCccccccchhHHHHHHH-------hhc----cchhhhhh--------ccccCCchhHHHHHHHHHHHHH
Q 025011 158 ELLTGLKPGSGMALASNEGISMVQYFLY-------SIE----NNSLRQIL--------NFQVADESEMEEIETVAGLASK 218 (259)
Q Consensus 158 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------~~~----~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~ 218 (259)
++++|+.||................... ... ........ ............++.+.+||.+
T Consensus 222 e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~ 301 (328)
T d3bqca1 222 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301 (328)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHH
T ss_pred HhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHH
Confidence 9999999997633211111111100000 000 00000000 0001111122234679999999
Q ss_pred hcccCCCCCCCHHHHHH
Q 025011 219 CLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 219 ~l~~~p~~Rpt~~~il~ 235 (259)
||..||.+|||++|+++
T Consensus 302 mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 302 LLRYDHQSRLTAREAME 318 (328)
T ss_dssp HSCSSGGGSCCHHHHHT
T ss_pred HccCChhHCcCHHHHhc
Confidence 99999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-42 Score=268.97 Aligned_cols=222 Identities=17% Similarity=0.175 Sum_probs=168.0
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCC
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSAS 82 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~ 82 (259)
+++.+|+.+++.++||||+++++++.+....+++++++.++++..++..... .++..+..++.|++.||+|||+++
T Consensus 46 ~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~---~~~~~~~~~~~q~~~aL~~lH~~~- 121 (292)
T d1unla_ 46 SSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDPEIVKSFLFQLLKGLGFCHSRN- 121 (292)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTC---CCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred HHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccc---cchhHHHHHHHHHHHHHHHhhcCC-
Confidence 5789999999999999999999999999999999999999988888765533 578899999999999999999999
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHHHHHHh
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLLAELLT 161 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~ 161 (259)
|+||||||+||+++.++.++++|||.++....... ......++..|+|||.+.+.. ++.++||||+||++|+|++
T Consensus 122 --IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~ 197 (292)
T d1unla_ 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197 (292)
T ss_dssp --EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred --EeeecccCcccccccCCceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh
Confidence 99999999999999999999999999987654322 233345778899999987765 6899999999999999999
Q ss_pred CCCCCCCCccccccchhHHHHHHHhhc--cchhhh---h---------hccccCCchhHHHHHHHHHHHHHhcccCCCCC
Q 025011 162 GLKPGSGMALASNEGISMVQYFLYSIE--NNSLRQ---I---------LNFQVADESEMEEIETVAGLASKCLSLSGRRR 227 (259)
Q Consensus 162 g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 227 (259)
|+.||....... ............ ...... . .............++.+.+|+.+||+.||++|
T Consensus 198 g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R 274 (292)
T d1unla_ 198 AGRPLFPGNDVD---DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQR 274 (292)
T ss_dssp TSCCSCCCSSHH---HHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCCCCCCCCHH---HHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHC
Confidence 998875422111 111111111100 000000 0 00000111112234678999999999999999
Q ss_pred CCHHHHHH
Q 025011 228 PTMKQVSE 235 (259)
Q Consensus 228 pt~~~il~ 235 (259)
||++|+++
T Consensus 275 ~sa~e~L~ 282 (292)
T d1unla_ 275 ISAEEALQ 282 (292)
T ss_dssp CCHHHHTT
T ss_pred cCHHHHhc
Confidence 99999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-41 Score=262.54 Aligned_cols=223 Identities=15% Similarity=0.149 Sum_probs=174.0
Q ss_pred hHHHHHHHHHhcCCC-ccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINH-KNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+++|++.++.++| +|++.+++++..++..++||||+ +++|.+++..... .++...+..++.|++.||.|||+++
T Consensus 45 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g 121 (293)
T d1csna_ 45 PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS 121 (293)
T ss_dssp CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC
Confidence 357899999999975 89999999999999999999999 7899999876543 2678999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCC-----CCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhh
Q 025011 82 SPPIIHGDVKSTNVLLDD-----NYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYS 151 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~-----~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 151 (259)
|+||||||+||+++. ++.++++|||+++........ .......||+.|+|||.+.+..++.++||||
T Consensus 122 ---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwS 198 (293)
T d1csna_ 122 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA 198 (293)
T ss_dssp ---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred ---ceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHH
Confidence 999999999999974 568999999999876543211 1233456999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHH
Q 025011 152 FGVLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMK 231 (259)
Q Consensus 152 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 231 (259)
||+++|+|++|..||.+........ ...............+. ....++.+.+++..|+..+|.+||+++
T Consensus 199 lG~~l~elltg~~Pf~~~~~~~~~~--~~~~i~~~~~~~~~~~l---------~~~~p~~l~~ii~~~~~~~~~~rP~y~ 267 (293)
T d1csna_ 199 LGHVFMYFLRGSLPWQGLKAATNKQ--KYERIGEKKQSTPLREL---------CAGFPEEFYKYMHYARNLAFDATPDYD 267 (293)
T ss_dssp HHHHHHHHHHSSCTTSSCCSCCHHH--HHHHHHHHHHHSCHHHH---------TTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred hhHHHHHHHhCCCcCCCccchhHHH--HHHHHHhccCCCChHHh---------cCCCCHHHHHHHHHHhcCCcccCcCHH
Confidence 9999999999999998743322111 00001000000111111 011236799999999999999999999
Q ss_pred HHHHHHHhccc
Q 025011 232 QVSEELDRLKI 242 (259)
Q Consensus 232 ~il~~l~~~~~ 242 (259)
.+.+.|+++-.
T Consensus 268 ~l~~~l~~~~~ 278 (293)
T d1csna_ 268 YLQGLFSKVLE 278 (293)
T ss_dssp HHHHHHHHHHH
T ss_pred HHHHHHHHHHH
Confidence 99988887643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=263.07 Aligned_cols=223 Identities=19% Similarity=0.159 Sum_probs=166.4
Q ss_pred hHHHHHHHHHhcCCCccc-cccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC
Q 025011 3 QVFQHELRVVSQINHKNV-VKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA 81 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~ 81 (259)
+.+..|+++++.++|+++ +.+.+++.+++..++||||+ ++++.+.+..... .+++..+..++.|++.||.|||+++
T Consensus 47 ~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 47 PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 468899999999987664 55566667788889999999 6677777655432 2688999999999999999999999
Q ss_pred CCCeEeCCCCCCCeEeCC---CCceEEeecCCcccccCCccc-----cccccccCcccccCcchhccCCcccccchhhHH
Q 025011 82 SPPIIHGDVKSTNVLLDD---NYKAKVADFGSSVLISSDNQT-----AMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFG 153 (259)
Q Consensus 82 ~~~i~h~di~p~nil~~~---~~~~~l~df~~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 153 (259)
|+||||||+||+++. +..++++|||+++........ .......||+.|+|||.+.+..++.++||||||
T Consensus 124 ---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 200 (299)
T d1ckia_ 124 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLG 200 (299)
T ss_dssp ---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHH
T ss_pred ---eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecC
Confidence 999999999999864 457999999999876543221 123345799999999999998899999999999
Q ss_pred HHHHHHHhCCCCCCCCccccccchhHHHHHHHhhccchhhhhhccccCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 025011 154 VLLAELLTGLKPGSGMALASNEGISMVQYFLYSIENNSLRQILNFQVADESEMEEIETVAGLASKCLSLSGRRRPTMKQV 233 (259)
Q Consensus 154 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 233 (259)
|++|+|++|..||.+........... ........ ..... .....++.+.+++.+||+.||.+|||+.++
T Consensus 201 ~~l~el~tg~~P~~~~~~~~~~~~~~-~~~~~~~~-~~~~~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i 269 (299)
T d1ckia_ 201 YVLMYFNLGSLPWQGLKAATKRQKYE-RISEKKMS-TPIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYL 269 (299)
T ss_dssp HHHHHHHHSSCTTCCCC-------HH-HHHHHHHH-SCHHH---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred HHHHHHHhCCCcccccchHHHHHHHH-HhhcccCC-CChhH---------hccCCCHHHHHHHHHHccCChhHCcCHHHH
Confidence 99999999999998743322111100 00000000 00000 011233679999999999999999999999
Q ss_pred HHHHHhccc
Q 025011 234 SEELDRLKI 242 (259)
Q Consensus 234 l~~l~~~~~ 242 (259)
.+.|+++..
T Consensus 270 ~~~l~~~~~ 278 (299)
T d1ckia_ 270 RQLFRNLFH 278 (299)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 999888754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=268.48 Aligned_cols=221 Identities=19% Similarity=0.240 Sum_probs=157.8
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEe------CCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLE------TKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDY 76 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~ 76 (259)
+++.+|+.++++++||||++++++|.. .+..|+||||+.++ +.+.+.. .+++..++.++.|++.||.|
T Consensus 61 ~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~~-----~~~~~~i~~~~~qil~gl~~ 134 (355)
T d2b1pa1 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKH 134 (355)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhhc-----CCCHHHHHHHHHHHHHHHHH
Confidence 458899999999999999999999964 35789999999664 5454432 25789999999999999999
Q ss_pred HhhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 77 LHSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 77 lh~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
||++| |+|+||||+||+++.++.++++|||+++...... ......+|..|+|||++.+..++.++||||+||++
T Consensus 135 LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l 208 (355)
T d2b1pa1 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 208 (355)
T ss_dssp HHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred hhhcc---cccccCCccccccccccceeeechhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchH
Confidence 99999 9999999999999999999999999987655432 23344689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHH------------------HHHhh--ccchhhhhhcc---ccCCchhHHHHHHHH
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQY------------------FLYSI--ENNSLRQILNF---QVADESEMEEIETVA 213 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~------------------~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~ 213 (259)
++|++|+.||.+.+............ ..... ........... ..........++.+.
T Consensus 209 ~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 288 (355)
T d2b1pa1 209 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288 (355)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHH
Confidence 99999999998743211110000000 00000 00000111111 111122344568899
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 025011 214 GLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 214 ~li~~~l~~~p~~Rpt~~~il~ 235 (259)
+||.+||..||++||||+|+++
T Consensus 289 dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 289 DLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHCcCChhHCcCHHHHhc
Confidence 9999999999999999999963
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-40 Score=265.60 Aligned_cols=222 Identities=20% Similarity=0.240 Sum_probs=161.2
Q ss_pred hHHHHHHHHHhcCCCccccccceeEEeC-----CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQINHKNVVKILGACLET-----KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYL 77 (259)
Q Consensus 3 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~l 77 (259)
+.+.+|+++|++++||||+++++++... ...+++++++.+|+|.+++.... +++..+..++.||+.||.||
T Consensus 62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~~----l~e~~~~~i~~qil~aL~~L 137 (348)
T d2gfsa1 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK----LTDDHVQFLIYQILRGLKYI 137 (348)
T ss_dssp HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTCC----CCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccccc----ccHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999999998643 33466677788999999996542 68899999999999999999
Q ss_pred hhCCCCCeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCC-cccccchhhHHHHH
Q 025011 78 HSSASPPIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK-LTEKSDVYSFGVLL 156 (259)
Q Consensus 78 h~~~~~~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il 156 (259)
|+++ |+||||||+||+++.++.++++|||++..... ......|+..|+|||.+.+.. ++.++||||+||++
T Consensus 138 H~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l 209 (348)
T d2gfsa1 138 HSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 209 (348)
T ss_dssp HHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHH
T ss_pred HhCC---CcccccCCccccccccccccccccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHH
Confidence 9999 99999999999999999999999999875432 233456889999999877765 68899999999999
Q ss_pred HHHHhCCCCCCCCccccccchhHHHHHHHhhc----------cchhhhhhc---cccCCc---hhHHHHHHHHHHHHHhc
Q 025011 157 AELLTGLKPGSGMALASNEGISMVQYFLYSIE----------NNSLRQILN---FQVADE---SEMEEIETVAGLASKCL 220 (259)
Q Consensus 157 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~---~~~~~~---~~~~~~~~~~~li~~~l 220 (259)
|+|++|+.||.+.+..... ......... ......... ...... .....++.+.+||.+||
T Consensus 210 ~~ll~g~~pF~~~~~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL 285 (348)
T d2gfsa1 210 AELLTGRTLFPGTDHIDQL----KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285 (348)
T ss_dssp HHHHHSSCSCCCSSHHHHH----HHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHhCCCCCCCCCHHHHH----HHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHC
Confidence 9999999999874321110 000000000 000000000 000000 00123467899999999
Q ss_pred ccCCCCCCCHHHHHH--HHHhc
Q 025011 221 SLSGRRRPTMKQVSE--ELDRL 240 (259)
Q Consensus 221 ~~~p~~Rpt~~~il~--~l~~~ 240 (259)
..||.+|||++|+++ .+.++
T Consensus 286 ~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 286 VLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCChhhCcCHHHHhcCHhhCCC
Confidence 999999999999986 44443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.6e-35 Score=238.51 Aligned_cols=225 Identities=21% Similarity=0.213 Sum_probs=156.1
Q ss_pred hHHHHHHHHHhcCC-----------CccccccceeEEeC--CcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHH
Q 025011 3 QVFQHELRVVSQIN-----------HKNVVKILGACLET--KVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAE 69 (259)
Q Consensus 3 ~~~~~E~~~l~~l~-----------h~~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~ 69 (259)
+.+.+|+++++.++ |+||+++++++... ...++++.++..+...............++..+..++.|
T Consensus 54 ~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~q 133 (362)
T d1q8ya_ 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133 (362)
T ss_dssp HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHH
Confidence 45788999998874 57899999988653 456677777655544444433334444688999999999
Q ss_pred HHHHHHHHhh-CCCCCeEeCCCCCCCeEeCCCCc------eEEeecCCcccccCCccccccccccCcccccCcchhccCC
Q 025011 70 TASALDYLHS-SASPPIIHGDVKSTNVLLDDNYK------AKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGK 142 (259)
Q Consensus 70 i~~~l~~lh~-~~~~~i~h~di~p~nil~~~~~~------~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 142 (259)
++.|+.|||+ .+ |+||||||+||+++.++. ++++|||.+..... ......+++.|+|||++.+..
T Consensus 134 il~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~ 205 (362)
T d1q8ya_ 134 LLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAP 205 (362)
T ss_dssp HHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCC
T ss_pred HHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccC
Confidence 9999999997 88 999999999999986553 89999999875432 223456999999999999989
Q ss_pred cccccchhhHHHHHHHHHhCCCCCCCCccccccc--hhHHHHHHHhhc--------cchhhhhh---------ccc----
Q 025011 143 LTEKSDVYSFGVLLAELLTGLKPGSGMALASNEG--ISMVQYFLYSIE--------NNSLRQIL---------NFQ---- 199 (259)
Q Consensus 143 ~~~~~DiwslG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~--------~~~~~~~~---------~~~---- 199 (259)
++.++||||+||++++|++|+.||.......... ............ ........ ...
T Consensus 206 ~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (362)
T d1q8ya_ 206 WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWP 285 (362)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCC
T ss_pred CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCc
Confidence 9999999999999999999999997643221111 011111100000 00000000 000
Q ss_pred ------cCCchhHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 025011 200 ------VADESEMEEIETVAGLASKCLSLSGRRRPTMKQVSE 235 (259)
Q Consensus 200 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 235 (259)
.........++.+.+||.+||..||.+|||++|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 286 LEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred hhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 011122345678999999999999999999999975
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.74 E-value=6e-19 Score=128.98 Aligned_cols=130 Identities=15% Similarity=0.189 Sum_probs=91.4
Q ss_pred HHHHHHHHHhcCCCccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCCCC
Q 025011 4 VFQHELRVVSQINHKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSASP 83 (259)
Q Consensus 4 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~ 83 (259)
...+|...+.++.|.+++..+++. ..+++|||+++..+..+ +...+..++.|++.++.+||+++
T Consensus 60 ~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g-- 123 (191)
T d1zara2 60 SARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG-- 123 (191)
T ss_dssp HHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT--
T ss_pred HHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC--
Confidence 356788999999999999887653 23799999987654332 22445678999999999999999
Q ss_pred CeEeCCCCCCCeEeCCCCceEEeecCCcccccCCccccccccccCcccccCcchhccCCcccccchhhHHHHH
Q 025011 84 PIIHGDVKSTNVLLDDNYKAKVADFGSSVLISSDNQTAMTTKKIGTFVNLDPEYVITGKLTEKSDVYSFGVLL 156 (259)
Q Consensus 84 ~i~h~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il 156 (259)
++|+||||+||+++++ .++++|||.++................. -.+ +....++.++|+||+.--+
T Consensus 124 -iiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~-~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 124 -IVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IIT-YFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp -EECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred -EEEccCChhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHH-HHcCCCCCcccHHHHHHHH
Confidence 9999999999999965 5889999998765433211100000000 011 1245678899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.28 E-value=1.1e-06 Score=65.91 Aligned_cols=101 Identities=19% Similarity=0.165 Sum_probs=68.8
Q ss_pred HHHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCChhhhhhccCCcccCCHHHHHHHHHHHHHHHHHHhhCC-
Q 025011 4 VFQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTLFDHIHDKSSQVLRNWKTCLRIAAETASALDYLHSSA- 81 (259)
Q Consensus 4 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~- 81 (259)
.+.+|..+++.+. +--+++++.+...++..++||++++|.++.+....... ...++.++...+..||+..
T Consensus 55 ~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~~~--------~~~~~~~l~~~l~~lH~~~~ 126 (263)
T d1j7la_ 55 DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQS--------PEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTCSC--------HHHHHHHHHHHHHHHHTSCC
T ss_pred hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccccc--------HHHHHHHHHHHHHHHhccCc
Confidence 3678999988884 43467888888888999999999999887654422111 1112333333344444310
Q ss_pred -------------------------------------------------------CCCeEeCCCCCCCeEeCCCCceEEe
Q 025011 82 -------------------------------------------------------SPPIIHGDVKSTNVLLDDNYKAKVA 106 (259)
Q Consensus 82 -------------------------------------------------------~~~i~h~di~p~nil~~~~~~~~l~ 106 (259)
...++|+|+.|.||++++++...++
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lI 206 (263)
T d1j7la_ 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEEC
T ss_pred cccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEe
Confidence 1127899999999999987667799
Q ss_pred ecCCcc
Q 025011 107 DFGSSV 112 (259)
Q Consensus 107 df~~~~ 112 (259)
||+.+.
T Consensus 207 Dwe~a~ 212 (263)
T d1j7la_ 207 DLGRSG 212 (263)
T ss_dssp CCTTCE
T ss_pred echhcc
Confidence 998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.96 E-value=5e-06 Score=61.88 Aligned_cols=43 Identities=21% Similarity=0.210 Sum_probs=33.9
Q ss_pred HHHHHHHHHhcCCC--ccccccceeEEeCCcceEEEEecCCCChh
Q 025011 4 VFQHELRVVSQINH--KNVVKILGACLETKVPLLVYEFVPNGTLF 46 (259)
Q Consensus 4 ~~~~E~~~l~~l~h--~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 46 (259)
.+..|+.+++.+.. -.+++++.+..+++..++||++++|.++.
T Consensus 50 ~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 50 ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 47789999988843 33677888888888899999999886653
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.08 E-value=0.0014 Score=51.51 Aligned_cols=28 Identities=25% Similarity=0.503 Sum_probs=24.8
Q ss_pred eEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 85 IIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 85 i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
++|||+.+.||+++++ .++++||..+..
T Consensus 225 LiHGDl~~gNIlv~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 225 LIHGDLHTGSIFASEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EECSCCCGGGEEECSS-CEEECCCTTCEE
T ss_pred eeccCCcCCceeEcCC-ceEEechhhccc
Confidence 8999999999999876 489999988754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.28 E-value=0.0016 Score=51.29 Aligned_cols=37 Identities=16% Similarity=0.210 Sum_probs=26.7
Q ss_pred HHHHHHHHhcCC-CccccccceeEEeCCcceEEEEecCCCCh
Q 025011 5 FQHELRVVSQIN-HKNVVKILGACLETKVPLLVYEFVPNGTL 45 (259)
Q Consensus 5 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 45 (259)
..+|..+++.+. +.-.+++++++.+ .+|++|++|..+
T Consensus 91 r~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 91 LVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 467899998884 4445678887753 589999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.05 E-value=0.0035 Score=47.54 Aligned_cols=30 Identities=23% Similarity=0.306 Sum_probs=26.4
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCcc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSV 112 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~ 112 (259)
.+++|+|+.++|++++++...-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 339999999999999998777999999864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=92.54 E-value=0.16 Score=38.15 Aligned_cols=29 Identities=24% Similarity=0.366 Sum_probs=23.3
Q ss_pred CCeEeCCCCCCCeEeCCCCceEEeecCCccc
Q 025011 83 PPIIHGDVKSTNVLLDDNYKAKVADFGSSVL 113 (259)
Q Consensus 83 ~~i~h~di~p~nil~~~~~~~~l~df~~~~~ 113 (259)
..++|+|+.+.||+++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 348999999999999753 45899988754
|